Rank,Task,ID,Name,Similarity,z-score,p-adjusted
1,Phenotype,HP:0002331,Recurrent paroxysmal headache,0.24879407369561202,4.096033178260126,0.18488544908686091
2,Phenotype,HP:0002666,Pheochromocytoma,0.2359101488329316,3.844884773040763,0.5305594264369107
3,Phenotype,HP:0003574,Positive regitine blocking test,0.2336713709381063,3.801243917950526,0.633330566472021
3,Phenotype,HP:0003639,Elevated urinary epinephrine level,0.2336713709381063,3.801243917950526,0.633330566472021
3,Phenotype,HP:0006737,Extraadrenal pheochromocytoma,0.2336713709381063,3.801243917950526,0.633330566472021
3,Phenotype,HP:0002640,Hypertension associated with pheochromocytoma,0.2336713709381063,3.801243917950526,0.633330566472021
3,Phenotype,HP:0008629,Pulsatile tinnitus,0.2336713709381063,3.801243917950526,0.633330566472021
3,Phenotype,HP:0000740,Episodic paroxysmal anxiety,0.2336713709381063,3.801243917950526,0.633330566472021
3,Phenotype,HP:0002864,Paraganglioma of head and neck,0.2336713709381063,3.801243917950526,0.633330566472021
10,Phenotype,HP:0011979,Elevated urinary dopamine level,0.2321154261355991,3.770913637393632,0.7155015728246881
11,Biological Process,GO:0032760,positive regulation of tumor necrosis factor production,0.23007418130432689,3.7311233258619927,0.8385720048209262
12,Biological Process,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,0.22869812596154793,3.704299659276233,0.9324804868232954
13,Phenotype,HP:0001095,Hypertensive retinopathy,0.22789848553788872,3.6887121407761314,0.9914996349827999
14,Phenotype,HP:0006748,Adrenal pheochromocytoma,0.22473505008283823,3.627046788174484,1
14,Phenotype,HP:0100642,Neoplasm of the adrenal medulla,0.22473505008283823,3.627046788174484,1
16,Phenotype,HP:0011281,Abnormality of urine catecholamine level,0.22273209702030994,3.588002904207082,1
16,Phenotype,HP:0011976,Elevated urinary catecholamine level,0.22273209702030994,3.588002904207082,1
18,Biological Process,GO:0043535,regulation of blood vessel endothelial cell migration,0.2226180110793452,3.5857790087376014,1
19,Phenotype,HP:0003345,Elevated urinary norepinephrine level,0.22243520747991818,3.5822155889758607,1
20,Biological Process,GO:0070374,positive regulation of ERK1 and ERK2 cascade,0.22217185526451233,3.5770820221773034,1
21,Phenotype,HP:0010532,Paroxysmal vertigo,0.21715836949629974,3.479353343323877,1
22,Phenotype,HP:0034902,Abnormal circulating calcitonin concentration,0.21451706131471093,3.427865901060039,1
22,Phenotype,HP:0003528,Elevated circulating calcitonin concentration,0.21451706131471093,3.427865901060039,1
24,Phenotype,HP:0100007,Neoplasm of the peripheral nervous system,0.21185808096761205,3.3760339724512454,1
25,Phenotype,HP:0012222,Arachnoid hemangiomatosis,0.20928724183673542,3.3259201946485333,1
26,Phenotype,HP:0002668,Paraganglioma,0.20879703773763492,3.3163645678474416,1
27,Phenotype,HP:0009594,Retinal hamartoma,0.20739922749461392,3.2891168295164857,1
28,Biological Process,GO:0001938,positive regulation of endothelial cell proliferation,0.20509182824758687,3.2441383274473075,1
29,Phenotype,HP:0030670,Hamartoma of the orbital region,0.20338194747813543,3.2108073484995114,1
29,Phenotype,HP:0010568,Hamartoma of the eye,0.20338194747813543,3.2108073484995114,1
31,Biological Process,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,0.20163452917121283,3.176744644338147,1
32,Phenotype,HP:0009711,Retinal capillary hemangioma,0.2012475797423312,3.169201777315873,1
33,Phenotype,HP:0100634,Neuroendocrine neoplasm,0.20087792441456043,3.1619960269688354,1
34,Phenotype,HP:0001482,Subcutaneous nodule,0.1988650479129831,3.1227587038190396,1
35,Phenotype,HP:0032148,Episodic pain,0.1986043978793921,3.1176778110822023,1
36,Biological Process,GO:0001936,regulation of endothelial cell proliferation,0.1977379924308751,3.1007888312885754,1
37,Biological Process,GO:0002716,negative regulation of natural killer cell mediated immunity,0.19765368628907554,3.099145438200768,1
37,Biological Process,GO:0045953,negative regulation of natural killer cell mediated cytotoxicity,0.19765368628907554,3.099145438200768,1
39,Phenotype,HP:0012032,Lipoma,0.19729333572801488,3.0921210671574046,1
40,Phenotype,HP:0100631,Neoplasm of the adrenal gland,0.19419720507371208,3.0317676977869192,1
41,Biological Process,GO:0050678,regulation of epithelial cell proliferation,0.1935495172295194,3.0191422151888223,1
42,Phenotype,HP:0002574,Episodic abdominal pain,0.19301704524285324,3.0087626537042196,1
43,Phenotype,HP:0010797,Hemangioblastoma,0.19184825994439325,2.985979335198356,1
44,Biological Process,GO:0070372,regulation of ERK1 and ERK2 cascade,0.19176971709334967,2.9844482868577904,1
45,Phenotype,HP:0200036,Skin nodule,0.19140800822213322,2.977397438057605,1
46,Biological Process,GO:0001525,angiogenesis,0.19004332790877254,2.9507955067371605,1
47,Biological Process,GO:0010632,regulation of epithelial cell migration,0.1861966475335305,2.8758115517756537,1
48,Phenotype,HP:0000912,Sprengel anomaly,0.18588581925597092,2.8697525265144703,1
49,Biological Process,GO:1904951,positive regulation of establishment of protein localization,0.18568676634450476,2.865872356317747,1
50,Phenotype,HP:0003453,Antineutrophil antibody positivity,0.18370578178004093,2.8272567077920105,1
51,Phenotype,HP:0011703,Sinus tachycardia,0.1836109729998131,2.8254085850957984,1
52,Biological Process,GO:0050679,positive regulation of epithelial cell proliferation,0.18339391281232575,2.8211773961914006,1
53,Biological Process,GO:0010594,regulation of endothelial cell migration,0.18336505913164602,2.8206149467852875,1
54,Phenotype,HP:0100012,Neoplasm of the eye,0.1828606339399539,2.810782105954858,1
55,Biological Process,GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,0.18282445027480587,2.8100767719907305,1
56,Biological Process,GO:0031342,negative regulation of cell killing,0.18131436045492633,2.7806403499343353,1
57,Phenotype,HP:0002321,Vertigo,0.18111913059061147,2.7768347030063643,1
58,Biological Process,GO:0043536,positive regulation of blood vessel endothelial cell migration,0.17956691366631872,2.7465770905749354,1
59,Biological Process,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,0.1791486811846814,2.7384244180086434,1
60,Disease,MONDO:0002082,endocrine gland neoplasm,0.17891646101618486,2.7338977131730218,1
61,Phenotype,HP:0010045,Aplasia/Hypoplasia of the 5th metacarpal,0.17872036377169132,2.730075158264686,1
62,Phenotype,HP:0010566,Hamartoma,0.1779508798485394,2.7150754852456886,1
63,Biological Process,GO:2000146,negative regulation of cell motility,0.17767810312214383,2.7097582049490883,1
64,Biological Process,GO:0032674,regulation of interleukin-5 production,0.17730461922409835,2.702477823670171,1
65,Biological Process,GO:0009611,response to wounding,0.17694906813528166,2.69554700950585,1
66,Phenotype,HP:0001069,Episodic hyperhidrosis,0.17600826718476448,2.6772078263089916,1
67,Phenotype,HP:0001342,Cerebral hemorrhage,0.1755735272729,2.6687333717686488,1
68,Biological Process,GO:1903578,regulation of ATP metabolic process,0.17483839387820255,2.6544032990874156,1
69,Biological Process,GO:0040013,negative regulation of locomotion,0.1746864070174482,2.651440594934792,1
70,Biological Process,GO:0043542,endothelial cell migration,0.1746811165830342,2.6513374676517514,1
71,Phenotype,HP:0001882,Leukopenia,0.17390182104119556,2.636146535182543,1
72,Biological Process,GO:0030949,positive regulation of vascular endothelial growth factor receptor signaling pathway,0.1736936693340796,2.632089000708922,1
73,Phenotype,HP:0000360,Tinnitus,0.17290099056137254,2.616637186782773,1
74,Phenotype,HP:0100749,Chest pain,0.17190742708957552,2.59726949533117,1
75,Biological Process,GO:0002040,sprouting angiogenesis,0.1716329102527805,2.591918294784616,1
76,Biological Process,GO:0002715,regulation of natural killer cell mediated immunity,0.1708089696904993,2.5758570898010427,1
76,Biological Process,GO:0042269,regulation of natural killer cell mediated cytotoxicity,0.1708089696904993,2.5758570898010427,1
78,Biological Process,GO:0043537,negative regulation of blood vessel endothelial cell migration,0.16999623194530644,2.56001426312033,1
79,Biological Process,GO:0006140,regulation of nucleotide metabolic process,0.16989248687056047,2.557991943807736,1
80,Biological Process,GO:0051222,positive regulation of protein transport,0.1694696281268171,2.5497490907752853,1
81,Biological Process,GO:2001056,positive regulation of cysteine-type endopeptidase activity,0.16907520481253258,2.5420605341110947,1
82,Biological Process,GO:2000116,regulation of cysteine-type endopeptidase activity,0.16858544333551984,2.5325135354130563,1
83,Phenotype,HP:0003756,Skeletal myopathy,0.16716931948933866,2.5049088070905787,1
84,Biological Process,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,0.1670295354486303,2.5021839744581937,1
85,Biological Process,GO:0030336,negative regulation of cell migration,0.16661950542661086,2.4941911937473615,1
86,Biological Process,GO:0045980,negative regulation of nucleotide metabolic process,0.16584014367143218,2.47899897057094,1
87,Phenotype,HP:0033331,Acute phase response,0.16561951228110938,2.4746981676392648,1
88,Phenotype,HP:0001291,Abnormal cranial nerve morphology,0.16554514918063956,2.4732485958442396,1
89,Biological Process,GO:0001910,regulation of leukocyte mediated cytotoxicity,0.16530450901233962,2.468557758607575,1
90,Phenotype,HP:0004312,Abnormal reticulocyte morphology,0.16527991149838706,2.4680782753392863,1
91,Biological Process,GO:0001775,cell activation,0.1652417935438396,2.4673352359629432,1
92,Phenotype,HP:0001974,Leukocytosis,0.16498531327220256,2.462335625061885,1
93,Biological Process,GO:0042060,wound healing,0.16467932739863145,2.456370993555096,1
94,Biological Process,GO:1900542,regulation of purine nucleotide metabolic process,0.1646595731759657,2.4559859213374504,1
95,Biological Process,GO:0010596,negative regulation of endothelial cell migration,0.1644240082814451,2.4513940172232096,1
96,Biological Process,GO:1904018,positive regulation of vasculature development,0.1638368621596903,2.439948684090556,1
97,Biological Process,GO:0048729,tissue morphogenesis,0.1637641698598712,2.4385316814794824,1
98,Biological Process,GO:0045766,positive regulation of angiogenesis,0.16327754529286476,2.429045831069237,1
99,Biological Process,GO:0070201,regulation of establishment of protein localization,0.1632073547262919,2.4276775951439187,1
100,Biological Process,GO:1903078,positive regulation of protein localization to plasma membrane,0.1629864540712307,2.42337154339169,1
101,Biological Process,GO:0002685,regulation of leukocyte migration,0.16256701909947935,2.415195430493538,1
102,Phenotype,HP:0012031,Lipomatous tumor,0.16255872432987728,2.415033739224812,1
102,Phenotype,HP:0200013,Neoplasm of fatty tissue,0.16255872432987728,2.415033739224812,1
104,Biological Process,GO:0045765,regulation of angiogenesis,0.16243005104545682,2.4125254903394007,1
105,Biological Process,GO:0045661,regulation of myoblast differentiation,0.16215684366206917,2.4071998151772678,1
106,Biological Process,GO:2000353,positive regulation of endothelial cell apoptotic process,0.16200581952845206,2.404255877618501,1
107,Biological Process,GO:0090050,positive regulation of cell migration involved in sprouting angiogenesis,0.16188590918258716,2.4019184460940046,1
108,Phenotype,HP:0003334,Elevated circulating catecholamine level,0.16127620762217143,2.3900334361928905,1
108,Phenotype,HP:0012099,Abnormality of circulating catecholamine level,0.16127620762217143,2.3900334361928905,1
110,Phenotype,HP:0001962,Palpitations,0.1610193689431222,2.3850268387989,1
111,Disease,MONDO:0006130,central nervous system neoplasm,0.16099612925901097,2.3845738239245864,1
112,Biological Process,GO:0048588,developmental cell growth,0.16097505662425116,2.3841630516894092,1
113,Biological Process,GO:0032680,regulation of tumor necrosis factor production,0.16063736306553644,2.3775803372116404,1
114,Biological Process,GO:0010633,negative regulation of epithelial cell migration,0.1604553412622256,2.3740321571264644,1
115,Biological Process,GO:0046649,lymphocyte activation,0.16021672411607213,2.369380754983626,1
116,Biological Process,GO:1905475,regulation of protein localization to membrane,0.15966597664272952,2.3586449465182064,1
117,Biological Process,GO:0050920,regulation of chemotaxis,0.15952178089757185,2.3558341158263367,1
118,Biological Process,GO:0001649,osteoblast differentiation,0.1590487536498113,2.3466133201319685,1
119,Phenotype,HP:0000790,Hematuria,0.1585652245926985,2.337187810990507,1
119,Phenotype,HP:0012614,Abnormal urine cytology,0.1585652245926985,2.337187810990507,1
121,Biological Process,GO:1900543,negative regulation of purine nucleotide metabolic process,0.15837782618873697,2.3335348239700746,1
122,Biological Process,GO:0043410,positive regulation of MAPK cascade,0.15799710494260633,2.3261133639089557,1
123,Biological Process,GO:0046879,hormone secretion,0.1577265874484448,2.3208401231871476,1
124,Phenotype,HP:0006501,Aplasia/Hypoplasia of the radius,0.1569492374457685,2.3056871154235794,1
125,Disease,MONDO:0021069,malignant endocrine neoplasm,0.15687118979566517,2.304165720114038,1
126,Disease,MONDO:0005267,heart disorder,0.1560393830000013,2.2879511773867103,1
127,Phenotype,HP:0001876,Pancytopenia,0.15589382438890298,2.2851137801313772,1
128,Biological Process,GO:1901342,regulation of vasculature development,0.15514678614533972,2.270551644329713,1
129,Biological Process,GO:1990138,neuron projection extension,0.1545438297642484,2.2587981192865363,1
130,Biological Process,GO:0045596,negative regulation of cell differentiation,0.15452113911721677,2.258355806879709,1
131,Biological Process,GO:0032102,negative regulation of response to external stimulus,0.15428695357440636,2.2537907906886705,1
132,Phenotype,HP:0012062,Bone cyst,0.15422193309215115,2.2525233360427426,1
133,Phenotype,HP:0006503,Aplasia/hypoplasia involving forearm bones,0.15415880756454636,2.2512928200504847,1
134,Phenotype,HP:0001981,Schistocytosis,0.1541147645283213,2.2504342821106227,1
135,Biological Process,GO:0048646,anatomical structure formation involved in morphogenesis,0.15408421746211676,2.24983882327,1
136,Biological Process,GO:0009746,response to hexose,0.15365037103726742,2.241381785614755,1
136,Biological Process,GO:0034284,response to monosaccharide,0.15365037103726742,2.241381785614755,1
136,Biological Process,GO:0009749,response to glucose,0.15365037103726742,2.241381785614755,1
139,Phenotype,HP:0010013,Abnormal 5th metacarpal morphology,0.15344951825469877,2.2374665302431485,1
140,Biological Process,GO:0045216,cell-cell junction organization,0.15334386840999914,2.23540708094561,1
141,Biological Process,GO:0001914,regulation of T cell mediated cytotoxicity,0.1529555189040328,2.227836921997098,1
142,Phenotype,HP:0004375,Neoplasm of the nervous system,0.15259764472371273,2.220860823439048,1
143,Biological Process,GO:0045745,positive regulation of G protein-coupled receptor signaling pathway,0.15238251307921535,2.2166672279311888,1
144,Disease,MONDO:0021227,adrenal gland neoplasm,0.15233267328698263,2.2156956929005887,1
145,Biological Process,GO:0050926,regulation of positive chemotaxis,0.15228919516376827,2.214848166900274,1
146,Biological Process,GO:0071276,cellular response to cadmium ion,0.15215400252130573,2.2122128351272514,1
147,Biological Process,GO:2000273,positive regulation of signaling receptor activity,0.1520004416236046,2.209219448021013,1
148,Biological Process,GO:0042110,T cell activation,0.15185401154179012,2.2063650630478153,1
149,Phenotype,HP:0000155,Oral ulcer,0.1515018833589069,2.1995009721355747,1
150,Biological Process,GO:1905477,positive regulation of protein localization to membrane,0.15149699035566178,2.1994055920417876,1
151,Biological Process,GO:0045662,negative regulation of myoblast differentiation,0.15143414263327615,2.198180491351039,1
152,Biological Process,GO:0034765,regulation of monoatomic ion transmembrane transport,0.15142643366966402,2.198030219292042,1
153,Phenotype,HP:0002633,Vasculitis,0.1514216959022764,2.19793786523562,1
154,Phenotype,HP:0001874,Abnormality of neutrophils,0.15121729143985574,2.19395337640137,1
155,Biological Process,GO:0010634,positive regulation of epithelial cell migration,0.1511793724254965,2.1932142149978917,1
156,Biological Process,GO:0071396,cellular response to lipid,0.15091584754984222,2.1880772825055335,1
157,Biological Process,GO:0090049,regulation of cell migration involved in sprouting angiogenesis,0.15089008785278635,2.187575144616383,1
158,Phenotype,HP:0003022,Hypoplasia of the ulna,0.15074367535092636,2.184721102332046,1
159,Biological Process,GO:0043547,positive regulation of GTPase activity,0.15072355949520522,2.1843289807434902,1
160,Phenotype,HP:0001639,Hypertrophic cardiomyopathy,0.15060583048665943,2.182034070375767,1
161,Biological Process,GO:0002686,negative regulation of leukocyte migration,0.1502309102205842,2.174725689745424,1
162,Biological Process,GO:2000351,regulation of endothelial cell apoptotic process,0.14973380195523567,2.165035478928898,1
163,Phenotype,HP:0100835,Benign neoplasm of the central nervous system,0.14970812242038356,2.1645349036543897,1
164,Biological Process,GO:0052547,regulation of peptidase activity,0.14894374837486923,2.1496348382963513,1
165,Phenotype,HP:0007379,Neoplasm of the genitourinary tract,0.1488772148731189,2.148337890119739,1
166,Phenotype,HP:0010741,Pedal edema,0.1486964847818627,2.1448148895839614,1
167,Biological Process,GO:0043269,regulation of monoatomic ion transport,0.14849915412517,2.1409682915746227,1
168,Biological Process,GO:0033121,regulation of purine nucleotide catabolic process,0.14849799643986028,2.14094572462997,1
168,Biological Process,GO:0006110,regulation of glycolytic process,0.14849799643986028,2.14094572462997,1
168,Biological Process,GO:0030811,regulation of nucleotide catabolic process,0.14849799643986028,2.14094572462997,1
171,Biological Process,GO:0050730,regulation of peptidyl-tyrosine phosphorylation,0.14846012782557982,2.140207545683277,1
172,Biological Process,GO:0001704,formation of primary germ layer,0.1484334666704632,2.1396878355281643,1
173,Biological Process,GO:1904037,positive regulation of epithelial cell apoptotic process,0.1482821948926082,2.136739070600713,1
174,Phenotype,HP:0002488,Acute leukemia,0.1480493414877555,2.1322000219876585,1
175,Phenotype,HP:0007417,Discoid lupus rash,0.14784564781712073,2.128229388731221,1
176,Biological Process,GO:2001235,positive regulation of apoptotic signaling pathway,0.14779787490002783,2.127298143627851,1
177,Phenotype,HP:0100530,Abnormal circulating calcium-phosphate regulating hormone concentration,0.14773726325686576,2.1261166311865627,1
178,Phenotype,HP:0100006,Neoplasm of the central nervous system,0.14760315867179719,2.1235025090901094,1
179,Biological Process,GO:0007498,mesoderm development,0.14715453553008428,2.114757426532848,1
180,Biological Process,GO:0048514,blood vessel morphogenesis,0.14688852623811377,2.1095720649164167,1
181,Biological Process,GO:1904062,regulation of monoatomic cation transmembrane transport,0.14685568044774833,2.1089317966785646,1
182,Phenotype,HP:0009553,Abnormality of the hairline,0.14683276095930364,2.1084850234295214,1
183,Biological Process,GO:0030879,mammary gland development,0.14680836781186346,2.1080095239103005,1
184,Biological Process,GO:0051046,regulation of secretion,0.14675841080697705,2.1070357040347205,1
185,Phenotype,HP:0002984,Hypoplasia of the radius,0.14671783097462243,2.1062446748810615,1
186,Biological Process,GO:0002762,negative regulation of myeloid leukocyte differentiation,0.14671018523806933,2.106095635317225,1
187,Phenotype,HP:0045040,Abnormal circulating lactate dehydrogenase concentration,0.14666969878040548,2.1053064263313273,1
188,Phenotype,HP:0100780,Conjunctival hamartoma,0.14649249446922985,2.101852154389811,1
189,Biological Process,GO:0010595,positive regulation of endothelial cell migration,0.1464798533218198,2.101605738484253,1
190,Biological Process,GO:0050927,positive regulation of positive chemotaxis,0.1463528918375412,2.099130857992423,1
191,Phenotype,HP:0045017,Congenital malformation of the left heart,0.14618601214175997,2.0958778454278786,1
192,Biological Process,GO:1902622,regulation of neutrophil migration,0.14605009852712192,2.093228459629082,1
193,Biological Process,GO:0045321,leukocyte activation,0.1456424159971722,2.0852814389561156,1
194,Phenotype,HP:0009824,Upper limb undergrowth,0.1456416185192384,2.085265893591376,1
195,Disease,MONDO:0100547,cardiogenetic disease,0.14560273284915715,2.08450788901351,1
196,Phenotype,HP:0011702,Abnormal electrophysiology of sinoatrial node origin,0.1455150773041497,2.082799205473991,1
197,Biological Process,GO:0036336,dendritic cell migration,0.14509511209005133,2.0746127564770767,1
197,Biological Process,GO:0002407,dendritic cell chemotaxis,0.14509511209005133,2.0746127564770767,1
199,Phenotype,HP:0005561,Abnormal bone marrow cell morphology,0.1445564671134688,2.0641128639140605,1
200,Biological Process,GO:0032675,regulation of interleukin-6 production,0.14436578655244947,2.0603958972818615,1
201,Biological Process,GO:0090022,regulation of neutrophil chemotaxis,0.14436202413427213,2.060322555863382,1
202,Phenotype,HP:0012145,Abnormality of multiple cell lineages in the bone marrow,0.14407787206782785,2.054783534246299,1
203,Phenotype,HP:0031284,Flushing,0.14383351517774645,2.0500202463582986,1
204,Phenotype,HP:0100836,Malignant neoplasm of the central nervous system,0.14377405516520447,2.048861182836631,1
205,Phenotype,HP:0001909,Leukemia,0.1434831366697702,2.0431902621384848,1
206,Phenotype,HP:0002018,Nausea,0.1433126290300849,2.0398665294839486,1
207,Biological Process,GO:0006874,intracellular calcium ion homeostasis,0.14315152556739175,2.0367261139535926,1
208,Biological Process,GO:2001233,regulation of apoptotic signaling pathway,0.14305745429421746,2.0348923676001727,1
209,Biological Process,GO:0051592,response to calcium ion,0.14260776651797125,2.0261265319519057,1
210,Phenotype,HP:0000782,Abnormal scapula morphology,0.14251878122631734,2.0243919274486153,1
211,Phenotype,HP:0030060,Nervous tissue neoplasm,0.14249751790362108,2.0239774381030355,1
211,Phenotype,HP:0030061,Neuroectodermal neoplasm,0.14249751790362108,2.0239774381030355,1
213,Phenotype,HP:0005916,Abnormal metacarpal morphology,0.14228732948141365,2.019880201616825,1
214,Phenotype,HP:0001896,Reticulocytopenia,0.14214766693571046,2.0171577373059817,1
215,Biological Process,GO:1903530,regulation of secretion by cell,0.1418217867002357,2.010805301825,1
216,Biological Process,GO:0051223,regulation of protein transport,0.14154736994893624,2.005456052260997,1
217,Phenotype,HP:0031910,Abnormal cranial nerve physiology,0.1412851744068201,2.000345032679624,1
218,Biological Process,GO:1903829,positive regulation of protein localization,0.1412488708760865,1.9996373621564918,1
219,Biological Process,GO:0002689,negative regulation of leukocyte chemotaxis,0.14112081353521888,1.9971411199571372,1
220,Biological Process,GO:0035025,positive regulation of Rho protein signal transduction,0.141036990286581,1.9955071399828603,1
221,Biological Process,GO:0060560,developmental growth involved in morphogenesis,0.1410128064761541,1.9950357211034755,1
222,Biological Process,GO:0007162,negative regulation of cell adhesion,0.14095749832146642,1.9939575904101126,1
223,Phenotype,HP:0004383,Hypoplastic left heart,0.14092634261029757,1.9933502671559853,1
224,Phenotype,HP:0009821,Forearm undergrowth,0.14087048781843448,1.992261480776851,1
225,Biological Process,GO:1904035,regulation of epithelial cell apoptotic process,0.14069169002913573,1.9887761469117646,1
226,Biological Process,GO:0050921,positive regulation of chemotaxis,0.14058334171859055,1.9866640959884894,1
227,Phenotype,HP:0005274,Prominent nasal tip,0.14052743407247825,1.9855742793130333,1
228,Phenotype,HP:0002960,Autoimmunity,0.14046414133316953,1.9843405038363233,1
229,Phenotype,HP:0001012,Multiple lipomas,0.14035028955905748,1.982121173018704,1
230,Phenotype,HP:0030063,Neuroepithelial neoplasm,0.14034642311514844,1.9820458038100217,1
231,Phenotype,HP:0009124,Abnormal adipose tissue morphology,0.1403445328426215,1.982008956425732,1
232,Biological Process,GO:0030168,platelet activation,0.14020719988428598,1.979331903133538,1
233,Phenotype,HP:0010012,Abnormal 4th metacarpal morphology,0.14018386576628772,1.9788770474443806,1
234,Biological Process,GO:0010738,regulation of protein kinase A signaling,0.1400541679817091,1.9763488278137498,1
235,Biological Process,GO:0090130,tissue migration,0.1400010049041407,1.9753125114512928,1
235,Biological Process,GO:0010631,epithelial cell migration,0.1400010049041407,1.9753125114512928,1
235,Biological Process,GO:0090132,epithelium migration,0.1400010049041407,1.9753125114512928,1
238,Disease,MONDO:0021248,nervous system neoplasm,0.13990471283507389,1.9734354747688256,1
239,Biological Process,GO:0010563,negative regulation of phosphorus metabolic process,0.13988903205172742,1.9731298067544567,1
240,Phenotype,HP:0004376,Neuroblastic tumor,0.13974659286277524,1.9703532168932645,1
240,Phenotype,HP:0003006,Neuroblastoma,0.13974659286277524,1.9703532168932645,1
242,Phenotype,HP:0001751,Abnormal vestibular function,0.13973759962665155,1.9701779103050705,1
243,Biological Process,GO:0045936,negative regulation of phosphate metabolic process,0.13962746309600582,1.9680310013217535,1
244,Phenotype,HP:0002721,Immunodeficiency,0.13948123400765278,1.9651805343462028,1
245,Phenotype,HP:0006824,Cranial nerve paralysis,0.13944528959152014,1.9644798641013457,1
246,Biological Process,GO:0043534,blood vessel endothelial cell migration,0.1393446673773191,1.962518419208149,1
247,Biological Process,GO:1903076,regulation of protein localization to plasma membrane,0.13924078102348503,1.9604933459197247,1
248,Phenotype,HP:0033020,Female reproductive system neoplasm,0.1391750161228823,1.9592113802080473,1
249,Biological Process,GO:0008277,regulation of G protein-coupled receptor signaling pathway,0.13902602511374662,1.9563070746695357,1
250,Phenotype,HP:0006801,Hyperactive deep tendon reflexes,0.13901945410318473,1.956178984911105,1
251,Biological Process,GO:0009266,response to temperature stimulus,0.13897618744415452,1.9553355810159083,1
252,Phenotype,HP:0030126,Abnormal endometrium morphology,0.13896898248424128,1.955195133581515,1
253,Biological Process,GO:1901184,regulation of ERBB signaling pathway,0.13894044593463084,1.9546388660619889,1
254,Biological Process,GO:0052548,regulation of endopeptidase activity,0.13883342075193095,1.952552607081137,1
255,Biological Process,GO:0044060,regulation of endocrine process,0.13863636000386192,1.94871127044371,1
256,Phenotype,HP:0009811,Abnormality of the elbow,0.13825369378151242,1.9412518966504975,1
257,Biological Process,GO:0032526,response to retinoic acid,0.13819619190407106,1.9401310033691073,1
258,Phenotype,HP:0000763,Sensory neuropathy,0.1379916309113869,1.9361434632654286,1
259,Biological Process,GO:0010035,response to inorganic substance,0.13794168078845348,1.9351697775408576,1
260,Phenotype,HP:0012640,Abnormality of intracranial pressure,0.137882368363771,1.9340135909729081,1
260,Phenotype,HP:0002516,Increased intracranial pressure,0.137882368363771,1.9340135909729081,1
262,Phenotype,HP:0009942,Duplication of thumb phalanx,0.13772701646008811,1.930985291501001,1
263,Phenotype,HP:0030065,Primitive neuroectodermal tumor,0.1376434895940244,1.9293570889595815,1
264,Biological Process,GO:0002834,regulation of response to tumor cell,0.13762391425831788,1.9289755038140048,1
265,Biological Process,GO:1901222,regulation of non-canonical NF-kappaB signal transduction,0.13754353668355446,1.9274086909109192,1
266,Biological Process,GO:0090316,positive regulation of intracellular protein transport,0.13726736186669974,1.9220251710942426,1
267,Biological Process,GO:0002688,regulation of leukocyte chemotaxis,0.13713194038754317,1.9193853785709927,1
268,Phenotype,HP:0100008,Schwannoma,0.13710044901519747,1.918771512219932,1
269,Biological Process,GO:0032735,positive regulation of interleukin-12 production,0.13709775483507258,1.9187189941364324,1
270,Biological Process,GO:1903900,regulation of viral life cycle,0.13705696682976676,1.9179239070341856,1
271,Phenotype,HP:0006495,Aplasia/Hypoplasia of the ulna,0.13697178228224993,1.9162633910434292,1
272,Biological Process,GO:0033993,response to lipid,0.13689574234423152,1.9147811323862385,1
273,Phenotype,HP:0001701,Pericarditis,0.13687593183862112,1.9143949630361632,1
274,Phenotype,HP:0000957,Cafe-au-lait spot,0.1368353152397369,1.9136032171866704,1
275,Biological Process,GO:0046651,lymphocyte proliferation,0.1366155406484546,1.9093191159755425,1
276,Biological Process,GO:0003091,renal water homeostasis,0.13647984814132252,1.906674040260676,1
277,Biological Process,GO:0051496,positive regulation of stress fiber assembly,0.1364264666563605,1.9056334664480106,1
278,Biological Process,GO:0007266,Rho protein signal transduction,0.13639401919917504,1.9050009629824591,1
279,Phenotype,HP:0002973,Abnormal forearm morphology,0.13638466393538673,1.9048185993311741,1
280,Phenotype,HP:0030067,Peripheral primitive neuroectodermal neoplasm,0.1362556449144463,1.9023036109485572,1
281,Biological Process,GO:0003158,endothelium development,0.13606750108374377,1.8986360932056001,1
282,Biological Process,GO:0045785,positive regulation of cell adhesion,0.1359506668718553,1.8963586252520388,1
283,Phenotype,HP:0001648,Cor pulmonale,0.13585775321139582,1.8945474444281667,1
284,Disease,MONDO:0021635,neurocristopathy,0.1358238247879977,1.8938860722516861,1
285,Biological Process,GO:0002837,regulation of immune response to tumor cell,0.13576915498123676,1.8928203849764187,1
286,Biological Process,GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway,0.13566255248182035,1.8907423654283242,1
287,Biological Process,GO:0016049,cell growth,0.13557149849452788,1.8889674355105313,1
288,Biological Process,GO:0043470,regulation of carbohydrate catabolic process,0.1354893083733636,1.8873652903509466,1
289,Biological Process,GO:0000422,autophagy of mitochondrion,0.13535503887498312,1.8847479535729639,1
290,Biological Process,GO:0042058,regulation of epidermal growth factor receptor signaling pathway,0.1353217771928814,1.8840995782910686,1
291,Biological Process,GO:0055074,calcium ion homeostasis,0.13530263174833834,1.8837263730826048,1
292,Biological Process,GO:0050727,regulation of inflammatory response,0.1352700922225627,1.8830920749093192,1
293,Phenotype,HP:0031801,Vocal cord dysfunction,0.1352180749665891,1.8820780942302253,1
293,Phenotype,HP:0001605,Vocal cord paralysis,0.1352180749665891,1.8820780942302253,1
295,Phenotype,HP:0010047,Short 5th metacarpal,0.13519203916850453,1.8815705742596227,1
296,Disease,MONDO:0009332,congenital hematological disorder,0.13516477794563708,1.8810391668879978,1
297,Phenotype,HP:0030247,Splanchnic vein thrombosis,0.13509844301741047,1.879746089536801,1
298,Phenotype,HP:0000574,Thick eyebrow,0.13491440520242293,1.8761586110140054,1
299,Biological Process,GO:0031280,negative regulation of cyclase activity,0.1347968284861223,1.8738666693033417,1
300,Biological Process,GO:0071300,cellular response to retinoic acid,0.13477861474924557,1.8735116260212341,1
301,Biological Process,GO:0007599,hemostasis,0.13472137133174378,1.872395770940728,1
302,Biological Process,GO:0071326,cellular response to monosaccharide stimulus,0.1346697490924127,1.8713894903841402,1
302,Biological Process,GO:0071331,cellular response to hexose stimulus,0.1346697490924127,1.8713894903841402,1
302,Biological Process,GO:0071333,cellular response to glucose stimulus,0.1346697490924127,1.8713894903841402,1
305,Phenotype,HP:0001875,Neutropenia,0.13466632241249554,1.8713226935651923,1
306,Biological Process,GO:0050714,positive regulation of protein secretion,0.13464403821567406,1.8708883041572315,1
307,Biological Process,GO:1903589,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,0.1345318971152778,1.8687023197755899,1
308,Phenotype,HP:0100669,Abnormal pigmentation of the oral mucosa,0.13446420664283099,1.8673828185843957,1
309,Phenotype,HP:0040072,Abnormal forearm bone morphology,0.1344336322188614,1.8667868264544893,1
310,Phenotype,HP:0003613,Antiphospholipid antibody positivity,0.13442887724392982,1.8666941369686647,1
311,Phenotype,HP:0002170,Intracranial hemorrhage,0.13428334193840163,1.8638571940125326,1
312,Biological Process,GO:0050878,regulation of body fluid levels,0.13426396902811155,1.8634795547779306,1
313,Phenotype,HP:0002818,Abnormal morphology of the radius,0.13418067186046512,1.8618558297844476,1
314,Biological Process,GO:0071621,granulocyte chemotaxis,0.13415276889496053,1.8613119128210953,1
315,Biological Process,GO:0061458,reproductive system development,0.13403627646185579,1.8590411072159552,1
316,Biological Process,GO:0035295,tube development,0.133985828355772,1.858057714226294,1
317,Biological Process,GO:0010721,negative regulation of cell development,0.13394735380408074,1.8573077236448696,1
318,Phenotype,HP:0003470,Paralysis,0.13386576614051782,1.8557173222875352,1
319,Biological Process,GO:0009914,hormone transport,0.13383564076675425,1.8551300835650189,1
320,Biological Process,GO:0030593,neutrophil chemotaxis,0.13378390014732466,1.8541214954062628,1
321,Biological Process,GO:0007492,endoderm development,0.1337614296691605,1.8536834747863353,1
322,Biological Process,GO:0002501,peptide antigen assembly with MHC protein complex,0.13367987702570572,1.8520937560815627,1
322,Biological Process,GO:0002396,MHC protein complex assembly,0.13367987702570572,1.8520937560815627,1
324,Biological Process,GO:0031589,cell-substrate adhesion,0.13334531171349662,1.8455720210125837,1
325,Phenotype,HP:0000599,Abnormality of the frontal hairline,0.13327201349468387,1.844143207125787,1
326,Phenotype,HP:0009237,Short 5th finger,0.13319577868669974,1.842657149837229,1
327,Biological Process,GO:0032233,positive regulation of actin filament bundle assembly,0.13318967697185657,1.8425382081352013,1
328,Phenotype,HP:0025018,Abnormal capillary physiology,0.133090661243348,1.8406080787242025,1
329,Phenotype,HP:0000870,Increased circulating prolactin concentration,0.1330533582480774,1.8398809254792114,1
330,Biological Process,GO:1902106,negative regulation of leukocyte differentiation,0.13300175448037588,1.838875004993049,1
331,Phenotype,HP:0010784,Uterine neoplasm,0.13275105190571557,1.8339880196619947,1
332,Biological Process,GO:0062014,negative regulation of small molecule metabolic process,0.13267483556238646,1.8325023223079064,1
333,Biological Process,GO:0000165,MAPK cascade,0.1326440216799124,1.8319016623751252,1
334,Biological Process,GO:2001242,regulation of intrinsic apoptotic signaling pathway,0.1326230712507741,1.8314932723136474,1
335,Phenotype,HP:0000236,Abnormality of the anterior fontanelle,0.13248475695755246,1.828797089703775,1
336,Biological Process,GO:0097530,granulocyte migration,0.13233834545041467,1.8259430668097167,1
337,Biological Process,GO:0010810,regulation of cell-substrate adhesion,0.13229615915922432,1.825120722697383,1
338,Biological Process,GO:1905476,negative regulation of protein localization to membrane,0.13161106640984144,1.8117661003079548,1
339,Phenotype,HP:0002891,Uterine leiomyosarcoma,0.13159783657568758,1.8115082090376724,1
339,Phenotype,HP:0100243,Leiomyosarcoma,0.13159783657568758,1.8115082090376724,1
341,Biological Process,GO:0031348,negative regulation of defense response,0.1314895355111778,1.8093970790889118,1
342,Phenotype,HP:0009765,Low hanging columella,0.13136071063877575,1.8068858752747632,1
343,Phenotype,HP:0002858,Meningioma,0.1313128015811713,1.805951976362657,1
344,Biological Process,GO:0071241,cellular response to inorganic substance,0.13125328122190216,1.8047917364925976,1
345,Biological Process,GO:1903036,positive regulation of response to wounding,0.13125091911370057,1.8047456915401388,1
345,Biological Process,GO:0090303,positive regulation of wound healing,0.13125091911370057,1.8047456915401388,1
347,Biological Process,GO:0034220,monoatomic ion transmembrane transport,0.1312377679285478,1.8044893333873968,1
348,Biological Process,GO:0070207,protein homotrimerization,0.13117004416269662,1.8031691832025536,1
348,Biological Process,GO:0070206,protein trimerization,0.13117004416269662,1.8031691832025536,1
350,Biological Process,GO:0045087,innate immune response,0.1310372764871306,1.80058112169657,1
351,Biological Process,GO:0010950,positive regulation of endopeptidase activity,0.13102164241935843,1.8002763643163524,1
352,Biological Process,GO:1990266,neutrophil migration,0.13092818555395624,1.7984545947117696,1
353,Phenotype,HP:0100584,Endocarditis,0.13082019374000553,1.7963494930335513,1
354,Biological Process,GO:0010038,response to metal ion,0.1308146765322955,1.7962419452224296,1
355,Phenotype,HP:0030057,Autoimmune antibody positivity,0.130769717857655,1.7953655585966861,1
356,Phenotype,HP:0025435,Increased circulating lactate dehydrogenase concentration,0.13059919291017374,1.7920414885585187,1
357,Biological Process,GO:0050891,multicellular organismal-level water homeostasis,0.13059042744250715,1.791870621897239,1
358,Phenotype,HP:0030949,Glomerular deposits,0.13041431147881322,1.788437565287019,1
359,Biological Process,GO:0072359,circulatory system development,0.13034515261230384,1.7870894404558255,1
360,Biological Process,GO:0001667,ameboidal-type cell migration,0.1302845516652854,1.7859081365161737,1
361,Biological Process,GO:0070141,response to UV-A,0.13027548304685133,1.7857313604885627,1
362,Phenotype,HP:0010787,Genital neoplasm,0.13016692748520498,1.7836152695864693,1
363,Biological Process,GO:1901654,response to ketone,0.13009266674073927,1.7821676930333814,1
364,Phenotype,HP:0032309,Abnormal granulocyte count,0.13001238897396517,1.7806028257033732,1
365,Biological Process,GO:0046887,positive regulation of hormone secretion,0.12998248533019852,1.7800199091991022,1
366,Biological Process,GO:0071622,regulation of granulocyte chemotaxis,0.12997084179353458,1.7797929398791608,1
367,Phenotype,HP:0000954,Single transverse palmar crease,0.12990994531154065,1.7786058750290277,1
368,Biological Process,GO:0070328,triglyceride homeostasis,0.1297841004939123,1.7761527618985693,1
368,Biological Process,GO:0055090,acylglycerol homeostasis,0.1297841004939123,1.7761527618985693,1
370,Biological Process,GO:0003013,circulatory system process,0.1297648155099671,1.7757768366262519,1
371,Phenotype,HP:0004306,Abnormal endocardium morphology,0.12976385949611524,1.7757582008955393,1
372,Biological Process,GO:0032926,negative regulation of activin receptor signaling pathway,0.12961976543721188,1.7729493523900663,1
373,Biological Process,GO:0048010,vascular endothelial growth factor receptor signaling pathway,0.12951211714222122,1.7708509469818046,1
374,Phenotype,HP:0100806,Sepsis,0.12941559961640037,1.76896951543482,1
375,Biological Process,GO:0032656,regulation of interleukin-13 production,0.12936501163481595,1.7679833958296838,1
376,Biological Process,GO:0051056,regulation of small GTPase mediated signal transduction,0.1293114107168688,1.7669385445747905,1
377,Phenotype,HP:0000160,Narrow mouth,0.1290207375897534,1.7612724068804755,1
378,Phenotype,HP:0001053,Hypopigmented skin patches,0.12895758544569114,1.7600413720493608,1
379,Phenotype,HP:0002354,Memory impairment,0.1289393590678496,1.759686082354907,1
380,Biological Process,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,0.1289166756016622,1.7592439099254238,1
381,Biological Process,GO:0002707,negative regulation of lymphocyte mediated immunity,0.12886813846769052,1.7582977678203717,1
382,Biological Process,GO:0007043,cell-cell junction assembly,0.1288396000972497,1.7577414648071084,1
383,Phenotype,HP:0100834,Neoplasm of the large intestine,0.12879050655638602,1.7567844765736391,1
384,Biological Process,GO:1904377,positive regulation of protein localization to cell periphery,0.128788506868733,1.7567454963428208,1
385,Biological Process,GO:0010762,regulation of fibroblast migration,0.12878708581749665,1.7567177955640947,1
386,Phenotype,HP:0000980,Pallor,0.1286597264256314,1.7542351585961224,1
387,Biological Process,GO:0002683,negative regulation of immune system process,0.1286519909046815,1.7540843688506982,1
388,Phenotype,HP:0031446,Erosion of oral mucosa,0.128461648881255,1.7503740013858693,1
389,Phenotype,HP:0000502,Abnormal conjunctiva morphology,0.12844916393813455,1.7501306303954782,1
390,Biological Process,GO:0010959,regulation of metal ion transport,0.12842045099222943,1.749570924354805,1
391,Biological Process,GO:0001937,negative regulation of endothelial cell proliferation,0.12836473943345317,1.7484849300411103,1
392,Disease,MONDO:0005217,familial cardiomyopathy,0.12822284830878594,1.7457190236845637,1
392,Disease,MONDO:0004994,cardiomyopathy,0.12822284830878594,1.7457190236845637,1
394,Biological Process,GO:0009408,response to heat,0.12802334512152092,1.7418300761897731,1
395,Biological Process,GO:0071248,cellular response to metal ion,0.1280076575158705,1.7415242751871436,1
396,Biological Process,GO:0097305,response to alcohol,0.1280043930391358,1.7414606402207389,1
397,Biological Process,GO:0035239,tube morphogenesis,0.12782467300054734,1.7379573288029428,1
398,Phenotype,HP:0000368,"Low-set, posteriorly rotated ears",0.12759870175380272,1.733552435197134,1
399,Biological Process,GO:0050792,regulation of viral process,0.12729766970605927,1.7276843694084487,1
400,Biological Process,GO:2001198,regulation of dendritic cell differentiation,0.12723669862270304,1.7264958503420447,1
401,Phenotype,HP:0001293,Cranial nerve compression,0.12710499972414002,1.72392862267689,1
402,Phenotype,HP:0002102,Pleuritis,0.12697405952503948,1.7213761844615396,1
403,Biological Process,GO:0034446,substrate adhesion-dependent cell spreading,0.12695409737207897,1.7209870590254468,1
404,Phenotype,HP:0005406,Recurrent bacterial skin infections,0.1269187586449524,1.720298195573128,1
405,Biological Process,GO:0035023,regulation of Rho protein signal transduction,0.12688179797992616,1.7195777154262688,1
406,Phenotype,HP:0005224,Rectal abscess,0.12679025533262545,1.7177932599808845,1
407,Biological Process,GO:0160049,negative regulation of cGAS/STING signaling pathway,0.12669030629779765,1.7158449374807334,1
408,Phenotype,HP:0000988,Skin rash,0.12668766546513388,1.7157934593078146,1
409,Phenotype,HP:0001961,Hypoplastic heart,0.1265722912813776,1.713544451915835,1
410,Phenotype,HP:0000520,Proptosis,0.12645449072917103,1.7112481469361052,1
411,Biological Process,GO:1903707,negative regulation of hemopoiesis,0.12635078848851355,1.7092266625952393,1
412,Biological Process,GO:0097306,cellular response to alcohol,0.12618805521456133,1.7060544768936903,1
413,Biological Process,GO:0098586,cellular response to virus,0.1260939035662887,1.7042191637756403,1
414,Biological Process,GO:0055088,lipid homeostasis,0.12602652079480414,1.7029056606484507,1
415,Disease,MONDO:0005495,adrenal gland disorder,0.12576950976310386,1.6978957035567046,1
416,Biological Process,GO:0051350,negative regulation of lyase activity,0.1257674599220433,1.6978557456775025,1
417,Biological Process,GO:0007596,blood coagulation,0.12572903064253171,1.6971066375939077,1
418,Phenotype,HP:0002890,Thyroid carcinoma,0.12563502173510588,1.6952741069459834,1
419,Phenotype,HP:0001933,Subcutaneous hemorrhage,0.12562370232397146,1.6950534558567594,1
420,Biological Process,GO:0010952,positive regulation of peptidase activity,0.12535160937705714,1.6897495045828033,1
421,Biological Process,GO:0033135,regulation of peptidyl-serine phosphorylation,0.12526892376422627,1.68813770072502,1
422,Phenotype,HP:0001611,Hypernasal speech,0.12519149038681177,1.6866282795311156,1
423,Biological Process,GO:1903532,positive regulation of secretion by cell,0.12518032755645303,1.6864106806959616,1
424,Biological Process,GO:0070202,regulation of establishment of protein localization to chromosome,0.1250700914370777,1.6842618304136319,1
425,Phenotype,HP:0001680,Coarctation of aorta,0.12495018487181253,1.6819244725849698,1
426,Biological Process,GO:0032350,regulation of hormone metabolic process,0.12478516308525012,1.6787076765415803,1
427,Biological Process,GO:0032943,mononuclear cell proliferation,0.12478068126561992,1.6786203117156748,1
428,Biological Process,GO:0055082,intracellular chemical homeostasis,0.12473225907755792,1.6776764102696,1
429,Phenotype,HP:0003199,Decreased muscle mass,0.12462185619354338,1.675524309217522,1
430,Phenotype,HP:0009591,Abnormality of the vestibulocochlear nerve,0.12424426843397374,1.6681639307104295,1
431,Biological Process,GO:0031341,regulation of cell killing,0.1241933122970651,1.6671706345947548,1
432,Disease,MONDO:0000591,intrinsic cardiomyopathy,0.12413391739156343,1.666012840215023,1
433,Biological Process,GO:0001706,endoderm formation,0.12411725678442387,1.6656880723389538,1
434,Biological Process,GO:0010811,positive regulation of cell-substrate adhesion,0.12411711160587169,1.6656852423502477,1
435,Phenotype,HP:0006262,Aplasia/Hypoplasia of the 5th finger,0.1241106239331009,1.6655587771086902,1
436,Biological Process,GO:0071675,regulation of mononuclear cell migration,0.12399671406022794,1.6633383137626447,1
437,Phenotype,HP:0430048,Intracranial calcification,0.12394160203337179,1.6622640062204281,1
437,Phenotype,HP:0002514,Cerebral calcification,0.12394160203337179,1.6622640062204281,1
439,Phenotype,HP:0004808,Acute myeloid leukemia,0.12376286655763358,1.6587798870435302,1
440,Phenotype,HP:0000465,Webbed neck,0.12372353056602958,1.6580131042762944,1
441,Phenotype,HP:0100579,Mucosal telangiectasiae,0.12368636941762212,1.657288716074863,1
442,Phenotype,HP:0004395,Malnutrition,0.12366332274061753,1.6568394635189068,1
443,Phenotype,HP:0005595,Generalized hyperkeratosis,0.12365855046428031,1.6567464367740186,1
444,Phenotype,HP:0004796,Gastrointestinal obstruction,0.12357533650978914,1.655124333867862,1
445,Biological Process,GO:0006959,humoral immune response,0.12342665765719585,1.6522261132466902,1
446,Phenotype,HP:0002733,Abnormal lymph node morphology,0.12328835061674515,1.6495300720162405,1
447,Biological Process,GO:0006099,tricarboxylic acid cycle,0.12328183934846182,1.6494031468235881,1
448,Phenotype,HP:0034221,Abnormal temporal lobe morphology,0.12315936553644857,1.647015745244015,1
449,Phenotype,HP:0000979,Purpura,0.12296075175136278,1.6431441350079632,1
450,Phenotype,HP:0001674,Complete atrioventricular canal defect,0.12293997553103397,1.642739140826634,1
451,Phenotype,HP:0100242,Sarcoma,0.12282665741855225,1.6405302127604136,1
452,Disease,MONDO:0000577,congenital anemia,0.12282314633100799,1.6404617705701086,1
453,Phenotype,HP:0009929,Abnormal columella morphology,0.12276045248949952,1.639239669503877,1
454,Biological Process,GO:1901186,positive regulation of ERBB signaling pathway,0.12273610779921484,1.6387651145677282,1
455,Biological Process,GO:0046329,negative regulation of JNK cascade,0.12272073232740766,1.63846539803996,1
456,Biological Process,GO:0002687,positive regulation of leukocyte migration,0.12271953306326366,1.63844202059245,1
457,Phenotype,HP:0009105,Abnormal ossification of the pubic bone,0.12252385565746415,1.6346276496668355,1
458,Phenotype,HP:0000975,Hyperhidrosis,0.12251304405312391,1.6344168973365591,1
459,Phenotype,HP:0031657,Abnormal heart sound,0.12247931041526039,1.6337593221456161,1
460,Biological Process,GO:0003018,vascular process in circulatory system,0.12244114837184372,1.6330154233379035,1
461,Biological Process,GO:0003014,renal system process,0.12239436095992429,1.6321033888442886,1
462,Phenotype,HP:0009937,Facial hirsutism,0.1223628303812695,1.6314887582383826,1
463,Phenotype,HP:0031071,Abnormal endocrine morphology,0.12233842442717924,1.6310130090770865,1
463,Phenotype,HP:0011732,Abnormal adrenal morphology,0.12233842442717924,1.6310130090770865,1
465,Biological Process,GO:0048524,positive regulation of viral process,0.12228906132083539,1.6300507661606563,1
466,Phenotype,HP:0001923,Reticulocytosis,0.12225940353944798,1.629472642291014,1
467,Phenotype,HP:0000892,Bifid ribs,0.12220270215875162,1.6283673532205325,1
468,Phenotype,HP:0009826,Limb undergrowth,0.12219807629760127,1.6282771805702678,1
469,Biological Process,GO:0032801,receptor catabolic process,0.12213246742276729,1.6269982562938217,1
470,Biological Process,GO:0007194,negative regulation of adenylate cyclase activity,0.12211262625730435,1.6266114892863437,1
471,Biological Process,GO:0001568,blood vessel development,0.12200524788266742,1.62451834547865,1
472,Phenotype,HP:0001972,Macrocytic anemia,0.12185819054546143,1.6216517333159175,1
473,Biological Process,GO:0071492,cellular response to UV-A,0.12181471026665736,1.6208041652963485,1
474,Biological Process,GO:0030003,intracellular monoatomic cation homeostasis,0.1217759975282584,1.620049531703387,1
475,Phenotype,HP:0100542,Abnormal localization of kidney,0.12177535139221529,1.6200369364702953,1
476,Phenotype,HP:0002138,Subarachnoid hemorrhage,0.12175670737799815,1.6196735057232652,1
477,Biological Process,GO:0070661,leukocyte proliferation,0.12169819463236864,1.6185329074268233,1
478,Phenotype,HP:0040202,Abnormal consumption behavior,0.12160450318556715,1.6167065650895556,1
479,Biological Process,GO:0009913,epidermal cell differentiation,0.12154784783182748,1.6156021732298926,1
480,Biological Process,GO:0050922,negative regulation of chemotaxis,0.12143884550085926,1.6134773733820482,1
481,Biological Process,GO:0035987,endodermal cell differentiation,0.12134358613756147,1.611620467398084,1
482,Phenotype,HP:0020100,Unusual fungal infection,0.121330554577049,1.6113664411075626,1
483,Phenotype,HP:0031364,Ecchymosis,0.12130371391648653,1.6108432318241226,1
484,Phenotype,HP:0031365,Macular purpura,0.12121241857367038,1.6090635971245562,1
485,Biological Process,GO:0034762,regulation of transmembrane transport,0.12119021450650136,1.6086307696967097,1
486,Phenotype,HP:0007400,Irregular hyperpigmentation,0.12096294013587316,1.6042004740888982,1
487,Phenotype,HP:0010042,Aplasia/Hypoplasia of the 4th metacarpal,0.12091965684304018,1.6033567459483271,1
488,Phenotype,HP:0000902,Rib fusion,0.12082960836845691,1.601601416650379,1
489,Biological Process,GO:0006954,inflammatory response,0.12068536728498502,1.5987897021715085,1
490,Phenotype,HP:0002230,Generalized hirsutism,0.12050423588667447,1.5952588788932218,1
491,Phenotype,HP:0011767,Abnormality of the parathyroid physiology,0.12045627187089714,1.594323908672673,1
492,Phenotype,HP:0012133,Erythroid hypoplasia,0.12041586482034106,1.5935362475822106,1
493,Phenotype,HP:0002672,Gastrointestinal carcinoma,0.1203598029813896,1.5924434252011124,1
493,Phenotype,HP:0006749,Malignant gastrointestinal tract tumors,0.1203598029813896,1.5924434252011124,1
495,Phenotype,HP:0004220,Short middle phalanx of the 5th finger,0.12031049196950239,1.5914821977702462,1
496,Phenotype,HP:0010615,Angiofibromas,0.12028491908729422,1.590983701492761,1
497,Phenotype,HP:0011904,Persistence of hemoglobin F,0.12025875429859512,1.5904736670875066,1
498,Phenotype,HP:0033282,Abnormal glomerular basement membrane morphology,0.12025344490730017,1.5903701702749573,1
499,Biological Process,GO:0043277,apoptotic cell clearance,0.12024236747240147,1.5901542360671455,1
500,Phenotype,HP:0100240,Synostosis of joints,0.12023400738124523,1.5899912714749305,1
501,Biological Process,GO:0032729,positive regulation of type II interferon production,0.12023088876646326,1.589930479818868,1
502,Phenotype,HP:0040188,Osteochondrosis,0.12021462860302923,1.5896135178559112,1
503,Phenotype,HP:0012114,Endometrial carcinoma,0.1201430154036699,1.588217550322458,1
504,Phenotype,HP:0000294,Low anterior hairline,0.12006834527744381,1.5867619936253268,1
505,Phenotype,HP:0034784,Vasculitis by anatomical site,0.11999482145037543,1.5853287819207682,1
506,Biological Process,GO:0032069,regulation of nuclease activity,0.11990988293647198,1.5836730619025348,1
507,Biological Process,GO:0046660,female sex differentiation,0.11989488567351725,1.5833807178603363,1
508,Phenotype,HP:0004332,Abnormal lymphocyte morphology,0.11979400805113949,1.5814142942547562,1
509,Phenotype,HP:0000987,Atypical scarring of skin,0.1197326901174186,1.5802190139787935,1
510,Phenotype,HP:0010500,Hyperextensibility of the knee,0.11969180131319157,1.5794219619870755,1
511,Biological Process,GO:0035051,cardiocyte differentiation,0.11953971904147453,1.576457397973317,1
512,Phenotype,HP:0005403,T lymphocytopenia,0.11953183004881551,1.5763036165793536,1
513,Biological Process,GO:0097006,regulation of plasma lipoprotein particle levels,0.11933340513123947,1.5724356879678358,1
514,Phenotype,HP:0003535,3-Methylglutaconic aciduria,0.11931988061951726,1.5721720525006466,1
515,Biological Process,GO:0071634,regulation of transforming growth factor beta production,0.11931956294430479,1.5721658600069897,1
516,Phenotype,HP:0010976,B lymphocytopenia,0.11931180544069653,1.5720146417500949,1
517,Biological Process,GO:0018149,peptide cross-linking,0.11930341393101995,1.5718510647116444,1
518,Biological Process,GO:1903902,positive regulation of viral life cycle,0.11928429131140872,1.5714783044332226,1
519,Biological Process,GO:0032677,regulation of interleukin-8 production,0.11925236628015279,1.5708559846997592,1
520,Phenotype,HP:0010490,Abnormality of the palmar creases,0.1191884367547007,1.5696097962490465,1
521,Phenotype,HP:0012166,Skin-picking,0.11912564464669617,1.5683857796583118,1
522,Biological Process,GO:0050680,negative regulation of epithelial cell proliferation,0.11899992875396326,1.5659351796814325,1
523,Phenotype,HP:0012842,Skin appendage neoplasm,0.11880568936944602,1.56214884033436,1
524,Biological Process,GO:2000106,regulation of leukocyte apoptotic process,0.1187953924713191,1.5619481212545108,1
525,Biological Process,GO:1903131,mononuclear cell differentiation,0.11877185572272975,1.5614893156548766,1
526,Phenotype,HP:0003416,Spinal canal stenosis,0.11876945273341633,1.5614424738003752,1
527,Biological Process,GO:0051924,regulation of calcium ion transport,0.11873183960964939,1.5607092751710703,1
528,Biological Process,GO:0051047,positive regulation of secretion,0.118722079858528,1.5605190267835953,1
529,Phenotype,HP:0000828,Abnormality of the parathyroid gland,0.1186396576547265,1.558912357600094,1
530,Biological Process,GO:0032967,positive regulation of collagen biosynthetic process,0.11860475656674019,1.5582320251174377,1
531,Phenotype,HP:0005421,Decreased circulating complement C3 concentration,0.1185943590091656,1.5580293438668975,1
532,Biological Process,GO:0010469,regulation of signaling receptor activity,0.11859356984749869,1.5580139606124765,1
533,Phenotype,HP:0008850,Severe postnatal growth retardation,0.11858177481648713,1.5577840381890196,1
534,Phenotype,HP:0031546,Cardiac conduction abnormality,0.11839757848088694,1.5541934695986022,1
535,Phenotype,HP:0005532,Macrocytic dyserythropoietic anemia,0.11836005650538595,1.5534620477370038,1
536,Biological Process,GO:0010332,response to gamma radiation,0.11820986250567078,1.55053429211098,1
537,Phenotype,HP:0011991,Abnormal neutrophil count,0.11799543182399552,1.5463543605833725,1
538,Biological Process,GO:0150117,positive regulation of cell-substrate junction organization,0.11797983697835512,1.5460503677664341,1
539,Biological Process,GO:0032024,positive regulation of insulin secretion,0.11793794992889128,1.5452338568208712,1
540,Phenotype,HP:0012740,Papilloma,0.11789018199138024,1.5443027087852856,1
541,Biological Process,GO:0070232,regulation of T cell apoptotic process,0.11785323836467021,1.5435825607690459,1
542,Biological Process,GO:0032755,positive regulation of interleukin-6 production,0.11778790023606212,1.5423089141920254,1
543,Biological Process,GO:0032925,regulation of activin receptor signaling pathway,0.11777753467302499,1.5421068566161142,1
544,Phenotype,HP:0033603,Glomerular subepithelial deposits,0.117749732706803,1.5415649084479097,1
545,Biological Process,GO:0042267,natural killer cell mediated cytotoxicity,0.11774508092664993,1.5414742305543851,1
546,Phenotype,HP:0040088,Abnormal lymphocyte count,0.11773254778564468,1.5412299200349273,1
547,Phenotype,HP:0011035,Abnormal renal cortex morphology,0.11769614659352956,1.5405203457828858,1
548,Phenotype,HP:0003083,Dislocated radial head,0.11769419474882592,1.5404822981623214,1
549,Biological Process,GO:0034330,cell junction organization,0.11757138317216398,1.5380883124825024,1
550,Phenotype,HP:0100568,Neoplasm of the endocrine system,0.1175156143379753,1.5370012016900452,1
551,Phenotype,HP:0025323,Abnormal arterial physiology,0.11743358623631917,1.535402214802611,1
552,Disease,MONDO:0021060,RASopathy,0.11736655202558022,1.5340955062257091,1
553,Biological Process,GO:0060392,negative regulation of SMAD protein signal transduction,0.11733091838358767,1.5334008939508028,1
554,Biological Process,GO:0045429,positive regulation of nitric oxide biosynthetic process,0.11732379665846082,1.5332620690253953,1
554,Biological Process,GO:1904407,positive regulation of nitric oxide metabolic process,0.11732379665846082,1.5332620690253953,1
556,Biological Process,GO:0007179,transforming growth factor beta receptor signaling pathway,0.1170514178269747,1.5279525449578186,1
557,Phenotype,HP:0033747,Abnormal exteroceptive sensation,0.11699712495756964,1.526894205382635,1
558,Biological Process,GO:0048608,reproductive structure development,0.1169005538615987,1.5250117295841585,1
559,Biological Process,GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,0.11686864796788243,1.5243897829018125,1
560,Biological Process,GO:0016032,viral process,0.11667407898564064,1.5205970186536504,1
561,Phenotype,HP:0002841,Recurrent fungal infections,0.11664729895018477,1.5200749911450966,1
562,Biological Process,GO:0001818,negative regulation of cytokine production,0.11657022090911029,1.518572496579224,1
563,Phenotype,HP:0004400,Abnormality of the pylorus,0.11651986890857158,1.5175909769903033,1
564,Phenotype,HP:0004970,Ascending tubular aorta aneurysm,0.1164235030064864,1.5157125010690162,1
565,Biological Process,GO:2001267,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,0.11634228699053595,1.5141293442979527,1
566,Disease,MONDO:0002917,disorder of pilosebaceous unit,0.11633500614300518,1.51398741757411,1
567,Phenotype,HP:0001085,Papilledema,0.11621002336149333,1.5115511082513582,1
568,Biological Process,GO:0098657,import into cell,0.11617576191303747,1.5108832443642346,1
569,Biological Process,GO:0038127,ERBB signaling pathway,0.11616896148717626,1.5107506825767314,1
570,Biological Process,GO:0090066,regulation of anatomical structure size,0.11613180541672019,1.5100263933606175,1
571,Biological Process,GO:2000341,regulation of chemokine (C-X-C motif) ligand 2 production,0.11610353810287799,1.5094753740969251,1
572,Biological Process,GO:0043117,positive regulation of vascular permeability,0.11604962227041515,1.5084243841630782,1
573,Biological Process,GO:0071695,anatomical structure maturation,0.11600812350578127,1.5076154421157242,1
574,Biological Process,GO:0008207,C21-steroid hormone metabolic process,0.11598802917540252,1.5072237401241058,1
575,Phenotype,HP:0030140,Oral cavity bleeding,0.11597333873951354,1.5069373771109078,1
576,Biological Process,GO:0032940,secretion by cell,0.11596770725782868,1.5068276017389421,1
577,Biological Process,GO:0071902,positive regulation of protein serine/threonine kinase activity,0.11588497320557056,1.5052148536436667,1
578,Biological Process,GO:0019058,viral life cycle,0.11568724783774531,1.501360561467176,1
579,Phenotype,HP:0500011,Moon facies,0.11559068088323732,1.4994781663988979,1
580,Biological Process,GO:0046686,response to cadmium ion,0.11555863685468992,1.4988535270322254,1
581,Biological Process,GO:0007369,gastrulation,0.1155151979885225,1.4980067662757972,1
582,Biological Process,GO:0090277,positive regulation of peptide hormone secretion,0.1153944699936662,1.4956533961889136,1
582,Biological Process,GO:0002793,positive regulation of peptide secretion,0.1153944699936662,1.4956533961889136,1
584,Phenotype,HP:0007543,Epidermal hyperkeratosis,0.1152991699978434,1.4937956981486495,1
585,Phenotype,HP:0010048,Aplasia of metacarpal bones,0.11528072685212942,1.4934361829634353,1
586,Biological Process,GO:0002521,leukocyte differentiation,0.11527024730104307,1.493231903400274,1
587,Phenotype,HP:0004722,Thickened glomerular basement membrane,0.1152234517634233,1.4923197105110846,1
588,Biological Process,GO:0002227,innate immune response in mucosa,0.11514536941245401,1.49079763877202,1
589,Phenotype,HP:0009891,Underdeveloped supraorbital ridges,0.11511957003295681,1.4902947273467027,1
590,Biological Process,GO:0033157,regulation of intracellular protein transport,0.11497211365308058,1.4874203365814627,1
591,Biological Process,GO:0046824,positive regulation of nucleocytoplasmic transport,0.11494962627149308,1.4869819864604046,1
592,Phenotype,HP:0033040,Anti-Sm antibody positivity,0.11494799470136785,1.4869501820033526,1
593,Phenotype,HP:0001646,Abnormal aortic valve morphology,0.11492819502838059,1.4865642238153303,1
594,Phenotype,HP:0030137,Prolonged bleeding following circumcision,0.11490540101934721,1.486119896556494,1
595,Biological Process,GO:0006873,intracellular monoatomic ion homeostasis,0.11489832188372961,1.4859819018351927,1
596,Biological Process,GO:0002385,mucosal immune response,0.11480905137531283,1.4842417375559878,1
597,Phenotype,HP:0001018,Abnormal palmar dermatoglyphics,0.11474617072884474,1.4830159950708413,1
598,Biological Process,GO:0051893,regulation of focal adhesion assembly,0.11469362724847121,1.4819917566154688,1
598,Biological Process,GO:0090109,regulation of cell-substrate junction assembly,0.11469362724847121,1.4819917566154688,1
600,Biological Process,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,0.11468463572194842,1.4818164833527983,1
601,Biological Process,GO:0051894,positive regulation of focal adhesion assembly,0.11461594600793679,1.4804775037861782,1
602,Phenotype,HP:0002021,Pyloric stenosis,0.11459082674659604,1.4799878500127157,1
603,Phenotype,HP:0100725,Lichenification,0.11453974455752147,1.4789920967420371,1
604,Biological Process,GO:0023061,signal release,0.11453693313953217,1.478937293322121,1
605,Phenotype,HP:0100625,Enlarged thorax,0.11447041911376332,1.4776407247939272,1
606,Phenotype,HP:0001017,Anemic pallor,0.11446205411269872,1.477477664492084,1
607,Biological Process,GO:0050817,coagulation,0.11444843724558496,1.4772122287264957,1
608,Biological Process,GO:0001944,vasculature development,0.11443379683314325,1.4769268408283454,1
609,Biological Process,GO:0071322,cellular response to carbohydrate stimulus,0.11443028876287253,1.4768584574542356,1
610,Phenotype,HP:0200042,Skin ulcer,0.11442038095418416,1.476665322956959,1
611,Biological Process,GO:0044042,glucan metabolic process,0.11436673322813928,1.4756195592643404,1
612,Biological Process,GO:0010715,regulation of extracellular matrix disassembly,0.11426063696026156,1.473551407768487,1
613,Phenotype,HP:0005214,Intestinal obstruction,0.11424192378921028,1.473186628936243,1
614,Biological Process,GO:0001935,endothelial cell proliferation,0.11423268838121059,1.4730066016529895,1
615,Biological Process,GO:0042407,cristae formation,0.11421005421776098,1.4725653902896485,1
616,Disease,MONDO:0005045,hypertrophic cardiomyopathy,0.11420639519464681,1.4724940643676505,1
616,Disease,MONDO:0024573,familial hypertrophic cardiomyopathy,0.11420639519464681,1.4724940643676505,1
618,Biological Process,GO:0007176,regulation of epidermal growth factor-activated receptor activity,0.11416078007727437,1.4716048815988836,1
619,Phenotype,HP:0008364,Abnormality of the calcaneus,0.11415521147886798,1.4714963320207095,1
620,Biological Process,GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation",0.11414140991510524,1.4712272959338424,1
621,Biological Process,GO:0140962,multicellular organismal-level chemical homeostasis,0.11405820743481665,1.4696054166961496,1
622,Phenotype,HP:0000490,Deeply set eye,0.11397619176249485,1.468006672095715,1
623,Biological Process,GO:0051604,protein maturation,0.11395743487587173,1.467641041108847,1
624,Phenotype,HP:0002716,Lymphadenopathy,0.11390682640706562,1.4666545221430258,1
625,Phenotype,HP:0006758,Malignant genitourinary tract tumor,0.11373009763059683,1.4632095198755046,1
626,Biological Process,GO:0002573,myeloid leukocyte differentiation,0.11359993697014847,1.4606722773316125,1
627,Biological Process,GO:0036314,response to sterol,0.11359034958197878,1.4604853888426852,1
628,Phenotype,HP:0001423,X-linked dominant inheritance,0.11356080718672668,1.4599095142134084,1
629,Phenotype,HP:0030255,Large intestinal polyposis,0.11348770273483955,1.4584844774562422,1
630,Biological Process,GO:0009743,response to carbohydrate,0.11348205944108214,1.45837447182966,1
631,Biological Process,GO:0022409,positive regulation of cell-cell adhesion,0.11348200185418711,1.458373349279117,1
632,Biological Process,GO:1903146,regulation of autophagy of mitochondrion,0.11346040249079326,1.4579523094385456,1
633,Biological Process,GO:0030001,metal ion transport,0.11343630323627873,1.4574825388210664,1
634,Phenotype,HP:0002293,Alopecia of scalp,0.11341819588908642,1.4571295694100697,1
635,Biological Process,GO:0001837,epithelial to mesenchymal transition,0.11340738426085073,1.4569188166139957,1
636,Phenotype,HP:0003995,Abnormality of the radial head,0.11338123240923581,1.4564090343933895,1
637,Phenotype,HP:0005584,Renal cell carcinoma,0.1131774355409152,1.4524363894879788,1
638,Phenotype,HP:0002843,Abnormal T cell morphology,0.11316732914416894,1.4522393838819705,1
639,Biological Process,GO:0005976,polysaccharide metabolic process,0.11316176045561854,1.452130832546605,1
640,Biological Process,GO:0031346,positive regulation of cell projection organization,0.11311750987360536,1.4512682488835449,1
641,Disease,MONDO:0021058,neoplastic syndrome,0.1131051350373411,1.4510270242236882,1
642,Biological Process,GO:0030072,peptide hormone secretion,0.1130128557355603,1.4492282090548623,1
642,Biological Process,GO:0002790,peptide secretion,0.1130128557355603,1.4492282090548623,1
644,Biological Process,GO:0071407,cellular response to organic cyclic compound,0.1130026342756757,1.4490289605047197,1
645,Phenotype,HP:0009997,Duplication of phalanx of hand,0.11297276726590588,1.4484467581128007,1
646,Phenotype,HP:0033476,Extractable nuclear antigen positivity,0.11290118667062765,1.447051426135908,1
647,Biological Process,GO:0030855,epithelial cell differentiation,0.11285395885067928,1.4461308066982412,1
648,Phenotype,HP:0001446,Abnormality of the musculature of the upper limbs,0.11280273773060134,1.4451323452233233,1
649,Biological Process,GO:0042744,hydrogen peroxide catabolic process,0.11275384982810988,1.4441793655314892,1
650,Phenotype,HP:0033726,Lupus nephritis,0.11273005663506441,1.4437155610191117,1
651,Phenotype,HP:0010766,Ectopic calcification,0.11272600144122369,1.443636512477863,1
652,Biological Process,GO:0034375,high-density lipoprotein particle remodeling,0.1127206429140496,1.4435320578517732,1
653,Phenotype,HP:0011895,Anemia due to reduced life span of red cells,0.11264680477881683,1.4420927192879638,1
654,Biological Process,GO:0002704,negative regulation of leukocyte mediated immunity,0.11261142020194526,1.4414029620792423,1
655,Phenotype,HP:0003745,Sporadic,0.11257876689940705,1.4407664460373513,1
656,Phenotype,HP:0008011,Peripheral opacification of the cornea,0.11251338448792769,1.4394919362472482,1
657,Biological Process,GO:0002009,morphogenesis of an epithelium,0.11251181609264627,1.4394613632675173,1
658,Phenotype,HP:0012575,Abnormal nephron morphology,0.11248898903729143,1.4390163918314585,1
659,Disease,MONDO:0011060,early-onset non-syndromic cataract,0.11240207474952035,1.437322157737645,1
660,Phenotype,HP:0005181,Premature coronary artery atherosclerosis,0.11236772107553772,1.4366524960835976,1
661,Phenotype,HP:0005640,Abnormal vertebral segmentation and fusion,0.11234739305085306,1.4362562386515476,1
662,Phenotype,HP:0002039,Anorexia,0.11233287825331684,1.4359732993848136,1
663,Phenotype,HP:0002679,Abnormal sella turcica morphology,0.1123274736995713,1.4358679475554152,1
664,Phenotype,HP:0001460,Aplasia/Hypoplasia involving the skeletal musculature,0.11229837150355726,1.4353006538001962,1
665,Phenotype,HP:0012733,Macule,0.11229763747402821,1.4352863452453444,1
666,Biological Process,GO:0046456,icosanoid biosynthetic process,0.11220310263893951,1.4334435626054849,1
667,Phenotype,HP:0030148,Heart murmur,0.11220193622511077,1.433420825514417,1
668,Disease,MONDO:0000942,corneal disorder,0.1121737749853049,1.4328718739688573,1
669,Biological Process,GO:1900744,regulation of p38MAPK cascade,0.11213030563286774,1.432024518938704,1
670,Phenotype,HP:0010562,Keloids,0.1121042837337538,1.431517269902956,1
671,Biological Process,GO:0032655,regulation of interleukin-12 production,0.11210115286116529,1.4314562393035126,1
672,Disease,MONDO:0015356,hereditary neoplastic syndrome,0.11207726245529459,1.4309905398060057,1
673,Biological Process,GO:0001954,positive regulation of cell-matrix adhesion,0.11205341034722116,1.4305255868535778,1
674,Phenotype,HP:0009720,Adenoma sebaceum,0.11203678843710307,1.430201573304729,1
675,Phenotype,HP:0000095,Abnormal renal glomerulus morphology,0.11203059664898363,1.43008087578994,1
676,Disease,MONDO:0020297,Noonan syndrome and Noonan-related syndrome,0.11192392410063179,1.4280014907667586,1
677,Biological Process,GO:0070542,response to fatty acid,0.11187371173060323,1.4270226930176748,1
678,Biological Process,GO:0008015,blood circulation,0.111867360200268,1.4268988816223587,1
679,Phenotype,HP:0004275,Duplication of hand bones,0.11186711754185563,1.4268941514431681,1
679,Phenotype,HP:0009142,Duplication of bones involving the upper extremities,0.11186711754185563,1.4268941514431681,1
681,Phenotype,HP:0100733,Neoplasm of the parathyroid gland,0.11181169605523633,1.4258138115523604,1
682,Biological Process,GO:0003007,heart morphogenesis,0.1117640315614552,1.4248846799619244,1
683,Phenotype,HP:0009144,Supernumerary bones of the axial skeleton,0.11171701558568392,1.4239681900366383,1
684,Phenotype,HP:0002162,Low posterior hairline,0.11165403568196275,1.4227405127140038,1
684,Phenotype,HP:0030141,Abnormality of the posterior hairline,0.11165403568196275,1.4227405127140038,1
686,Phenotype,HP:0001928,Abnormality of coagulation,0.11163318922384202,1.422334149376178,1
687,Biological Process,GO:0034767,positive regulation of monoatomic ion transmembrane transport,0.11162029350173286,1.4220827710053487,1
688,Biological Process,GO:0051057,positive regulation of small GTPase mediated signal transduction,0.11159918046853057,1.42167121127688,1
689,Biological Process,GO:0032070,regulation of deoxyribonuclease activity,0.11157952975561058,1.4212881567912414,1
690,Biological Process,GO:0071827,plasma lipoprotein particle organization,0.11149293709822772,1.4196001922899577,1
691,Biological Process,GO:0055080,monoatomic cation homeostasis,0.1113728010985755,1.4172583620601429,1
692,Biological Process,GO:1903214,regulation of protein targeting to mitochondrion,0.11130019948055514,1.415843127123856,1
693,Biological Process,GO:0051100,negative regulation of binding,0.11129809931639101,1.415802188288358,1
694,Phenotype,HP:0012780,Neoplasm of the ear,0.11124130770062379,1.4146951402512276,1
695,Biological Process,GO:0018208,peptidyl-proline modification,0.1110902931019716,1.4117513885590551,1
696,Phenotype,HP:0006740,Transitional cell carcinoma of the bladder,0.11105158538003335,1.410996852752763,1
697,Phenotype,HP:0002863,Myelodysplasia,0.11100151953730308,1.4100209112837088,1
698,Biological Process,GO:0043903,regulation of biological process involved in symbiotic interaction,0.11098804544801188,1.409758258709021,1
699,Biological Process,GO:0010155,regulation of proton transport,0.11097720473610517,1.4095469389803024,1
700,Phenotype,HP:0012450,Chronic constipation,0.11089870587228245,1.4080167480896588,1
701,Biological Process,GO:1903579,negative regulation of ATP metabolic process,0.11089551473379944,1.4079545427175082,1
702,Biological Process,GO:0010644,cell communication by electrical coupling,0.11086872039038309,1.4074322363015954,1
703,Phenotype,HP:0012131,Abnormal number of erythroid precursors,0.11080334158945726,1.4061577968925891,1
704,Phenotype,HP:0005266,Intestinal polyp,0.11079641862543044,1.4060228464490512,1
705,Phenotype,HP:0200008,Intestinal polyposis,0.11073437238838069,1.4048133692399716,1
706,Phenotype,HP:0002665,Lymphoma,0.11070415025105529,1.404224244289889,1
707,Phenotype,HP:0025300,Malar rash,0.11065602775208605,1.4032861847311668,1
708,Biological Process,GO:0097746,blood vessel diameter maintenance,0.110623879396756,1.4026595117058565,1
708,Biological Process,GO:0035296,regulation of tube diameter,0.110623879396756,1.4026595117058565,1
708,Biological Process,GO:0035150,regulation of tube size,0.110623879396756,1.4026595117058565,1
711,Phenotype,HP:0001878,Hemolytic anemia,0.11059819701505769,1.4021588809373202,1
712,Biological Process,GO:0002690,positive regulation of leukocyte chemotaxis,0.11054438696724234,1.4011099530805033,1
713,Biological Process,GO:0010758,regulation of macrophage chemotaxis,0.11054370657630308,1.4010966901112496,1
714,Biological Process,GO:0021700,developmental maturation,0.11053053347256847,1.400839904696091,1
715,Biological Process,GO:0005975,carbohydrate metabolic process,0.11044545270798567,1.3991814117626442,1
716,Biological Process,GO:0007160,cell-matrix adhesion,0.11041619473998798,1.3986110815192676,1
717,Biological Process,GO:0002832,negative regulation of response to biotic stimulus,0.1103236817764186,1.3968077115438755,1
718,Biological Process,GO:0006821,chloride transport,0.1102860863702686,1.3960748582869074,1
719,Phenotype,HP:0031263,Abnormal renal corpuscle morphology,0.11026150987434857,1.3955957847264837,1
720,Phenotype,HP:0033401,Tissue ischemia,0.11022528615919236,1.3948896700611495,1
720,Phenotype,HP:0002637,Cerebral ischemia,0.11022528615919236,1.3948896700611495,1
722,Biological Process,GO:0006091,generation of precursor metabolites and energy,0.11020505360147226,1.3944952735818879,1
723,Biological Process,GO:0045446,endothelial cell differentiation,0.1101863256404837,1.3941302064470342,1
724,Biological Process,GO:0006476,protein deacetylation,0.11010003157035086,1.3924480623547069,1
725,Biological Process,GO:0016045,detection of bacterium,0.11008056629058516,1.3920686225471628,1
726,Biological Process,GO:1903706,regulation of hemopoiesis,0.11004376356463608,1.3913512211319614,1
727,Biological Process,GO:1903533,regulation of protein targeting,0.11003782149553254,1.3912353914298354,1
728,Disease,MONDO:0019695,acromelic dysplasia,0.1100097412530836,1.3906880187786916,1
729,Biological Process,GO:0045599,negative regulation of fat cell differentiation,0.10998704444345675,1.3902455862434118,1
730,Phenotype,HP:0000829,Hypoparathyroidism,0.1099404345145808,1.3893370114551116,1
731,Biological Process,GO:0046457,prostanoid biosynthetic process,0.10990839232593896,1.388712407954012,1
731,Biological Process,GO:0001516,prostaglandin biosynthetic process,0.10990839232593896,1.388712407954012,1
733,Phenotype,HP:0003221,Chromosomal breakage induced by crosslinking agents,0.10989401628516982,1.3884321734951013,1
734,Phenotype,HP:0025074,Abnormal QRS complex,0.10984237995252755,1.3874256182153475,1
735,Biological Process,GO:0046364,monosaccharide biosynthetic process,0.10983410673941307,1.387264347150677,1
736,Phenotype,HP:0031064,Impaired continence,0.10981462092890903,1.3868845071341713,1
737,Biological Process,GO:0001952,regulation of cell-matrix adhesion,0.10973417407039765,1.3853163436719205,1
738,Phenotype,HP:0008069,Neoplasm of the skin,0.10970496875659108,1.3847470398251014,1
739,Biological Process,GO:1903587,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,0.10963429024955751,1.383369292398447,1
740,Biological Process,GO:1902305,regulation of sodium ion transmembrane transport,0.10956484474049522,1.382015579998186,1
741,Biological Process,GO:1902905,positive regulation of supramolecular fiber organization,0.10953605028762725,1.3814542851292675,1
742,Phenotype,HP:0000421,Epistaxis,0.1095026686812689,1.3808035721446827,1
743,Biological Process,GO:2000107,negative regulation of leukocyte apoptotic process,0.10948933151596252,1.380543588651101,1
744,Biological Process,GO:0001678,intracellular glucose homeostasis,0.1094864272277628,1.3804869748973396,1
745,Phenotype,HP:0001034,Hypermelanotic macule,0.10939115137807509,1.3786297475415437,1
746,Biological Process,GO:1904894,positive regulation of receptor signaling pathway via STAT,0.10930822344263691,1.3770132200504714,1
747,Biological Process,GO:0030010,establishment of cell polarity,0.10929727161252034,1.3767997342767397,1
748,Phenotype,HP:0004823,Anisopoikilocytosis,0.109281631267232,1.3764948545278968,1
749,Biological Process,GO:0050801,monoatomic ion homeostasis,0.10927879885920433,1.37643964194581,1
750,Phenotype,HP:0001888,Lymphopenia,0.10925865598851592,1.3760469937501822,1
751,Phenotype,HP:0002948,Vertebral fusion,0.10920360376483573,1.3749738519608268,1
752,Biological Process,GO:0046598,positive regulation of viral entry into host cell,0.10915284122345437,1.373984329633687,1
752,Biological Process,GO:0075294,positive regulation by symbiont of entry into host,0.10915284122345437,1.373984329633687,1
754,Biological Process,GO:1901888,regulation of cell junction assembly,0.10908901354148304,1.3727401264342116,1
755,Biological Process,GO:0009615,response to virus,0.10906993754507821,1.3723682749893993,1
756,Biological Process,GO:0044403,biological process involved in symbiotic interaction,0.10900331353253656,1.3710695624714757,1
757,Biological Process,GO:0031349,positive regulation of defense response,0.10899156177022795,1.3708404834917562,1
758,Phenotype,HP:0001097,Keratoconjunctivitis sicca,0.108971481225839,1.3704490502326387,1
759,Biological Process,GO:0045744,negative regulation of G protein-coupled receptor signaling pathway,0.10893786494219548,1.3697937626462509,1
760,Biological Process,GO:0051701,biological process involved in interaction with host,0.10892340077694418,1.369511810362734,1
761,Phenotype,HP:0002840,Lymphadenitis,0.1089173081361623,1.369393045542832,1
762,Biological Process,GO:1903747,regulation of establishment of protein localization to mitochondrion,0.10889845364958739,1.3690255120245147,1
763,Biological Process,GO:0007034,vacuolar transport,0.10884151915900009,1.3679156789056957,1
764,Biological Process,GO:0045786,negative regulation of cell cycle,0.10883569160643314,1.3678020814927085,1
765,Phenotype,HP:0001007,Hirsutism,0.10879227587296092,1.366955771665603,1
766,Biological Process,GO:0071345,cellular response to cytokine stimulus,0.1087778327037392,1.3666742286610443,1
767,Phenotype,HP:0010280,Stomatitis,0.10877519950013503,1.3666228992026026,1
768,Phenotype,HP:0007550,Hypohidrosis or hyperhidrosis,0.10872732005405927,1.3656895775127544,1
769,Biological Process,GO:0050688,regulation of defense response to virus,0.10870981869892182,1.3653484208016748,1
770,Phenotype,HP:0200097,Oral mucosal blisters,0.10863498073552613,1.363889592427789,1
771,Biological Process,GO:0030595,leukocyte chemotaxis,0.10860622296110889,1.3633290125377688,1
772,Biological Process,GO:0001916,positive regulation of T cell mediated cytotoxicity,0.10844723939485235,1.3602299204872497,1
773,Disease,MONDO:0019293,skin vascular disease,0.10832283787886776,1.357804941866263,1
774,Biological Process,GO:1905521,regulation of macrophage migration,0.10832169406621328,1.357782645343495,1
775,Biological Process,GO:0001503,ossification,0.10827516845202878,1.3568757141149423,1
776,Biological Process,GO:0097529,myeloid leukocyte migration,0.10826003598743883,1.3565807345656737,1
777,Disease,MONDO:0017855,T-B- severe combined immunodeficiency,0.10824779246480765,1.3563420696234405,1
778,Biological Process,GO:0150116,regulation of cell-substrate junction organization,0.10820345969671918,1.3554778838940882,1
779,Phenotype,HP:0100735,Hypertensive crisis,0.10815418425908185,1.354517349917757,1
780,Phenotype,HP:0001084,Corneal arcus,0.10815356019314093,1.3545051849006924,1
781,Biological Process,GO:0009725,response to hormone,0.10810617570460157,1.3535815114971579,1
782,Phenotype,HP:0005914,Aplasia/Hypoplasia involving the metacarpal bones,0.1080410306991505,1.3523116295006836,1
783,Phenotype,HP:0020085,Infection following live vaccination,0.10803937619016746,1.3522793778928126,1
784,Disease,MONDO:0004805,leukocyte disorder,0.10795974738925074,1.3507271609579177,1
785,Biological Process,GO:0034113,heterotypic cell-cell adhesion,0.10778711812887654,1.3473620712124192,1
786,Phenotype,HP:0004387,Enterocolitis,0.10775112144186816,1.3466603820430325,1
787,Phenotype,HP:0040133,Abnormal circulating ferritin concentration,0.10772755669821632,1.3462010307311738,1
788,Phenotype,HP:0008843,Hip osteoarthritis,0.10768973381229274,1.3454637431746455,1
789,Phenotype,HP:0004552,Scarring alopecia of scalp,0.10764509771921715,1.3445936446828708,1
790,Biological Process,GO:0005977,glycogen metabolic process,0.10750428800125134,1.3418488183598813,1
791,Biological Process,GO:0032732,positive regulation of interleukin-1 production,0.10749938263850067,1.3417531973402788,1
792,Phenotype,HP:0001618,Dysphonia,0.1074571533052967,1.3409300142030987,1
793,Phenotype,HP:0001325,Hypoglycemic coma,0.10736955201717324,1.3392223883016858,1
794,Phenotype,HP:0200034,Papule,0.10734945848777777,1.3388307019237624,1
795,Phenotype,HP:0001844,Abnormal hallux morphology,0.10733111053295474,1.3384730423097897,1
796,Biological Process,GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,0.10730646505443886,1.3379926240606068,1
797,Phenotype,HP:0003974,Absent radius,0.1072724262728525,1.3373291006543357,1
798,Biological Process,GO:0042113,B cell activation,0.10726136122892527,1.33711340798571,1
799,Biological Process,GO:0051251,positive regulation of lymphocyte activation,0.10725716040476263,1.3370315206493357,1
800,Phenotype,HP:0000039,Epispadias,0.10724268735559495,1.3367493951902176,1
801,Phenotype,HP:0100751,Esophageal neoplasm,0.10723384114583989,1.336576954610511,1
802,Phenotype,HP:0002916,Abnormality of chromosome segregation,0.10715903412826655,1.3351187294684828,1
803,Biological Process,GO:0045664,regulation of neuron differentiation,0.1071583977351428,1.3351063241556742,1
804,Phenotype,HP:0001004,Lymphedema,0.10715329517904215,1.335006859214604,1
805,Phenotype,HP:0009999,Partial duplication of the phalanx of hand,0.1071437320229307,1.3348204430850588,1
806,Biological Process,GO:0002285,lymphocyte activation involved in immune response,0.10713719499012309,1.3346930156604193,1
807,Disease,MONDO:0003689,familial hemolytic anemia,0.10712573116806223,1.3344695495459404,1
808,Biological Process,GO:0039702,viral budding via host ESCRT complex,0.10707552306793322,1.3334908350306904,1
809,Phenotype,HP:0012286,Abnormal hypothalamus morphology,0.10701538895451734,1.3323186311530177,1
810,Phenotype,HP:0012410,Pure red cell aplasia,0.10698305066096381,1.3316882556315792,1
811,Phenotype,HP:0031640,Abnormal radial artery morphology,0.10690205301838207,1.3301093556474715,1
811,Phenotype,HP:0020118,Radial artery aplasia,0.10690205301838207,1.3301093556474715,1
811,Phenotype,HP:0030270,Elevated red cell adenosine deaminase activity,0.10690205301838207,1.3301093556474715,1
814,Biological Process,GO:0050900,leukocyte migration,0.1068054099324397,1.3282254765369832,1
815,Phenotype,HP:0004602,Cervical C2/C3 vertebral fusion,0.10679135010666263,1.32795140610742,1
816,Phenotype,HP:0009944,Partial duplication of thumb phalanx,0.10677392455879653,1.327611727119589,1
817,Phenotype,HP:0030448,Soft tissue sarcoma,0.10674926614843017,1.3271310567877794,1
818,Biological Process,GO:0022904,respiratory electron transport chain,0.10674150942001781,1.3269798536419022,1
819,Phenotype,HP:0011227,Elevated circulating C-reactive protein concentration,0.10669442667109996,1.3260620620970047,1
820,Biological Process,GO:0051897,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,0.10664096457877736,1.3250199169921848,1
821,Disease,MONDO:0019254,inborn disorder of purine or pyrimidine metabolism,0.106610204146108,1.3244202989649836,1
822,Phenotype,HP:0012122,Anterior uveitis,0.10657447201672288,1.3237237668596034,1
823,Biological Process,GO:1904375,regulation of protein localization to cell periphery,0.10656044728343705,1.323450380493577,1
824,Biological Process,GO:0030857,negative regulation of epithelial cell differentiation,0.10654518261555534,1.3231528238844263,1
825,Phenotype,HP:0100743,Neoplasm of the rectum,0.10652735586654127,1.3228053242185365,1
826,Biological Process,GO:0045666,positive regulation of neuron differentiation,0.10650108949361337,1.3222933096156844,1
827,Phenotype,HP:4000074,Involuntary vocalization,0.1064622184854247,1.3215355908444326,1
827,Phenotype,HP:4000072,Abnormal language feature,0.1064622184854247,1.3215355908444326,1
829,Biological Process,GO:0016050,vesicle organization,0.10631276171846193,1.318622206214205,1
830,Phenotype,HP:0002202,Pleural effusion,0.10626084942640801,1.3176102716135625,1
831,Phenotype,HP:0003189,Long nose,0.10618936492764808,1.3162168128614498,1
832,Phenotype,HP:0000283,Broad face,0.10613737525794797,1.3152033699259913,1
833,Biological Process,GO:0071478,cellular response to radiation,0.10613206849909873,1.3150999244281265,1
834,Biological Process,GO:0071402,cellular response to lipoprotein particle stimulus,0.10611369712428687,1.3147418082845708,1
835,Biological Process,GO:0006109,regulation of carbohydrate metabolic process,0.10603910545732997,1.3132877810065058,1
836,Phenotype,HP:0001319,Neonatal hypotonia,0.10599701424666863,1.3124672903141104,1
837,Biological Process,GO:0061919,process utilizing autophagic mechanism,0.1059514126516079,1.3115783711379256,1
837,Biological Process,GO:0006914,autophagy,0.1059514126516079,1.3115783711379256,1
839,Phenotype,HP:0000337,Broad forehead,0.10591105922472199,1.3107917553422306,1
840,Biological Process,GO:0034377,plasma lipoprotein particle assembly,0.10584613959953881,1.309526266719317,1
841,Biological Process,GO:0051346,negative regulation of hydrolase activity,0.10584200935055654,1.3094457551162062,1
842,Biological Process,GO:0010975,regulation of neuron projection development,0.10578976830049469,1.3084274119832044,1
843,Biological Process,GO:0002042,cell migration involved in sprouting angiogenesis,0.10576559491960513,1.307956196408457,1
844,Biological Process,GO:0009306,protein secretion,0.10572942647618522,1.3072511591639064,1
845,Phenotype,HP:0006716,Hereditary nonpolyposis colorectal carcinoma,0.10565436035238118,1.305787883222738,1
846,Disease,MONDO:0002412,disorder of glycogen metabolism,0.10561624658926916,1.3050449255507153,1
847,Biological Process,GO:0090023,positive regulation of neutrophil chemotaxis,0.10558933920198033,1.3045204155525403,1
848,Biological Process,GO:0051560,mitochondrial calcium ion homeostasis,0.10556912747209857,1.3041264250736584,1
849,Biological Process,GO:0050673,epithelial cell proliferation,0.10552287703500529,1.3032248579160974,1
850,Phenotype,HP:0001697,Abnormal pericardium morphology,0.10549053036060552,1.3025943190254845,1
851,Biological Process,GO:0051249,regulation of lymphocyte activation,0.10545274248406944,1.3018577139125387,1
852,Biological Process,GO:0050852,T cell receptor signaling pathway,0.1054427182899127,1.3016623106947376,1
853,Phenotype,HP:0010055,Broad hallux,0.10543858916898552,1.3015818210809846,1
854,Phenotype,HP:0100879,Enlarged ovaries,0.10540413872772258,1.3009102731268862,1
855,Disease,MONDO:0007254,breast cancer,0.10528206977141863,1.2985307634643197,1
855,Disease,MONDO:0004989,breast carcinoma,0.10528206977141863,1.2985307634643197,1
855,Disease,MONDO:0016419,hereditary breast carcinoma,0.10528206977141863,1.2985307634643197,1
858,Phenotype,HP:0032235,Anti-La/SS-B antibody positivity,0.10524811813836199,1.2978689388582583,1
858,Phenotype,HP:0012085,Pyuria,0.10524811813836199,1.2978689388582583,1
860,Phenotype,HP:0001182,Tapered finger,0.10522907471279153,1.2974977223219224,1
861,Phenotype,HP:4000209,Abnormal erythrocyte adenosine deaminase activity,0.10522863113159486,1.2974890755228055,1
862,Biological Process,GO:0050708,regulation of protein secretion,0.10515305431386235,1.296015844543319,1
863,Biological Process,GO:0090398,cellular senescence,0.10513489526157871,1.2956618672367188,1
864,Phenotype,HP:0000466,Limited neck range of motion,0.10509828799093812,1.2949482758630646,1
865,Biological Process,GO:0032148,activation of protein kinase B activity,0.10509772264552486,1.2949372554946248,1
866,Phenotype,HP:0002105,Hemoptysis,0.10503948282130482,1.2938019772988099,1
867,Biological Process,GO:0042391,regulation of membrane potential,0.10498584240614328,1.292756356118408,1
868,Phenotype,HP:0008331,Elevated creatine kinase after exercise,0.10494754914401927,1.292009899443474,1
869,Biological Process,GO:0030225,macrophage differentiation,0.10494642410868038,1.291987968949918,1
870,Biological Process,GO:0002250,adaptive immune response,0.10493979445143353,1.2918587359822904,1
871,Biological Process,GO:1902624,positive regulation of neutrophil migration,0.10492764680921673,1.2916219400522893,1
872,Biological Process,GO:0034764,positive regulation of transmembrane transport,0.10490105798697646,1.2911036398934883,1
873,Biological Process,GO:0098771,inorganic ion homeostasis,0.10490004301821099,1.2910838549452281,1
874,Phenotype,HP:0002605,Hepatic necrosis,0.10487975128491178,1.2906883049469513,1
875,Biological Process,GO:0044319,"wound healing, spreading of cells",0.10475072742962022,1.2881732223275553,1
875,Biological Process,GO:0090505,epiboly involved in wound healing,0.10475072742962022,1.2881732223275553,1
877,Biological Process,GO:0015802,basic amino acid transport,0.10470629733313996,1.2873071393603162,1
878,Phenotype,HP:0011839,Abnormal T cell count,0.10469603795920757,1.2871071517455843,1
879,Biological Process,GO:0007163,establishment or maintenance of cell polarity,0.10469282109791489,1.2870444449545964,1
880,Disease,MONDO:0021118,intestinal neoplasm,0.10468784220996175,1.2869473906964783,1
881,Biological Process,GO:0141091,transforming growth factor beta receptor superfamily signaling pathway,0.1045913816022872,1.2850670686640109,1
882,Biological Process,GO:0032965,regulation of collagen biosynthetic process,0.10449512085710588,1.2831906425830468,1
883,Phenotype,HP:0002097,Emphysema,0.10448475802777801,1.2829886382957667,1
884,Phenotype,HP:0001785,Ankle swelling,0.10438522104857917,1.281048348061806,1
885,Phenotype,HP:0045042,Decreased circulating complement C4 concentration,0.10429238930461426,1.2792387640492469,1
886,Phenotype,HP:0006753,Neoplasm of the stomach,0.10428686629831208,1.2791311032052421,1
887,Biological Process,GO:0097190,apoptotic signaling pathway,0.10424808816678754,1.2783751948936388,1
888,Biological Process,GO:1902475,L-alpha-amino acid transmembrane transport,0.1042272120403327,1.2779682532262375,1
889,Biological Process,GO:0007264,small GTPase-mediated signal transduction,0.10422161858549739,1.2778592191177243,1
890,Biological Process,GO:0022414,reproductive process,0.10421761209164693,1.2777811198931641,1
891,Phenotype,HP:0005374,Cellular immunodeficiency,0.1041999358555199,1.277436554199022,1
892,Biological Process,GO:0070665,positive regulation of leukocyte proliferation,0.10418878828310896,1.2772192527894815,1
893,Biological Process,GO:0043112,receptor metabolic process,0.10413164912149253,1.276105429985601,1
894,Biological Process,GO:0070203,regulation of establishment of protein localization to telomere,0.10410319037561988,1.2755506791067626,1
895,Biological Process,GO:0016485,protein processing,0.10406901194217288,1.2748844334444667,1
896,Biological Process,GO:0048469,cell maturation,0.10401374481251724,1.273807102458606,1
897,Biological Process,GO:0002520,immune system development,0.10388652190958014,1.2713271260911108,1
898,Biological Process,GO:0036315,cellular response to sterol,0.1038281291968769,1.2701888676156727,1
899,Phenotype,HP:0030681,Abnormal morphology of myocardial trabeculae,0.10381112023205552,1.269857309147671,1
900,Biological Process,GO:0032355,response to estradiol,0.10378548619944639,1.2693576208556525,1
901,Disease,MONDO:0016342,familial isolated arrhythmogenic right ventricular dysplasia,0.10378401915159574,1.2693290234575774,1
901,Disease,MONDO:0016587,arrhythmogenic right ventricular cardiomyopathy,0.10378401915159574,1.2693290234575774,1
903,Phenotype,HP:0011335,Frontal hirsutism,0.10376113299296874,1.2688828999119939,1
904,Biological Process,GO:0016051,carbohydrate biosynthetic process,0.1037135473631452,1.2679553056292798,1
905,Biological Process,GO:0042326,negative regulation of phosphorylation,0.10371316594600255,1.2679478706039966,1
906,Biological Process,GO:0055010,ventricular cardiac muscle tissue morphogenesis,0.10364655700381398,1.2666494518548728,1
907,Biological Process,GO:0071559,response to transforming growth factor beta,0.10361770027112938,1.266086942955541,1
908,Phenotype,HP:0001924,Sideroblastic anemia,0.1035907325003187,1.26556125589173,1
909,Biological Process,GO:1905952,regulation of lipid localization,0.10356793000215314,1.2651167631528841,1
910,Biological Process,GO:0015980,energy derivation by oxidation of organic compounds,0.10350758925631376,1.2639405313563759,1
911,Biological Process,GO:0001933,negative regulation of protein phosphorylation,0.10348091497207168,1.2634205652731236,1
912,Biological Process,GO:2000377,regulation of reactive oxygen species metabolic process,0.10346494024009911,1.2631091672712353,1
913,Biological Process,GO:0098543,detection of other organism,0.1034645411202183,1.2631013871636496,1
914,Biological Process,GO:2000811,negative regulation of anoikis,0.10344665791098873,1.262752786909761,1
915,Phenotype,HP:0025269,Panic attack,0.10341355867510726,1.2621075782179836,1
916,Biological Process,GO:0060429,epithelium development,0.1034020517654326,1.2618832721897666,1
917,Phenotype,HP:0033028,Anti-U1 ribonucleoprotein antibody positivity,0.10327942968314952,1.2594929803541413,1
918,Phenotype,HP:0031936,Delayed ability to walk,0.10316820176784391,1.2573247968353292,1
919,Biological Process,GO:0010976,positive regulation of neuron projection development,0.10312079982228106,1.2564007831392474,1
920,Phenotype,HP:0008897,Postnatal growth retardation,0.103076419225268,1.2555356650730285,1
921,Phenotype,HP:0002897,Parathyroid adenoma,0.10305365819598555,1.2550919806937446,1
922,Phenotype,HP:0031058,Impairment of activities of daily living,0.10304377431261136,1.2548993125764387,1
923,Phenotype,HP:0100273,Neoplasm of the colon,0.10301082333745748,1.2542569939547048,1
924,Biological Process,GO:0090504,epiboly,0.10299731552369351,1.2539936839834827,1
925,Disease,MONDO:0003240,thyroid gland disorder,0.10298434904930842,1.253740926427238,1
926,Biological Process,GO:0071825,protein-lipid complex organization,0.10297199685862346,1.2535001432012753,1
927,Biological Process,GO:0002429,immune response-activating cell surface receptor signaling pathway,0.10293972846663324,1.2528711302821756,1
928,Phenotype,HP:0011546,Abnormal atrioventricular connection,0.10293162756826524,1.252713218176381,1
929,Phenotype,HP:0010975,Abnormal B cell count,0.10292665239408094,1.252616236311352,1
930,Biological Process,GO:0051154,negative regulation of striated muscle cell differentiation,0.10286365240172435,1.2513881673977385,1
931,Biological Process,GO:0002253,activation of immune response,0.10279718490028711,1.2500925057757717,1
932,Phenotype,HP:0100723,Gastrointestinal stroma tumor,0.10279373064200525,1.2500251713673558,1
933,Biological Process,GO:1905562,regulation of vascular endothelial cell proliferation,0.10270180165868337,1.2482331850122035,1
934,Biological Process,GO:2000648,positive regulation of stem cell proliferation,0.10269553955618427,1.248111116847981,1
935,Biological Process,GO:0006897,endocytosis,0.10264148155508523,1.247057355598201,1
936,Biological Process,GO:0032733,positive regulation of interleukin-10 production,0.10258578540836538,1.2459716617141834,1
937,Biological Process,GO:1903531,negative regulation of secretion by cell,0.10257201938408689,1.2457033184041593,1
938,Biological Process,GO:0032673,regulation of interleukin-4 production,0.10257047553176468,1.2456732238442523,1
939,Biological Process,GO:0035592,establishment of protein localization to extracellular region,0.10255335175558478,1.2453394273401006,1
940,Phenotype,HP:0032170,Severe varicella zoster infection,0.10250894463512084,1.2444737922480171,1
941,Biological Process,GO:0009887,animal organ morphogenesis,0.10250804762021748,1.2444563065932313,1
942,Biological Process,GO:0032649,regulation of type II interferon production,0.10249506475699188,1.2442032295667007,1
943,Phenotype,HP:0010984,Digenic inheritance,0.10246874993813582,1.243690270599633,1
944,Phenotype,HP:0007987,Progressive visual field defects,0.10243389640826617,1.2430108651749412,1
945,Phenotype,HP:0000992,Cutaneous photosensitivity,0.10242420908181082,1.2428220285730494,1
946,Biological Process,GO:0031279,regulation of cyclase activity,0.10241669775903683,1.2426756091584779,1
947,Biological Process,GO:0030183,B cell differentiation,0.1023505412632586,1.241386010019497,1
948,Biological Process,GO:0061337,cardiac conduction,0.10233882757130042,1.2411576731511993,1
949,Biological Process,GO:0098609,cell-cell adhesion,0.10229985267035124,1.2403979291817728,1
950,Disease,MONDO:0016789,pyruvate metabolism disorder,0.1022682228402867,1.2397813638522837,1
951,Biological Process,GO:1901861,regulation of muscle tissue development,0.10220391004440565,1.238527704249882,1
952,Phenotype,HP:0001895,Normochromic anemia,0.10215711957793205,1.2376156102133549,1
953,Phenotype,HP:0010651,Abnormal meningeal morphology,0.10214877504204478,1.2374529488424821,1
954,Disease,MONDO:0015979,hereditary predisposition to infections,0.10203158258706879,1.2351684975991954,1
955,Phenotype,HP:0011104,Abnormality of blood volume homeostasis,0.10194441854916003,1.2334693950860571,1
955,Phenotype,HP:0011106,Hypovolemia,0.10194441854916003,1.2334693950860571,1
957,Phenotype,HP:0001677,Coronary artery atherosclerosis,0.1018881897278262,1.2323733176907086,1
958,Biological Process,GO:0086065,cell communication involved in cardiac conduction,0.10187412471612711,1.232099146171139,1
959,Phenotype,HP:0003953,Absent forearm bone,0.10186608631329364,1.231942452300781,1
959,Phenotype,HP:0009822,Aplasia involving forearm bones,0.10186608631329364,1.231942452300781,1
961,Biological Process,GO:0032970,regulation of actin filament-based process,0.10181289597286414,1.2309056044990183,1
962,Phenotype,HP:0009136,Duplication involving bones of the feet,0.1017867112871591,1.230395182238249,1
963,Biological Process,GO:0003279,cardiac septum development,0.10172751834923333,1.2292413248447331,1
964,Phenotype,HP:0002164,Nail dysplasia,0.10171186191877735,1.2289361315451481,1
965,Biological Process,GO:0006820,monoatomic anion transport,0.10163107794265358,1.2273613965954333,1
966,Biological Process,GO:0050691,regulation of defense response to virus by host,0.10160530447952842,1.2268589903620957,1
967,Phenotype,HP:0001264,Spastic diplegia,0.10159662517838797,1.2266898033586728,1
968,Biological Process,GO:0002228,natural killer cell mediated immunity,0.10159335106660816,1.226625980574795,1
969,Biological Process,GO:0002697,regulation of immune effector process,0.10159298984111831,1.2266189391486249,1
970,Phenotype,HP:0100238,Synostosis involving bones of the upper limbs,0.1015754547278156,1.2262771243842379,1
971,Biological Process,GO:0010817,regulation of hormone levels,0.10157437812650871,1.226256138023004,1
972,Phenotype,HP:0003281,Increased circulating ferritin concentration,0.10142390454730388,1.2233229325093322,1
973,Phenotype,HP:0001287,Meningitis,0.10140900231088268,1.22303244083453,1
974,Phenotype,HP:0005150,Abnormal atrioventricular conduction,0.1013987671489982,1.2228329251891157,1
975,Biological Process,GO:0045912,negative regulation of carbohydrate metabolic process,0.10108777182038009,1.2167706435749663,1
976,Biological Process,GO:0048738,cardiac muscle tissue development,0.1010706562225091,1.2164370064918966,1
976,Biological Process,GO:0014706,striated muscle tissue development,0.1010706562225091,1.2164370064918966,1
978,Biological Process,GO:0034114,regulation of heterotypic cell-cell adhesion,0.10106830206519313,1.2163911165273211,1
979,Biological Process,GO:0046827,positive regulation of protein export from nucleus,0.1010050711683117,1.215158546554924,1
980,Biological Process,GO:0061097,regulation of protein tyrosine kinase activity,0.10099693735936777,1.214999992918016,1
981,Biological Process,GO:0071479,cellular response to ionizing radiation,0.10097880021190664,1.2146464426056196,1
982,Biological Process,GO:0046328,regulation of JNK cascade,0.10097871620498489,1.214644805045276,1
983,Biological Process,GO:0034116,positive regulation of heterotypic cell-cell adhesion,0.10095965611146729,1.2142732635979845,1
984,Biological Process,GO:1901224,positive regulation of non-canonical NF-kappaB signal transduction,0.10089458776328541,1.2130048758939027,1
985,Phenotype,HP:0025420,Diffuse alveolar hemorrhage,0.10089441686190936,1.2130015444860822,1
986,Biological Process,GO:0007229,integrin-mediated signaling pathway,0.10088244346810948,1.2127681452083037,1
987,Phenotype,HP:0002846,Abnormal B cell morphology,0.1008534535396911,1.212203039903259,1
988,Phenotype,HP:0100653,Optic neuritis,0.1008394358732112,1.2119297912916094,1
988,Phenotype,HP:0033429,Neuroinflammation,0.1008394358732112,1.2119297912916094,1
990,Biological Process,GO:0007156,homophilic cell adhesion via plasma membrane adhesion molecules,0.10076292293169176,1.210438312301623,1
991,Phenotype,HP:0008675,Enlarged polycystic ovaries,0.1007554711791796,1.2102930540996804,1
992,Biological Process,GO:0002699,positive regulation of immune effector process,0.10070042012376323,1.209219935083478,1
993,Biological Process,GO:0015807,L-amino acid transport,0.10069182205083882,1.2090523314746444,1
994,Phenotype,HP:0006538,Recurrent bronchopulmonary infections,0.10067584307632849,1.2087408507722899,1
995,Biological Process,GO:0060284,regulation of cell development,0.10066790734133746,1.208586158222583,1
996,Phenotype,HP:0000585,Band keratopathy,0.10066161361044279,1.2084634735209938,1
997,Biological Process,GO:0030098,lymphocyte differentiation,0.10058999836230487,1.2070674660503722,1
998,Biological Process,GO:0046755,viral budding,0.10056199508640196,1.2065215937204035,1
999,Disease,MONDO:0024276,glandular cell neoplasm,0.10051565933814832,1.2056183635787674,1
999,Disease,MONDO:0004970,adenocarcinoma,0.10051565933814832,1.2056183635787674,1
1001,Biological Process,GO:0030217,T cell differentiation,0.10051251528694838,1.2055570760865468,1
1002,Biological Process,GO:0048261,negative regulation of receptor-mediated endocytosis,0.10048993379036386,1.2051168913668193,1
1003,Biological Process,GO:0019221,cytokine-mediated signaling pathway,0.10047503050614859,1.2048263792671998,1
1004,Biological Process,GO:0032368,regulation of lipid transport,0.10045838102643168,1.2045018282997577,1
1005,Biological Process,GO:0019433,triglyceride catabolic process,0.10045436550378406,1.2044235530754128,1
1006,Biological Process,GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,0.10045130571185723,1.2043639080626611,1
1007,Biological Process,GO:0072676,lymphocyte migration,0.10034645044796031,1.2023199476556234,1
1008,Biological Process,GO:0002252,immune effector process,0.10029585131613761,1.201333610697111,1
1009,Phenotype,HP:0100654,Retrobulbar optic neuritis,0.10027526179300028,1.2009322558339557,1
1010,Biological Process,GO:0071560,cellular response to transforming growth factor beta stimulus,0.10026572788611654,1.2007464098642777,1
1011,Phenotype,HP:0003115,Abnormal EKG,0.10021866513962263,1.199829008229825,1
1012,Biological Process,GO:0071277,cellular response to calcium ion,0.10017079162534626,1.1988958021694898,1
1013,Phenotype,HP:0012732,Anorectal anomaly,0.10014755357834715,1.198442819207664,1
1014,Biological Process,GO:0046006,regulation of activated T cell proliferation,0.10012807629554343,1.198063145422983,1
1015,Phenotype,HP:0002885,Medulloblastoma,0.10012365218515917,1.1979769055326264,1
1016,Disease,MONDO:0018751,hereditary otorhinolaryngologic disease,0.10007318948660116,1.1969932280895343,1
1016,Disease,MONDO:0024623,otorhinolaryngologic disease,0.10007318948660116,1.1969932280895343,1
1018,Biological Process,GO:0050687,negative regulation of defense response to virus,0.10006405348138592,1.196815138480635,1
1019,Biological Process,GO:1901163,regulation of trophoblast cell migration,0.09994759279000665,1.1945449516220192,1
1020,Phenotype,HP:0031393,Abnormal proportion of CD8-positive T cells,0.0999364327647978,1.1943274074681,1
1021,Phenotype,HP:0001003,Multiple lentigines,0.09993386799385862,1.1942774119785273,1
1022,Biological Process,GO:1902807,negative regulation of cell cycle G1/S phase transition,0.09993357653844381,1.1942717305915742,1
1023,Biological Process,GO:0002696,positive regulation of leukocyte activation,0.09989406572474624,1.193501539989345,1
1024,Disease,MONDO:0005129,cataract,0.09988446227717995,1.1933143384520348,1
1025,Biological Process,GO:0043409,negative regulation of MAPK cascade,0.0998244447169585,1.1921444065643976,1
1026,Biological Process,GO:0031334,positive regulation of protein-containing complex assembly,0.09981955108381269,1.1920490141918556,1
1027,Biological Process,GO:0043087,regulation of GTPase activity,0.09977061255508901,1.1910950476347908,1
1028,Biological Process,GO:0080164,regulation of nitric oxide metabolic process,0.09976858926990184,1.1910556074134704,1
1029,Biological Process,GO:0033500,carbohydrate homeostasis,0.09976396580826619,1.190965481537329,1
1030,Biological Process,GO:0043270,positive regulation of monoatomic ion transport,0.09969480334116687,1.189617286519261,1
1031,Biological Process,GO:1900745,positive regulation of p38MAPK cascade,0.09965497554388236,1.1888409169053415,1
1032,Biological Process,GO:0071404,cellular response to low-density lipoprotein particle stimulus,0.09949379753881915,1.1856990483086598,1
1032,Biological Process,GO:0055094,response to lipoprotein particle,0.09949379753881915,1.1856990483086598,1
1034,Phenotype,HP:0040273,Adenocarcinoma of the intestines,0.09943019165057543,1.1844591685697423,1
1035,Biological Process,GO:1903055,positive regulation of extracellular matrix organization,0.09942442664425499,1.1843467903807285,1
1036,Phenotype,HP:0000712,Emotional lability,0.09940040542042672,1.1838785408278798,1
1037,Biological Process,GO:0042593,glucose homeostasis,0.0992733284872599,1.1814014098724315,1
1038,Phenotype,HP:0100649,Neoplasm of the oral cavity,0.0992614006236282,1.1811688981214936,1
1039,Biological Process,GO:0003229,ventricular cardiac muscle tissue development,0.09921658329491567,1.1802952667745004,1
1040,Phenotype,HP:0012227,Urethral stricture,0.09921265808178104,1.1802187519679164,1
1041,Biological Process,GO:0045428,regulation of nitric oxide biosynthetic process,0.09918595996228496,1.1796983212602508,1
1042,Phenotype,HP:0000967,Petechiae,0.09907729351984107,1.1775800689410605,1
1043,Phenotype,HP:0001067,Neurofibroma,0.09901695317393666,1.1764038449405487,1
1044,Biological Process,GO:0032652,regulation of interleukin-1 production,0.0989614507694182,1.1753219277042082,1
1045,Biological Process,GO:0002251,organ or tissue specific immune response,0.09882027493767054,1.172569964666792,1
1046,Phenotype,HP:0002842,Recurrent Burkholderia cepacia infections,0.0987910923799803,1.1720011044085832,1
1047,Biological Process,GO:0016601,Rac protein signal transduction,0.09875896194941647,1.171374780793604,1
1048,Phenotype,HP:0007565,Multiple cafe-au-lait spots,0.09875827449832897,1.1713613801997529,1
1049,Biological Process,GO:0031294,lymphocyte costimulation,0.09875621845493388,1.1713213014174528,1
1050,Phenotype,HP:0000298,Mask-like facies,0.09875045182529041,1.171208891584744,1
1051,Biological Process,GO:0051873,killing by host of symbiont cells,0.0987284810289637,1.1707806113426855,1
1052,Phenotype,HP:0030080,Burkitt lymphoma,0.0986905812240122,1.17004182439126,1
1053,Phenotype,HP:0002816,Genu recurvatum,0.09868109106044298,1.1698568311169992,1
1054,Phenotype,HP:0000786,Primary amenorrhea,0.09858777577264366,1.1680378213072422,1
1055,Phenotype,HP:0010816,Epidermal nevus,0.09858521140719423,1.167987833721946,1
1056,Biological Process,GO:0060191,regulation of lipase activity,0.09855945577978809,1.167485775163128,1
1057,Phenotype,HP:0031192,Abnormal morphology of left ventricular trabeculae,0.09855450362121132,1.167389241945013,1
1057,Phenotype,HP:0030682,Left ventricular noncompaction,0.09855450362121132,1.167389241945013,1
1059,Biological Process,GO:2000629,negative regulation of miRNA metabolic process,0.09835575236680949,1.1635149519976262,1
1060,Phenotype,HP:0030875,Abnormality of pulmonary circulation,0.0983129511338503,1.1626806207271716,1
1061,Biological Process,GO:0030522,intracellular receptor signaling pathway,0.09829504938139388,1.1623316590072004,1
1062,Phenotype,HP:0002043,Esophageal stricture,0.09826751770420616,1.1617949796263123,1
1063,Biological Process,GO:0045730,respiratory burst,0.09821945216927674,1.1608580304767169,1
1064,Phenotype,HP:0000270,Delayed cranial suture closure,0.09821347816694437,1.1607415782950607,1
1065,Biological Process,GO:0007041,lysosomal transport,0.09819627663343422,1.1604062660548509,1
1066,Biological Process,GO:1904064,positive regulation of cation transmembrane transport,0.09818597688208697,1.1602054913567221,1
1067,Phenotype,HP:0004936,Venous thrombosis,0.0981739860670231,1.159971752483462,1
1068,Phenotype,HP:0001636,Tetralogy of Fallot,0.0980631275774203,1.157810770238881,1
1069,Biological Process,GO:0002757,immune response-activating signaling pathway,0.09799482452795294,1.156479327985982,1
1070,Biological Process,GO:0048872,homeostasis of number of cells,0.09796167048834736,1.155833050996457,1
1071,Phenotype,HP:0006744,Adrenocortical carcinoma,0.09795329856244472,1.15566985570764,1
1072,Phenotype,HP:0002249,Melena,0.09792254033753212,1.1550702807165938,1
1073,Biological Process,GO:0032570,response to progesterone,0.09786865682524992,1.1540199208051904,1
1074,Phenotype,HP:0000189,Narrow palate,0.09779891566354493,1.1526604452007425,1
1075,Biological Process,GO:2000649,regulation of sodium ion transmembrane transporter activity,0.09778117842641121,1.1523146904042336,1
1076,Phenotype,HP:0040276,Adenocarcinoma of the colon,0.09777899629518372,1.1522721537716776,1
1077,Biological Process,GO:0002639,positive regulation of immunoglobulin production,0.09775414032683605,1.1517876324105836,1
1078,Biological Process,GO:0002347,response to tumor cell,0.09775355757826643,1.151776272799637,1
1079,Phenotype,HP:0040071,Abnormal morphology of ulna,0.097730427526462,1.1513253950053903,1
1080,Biological Process,GO:0032388,positive regulation of intracellular transport,0.09772985749199214,1.1513142832324215,1
1081,Phenotype,HP:0003542,Increased serum pyruvate,0.09772643938366588,1.1512476535008638,1
1081,Phenotype,HP:0004366,Abnormality of glycolysis,0.09772643938366588,1.1512476535008638,1
1083,Phenotype,HP:0010614,Fibroma,0.09769322414429193,1.150600183534479,1
1084,Disease,MONDO:0005558,ovarian disorder,0.09768529564744743,1.1504456320791183,1
1085,Biological Process,GO:0002819,regulation of adaptive immune response,0.09768251380956106,1.150391405268873,1
1086,Phenotype,HP:0008362,Aplasia/Hypoplasia of the hallux,0.09767802991341967,1.1503039999652036,1
1087,Phenotype,HP:0011990,Abnormality of neutrophil physiology,0.09762794379045026,1.1493276631702083,1
1088,Phenotype,HP:0001102,Angioid streaks of the fundus,0.09756378322632464,1.1480769710457301,1
1089,Phenotype,HP:0031318,Myofiber disarray,0.09756184996489392,1.148039285671873,1
1090,Phenotype,HP:0009602,Abnormality of thumb phalanx,0.09755184832332242,1.1478443220752184,1
1091,Biological Process,GO:0007548,sex differentiation,0.09744692883985795,1.1457991098258928,1
1092,Disease,MONDO:0009299,46 XX gonadal dysgenesis,0.09739335626261025,1.1447548110207808,1
1093,Biological Process,GO:0006968,cellular defense response,0.09739199625163042,1.1447283001095248,1
1094,Biological Process,GO:0014070,response to organic cyclic compound,0.09733559439080974,1.1436288496278204,1
1095,Phenotype,HP:0000053,Macroorchidism,0.09730709558053308,1.1430733177671553,1
1096,Biological Process,GO:0022604,regulation of cell morphogenesis,0.09730415601046072,1.143016016258215,1
1097,Biological Process,GO:0002764,immune response-regulating signaling pathway,0.09729720492294325,1.142880517598982,1
1098,Phenotype,HP:0001241,Capitate-hamate fusion,0.09728375276432699,1.1426182925224437,1
1098,Phenotype,HP:0004259,Abnormality of the hamate bone,0.09728375276432699,1.1426182925224437,1
1098,Phenotype,HP:0004262,Abnormality of the capitate bone,0.09728375276432699,1.1426182925224437,1
1101,Phenotype,HP:0000488,Retinopathy,0.0972242509204474,1.1414584135758303,1
1102,Biological Process,GO:1904892,regulation of receptor signaling pathway via STAT,0.09720702209869148,1.1411225694014868,1
1103,Phenotype,HP:0000676,Abnormality of the incisor,0.09718748075281192,1.140741646825036,1
1104,Biological Process,GO:0050832,defense response to fungus,0.0971781322211267,1.140559414403712,1
1105,Biological Process,GO:0032870,cellular response to hormone stimulus,0.09712081712955944,1.1394421621691997,1
1106,Biological Process,GO:0002768,immune response-regulating cell surface receptor signaling pathway,0.09708772537440924,1.1387970993005114,1
1107,Biological Process,GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,0.09707317844122643,1.1385135336084855,1
1108,Biological Process,GO:0071398,cellular response to fatty acid,0.09703619751059533,1.137792658420954,1
1109,Biological Process,GO:0001816,cytokine production,0.09702731361988148,1.137619483320299,1
1110,Phenotype,HP:0100758,Gangrene,0.09701998154807634,1.137476558073494,1
1111,Biological Process,GO:0030947,regulation of vascular endothelial growth factor receptor signaling pathway,0.09688626378327048,1.1348699763262062,1
1112,Phenotype,HP:0000096,Glomerular sclerosis,0.09687755799431907,1.1347002729916535,1
1113,Biological Process,GO:0010712,regulation of collagen metabolic process,0.09687668470312816,1.1346832497869836,1
1114,Biological Process,GO:0002244,hematopoietic progenitor cell differentiation,0.09686128589367149,1.1343830783346864,1
1115,Biological Process,GO:0120035,regulation of plasma membrane bounded cell projection organization,0.09678385315411653,1.13287366957468,1
1116,Biological Process,GO:0050851,antigen receptor-mediated signaling pathway,0.0967748363959744,1.1326979044680232,1
1117,Biological Process,GO:0038084,vascular endothelial growth factor signaling pathway,0.09669040153860775,1.1310520023071078,1
1118,Phenotype,HP:0410151,Eosinophilic infiltration of the esophagus,0.09667713241362552,1.1307933451344325,1
1119,Biological Process,GO:0046637,regulation of alpha-beta T cell differentiation,0.09657101272568547,1.1287247371075633,1
1120,Phenotype,HP:0025065,Abnormal mean corpuscular volume,0.0965479919015475,1.1282759885056652,1
1121,Disease,MONDO:0045024,cancer or benign tumor,0.09649454774955935,1.1272341931146501,1
1121,Disease,MONDO:0023370,neoplastic disease or syndrome,0.09649454774955935,1.1272341931146501,1
1123,Phenotype,HP:0033834,Malaise,0.09648879593593884,1.1271220720930433,1
1124,Phenotype,HP:0006695,Atrioventricular canal defect,0.09646092480702895,1.1265787757255163,1
1125,Biological Process,GO:0042752,regulation of circadian rhythm,0.09643364547037558,1.1260470152589694,1
1126,Biological Process,GO:0001738,morphogenesis of a polarized epithelium,0.09634232354062844,1.1242668622961107,1
1127,Biological Process,GO:0000423,mitophagy,0.09633191004495867,1.1240638703617354,1
1128,Disease,MONDO:0002263,female reproductive system disorder,0.09624238339132596,1.122318713002924,1
1129,Phenotype,HP:0001054,Numerous nevi,0.09623986309381649,1.12226958444102,1
1130,Phenotype,HP:0001096,Keratoconjunctivitis,0.0962315509152677,1.1221075538169145,1
1131,Biological Process,GO:0008333,endosome to lysosome transport,0.09617265541946007,1.1209594945101164,1
1132,Phenotype,HP:0003396,Syringomyelia,0.09617213252121248,1.1209493015710568,1
1133,Phenotype,HP:0001829,Foot polydactyly,0.09616939035725869,1.1208958481311162,1
1134,Biological Process,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,0.09616710859573685,1.1208513693893192,1
1135,Biological Process,GO:0002836,positive regulation of response to tumor cell,0.09611633625970128,1.1198616561334207,1
1135,Biological Process,GO:0002839,positive regulation of immune response to tumor cell,0.09611633625970128,1.1198616561334207,1
1137,Phenotype,HP:0001917,Renal amyloidosis,0.09611460140391481,1.1198278383124771,1
1138,Biological Process,GO:0010948,negative regulation of cell cycle process,0.09605892028814822,1.118742437429232,1
1139,Biological Process,GO:0030574,collagen catabolic process,0.09596849576152566,1.1169797776888177,1
1140,Phenotype,HP:0011993,Impaired neutrophil bactericidal activity,0.09591962622599381,1.1160271560270612,1
1141,Biological Process,GO:1903039,positive regulation of leukocyte cell-cell adhesion,0.09590968672361944,1.1158334037197009,1
1142,Phenotype,HP:0001640,Cardiomegaly,0.09588041121828961,1.1152627316183077,1
1143,Phenotype,HP:0100742,Vascular neoplasm,0.09587864307045346,1.1152282648301222,1
1144,Disease,MONDO:0019512,congenital heart malformation,0.09584160773233852,1.1145063290688177,1
1145,Biological Process,GO:0010714,positive regulation of collagen metabolic process,0.09581966286101906,1.1140785541870666,1
1146,Phenotype,HP:0012288,Neoplasm of head and neck,0.09579172690021842,1.1135339940411382,1
1147,Biological Process,GO:0051347,positive regulation of transferase activity,0.09576786351053101,1.113068821174407,1
1148,Phenotype,HP:0005518,Increased mean corpuscular volume,0.09576468517317338,1.1130068653366383,1
1149,Phenotype,HP:0001254,Lethargy,0.09570208894153542,1.1117866669952032,1
1150,Phenotype,HP:0001601,Laryngomalacia,0.09568486683982547,1.1114509538157893,1
1151,Biological Process,GO:0071676,negative regulation of mononuclear cell migration,0.09566083992326557,1.1109825932936137,1
1152,Biological Process,GO:0042542,response to hydrogen peroxide,0.09561444329999214,1.1100781765054935,1
1153,Phenotype,HP:0010529,Echolalia,0.09560946940487414,1.1099812195735084,1
1154,Phenotype,HP:0200063,Colorectal polyposis,0.09560046494810892,1.1098056942595567,1
1155,Phenotype,HP:0005815,Supernumerary ribs,0.09559220389169687,1.1096446601674281,1
1156,Biological Process,GO:0002694,regulation of leukocyte activation,0.09548850088249572,1.1076231608452178,1
1157,Phenotype,HP:0002955,Granulomatosis,0.09546665189752634,1.107197255091404,1
1158,Biological Process,GO:0019319,hexose biosynthetic process,0.09546182028839534,1.1071030717628896,1
1159,Biological Process,GO:0046928,regulation of neurotransmitter secretion,0.09544427757029006,1.1067611087568716,1
1160,Biological Process,GO:0062012,regulation of small molecule metabolic process,0.09543115825676896,1.1065053718829363,1
1161,Biological Process,GO:1900371,regulation of purine nucleotide biosynthetic process,0.09542159555220586,1.1063189645554952,1
1161,Biological Process,GO:0030808,regulation of nucleotide biosynthetic process,0.09542159555220586,1.1063189645554952,1
1163,Phenotype,HP:0011343,Moderate global developmental delay,0.09540036353211412,1.105905085396585,1
1164,Biological Process,GO:0002286,T cell activation involved in immune response,0.09539801486140131,1.1058593023832415,1
1165,Biological Process,GO:0031400,negative regulation of protein modification process,0.09538354803782179,1.1055772982805079,1
1166,Biological Process,GO:0030097,hemopoiesis,0.09538114355745997,1.1055304273607618,1
1167,Phenotype,HP:0006707,Abnormality of the hepatic vasculature,0.0953748329311691,1.105407413314516,1
1168,Disease,MONDO:0005165,benign neoplasm,0.09535547642263631,1.1050300938019886,1
1169,Biological Process,GO:0110053,regulation of actin filament organization,0.09524909982850327,1.1029564778616654,1
1170,Biological Process,GO:0048754,branching morphogenesis of an epithelial tube,0.09521963404704015,1.1023820966772142,1
1170,Biological Process,GO:0061138,morphogenesis of a branching epithelium,0.09521963404704015,1.1023820966772142,1
1172,Biological Process,GO:0015833,peptide transport,0.09519448837575828,1.1018919280905513,1
1173,Disease,MONDO:0018997,Noonan syndrome,0.09517346140814531,1.1014820460523618,1
1174,Biological Process,GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,0.09515297017778368,1.1010826072259827,1
1175,Biological Process,GO:0048146,positive regulation of fibroblast proliferation,0.09511658319078642,1.1003733098765724,1
1176,Disease,MONDO:0004139,normocytic anemia,0.09510223218681024,1.100093563463866,1
1176,Disease,MONDO:0003664,hemolytic anemia,0.09510223218681024,1.100093563463866,1
1178,Phenotype,HP:0009370,Type A brachydactyly,0.09509953705799012,1.1000410268872989,1
1179,Phenotype,HP:0004390,Hamartomatous polyposis,0.09506064341131792,1.0992828668204715,1
1180,Biological Process,GO:0035088,establishment or maintenance of apical/basal cell polarity,0.09505958135080683,1.0992621639052924,1
1180,Biological Process,GO:0061245,establishment or maintenance of bipolar cell polarity,0.09505958135080683,1.0992621639052924,1
1182,Phenotype,HP:0000519,Developmental cataract,0.09504132708147128,1.0989063305174909,1
1183,Biological Process,GO:0050830,defense response to Gram-positive bacterium,0.09503413987471787,1.0987662291482776,1
1184,Biological Process,GO:0017157,regulation of exocytosis,0.09503018837348143,1.0986892019035264,1
1185,Biological Process,GO:0006909,phagocytosis,0.09500237424572389,1.0981470166685667,1
1186,Biological Process,GO:0043254,regulation of protein-containing complex assembly,0.09496846113573931,1.0974859429989021,1
1187,Phenotype,HP:0003042,Elbow dislocation,0.09496748367940822,1.097466889286517,1
1188,Biological Process,GO:0034368,protein-lipid complex remodeling,0.09494605715922255,1.0970492187062097,1
1188,Biological Process,GO:0034369,plasma lipoprotein particle remodeling,0.09494605715922255,1.0970492187062097,1
1190,Phenotype,HP:0032443,Past medical history,0.09491525688649616,1.0964488240704136,1
1190,Phenotype,HP:0002686,Pregnancy history,0.09491525688649616,1.0964488240704136,1
1192,Phenotype,HP:0002033,Poor suck,0.09490632526763709,1.0962747185974004,1
1193,Disease,MONDO:0024481,skin appendage disorder,0.09489609599645588,1.0960753177804057,1
1194,Biological Process,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,0.09484773894261012,1.0951326860060113,1
1195,Biological Process,GO:1900015,regulation of cytokine production involved in inflammatory response,0.09479014938327768,1.0940100835275133,1
1196,Phenotype,HP:0008551,Microtia,0.09470598583361889,1.0923694700110815,1
1197,Biological Process,GO:0031344,regulation of cell projection organization,0.0946619422422863,1.09151092125042,1
1198,Biological Process,GO:0051607,defense response to virus,0.09465064121568922,1.0912906285339186,1
1199,Biological Process,GO:0071674,mononuclear cell migration,0.09464016088253535,1.0910863337257901,1
1200,Biological Process,GO:0032956,regulation of actin cytoskeleton organization,0.09461631336576781,1.0906214702724213,1
1201,Phenotype,HP:0032436,Abnormal circulating C-reactive protein concentration,0.09457678122652113,1.0898508639678572,1
1202,Phenotype,HP:0025409,Abnormal spleen physiology,0.09452575600148272,1.0888562211062338,1
1202,Phenotype,HP:0001971,Hypersplenism,0.09452575600148272,1.0888562211062338,1
1204,Biological Process,GO:0032816,positive regulation of natural killer cell activation,0.09449864316794865,1.0883277063115857,1
1205,Biological Process,GO:0034332,adherens junction organization,0.09447448400564562,1.0878567679020166,1
1206,Phenotype,HP:0010972,Anemia of inadequate production,0.09446845659888925,1.0877392746993935,1
1207,Phenotype,HP:0010619,Fibroadenoma of the breast,0.09440543862725237,1.0865108553127976,1
1208,Biological Process,GO:0042509,regulation of tyrosine phosphorylation of STAT protein,0.09440392665862618,1.0864813822668697,1
1209,Biological Process,GO:0045668,negative regulation of osteoblast differentiation,0.09439593925400502,1.0863256825128098,1
1210,Phenotype,HP:0011482,Abnormal lacrimal gland morphology,0.09434065432974481,1.08524800465388,1
1211,Phenotype,HP:0001837,Broad toe,0.09415295584982541,1.081589168204872,1
1212,Phenotype,HP:0030310,Upper extremity joint dislocation,0.09412775185050282,1.0810978626203946,1
1213,Phenotype,HP:0004422,Biparietal narrowing,0.09410449540800381,1.0806445210721511,1
1214,Phenotype,HP:0001977,Abnormal thrombosis,0.09410044665785222,1.080565598138764,1
1215,Biological Process,GO:0048511,rhythmic process,0.09406562299499055,1.0798867749164291,1
1216,Biological Process,GO:0046661,male sex differentiation,0.09402795129131747,1.079152434379657,1
1217,Biological Process,GO:0060627,regulation of vesicle-mediated transport,0.09402480422090542,1.0790910880334526,1
1218,Biological Process,GO:0045197,establishment or maintenance of epithelial cell apical/basal polarity,0.09394599824184435,1.0775549104964144,1
1219,Biological Process,GO:0038128,ERBB2 signaling pathway,0.0939087447014455,1.0768287212831376,1
1220,Phenotype,HP:0010109,Short hallux,0.09383312142062061,1.0753545845911703,1
1221,Biological Process,GO:0022411,cellular component disassembly,0.09380587073329172,1.0748233825904812,1
1222,Phenotype,HP:0000248,Brachycephaly,0.09377557783126689,1.0742328782128099,1
1223,Biological Process,GO:0006984,ER-nucleus signaling pathway,0.09370197220949239,1.0727980720709802,1
1224,Biological Process,GO:2000773,negative regulation of cellular senescence,0.0936925105894707,1.0726136352006503,1
1225,Biological Process,GO:0009798,axis specification,0.09363743757049547,1.071540088045287,1
1226,Phenotype,HP:0031987,Diminished ability to concentrate,0.09362653240742791,1.0713275119597956,1
1227,Biological Process,GO:0060326,cell chemotaxis,0.09358114838262521,1.0704428339154017,1
1228,Biological Process,GO:1901655,cellular response to ketone,0.09354549032057602,1.0697477456164308,1
1229,Biological Process,GO:2001026,regulation of endothelial cell chemotaxis,0.09353279309843021,1.0695002366370925,1
1230,Biological Process,GO:0048675,axon extension,0.09349459730973186,1.068755680027214,1
1231,Biological Process,GO:0048762,mesenchymal cell differentiation,0.09346750848594365,1.0682276332583769,1
1232,Biological Process,GO:0050867,positive regulation of cell activation,0.09341507297153195,1.0672054994007432,1
1233,Biological Process,GO:0006470,protein dephosphorylation,0.09341306604894839,1.067166378138268,1
1234,Phenotype,HP:0006731,Follicular thyroid carcinoma,0.09339720157494469,1.066857129412578,1
1235,Phenotype,HP:0100721,Mediastinal lymphadenopathy,0.09337465428197855,1.0664176114294468,1
1236,Biological Process,GO:0071677,positive regulation of mononuclear cell migration,0.09336671171684874,1.0662627857387534,1
1237,Phenotype,HP:0008518,Aplasia/Hypoplasia involving the vertebral column,0.09332325794504137,1.0654157344243051,1
1238,Phenotype,HP:0100796,Orchitis,0.09331190875613482,1.0651945028722127,1
1239,Biological Process,GO:1904851,positive regulation of establishment of protein localization to telomere,0.09329422445578861,1.0648497799809582,1
1240,Biological Process,GO:0070371,ERK1 and ERK2 cascade,0.09325408494563037,1.0640673340982032,1
1241,Biological Process,GO:0050870,positive regulation of T cell activation,0.09323274088904543,1.0636512709940362,1
1242,Biological Process,GO:0009112,nucleobase metabolic process,0.09322607586430876,1.0635213486022803,1
1243,Phenotype,HP:0100255,Metaphyseal dysplasia,0.0931931214063817,1.0628789620902925,1
1244,Phenotype,HP:0001028,Hemangioma,0.09318728338668159,1.0627651606398067,1
1245,Phenotype,HP:0011731,Abnormality of circulating cortisol level,0.09313951098115414,1.061833925508464,1
1246,Phenotype,HP:0011384,Abnormality of the internal auditory canal,0.09310385067679872,1.0611387934998597,1
1247,Biological Process,GO:0010212,response to ionizing radiation,0.09307156983675124,1.0605095379287917,1
1248,Phenotype,HP:0000260,Wide anterior fontanel,0.09305705157380184,1.0602265311102048,1
1249,Biological Process,GO:0031295,T cell costimulation,0.0930123826873499,1.059355793371907,1
1250,Phenotype,HP:0002239,Gastrointestinal hemorrhage,0.0930039152590153,1.0591907364389297,1
1251,Biological Process,GO:1905563,negative regulation of vascular endothelial cell proliferation,0.09296013439209094,1.058337309007121,1
1252,Phenotype,HP:0031691,Severe viral infection,0.09287763915998293,1.0567292162711766,1
1253,Biological Process,GO:0050671,positive regulation of lymphocyte proliferation,0.09287663330728868,1.056709609023949,1
1254,Phenotype,HP:0010937,Abnormal nasal skeleton morphology,0.09286882597397894,1.0565574194287242,1
1255,Biological Process,GO:0051492,regulation of stress fiber assembly,0.09286267518248748,1.0564375210677523,1
1256,Biological Process,GO:0001909,leukocyte mediated cytotoxicity,0.09285390620092415,1.0562665859095224,1
1257,Biological Process,GO:0006094,gluconeogenesis,0.09280373564951006,1.0552886033373696,1
1258,Phenotype,HP:0010788,Testicular neoplasm,0.0928020597878968,1.0552559354992672,1
1259,Biological Process,GO:0050919,negative chemotaxis,0.0927855421671181,1.0549339548791687,1
1260,Phenotype,HP:0003256,Abnormality of the coagulation cascade,0.09274807455502065,1.054203592732079,1
1261,Biological Process,GO:0050865,regulation of cell activation,0.09273084220295391,1.0538676797408228,1
1262,Phenotype,HP:0009161,Aplasia/Hypoplasia of the middle phalanx of the 5th finger,0.09271013334138312,1.0534639985945227,1
1262,Phenotype,HP:0004219,Abnormality of the middle phalanx of the 5th finger,0.09271013334138312,1.0534639985945227,1
1264,Disease,MONDO:0019040,chromosomal disorder,0.09270697404061012,1.0534024138399387,1
1265,Phenotype,HP:0007499,Recurrent staphylococcal infections,0.09269637157405819,1.0531957382659742,1
1266,Phenotype,HP:0003565,Elevated erythrocyte sedimentation rate,0.09265454058350309,1.0523803200856734,1
1267,Biological Process,GO:0033138,positive regulation of peptidyl-serine phosphorylation,0.09264222495437902,1.0521402495600571,1
1268,Biological Process,GO:0001778,plasma membrane repair,0.09257975497457016,1.0509225122656922,1
1269,Biological Process,GO:2001236,regulation of extrinsic apoptotic signaling pathway,0.09257746048850979,1.0508777854824332,1
1270,Phenotype,HP:0000647,Sclerocornea,0.09256399763413636,1.050615351911792,1
1271,Biological Process,GO:0050729,positive regulation of inflammatory response,0.09256358301878442,1.0506072697485125,1
1272,Phenotype,HP:0009800,Maternal diabetes,0.0925558694913996,1.0504569087271654,1
1273,Biological Process,GO:0032091,negative regulation of protein binding,0.0925400981285156,1.0501494750314033,1
1274,Phenotype,HP:0009887,Abnormality of hair pigmentation,0.09241355300954124,1.0476827108149522,1
1275,Biological Process,GO:0002263,cell activation involved in immune response,0.09238094506779182,1.047047078998162,1
1276,Phenotype,HP:0001199,Triphalangeal thumb,0.09237986878651516,1.0470260988753284,1
1277,Phenotype,HP:0012504,Abnormal size of pituitary gland,0.09234249113344994,1.0462974903140223,1
1278,Phenotype,HP:0001297,Stroke,0.09231503052110313,1.045762196211429,1
1279,Phenotype,HP:0002621,Atherosclerosis,0.09229817074989,1.0454335459982624,1
1280,Biological Process,GO:1901873,regulation of post-translational protein modification,0.09228427527412664,1.0451626792697672,1
1281,Biological Process,GO:1903053,regulation of extracellular matrix organization,0.09226230471095165,1.0447344035725725,1
1282,Disease,MONDO:0018995,Charcot-Marie-Tooth disease type 4,0.09214402200576144,1.042428699907721,1
1283,Biological Process,GO:0003231,cardiac ventricle development,0.09211783139098284,1.0419181620705738,1
1284,Biological Process,GO:1900026,positive regulation of substrate adhesion-dependent cell spreading,0.09208588344807656,1.0412953957166504,1
1285,Phenotype,HP:0009778,Short thumb,0.09205682662118875,1.0407289863490559,1
1286,Biological Process,GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,0.09201222953703991,1.039859648264521,1
1287,Phenotype,HP:0005415,Decreased proportion of CD8-positive T cells,0.09199996675315325,1.0396206078595582,1
1288,Biological Process,GO:0045761,regulation of adenylate cyclase activity,0.09194312478590716,1.0385125783130076,1
1289,Biological Process,GO:0070301,cellular response to hydrogen peroxide,0.09187653098674886,1.0372144547493916,1
1290,Disease,MONDO:0020573,inherited disease susceptibility,0.09183319976870441,1.0363697923950186,1
1290,Disease,MONDO:0042489,disease susceptibility,0.09183319976870441,1.0363697923950186,1
1292,Biological Process,GO:0031333,negative regulation of protein-containing complex assembly,0.09180743206756414,1.0358674984809728,1
1293,Biological Process,GO:0065005,protein-lipid complex assembly,0.09180633175436714,1.0358460499000772,1
1294,Phenotype,HP:0030895,Abnormal gastrointestinal motility,0.09179098689929133,1.0355469301891438,1
1295,Phenotype,HP:0011869,Abnormal platelet function,0.09178917887115168,1.0355116860078324,1
1296,Biological Process,GO:0008406,gonad development,0.09171532104863078,1.0340719636765707,1
1297,Biological Process,GO:0051048,negative regulation of secretion,0.09168275306451168,1.0334371107602505,1
1298,Biological Process,GO:0003151,outflow tract morphogenesis,0.09166733599112331,1.0331365832862156,1
1299,Biological Process,GO:0046903,secretion,0.0916533526135741,1.0328640030741687,1
1300,Biological Process,GO:1903034,regulation of response to wounding,0.0916266929548405,1.032344322088289,1
1301,Biological Process,GO:0071624,positive regulation of granulocyte chemotaxis,0.09162056436044785,1.03222485641891,1
1302,Biological Process,GO:0009411,response to UV,0.09161639380863285,1.0321435591862431,1
1303,Biological Process,GO:0030029,actin filament-based process,0.09161429285365008,1.0321026049351913,1
1304,Phenotype,HP:0002344,Progressive neurologic deterioration,0.09157784499800925,1.03139212106359,1
1305,Phenotype,HP:0001662,Bradycardia,0.09157131997068335,1.0312649276637231,1
1306,Biological Process,GO:0031343,positive regulation of cell killing,0.09152389935549587,1.0303405500376666,1
1307,Phenotype,HP:0004890,Elevated pulmonary artery pressure,0.09146557041453485,1.0292035346749855,1
1308,Phenotype,HP:0001718,Mitral stenosis,0.09145080143057305,1.028915640511658,1
1309,Biological Process,GO:0010743,regulation of macrophage derived foam cell differentiation,0.09140325116187098,1.0279887355289326,1
1310,Phenotype,HP:0025276,Abnormality of skin adnexa physiology,0.09135001675599452,1.0269510287523742,1
1311,Phenotype,HP:0011965,Abnormal circulating citrulline concentration,0.09134734545579026,1.026898956670822,1
1312,Biological Process,GO:0070723,response to cholesterol,0.09132465026354453,1.0264565556634104,1
1313,Biological Process,GO:0019068,virion assembly,0.09127682136710602,1.0255242193457152,1
1314,Biological Process,GO:0046596,regulation of viral entry into host cell,0.09127455865564538,1.0254801119498038,1
1315,Biological Process,GO:0038083,peptidyl-tyrosine autophosphorylation,0.09125634459935417,1.0251250624412986,1
1316,Biological Process,GO:1902894,negative regulation of miRNA transcription,0.09120063600668282,1.0240391259463606,1
1317,Phenotype,HP:0000853,Goiter,0.09118815762822807,1.0237958829220466,1
1318,Phenotype,HP:0030890,Hyperintensity of cerebral white matter on MRI,0.09118292393394989,1.0236938616835356,1
1319,Phenotype,HP:0100545,Arterial stenosis,0.09114030131756967,1.0228630122145843,1
1320,Phenotype,HP:0012304,Hypoplastic aortic arch,0.09113643552429873,1.0227876556888942,1
1321,Biological Process,GO:1902410,mitotic cytokinetic process,0.09107572427690702,1.0216042016464484,1
1322,Phenotype,HP:0000268,Dolichocephaly,0.09106707586949947,1.0214356168594954,1
1323,Biological Process,GO:0048871,multicellular organismal-level homeostasis,0.09104851556508575,1.021073817881034,1
1324,Phenotype,HP:0100658,Cellulitis,0.09100984623442132,1.0203200304419746,1
1325,Biological Process,GO:0042306,regulation of protein import into nucleus,0.09099705048141138,1.020070600784764,1
1326,Phenotype,HP:0000978,Bruising susceptibility,0.09095658508107507,1.0192818022727155,1
1327,Biological Process,GO:0060485,mesenchyme development,0.09089630242275526,1.0181067027855042,1
1328,Phenotype,HP:0002634,Arteriosclerosis,0.09089573714609744,1.0180956837573252,1
1329,Phenotype,HP:0004431,Reduced circulating complement concentration,0.09088571900907616,1.017900398612233,1
1330,Biological Process,GO:1905039,carboxylic acid transmembrane transport,0.090874259160025,1.0176770099442667,1
1331,Phenotype,HP:0025021,Abnormal erythrocyte sedimentation rate,0.09085960741877175,1.0173914012117833,1
1332,Biological Process,GO:0016241,regulation of macroautophagy,0.09084073525936032,1.0170235231940408,1
1333,Phenotype,HP:0005048,Synostosis of carpal bones,0.09082833765882603,1.0167818547866323,1
1334,Biological Process,GO:0009620,response to fungus,0.09081418992762347,1.0165060708025695,1
1335,Biological Process,GO:1903077,negative regulation of protein localization to plasma membrane,0.09079573078037817,1.0161462436969493,1
1336,Phenotype,HP:0002215,Sparse axillary hair,0.09075265604282645,1.0153065809577873,1
1337,Phenotype,HP:0011766,Abnormal parathyroid morphology,0.09073551513535028,1.014972450510541,1
1338,Phenotype,HP:0012539,Non-Hodgkin lymphoma,0.09072734589806863,1.0148132062633872,1
1339,Phenotype,HP:0033804,Subepidermal blistering,0.0906699114117605,1.0136936266481211,1
1340,Phenotype,HP:0002176,Spinal cord compression,0.0906535210012056,1.0133741257572335,1
1341,Biological Process,GO:0045671,negative regulation of osteoclast differentiation,0.09064555099821647,1.013218765215966,1
1342,Biological Process,GO:0034244,negative regulation of transcription elongation by RNA polymerase II,0.09062001046549684,1.0127208995322279,1
1343,Phenotype,HP:0012438,Abnormal gallbladder physiology,0.09061177845516677,1.012560431640015,1
1343,Phenotype,HP:0001082,Cholecystitis,0.09061177845516677,1.012560431640015,1
1345,Biological Process,GO:0002703,regulation of leukocyte mediated immunity,0.09059363566745982,1.0122067713814058,1
1346,Phenotype,HP:0012382,Left-to-right shunt,0.09058841989890887,1.0121050995719592,1
1347,Biological Process,GO:0019082,viral protein processing,0.09048608813130987,1.0101103300813197,1
1348,Biological Process,GO:0007178,cell surface receptor protein serine/threonine kinase signaling pathway,0.09039562673439216,1.0083469516223529,1
1349,Phenotype,HP:0012707,Elevated brain lactate level by MRS,0.09039288027191228,1.0082934143905566,1
1350,Phenotype,HP:0001417,X-linked inheritance,0.09037632124779915,1.007970626688647,1
1351,Phenotype,HP:0001413,Micronodular cirrhosis,0.09033670039004393,1.0071982909800254,1
1352,Biological Process,GO:0006935,chemotaxis,0.09030373662096403,1.006555722964248,1
1352,Biological Process,GO:0042330,taxis,0.09030373662096403,1.006555722964248,1
1354,Phenotype,HP:0033578,Pre-capillary pulmonary hypertension,0.09030177002902984,1.0065173878735632,1
1354,Phenotype,HP:0002092,Pulmonary arterial hypertension,0.09030177002902984,1.0065173878735632,1
1356,Biological Process,GO:0032231,regulation of actin filament bundle assembly,0.09026596228626149,1.0058193818244263,1
1357,Phenotype,HP:0004334,Dermal atrophy,0.09026267374123598,1.0057552776909846,1
1358,Phenotype,HP:0012705,Abnormal metabolic brain imaging by MRS,0.0902531640880051,1.0055699045016357,1
1359,Biological Process,GO:0006754,ATP biosynthetic process,0.09024712343416508,1.0054521530714953,1
1360,Biological Process,GO:0071383,cellular response to steroid hormone stimulus,0.0902294715380163,1.0051080618404369,1
1361,Phenotype,HP:0030880,Raynaud phenomenon,0.09011708697508036,1.0029173316046225,1
1362,Phenotype,HP:0004420,Arterial thrombosis,0.090108522106501,1.0027503752533904,1
1363,Biological Process,GO:0002011,morphogenesis of an epithelial sheet,0.09010833692726916,1.0027467655250466,1
1364,Biological Process,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.0901076005449073,1.002732411106049,1
1365,Biological Process,GO:0030101,natural killer cell activation,0.09010243882778002,1.0026317929296371,1
1366,Phenotype,HP:0001041,Facial erythema,0.09001556757859053,1.000938397793769,1
1367,Biological Process,GO:0032946,positive regulation of mononuclear cell proliferation,0.08993521802846649,0.999372131179455,1
1368,Biological Process,GO:0050728,negative regulation of inflammatory response,0.08991563859386231,0.9989904661334115,1
1369,Biological Process,GO:0045637,regulation of myeloid cell differentiation,0.08990270119794519,0.9987382754083873,1
1370,Phenotype,HP:0100533,Inflammatory abnormality of the eye,0.08985436761613608,0.9977961011781525,1
1371,Phenotype,HP:0010318,Aplasia/Hypoplasia of the abdominal wall musculature,0.08985056459606378,0.9977219683004499,1
1372,Biological Process,GO:0010804,negative regulation of tumor necrosis factor-mediated signaling pathway,0.08984577797518467,0.9976286619351156,1
1373,Phenotype,HP:0003648,Lacticaciduria,0.08978966819944412,0.996534905114531,1
1374,Phenotype,HP:0010059,Broad hallux phalanx,0.08976427530030517,0.9960399172757619,1
1375,Biological Process,GO:0072091,regulation of stem cell proliferation,0.08976228435458955,0.9960011074529256,1
1376,Phenotype,HP:0000410,Mixed hearing impairment,0.08971468898275836,0.9950733232677003,1
1377,Biological Process,GO:0045824,negative regulation of innate immune response,0.08959482747901315,0.9927368438304442,1
1378,Disease,MONDO:0002149,reproductive system cancer,0.0895848812099862,0.9925429596196447,1
1379,Biological Process,GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,0.08957842786700854,0.9924171635742278,1
1380,Biological Process,GO:0071480,cellular response to gamma radiation,0.08950351245064547,0.9909568253972777,1
1381,Phenotype,HP:0001518,Small for gestational age,0.08949552145672446,0.9908010556764224,1
1382,Phenotype,HP:0030319,Weakness of facial musculature,0.08946080726104866,0.9901243663154262,1
1383,Phenotype,HP:0012056,Cutaneous melanoma,0.08942962716729264,0.989516567767633,1
1384,Biological Process,GO:0034605,cellular response to heat,0.08940799187859638,0.9890948276294035,1
1385,Biological Process,GO:0001906,cell killing,0.08939634865538393,0.9888678644196217,1
1386,Phenotype,HP:0006562,Viral hepatitis,0.08939041767954614,0.988752250960297,1
1387,Biological Process,GO:0003012,muscle system process,0.08931969048346267,0.987373554430216,1
1388,Biological Process,GO:0010718,positive regulation of epithelial to mesenchymal transition,0.0893035116526727,0.9870581778974806,1
1389,Biological Process,GO:0048639,positive regulation of developmental growth,0.08920282754806941,0.9850955265647877,1
1390,Biological Process,GO:0141193,nuclear receptor signaling pathway,0.08918745015228469,0.984795772532618,1
1390,Biological Process,GO:0030518,intracellular steroid hormone receptor signaling pathway,0.08918745015228469,0.984795772532618,1
1392,Biological Process,GO:0032715,negative regulation of interleukin-6 production,0.08911412470705615,0.9833664279169497,1
1393,Biological Process,GO:1903825,organic acid transmembrane transport,0.08907586229137543,0.982620572536662,1
1394,Biological Process,GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",0.08907379761434886,0.9825803254576048,1
1395,Disease,MONDO:0020584,anemia due to enzyme disorder,0.08904314008213488,0.981982713285416,1
1396,Biological Process,GO:0010591,regulation of lamellipodium assembly,0.08902979344732276,0.9817225452012464,1
1397,Biological Process,GO:0010812,negative regulation of cell-substrate adhesion,0.08894724598363812,0.9801134343068363,1
1398,Biological Process,GO:0050863,regulation of T cell activation,0.08894319393031158,0.9800344469841321,1
1399,Phenotype,HP:0025318,Ovarian carcinoma,0.088913648997196,0.9794585228838774,1
1400,Biological Process,GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus,0.08884158081872473,0.978053686369924,1
1401,Phenotype,HP:0001239,Wrist flexion contracture,0.08882891632737433,0.9778068154172083,1
1402,Biological Process,GO:0002230,positive regulation of defense response to virus by host,0.08882533563430728,0.9777370163953298,1
1403,Biological Process,GO:0045333,cellular respiration,0.08877456213157753,0.9767472803968753,1
1404,Biological Process,GO:0042180,cellular ketone metabolic process,0.08877209110741058,0.9766991123281074,1
1405,Phenotype,HP:0009928,Thick nasal alae,0.08877096721387234,0.9766772040918538,1
1406,Phenotype,HP:0012111,Abnormality of circulating glucocorticoid level,0.08876073479071511,0.976477741832887,1
1407,Biological Process,GO:0031579,membrane raft organization,0.08875223095665485,0.9763119752372846,1
1408,Biological Process,GO:0050860,negative regulation of T cell receptor signaling pathway,0.08873609171981467,0.9759973705157365,1
1409,Phenotype,HP:0031105,Abnormal uterus morphology,0.08871619778021544,0.9756095747735906,1
1410,Biological Process,GO:0017004,cytochrome complex assembly,0.08864362031505524,0.9741948106528646,1
1411,Phenotype,HP:0002615,Hypotension,0.08862069576107212,0.9737479386604718,1
1412,Phenotype,HP:0000072,Hydroureter,0.0885897459132694,0.973144628333822,1
1413,Biological Process,GO:1903169,regulation of calcium ion transmembrane transport,0.08858666203604648,0.9730845138225467,1
1414,Phenotype,HP:0002619,Varicose veins,0.0885675196357707,0.9727113679564714,1
1415,Phenotype,HP:0009889,Localized hirsutism,0.0885648035254607,0.9726584223843707,1
1416,Phenotype,HP:0012316,Fibrous tissue neoplasm,0.08855292720912145,0.9724269154530377,1
1417,Biological Process,GO:0070848,response to growth factor,0.08852710555444987,0.9719235698141885,1
1418,Phenotype,HP:0002967,Cubitus valgus,0.08851194236765947,0.9716279913921594,1
1419,Disease,MONDO:0004993,carcinoma,0.08848107607549349,0.9710263098288825,1
1420,Phenotype,HP:0002862,Bladder carcinoma,0.08842202553727097,0.9698752282555266,1
1421,Biological Process,GO:0141060,disruption of anatomical structure in another organism,0.08836516832628138,0.9687669015602495,1
1422,Phenotype,HP:0010927,Abnormal blood inorganic cation concentration,0.08835309479849984,0.9685315503547726,1
1423,Disease,MONDO:0015514,hereditary endocrine growth disease,0.08830790999668359,0.9676507557958741,1
1424,Biological Process,GO:0022407,regulation of cell-cell adhesion,0.08830521606156005,0.9675982424882251,1
1425,Phenotype,HP:0200125,Mitochondrial respiratory chain defects,0.08829807847183191,0.9674591083116105,1
1426,Phenotype,HP:0011328,Abnormality of fontanelles,0.0882737915273979,0.966985679024552,1
1427,Biological Process,GO:0050764,regulation of phagocytosis,0.0882621321852024,0.9667584016048593,1
1428,Biological Process,GO:0046473,phosphatidic acid metabolic process,0.08818070587463345,0.9651711455272082,1
1429,Biological Process,GO:0034341,response to type II interferon,0.08812973326704854,0.9641775283460102,1
1430,Biological Process,GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.08811325926117841,0.9638563979182909,1
1431,Biological Process,GO:0045862,positive regulation of proteolysis,0.08809990945421653,0.9635961679988992,1
1432,Phenotype,HP:0009777,Absent thumb,0.08809988582893902,0.9635957074675913,1
1433,Disease,MONDO:0005626,epithelial neoplasm,0.08806620105406637,0.9629390847707341,1
1434,Phenotype,HP:0100014,Epiretinal membrane,0.08806350834240928,0.9628865953123119,1
1435,Biological Process,GO:2000209,regulation of anoikis,0.08804421043303101,0.9625104180824633,1
1436,Phenotype,HP:0100000,Early onset of sexual maturation,0.08797905375496362,0.9612403085498149,1
1437,Phenotype,HP:0004378,Abnormality of the anus,0.08797410174513631,0.9611437782312967,1
1438,Biological Process,GO:0006816,calcium ion transport,0.087957263067731,0.960815539203095,1
1439,Phenotype,HP:0001727,Thromboembolic stroke,0.0879257501930868,0.9602012537042954,1
1440,Biological Process,GO:0071363,cellular response to growth factor stimulus,0.08789316773456246,0.9595661186360822,1
1441,Biological Process,GO:0060562,epithelial tube morphogenesis,0.08787261824173209,0.959165544090094,1
1442,Biological Process,GO:0046753,non-lytic viral release,0.08781775130341796,0.9580960140979735,1
1443,Phenotype,HP:0012432,Chronic fatigue,0.0878055569572942,0.9578583077612541,1
1444,Phenotype,HP:0005339,Abnormality of complement system,0.08770229680562258,0.955845441131602,1
1445,Biological Process,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,0.08768339511698942,0.9554769874960236,1
1446,Biological Process,GO:1902743,regulation of lamellipodium organization,0.0876386774702329,0.9546052992653207,1
1447,Biological Process,GO:0034329,cell junction assembly,0.08761907969958915,0.954223276791929,1
1448,Biological Process,GO:0002028,regulation of sodium ion transport,0.0876013741842625,0.9538781403536721,1
1449,Phenotype,HP:0008771,Aplasia/Hypoplasia of the ear,0.08756822459430191,0.9532319501017874,1
1450,Phenotype,HP:0200035,Skin plaque,0.08755394611188794,0.9529536173634765,1
1451,Biological Process,GO:0071482,cellular response to light stimulus,0.08754794641683283,0.9528366643494725,1
1452,Phenotype,HP:0040275,Adenocarcinoma of the large intestine,0.08753444338501537,0.9525734475934973,1
1453,Biological Process,GO:0032412,regulation of monoatomic ion transmembrane transporter activity,0.08749377037451533,0.9517806021033669,1
1454,Phenotype,HP:0010980,Hyperlipoproteinemia,0.08746948699076917,0.9513072422253656,1
1455,Phenotype,HP:0010624,Aplastic/hypoplastic toenail,0.0874681789929802,0.9512817452155466,1
1456,Disease,MONDO:0002908,glucose metabolism disease,0.08746104418304546,0.9511426652258886,1
1457,Biological Process,GO:0043401,steroid hormone mediated signaling pathway,0.08744610698480093,0.9508514920346801,1
1458,Phenotype,HP:0100027,Recurrent pancreatitis,0.08742546312827593,0.9504490780421202,1
1459,Biological Process,GO:0030512,negative regulation of transforming growth factor beta receptor signaling pathway,0.08742422585922693,0.9504249597589267,1
1460,Phenotype,HP:0030088,Increased serum testosterone level,0.08741169898009615,0.950180771303188,1
1461,Phenotype,HP:0005528,Bone marrow hypocellularity,0.08739703949475797,0.9498950116140201,1
1462,Disease,MONDO:0000425,X-linked disease,0.08739468974106257,0.9498492074899239,1
1463,Phenotype,HP:0003072,Hypercalcemia,0.08738553197369414,0.9496706936678965,1
1464,Phenotype,HP:0200043,Verrucae,0.08738166686788651,0.9495953505430385,1
1465,Disease,MONDO:0021100,breast neoplasm,0.08735765264421436,0.949127237445351,1
1466,Phenotype,HP:0004308,Ventricular arrhythmia,0.08735493900932811,0.949074340127081,1
1467,Biological Process,GO:0045638,negative regulation of myeloid cell differentiation,0.08733421526381913,0.9486703688457961,1
1468,Biological Process,GO:0006511,ubiquitin-dependent protein catabolic process,0.08731535755888387,0.9483027725914663,1
1469,Phenotype,HP:0000995,Melanocytic nevus,0.08728568445822649,0.9477243501008478,1
1470,Biological Process,GO:0140352,export from cell,0.08728292049961572,0.9476704718141779,1
1471,Biological Process,GO:0036293,response to decreased oxygen levels,0.0872791916633997,0.9475977850142345,1
1471,Biological Process,GO:0001666,response to hypoxia,0.0872791916633997,0.9475977850142345,1
1473,Biological Process,GO:0040007,growth,0.08722448924269999,0.9465314619902493,1
1473,Biological Process,GO:0048589,developmental growth,0.08722448924269999,0.9465314619902493,1
1475,Biological Process,GO:0046688,response to copper ion,0.08722249442047725,0.9464925766020406,1
1476,Biological Process,GO:0061162,establishment of monopolar cell polarity,0.08721360599070715,0.9463193130208373,1
1477,Phenotype,HP:0000402,Stenosis of the external auditory canal,0.0872037760035076,0.946127695510272,1
1478,Biological Process,GO:0010324,membrane invagination,0.08719592635019324,0.9459746809644378,1
1479,Phenotype,HP:0010701,Abnormal immunoglobulin level,0.08716291454929126,0.9453311766566809,1
1480,Phenotype,HP:0000717,Autism,0.08713112075536378,0.9447114151534227,1
1481,Phenotype,HP:0025045,Abnormal brain lactate level by MRS,0.08708802477804911,0.9438713383841689,1
1482,Phenotype,HP:0003765,Psoriasiform dermatitis,0.0870570907266206,0.9432683359787647,1
1483,Phenotype,HP:0000872,Hashimoto thyroiditis,0.08702596054268896,0.9426615103311499,1
1484,Phenotype,HP:0030521,Bitemporal hemianopia,0.08702451963642088,0.942633422515119,1
1484,Phenotype,HP:0030517,Heteronymous hemianopia,0.08702451963642088,0.942633422515119,1
1486,Biological Process,GO:0044057,regulation of system process,0.08700333052156994,0.9422203797149209,1
1487,Biological Process,GO:0051646,mitochondrion localization,0.08700060042873181,0.942167161579166,1
1488,Phenotype,HP:0005372,Abnormality of B cell physiology,0.08695728890072818,0.9413228830459037,1
1489,Biological Process,GO:0009595,detection of biotic stimulus,0.08694412385564454,0.9410662547193156,1
1490,Biological Process,GO:0022408,negative regulation of cell-cell adhesion,0.0869109316505442,0.9404192337637051,1
1491,Phenotype,HP:0009803,Short phalanx of finger,0.0869049814489351,0.9403032455333494,1
1492,Biological Process,GO:0010232,vascular transport,0.08689528827173987,0.9401142948820503,1
1492,Biological Process,GO:0150104,transport across blood-brain barrier,0.08689528827173987,0.9401142948820503,1
1494,Biological Process,GO:0032928,regulation of superoxide anion generation,0.08687298945266408,0.939679620440151,1
1495,Disease,MONDO:0019243,inborn disorder of energy metabolism,0.08686708762781115,0.93956457522563,1
1496,Phenotype,HP:0002080,Intention tremor,0.08684207453721482,0.9390769910554466,1
1497,Biological Process,GO:2000117,negative regulation of cysteine-type endopeptidase activity,0.08683388852949825,0.9389174198995262,1
1498,Disease,MONDO:0015160,multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome,0.0868317422556667,0.9388755822409165,1
1499,Biological Process,GO:1901096,regulation of autophagosome maturation,0.08683146931185748,0.9388702617036477,1
1500,Phenotype,HP:0001269,Hemiparesis,0.08678787774416374,0.9380205243119771,1
1501,Phenotype,HP:0001010,Hypopigmentation of the skin,0.08672893049470654,0.9368714561630214,1
1502,Biological Process,GO:0016441,post-transcriptional gene silencing,0.08670420061794326,0.9363893927253217,1
1503,Biological Process,GO:0044819,mitotic G1/S transition checkpoint signaling,0.0867002817057666,0.936313000744318,1
1503,Biological Process,GO:0031571,mitotic G1 DNA damage checkpoint signaling,0.0867002817057666,0.936313000744318,1
1505,Phenotype,HP:0031664,Systolic heart murmur,0.08669042108467995,0.9361207860824987,1
1506,Biological Process,GO:0040011,locomotion,0.08666499174267106,0.935625087857045,1
1507,Biological Process,GO:0071692,protein localization to extracellular region,0.08665016435762629,0.9353360552720791,1
1508,Biological Process,GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,0.0866460834507169,0.9352565055018757,1
1509,Biological Process,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,0.08661379024234794,0.9346270088331415,1
1510,Biological Process,GO:0030099,myeloid cell differentiation,0.08660961898067931,0.9345456977631846,1
1511,Biological Process,GO:0019941,modification-dependent protein catabolic process,0.08660702219962846,0.9344950782953922,1
1512,Phenotype,HP:0000020,Urinary incontinence,0.08660562719264231,0.9344678852013952,1
1513,Biological Process,GO:0048598,embryonic morphogenesis,0.08653662625321679,0.9331228388680721,1
1514,Phenotype,HP:0008386,Aplasia/Hypoplasia of the nails,0.08649620356061238,0.9323348728646631,1
1515,Biological Process,GO:0050746,regulation of lipoprotein metabolic process,0.08646863058857257,0.9317973885166275,1
1516,Biological Process,GO:0042119,neutrophil activation,0.08645569170332701,0.9315451687598862,1
1517,Phenotype,HP:0100848,Neoplasm of the male external genitalia,0.08643372970183405,0.9311170599569267,1
1518,Phenotype,HP:0011228,Horizontal eyebrow,0.08637543568605488,0.929980725396394,1
1519,Phenotype,HP:0032988,Persistent head lag,0.08637288876355098,0.929931077829221,1
1520,Biological Process,GO:0010745,negative regulation of macrophage derived foam cell differentiation,0.08634834478271702,0.9294526380905636,1
1521,Biological Process,GO:0001885,endothelial cell development,0.08634671479019307,0.9294208643859453,1
1522,Phenotype,HP:0012246,Oculomotor nerve palsy,0.08633297486564673,0.9291530298421687,1
1523,Phenotype,HP:0011471,Gastrostomy tube feeding in infancy,0.0863005998619717,0.9285219387244684,1
1524,Disease,MONDO:0002243,hemorrhagic disease,0.08629242611026855,0.9283626064769752,1
1525,Biological Process,GO:0044409,symbiont entry into host,0.08625133542355223,0.927561619157648,1
1526,Biological Process,GO:0043632,modification-dependent macromolecule catabolic process,0.08623826526862388,0.9273068405400131,1
1527,Biological Process,GO:0046471,phosphatidylglycerol metabolic process,0.08623351662460776,0.9272142744637349,1
1528,Phenotype,HP:0001555,Asymmetry of the thorax,0.08621832484161362,0.9269181386113389,1
1529,Phenotype,HP:0025190,Bilateral tonic-clonic seizure with generalized onset,0.08619694115918808,0.9265013030743318,1
1530,Phenotype,HP:0011999,Paranoia,0.08619480966114845,0.9264597534425941,1
1531,Biological Process,GO:0022898,regulation of transmembrane transporter activity,0.08618930551571102,0.9263524602564386,1
1532,Disease,MONDO:0005070,neoplasm,0.08617428934063742,0.9260597475572864,1
1533,Biological Process,GO:0046885,regulation of hormone biosynthetic process,0.08616717599081192,0.9259210858929656,1
1534,Biological Process,GO:0070228,regulation of lymphocyte apoptotic process,0.08613527383885611,0.9252992121493538,1
1535,Biological Process,GO:1900016,negative regulation of cytokine production involved in inflammatory response,0.08611796654000092,0.92496183820838,1
1536,Phenotype,HP:0002225,Sparse pubic hair,0.08610165744582965,0.9246439224307467,1
1537,Phenotype,HP:0000823,Delayed puberty,0.08608311036418592,0.9242823812058527,1
1538,Biological Process,GO:0071900,regulation of protein serine/threonine kinase activity,0.08607410316686637,0.9241068024698376,1
1539,Phenotype,HP:0002861,Melanoma,0.08605862386092944,0.9238050618867935,1
1540,Disease,MONDO:0003939,muscle tissue disorder,0.08601835639706268,0.923020121781961,1
1541,Phenotype,HP:0025133,Abnormal serum estradiol,0.08601112627225893,0.9228791838043376,1
1542,Phenotype,HP:0010305,Absence of the sacrum,0.0859861585207995,0.9223924834371914,1
1543,Phenotype,HP:0001693,Cardiac shunt,0.0859798054111156,0.9222686412553798,1
1544,Biological Process,GO:0043406,positive regulation of MAP kinase activity,0.0859790946079908,0.9222547854565356,1
1545,Phenotype,HP:0005401,Recurrent candida infections,0.08597380135850996,0.922151603298947,1
1546,Phenotype,HP:0000326,Abnormal maxilla morphology,0.08596813559743999,0.9220411597134524,1
1547,Biological Process,GO:0051899,membrane depolarization,0.08596566446068954,0.9219929894500762,1
1548,Biological Process,GO:0051090,regulation of DNA-binding transcription factor activity,0.08596532281953573,0.9219863297844967,1
1549,Phenotype,HP:0002724,Recurrent Aspergillus infections,0.08594495320453965,0.9215892616258632,1
1550,Biological Process,GO:0036257,multivesicular body organization,0.08594062602676,0.9215049112582506,1
1551,Biological Process,GO:0045667,regulation of osteoblast differentiation,0.0859003782351,0.9207203546268866,1
1552,Biological Process,GO:2001234,negative regulation of apoptotic signaling pathway,0.08587106270258871,0.920148902269252,1
1553,Phenotype,HP:0003302,Spondylolisthesis,0.08586415038680817,0.9200141593936797,1
1554,Biological Process,GO:0006979,response to oxidative stress,0.08574771128093206,0.9177443933047249,1
1555,Phenotype,HP:0002034,Abnormal rectum morphology,0.085680759749166,0.9164392964022472,1
1556,Disease,MONDO:0003620,peripheral nervous system disorder,0.08562704995573711,0.9153923228201984,1
1557,Phenotype,HP:0011800,Midface retrusion,0.08558021606262367,0.9144793822612447,1
1558,Biological Process,GO:1902105,regulation of leukocyte differentiation,0.08557036679136243,0.9142873888433849,1
1559,Phenotype,HP:0012368,Flat face,0.08556592860571477,0.9142008745816707,1
1560,Biological Process,GO:0032414,positive regulation of ion transmembrane transporter activity,0.0855152647142986,0.9132132752540594,1
1561,Biological Process,GO:0048732,gland development,0.08551422953915011,0.9131930964195476,1
1562,Biological Process,GO:0048545,response to steroid hormone,0.08550875672586145,0.9130864139959723,1
1563,Biological Process,GO:0033137,negative regulation of peptidyl-serine phosphorylation,0.0854997437409446,0.9129107224413989,1
1564,Phenotype,HP:0006713,Aplasia/Hypoplasia of the scapulae,0.08548102482628828,0.9125458316481445,1
1565,Biological Process,GO:0098581,detection of external biotic stimulus,0.08546592760987082,0.9122515391971323,1
1566,Biological Process,GO:0045738,negative regulation of DNA repair,0.08546062254868003,0.9121481267919951,1
1567,Biological Process,GO:1900024,regulation of substrate adhesion-dependent cell spreading,0.08544704056097807,0.9118833709363523,1
1568,Biological Process,GO:0098660,inorganic ion transmembrane transport,0.08542149777447117,0.9113854613191789,1
1569,Biological Process,GO:0048145,regulation of fibroblast proliferation,0.08541755069324508,0.9113085202343955,1
1570,Phenotype,HP:0031886,Abnormal LDL cholesterol concentration,0.08539385421891676,0.9108466010754196,1
1571,Biological Process,GO:0046718,symbiont entry into host cell,0.08539135788742791,0.9107979396869834,1
1572,Biological Process,GO:0043123,positive regulation of canonical NF-kappaB signal transduction,0.08538128488738961,0.9106015850883377,1
1573,Phenotype,HP:0000225,Gingival bleeding,0.08536539223383,0.910291787054063,1
1574,Biological Process,GO:0036294,cellular response to decreased oxygen levels,0.08534603161446919,0.9099143874085085,1
1574,Biological Process,GO:0071456,cellular response to hypoxia,0.08534603161446919,0.9099143874085085,1
1576,Phenotype,HP:0001581,Recurrent skin infections,0.0852646719586494,0.9083284306425292,1
1577,Phenotype,HP:0001409,Portal hypertension,0.08524445726592778,0.9079343824085365,1
1578,Biological Process,GO:0006469,negative regulation of protein kinase activity,0.0851934831320047,0.9069407354741849,1
1579,Disease,MONDO:0021223,digestive system neoplasm,0.08515869921760166,0.9062626870749029,1
1580,Phenotype,HP:0100013,Neoplasm of the breast,0.08512477304943367,0.9056013588599832,1
1581,Biological Process,GO:0035194,regulatory ncRNA-mediated post-transcriptional gene silencing,0.08512167114286706,0.9055408928998316,1
1582,Biological Process,GO:0052372,modulation by symbiont of entry into host,0.08509096549269135,0.9049423427565293,1
1583,Phenotype,HP:0003118,Increased circulating cortisol level,0.08508610156730312,0.9048475294820513,1
1584,Biological Process,GO:0032757,positive regulation of interleukin-8 production,0.08506763434734932,0.9044875450138349,1
1585,Phenotype,HP:0001402,Hepatocellular carcinoma,0.08504686611867063,0.904082706615018,1
1586,Phenotype,HP:0010995,Abnormal circulating dicarboxylic acid concentration,0.0850384071345035,0.903917814285546,1
1587,Biological Process,GO:0002698,negative regulation of immune effector process,0.0850008275787002,0.9031852700019178,1
1588,Phenotype,HP:0003393,Thenar muscle atrophy,0.08499961336604789,0.9031616011607475,1
1589,Biological Process,GO:0016236,macroautophagy,0.0849826604036481,0.9028311343568947,1
1590,Biological Process,GO:1901136,carbohydrate derivative catabolic process,0.08491982202233028,0.9016062157530731,1
1591,Phenotype,HP:0009767,Aplasia/Hypoplasia of the phalanges of the hand,0.08485843597657805,0.9004096077584043,1
1592,Phenotype,HP:0009376,Aplasia/Hypoplasia of the phalanges of the 5th finger,0.08482347246533384,0.8997280584492113,1
1593,Phenotype,HP:0000826,Precocious puberty,0.08481371257578152,0.89953780736328,1
1594,Phenotype,HP:0003002,Breast carcinoma,0.08479185022196811,0.8991116410084542,1
1595,Phenotype,HP:0008772,Aplasia/Hypoplasia of the external ear,0.08467947703838585,0.8969211325921985,1
1596,Phenotype,HP:0025132,Abnormal circulating estrogen level,0.08465672899600785,0.8964777013687173,1
1597,Phenotype,HP:0030085,Abnormal CSF lactate concentration,0.08464007496958026,0.8961530617715178,1
1597,Phenotype,HP:0002490,Increased CSF lactate,0.08464007496958026,0.8961530617715178,1
1599,Phenotype,HP:0007766,Optic disc hypoplasia,0.08463672977469006,0.8960878533532153,1
1600,Phenotype,HP:0010628,Facial palsy,0.08459758202760548,0.8953247400664636,1
1601,Biological Process,GO:0035089,establishment of apical/basal cell polarity,0.08458259791031841,0.8950326522748647,1
1602,Biological Process,GO:0003015,heart process,0.08455340305781356,0.8944635523518709,1
1603,Biological Process,GO:0110020,regulation of actomyosin structure organization,0.08452876032487877,0.893983187622739,1
1604,Phenotype,HP:0001259,Coma,0.08448885964716557,0.8932053973389824,1
1605,Biological Process,GO:0061041,regulation of wound healing,0.08447571677283883,0.8929492011904996,1
1606,Phenotype,HP:0000637,Long palpebral fissure,0.08447425656946761,0.8929207372129551,1
1607,Biological Process,GO:1901890,positive regulation of cell junction assembly,0.08444984134817268,0.8924448074045579,1
1608,Biological Process,GO:0002200,somatic diversification of immune receptors,0.08441891743723051,0.8918420026692735,1
1609,Phenotype,HP:0002859,Rhabdomyosarcoma,0.08435187932164578,0.890535217974589,1
1610,Biological Process,GO:0051491,positive regulation of filopodium assembly,0.08435143400226808,0.8905265372928313,1
1611,Phenotype,HP:0005249,Functional intestinal obstruction,0.08428431517888846,0.88921817934821,1
1612,Biological Process,GO:0034394,protein localization to cell surface,0.08428318549369851,0.8891961582143646,1
1613,Phenotype,HP:0001907,Thromboembolism,0.08425779727036997,0.8887012615219145,1
1614,Phenotype,HP:0002113,Pulmonary infiltrates,0.08424220940061256,0.8883974046869774,1
1615,Biological Process,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.08419870569684729,0.8875493800408983,1
1616,Biological Process,GO:0043467,regulation of generation of precursor metabolites and energy,0.08416283459106655,0.8868501388464404,1
1617,Phenotype,HP:0002209,Sparse scalp hair,0.08414436956288907,0.8864901971028698,1
1618,Biological Process,GO:0051588,regulation of neurotransmitter transport,0.08411875030282245,0.8859907967743824,1
1619,Phenotype,HP:0005135,Abnormal T-wave,0.08408974603501451,0.8854254119493266,1
1620,Biological Process,GO:0019377,glycolipid catabolic process,0.08405187108236911,0.8846871094478733,1
1621,Biological Process,GO:0070486,leukocyte aggregation,0.08405099223934198,0.8846699780203733,1
1622,Biological Process,GO:0003333,amino acid transmembrane transport,0.0840372811951694,0.8844027064463352,1
1623,Biological Process,GO:0007187,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",0.08401472340021687,0.8839629837463059,1
1624,Phenotype,HP:0002151,Increased circulating lactate concentration,0.08399026151221889,0.8834861442564124,1
1625,Phenotype,HP:0012703,Abnormal subarachnoid space morphology,0.08385452759603873,0.8808402613483577,1
1626,Biological Process,GO:0005513,detection of calcium ion,0.08384048155496149,0.8805664596261501,1
1627,Phenotype,HP:0000303,Mandibular prognathia,0.08383648221164441,0.8804884997880795,1
1628,Biological Process,GO:0034367,protein-containing complex remodeling,0.08383447737852778,0.8804494192559172,1
1629,Biological Process,GO:0032814,regulation of natural killer cell activation,0.08380080772822074,0.8797930913846331,1
1630,Phenotype,HP:0003390,Sensory axonal neuropathy,0.08378578282471394,0.8795002085407384,1
1631,Biological Process,GO:0045655,regulation of monocyte differentiation,0.08376277143674149,0.8790516438795221,1
1632,Biological Process,GO:0007193,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,0.08374662659662324,0.8787369299323797,1
1633,Biological Process,GO:0002710,negative regulation of T cell mediated immunity,0.08374240840796698,0.8786547041071576,1
1634,Biological Process,GO:2000406,positive regulation of T cell migration,0.08371651810911529,0.8781500203763413,1
1635,Phenotype,HP:0011925,Decreased activity of mitochondrial ATP synthase complex,0.0837133743717775,0.8780887390022857,1
1636,Phenotype,HP:0008305,Exercise-induced myoglobinuria,0.08363416483972064,0.8765446949422433,1
1637,Biological Process,GO:0009952,anterior/posterior pattern specification,0.0836174232918131,0.8762183492748558,1
1638,Biological Process,GO:0099536,synaptic signaling,0.08360100332286824,0.8758982721975517,1
1639,Biological Process,GO:1901203,positive regulation of extracellular matrix assembly,0.08358887481934296,0.8756618493411211,1
1640,Phenotype,HP:0025546,Abnormal mean corpuscular hemoglobin concentration,0.08358052181376607,0.875499022869236,1
1641,Biological Process,GO:0001501,skeletal system development,0.08355997322598141,0.8750984659654483,1
1642,Disease,MONDO:0006181,digestive system carcinoma,0.08350691619945882,0.8740642168729666,1
1643,Phenotype,HP:0004447,Poikilocytosis,0.0834904316488514,0.8737428808949987,1
1644,Biological Process,GO:0003206,cardiac chamber morphogenesis,0.08345787280243744,0.8731082061014246,1
1645,Biological Process,GO:1903779,regulation of cardiac conduction,0.08345138353990988,0.8729817098704845,1
1646,Biological Process,GO:0032722,positive regulation of chemokine production,0.08343331945318233,0.8726295837426373,1
1647,Phenotype,HP:0006510,Chronic pulmonary obstruction,0.0834240018231518,0.8724479536922035,1
1648,Phenotype,HP:0002445,Tetraplegia,0.08337589232158304,0.8715101474938852,1
1649,Biological Process,GO:0042743,hydrogen peroxide metabolic process,0.08334224710477878,0.8708542959087733,1
1650,Phenotype,HP:0100266,Synostosis of carpals/tarsals,0.08333891724481313,0.8707893864166045,1
1651,Biological Process,GO:1990868,response to chemokine,0.08319466938010456,0.8679775397500044,1
1651,Biological Process,GO:1990869,cellular response to chemokine,0.08319466938010456,0.8679775397500044,1
1653,Phenotype,HP:0011748,Adrenocorticotropic hormone deficiency,0.08314916102967063,0.867090438206223,1
1654,Phenotype,HP:0100133,Abnormality of the pubic hair,0.08314626064201569,0.867033900486404,1
1655,Biological Process,GO:0003205,cardiac chamber development,0.08314350827915107,0.8669802482374658,1
1656,Phenotype,HP:0001678,Atrioventricular block,0.08314320822230836,0.8669743991815047,1
1657,Biological Process,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,0.08310091668584474,0.8661500035062487,1
1658,Phenotype,HP:0002579,Gastrointestinal dysmotility,0.08306838574084874,0.8655158725994713,1
1659,Biological Process,GO:0072657,protein localization to membrane,0.08304049763229082,0.8649722452449534,1
1660,Phenotype,HP:0000273,Facial grimacing,0.08300594863718203,0.8642987761649964,1
1661,Biological Process,GO:0090287,regulation of cellular response to growth factor stimulus,0.0829176535371331,0.8625776256769021,1
1662,Phenotype,HP:0001374,Congenital hip dislocation,0.08287790595195643,0.8618028196504127,1
1663,Phenotype,HP:0001227,Abnormality of the thenar eminence,0.0828284509649635,0.8608387856898145,1
1664,Phenotype,HP:0008054,Abnormal morphology of the conjunctival vasculature,0.08279896872580417,0.8602640836928626,1
1665,Phenotype,HP:0005819,Short middle phalanx of finger,0.08277948466442075,0.8598842777722449,1
1666,Biological Process,GO:1903320,regulation of protein modification by small protein conjugation or removal,0.08276901342015919,0.8596801601353458,1
1667,Phenotype,HP:0011043,Abnormal circulating adrenocorticotropin concentration,0.08268007856753878,0.8579465388481919,1
1668,Biological Process,GO:0140053,mitochondrial gene expression,0.08266546912522688,0.8576617546557284,1
1669,Disease,MONDO:0005575,colorectal cancer,0.08264688666897113,0.8572995238678721,1
1669,Disease,MONDO:0024634,large intestine disorder,0.08264688666897113,0.8572995238678721,1
1669,Disease,MONDO:0005814,intestinal cancer,0.08264688666897113,0.8572995238678721,1
1669,Disease,MONDO:0005335,colorectal neoplasm,0.08264688666897113,0.8572995238678721,1
1673,Phenotype,HP:0010789,Abnormality of the Leydig cells,0.08264602710913738,0.8572827683307405,1
1674,Phenotype,HP:0003781,Excessive salivation,0.08263296303201106,0.8570281081886715,1
1675,Phenotype,HP:0010827,Abnormal seventh cranial physiology,0.08262001984351253,0.8567758045479326,1
1676,Phenotype,HP:0006297,Enamel hypoplasia,0.08261373619116785,0.8566533163091282,1
1677,Biological Process,GO:0003254,regulation of membrane depolarization,0.08260657918485104,0.8565138036418493,1
1678,Biological Process,GO:1903037,regulation of leukocyte cell-cell adhesion,0.08260586135425685,0.856499810855422,1
1679,Phenotype,HP:0002599,Head titubation,0.0825911359584145,0.856212766362269,1
1680,Phenotype,HP:0001059,Pterygium,0.08257722808771084,0.8559416580172228,1
1681,Biological Process,GO:0030194,positive regulation of blood coagulation,0.08256793551881259,0.8557605164874434,1
1681,Biological Process,GO:0050820,positive regulation of coagulation,0.08256793551881259,0.8557605164874434,1
1681,Biological Process,GO:1900048,positive regulation of hemostasis,0.08256793551881259,0.8557605164874434,1
1684,Biological Process,GO:0006112,energy reserve metabolic process,0.0825031520534476,0.8544976820496141,1
1685,Biological Process,GO:1900034,regulation of cellular response to heat,0.08243411387614374,0.8531519098323809,1
1686,Biological Process,GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis,0.08239226235051766,0.8523360913586615,1
1687,Biological Process,GO:0006734,NADH metabolic process,0.08238676658840793,0.8522289615900518,1
1688,Phenotype,HP:0003026,Short long bone,0.0823763534509313,0.8520259766379926,1
1689,Biological Process,GO:0050918,positive chemotaxis,0.08235715344382655,0.8516517078327989,1
1690,Biological Process,GO:0032469,endoplasmic reticulum calcium ion homeostasis,0.08235332719579114,0.8515771221687013,1
1691,Biological Process,GO:0006749,glutathione metabolic process,0.08234559511171258,0.8514263994187591,1
1692,Phenotype,HP:0004313,Decreased circulating antibody level,0.08229307337274638,0.8504025847721124,1
1693,Phenotype,HP:0012115,Hepatitis,0.08227353494450451,0.850021719069639,1
1694,Biological Process,GO:0090322,regulation of superoxide metabolic process,0.08225992666916493,0.8497564507848773,1
1695,Phenotype,HP:0040170,Abnormality of hair growth,0.08225690452147183,0.8496975395771864,1
1696,Phenotype,HP:0002669,Osteosarcoma,0.08224916188837861,0.8495466111936164,1
1697,Biological Process,GO:0045198,establishment of epithelial cell apical/basal polarity,0.08224593107923972,0.8494836325150346,1
1698,Phenotype,HP:0001552,Barrel-shaped chest,0.08222530573164333,0.8490815793199764,1
1699,Phenotype,HP:0001426,Non-Mendelian inheritance,0.08221770993715827,0.848933513284849,1
1700,Biological Process,GO:0032506,cytokinetic process,0.0821940076403338,0.8484714806270256,1
1701,Biological Process,GO:0002706,regulation of lymphocyte mediated immunity,0.08215394839969925,0.847690599450917,1
1702,Phenotype,HP:0001711,Abnormal left ventricle morphology,0.08212666006666414,0.8471586636164636,1
1703,Disease,MONDO:0006054,reproductive system neoplasm,0.08210557412693664,0.8467476320254264,1
1704,Biological Process,GO:0006027,glycosaminoglycan catabolic process,0.08202815255959062,0.8452384410470731,1
1705,Disease,MONDO:0021148,female reproductive system neoplasm,0.0820179180272066,0.8450389376726116,1
1706,Biological Process,GO:0008283,cell population proliferation,0.08193792722037796,0.8434796640986549,1
1707,Biological Process,GO:0035303,regulation of dephosphorylation,0.08193232086670299,0.8433703785509999,1
1708,Biological Process,GO:0010566,regulation of ketone biosynthetic process,0.08192309296251299,0.8431904975407071,1
1709,Phenotype,HP:0005484,Secondary microcephaly,0.08187382267115906,0.8422300638817003,1
1710,Phenotype,HP:0033019,Male reproductive system neoplasm,0.08183600838917027,0.841492944043047,1
1711,Phenotype,HP:0008034,Abnormal iris pigmentation,0.0818278939480176,0.8413347679455875,1
1712,Biological Process,GO:0098732,macromolecule deacylation,0.08178791246493022,0.8405554025097657,1
1712,Biological Process,GO:0035601,protein deacylation,0.08178791246493022,0.8405554025097657,1
1714,Phenotype,HP:0009601,Aplasia/Hypoplasia of the thumb,0.08178594453407573,0.8405170413192933,1
1715,Biological Process,GO:0043393,regulation of protein binding,0.08175720535205477,0.8399568238538238,1
1716,Phenotype,HP:0005346,Abnormal facial expression,0.08174534837241221,0.8397256938558078,1
1717,Biological Process,GO:0045619,regulation of lymphocyte differentiation,0.08166377741662345,0.8381356181857837,1
1718,Phenotype,HP:0025548,Increased mean corpuscular hemoglobin concentration,0.0816637447649633,0.8381349817017572,1
1719,Phenotype,HP:0010044,Short 4th metacarpal,0.08162190827652616,0.8373194563503635,1
1720,Phenotype,HP:0010979,Abnormality of lipoprotein cholesterol concentration,0.08161452378281442,0.8371755092349603,1
1721,Phenotype,HP:0011611,Interrupted aortic arch,0.08158765210563923,0.8366516953397344,1
1722,Phenotype,HP:0002345,Action tremor,0.08153498118749292,0.8356249727195022,1
1723,Biological Process,GO:0010569,regulation of double-strand break repair via homologous recombination,0.081514906735762,0.8352336582255412,1
1724,Phenotype,HP:0100744,Abnormality of the humeroradial joint,0.08148643445148096,0.8346786434403456,1
1725,Phenotype,HP:0002726,Recurrent Staphylococcus aureus infections,0.08144179729233647,0.8338085241675195,1
1726,Biological Process,GO:0051339,regulation of lyase activity,0.08142024198079634,0.8333883430367686,1
1727,Biological Process,GO:0042953,lipoprotein transport,0.08140694717153207,0.8331291851962811,1
1728,Biological Process,GO:0051091,positive regulation of DNA-binding transcription factor activity,0.08138113708620298,0.8326260650804728,1
1729,Phenotype,HP:0020061,Abnormal hemoglobin concentration,0.08136105120514636,0.8322345277928401,1
1730,Biological Process,GO:0098655,monoatomic cation transmembrane transport,0.08134345701962198,0.8318915615242009,1
1731,Phenotype,HP:0032064,Gastrointestinal eosinophilia,0.08130240305512959,0.8310912900370502,1
1732,Phenotype,HP:0046506,Pain in head and neck region,0.08128970805786928,0.8308438244277601,1
1733,Biological Process,GO:0043122,regulation of canonical NF-kappaB signal transduction,0.08123962841428245,0.8298676139364044,1
1734,Biological Process,GO:0043243,positive regulation of protein-containing complex disassembly,0.0812068508323347,0.8292286752961326,1
1735,Biological Process,GO:1903828,negative regulation of protein localization,0.08120194670894898,0.829133078435669,1
1736,Biological Process,GO:0043244,regulation of protein-containing complex disassembly,0.08118248055532384,0.8287536215938436,1
1737,Phenotype,HP:0007375,Abnormal septum pellucidum morphology,0.08112058558032964,0.8275470929601728,1
1738,Phenotype,HP:0002370,Poor coordination,0.08111233579379451,0.8273862785535552,1
1739,Phenotype,HP:0040223,Pulmonary hemorrhage,0.08108875413362426,0.8269265974853011,1
1740,Biological Process,GO:0000963,mitochondrial RNA processing,0.08101553382650428,0.8254993023435759,1
1741,Disease,MONDO:0002657,breast disorder,0.08098136006855472,0.8248331478214982,1
1742,Biological Process,GO:0006677,glycosylceramide metabolic process,0.08097149003312976,0.8246407496444784,1
1743,Phenotype,HP:0001048,Cavernous hemangioma,0.08096273776270746,0.8244701402391896,1
1744,Phenotype,HP:0001094,Iridocyclitis,0.08095079926998472,0.8242374212936823,1
1745,Phenotype,HP:0002135,Basal ganglia calcification,0.08092781540790595,0.8237893931991078,1
1746,Biological Process,GO:0035891,exit from host cell,0.08090162520700706,0.823278863429784,1
1746,Biological Process,GO:0019076,viral release from host cell,0.08090162520700706,0.823278863429784,1
1748,Phenotype,HP:0031784,Abnormal ascending aorta morphology,0.08082470690480492,0.8217794826792642,1
1749,Disease,MONDO:0021094,immunodeficiency disease,0.08079871877838873,0.8212728919801077,1
1750,Phenotype,HP:0001161,Hand polydactyly,0.08078544264196375,0.8210140981322587,1
1751,Biological Process,GO:0006636,unsaturated fatty acid biosynthetic process,0.08077974738641347,0.8209030796061485,1
1752,Phenotype,HP:0012505,Enlarged pituitary gland,0.08075065988741836,0.8203360723422672,1
1753,Phenotype,HP:0004490,Calvarial hyperostosis,0.08073674418691468,0.8200648113696785,1
1754,Biological Process,GO:0045445,myoblast differentiation,0.0807269413381021,0.8198737228720253,1
1755,Biological Process,GO:0019883,antigen processing and presentation of endogenous antigen,0.0807169273651055,0.8196785188969313,1
1756,Biological Process,GO:2000780,negative regulation of double-strand break repair,0.0806345641762658,0.8180730001015069,1
1757,Phenotype,HP:0011013,Abnormal circulating carbohydrate concentration,0.08053820313266213,0.8161946188873759,1
1758,Biological Process,GO:1905209,positive regulation of cardiocyte differentiation,0.08050279947227301,0.8155044896805989,1
1759,Biological Process,GO:0061028,establishment of endothelial barrier,0.08043666240412783,0.8142152692475724,1
1760,Phenotype,HP:0004887,Respiratory failure requiring assisted ventilation,0.08041729387321184,0.813837715380809,1
1761,Biological Process,GO:2000379,positive regulation of reactive oxygen species metabolic process,0.08040054720835321,0.8135112699678766,1
1762,Phenotype,HP:0010903,Abnormal circulating glutamine concentration,0.080359758113692,0.8127161616306511,1
1763,Biological Process,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,0.08034575101090369,0.8124431189387289,1
1764,Biological Process,GO:0043414,macromolecule methylation,0.08027787034471257,0.8111199102704985,1
1765,Biological Process,GO:0003197,endocardial cushion development,0.08022243552973718,0.8100393105679167,1
1766,Phenotype,HP:0003201,Rhabdomyolysis,0.08021906382679622,0.8099735854239469,1
1767,Phenotype,HP:0100615,Ovarian neoplasm,0.08020651292222425,0.8097289286364456,1
1768,Biological Process,GO:0042531,positive regulation of tyrosine phosphorylation of STAT protein,0.08020514195879269,0.8097022042272987,1
1769,Phenotype,HP:0004406,"Spontaneous, recurrent epistaxis",0.08020362262353442,0.809672587582435,1
1770,Phenotype,HP:0100260,Mesoaxial polydactyly,0.08015060094174631,0.8086390274705078,1
1771,Biological Process,GO:0010224,response to UV-B,0.08013480425431685,0.8083311001193363,1
1772,Biological Process,GO:0045137,development of primary sexual characteristics,0.08010661881529002,0.8077816768544972,1
1773,Phenotype,HP:0001331,Absent septum pellucidum,0.08009662427427633,0.80758685167015,1
1774,Phenotype,HP:0008517,Aplasia/Hypoplasia of the sacrum,0.08006694127875047,0.8070082362972796,1
1775,Phenotype,HP:0010920,Zonular cataract,0.08006582614534286,0.8069864988236515,1
1776,Phenotype,HP:0001900,Increased circulating hemoglobin concentration,0.08004605288037969,0.806601055411461,1
1777,Biological Process,GO:0048638,regulation of developmental growth,0.08002234785340356,0.8061389695343552,1
1778,Phenotype,HP:0010049,Short metacarpal,0.07999115517156707,0.8055309256050986,1
1779,Biological Process,GO:0032411,positive regulation of transporter activity,0.07996281437231723,0.8049784738786175,1
1780,Biological Process,GO:0045089,positive regulation of innate immune response,0.07996066797090096,0.8049366337329785,1
1781,Phenotype,HP:0004389,Intestinal pseudo-obstruction,0.07995984527561906,0.8049205968024443,1
1782,Phenotype,HP:0410242,Abnormal circulating IgG level,0.07995779337436382,0.8048805987635382,1
1783,Phenotype,HP:0008066,Abnormal blistering of the skin,0.07993007010838415,0.8043401847117276,1
1784,Biological Process,GO:0048771,tissue remodeling,0.07991264465706571,0.8040005076059156,1
1785,Phenotype,HP:0000882,Hypoplastic scapulae,0.07988896534590362,0.8035389230112802,1
1786,Phenotype,HP:0011342,Mild global developmental delay,0.0798709345349391,0.8031874455331968,1
1787,Phenotype,HP:0002385,Paraparesis,0.07977331892742301,0.8012846089043371,1
1788,Disease,MONDO:0021189,intestinal motility disease,0.07975451519478516,0.8009180647406213,1
1789,Phenotype,HP:0002850,Decreased circulating total IgM,0.07971289565006445,0.8001067683077433,1
1790,Phenotype,HP:0100660,Dyskinesia,0.07967508499527076,0.7993697191745834,1
1791,Biological Process,GO:0032535,regulation of cellular component size,0.07966532689999106,0.7991795030646949,1
1792,Biological Process,GO:0019882,antigen processing and presentation,0.07965607997294233,0.7989992512387784,1
1793,Phenotype,HP:0003187,Breast hypoplasia,0.07962498047919542,0.7983930238398365,1
1794,Biological Process,GO:0072593,reactive oxygen species metabolic process,0.07961924318363867,0.7982811858211653,1
1795,Phenotype,HP:0012338,Abnormal energy expenditure,0.07959834954684541,0.7978739028219406,1
1796,Phenotype,HP:0010450,Esophageal stenosis,0.07959774005672215,0.7978620219336178,1
1797,Biological Process,GO:0060415,muscle tissue morphogenesis,0.07957828313077431,0.7974827449683797,1
1797,Biological Process,GO:0048644,muscle organ morphogenesis,0.07957828313077431,0.7974827449683797,1
1799,Biological Process,GO:0016052,carbohydrate catabolic process,0.07953205246596773,0.7965815632351615,1
1800,Biological Process,GO:0046822,regulation of nucleocytoplasmic transport,0.07952875240907553,0.7965172346990638,1
1801,Phenotype,HP:0009816,Lower limb undergrowth,0.0794919235960384,0.7957993247640883,1
1802,Biological Process,GO:2000191,regulation of fatty acid transport,0.07944827635621776,0.7949485021467557,1
1803,Biological Process,GO:0009880,embryonic pattern specification,0.0794399896479484,0.7947869680188756,1
1804,Phenotype,HP:0002421,Poor head control,0.07943416644932055,0.7946734554779187,1
1805,Biological Process,GO:0055007,cardiac muscle cell differentiation,0.07943130936651221,0.7946177619063912,1
1806,Phenotype,HP:0002925,Elevated circulating thyroid-stimulating hormone concentration,0.07937988488443515,0.7936153362635425,1
1807,Phenotype,HP:0001592,Selective tooth agenesis,0.07937958887515073,0.7936095661072816,1
1808,Biological Process,GO:0032930,positive regulation of superoxide anion generation,0.07935936331656568,0.7932153060632774,1
1809,Phenotype,HP:0004374,Hemiplegia/hemiparesis,0.07934345664187992,0.7929052347129513,1
1810,Biological Process,GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway,0.07933894202198433,0.7928172305062337,1
1811,Biological Process,GO:0033628,regulation of cell adhesion mediated by integrin,0.07933186406367931,0.7926792587344748,1
1812,Phenotype,HP:0005162,Abnormal left ventricular function,0.07931146402365308,0.7922815974958687,1
1813,Disease,MONDO:0002245,blood platelet disease,0.07926495218394769,0.7913749347754376,1
1814,Phenotype,HP:0032388,Periventricular nodular heterotopia,0.07926326331755629,0.7913420134331177,1
1815,Phenotype,HP:0001699,Sudden death,0.07923675390882545,0.7908252612945406,1
1816,Disease,MONDO:0017688,disorder of glycolysis,0.07919486226275751,0.7900086607466398,1
1817,Phenotype,HP:0009062,Infantile axial hypotonia,0.07912192622852166,0.78858690698165,1
1818,Biological Process,GO:0070920,regulation of regulatory ncRNA processing,0.07910961418310303,0.7883469063137765,1
1818,Biological Process,GO:1903798,regulation of miRNA processing,0.07910961418310303,0.7883469063137765,1
1820,Biological Process,GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,0.07908147817537858,0.7877984466212101,1
1821,Phenotype,HP:0002307,Drooling,0.07907445375828626,0.7876615185368618,1
1822,Phenotype,HP:0005599,Hypopigmentation of hair,0.07906911432427555,0.7875574360968557,1
1823,Phenotype,HP:0004315,Decreased circulating IgG level,0.07885176897479429,0.7833206884841638,1
1824,Phenotype,HP:0025427,Abnormal bronchus physiology,0.07882719692557782,0.782841701604043,1
1825,Biological Process,GO:0045580,regulation of T cell differentiation,0.07881838677730602,0.7826699639765891,1
1826,Phenotype,HP:0000883,Thin ribs,0.07881534371249121,0.7826106450281038,1
1827,Phenotype,HP:0002075,Dysdiadochokinesis,0.07881230421345531,0.7825513955879162,1
1828,Phenotype,HP:0001645,Sudden cardiac death,0.07881190432030616,0.7825436004068873,1
1829,Biological Process,GO:0032409,regulation of transporter activity,0.07879873256586623,0.7822868412937453,1
1830,Biological Process,GO:0009612,response to mechanical stimulus,0.07878777001336501,0.7820731465068571,1
1831,Phenotype,HP:0009113,Diaphragmatic weakness,0.07876721196103542,0.7816724051091835,1
1832,Biological Process,GO:1905564,positive regulation of vascular endothelial cell proliferation,0.07874507580335066,0.7812409014517603,1
1833,Phenotype,HP:0000383,Abnormal periauricular region morphology,0.07874194142126845,0.7811798024411959,1
1834,Disease,MONDO:0001336,familial hyperlipidemia,0.07869649528352407,0.780293913619309,1
1834,Disease,MONDO:0021187,hyperlipidemia,0.07869649528352407,0.780293913619309,1
1836,Phenotype,HP:0000327,Hypoplasia of the maxilla,0.07868783621094133,0.7801251209343925,1
1837,Phenotype,HP:0034295,Reduced cerebral white matter volume,0.07865787090073251,0.7795410023563147,1
1838,Biological Process,GO:0009267,cellular response to starvation,0.07865248062519725,0.77943592885435,1
1839,Biological Process,GO:0061339,establishment or maintenance of monopolar cell polarity,0.07861683621489202,0.7787411066710047,1
1840,Phenotype,HP:0000891,Cervical ribs,0.07857521121301236,0.7779297038608557,1
1841,Phenotype,HP:0000191,Accessory oral frenulum,0.07851685158124821,0.7767920902374473,1
1842,Biological Process,GO:0032651,regulation of interleukin-1 beta production,0.07849799460363072,0.7764245081608387,1
1843,Phenotype,HP:0002577,Abnormal stomach morphology,0.07845792705238575,0.7756434649846737,1
1844,Phenotype,HP:0007165,Periventricular heterotopia,0.07843360342273198,0.7751693205867671,1
1845,Biological Process,GO:2000401,regulation of lymphocyte migration,0.07843352231060341,0.7751677394550893,1
1846,Biological Process,GO:0051654,establishment of mitochondrion localization,0.07838326226376968,0.7741880123344272,1
1847,Phenotype,HP:0008064,Ichthyosis,0.07837822707721842,0.7740898606387437,1
1848,Biological Process,GO:0170041,non-proteinogenic amino acid metabolic process,0.07835703895392498,0.7736768371671344,1
1849,Phenotype,HP:0005625,Osteoporosis of vertebrae,0.07831589207417078,0.7728747544679443,1
1850,Phenotype,HP:0001647,Bicuspid aortic valve,0.07829007484082218,0.77237149501465,1
1851,Phenotype,HP:0012722,Heart block,0.07825071218177504,0.7716041924146855,1
1852,Phenotype,HP:0011772,Abnormal thyroid morphology,0.07824625619004077,0.7715173310560809,1
1853,Biological Process,GO:0007173,epidermal growth factor receptor signaling pathway,0.0782293251042464,0.7711872906963917,1
1854,Biological Process,GO:1902229,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,0.07821709321591808,0.7709488525434822,1
1855,Phenotype,HP:0009728,Neoplasm of striated muscle,0.07813996269869194,0.7694453350516038,1
1856,Phenotype,HP:0010732,Nodular changes affecting the eyelids,0.07810424546854455,0.7687490933794443,1
1857,Phenotype,HP:0000554,Uveitis,0.07806743678000849,0.7680315757345824,1
1858,Biological Process,GO:1903522,regulation of blood circulation,0.07805031554861741,0.7676978288364056,1
1859,Biological Process,GO:0051153,regulation of striated muscle cell differentiation,0.07800716198437763,0.7668566295160226,1
1860,Biological Process,GO:0006941,striated muscle contraction,0.07799617096124889,0.7666423797466447,1
1861,Biological Process,GO:0030656,regulation of vitamin metabolic process,0.0779814346992802,0.7663551234383554,1
1862,Phenotype,HP:0025085,Bloody diarrhea,0.07796058218215263,0.7659486419913415,1
1863,Biological Process,GO:0006026,aminoglycan catabolic process,0.07795741592010186,0.765886921539458,1
1864,Disease,MONDO:0000009,"inherited bleeding disorder, platelet-type",0.07791325699816487,0.7650261246209037,1
1865,Phenotype,HP:0011492,Abnormal corneal stroma morphology,0.0779109861611399,0.7649818588320688,1
1866,Biological Process,GO:0071875,adrenergic receptor signaling pathway,0.07788397572687733,0.7644553401227759,1
1867,Biological Process,GO:0098780,response to mitochondrial depolarisation,0.07787121180949885,0.7642065310426142,1
1868,Phenotype,HP:0100641,Neoplasm of the adrenal cortex,0.07783876183600169,0.7635739785261967,1
1869,Phenotype,HP:0000239,Large fontanelles,0.07782984737217757,0.7634002074590199,1
1870,Biological Process,GO:0099537,trans-synaptic signaling,0.07782885269051154,0.7633808179704294,1
1871,Phenotype,HP:0000262,Turricephaly,0.07781322342114438,0.7630761541262872,1
1872,Biological Process,GO:0022900,electron transport chain,0.07781069205563185,0.7630268098140316,1
1873,Phenotype,HP:0032466,Aplasia of the olfactory bulb,0.07779576476325467,0.7627358297194775,1
1874,Biological Process,GO:0051495,positive regulation of cytoskeleton organization,0.0777668666320055,0.7621725138313141,1
1875,Disease,MONDO:0005385,vascular disorder,0.07774493643546276,0.7617450250073295,1
1876,Biological Process,GO:0010517,regulation of phospholipase activity,0.0777273111883261,0.7614014532497207,1
1877,Biological Process,GO:0042307,positive regulation of protein import into nucleus,0.07771658959927163,0.7611924556017877,1
1878,Biological Process,GO:0006936,muscle contraction,0.07770319965962147,0.7609314433694933,1
1879,Biological Process,GO:0016540,protein autoprocessing,0.07766901288244255,0.760265035061498,1
1880,Phenotype,HP:0001019,Erythroderma,0.07764350661368202,0.7597678372905876,1
1881,Phenotype,HP:0002705,"High, narrow palate",0.07763741292646975,0.7596490520724511,1
1882,Phenotype,HP:0003065,Patellar hypoplasia,0.07763524540385502,0.759606800207917,1
1883,Disease,MONDO:0001967,gonadal dysgenesis,0.07761764460931764,0.7592637051087316,1
1884,Phenotype,HP:0005160,Total anomalous pulmonary venous return,0.0776145515202884,0.7592034110302444,1
1885,Biological Process,GO:1904376,negative regulation of protein localization to cell periphery,0.07761245021700036,0.7591624499896222,1
1886,Phenotype,HP:0033835,Abnormal renal vascular morphology,0.07759543352369391,0.7588307408690265,1
1887,Biological Process,GO:0050804,modulation of chemical synaptic transmission,0.0775947338825036,0.7588171026515542,1
1887,Biological Process,GO:0099177,regulation of trans-synaptic signaling,0.0775947338825036,0.7588171026515542,1
1889,Phenotype,HP:0002301,Hemiplegia,0.07758148941197351,0.7585589260720523,1
1890,Biological Process,GO:1905953,negative regulation of lipid localization,0.07757418576301545,0.7584165548763452,1
1891,Biological Process,GO:0042742,defense response to bacterium,0.07756982442899929,0.7583315386957589,1
1892,Biological Process,GO:0010661,positive regulation of muscle cell apoptotic process,0.07755243141566082,0.7579924939086715,1
1893,Biological Process,GO:0010951,negative regulation of endopeptidase activity,0.07750174531855358,0.7570044617219776,1
1894,Biological Process,GO:0009314,response to radiation,0.0774964413195417,0.7569010700220633,1
1895,Biological Process,GO:0032731,positive regulation of interleukin-1 beta production,0.07746619612837158,0.7563114956797032,1
1896,Phenotype,HP:0002919,Ketonuria,0.07743973558897921,0.7557956961589464,1
1897,Phenotype,HP:0012176,Abnormal natural killer cell morphology,0.07740696891643695,0.7551569701774583,1
1898,Biological Process,GO:0001959,regulation of cytokine-mediated signaling pathway,0.0773944784318139,0.7549134911656721,1
1899,Phenotype,HP:0003563,Decreased LDL cholesterol concentration,0.07737037578970796,0.7544436545133321,1
1900,Disease,MONDO:0007794,hypogonadotropic hypogonadism 7 with or without anosmia,0.07735087500471916,0.7540635225968033,1
1901,Phenotype,HP:0007376,Abnormal choroid plexus morphology,0.07732682901731425,0.7535947903235998,1
1902,Phenotype,HP:0001537,Umbilical hernia,0.07728539987639516,0.7527872054624387,1
1903,Phenotype,HP:0011734,Central adrenal insufficiency,0.07723876741731106,0.7518781914891927,1
1904,Phenotype,HP:0430050,Anti-thyroid antibody positivity,0.07722076634219244,0.7515272936567029,1
1905,Phenotype,HP:0001831,Short toe,0.07719898679374104,0.7511027414400248,1
1906,Phenotype,HP:0031567,Abnormal aortic valve cusp morphology,0.07719445606525444,0.7510144232259696,1
1907,Phenotype,HP:0100592,Peritoneal abscess,0.07717147205782104,0.7505663922979744,1
1908,Phenotype,HP:0009733,Glioma,0.0771550467989649,0.7502462121035847,1
1909,Biological Process,GO:0002761,regulation of myeloid leukocyte differentiation,0.0771534650180068,0.7502153781947201,1
1910,Phenotype,HP:0000267,Cranial asymmetry,0.0771178694984408,0.7495215090463637,1
1911,Phenotype,HP:0000836,Hyperthyroidism,0.0770915209245212,0.7490078920864514,1
1912,Phenotype,HP:0030450,Neoplasm of the autonomic nervous system,0.07708656317869289,0.7489112499551493,1
1912,Phenotype,HP:0003005,Ganglioneuroma,0.07708656317869289,0.7489112499551493,1
1914,Phenotype,HP:0000034,Hydrocele testis,0.07705220667229162,0.7482415330883131,1
1915,Biological Process,GO:0003170,heart valve development,0.07705012715860471,0.748200996795866,1
1915,Biological Process,GO:0003179,heart valve morphogenesis,0.07705012715860471,0.748200996795866,1
1917,Biological Process,GO:0030041,actin filament polymerization,0.07704405058762387,0.7480825452271627,1
1918,Phenotype,HP:0100779,Urogenital sinus anomaly,0.07702550679324272,0.7477210680814032,1
1919,Biological Process,GO:1905314,semi-lunar valve development,0.07702337118887492,0.7476794384043546,1
1920,Phenotype,HP:0000863,Central diabetes insipidus,0.07702095744713622,0.7476323869511097,1
1921,Phenotype,HP:0005575,Hemolytic-uremic syndrome,0.07699499932167597,0.7471263810653793,1
1922,Phenotype,HP:0001531,Failure to thrive in infancy,0.07697161581287182,0.746670562593354,1
1923,Biological Process,GO:0099024,plasma membrane invagination,0.07695732649000475,0.7463920185403594,1
1924,Phenotype,HP:0033836,Abnormal intrarenal artery morphology,0.07690593298437143,0.7453901967262763,1
1924,Phenotype,HP:0008776,Abnormal renal artery morphology,0.07690593298437143,0.7453901967262763,1
1926,Biological Process,GO:0045954,positive regulation of natural killer cell mediated cytotoxicity,0.07689857568193692,0.7452467796547831,1
1927,Biological Process,GO:1903670,regulation of sprouting angiogenesis,0.07687267334341541,0.74474186123276,1
1928,Biological Process,GO:0010466,negative regulation of peptidase activity,0.07685648336163475,0.744426267331982,1
1929,Biological Process,GO:0010759,positive regulation of macrophage chemotaxis,0.07681989593698813,0.743713062819458,1
1930,Phenotype,HP:0001289,Confusion,0.07681969822367585,0.7437092087622823,1
1931,Biological Process,GO:0071384,cellular response to corticosteroid stimulus,0.07680191863421959,0.7433626283851855,1
1932,Biological Process,GO:0030534,adult behavior,0.0767739174919263,0.7428167976460099,1
1933,Biological Process,GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,0.0767678112758895,0.7426977682014956,1
1934,Biological Process,GO:1900117,regulation of execution phase of apoptosis,0.07671601721530819,0.7416881383058331,1
1935,Phenotype,HP:0005407,Decreased proportion of CD4-positive helper T cells,0.0767151097685731,0.7416704493016851,1
1935,Phenotype,HP:0500267,Abnormal proportion of CD4-positive helper T cells,0.0767151097685731,0.7416704493016851,1
1937,Phenotype,HP:0002099,Asthma,0.07670670326733886,0.7415065800304067,1
1938,Biological Process,GO:0032869,cellular response to insulin stimulus,0.0767045309177733,0.7414642340733489,1
1939,Biological Process,GO:0050777,negative regulation of immune response,0.07669848030246817,0.7413462884627782,1
1940,Phenotype,HP:0009835,Aplasia/Hypoplasia of the distal phalanges of the hand,0.07668776052443171,0.7411373261173083,1
1941,Biological Process,GO:0002449,lymphocyte mediated immunity,0.07665458064648967,0.7404905454569635,1
1942,Phenotype,HP:0010299,Abnormal dentin morphology,0.07656885965520699,0.7388195724821964,1
1943,Biological Process,GO:0010660,regulation of muscle cell apoptotic process,0.07656183946960982,0.7386827268830591,1
1944,Phenotype,HP:0012084,Abnormality of skeletal muscle fiber size,0.07655395100701756,0.738528955821772,1
1945,Biological Process,GO:0051216,cartilage development,0.07653530282408216,0.7381654438132512,1
1946,Phenotype,HP:0000141,Amenorrhea,0.07649494595264739,0.7373787608724149,1
1947,Biological Process,GO:0007200,phospholipase C-activating G protein-coupled receptor signaling pathway,0.07649327236402637,0.7373461373421132,1
1948,Phenotype,HP:0009909,Uplifted earlobe,0.07648462406276557,0.7371775546242959,1
1949,Phenotype,HP:0002625,Deep venous thrombosis,0.07647869165886412,0.7370619133274979,1
1950,Biological Process,GO:0016064,immunoglobulin mediated immune response,0.07646540858253803,0.7368029841990483,1
1951,Phenotype,HP:0012400,Abnormal circulating aldolase concentration,0.07645484278941861,0.7365970235061614,1
1952,Phenotype,HP:0100684,Salivary gland neoplasm,0.07645158700784427,0.7365335580359066,1
1953,Phenotype,HP:0006705,Abnormal atrioventricular valve morphology,0.07641337757028566,0.735788735366615,1
1954,Phenotype,HP:0001734,Annular pancreas,0.07641185360692015,0.7357590285053178,1
1955,Phenotype,HP:0025483,Abnormal circulating thyroglobulin concentration,0.07640396497803215,0.7356052542024011,1
1956,Biological Process,GO:0009145,purine nucleoside triphosphate biosynthetic process,0.07639256189580179,0.7353829720991396,1
1956,Biological Process,GO:0009206,purine ribonucleoside triphosphate biosynthetic process,0.07639256189580179,0.7353829720991396,1
1958,Biological Process,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,0.07638526426420422,0.7352407182008018,1
1959,Phenotype,HP:0010311,Aplasia/Hypoplasia of the breasts,0.0763808809810812,0.7351552741627695,1
1960,Biological Process,GO:0051259,protein complex oligomerization,0.07634762813045426,0.7345070710342225,1
1961,Biological Process,GO:0050850,positive regulation of calcium-mediated signaling,0.07634154560767925,0.7343885034462448,1
1962,Phenotype,HP:0100724,Hypercoagulability,0.07634152023759477,0.7343880089031359,1
1963,Biological Process,GO:0035455,response to interferon-alpha,0.07634054522719158,0.7343690028696139,1
1964,Biological Process,GO:1901988,negative regulation of cell cycle phase transition,0.07630708749291015,0.7337168059112652,1
1965,Biological Process,GO:2000479,regulation of cAMP-dependent protein kinase activity,0.07630511441584464,0.7336783444048797,1
1966,Phenotype,HP:0009882,Short distal phalanx of finger,0.07628544305647544,0.7332948874547089,1
1967,Phenotype,HP:0001107,Ocular albinism,0.07627633524476873,0.7331173474263746,1
1968,Phenotype,HP:0200102,Sparse or absent eyelashes,0.07626531803325176,0.7329025871625618,1
1969,Phenotype,HP:0031650,Abnormal atrioventricular valve physiology,0.07623781637087423,0.7323664928651631,1
1970,Phenotype,HP:0003493,Antinuclear antibody positivity,0.07621759513385329,0.7319723170620983,1
1971,Disease,MONDO:0021166,inflammatory disease,0.07616833682907032,0.7310121170592337,1
1972,Biological Process,GO:0046777,protein autophosphorylation,0.07616174455546754,0.7308836128169509,1
1973,Phenotype,HP:0032255,Opportunistic fungal infection,0.07615435716348262,0.7307396092050457,1
1974,Biological Process,GO:0043113,receptor clustering,0.07611805951998829,0.7300320534428083,1
1975,Disease,MONDO:0005453,congenital heart disease,0.0761133362267139,0.7299399815325878,1
1976,Phenotype,HP:0009789,Perianal abscess,0.0760991376838247,0.7296632070682014,1
1977,Biological Process,GO:0000302,response to reactive oxygen species,0.07603193928127272,0.7283532978740627,1
1978,Phenotype,HP:0002745,Oral leukoplakia,0.0759687542557912,0.7271216220801905,1
1978,Phenotype,HP:0025125,White lesion of the oral mucosa,0.0759687542557912,0.7271216220801905,1
1980,Biological Process,GO:0098916,anterograde trans-synaptic signaling,0.07593691357315036,0.7265009465677537,1
1980,Biological Process,GO:0007268,chemical synaptic transmission,0.07593691357315036,0.7265009465677537,1
1982,Biological Process,GO:0050829,defense response to Gram-negative bacterium,0.07592841681791296,0.7263353179607759,1
1983,Biological Process,GO:0045581,negative regulation of T cell differentiation,0.0759249381859155,0.7262675084316288,1
1984,Biological Process,GO:0032481,positive regulation of type I interferon production,0.0759225043857541,0.7262200659763464,1
1985,Phenotype,HP:0001396,Cholestasis,0.07589012895529379,0.7255889665392525,1
1986,Disease,MONDO:0021350,neoplasm of thorax,0.07588406181296747,0.7254706987648178,1
1987,Phenotype,HP:0045026,Abnormal mediastinum morphology,0.07586462147998785,0.7250917452489596,1
1988,Phenotype,HP:0000703,Dentinogenesis imperfecta,0.07585818960561563,0.7249663676944977,1
1989,Biological Process,GO:0009201,ribonucleoside triphosphate biosynthetic process,0.07584308043711796,0.7246718422596767,1
1990,Phenotype,HP:0011733,Abnormality of adrenal physiology,0.07583054452650517,0.7244274777518168,1
1991,Phenotype,HP:0000093,Proteinuria,0.07580475449665136,0.7239247485805914,1
1992,Phenotype,HP:0001009,Telangiectasia,0.07576193712106816,0.7230901026393884,1
1993,Biological Process,GO:0043648,dicarboxylic acid metabolic process,0.0757177967603424,0.7222296675374894,1
1994,Phenotype,HP:0001634,Mitral valve prolapse,0.07571749280934692,0.7222237425721862,1
1995,Biological Process,GO:0043062,extracellular structure organization,0.07571352364671313,0.7221463710509956,1
1996,Biological Process,GO:0045017,glycerolipid biosynthetic process,0.07569026095084985,0.7216929076049233,1
1997,Phenotype,HP:0000168,Abnormality of the gingiva,0.07567651412139864,0.7214249384627333,1
1998,Phenotype,HP:0034391,Elbow contracture,0.07566136330590056,0.7211296011962814,1
1999,Phenotype,HP:0000325,Triangular face,0.07562280837092616,0.7203780436906797,1
2000,Biological Process,GO:1903901,negative regulation of viral life cycle,0.07560450082005243,0.720021171677344,1
2001,Phenotype,HP:0032677,Generalized-onset motor seizure,0.07558502882041396,0.7196416008782469,1
2002,Biological Process,GO:0009313,oligosaccharide catabolic process,0.07554108450452857,0.7187849873097341,1
2003,Phenotype,HP:0012209,Juvenile myelomonocytic leukemia,0.07552783724364664,0.7185267563374581,1
2004,Phenotype,HP:0040313,Oligoarthritis,0.07551688792245637,0.7183133194706274,1
2005,Biological Process,GO:0033673,negative regulation of kinase activity,0.07551684531792768,0.7183124889737448,1
2006,Phenotype,HP:0010621,Cutaneous syndactyly of toes,0.07551383735284833,0.7182538542300091,1
2007,Biological Process,GO:0031669,cellular response to nutrient levels,0.07550450944041653,0.7180720237430851,1
2008,Biological Process,GO:0045069,regulation of viral genome replication,0.07549110649629454,0.7178107580125441,1
2009,Phenotype,HP:0004493,Craniofacial hyperostosis,0.07546775569945063,0.7173555771999849,1
2010,Biological Process,GO:0010256,endomembrane system organization,0.07546690731245542,0.7173390394567795,1
2011,Biological Process,GO:1900120,regulation of receptor binding,0.07542326385942022,0.7164882906558604,1
2012,Biological Process,GO:0039532,negative regulation of cytoplasmic pattern recognition receptor signaling pathway,0.07538719422628237,0.7157851795359207,1
2013,Phenotype,HP:0009536,Short 2nd finger,0.07538706315562915,0.7157826245547424,1
2014,Phenotype,HP:0004452,Abnormality of the middle ear ossicles,0.0753776240409415,0.7155986263844835,1
2015,Phenotype,HP:0008404,Nail dystrophy,0.07536259722264183,0.7153057062152254,1
2016,Biological Process,GO:0002443,leukocyte mediated immunity,0.0753185430194202,0.7144469505953157,1
2017,Disease,MONDO:0020585,anemia due to erythrocyte enzyme disorder,0.07531475268658783,0.7143730650320074,1
2018,Biological Process,GO:0001510,RNA methylation,0.07530199787979874,0.7141244335460198,1
2019,Biological Process,GO:2000242,negative regulation of reproductive process,0.07527987722785345,0.7136932321444528,1
2020,Phenotype,HP:0100827,Lymphocytosis,0.07523330759604274,0.7127854428732819,1
2021,Phenotype,HP:0100729,Large face,0.0752226946808936,0.7125785636231432,1
2022,Biological Process,GO:0043124,negative regulation of canonical NF-kappaB signal transduction,0.07521785693473237,0.7124842606645186,1
2023,Phenotype,HP:0200041,Skin erosion,0.0751990935639012,0.7121185032799471,1
2024,Phenotype,HP:0002395,Lower limb hyperreflexia,0.07519381757697341,0.7120156576240624,1
2025,Biological Process,GO:0046638,positive regulation of alpha-beta T cell differentiation,0.07516521071366455,0.7114580194683822,1
2026,Phenotype,HP:0002922,Increased CSF protein concentration,0.07513301240357506,0.710830372666967,1
2027,Phenotype,HP:0002031,Abnormal esophagus morphology,0.07510519673059746,0.7102881573107859,1
2028,Phenotype,HP:0000322,Short philtrum,0.0750967707364033,0.7101239080601264,1
2029,Phenotype,HP:0100277,Periauricular skin pits,0.07505334784047701,0.7092774586141595,1
2030,Biological Process,GO:0051928,positive regulation of calcium ion transport,0.07503940299153755,0.7090056294464565,1
2031,Phenotype,HP:0000656,Ectropion,0.07503417049198646,0.7089036314969517,1
2032,Phenotype,HP:0032260,Opportunistic bacterial infection,0.07501558594874869,0.7085413600272215,1
2033,Phenotype,HP:0001387,Joint stiffness,0.07499989007443997,0.7082353978423148,1
2034,Phenotype,HP:0012534,Dysesthesia,0.07496697356789372,0.7075937511226551,1
2035,Biological Process,GO:0051348,negative regulation of transferase activity,0.07495483434058414,0.7073571192257843,1
2036,Biological Process,GO:0060047,heart contraction,0.07495389416317577,0.707338792197394,1
2037,Biological Process,GO:0002717,positive regulation of natural killer cell mediated immunity,0.07494964819059313,0.7072560247756572,1
2038,Biological Process,GO:0032653,regulation of interleukin-10 production,0.07494482660649315,0.707162036866674,1
2039,Phenotype,HP:0000675,Macrodontia of permanent maxillary central incisor,0.07493980924987376,0.7070642327327001,1
2040,Biological Process,GO:2000404,regulation of T cell migration,0.07490960035831273,0.7064753659844182,1
2041,Biological Process,GO:0006623,protein targeting to vacuole,0.07489901300367319,0.7062689849893756,1
2041,Biological Process,GO:0072666,establishment of protein localization to vacuole,0.07489901300367319,0.7062689849893756,1
2043,Disease,MONDO:0024239,congenital anomaly of cardiovascular system,0.0748974810459162,0.7062391222921284,1
2044,Biological Process,GO:0051668,localization within membrane,0.07489097347510432,0.7061122691748775,1
2045,Biological Process,GO:0030182,neuron differentiation,0.07485461550702244,0.7054035374958199,1
2046,Phenotype,HP:0031860,Abnormal heart rate variability,0.07484614139622847,0.7052383503005948,1
2047,Phenotype,HP:0410243,Abnormal circulating IgM level,0.0748094638382879,0.7045233888053755,1
2048,Phenotype,HP:4000007,Bronchoconstriction,0.07475241505278807,0.7034113277175709,1
2049,Biological Process,GO:2001028,positive regulation of endothelial cell chemotaxis,0.07473521537131134,0.7030760515793442,1
2050,Biological Process,GO:0055008,cardiac muscle tissue morphogenesis,0.07472380154383784,0.702853560017342,1
2051,Phenotype,HP:0003141,Increased LDL cholesterol concentration,0.07468823761537524,0.70216030667941,1
2052,Disease,MONDO:0018102,corneal dystrophy,0.07467784856431381,0.7019577912476894,1
2053,Phenotype,HP:0000873,Diabetes insipidus,0.07466769762519854,0.7017599173701675,1
2054,Phenotype,HP:0100031,Neoplasm of the thyroid gland,0.07464521001236624,0.7013215627414175,1
2055,Phenotype,HP:0100490,Camptodactyly of finger,0.07464275213374627,0.7012736509208966,1
2056,Disease,MONDO:0002514,hepatobiliary neoplasm,0.0745802313643591,0.7000549235771693,1
2056,Disease,MONDO:0024477,liver and intrahepatic bile duct neoplasm,0.0745802313643591,0.7000549235771693,1
2058,Biological Process,GO:0051000,positive regulation of nitric-oxide synthase activity,0.07457417139866362,0.6999367956979459,1
2059,Phenotype,HP:0001649,Tachycardia,0.07454939359220869,0.6994537979591112,1
2060,Biological Process,GO:2000725,regulation of cardiac muscle cell differentiation,0.0745352064754019,0.6991772462251744,1
2061,Biological Process,GO:0060759,regulation of response to cytokine stimulus,0.07452266168159438,0.6989327085557806,1
2062,Biological Process,GO:0048013,ephrin receptor signaling pathway,0.07450588089066745,0.6986055979179481,1
2063,Phenotype,HP:0009725,Bladder neoplasm,0.07445797194495873,0.6976717011870428,1
2064,Biological Process,GO:0097191,extrinsic apoptotic signaling pathway,0.07445552552551138,0.6976240127420038,1
2065,Phenotype,HP:0008388,Abnormal toenail morphology,0.07440917150765403,0.6967204264680644,1
2066,Biological Process,GO:0070663,regulation of leukocyte proliferation,0.07438934730355062,0.696333990091077,1
2067,Phenotype,HP:0010785,Gonadal neoplasm,0.07438269191182056,0.6962042554770577,1
2068,Phenotype,HP:0001894,Thrombocytosis,0.07438194098582973,0.6961896175567774,1
2069,Biological Process,GO:0002758,innate immune response-activating signaling pathway,0.07436864484939298,0.6959304338455048,1
2070,Phenotype,HP:0005522,Pyridoxine-responsive sideroblastic anemia,0.07434810372379363,0.6955300224032873,1
2071,Phenotype,HP:0002913,Myoglobinuria,0.07430387923203519,0.6946679473217302,1
2072,Phenotype,HP:0100018,Nuclear cataract,0.07426771867950432,0.6939630638955405,1
2073,Biological Process,GO:2000810,regulation of bicellular tight junction assembly,0.07425878107938,0.6937888418287683,1
2074,Biological Process,GO:0006638,neutral lipid metabolic process,0.07424556617159617,0.6935312415206011,1
2074,Biological Process,GO:0006639,acylglycerol metabolic process,0.07424556617159617,0.6935312415206011,1
2076,Phenotype,HP:0031066,Abnormal ovarian physiology,0.07421219718058181,0.6928807744489317,1
2077,Phenotype,HP:0006704,Abnormal coronary artery morphology,0.07417611841429328,0.6921774852950271,1
2078,Phenotype,HP:0100775,Dural ectasia,0.07417364161969808,0.6921292047423796,1
2079,Biological Process,GO:0000966,RNA 5'-end processing,0.07414995479773279,0.6916674737384577,1
2080,Biological Process,GO:0044872,lipoprotein localization,0.07414593707056527,0.6915891555410542,1
2081,Biological Process,GO:0030036,actin cytoskeleton organization,0.07414590453151004,0.6915885212520533,1
2082,Phenotype,HP:0200064,Asymmetry of iris pigmentation,0.07413312131387095,0.6913393359488288,1
2082,Phenotype,HP:0001100,Heterochromia iridis,0.07413312131387095,0.6913393359488288,1
2084,Phenotype,HP:0000086,Ectopic kidney,0.07411422776801802,0.690971041041766,1
2085,Phenotype,HP:0040327,Abnormal morphology of the olfactory bulb,0.07409098972792694,0.6905180582145994,1
2086,Biological Process,GO:1902806,regulation of cell cycle G1/S phase transition,0.07407138988378947,0.6901359953222638,1
2087,Biological Process,GO:0008544,epidermis development,0.07406189810124797,0.6899509704891174,1
2088,Phenotype,HP:0100648,Neoplasm of the tongue,0.07405223701946617,0.6897626454788388,1
2089,Biological Process,GO:1902993,positive regulation of amyloid precursor protein catabolic process,0.07401000934739155,0.6889394947223184,1
2090,Biological Process,GO:1900225,regulation of NLRP3 inflammasome complex assembly,0.07400779945457159,0.6888964169286061,1
2091,Biological Process,GO:0050858,negative regulation of antigen receptor-mediated signaling pathway,0.07397567646996783,0.6882702384589158,1
2092,Biological Process,GO:0043038,amino acid activation,0.07397125798349324,0.6881841081963286,1
2092,Biological Process,GO:0043039,tRNA aminoacylation,0.07397125798349324,0.6881841081963286,1
2094,Phenotype,HP:0033800,Blistering by anatomical location,0.0739679114979539,0.6881188746191962,1
2095,Phenotype,HP:0020080,Erythrocyte inclusion bodies,0.07394802454564153,0.6877312150813492,1
2096,Biological Process,GO:0050847,progesterone receptor signaling pathway,0.0739471622454313,0.687714406125621,1
2097,Phenotype,HP:0000991,Xanthomatosis,0.07393041846736659,0.6873880169854235,1
2098,Phenotype,HP:0020129,Abnormal urine protein level,0.07392522652491385,0.6872868096219148,1
2099,Biological Process,GO:0042278,purine nucleoside metabolic process,0.07389283150757153,0.6866553283746015,1
2100,Biological Process,GO:0090162,establishment of epithelial cell polarity,0.07386305743290511,0.6860749375814967,1
2101,Phenotype,HP:0000568,Microphthalmia,0.07383310981146773,0.6854911638134661,1
2102,Phenotype,HP:0010057,Abnormal hallux phalanx morphology,0.0738177552643603,0.6851918551742122,1
2103,Phenotype,HP:0000190,Abnormal oral frenulum morphology,0.07375652284908296,0.683998241922929,1
2104,Biological Process,GO:0006898,receptor-mediated endocytosis,0.07372799704923194,0.6834421839501802,1
2105,Disease,MONDO:0005020,intestinal disorder,0.07370652118173227,0.683023551434799,1
2106,Biological Process,GO:0046425,regulation of receptor signaling pathway via JAK-STAT,0.07369550459197738,0.682808803291094,1
2107,Biological Process,GO:0070972,protein localization to endoplasmic reticulum,0.07368938948363402,0.6826896005074276,1
2108,Biological Process,GO:0050856,regulation of T cell receptor signaling pathway,0.07367358430092019,0.6823815075563211,1
2109,Phenotype,HP:0100258,Preaxial polydactyly,0.07367011194307826,0.6823138203302898,1
2110,Biological Process,GO:0002366,leukocyte activation involved in immune response,0.07366708256788812,0.6822547682358446,1
2111,Biological Process,GO:0009081,branched-chain amino acid metabolic process,0.0736446475618946,0.6818174390806054,1
2112,Phenotype,HP:0003418,Back pain,0.07362720515413912,0.681477431440258,1
2113,Disease,MONDO:0004069,inborn mitochondrial metabolism disorder,0.07362436192680788,0.6814220079557587,1
2114,Biological Process,GO:0032369,negative regulation of lipid transport,0.073564937829383,0.6802636445332051,1
2115,Phenotype,HP:0012764,Orthopnea,0.07354281084491376,0.6798323196907373,1
2116,Phenotype,HP:0000725,Psychotic episodes,0.07351834881388086,0.6793554774126411,1
2117,Phenotype,HP:0009485,Radial deviation of the hand or of fingers of the hand,0.07343907345352818,0.6778101501511141,1
2118,Phenotype,HP:0000022,Abnormal male internal genitalia morphology,0.073421912424389,0.6774756274690771,1
2119,Biological Process,GO:0007611,learning or memory,0.07341551893349096,0.677350998129808,1
2120,Biological Process,GO:0140014,mitotic nuclear division,0.07339188496477367,0.6768902974026915,1
2121,Biological Process,GO:0003208,cardiac ventricle morphogenesis,0.07336422241143836,0.6763510668321545,1
2122,Phenotype,HP:0001177,Preaxial hand polydactyly,0.07335967158709411,0.6762623568863365,1
2123,Biological Process,GO:0050766,positive regulation of phagocytosis,0.07335306342702741,0.6761335429666749,1
2124,Phenotype,HP:0002313,Spastic paraparesis,0.07333448732507308,0.6757714360442313,1
2125,Phenotype,HP:0002595,Ileus,0.07333327862531358,0.675747874666761,1
2126,Biological Process,GO:0034644,cellular response to UV,0.07331622314053221,0.6754154093777487,1
2127,Phenotype,HP:0030718,Right atrial enlargement,0.07330814818597542,0.6752580029988097,1
2127,Phenotype,HP:0025580,Abnormal right atrium morphology,0.07330814818597542,0.6752580029988097,1
2129,Biological Process,GO:0048806,genitalia development,0.07329249421872475,0.674952857714879,1
2130,Phenotype,HP:0040089,Abnormal natural killer cell count,0.07327203365660451,0.6745540167094278,1
2131,Phenotype,HP:0001798,Anonychia,0.07325879208305752,0.6742958966012802,1
2132,Phenotype,HP:0032218,Decreased proportion of CD4-positive T cells,0.07325165968165293,0.6741568635614852,1
2133,Phenotype,HP:0005957,Breathing dysregulation,0.07324330280561708,0.6739939616421254,1
2134,Phenotype,HP:0008669,Abnormal spermatogenesis,0.07323468736525518,0.6738260194870589,1
2135,Phenotype,HP:0003254,Abnormality of DNA repair,0.07319296676264309,0.6730127531165626,1
2136,Phenotype,HP:0010982,Polygenic inheritance,0.07313189150232047,0.6718222033119131,1
2137,Phenotype,HP:0004467,Preauricular pit,0.07312396672217114,0.6716677243066853,1
2138,Phenotype,HP:0010945,Fetal pyelectasis,0.0731106271242139,0.6714076933930517,1
2139,Biological Process,GO:0050848,regulation of calcium-mediated signaling,0.07307431684979615,0.6706998914142067,1
2140,Biological Process,GO:0009199,ribonucleoside triphosphate metabolic process,0.07301611297275079,0.6695653139424095,1
2141,Phenotype,HP:0001644,Dilated cardiomyopathy,0.07296700667891609,0.6686080771132393,1
2142,Biological Process,GO:0046474,glycerophospholipid biosynthetic process,0.07296148508741696,0.6685004438482164,1
2143,Biological Process,GO:0010883,regulation of lipid storage,0.07295843492602727,0.6684409865650636,1
2144,Biological Process,GO:0045920,negative regulation of exocytosis,0.07294833712571935,0.6682441485308009,1
2145,Phenotype,HP:0000846,Adrenal insufficiency,0.07292971776883383,0.6678811984330746,1
2146,Biological Process,GO:0051276,chromosome organization,0.07292402834258715,0.6677702935385106,1
2147,Phenotype,HP:0031097,Abnormal thyroid-stimulating hormone level,0.07290501506238534,0.6673996646306607,1
2148,Biological Process,GO:0030198,extracellular matrix organization,0.07289298750127593,0.6671652094608657,1
2149,Biological Process,GO:0060048,cardiac muscle contraction,0.07288305233773185,0.6669715417310175,1
2150,Phenotype,HP:0002333,Motor deterioration,0.07281054027192657,0.6655580524503629,1
2151,Phenotype,HP:0033118,Abnormal right ventricular function,0.07280693350488443,0.6654877451643235,1
2152,Biological Process,GO:0046034,ATP metabolic process,0.0728066655571048,0.6654825220154574,1
2153,Phenotype,HP:0001809,Split nail,0.07277829543146797,0.6649294986250307,1
2154,Disease,MONDO:0009637,inborn mitochondrial myopathy,0.07275467959488213,0.6644691513504488,1
2155,Biological Process,GO:0006654,phosphatidic acid biosynthetic process,0.0727498699759267,0.6643753966799392,1
2156,Phenotype,HP:0002645,Wormian bones,0.07274862814781369,0.6643511895261827,1
2157,Phenotype,HP:0100621,Dysgerminoma,0.07273904881149451,0.6641644579932637,1
2158,Phenotype,HP:0100519,Anuria,0.07272852003542674,0.663959218879677,1
2159,Phenotype,HP:0007024,Pseudobulbar paralysis,0.07268591669861002,0.6631287452303364,1
2160,Biological Process,GO:0030859,polarized epithelial cell differentiation,0.07267726417237652,0.6629600801544512,1
2161,Phenotype,HP:0002212,Curly hair,0.07267633551321573,0.6629419776531008,1
2162,Phenotype,HP:0001500,Broad finger,0.07264199580541297,0.6622725882440286,1
2163,Biological Process,GO:0071453,cellular response to oxygen levels,0.07263990004412157,0.6622317352344321,1
2164,Biological Process,GO:1904816,"positive regulation of protein localization to chromosome, telomeric region",0.07263782962296039,0.6621913761840413,1
2165,Biological Process,GO:0045663,positive regulation of myoblast differentiation,0.07263649294159324,0.6621653200406515,1
2166,Phenotype,HP:0011750,Neoplasm of the anterior pituitary,0.07263358214506155,0.6621085794189353,1
2166,Phenotype,HP:0040277,Neoplasm of the pituitary gland,0.07263358214506155,0.6621085794189353,1
2168,Biological Process,GO:0018126,protein hydroxylation,0.0726289759196439,0.6620187895311447,1
2169,Phenotype,HP:0011363,Abnormality of hair growth rate,0.07261882256198504,0.6618208685085664,1
2169,Phenotype,HP:0002217,Slow-growing hair,0.07261882256198504,0.6618208685085664,1
2171,Phenotype,HP:0100755,Abnormality of salivation,0.0726099902220555,0.6616486982955837,1
2172,Biological Process,GO:0043149,stress fiber assembly,0.07258555305156167,0.6611723406279465,1
2172,Biological Process,GO:0030038,contractile actin filament bundle assembly,0.07258555305156167,0.6611723406279465,1
2174,Biological Process,GO:0051591,response to cAMP,0.07255284178098698,0.6605346946058613,1
2175,Biological Process,GO:0008360,regulation of cell shape,0.07253656427426303,0.6602173945673839,1
2176,Biological Process,GO:0051054,positive regulation of DNA metabolic process,0.07252695506911921,0.6600300807966957,1
2177,Phenotype,HP:0000372,Abnormal auditory canal morphology,0.07252278065392781,0.6599487082546156,1
2178,Biological Process,GO:0072524,pyridine-containing compound metabolic process,0.07249836718034941,0.6594728125147359,1
2179,Phenotype,HP:0045045,Elevated circulating acylcarnitine concentration,0.07247932113819244,0.6591015449728613,1
2180,Disease,MONDO:0006617,vesiculobullous skin disease,0.07247273283530009,0.6589731181322711,1
2181,Biological Process,GO:1901201,regulation of extracellular matrix assembly,0.07247209657140408,0.6589607153385195,1
2182,Biological Process,GO:0002709,regulation of T cell mediated immunity,0.07244306087056196,0.6583947177843078,1
2183,Phenotype,HP:0040218,Reduced natural killer cell count,0.07242771701635231,0.6580956175834184,1
2184,Phenotype,HP:0007759,Opacification of the corneal stroma,0.07241659860203686,0.6578788845572906,1
2185,Phenotype,HP:0011103,Abnormal left ventricular outflow tract morphology,0.07241037221922264,0.6577575126825905,1
2186,Phenotype,HP:0006094,Finger joint hypermobility,0.07239255514605525,0.6574102016295256,1
2187,Phenotype,HP:0006528,Chronic lung disease,0.07239065946933942,0.6573732489005191,1
2188,Biological Process,GO:0033015,tetrapyrrole catabolic process,0.0723841102007795,0.6572455829624057,1
2188,Biological Process,GO:0006787,porphyrin-containing compound catabolic process,0.0723841102007795,0.6572455829624057,1
2190,Phenotype,HP:0004933,Ascending aortic dissection,0.07236584400671986,0.6568895171240526,1
2191,Phenotype,HP:0004429,Recurrent viral infections,0.07232464468704458,0.6560864122051051,1
2192,Biological Process,GO:0046634,regulation of alpha-beta T cell activation,0.07231099858752699,0.6558204066076,1
2193,Phenotype,HP:0002219,Facial hypertrichosis,0.0722916127765465,0.6554425158977795,1
2194,Phenotype,HP:0100587,Abnormal preputium morphology,0.07225735705520042,0.6547747636501219,1
2195,Biological Process,GO:0051051,negative regulation of transport,0.07224511642677289,0.6545361551250627,1
2196,Biological Process,GO:0032691,negative regulation of interleukin-1 beta production,0.07223556727479041,0.6543500119802401,1
2197,Phenotype,HP:0002717,Adrenal overactivity,0.07222686399631173,0.6541803575827333,1
2198,Biological Process,GO:0051044,positive regulation of membrane protein ectodomain proteolysis,0.07221059645401817,0.6538632517824892,1
2199,Phenotype,HP:0001836,Camptodactyly of toe,0.07218697428906862,0.6534027811481025,1
2200,Phenotype,HP:0002107,Pneumothorax,0.07216965475414927,0.6530651686875755,1
2201,Biological Process,GO:0008535,respiratory chain complex IV assembly,0.07214557152181622,0.6525957103930388,1
2202,Phenotype,HP:0000965,Cutis marmorata,0.07212092825715133,0.6521153352988068,1
2203,Disease,MONDO:0003274,thoracic cancer,0.07211779793312656,0.6520543153926044,1
2204,Phenotype,HP:0100275,Diffuse cerebellar atrophy,0.07207813865181101,0.651281230687384,1
2205,Phenotype,HP:0010646,Cervical spine instability,0.07206984775162473,0.6511196148457976,1
2206,Phenotype,HP:0004401,Meconium ileus,0.07206911080900347,0.651105249505574,1
2206,Phenotype,HP:0010676,Mechanical ileus,0.07206911080900347,0.651105249505574,1
2208,Phenotype,HP:0002134,Abnormal basal ganglia morphology,0.07201140384196603,0.6499803583799295,1
2209,Disease,MONDO:0005387,primary ovarian failure,0.07198754527556006,0.6495152795341941,1
2209,Disease,MONDO:0019852,inherited primary ovarian failure,0.07198754527556006,0.6495152795341941,1
2209,Disease,MONDO:0001889,ovarian dysfunction,0.07198754527556006,0.6495152795341941,1
2212,Phenotype,HP:0011876,Abnormal platelet volume,0.07197203000558305,0.6492128378983724,1
2213,Disease,MONDO:0002516,digestive system cancer,0.07193600554341129,0.6485106073032894,1
2214,Biological Process,GO:0034614,cellular response to reactive oxygen species,0.07187999397913536,0.6474187649344714,1
2215,Phenotype,HP:0030242,Portal vein thrombosis,0.07187686902493995,0.6473578497032103,1
2216,Biological Process,GO:0046031,ADP metabolic process,0.07183252921593453,0.646493526724139,1
2217,Phenotype,HP:0025540,Abnormal T cell subset distribution,0.07177989192482803,0.645467459601165,1
2218,Phenotype,HP:0025383,Dorsocervical fat pad,0.07177827271314485,0.6454358960491979,1
2219,Phenotype,HP:0012071,Abnormal circulating acylcarnitine concentration,0.07173314530062225,0.6445562201889671,1
2220,Biological Process,GO:0090646,mitochondrial tRNA processing,0.07170544802619994,0.6440163127947354,1
2221,Biological Process,GO:0050767,regulation of neurogenesis,0.07170043312723973,0.6439185565683047,1
2222,Biological Process,GO:0030890,positive regulation of B cell proliferation,0.07169397970434366,0.6437927589650254,1
2223,Biological Process,GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,0.07168956822409722,0.6437067652759627,1
2224,Biological Process,GO:0043525,positive regulation of neuron apoptotic process,0.07167945296373013,0.6435095868899778,1
2225,Biological Process,GO:0002262,myeloid cell homeostasis,0.07167867061495448,0.6434943364403342,1
2226,Phenotype,HP:0006887,"Intellectual disability, progressive",0.07166482393507945,0.6432244208978841,1
2227,Phenotype,HP:0001800,Hypoplastic toenails,0.07163819587843878,0.6427053559366497,1
2228,Biological Process,GO:0071214,cellular response to abiotic stimulus,0.07163612837737021,0.6426650538080907,1
2228,Biological Process,GO:0104004,cellular response to environmental stimulus,0.07163612837737021,0.6426650538080907,1
2230,Biological Process,GO:0046461,neutral lipid catabolic process,0.07162508211665286,0.6424497272835752,1
2230,Biological Process,GO:0046464,acylglycerol catabolic process,0.07162508211665286,0.6424497272835752,1
2232,Biological Process,GO:0042168,heme metabolic process,0.07158335675682559,0.6416363681799236,1
2233,Phenotype,HP:0009888,Abnormality of secondary sexual hair,0.07156726819429393,0.6413227512607655,1
2234,Phenotype,HP:0009380,Finger aplasia,0.07155865436486253,0.6411548405078246,1
2235,Phenotype,HP:0045082,Decreased body mass index,0.07154443530202659,0.640877666044839,1
2236,Biological Process,GO:0045648,positive regulation of erythrocyte differentiation,0.07149917526107741,0.6399954048375048,1
2237,Phenotype,HP:0003715,Myofibrillar myopathy,0.07148950658835451,0.6398069318557991,1
2238,Disease,MONDO:0003569,cranial nerve neuropathy,0.07148229285099872,0.6396663133213161,1
2239,Biological Process,GO:1904036,negative regulation of epithelial cell apoptotic process,0.07146934368267988,0.6394138931149848,1
2240,Phenotype,HP:0001370,Rheumatoid arthritis,0.07146448787190707,0.6393192380200012,1
2241,Biological Process,GO:0031329,regulation of cellular catabolic process,0.07142676579377027,0.6385839155257621,1
2242,Phenotype,HP:0000653,Sparse eyelashes,0.07140411320594076,0.6381423450130409,1
2243,Biological Process,GO:0031623,receptor internalization,0.07137601637703916,0.6375946490395262,1
2244,Biological Process,GO:0034331,cell junction maintenance,0.07134446820379925,0.6369796754595622,1
2245,Phenotype,HP:0031547,Abnormal QT interval,0.07133698344878137,0.6368337739345042,1
2246,Biological Process,GO:0060390,regulation of SMAD protein signal transduction,0.07130894902619755,0.6362872944573098,1
2247,Phenotype,HP:0000532,Abnormal chorioretinal morphology,0.07127559921938242,0.6356372013463002,1
2248,Biological Process,GO:0046514,ceramide catabolic process,0.07125962243507211,0.6353257633378644,1
2249,Biological Process,GO:0046479,glycosphingolipid catabolic process,0.07123434271739915,0.6348329817634895,1
2250,Phenotype,HP:0001087,Developmental glaucoma,0.07121670608851993,0.6344891881397552,1
2251,Biological Process,GO:0002637,regulation of immunoglobulin production,0.07120490674079905,0.6342591815699937,1
2252,Phenotype,HP:0004673,Decreased facial expression,0.07116858015286154,0.6335510615891025,1
2253,Phenotype,HP:0012236,Elevated sweat chloride,0.0711584805377865,0.6333541881792947,1
2254,Biological Process,GO:0034599,cellular response to oxidative stress,0.07107890367593928,0.6318029837009773,1
2255,Phenotype,HP:0003341,Lamina lucida cleavage,0.0710693449291665,0.631616653523375,1
2256,Biological Process,GO:0043045,epigenetic programming of gene expression,0.0710659611151302,0.6315506922958892,1
2257,Phenotype,HP:0003310,Abnormal odontoid process morphology,0.07103017957868318,0.6308531970907599,1
2258,Biological Process,GO:0043491,phosphatidylinositol 3-kinase/protein kinase B signal transduction,0.07101595469532185,0.6305759091673432,1
2259,Biological Process,GO:0043405,regulation of MAP kinase activity,0.07098421422306056,0.6299571870718408,1
2260,Biological Process,GO:0031047,regulatory ncRNA-mediated gene silencing,0.07098054807137488,0.6298857221914598,1
2261,Biological Process,GO:2000402,negative regulation of lymphocyte migration,0.07096096897308268,0.6295040637011994,1
2262,Phenotype,HP:0002882,Sudden episodic apnea,0.07094513317891671,0.6291953740361667,1
2263,Phenotype,HP:0001633,Abnormal mitral valve morphology,0.07093033000121574,0.6289068133288199,1
2264,Phenotype,HP:0003220,Abnormality of chromosome stability,0.07090168849707723,0.6283484999139144,1
2265,Biological Process,GO:0030048,actin filament-based movement,0.07089487438937891,0.628215671424175,1
2266,Biological Process,GO:1903376,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,0.07085437765846758,0.6274262621802233,1
2267,Phenotype,HP:0100833,Neoplasm of the small intestine,0.07084340560289482,0.6272123821484435,1
2268,Biological Process,GO:0043255,regulation of carbohydrate biosynthetic process,0.07084295710242494,0.6272036394571481,1
2269,Biological Process,GO:0051493,regulation of cytoskeleton organization,0.0708124908942378,0.6266097567947736,1
2270,Phenotype,HP:0001937,Microangiopathic hemolytic anemia,0.07076449039658939,0.6256740754272848,1
2271,Phenotype,HP:0001435,Abnormality of the shoulder girdle musculature,0.07073982214698848,0.6251932132977046,1
2272,Phenotype,HP:0033801,Blistering by histological location,0.07072821788041628,0.6249670094759335,1
2273,Biological Process,GO:0051650,establishment of vesicle localization,0.07071674693158947,0.6247434044382675,1
2274,Phenotype,HP:0000491,Keratitis,0.07071438949507014,0.6246974505516572,1
2275,Biological Process,GO:0010988,regulation of low-density lipoprotein particle clearance,0.07067115561836146,0.62385468568749,1
2276,Phenotype,HP:0000059,Hypoplastic labia majora,0.0706654885874386,0.6237442173485502,1
2277,Phenotype,HP:0006554,Acute hepatic failure,0.07064592200261133,0.6233628027852605,1
2278,Biological Process,GO:0070585,protein localization to mitochondrion,0.07064278706302085,0.6233016929070984,1
2279,Phenotype,HP:0032261,Nontuberculous mycobacterial pulmonary infection,0.07064141814050406,0.623275008281829,1
2280,Phenotype,HP:0002888,Ependymoma,0.07062788777638684,0.623011258732969,1
2281,Biological Process,GO:1990778,protein localization to cell periphery,0.07061944953122912,0.6228467706723197,1
2282,Biological Process,GO:0035994,response to muscle stretch,0.07061116958772051,0.6226853684110014,1
2283,Biological Process,GO:0035633,maintenance of blood-brain barrier,0.07058188873387317,0.622114592050102,1
2284,Biological Process,GO:0043954,cellular component maintenance,0.07056910117226745,0.621865322069242,1
2285,Biological Process,GO:0060491,regulation of cell projection assembly,0.0705631928102598,0.6217501494249202,1
2286,Phenotype,HP:0002037,Inflammation of the large intestine,0.07053609136202454,0.6212218565657206,1
2287,Biological Process,GO:0050871,positive regulation of B cell activation,0.07052612770327638,0.6210276333743078,1
2288,Biological Process,GO:0009205,purine ribonucleoside triphosphate metabolic process,0.07051404952799967,0.6207921915744652,1
2289,Biological Process,GO:0050807,regulation of synapse organization,0.07045390326982881,0.6196197509571438,1
2289,Biological Process,GO:0050803,regulation of synapse structure or activity,0.07045390326982881,0.6196197509571438,1
2291,Phenotype,HP:0009106,Abnormal pelvis bone ossification,0.07040877942548596,0.6187401446520108,1
2292,Phenotype,HP:0004213,Abnormal 5th finger phalanx morphology,0.07040719988266342,0.6187093543714802,1
2293,Biological Process,GO:0061061,muscle structure development,0.0704035556587096,0.6186383169318785,1
2294,Phenotype,HP:0009763,Limb pain,0.070379163677591,0.6181628401479509,1
2295,Phenotype,HP:0200065,Chorioretinal degeneration,0.07035663014722948,0.6177235904414696,1
2296,Disease,MONDO:0015974,severe combined immunodeficiency,0.07033299835629814,0.6172629321662824,1
2297,Biological Process,GO:0010985,negative regulation of lipoprotein particle clearance,0.07029342978817643,0.6164916157478386,1
2298,Phenotype,HP:0032342,Reduced forced expiratory volume in one second,0.0702868583117855,0.6163635169089281,1
2299,Biological Process,GO:0141061,disruption of cell in another organism,0.070286568105138,0.6163578598643956,1
2299,Biological Process,GO:0031640,killing of cells of another organism,0.070286568105138,0.6163578598643956,1
2301,Phenotype,HP:0011877,Increased mean platelet volume,0.07027527389849941,0.6161377000904344,1
2302,Biological Process,GO:0051438,regulation of ubiquitin-protein transferase activity,0.07027469887465787,0.6161264910588462,1
2303,Phenotype,HP:0011565,Common atrium,0.07020440361409219,0.614756214316804,1
2304,Phenotype,HP:0030186,Kinetic tremor,0.07013936785464758,0.613488461870183,1
2305,Biological Process,GO:0007338,single fertilization,0.07010538184078585,0.6128259670735966,1
2306,Phenotype,HP:5200430,Abnormal psychotic pattern,0.07008536813191935,0.6124358366499935,1
2307,Biological Process,GO:0043949,regulation of cAMP-mediated signaling,0.07005748324854844,0.6118922721645612,1
2308,Phenotype,HP:0000799,Renal steatosis,0.0700319536859847,0.6113946203238241,1
2309,Phenotype,HP:0001220,Interphalangeal joint contracture of finger,0.06999446478830551,0.6106638432534895,1
2310,Phenotype,HP:0009466,Radial deviation of finger,0.06998485167635349,0.6104764533267648,1
2311,Phenotype,HP:0007730,Iris hypopigmentation,0.06993753227397503,0.6095540486581605,1
2312,Biological Process,GO:0006090,pyruvate metabolic process,0.06991772942513175,0.6091680285626695,1
2313,Biological Process,GO:0140888,interferon-mediated signaling pathway,0.06991690348646418,0.6091519284083003,1
2314,Phenotype,HP:0011545,Abnormal connection of the cardiac segments,0.06982511390908774,0.6073626595155094,1
2315,Biological Process,GO:1990542,mitochondrial transmembrane transport,0.06982148283299783,0.607291878369319,1
2316,Biological Process,GO:0006911,"phagocytosis, engulfment",0.06981415785922507,0.6071490914855929,1
2317,Biological Process,GO:0000819,sister chromatid segregation,0.06980381985756545,0.6069475711680158,1
2318,Biological Process,GO:0048662,negative regulation of smooth muscle cell proliferation,0.06979296847397132,0.6067360434143896,1
2319,Disease,MONDO:0004335,digestive system disorder,0.06978874310743133,0.6066536776695335,1
2320,Biological Process,GO:0070527,platelet aggregation,0.06978088146369399,0.6065004293924688,1
2321,Biological Process,GO:0002833,positive regulation of response to biotic stimulus,0.06977774791060631,0.6064393465416273,1
2322,Biological Process,GO:0035305,negative regulation of dephosphorylation,0.06977574929665864,0.6064003872407189,1
2323,Biological Process,GO:0000018,regulation of DNA recombination,0.0697746880651553,0.6063797004855203,1
2324,Phenotype,HP:0001142,Lenticonus,0.06975047340574803,0.6059076802620337,1
2325,Phenotype,HP:0001030,Fragile skin,0.06974467535715723,0.6057946579747661,1
2326,Biological Process,GO:0007610,behavior,0.06972532684348143,0.605417494307263,1
2327,Biological Process,GO:0030888,regulation of B cell proliferation,0.06970747570975,0.605069519306183,1
2328,Biological Process,GO:0002027,regulation of heart rate,0.06970112392454575,0.6049457029426645,1
2329,Phenotype,HP:0000049,Shawl scrotum,0.0696939329297922,0.6048055277333596,1
2330,Phenotype,HP:0025456,Abnormal CSF protein concentration,0.06964843628833184,0.6039186544344703,1
2331,Phenotype,HP:0001187,Hyperextensibility of the finger joints,0.06957756377812507,0.6025371252729739,1
2332,Biological Process,GO:0015698,inorganic anion transport,0.0695670629383911,0.6023324307268041,1
2333,Biological Process,GO:0042102,positive regulation of T cell proliferation,0.06953783989086715,0.6017627811937997,1
2334,Biological Process,GO:0048705,skeletal system morphogenesis,0.06951640407804427,0.601344929470631,1
2335,Phenotype,HP:0007068,Inferior cerebellar vermis hypoplasia,0.06946066282500796,0.6002583563219821,1
2336,Biological Process,GO:0010944,negative regulation of transcription by competitive promoter binding,0.06937556926919508,0.5985996140470444,1
2337,Phenotype,HP:0005986,Limitation of neck motion,0.06935456009929575,0.5981900789425295,1
2337,Phenotype,HP:0025669,Abnormal neck physiology,0.06935456009929575,0.5981900789425295,1
2339,Phenotype,HP:0003306,Spinal rigidity,0.06934798245552676,0.5980618598819334,1
2340,Phenotype,HP:0011304,Broad thumb,0.06929843097649613,0.5970959449866323,1
2341,Biological Process,GO:0002820,negative regulation of adaptive immune response,0.06929431677790299,0.5970157462563203,1
2342,Disease,MONDO:0018677,visceral heterotaxy,0.06928466009249468,0.5968275069452523,1
2343,Biological Process,GO:0042886,amide transport,0.06927643937557715,0.5966672591973337,1
2344,Phenotype,HP:0002872,"Apneic episodes precipitated by illness, fatigue, stress",0.06918381549237185,0.594861727047762,1
2345,Phenotype,HP:0000130,Abnormality of the uterus,0.0691578016885308,0.5943546358144616,1
2346,Phenotype,HP:0030588,Abnormal visual field test,0.06912427563333423,0.5937011070656013,1
2347,Disease,MONDO:0001713,inherited aplastic anemia,0.06907928854224865,0.5928241665135551,1
2348,Biological Process,GO:0031330,negative regulation of cellular catabolic process,0.06905657504322926,0.5923814086492808,1
2349,Biological Process,GO:1903672,positive regulation of sprouting angiogenesis,0.06905337108026754,0.5923189532875184,1
2350,Biological Process,GO:0032088,negative regulation of NF-kappaB transcription factor activity,0.06905295009760115,0.5923107470051614,1
2351,Biological Process,GO:0006956,complement activation,0.06903173117697836,0.591897123196292,1
2352,Biological Process,GO:0051146,striated muscle cell differentiation,0.06901658707477798,0.5916019167932244,1
2353,Phenotype,HP:0100608,Metrorrhagia,0.0690009355066804,0.5912968182763684,1
2354,Phenotype,HP:0031888,Abnormal HDL cholesterol concentration,0.06900034302874658,0.5912852690093714,1
2355,Biological Process,GO:1905523,positive regulation of macrophage migration,0.06898853317001319,0.5910550575467644,1
2356,Biological Process,GO:0098662,inorganic cation transmembrane transport,0.06896852072822535,0.590664951822528,1
2357,Biological Process,GO:0035195,miRNA-mediated post-transcriptional gene silencing,0.06896577559790495,0.5906114405587296,1
2358,Phenotype,HP:0012324,Myeloid leukemia,0.06896344316564229,0.5905659740840883,1
2359,Phenotype,HP:0000176,Submucous cleft hard palate,0.06892299218422371,0.5897774566423061,1
2360,Phenotype,HP:0009592,Astrocytoma,0.06890901047565767,0.5895049089640149,1
2361,Phenotype,HP:0000869,Secondary amenorrhea,0.06890343560156653,0.5893962370529154,1
2362,Phenotype,HP:0008947,Infantile muscular hypotonia,0.06889739177030552,0.5892784236848,1
2363,Biological Process,GO:0002218,activation of innate immune response,0.06886263126209602,0.5886008315461871,1
2364,Phenotype,HP:0001761,Pes cavus,0.06884738152310921,0.588303565948369,1
2365,Biological Process,GO:1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,0.06884005785032232,0.5881608044249684,1
2366,Biological Process,GO:0007265,Ras protein signal transduction,0.06875807617004781,0.5865627224369411,1
2367,Biological Process,GO:0016311,dephosphorylation,0.06871569565017999,0.5857365921939743,1
2368,Disease,MONDO:0021066,urinary system neoplasm,0.06864610931412285,0.5843801346306093,1
2368,Disease,MONDO:0006295,malignant urinary system neoplasm,0.06864610931412285,0.5843801346306093,1
2370,Biological Process,GO:0002444,myeloid leukocyte mediated immunity,0.0686355564825919,0.5841744266000368,1
2371,Phenotype,HP:0034681,Finger joint contracture,0.06862480745269195,0.5839648940433197,1
2372,Phenotype,HP:0001879,Abnormal eosinophil morphology,0.06861308913698916,0.5837364670436298,1
2373,Biological Process,GO:0048199,"vesicle targeting, to, from or within Golgi",0.06856658744226973,0.5828300020810305,1
2374,Biological Process,GO:0046761,viral budding from plasma membrane,0.06855549797727378,0.5826138333686115,1
2375,Phenotype,HP:0025423,Abnormal larynx morphology,0.06854857645621415,0.5824789110530636,1
2376,Phenotype,HP:0005244,Gastrointestinal infarctions,0.06849893172071675,0.5815111782945604,1
2377,Biological Process,GO:0009141,nucleoside triphosphate metabolic process,0.06845384221311235,0.5806322413209544,1
2378,Phenotype,HP:0100840,Aplasia/Hypoplasia of the eyebrow,0.06843130404519093,0.5801929012137774,1
2379,Phenotype,HP:0010885,Avascular necrosis,0.06842149294625366,0.5800016518951259,1
2380,Biological Process,GO:0034381,plasma lipoprotein particle clearance,0.06839759720748972,0.5795358484426791,1
2381,Phenotype,HP:0007240,Progressive gait ataxia,0.06838818192223162,0.5793523147832965,1
2382,Phenotype,HP:0025245,Cutaneous cyst,0.06838318385164299,0.5792548865950009,1
2383,Disease,MONDO:0017713,disorder of fatty acid oxidation and ketogenesis,0.06838144720911188,0.5792210339447585,1
2384,Biological Process,GO:0071346,cellular response to type II interferon,0.06837850222671726,0.5791636269325562,1
2385,Phenotype,HP:0012815,Hypoplastic female external genitalia,0.068359209043508,0.578787541830675,1
2386,Phenotype,HP:0002936,Distal sensory impairment,0.06835818006050776,0.578767483700698,1
2387,Phenotype,HP:0005293,Venous insufficiency,0.06832691006240199,0.5781579326330553,1
2388,Biological Process,GO:0032689,negative regulation of type II interferon production,0.06831627247120153,0.5779505723687068,1
2389,Biological Process,GO:0042632,cholesterol homeostasis,0.0682798597432408,0.5772407732465842,1
2389,Biological Process,GO:0055092,sterol homeostasis,0.0682798597432408,0.5772407732465842,1
2391,Phenotype,HP:0008445,Cervical spinal canal stenosis,0.06822501787741786,0.5761717319965391,1
2392,Phenotype,HP:0032653,Elevated lactate:pyruvate ratio,0.06822244541361289,0.5761215865487048,1
2393,Phenotype,HP:0045075,Sparse eyebrow,0.06820001179006507,0.5756842843417007,1
2394,Phenotype,HP:0031980,Abnormal urine carboxylic acid level,0.06818394976731978,0.5753711847668374,1
2395,Phenotype,HP:0006256,Abnormality of hand joint mobility,0.06816728970112007,0.575046427435395,1
2396,Biological Process,GO:0010457,centriole-centriole cohesion,0.06816553057040753,0.5750121364194403,1
2397,Biological Process,GO:0031396,regulation of protein ubiquitination,0.06816223616601047,0.5749479180683331,1
2398,Biological Process,GO:0051973,positive regulation of telomerase activity,0.06813778131272863,0.5744712157072849,1
2399,Phenotype,HP:0000446,Narrow nasal bridge,0.0681318957374707,0.5743564872487147,1
2400,Phenotype,HP:0001987,Hyperammonemia,0.06806773062593718,0.5731057064808881,1
2401,Phenotype,HP:0004889,Intermittent episodes of respiratory insufficiency due to muscle weakness,0.06803393158000626,0.5724468562800401,1
2402,Phenotype,HP:0410263,Brain imaging abnormality,0.068021897230499,0.5722122687829216,1
2403,Phenotype,HP:0100538,Abnormality of the supraorbital ridges,0.06801381789621996,0.5720547770293573,1
2404,Biological Process,GO:0001953,negative regulation of cell-matrix adhesion,0.06799842170238457,0.5717546565637833,1
2405,Phenotype,HP:0002681,Deformed sella turcica,0.06790622850216932,0.569957519786527,1
2406,Biological Process,GO:2000403,positive regulation of lymphocyte migration,0.06789254955713675,0.5696908739261523,1
2407,Phenotype,HP:0100559,Lower limb asymmetry,0.06786070323380933,0.5690700884589108,1
2408,Biological Process,GO:1903689,"regulation of wound healing, spreading of epidermal cells",0.06784651710036482,0.5687935558938121,1
2409,Phenotype,HP:0006891,Thick cerebral cortex,0.06776196954743885,0.5671454569403586,1
2410,Phenotype,HP:0010902,Abnormal circulating glutamine family amino acid concentration,0.06775473436336843,0.5670044203416418,1
2411,Biological Process,GO:0033627,cell adhesion mediated by integrin,0.06774748935381258,0.5668631922131683,1
2412,Biological Process,GO:0030832,regulation of actin filament length,0.06772703076554087,0.5664643896842617,1
2412,Biological Process,GO:0008064,regulation of actin polymerization or depolymerization,0.06772703076554087,0.5664643896842617,1
2414,Phenotype,HP:0002866,Hypoplastic iliac wing,0.06771485059122562,0.566226959600869,1
2415,Phenotype,HP:0000359,Abnormality of the inner ear,0.06770805920203782,0.5660945739666838,1
2416,Disease,MONDO:0002259,gonadal disorder,0.06760675520020354,0.5641198388782548,1
2417,Biological Process,GO:0030203,glycosaminoglycan metabolic process,0.0675901384239036,0.5637959254037432,1
2418,Phenotype,HP:0000081,Duplicated collecting system,0.06754279824689291,0.5628731157719147,1
2419,Biological Process,GO:0045217,cell-cell junction maintenance,0.0675381921641498,0.5627833286653017,1
2420,Phenotype,HP:0100797,Toenail dysplasia,0.06751872327098052,0.5624038184211047,1
2421,Phenotype,HP:0002173,Hypoglycemic seizures,0.06751763673074451,0.5623826383187377,1
2422,Phenotype,HP:0006937,Impaired distal tactile sensation,0.06748665371667806,0.5617786814768114,1
2423,Phenotype,HP:0006721,Acute lymphoblastic leukemia,0.06746508692927278,0.5613582766451882,1
2424,Biological Process,GO:0040029,epigenetic regulation of gene expression,0.06746445167746595,0.5613458935802529,1
2425,Phenotype,HP:0003540,Impaired platelet aggregation,0.06745688547500328,0.5611984043871444,1
2426,Biological Process,GO:0046427,positive regulation of receptor signaling pathway via JAK-STAT,0.06744361439946522,0.5609397091919728,1
2427,Biological Process,GO:0007613,memory,0.06744176918043887,0.5609037400427664,1
2428,Biological Process,GO:0002221,pattern recognition receptor signaling pathway,0.06743699613879595,0.5608106983796519,1
2429,Phenotype,HP:0100576,Amaurosis fugax,0.06737876025230705,0.5596754969426591,1
2430,Phenotype,HP:5200010,Abnormal Intonation,0.06737281275494489,0.5595595614266208,1
2431,Disease,MONDO:0005244,peripheral neuropathy,0.06736303319197978,0.5593689268437118,1
2432,Phenotype,HP:0001476,Delayed closure of the anterior fontanelle,0.06735961430367943,0.5593022819079947,1
2433,Biological Process,GO:0071392,cellular response to estradiol stimulus,0.06733372925311232,0.558797700482828,1
2434,Phenotype,HP:0040127,Abnormal sweat homeostasis,0.06732976735193064,0.558720470510283,1
2435,Phenotype,HP:0001805,Onychogryposis,0.06732935765469406,0.5587124842166119,1
2436,Phenotype,HP:0000610,Abnormal choroid morphology,0.06730456554925557,0.5582292077454069,1
2437,Biological Process,GO:0048167,regulation of synaptic plasticity,0.06729774155249746,0.5580961864866455,1
2438,Disease,MONDO:0015131,combined immunodeficiency,0.06726655603290177,0.5574882821720929,1
2439,Phenotype,HP:0000952,Jaundice,0.06725587221530238,0.5572800208091666,1
2440,Biological Process,GO:0001763,morphogenesis of a branching structure,0.06725214383779154,0.5572073429508368,1
2441,Biological Process,GO:0009060,aerobic respiration,0.06724728703537863,0.5571126685256543,1
2442,Biological Process,GO:1905709,negative regulation of membrane permeability,0.06724606947905187,0.557088934505704,1
2443,Phenotype,HP:0000457,Depressed nasal ridge,0.0672378205092169,0.5569281360191528,1
2444,Phenotype,HP:0002123,Generalized myoclonic seizure,0.06723039739167003,0.5567834360031622,1
2445,Biological Process,GO:0032785,"negative regulation of DNA-templated transcription, elongation",0.06722027541963782,0.5565861267856173,1
2446,Biological Process,GO:0043030,regulation of macrophage activation,0.06720920262386398,0.5563702830090074,1
2447,Biological Process,GO:0009144,purine nucleoside triphosphate metabolic process,0.06718212888279684,0.5558425302500613,1
2448,Phenotype,HP:0100737,Abnormal hard palate morphology,0.06713840892587741,0.5549902901467073,1
2449,Phenotype,HP:0002144,Tethered cord,0.0671160435744862,0.5545543187797565,1
2450,Phenotype,HP:0004278,Synostosis involving bones of the hand,0.06710895720605081,0.5544161830679829,1
2451,Biological Process,GO:1903305,regulation of regulated secretory pathway,0.06709368777130187,0.5541185335375276,1
2452,Phenotype,HP:0002894,Neoplasm of the pancreas,0.06704758890499884,0.5532199209735906,1
2453,Biological Process,GO:0120032,regulation of plasma membrane bounded cell projection assembly,0.06704732967691474,0.5532148677991421,1
2454,Phenotype,HP:0008214,Decreased serum estradiol,0.06704552883107706,0.5531797636235901,1
2455,Phenotype,HP:0001061,Acne,0.06703468607098428,0.5529684039692534,1
2456,Phenotype,HP:0000104,Renal agenesis,0.06701089310434372,0.5525046038702226,1
2457,Biological Process,GO:0042104,positive regulation of activated T cell proliferation,0.06700683033015808,0.5524254075640999,1
2458,Biological Process,GO:0010592,positive regulation of lamellipodium assembly,0.06699347119671373,0.5521649958420957,1
2459,Biological Process,GO:1905330,regulation of morphogenesis of an epithelium,0.06697331392689299,0.5517720669618815,1
2460,Phenotype,HP:0001770,Toe syndactyly,0.06694207667536001,0.5511631542284126,1
2461,Phenotype,HP:0010990,Abnormality of the common coagulation pathway,0.06691723075528688,0.5506788287399391,1
2462,Phenotype,HP:0004340,Abnormality of vitamin B metabolism,0.06691141772665676,0.5505655144443724,1
2463,Phenotype,HP:0002389,Cavum septum pellucidum,0.06689317317774357,0.5502098705383165,1
2464,Biological Process,GO:0048660,regulation of smooth muscle cell proliferation,0.06688235371929818,0.5499989651067141,1
2465,Biological Process,GO:0009566,fertilization,0.06686813217670284,0.5497217423053824,1
2466,Biological Process,GO:0006085,acetyl-CoA biosynthetic process,0.06686155701742724,0.5495935716754129,1
2467,Biological Process,GO:0045598,regulation of fat cell differentiation,0.06686097452686879,0.5495822170939192,1
2468,Phenotype,HP:0031818,Abnormal waist to hip ratio,0.06679431041267525,0.5482827228680902,1
2468,Phenotype,HP:0031819,Increased waist to hip ratio,0.06679431041267525,0.5482827228680902,1
2470,Phenotype,HP:0010981,Hypolipoproteinemia,0.06677917168751335,0.5479876212804925,1
2471,Biological Process,GO:0150118,negative regulation of cell-substrate junction organization,0.06672640530621754,0.5469590377818394,1
2471,Biological Process,GO:0051895,negative regulation of focal adhesion assembly,0.06672640530621754,0.5469590377818394,1
2473,Phenotype,HP:0005184,Prolonged QTc interval,0.06669269758992502,0.5463019678842204,1
2474,Biological Process,GO:0045921,positive regulation of exocytosis,0.06668084949451059,0.5460710110678825,1
2475,Phenotype,HP:0008366,Foot joint contracture,0.06661943299123518,0.5448738093598496,1
2476,Phenotype,HP:0004926,Orthostatic hypotension due to autonomic dysfunction,0.06659240417250434,0.5443469322791801,1
2477,Phenotype,HP:0030872,Abnormal cardiac ventricular function,0.06657473574468376,0.5440025187936027,1
2478,Biological Process,GO:0030216,keratinocyte differentiation,0.0665620860670143,0.5437559366063358,1
2479,Phenotype,HP:0010174,Broad phalanx of the toes,0.06654592314808438,0.5434408702460299,1
2480,Phenotype,HP:0011220,Prominent forehead,0.06653545378982217,0.5432367893732176,1
2481,Biological Process,GO:0045646,regulation of erythrocyte differentiation,0.06653467194523122,0.5432215487517268,1
2482,Biological Process,GO:0019730,antimicrobial humoral response,0.06653236590032541,0.5431765966500474,1
2483,Phenotype,HP:0100774,Hyperostosis,0.0665108741041196,0.5427576536338533,1
2484,Phenotype,HP:0007099,Chiari type I malformation,0.06651051033016009,0.5427505625299571,1
2485,Biological Process,GO:0007517,muscle organ development,0.06648277703164052,0.5422099529122436,1
2486,Phenotype,HP:0030402,Abnormal platelet aggregation,0.0664288159778923,0.541158081472658,1
2487,Biological Process,GO:0051156,glucose 6-phosphate metabolic process,0.06641897912263994,0.5409663300820426,1
2488,Phenotype,HP:0034435,Abnormal eye contact,0.06639688966626134,0.5405357367806397,1
2488,Phenotype,HP:0000817,Reduced eye contact,0.06639688966626134,0.5405357367806397,1
2490,Phenotype,HP:0007207,Photosensitive tonic-clonic seizure,0.06638441250811877,0.5402925175440659,1
2491,Biological Process,GO:0010954,positive regulation of protein processing,0.06637762415378667,0.5401601910688076,1
2492,Phenotype,HP:0032152,Keratosis pilaris,0.0663029948683952,0.5387054304885887,1
2493,Phenotype,HP:0001803,Nail pits,0.06629625679752271,0.5385740841968402,1
2494,Biological Process,GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,0.06629230257568286,0.5384970039189321,1
2495,Phenotype,HP:0100646,Thyroiditis,0.06627154492122833,0.5380923716451558,1
2496,Biological Process,GO:0050854,regulation of antigen receptor-mediated signaling pathway,0.0662585185564809,0.537838446636512,1
2497,Phenotype,HP:0011034,Amyloidosis,0.06625383868821355,0.5377472212168894,1
2498,Biological Process,GO:0061952,midbody abscission,0.06624861341102561,0.5376453640540633,1
2499,Phenotype,HP:0001708,Right ventricular failure,0.06624267851019061,0.5375296740841409,1
2500,Phenotype,HP:0001363,Craniosynostosis,0.06620048253715172,0.5367071412419869,1
2501,Phenotype,HP:0000709,Psychosis,0.06618627045293823,0.5364301028144035,1
2502,Phenotype,HP:0003043,Abnormal shoulder morphology,0.0661823247611184,0.5363531888135382,1
2503,Biological Process,GO:0032885,regulation of polysaccharide biosynthetic process,0.0661750080545751,0.5362105630842364,1
2504,Phenotype,HP:0011273,Anisocytosis,0.06617436239634555,0.5361979771652409,1
2505,Disease,MONDO:0015626,Charcot-Marie-Tooth disease,0.06617382103292724,0.5361874242816589,1
2506,Phenotype,HP:0025404,Abnormal visual fixation,0.06617089088035943,0.5361303063496392,1
2507,Phenotype,HP:0002494,Abnormal rapid eye movement sleep,0.066166329467366,0.5360413899975914,1
2508,Biological Process,GO:0042063,gliogenesis,0.06616053798172528,0.5359284956429579,1
2509,Phenotype,HP:0002103,Abnormal pleura morphology,0.06614147710325557,0.5355569388944695,1
2510,Phenotype,HP:0000851,Congenital hypothyroidism,0.06613989632409045,0.5355261245137155,1
2511,Biological Process,GO:0050886,endocrine process,0.06604260471474865,0.5336296036330175,1
2512,Phenotype,HP:0002949,Fused cervical vertebrae,0.06603832149122146,0.5335461100726687,1
2513,Phenotype,HP:0003128,Lactic acidosis,0.06603778328806797,0.5335356187926338,1
2514,Phenotype,HP:0031941,Abnormal portal venous system morphology,0.06602263011763587,0.5332402356210769,1
2515,Phenotype,HP:0200007,Abnormal size of the palpebral fissures,0.06601610342408348,0.533113009741191,1
2516,Phenotype,HP:0002725,Systemic lupus erythematosus,0.06601578240328887,0.5331067520315669,1
2517,Phenotype,HP:0004363,Abnormal circulating calcium concentration,0.06600827103168005,0.5329603316650505,1
2518,Biological Process,GO:0006884,cell volume homeostasis,0.06600548043444299,0.5329059341073832,1
2519,Biological Process,GO:1905207,regulation of cardiocyte differentiation,0.06600455748321099,0.5328879428716005,1
2520,Phenotype,HP:0004326,Cachexia,0.06596609778236406,0.5321382417800566,1
2521,Phenotype,HP:0040196,Mild microcephaly,0.06591825070598722,0.5312055510779198,1
2522,Biological Process,GO:0044703,multi-organism reproductive process,0.06590038468028059,0.5308572857851884,1
2523,Biological Process,GO:0008286,insulin receptor signaling pathway,0.06587952150667142,0.5304505966096769,1
2524,Biological Process,GO:0170036,import into the mitochondrion,0.06587834992962593,0.5304277588712003,1
2525,Phenotype,HP:0012132,Erythroid hyperplasia,0.06587067768509458,0.5302782025831095,1
2526,Phenotype,HP:0002002,Deep philtrum,0.06583746539381596,0.5296307900844177,1
2527,Biological Process,GO:0009617,response to bacterium,0.06582879623771798,0.529461800839928,1
2528,Biological Process,GO:1902774,late endosome to lysosome transport,0.06582758201945604,0.5294381318894084,1
2529,Phenotype,HP:0200146,Mucoid extracellular matrix accumulation,0.06582240169504239,0.5293371509981912,1
2529,Phenotype,HP:0012180,Cystic medial necrosis,0.06582240169504239,0.5293371509981912,1
2529,Phenotype,HP:0004959,Descending thoracic aorta aneurysm,0.06582240169504239,0.5293371509981912,1
2529,Phenotype,HP:0032079,Medial degeneration,0.06582240169504239,0.5293371509981912,1
2533,Phenotype,HP:0100134,Abnormality of the axillary hair,0.06581254922462176,0.5291450952186066,1
2534,Biological Process,GO:2000114,regulation of establishment of cell polarity,0.0657813559228293,0.5285370392044494,1
2535,Biological Process,GO:0018022,peptidyl-lysine methylation,0.065686562653968,0.5266892188737824,1
2536,Phenotype,HP:0011563,Abnormal ventriculoarterial connection,0.06568284100530164,0.5266166721818928,1
2537,Phenotype,HP:0005086,Knee osteoarthritis,0.06565181964478894,0.5260119678465651,1
2538,Biological Process,GO:0048247,lymphocyte chemotaxis,0.06562595781571046,0.5255078390815852,1
2539,Phenotype,HP:0009702,Carpal synostosis,0.06556837923102832,0.5243854505336982,1
2540,Phenotype,HP:0001710,Conotruncal defect,0.06555276489640405,0.5240810778148844,1
2541,Phenotype,HP:0009851,Aplasia/Hypoplasia of the proximal phalanges of the hand,0.06551265401329076,0.5232991899636892,1
2542,Phenotype,HP:0008368,Tarsal synostosis,0.06549678450478091,0.5229898430995664,1
2543,Biological Process,GO:0045071,negative regulation of viral genome replication,0.06548556368840652,0.5227711139337475,1
2544,Phenotype,HP:0100578,Lipoatrophy,0.06548510304416966,0.5227621345220624,1
2545,Phenotype,HP:0410005,Cleft hard palate,0.06546225185666343,0.5223166926741221,1
2546,Biological Process,GO:1902547,regulation of cellular response to vascular endothelial growth factor stimulus,0.06544041722054339,0.5218910666247202,1
2547,Biological Process,GO:0042594,response to starvation,0.06543373812549125,0.5217608699580574,1
2548,Biological Process,GO:0051148,negative regulation of muscle cell differentiation,0.06538832278250617,0.5208755814233321,1
2549,Phenotype,HP:0008163,Decreased circulating cortisol level,0.06535519443443472,0.5202298052429853,1
2550,Disease,MONDO:0001223,parathyroid gland disorder,0.06535367829055905,0.5202002508082524,1
2551,Biological Process,GO:0009755,hormone-mediated signaling pathway,0.06532214557072924,0.51958557846408,1
2552,Biological Process,GO:0061013,regulation of mRNA catabolic process,0.06530807853577492,0.5193113675048733,1
2553,Disease,MONDO:0002280,anemia,0.06530791802052627,0.5193082385554932,1
2554,Phenotype,HP:0002317,Unsteady gait,0.0653019467526339,0.5191918396767129,1
2555,Phenotype,HP:0030917,Low APGAR score,0.06530111011274842,0.5191755309217938,1
2556,Phenotype,HP:0100771,Hypoperistalsis,0.0652798723939394,0.5187615406768776,1
2557,Phenotype,HP:0032169,Severe infection,0.06520825383558704,0.5173654686797173,1
2558,Disease,MONDO:0019175,primary lymphedema,0.06515911798074148,0.5164076556130409,1
2558,Disease,MONDO:0019297,lymphedema,0.06515911798074148,0.5164076556130409,1
2558,Disease,MONDO:0019313,lymphatic malformation,0.06515911798074148,0.5164076556130409,1
2561,Biological Process,GO:0051043,regulation of membrane protein ectodomain proteolysis,0.06515490378550448,0.5163255076321783,1
2562,Biological Process,GO:0006885,regulation of pH,0.06514860013869528,0.5162026296380833,1
2563,Phenotype,HP:0011623,Muscular ventricular septal defect,0.06508136619167537,0.5148920275699539,1
2564,Biological Process,GO:0072678,T cell migration,0.06506290531339365,0.5145321667209641,1
2565,Phenotype,HP:0001790,Nonimmune hydrops fetalis,0.06506014593135057,0.5144783776460591,1
2566,Biological Process,GO:0009083,branched-chain amino acid catabolic process,0.06500801119079247,0.5134621068211943,1
2567,Phenotype,HP:0003466,Paradoxical increased cortisol secretion on dexamethasone suppression test,0.06497415081893554,0.5128020611842754,1
2568,Biological Process,GO:0006882,intracellular zinc ion homeostasis,0.0649676164515185,0.5126746857165202,1
2569,Phenotype,HP:0100825,Cheilitis,0.06495649586860885,0.5124579104176393,1
2570,Biological Process,GO:0051984,positive regulation of chromosome segregation,0.06494850185770651,0.512302081886285,1
2571,Biological Process,GO:0032351,negative regulation of hormone metabolic process,0.0648787350138671,0.5109421056558887,1
2572,Phenotype,HP:0001991,Aplasia/Hypoplasia of toe,0.06484577716256135,0.5102996529962283,1
2573,Phenotype,HP:0100699,Scarring,0.06479742399227517,0.5093570969246813,1
2574,Biological Process,GO:2000042,negative regulation of double-strand break repair via homologous recombination,0.06479350354757474,0.5092806750699469,1
2575,Phenotype,HP:0006466,Ankle flexion contracture,0.06479312922753167,0.5092733783895594,1
2576,Biological Process,GO:0046597,negative regulation of viral entry into host cell,0.06478066703572061,0.5090304508940762,1
2577,Biological Process,GO:0019229,regulation of vasoconstriction,0.06475846632158855,0.5085976888275147,1
2578,Phenotype,HP:0010991,Abnormal morphology of the abdominal musculature,0.06473853730756751,0.5082092093740621,1
2579,Biological Process,GO:0003230,cardiac atrium development,0.06472607698719901,0.5079663183589076,1
2580,Phenotype,HP:0011338,Abnormality of mouth shape,0.06467095021743774,0.5068917234308867,1
2581,Phenotype,HP:3000050,Abnormal odontoid tissue morphology,0.06463209863719166,0.5061343833716228,1
2582,Biological Process,GO:1902745,positive regulation of lamellipodium organization,0.06460853385253418,0.5056750312604343,1
2583,Biological Process,GO:0006022,aminoglycan metabolic process,0.06460850838511212,0.5056745348199084,1
2584,Biological Process,GO:0051147,regulation of muscle cell differentiation,0.06459998643714326,0.5055084151269925,1
2585,Phenotype,HP:0025155,Abnormality of hepatobiliary system physiology,0.06458981919110762,0.5053102233760672,1
2586,Biological Process,GO:0043433,negative regulation of DNA-binding transcription factor activity,0.06457862459605757,0.5050920053467117,1
2587,Phenotype,HP:0002928,Decreased activity of the pyruvate dehydrogenase complex,0.06456226423570643,0.5047730902292461,1
2588,Biological Process,GO:0070534,protein K63-linked ubiquitination,0.06454769696929918,0.5044891281784285,1
2589,Biological Process,GO:2000352,negative regulation of endothelial cell apoptotic process,0.06453993377901468,0.5043377990702453,1
2590,Phenotype,HP:0003109,Hyperphosphaturia,0.06444798585849543,0.5025454435692802,1
2591,Biological Process,GO:0051648,vesicle localization,0.06443746690043639,0.502340395839706,1
2592,Phenotype,HP:0000085,Horseshoe kidney,0.06443514954228446,0.502295223207113,1
2593,Phenotype,HP:0002435,Meningocele,0.06441266289484637,0.5018568873969466,1
2594,Phenotype,HP:0009125,Lipodystrophy,0.06440893931600622,0.5017843030798708,1
2595,Biological Process,GO:0006418,tRNA aminoacylation for protein translation,0.06438383510401013,0.5012949426656876,1
2596,Biological Process,GO:0002705,positive regulation of leukocyte mediated immunity,0.06435696535049817,0.5007711662687363,1
2597,Biological Process,GO:0043300,regulation of leukocyte degranulation,0.06432661824820807,0.5001796053566367,1
2598,Biological Process,GO:0036258,multivesicular body assembly,0.06426809878672246,0.49903887614693937,1
2599,Phenotype,HP:0010609,Skin tags,0.06423440713529993,0.498382119404397,1
2600,Biological Process,GO:0002695,negative regulation of leukocyte activation,0.06422934103008016,0.49828336500616965,1
2601,Biological Process,GO:0001508,action potential,0.06422477440593266,0.4981943470722634,1
2602,Phenotype,HP:0001369,Arthritis,0.06422352946797583,0.4981700792978244,1
2603,Biological Process,GO:1902307,positive regulation of sodium ion transmembrane transport,0.06421563058381263,0.49801610508719046,1
2604,Biological Process,GO:1990000,amyloid fibril formation,0.06421413720581226,0.497986994431301,1
2605,Phenotype,HP:0410240,Abnormal circulating IgA level,0.06420038208674128,0.4977188636982287,1
2606,Disease,MONDO:0020049,autosomal anomaly,0.06417896100542564,0.49730129913868354,1
2607,Phenotype,HP:0010508,Metatarsus valgus,0.06417479054641495,0.4972200037150661,1
2608,Phenotype,HP:0100337,Bilateral cleft palate,0.06417100249138852,0.4971461625533928,1
2609,Phenotype,HP:0011390,Abnormal inner ear morphology,0.06416528500674767,0.4970347107120697,1
2610,Phenotype,HP:0008209,Premature ovarian insufficiency,0.06416162318320784,0.49696333020092687,1
2611,Biological Process,GO:0002753,cytoplasmic pattern recognition receptor signaling pathway,0.0641416367387514,0.4965737312468239,1
2612,Biological Process,GO:0070482,response to oxygen levels,0.0641414039100956,0.4965691926806481,1
2613,Biological Process,GO:0006977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",0.06412669178449126,0.49628240686636427,1
2614,Biological Process,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.06412322906566004,0.4962149075351081,1
2615,Biological Process,GO:0070671,response to interleukin-12,0.0641083213993987,0.4959243100155649,1
2615,Biological Process,GO:0071349,cellular response to interleukin-12,0.0641083213993987,0.4959243100155649,1
2617,Phenotype,HP:0031507,Decreased circulating T4 concentration,0.06409980553108463,0.4957583088343307,1
2618,Phenotype,HP:0000670,Carious teeth,0.06408060758239986,0.4953840801542467,1
2619,Biological Process,GO:0045229,external encapsulating structure organization,0.06407480140899469,0.49527089948867475,1
2620,Biological Process,GO:0051489,regulation of filopodium assembly,0.06407155564617695,0.49520762931564255,1
2621,Biological Process,GO:0010923,negative regulation of phosphatase activity,0.06406775607196946,0.4951335636087331,1
2622,Disease,MONDO:0015150,complex hereditary spastic paraplegia,0.06404928846502711,0.49477357159688706,1
2623,Biological Process,GO:0046496,nicotinamide nucleotide metabolic process,0.06403814292120869,0.49455630973102443,1
2623,Biological Process,GO:0019362,pyridine nucleotide metabolic process,0.06403814292120869,0.49455630973102443,1
2625,Phenotype,HP:0011495,Abnormal corneal epithelium morphology,0.06401865159505304,0.49417636219704125,1
2626,Biological Process,GO:1902686,mitochondrial outer membrane permeabilization involved in programmed cell death,0.06400811825727426,0.4939710341612933,1
2627,Biological Process,GO:0007015,actin filament organization,0.06399358970296787,0.49368782673164097,1
2628,Phenotype,HP:0002206,Pulmonary fibrosis,0.06398653194563053,0.4935502487405715,1
2629,Phenotype,HP:0009726,Renal neoplasm,0.06396051647494416,0.4930431250151889,1
2630,Disease,MONDO:0002356,pancreas disorder,0.06392148187037894,0.49228221723363846,1
2631,Phenotype,HP:0003326,Myalgia,0.06388669515022705,0.4916041141414459,1
2632,Phenotype,HP:0001169,Broad palm,0.0638557399002937,0.4910006985102009,1
2633,Biological Process,GO:0061098,positive regulation of protein tyrosine kinase activity,0.06385416568475699,0.490970012075304,1
2634,Biological Process,GO:0071385,cellular response to glucocorticoid stimulus,0.06375260389238568,0.48899025183476136,1
2635,Phenotype,HP:0004100,Abnormal 2nd finger morphology,0.0637338207237268,0.4886241085279721,1
2636,Phenotype,HP:0000430,Underdeveloped nasal alae,0.06372695125188366,0.4884902008161147,1
2637,Phenotype,HP:0030500,Yellow/white lesions of the macula,0.063713594286962,0.4882298313654698,1
2638,Biological Process,GO:1902903,regulation of supramolecular fiber organization,0.06369507983557954,0.48786892620747063,1
2639,Biological Process,GO:0042634,regulation of hair cycle,0.06369259906640012,0.4878205681776181,1
2640,Biological Process,GO:1904705,regulation of vascular associated smooth muscle cell proliferation,0.06367138186478649,0.4874069778776687,1
2641,Biological Process,GO:0072659,protein localization to plasma membrane,0.06366908985484498,0.48736229936179004,1
2642,Biological Process,GO:0006865,amino acid transport,0.06365652574107827,0.4871173850853459,1
2643,Phenotype,HP:0100838,Recurrent cutaneous abscess formation,0.06365163608233937,0.4870220701865529,1
2644,Phenotype,HP:0002444,Hypothalamic hamartoma,0.06362145809586939,0.48643380587614693,1
2645,Phenotype,HP:0010286,Abnormal salivary gland morphology,0.06360514551930707,0.4861158222157088,1
2646,Phenotype,HP:0001421,Abnormality of the musculature of the hand,0.06355973186100095,0.48523056652069946,1
2647,Phenotype,HP:0006097,3-4 finger syndactyly,0.0635500062869343,0.4850409843520115,1
2648,Biological Process,GO:0106056,regulation of calcineurin-mediated signaling,0.06354405169506472,0.48492491054160686,1
2648,Biological Process,GO:0070884,regulation of calcineurin-NFAT signaling cascade,0.06354405169506472,0.48492491054160686,1
2650,Phenotype,HP:0009834,Abnormal proximal phalanx morphology of the hand,0.06351356989057455,0.48433072385800635,1
2651,Phenotype,HP:5200242,Cognitive distortion,0.06350299235488743,0.4841245342653718,1
2652,Phenotype,HP:0034677,Ankle contracture,0.0634882450904719,0.48383706348462885,1
2653,Biological Process,GO:1903054,negative regulation of extracellular matrix organization,0.06346450791523706,0.483374350936381,1
2654,Biological Process,GO:0044706,multi-multicellular organism process,0.06344696650467374,0.4830324134184872,1
2655,Biological Process,GO:0050849,negative regulation of calcium-mediated signaling,0.06343249942754137,0.4827504043732074,1
2656,Phenotype,HP:0001596,Alopecia,0.06342238040983061,0.4825531527447224,1
2657,Biological Process,GO:0045746,negative regulation of Notch signaling pathway,0.06339992749686474,0.48211547452601106,1
2658,Phenotype,HP:0008628,Abnormality of the stapes,0.06338418296674275,0.4818085638855649,1
2659,Biological Process,GO:0007088,regulation of mitotic nuclear division,0.0633819647218189,0.4817653232829574,1
2660,Disease,MONDO:0015161,multiple congenital anomalies/dysmorphic syndrome without intellectual disability,0.06330677596231782,0.4802996567845586,1
2661,Phenotype,HP:0002326,Transient ischemic attack,0.06327995436024325,0.47977681901126734,1
2662,Phenotype,HP:0001075,Atrophic scars,0.06326848795553064,0.47955330255274514,1
2663,Biological Process,GO:0086064,cell communication by electrical coupling involved in cardiac conduction,0.06324797688185546,0.47915347691748555,1
2664,Phenotype,HP:0011840,Abnormality of T cell physiology,0.06324628325240667,0.47912046272812703,1
2665,Phenotype,HP:0002953,Vertebral compression fracture,0.0632358863046576,0.47891779336501306,1
2666,Biological Process,GO:0070613,regulation of protein processing,0.0632313769368874,0.4788298915388148,1
2667,Biological Process,GO:0006692,prostanoid metabolic process,0.06320973134350993,0.47840795052978846,1
2668,Biological Process,GO:0034109,homotypic cell-cell adhesion,0.06318534436745482,0.47793257131036243,1
2669,Biological Process,GO:0070509,calcium ion import,0.06317941138898131,0.47781691881333965,1
2670,Biological Process,GO:0051092,positive regulation of NF-kappaB transcription factor activity,0.06315086922184909,0.47726054179056415,1
2671,Phenotype,HP:0002512,Brain stem compression,0.06312950037902332,0.4768439955242458,1
2672,Phenotype,HP:0000834,Abnormality of the adrenal glands,0.06312501155877959,0.4767564942342627,1
2673,Phenotype,HP:0000378,Cupped ear,0.06310702200907059,0.4764058210684236,1
2674,Biological Process,GO:1902991,regulation of amyloid precursor protein catabolic process,0.06309798193098792,0.47622960138244136,1
2675,Biological Process,GO:0000070,mitotic sister chromatid segregation,0.06309241794617615,0.4761211417378039,1
2676,Biological Process,GO:0019674,NAD metabolic process,0.06309035248855643,0.4760808794425198,1
2677,Disease,MONDO:0016340,familial restrictive cardiomyopathy,0.06308619166805474,0.4759997719038976,1
2677,Disease,MONDO:0005201,restrictive cardiomyopathy,0.06308619166805474,0.4759997719038976,1
2679,Phenotype,HP:0003015,Flared metaphysis,0.06307195110718644,0.47572217837633357,1
2680,Phenotype,HP:0004482,Relative macrocephaly,0.06305545525894607,0.47540062217180223,1
2681,Biological Process,GO:0060193,positive regulation of lipase activity,0.06303268316780652,0.47495672216197116,1
2682,Biological Process,GO:0055001,muscle cell development,0.0630027162366017,0.4743725719855594,1
2683,Biological Process,GO:0050808,synapse organization,0.06298236676661728,0.47397589651685584,1
2684,Biological Process,GO:0007218,neuropeptide signaling pathway,0.06298152582967087,0.4739595039986417,1
2685,Phenotype,HP:0000664,Synophrys,0.06296149618564639,0.4735690629484591,1
2686,Biological Process,GO:0051702,biological process involved in interaction with symbiont,0.06294451068638462,0.4732379618983587,1
2687,Disease,MONDO:0019019,osteogenesis imperfecta,0.06292079510643056,0.47277567031036843,1
2688,Phenotype,HP:0001001,Abnormality of subcutaneous fat tissue,0.06291395894687069,0.4726424119601695,1
2689,Phenotype,HP:0000526,Aniridia,0.06290190755761504,0.472407492304514,1
2690,Biological Process,GO:1901185,negative regulation of ERBB signaling pathway,0.06289503086683546,0.4722734438727754,1
2691,Biological Process,GO:0033630,positive regulation of cell adhesion mediated by integrin,0.06287516226905754,0.47188614212279995,1
2692,Phenotype,HP:0030272,Abnormal erythrocyte enzyme concentration or activity,0.06285062454166102,0.4714078242833972,1
2693,Biological Process,GO:0031365,N-terminal protein amino acid modification,0.06283872917144251,0.47117594593175255,1
2694,Biological Process,GO:0046854,phosphatidylinositol phosphate biosynthetic process,0.06283479533310499,0.4710992629927111,1
2695,Phenotype,HP:0000133,Gonadal dysgenesis,0.06282474632749935,0.47090337612137373,1
2696,Biological Process,GO:0070252,actin-mediated cell contraction,0.06279157442678795,0.4702567509624601,1
2697,Phenotype,HP:0004944,Dilatation of the cerebral artery,0.06278900963438461,0.47020675505448295,1
2698,Biological Process,GO:1905332,positive regulation of morphogenesis of an epithelium,0.06278634663040628,0.47015484469258784,1
2699,Phenotype,HP:0007420,Spontaneous hematomas,0.0627537403588192,0.4695192454325391,1
2700,Phenotype,HP:0001833,Long foot,0.06274757677768816,0.4693990977610804,1
2701,Phenotype,HP:0001114,Xanthelasma,0.06272591312007436,0.46897680462301,1
2702,Phenotype,HP:0000514,Slow saccadic eye movements,0.06271964510991446,0.46885462129981176,1
2703,Biological Process,GO:0090199,regulation of release of cytochrome c from mitochondria,0.06270329792045326,0.46853596292460725,1
2704,Biological Process,GO:0035308,negative regulation of protein dephosphorylation,0.06270239857093396,0.4685184317607799,1
2705,Biological Process,GO:0006693,prostaglandin metabolic process,0.06269321887440571,0.4683394904701375,1
2706,Phenotype,HP:0011298,Prominent digit pad,0.06267574624965333,0.46799889380504306,1
2707,Biological Process,GO:0034250,positive regulation of amide metabolic process,0.06267276535343491,0.46794078671893696,1
2708,Phenotype,HP:0002040,Esophageal varix,0.06265009230584107,0.46749881738076177,1
2709,Disease,MONDO:0005039,reproductive system disorder,0.06264901192827588,0.4674777574083214,1
2710,Phenotype,HP:0030498,Macular thickening,0.06260059923529815,0.4665340410514409,1
2711,Phenotype,HP:0030187,Titubation,0.06259159219722754,0.466358465419691,1
2712,Biological Process,GO:0051402,neuron apoptotic process,0.06257982237620352,0.4661290344185477,1
2713,Phenotype,HP:0000385,Small earlobe,0.06253218959810103,0.46520052106690124,1
2714,Biological Process,GO:0007059,chromosome segregation,0.06251926651566331,0.4649486093568172,1
2715,Phenotype,HP:0011560,Mitral atresia,0.06251510369522817,0.464867462833173,1
2716,Phenotype,HP:0012040,Corneal stromal edema,0.06251406095530043,0.4648471365372111,1
2717,Phenotype,HP:0002169,Clonus,0.06250644081105228,0.4646985958482624,1
2718,Phenotype,HP:0012181,Entrapment neuropathy,0.06250637900090916,0.4646973909732701,1
2719,Biological Process,GO:0071985,multivesicular body sorting pathway,0.06244874216705676,0.4635738669650035,1
2720,Phenotype,HP:0008151,Prolonged prothrombin time,0.06244038653334161,0.4634109892623994,1
2721,Biological Process,GO:0046825,regulation of protein export from nucleus,0.062412103354827164,0.4628596607461169,1
2722,Biological Process,GO:0009142,nucleoside triphosphate biosynthetic process,0.062411392257258114,0.4628457992076241,1
2723,Phenotype,HP:0030348,Increased circulating androgen concentration,0.062406867008529154,0.46275758781135995,1
2724,Phenotype,HP:0011107,Recurrent aphthous stomatitis,0.062394226830181365,0.46251119079588754,1
2725,Biological Process,GO:0036230,granulocyte activation,0.062391155935031306,0.46245132934623195,1
2726,Biological Process,GO:0034393,positive regulation of smooth muscle cell apoptotic process,0.06236936850436625,0.462026623480304,1
2727,Biological Process,GO:0003006,developmental process involved in reproduction,0.062333196352510334,0.46132151394661824,1
2728,Disease,MONDO:0019722,glomerular disorder,0.06230779556285215,0.4608263722966974,1
2729,Phenotype,HP:0012785,Flexion contracture of finger,0.062301639695938604,0.4607063749997123,1
2730,Biological Process,GO:0034405,response to fluid shear stress,0.062300335646143234,0.46068095494876315,1
2731,Biological Process,GO:0072665,protein localization to vacuole,0.06229573857923287,0.4605913435892179,1
2732,Biological Process,GO:0007507,heart development,0.062284467177154634,0.4603716283481941,1
2733,Biological Process,GO:1904427,positive regulation of calcium ion transmembrane transport,0.06226495790977271,0.4599913310830214,1
2734,Phenotype,HP:0020064,Abnormal eosinophil count,0.06224869225285401,0.4596742620346905,1
2735,Biological Process,GO:0000959,mitochondrial RNA metabolic process,0.06222308298909407,0.4591750565658057,1
2736,Disease,MONDO:0002531,skin neoplasm,0.06220947105906449,0.45890971703958816,1
2737,Phenotype,HP:0000889,Abnormal clavicle morphology,0.06219199061222702,0.45856896789733964,1
2738,Phenotype,HP:0000411,Protruding ear,0.0621695336200373,0.4581312101616663,1
2739,Biological Process,GO:0043583,ear development,0.06215003381582529,0.4577510973635762,1
2740,Biological Process,GO:0061036,positive regulation of cartilage development,0.06213456234939585,0.4574495095973037,1
2741,Phenotype,HP:0010442,Polydactyly,0.062100403663138515,0.4567836488701298,1
2742,Biological Process,GO:0006282,regulation of DNA repair,0.06208260315331349,0.4564366606889431,1
2743,Biological Process,GO:0009218,pyrimidine ribonucleotide metabolic process,0.06207916187499496,0.45636957930102556,1
2744,Phenotype,HP:0006159,Mesoaxial hand polydactyly,0.06206733479166349,0.4561390320765769,1
2745,Phenotype,HP:0003447,Axonal loss,0.062063736846366124,0.45606889675421747,1
2746,Phenotype,HP:0007034,Generalized hyperreflexia,0.06204861837483744,0.45577418997392705,1
2747,Biological Process,GO:0051781,positive regulation of cell division,0.062024629927633024,0.4553065793410423,1
2748,Biological Process,GO:1904706,negative regulation of vascular associated smooth muscle cell proliferation,0.06202017337349741,0.45521970701945846,1
2749,Phenotype,HP:0010944,Abnormal renal pelvis morphology,0.06201641934058444,0.455146529056277,1
2750,Phenotype,HP:0001212,Prominent fingertip pads,0.0620118486777006,0.45505743239463803,1
2751,Phenotype,HP:0001931,Hypochromic anemia,0.06198749458867303,0.4545826942472928,1
2752,Biological Process,GO:0019370,leukotriene biosynthetic process,0.06197756443735658,0.45438912422159844,1
2753,Phenotype,HP:0000685,Hypoplasia of teeth,0.061950630028499654,0.4538640874876807,1
2754,Biological Process,GO:0034391,regulation of smooth muscle cell apoptotic process,0.061930764508432046,0.4534768457320038,1
2755,Biological Process,GO:0002220,innate immune response activating cell surface receptor signaling pathway,0.06191019217005489,0.45307582585412315,1
2756,Phenotype,HP:0007461,Hemangiomatosis,0.0619037067819479,0.4529494051478819,1
2757,Disease,MONDO:0000732,combined oxidative phosphorylation deficiency,0.06190105583875227,0.4528977298887505,1
2758,Biological Process,GO:0035970,peptidyl-threonine dephosphorylation,0.061900111366535504,0.4528793191409742,1
2759,Phenotype,HP:0003172,Abnormal pubic bone morphology,0.06189801206721568,0.4528383971640245,1
2760,Phenotype,HP:0000066,Labial hypoplasia,0.061875650990020015,0.45240250911465024,1
2761,Phenotype,HP:0001733,Pancreatitis,0.06186686359403559,0.4522312150011685,1
2762,Biological Process,GO:0035329,hippo signaling,0.061859537371601436,0.4520884037770864,1
2763,Phenotype,HP:0100728,Germ cell neoplasia,0.06185455178635746,0.4519912189676083,1
2764,Phenotype,HP:0012433,Abnormal social behavior,0.06184091099091438,0.4517253167632748,1
2765,Phenotype,HP:0025160,Abnormal temper tantrums,0.06182525276253803,0.4514200884165409,1
2766,Phenotype,HP:0011863,Abnormal sternal ossification,0.06181533850178933,0.4512268281482218,1
2767,Biological Process,GO:0051403,stress-activated MAPK cascade,0.0618068255046641,0.45106088293553026,1
2768,Disease,MONDO:0020127,hereditary peripheral neuropathy,0.06180322242381753,0.4509906475050898,1
2769,Phenotype,HP:0004309,Ventricular preexcitation,0.06177911611565101,0.4505207393896456,1
2770,Biological Process,GO:0008154,actin polymerization or depolymerization,0.06176508641790823,0.45024725625066714,1
2771,Disease,MONDO:0001115,familial polycythemia,0.061758606168547336,0.45012093571482426,1
2771,Disease,MONDO:0005571,polycythemia,0.061758606168547336,0.45012093571482426,1
2773,Biological Process,GO:0032259,methylation,0.061756727094753106,0.4500843066292203,1
2774,Phenotype,HP:0008291,Pituitary corticotropic cell adenoma,0.061733823500781826,0.44963784321368605,1
2775,Biological Process,GO:0141085,regulation of inflammasome-mediated signaling pathway,0.06170714477818584,0.44911779061289203,1
2776,Biological Process,GO:0032781,positive regulation of ATP-dependent activity,0.061680154149387656,0.4485916579746797,1
2777,Biological Process,GO:0032881,regulation of polysaccharide metabolic process,0.06162851943012149,0.4475851341447239,1
2778,Phenotype,HP:0002904,Hyperbilirubinemia,0.06161936304930404,0.4474066473509563,1
2779,Phenotype,HP:0000998,Hypertrichosis,0.06160240437334019,0.4470760691716866,1
2780,Phenotype,HP:0001056,Milia,0.06157935535181558,0.44662677091362696,1
2781,Biological Process,GO:0002090,regulation of receptor internalization,0.0615557473371795,0.4461665761135609,1
2782,Phenotype,HP:0008316,Abnormal mitochondria in muscle tissue,0.061553558591782354,0.44612391054993933,1
2783,Biological Process,GO:1904753,negative regulation of vascular associated smooth muscle cell migration,0.06155191322562137,0.4460918371645589,1
2784,Biological Process,GO:0002821,positive regulation of adaptive immune response,0.06154465341901261,0.44595032059476947,1
2785,Phenotype,HP:0012310,Abnormal monocyte count,0.06153309318285716,0.4457249750649449,1
2785,Phenotype,HP:0012144,Abnormal monocyte morphology,0.06153309318285716,0.4457249750649449,1
2787,Phenotype,HP:0006292,Abnormality of dental eruption,0.06152244946708485,0.4455174954133392,1
2788,Phenotype,HP:0005622,Broad long bones,0.06151858689978307,0.44544220177198113,1
2789,Phenotype,HP:0000854,Thyroid adenoma,0.06139273124586697,0.4429888774080348,1
2790,Phenotype,HP:0003233,Decreased HDL cholesterol concentration,0.06138958004512518,0.4429274505486529,1
2791,Phenotype,HP:0009832,Abnormal distal phalanx morphology of finger,0.06138309326784297,0.44280100276299716,1
2792,Phenotype,HP:0040161,Localized osteoporosis,0.06136354375844699,0.4424199210538169,1
2793,Phenotype,HP:0000243,Trigonocephaly,0.06135274980137473,0.442209512724554,1
2794,Biological Process,GO:0051900,regulation of mitochondrial depolarization,0.06134502068379455,0.4420588478010385,1
2795,Disease,MONDO:0001531,blood coagulation disease,0.0613288901310971,0.44174441236087186,1
2796,Phenotype,HP:0001852,Sandal gap,0.06127360000269233,0.44066663305672094,1
2797,Phenotype,HP:0000319,Smooth philtrum,0.061231933402332794,0.4398544193607593,1
2798,Phenotype,HP:0001901,Polycythemia,0.06121016558165793,0.43943009575550224,1
2799,Phenotype,HP:0033109,Abnormal circulating non-proteinogenic amino acid concentration,0.06120876109876261,0.43940271794609426,1
2800,Biological Process,GO:1903313,positive regulation of mRNA metabolic process,0.061206809085341374,0.43936466703669086,1
2801,Phenotype,HP:0009731,Cerebral hamartoma,0.061200687701965295,0.4392453419328095,1
2802,Biological Process,GO:0002719,negative regulation of cytokine production involved in immune response,0.06119866228788484,0.43920586021263214,1
2803,Phenotype,HP:0012219,Erythema nodosum,0.061183963426650556,0.4389193329628323,1
2804,Disease,MONDO:0044970,mitochondrial disease,0.06117528013418161,0.43875006815580553,1
2805,Biological Process,GO:0031281,positive regulation of cyclase activity,0.06114519546439423,0.4381636228823984,1
2806,Phenotype,HP:0001920,Renal artery stenosis,0.06112223780287751,0.437716105519565,1
2807,Biological Process,GO:0090630,activation of GTPase activity,0.061102200674856055,0.4373255185826339,1
2808,Disease,MONDO:0002211,B cell deficiency,0.06109579276111354,0.437200608096554,1
2809,Phenotype,HP:0000016,Urinary retention,0.061089116326412674,0.43707046328854354,1
2810,Phenotype,HP:0011898,Abnormality of circulating fibrinogen,0.061073658451192614,0.4367691404578863,1
2811,Phenotype,HP:0000798,Oligozoospermia,0.06107217750472693,0.43674027213188815,1
2812,Biological Process,GO:2000573,positive regulation of DNA biosynthetic process,0.06105652589799049,0.43643517286183847,1
2813,Biological Process,GO:0010744,positive regulation of macrophage derived foam cell differentiation,0.06105413824408468,0.4363886299428871,1
2814,Biological Process,GO:0022617,extracellular matrix disassembly,0.06099279794333634,0.4351929136628857,1
2815,Phenotype,HP:0000221,Furrowed tongue,0.06096464682465763,0.4346441594100743,1
2816,Biological Process,GO:0070849,response to epidermal growth factor,0.06095197624487858,0.43439716977464643,1
2817,Phenotype,HP:0003573,Increased total bilirubin,0.06090018637001149,0.4333876214717798,1
2818,Phenotype,HP:0001300,Parkinsonism,0.06088954781708655,0.4331802424603825,1
2819,Biological Process,GO:0003180,aortic valve morphogenesis,0.06084406134129916,0.4322935673225801,1
2819,Biological Process,GO:0003176,aortic valve development,0.06084406134129916,0.4322935673225801,1
2821,Phenotype,HP:0007266,Cerebral dysmyelination,0.06081552465890083,0.4317372972145984,1
2822,Phenotype,HP:0001377,Limited elbow extension,0.060808701167561874,0.4316042858080532,1
2823,Disease,MONDO:0015977,agammaglobulinemia,0.06079155184012042,0.4312699912290789,1
2824,Phenotype,HP:0033479,Abnormal circulating bilirubin concentration,0.06078329326471299,0.43110900549956976,1
2825,Biological Process,GO:0046466,membrane lipid catabolic process,0.060774324535030066,0.4309341766193398,1
2826,Phenotype,HP:0002869,Flared iliac wing,0.060767675792788745,0.43080457162486646,1
2827,Phenotype,HP:0000076,Vesicoureteral reflux,0.060763009726185646,0.43071361524328977,1
2828,Biological Process,GO:0030212,hyaluronan metabolic process,0.06075383973244819,0.43053486309069805,1
2829,Phenotype,HP:0005709,2-3 toe cutaneous syndactyly,0.06071634122856773,0.42980389876514774,1
2830,Phenotype,HP:0003383,Onion bulb formation,0.06068147527601997,0.42912425118320724,1
2831,Phenotype,HP:0006485,Agenesis of incisor,0.06067269900999117,0.4289531740277282,1
2832,Biological Process,GO:0050864,regulation of B cell activation,0.0606685274182579,0.4288718565237685,1
2833,Biological Process,GO:0070588,calcium ion transmembrane transport,0.06066154576826044,0.4287357621052314,1
2834,Phenotype,HP:0011145,Symptomatic seizures,0.060654176015984995,0.42859210234700035,1
2835,Biological Process,GO:0045055,regulated exocytosis,0.060638862977258845,0.42829360283725276,1
2836,Biological Process,GO:0098656,monoatomic anion transmembrane transport,0.06062538608530599,0.42803089562983354,1
2837,Disease,MONDO:0021181,inherited blood coagulation disorder,0.06061429964191012,0.4278147858179476,1
2838,Biological Process,GO:1990858,cellular response to lectin,0.060613732514278706,0.4278037307084446,1
2838,Biological Process,GO:0002223,stimulatory C-type lectin receptor signaling pathway,0.060613732514278706,0.4278037307084446,1
2838,Biological Process,GO:1990840,response to lectin,0.060613732514278706,0.4278037307084446,1
2841,Phenotype,HP:0000509,Conjunctivitis,0.06060816376342626,0.4276951781586151,1
2842,Phenotype,HP:0006261,Abnormal phalangeal joint morphology of the hand,0.06058112978057695,0.4271682004129594,1
2843,Phenotype,HP:0000591,Abnormal sclera morphology,0.06055597270063873,0.42667780943553596,1
2844,Biological Process,GO:1902414,protein localization to cell junction,0.06052108225677688,0.4259976844404981,1
2845,Phenotype,HP:0003368,Abnormal femoral head morphology,0.06051235041895808,0.4258274733312128,1
2846,Disease,MONDO:0021440,benign neoplasm of skin,0.06051025758065709,0.4257866772999352,1
2847,Biological Process,GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation",0.06050559109638198,0.42569571277661133,1
2848,Biological Process,GO:0006778,porphyrin-containing compound metabolic process,0.06046458293500534,0.42489633413691164,1
2849,Phenotype,HP:0100561,Spinal cord lesion,0.06045764239029028,0.42476104099020984,1
2850,Phenotype,HP:0009099,Median cleft palate,0.060445546475628054,0.42452525339369207,1
2851,Biological Process,GO:0051960,regulation of nervous system development,0.060440705082351776,0.4244308793412712,1
2852,Biological Process,GO:0006690,icosanoid metabolic process,0.06041266415965385,0.42388427315631416,1
2853,Phenotype,HP:0025634,Abnormal ureter physiology,0.06040642610350444,0.42376267373142684,1
2854,Phenotype,HP:0005262,Abnormal synovial membrane morphology,0.0603939268140774,0.42351902308618994,1
2855,Phenotype,HP:0200134,Epileptic encephalopathy,0.06038841993271349,0.4234116765681824,1
2856,Phenotype,HP:0002996,Limited elbow movement,0.060382648960984,0.42329918209449713,1
2857,Biological Process,GO:0009179,purine ribonucleoside diphosphate metabolic process,0.06036456197442752,0.42294660957662716,1
2858,Biological Process,GO:1901991,negative regulation of mitotic cell cycle phase transition,0.0603513168919283,0.4226884210679131,1
2859,Biological Process,GO:0051220,cytoplasmic sequestering of protein,0.06033794468608189,0.4224277545234878,1
2860,Phenotype,HP:0002720,Decreased circulating IgA level,0.060314916584695455,0.42197886406502316,1
2861,Biological Process,GO:0007169,cell surface receptor protein tyrosine kinase signaling pathway,0.06028919972202551,0.4214775611533995,1
2862,Phenotype,HP:0002487,Hyperkinetic movements,0.06027617590769341,0.421223685860409,1
2863,Phenotype,HP:0010647,Abnormal elasticity of skin,0.06026227571215703,0.4209527271286245,1
2864,Biological Process,GO:0046486,glycerolipid metabolic process,0.060252820450799716,0.4207684142087549,1
2865,Disease,MONDO:0002242,coagulation protein disease,0.06025149349812309,0.42074254770828323,1
2866,Biological Process,GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,0.06023401708921683,0.4204018772780728,1
2866,Biological Process,GO:1901099,negative regulation of signal transduction in absence of ligand,0.06023401708921683,0.4204018772780728,1
2868,Phenotype,HP:0000071,Ureteral stenosis,0.06022764327194885,0.42027763144001695,1
2869,Phenotype,HP:0002553,Highly arched eyebrow,0.060226539106091104,0.4202561077585902,1
2870,Phenotype,HP:0000188,Short upper lip,0.06021191855865904,0.4199711070922456,1
2871,Biological Process,GO:0043588,skin development,0.060156279101180266,0.418886518260659,1
2872,Phenotype,HP:0001704,Tricuspid valve prolapse,0.06013574132545774,0.41848617211812544,1
2873,Biological Process,GO:0070633,transepithelial transport,0.06012883379581224,0.418351522539448,1
2874,Phenotype,HP:0011365,Patchy hypopigmentation of hair,0.06007929564148473,0.41738586738471306,1
2875,Phenotype,HP:0008240,Secondary growth hormone deficiency,0.06007194450012121,0.4172425704119608,1
2876,Biological Process,GO:0034103,regulation of tissue remodeling,0.06005000308228925,0.41681486284959285,1
2877,Biological Process,GO:0045737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,0.06001661768099242,0.41616407588966625,1
2878,Phenotype,HP:0025429,Abnormal cry,0.06000790915194609,0.41599431914200563,1
2879,Phenotype,HP:0012680,Abnormality of the pineal gland,0.06000127802474853,0.41586505752039377,1
2880,Biological Process,GO:0043116,negative regulation of vascular permeability,0.059985969539146256,0.4155666467654172,1
2881,Biological Process,GO:0046339,diacylglycerol metabolic process,0.059868330989755525,0.41327349973245203,1
2882,Phenotype,HP:0000012,Urinary urgency,0.059861089779597365,0.41313234566624446,1
2883,Phenotype,HP:0002221,Absent axillary hair,0.059851774339165775,0.41295075829801275,1
2884,Biological Process,GO:1902236,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.0598496330750099,0.41290901829381116,1
2885,Biological Process,GO:0015800,acidic amino acid transport,0.05984285718790838,0.4127769348442699,1
2886,Phenotype,HP:0000962,Hyperkeratosis,0.059824897618978023,0.41242684609853747,1
2887,Phenotype,HP:0012881,Abnormal labia majora morphology,0.05982193144171477,0.41236902593137537,1
2888,Biological Process,GO:0002825,regulation of T-helper 1 type immune response,0.05979862652677781,0.41191473950215657,1
2889,Biological Process,GO:0051058,negative regulation of small GTPase mediated signal transduction,0.05977720017259547,0.41149707215777864,1
2890,Phenotype,HP:0012250,ST segment depression,0.059750051867660026,0.4109678659134381,1
2891,Phenotype,HP:0012472,Eclabion,0.05973576694372518,0.4106894076095319,1
2892,Biological Process,GO:0046636,negative regulation of alpha-beta T cell activation,0.0597305986199933,0.41058866064952143,1
2893,Phenotype,HP:0005924,Abnormal hand epiphysis morphology,0.059727843358029276,0.4105349518879754,1
2894,Phenotype,HP:0032449,Abnormal dermoepidermal hemidesmosome morphology,0.0597081587684426,0.41015123703906226,1
2895,Phenotype,HP:0000293,Full cheeks,0.059706463265599696,0.4101181863313332,1
2896,Disease,MONDO:0024626,defective phagocytic cell engulfment,0.05970207176384057,0.4100325820861146,1
2896,Disease,MONDO:0024627,phagocytic cell dysfunction,0.05970207176384057,0.4100325820861146,1
2898,Biological Process,GO:0008654,phospholipid biosynthetic process,0.059686785622629523,0.4097346068939251,1
2899,Disease,MONDO:0100241,inherited thrombocytopenia,0.059669110639364975,0.40939006562203145,1
2899,Disease,MONDO:0002049,thrombocytopenia,0.059669110639364975,0.40939006562203145,1
2901,Phenotype,HP:0034675,Toe joint contracture,0.05965003116900891,0.40901814645893264,1
2902,Disease,MONDO:0007179,autoimmune disease,0.05962321346640531,0.4084953846986518,1
2903,Phenotype,HP:0003287,Abnormality of mitochondrial metabolism,0.059591657482422344,0.40788025886262597,1
2904,Biological Process,GO:1900746,regulation of vascular endothelial growth factor signaling pathway,0.05955821199418343,0.40722830061834,1
2905,Phenotype,HP:0007064,Progressive language deterioration,0.05953462438613133,0.4067685036070749,1
2906,Phenotype,HP:0000201,Pierre-Robin sequence,0.05951952888565004,0.4064742446050804,1
2907,Biological Process,GO:0031214,biomineral tissue development,0.05947243207912534,0.4055561790330073,1
2908,Phenotype,HP:0007352,Cerebellar calcifications,0.05945281294834781,0.40517374018311625,1
2909,Biological Process,GO:0035458,cellular response to interferon-beta,0.059445040454035425,0.40502222971003154,1
2910,Phenotype,HP:0002791,Hypoventilation,0.05941260150653771,0.40438989212518234,1
2911,Phenotype,HP:0001741,Phimosis,0.05937651326829052,0.4036864183328746,1
2912,Biological Process,GO:1904355,positive regulation of telomere capping,0.05937212316159457,0.4036008412818453,1
2913,Biological Process,GO:2000108,positive regulation of leukocyte apoptotic process,0.0593693129842674,0.4035460620463542,1
2914,Phenotype,HP:0006009,Broad phalanx,0.05934759455860106,0.4031227013058879,1
2915,Phenotype,HP:0002588,Duodenal ulcer,0.05933077480427951,0.4027948311483806,1
2916,Biological Process,GO:0051783,regulation of nuclear division,0.05932445724210922,0.4026716818999293,1
2917,Biological Process,GO:0002823,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.05931060605013494,0.40240167840240787,1
2918,Phenotype,HP:0025439,Pharyngitis,0.05930372327713895,0.40226751140905354,1
2919,Biological Process,GO:0030641,regulation of cellular pH,0.05925556474228255,0.4013287493970272,1
2920,Biological Process,GO:0070302,regulation of stress-activated protein kinase signaling cascade,0.059250759515132034,0.4012350803366724,1
2921,Phenotype,HP:0000982,Palmoplantar keratoderma,0.05924743374021291,0.40117025047496796,1
2922,Disease,MONDO:0019278,hair anomaly,0.05924733900556445,0.40116840379733415,1
2923,Biological Process,GO:0032515,negative regulation of phosphoprotein phosphatase activity,0.05924062775327965,0.401037580284599,1
2924,Phenotype,HP:0002460,Distal muscle weakness,0.0592308419477211,0.4008468240138189,1
2925,Biological Process,GO:0021543,pallium development,0.059228345909307034,0.40079816833833637,1
2925,Biological Process,GO:0021987,cerebral cortex development,0.059228345909307034,0.40079816833833637,1
2927,Biological Process,GO:0001961,positive regulation of cytokine-mediated signaling pathway,0.059213269838623295,0.40050428808448896,1
2928,Phenotype,HP:0003641,Hemoglobinuria,0.05920156315317626,0.4002760877952321,1
2929,Phenotype,HP:0004437,Cranial hyperostosis,0.05919755613265176,0.400197978304131,1
2930,Biological Process,GO:0086019,cell-cell signaling involved in cardiac conduction,0.05918786405818921,0.4000090491485762,1
2931,Phenotype,HP:0100498,Deviation of toes,0.05918361506702263,0.39992622288510055,1
2932,Biological Process,GO:0006308,DNA catabolic process,0.05914923244636616,0.3992559969689166,1
2933,Disease,MONDO:0800153,urea cycle disorder or inherited hyperammonemia,0.059137901008030846,0.3990351114315444,1
2934,Biological Process,GO:0086026,atrial cardiac muscle cell to AV node cell signaling,0.05913269643006547,0.39893365776196965,1
2934,Biological Process,GO:0086014,atrial cardiac muscle cell action potential,0.05913269643006547,0.39893365776196965,1
2936,Phenotype,HP:0031292,Cutaneous abscess,0.059117626804666035,0.3986399031470787,1
2937,Phenotype,HP:0012249,Abnormal ST segment,0.05910097209025966,0.3983152501389988,1
2938,Biological Process,GO:0006903,vesicle targeting,0.0590895903600237,0.39809338425357454,1
2939,Phenotype,HP:0001230,Broad metacarpals,0.05907957695581345,0.3978981913659238,1
2940,Phenotype,HP:0010301,Spinal dysraphism,0.05906609406401819,0.39763536720261833,1
2941,Phenotype,HP:0040185,Macrothrombocytopenia,0.059065768305698985,0.3976290171436706,1
2942,Phenotype,HP:0032199,Abnormal prothrombin time,0.059042262848532534,0.39717082151274097,1
2943,Phenotype,HP:0011096,Peripheral demyelination,0.058987906457099504,0.3961112436925204,1
2944,Phenotype,HP:0002414,Spina bifida,0.05898182144261355,0.3959926275332232,1
2945,Phenotype,HP:0002035,Rectal prolapse,0.05897689978608689,0.3958966888964427,1
2946,Biological Process,GO:2000241,regulation of reproductive process,0.05897607512316383,0.3958806136103651,1
2947,Biological Process,GO:0032890,regulation of organic acid transport,0.05895554468525255,0.3954804105049582,1
2948,Phenotype,HP:0002983,Micromelia,0.058939080006985556,0.3951594619016966,1
2949,Phenotype,HP:0012030,Increased urinary cortisol level,0.058936778207255625,0.39511459255190856,1
2950,Biological Process,GO:1902004,positive regulation of amyloid-beta formation,0.05892124398798326,0.3948117815344458,1
2951,Biological Process,GO:0002691,regulation of cellular extravasation,0.05891955978581864,0.3947789511126435,1
2952,Phenotype,HP:0025352,Typically de novo,0.05890334021680621,0.3944627804632308,1
2953,Phenotype,HP:0001899,Increased hematocrit,0.05887530826110998,0.39391634907347006,1
2954,Biological Process,GO:0031638,zymogen activation,0.058860446728400184,0.39362665084261556,1
2955,Phenotype,HP:0012520,Dilation of Virchow-Robin spaces,0.05885596483854183,0.39353928464774157,1
2956,Biological Process,GO:0071320,cellular response to cAMP,0.058853997288736415,0.39350093088511984,1
2957,Biological Process,GO:0042445,hormone metabolic process,0.058821790478038594,0.39287311837998873,1
2958,Phenotype,HP:0000849,Adrenocortical abnormality,0.0588033302918296,0.3925132710216834,1
2959,Biological Process,GO:0039531,regulation of cytoplasmic pattern recognition receptor signaling pathway,0.058802276454518965,0.3924927284026641,1
2960,Phenotype,HP:0000894,Short clavicles,0.05879475209361151,0.39234605483367463,1
2961,Disease,MONDO:0002146,hypogonadism,0.05878688078902883,0.3921926182362086,1
2962,Phenotype,HP:0010871,Sensory ataxia,0.05875811315233492,0.3916318460992543,1
2963,Phenotype,HP:0006298,Prolonged bleeding after dental extraction,0.058743076942045835,0.39133874285044645,1
2964,Phenotype,HP:0004372,Reduced consciousness,0.05871286623022087,0.3907498406194688,1
2965,Phenotype,HP:0100570,Carcinoid tumor,0.05867219693536074,0.38995706755890064,1
2966,Phenotype,HP:0009473,Joint contracture of the hand,0.05864111160618135,0.38935111627213576,1
2967,Phenotype,HP:0004039,Abnormal ulnar metaphysis morphology,0.05863209589991669,0.3891753716698947,1
2968,Phenotype,HP:0000363,Abnormal earlobe morphology,0.05862934330283143,0.389121714855256,1
2969,Phenotype,HP:0100807,Long fingers,0.05861313716996197,0.38880580611872445,1
2970,Biological Process,GO:0006474,N-terminal protein amino acid acetylation,0.058610165532218206,0.38874787950954354,1
2971,Disease,MONDO:0019276,inherited epidermolysis bullosa,0.05860404795525376,0.38862862860465214,1
2971,Disease,MONDO:0006541,epidermolysis bullosa,0.05860404795525376,0.38862862860465214,1
2973,Phenotype,HP:0011992,Abnormal neutrophil morphology,0.058581728443306114,0.3881935507932965,1
2974,Biological Process,GO:2000779,regulation of double-strand break repair,0.05855978329947431,0.3877657705994185,1
2975,Phenotype,HP:0006000,Ureteral obstruction,0.05855272031162839,0.38762809064920983,1
2976,Biological Process,GO:1903008,organelle disassembly,0.058520194606670906,0.3869940618873401,1
2977,Phenotype,HP:0009051,Increased muscle glycogen content,0.0584796529564352,0.38620377702382375,1
2978,Phenotype,HP:0040131,Abnormal motor nerve conduction velocity,0.05844440883774815,0.38551675778892786,1
2979,Biological Process,GO:0046888,negative regulation of hormone secretion,0.05843719718251639,0.38537617984162115,1
2980,Phenotype,HP:0001723,Restrictive cardiomyopathy,0.0584362883026005,0.38535846290025094,1
2981,Phenotype,HP:0012248,Prolonged PR interval,0.05836728786864831,0.38401342642020025,1
2982,Phenotype,HP:0031538,Abnormal dermoepidermal junction morphology,0.05835783369119707,0.3838291346290848,1
2983,Biological Process,GO:0031123,RNA 3'-end processing,0.058345825724781974,0.3835950614217958,1
2984,Biological Process,GO:0090313,regulation of protein targeting to membrane,0.05833799516296456,0.38344241902956083,1
2985,Phenotype,HP:0001738,Exocrine pancreatic insufficiency,0.058263443205417986,0.38198916581337367,1
2986,Phenotype,HP:0010786,Urinary tract neoplasm,0.058256939748530745,0.38186239288951296,1
2987,Phenotype,HP:0001399,Hepatic failure,0.05824658638610303,0.3816605731420297,1
2988,Phenotype,HP:0011682,Perimembranous ventricular septal defect,0.05824629611041032,0.38165491475158786,1
2989,Biological Process,GO:0018209,peptidyl-serine modification,0.058195932995547706,0.3806731785093761,1
2990,Phenotype,HP:0012763,Paroxysmal dyspnea,0.058191423179653534,0.3805852679478255,1
2991,Biological Process,GO:0045860,positive regulation of protein kinase activity,0.05818921092763962,0.38054214416596877,1
2992,Biological Process,GO:0002483,antigen processing and presentation of endogenous peptide antigen,0.058188762015501494,0.3805333934499582,1
2993,Phenotype,HP:0002418,Abnormal midbrain morphology,0.058143653613784596,0.3796540881703994,1
2994,Phenotype,HP:0031938,Abnormal conus terminalis morphology,0.05814363604063666,0.37965374561421983,1
2995,Biological Process,GO:1901223,negative regulation of non-canonical NF-kappaB signal transduction,0.0581142160383219,0.3790802568100198,1
2996,Biological Process,GO:0001960,negative regulation of cytokine-mediated signaling pathway,0.058101286518714046,0.3788282196191502,1
2997,Phenotype,HP:0003075,Hypoproteinemia,0.05806514182761857,0.37812364538245397,1
2998,Phenotype,HP:0003557,Increased variability in muscle fiber diameter,0.05804664287568739,0.37776304235773417,1
2999,Biological Process,GO:0007204,positive regulation of cytosolic calcium ion concentration,0.05803607614266304,0.3775570633431303,1
3000,Biological Process,GO:0051250,negative regulation of lymphocyte activation,0.058027721051530645,0.3773941962171785,1
3001,Biological Process,GO:0150105,protein localization to cell-cell junction,0.05799852506008418,0.37682507409261407,1
3002,Phenotype,HP:0002076,Migraine,0.05798479545126478,0.3765574406349504,1
3003,Phenotype,HP:0001902,Giant platelets,0.05798152557863656,0.3764937004855316,1
3004,Phenotype,HP:0010303,Abnormal spinal meningeal morphology,0.05797939294695342,0.3764521287554998,1
3005,Phenotype,HP:0030919,Low 5-minute APGAR score,0.05796769453404804,0.3762240897242188,1
3006,Phenotype,HP:0010300,Abnormally low-pitched voice,0.057964207328322415,0.37615611306601887,1
3007,Phenotype,HP:0001655,Patent foramen ovale,0.057951782946992214,0.37591392261627826,1
3008,Biological Process,GO:0032944,regulation of mononuclear cell proliferation,0.05794369033563285,0.3757561720504664,1
3009,Biological Process,GO:0019731,antibacterial humoral response,0.057940266318465605,0.3756894271369279,1
3010,Biological Process,GO:0034101,erythrocyte homeostasis,0.05789782423395795,0.3748620968046036,1
3011,Phenotype,HP:0000171,Microglossia,0.05788320224412713,0.37457706802134966,1
3012,Biological Process,GO:0046635,positive regulation of alpha-beta T cell activation,0.0578525073575491,0.37397872769457613,1
3013,Phenotype,HP:0003651,Foam cells,0.05785041700429561,0.3739379801047264,1
3014,Phenotype,HP:0004742,Abnormal renal collecting system morphology,0.057844908855687716,0.3738306088841296,1
3015,Phenotype,HP:0005112,Abdominal aortic aneurysm,0.057836525286734,0.37366718663545817,1
3016,Biological Process,GO:0007585,respiratory gaseous exchange by respiratory system,0.05781716335712106,0.37328976144894965,1
3017,Phenotype,HP:0010830,Impaired tactile sensation,0.05779152474964344,0.3727899839782893,1
3018,Disease,MONDO:0019223,disorder of fatty acid and ketone body metabolism,0.057788643545525153,0.37273382020621426,1
3019,Phenotype,HP:0012340,Decreased resting energy expenditure,0.057759993219520744,0.3721753348252676,1
3020,Phenotype,HP:0002895,Papillary thyroid carcinoma,0.05772647517780827,0.3715219622845329,1
3021,Phenotype,HP:0040012,Chromosome breakage,0.05769997311627906,0.3710053533661305,1
3022,Biological Process,GO:1903510,mucopolysaccharide metabolic process,0.05769657783647819,0.3709391686346648,1
3023,Biological Process,GO:1900180,regulation of protein localization to nucleus,0.05769108917045129,0.37083217719113115,1
3024,Biological Process,GO:0032692,negative regulation of interleukin-1 production,0.05766071837002784,0.37024015432753316,1
3025,Phenotype,HP:0000557,Buphthalmos,0.057647855975558215,0.36998942561770454,1
3026,Phenotype,HP:0007083,Hyperactive patellar reflex,0.057612012673980306,0.36929072641501326,1
3027,Phenotype,HP:0000651,Diplopia,0.05760235092696342,0.3691023884372009,1
3027,Phenotype,HP:0011514,Abnormality of binocular vision,0.05760235092696342,0.3691023884372009,1
3029,Biological Process,GO:0045930,negative regulation of mitotic cell cycle,0.057566463592445105,0.3684028308933692,1
3030,Phenotype,HP:0010916,Abnormal circulating alanine concentration,0.057564001226096506,0.36835483159283716,1
3030,Phenotype,HP:0010915,Abnormal circulating pyruvate family amino acid concentration,0.057564001226096506,0.36835483159283716,1
3032,Biological Process,GO:0008361,regulation of cell size,0.05756288557772593,0.3683330840809538,1
3033,Phenotype,HP:0009998,Complete duplication of phalanx of hand,0.057561116530606804,0.36829859976290147,1
3034,Phenotype,HP:0009145,Abnormal cerebral artery morphology,0.05755462322194538,0.3681720246600275,1
3035,Biological Process,GO:0043434,response to peptide hormone,0.05748906949342758,0.36689417535953084,1
3036,Phenotype,HP:0004408,Abnormality of the sense of smell,0.05748717515433821,0.36685724870509046,1
3037,Biological Process,GO:0045806,negative regulation of endocytosis,0.05747624869004697,0.3666442573914435,1
3038,Phenotype,HP:0001682,Subvalvular aortic stenosis,0.05747077300006509,0.36653751889202796,1
3039,Phenotype,HP:0001279,Syncope,0.05746140632788699,0.3663549328551785,1
3040,Phenotype,HP:0007686,Abnormal pupillary function,0.05745949020040719,0.36631758147616345,1
3041,Disease,MONDO:0019391,Fanconi anemia,0.05745777954707865,0.3662842354375978,1
3042,Disease,MONDO:0005154,liver disorder,0.05745615839474549,0.3662526340562308,1
3043,Phenotype,HP:0001792,Small nail,0.057402381178541906,0.3652043461912659,1
3044,Biological Process,GO:0034643,"establishment of mitochondrion localization, microtubule-mediated",0.05736922452995252,0.36455801834440277,1
3044,Biological Process,GO:0047497,mitochondrion transport along microtubule,0.05736922452995252,0.36455801834440277,1
3046,Biological Process,GO:0043922,negative regulation by host of viral transcription,0.057357930452871186,0.36433786109592187,1
3047,Phenotype,HP:0000567,Chorioretinal coloboma,0.05735456818766427,0.3642723199232092,1
3048,Phenotype,HP:0410241,Abnormal circulating IgE level,0.05735451882352893,0.3642713576602345,1
3049,Biological Process,GO:0098661,inorganic anion transmembrane transport,0.05735177571870298,0.3642178858797227,1
3050,Phenotype,HP:0000025,Functional abnormality of male internal genitalia,0.05733250094314346,0.36384215960109806,1
3051,Phenotype,HP:0031943,Akathisia,0.05732308239820261,0.36365856240019895,1
3051,Phenotype,HP:0012452,Restless legs,0.05732308239820261,0.36365856240019895,1
3053,Biological Process,GO:0062208,positive regulation of pattern recognition receptor signaling pathway,0.057299025208502385,0.3631896117588636,1
3054,Phenotype,HP:0003584,Late onset,0.05728340012816924,0.3628850295722303,1
3055,Biological Process,GO:0061099,negative regulation of protein tyrosine kinase activity,0.05727014965092192,0.36262673590283,1
3056,Biological Process,GO:0045620,negative regulation of lymphocyte differentiation,0.05726823642260426,0.36258944103764545,1
3057,Phenotype,HP:0011370,Recurrent cutaneous fungal infections,0.0572675718752752,0.3625764869104161,1
3058,Phenotype,HP:0001131,Corneal dystrophy,0.05726453362038131,0.3625172617224874,1
3059,Biological Process,GO:0008016,regulation of heart contraction,0.05724131631755036,0.36206468313004486,1
3060,Biological Process,GO:0006338,chromatin remodeling,0.057215626940047226,0.3615639159911679,1
3061,Biological Process,GO:1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,0.05721353220186853,0.3615230829252708,1
3062,Phenotype,HP:0010760,Absent toe,0.05717544461479418,0.3607806355069313,1
3063,Disease,MONDO:0005420,hypothyroidism,0.05717004737252529,0.36067542620131504,1
3063,Disease,MONDO:0018612,congenital hypothyroidism,0.05717004737252529,0.36067542620131504,1
3065,Phenotype,HP:0002920,Decreased circulating ACTH concentration,0.05714246571072423,0.3601377724623756,1
3066,Phenotype,HP:0010469,Absent testis,0.05713394563414553,0.3599716892487669,1
3067,Phenotype,HP:4000054,Exanthem,0.05710944647047955,0.35949412313832313,1
3068,Biological Process,GO:0032922,circadian regulation of gene expression,0.05705935950800811,0.35851776997878076,1
3069,Phenotype,HP:0011710,Bundle branch block,0.05704873388353682,0.35831064298379534,1
3070,Biological Process,GO:0086066,atrial cardiac muscle cell to AV node cell communication,0.057046704728417996,0.3582710883389595,1
3071,Biological Process,GO:1902914,regulation of protein polyubiquitination,0.056990725719291646,0.35717988057287214,1
3072,Phenotype,HP:0008944,Distal lower limb amyotrophy,0.0569896860496929,0.35715961412732367,1
3073,Phenotype,HP:0012174,Glioblastoma multiforme,0.056951419014801496,0.3564136687040243,1
3074,Biological Process,GO:0048704,embryonic skeletal system morphogenesis,0.05693185125025957,0.3560322311443682,1
3075,Phenotype,HP:0000220,Velopharyngeal insufficiency,0.05692871717510761,0.35597113811684433,1
3076,Biological Process,GO:0010977,negative regulation of neuron projection development,0.05691501909557617,0.35570411926462675,1
3077,Phenotype,HP:0006640,Multiple rib fractures,0.05690558074430063,0.35552013597568216,1
3078,Phenotype,HP:0009108,Aplasia/Hypoplasia involving the femoral head and neck,0.05689956365327398,0.3554028438592261,1
3079,Phenotype,HP:0010230,Cone-shaped epiphyses of the phalanges of the hand,0.05687114396750104,0.35484885438515024,1
3080,Biological Process,GO:0018108,peptidyl-tyrosine phosphorylation,0.05685687249034055,0.3545706582013644,1
3081,Biological Process,GO:0002287,alpha-beta T cell activation involved in immune response,0.056854138572470125,0.35451736550364416,1
3081,Biological Process,GO:0002292,T cell differentiation involved in immune response,0.056854138572470125,0.35451736550364416,1
3081,Biological Process,GO:0002293,alpha-beta T cell differentiation involved in immune response,0.056854138572470125,0.35451736550364416,1
3084,Biological Process,GO:0006520,amino acid metabolic process,0.05684495243971477,0.35433829875059875,1
3085,Phenotype,HP:0002558,Supernumerary nipple,0.05684009186785233,0.3542435508469345,1
3086,Biological Process,GO:1903859,regulation of dendrite extension,0.056833106564251,0.3541073852081137,1
3087,Phenotype,HP:0000276,Long face,0.056826128209336746,0.35397135502115984,1
3088,Biological Process,GO:0051453,regulation of intracellular pH,0.05682401423007022,0.3539301468856644,1
3089,Biological Process,GO:0045639,positive regulation of myeloid cell differentiation,0.05682302130519867,0.35391079164254946,1
3090,Phenotype,HP:0001948,Alkalosis,0.05676801754935712,0.3528385946445139,1
3091,Phenotype,HP:0003834,Shoulder dislocation,0.05676558333587334,0.3527911441322724,1
3092,Biological Process,GO:0048002,antigen processing and presentation of peptide antigen,0.05676481162161806,0.3527761009830331,1
3093,Biological Process,GO:0030488,tRNA methylation,0.056757420964541616,0.3526320337241771,1
3094,Phenotype,HP:0010743,Short metatarsal,0.056715880870719215,0.35182228604034993,1
3095,Biological Process,GO:0032717,negative regulation of interleukin-8 production,0.05670871296605673,0.3516825609298782,1
3096,Phenotype,HP:0005376,Recurrent Haemophilus influenzae infections,0.056708638970744074,0.3516811185274298,1
3097,Phenotype,HP:0001338,Partial agenesis of the corpus callosum,0.056695869542205846,0.35143220201735076,1
3098,Phenotype,HP:0002476,Primitive reflex,0.05666988125931738,0.35092560826805513,1
3099,Biological Process,GO:0042440,pigment metabolic process,0.05666694535287964,0.3508683781749298,1
3100,Phenotype,HP:0011064,Abnormal number of incisors,0.056664543654912136,0.3508215614928406,1
3101,Phenotype,HP:0004885,Episodic respiratory distress,0.05664745590372766,0.35048846722967886,1
3101,Phenotype,HP:3000004,Abnormal frontalis muscle physiology,0.05664745590372766,0.35048846722967886,1
3101,Phenotype,HP:0004661,Frontalis muscle weakness,0.05664745590372766,0.35048846722967886,1
3101,Phenotype,HP:0040172,Abnormality of occipitofrontalis muscle,0.05664745590372766,0.35048846722967886,1
3105,Biological Process,GO:1905144,response to acetylcholine,0.05662713266473429,0.35009230308587347,1
3106,Phenotype,HP:0001670,Asymmetric septal hypertrophy,0.056567950903592346,0.3489386635631899,1
3107,Phenotype,HP:0000280,Coarse facial features,0.056563144988663994,0.3488449810958719,1
3108,Biological Process,GO:1901524,regulation of mitophagy,0.05653075502227256,0.34821359830755094,1
3109,Biological Process,GO:0048565,digestive tract development,0.05652592414971924,0.34811942933726314,1
3109,Biological Process,GO:0055123,digestive system development,0.05652592414971924,0.34811942933726314,1
3111,Phenotype,HP:0001211,Abnormal fingertip morphology,0.05641895694468402,0.34603430052428896,1
3112,Biological Process,GO:0002861,regulation of inflammatory response to antigenic stimulus,0.05638831283726953,0.345436950043861,1
3113,Biological Process,GO:0006826,iron ion transport,0.05637915260564674,0.34525838818572985,1
3114,Biological Process,GO:1900017,positive regulation of cytokine production involved in inflammatory response,0.05636910626364511,0.34506255323645074,1
3115,Phenotype,HP:0033754,Abnormal left ventricular end-diastolic volume,0.0563468645706976,0.34462899236329425,1
3115,Phenotype,HP:0033755,Increased left ventricular end-diastolic volume,0.0563468645706976,0.34462899236329425,1
3117,Biological Process,GO:0048699,generation of neurons,0.056315655223076244,0.3440206235652315,1
3118,Phenotype,HP:0001065,Striae distensae,0.05631338901786498,0.3439764480650811,1
3119,Biological Process,GO:0007623,circadian rhythm,0.05630678652797394,0.34384774467505946,1
3120,Phenotype,HP:0012029,Abnormal urine hormone level,0.056270913044788484,0.3431484571374716,1
3121,Phenotype,HP:0001488,Bilateral ptosis,0.05626804135053798,0.34309247874276816,1
3122,Biological Process,GO:0030510,regulation of BMP signaling pathway,0.05626641336457705,0.3430607441524035,1
3123,Biological Process,GO:0050770,regulation of axonogenesis,0.05626540743346242,0.34304113537651476,1
3124,Phenotype,HP:0031908,Micrographia,0.056252017950983,0.34278013205592267,1
3125,Biological Process,GO:0060760,positive regulation of response to cytokine stimulus,0.05624831493801863,0.34270794863274834,1
3126,Phenotype,HP:0034059,Abnormal fetal physiology,0.056232733959947656,0.3424042261385558,1
3127,Disease,MONDO:0000473,arterial disorder,0.05621519291102728,0.34206229567022556,1
3128,Phenotype,HP:0009924,Aplasia/Hypoplasia involving the nose,0.05621516086451728,0.3420616709824875,1
3129,Phenotype,HP:0001055,Erysipelas,0.05619422069133617,0.34165348084202146,1
3130,Biological Process,GO:0030199,collagen fibril organization,0.056194035406892384,0.34164986906276434,1
3131,Phenotype,HP:0011469,Nasal regurgitation,0.05618849339487264,0.34154183773727154,1
3132,Phenotype,HP:0002617,Vascular dilatation,0.05618819952363818,0.34153610925836,1
3133,Phenotype,HP:0001058,Poor wound healing,0.056169886549714776,0.3411791315326508,1
3134,Phenotype,HP:0008775,Abnormal prostate morphology,0.05616592371412521,0.3411018833455437,1
3135,Biological Process,GO:0007292,female gamete generation,0.056159034759929005,0.34096759586106623,1
3136,Phenotype,HP:0031035,Chronic infection,0.056145315982071176,0.3407001735330664,1
3137,Phenotype,HP:0200005,Abnormal shape of the palpebral fissure,0.0561339512940805,0.3404786398548515,1
3138,Biological Process,GO:0000075,cell cycle checkpoint signaling,0.05611461079122493,0.34010163234354673,1
3139,Biological Process,GO:0010717,regulation of epithelial to mesenchymal transition,0.05605028041842708,0.33884763011149815,1
3140,Biological Process,GO:0010984,regulation of lipoprotein particle clearance,0.05601824279051126,0.3382231155133593,1
3141,Phenotype,HP:0025405,Visual fixation instability,0.0560079981663727,0.33802341541871456,1
3142,Phenotype,HP:0005830,Flexion contracture of toe,0.05599603222077232,0.33779016132987855,1
3143,Phenotype,HP:0001410,Decreased liver function,0.05599487265398073,0.3377675577091996,1
3144,Disease,MONDO:0017731,glycoproteinosis,0.055956892590108165,0.33702720625780647,1
3145,Phenotype,HP:0001822,Hallux valgus,0.05595126678551132,0.33691754155022463,1
3146,Disease,MONDO:0019952,congenital myopathy,0.0559487773514612,0.33686901461466334,1
3147,Phenotype,HP:0030914,Abnormal peristalsis,0.055946851463413605,0.3368314729713412,1
3148,Phenotype,HP:0010946,Dilatation of the renal pelvis,0.05590478925768405,0.33601154767671415,1
3149,Biological Process,GO:0010820,positive regulation of T cell chemotaxis,0.055884196522615115,0.33561013020286273,1
3150,Phenotype,HP:0040186,Maculopapular exanthema,0.0558815397446536,0.3355583412057079,1
3151,Phenotype,HP:0005144,Ventricular septal hypertrophy,0.05583870461254947,0.33472334913380647,1
3152,Phenotype,HP:0000499,Abnormal eyelash morphology,0.055816901521873796,0.33429833800479014,1
3153,Phenotype,HP:0040270,Impaired glucose tolerance,0.055815511402419804,0.3342712401842381,1
3154,Phenotype,HP:0007648,Punctate cataract,0.05578272408937146,0.3336321118540682,1
3155,Biological Process,GO:0048008,platelet-derived growth factor receptor signaling pathway,0.055776207350485274,0.3335050800220806,1
3156,Phenotype,HP:0006710,Aplasia/Hypoplasia of the clavicles,0.05576784570065674,0.3333420850464174,1
3157,Biological Process,GO:0015031,protein transport,0.055767438730996655,0.3333341519218306,1
3158,Phenotype,HP:0002963,Abnormal delayed hypersensitivity skin test,0.05576577926112225,0.33330180361051176,1
3159,Biological Process,GO:1902476,chloride transmembrane transport,0.055734837585479036,0.3326986525850725,1
3160,Phenotype,HP:0001688,Sinus bradycardia,0.055733557151095625,0.33267369287312065,1
3161,Disease,MONDO:0003225,bone marrow disorder,0.055713515560240956,0.3322830189414689,1
3162,Phenotype,HP:0008619,Bilateral sensorineural hearing impairment,0.055697997668522015,0.3319805261996129,1
3163,Biological Process,GO:0048259,regulation of receptor-mediated endocytosis,0.05568967057550167,0.3318182048453313,1
3164,Biological Process,GO:0070229,negative regulation of lymphocyte apoptotic process,0.055687037578320275,0.3317668794107217,1
3165,Biological Process,GO:0045165,cell fate commitment,0.05568643454714162,0.3317551244276376,1
3166,Phenotype,HP:0001320,Cerebellar vermis hypoplasia,0.0556631174667509,0.3313006008552856,1
3167,Phenotype,HP:0010874,Tendon xanthomatosis,0.055655932919625783,0.3311605513306316,1
3168,Biological Process,GO:0006605,protein targeting,0.05565128814730613,0.3310700100419233,1
3169,Biological Process,GO:0030838,positive regulation of actin filament polymerization,0.05563821807307745,0.33081523299737997,1
3170,Biological Process,GO:1904950,negative regulation of establishment of protein localization,0.05562521126719411,0.33056168925279783,1
3171,Biological Process,GO:0097193,intrinsic apoptotic signaling pathway,0.05558587900137746,0.32979497911292976,1
3172,Biological Process,GO:0008589,regulation of smoothened signaling pathway,0.055584157547103885,0.32976142252981755,1
3173,Phenotype,HP:0001025,Urticaria,0.055582422875798065,0.32972760830498465,1
3174,Phenotype,HP:0000733,Motor stereotypy,0.05557704247557671,0.3296227273040911,1
3175,Phenotype,HP:0001712,Left ventricular hypertrophy,0.055571607190829875,0.329516776430376,1
3176,Phenotype,HP:0005523,Lymphoproliferative disorder,0.055560842516129916,0.3293069389070735,1
3177,Phenotype,HP:0033799,Abnormal circulating sex hormone concentration,0.05555552894230953,0.3292033605638878,1
3178,Phenotype,HP:0001191,Abnormal carpal morphology,0.05554156986578107,0.32893125405552004,1
3179,Phenotype,HP:0004426,Abnormal cheek morphology,0.055534954742332054,0.32880230439753483,1
3180,Biological Process,GO:0006111,regulation of gluconeogenesis,0.055529479109911906,0.3286955670201793,1
3181,Biological Process,GO:1903543,positive regulation of exosomal secretion,0.05552378424721516,0.32858455615202575,1
3182,Phenotype,HP:0010293,Aplasia/Hypoplasia of the uvula,0.0555046242286833,0.3282110668504707,1
3183,Phenotype,HP:0030405,Pancreatic endocrine tumor,0.05550212709936586,0.3281623899098346,1
3184,Phenotype,HP:0002270,Abnormality of the autonomic nervous system,0.0554865926377035,0.32785957416742495,1
3185,Biological Process,GO:0018105,peptidyl-serine phosphorylation,0.05546837305293306,0.32750441689139104,1
3186,Biological Process,GO:0034198,cellular response to amino acid starvation,0.05546744790146663,0.327486382766087,1
3187,Phenotype,HP:0000245,Abnormal paranasal sinus morphology,0.05546348099368059,0.3274090551990037,1
3188,Biological Process,GO:0043462,regulation of ATP-dependent activity,0.055444721726310764,0.3270433778038597,1
3189,Biological Process,GO:1903729,regulation of plasma membrane organization,0.05544065954125266,0.3269641929816939,1
3190,Biological Process,GO:0035825,homologous recombination,0.05544023386333852,0.3269558951741226,1
3191,Phenotype,HP:0001622,Premature birth,0.05542940325449519,0.3267447723860322,1
3192,Phenotype,HP:0002987,Elbow flexion contracture,0.05542736440141982,0.3267050286973804,1
3193,Phenotype,HP:0008479,Hypoplastic vertebral bodies,0.05542554344319084,0.32666953246777225,1
3194,Biological Process,GO:0048666,neuron development,0.05541906204846714,0.3265431896051893,1
3195,Biological Process,GO:0006901,vesicle coating,0.05539519757466704,0.32607799560567646,1
3196,Phenotype,HP:0000437,Depressed nasal tip,0.05538803409326476,0.32593835671852234,1
3197,Phenotype,HP:0006109,Absent phalangeal crease,0.055368147166243276,0.32555069767367434,1
3198,Biological Process,GO:0050866,negative regulation of cell activation,0.05533646521006064,0.32493311624143956,1
3199,Phenotype,HP:0012416,Hypercapnia,0.05533566404767343,0.3249174990550609,1
3199,Phenotype,HP:0500164,Abnormal blood carbon dioxide level,0.05533566404767343,0.3249174990550609,1
3201,Phenotype,HP:0001915,Aplastic anemia,0.055334467696333656,0.3248941783873088,1
3202,Biological Process,GO:2000047,regulation of cell-cell adhesion mediated by cadherin,0.05531533707192038,0.32452126207000226,1
3203,Phenotype,HP:0010295,Aplasia/Hypoplasia of the tongue,0.05531153396762445,0.3244471275505149,1
3204,Biological Process,GO:0051972,regulation of telomerase activity,0.05527191468638337,0.32367482257313523,1
3205,Phenotype,HP:0005435,Impaired T cell function,0.055233676001709586,0.32292942978515604,1
3206,Phenotype,HP:0007431,Congenital ichthyosiform erythroderma,0.05519585102317914,0.32219210143710786,1
3207,Biological Process,GO:1903322,positive regulation of protein modification by small protein conjugation or removal,0.055189136993457066,0.3220612237833442,1
3208,Biological Process,GO:0007565,female pregnancy,0.05518436845753527,0.32196826995097133,1
3209,Biological Process,GO:0034340,response to type I interferon,0.05517247845089446,0.32173649615240335,1
3210,Biological Process,GO:2000628,regulation of miRNA metabolic process,0.05516858386019696,0.32166057827387773,1
3211,Disease,MONDO:0004739,urea cycle disorder,0.05516366809466022,0.32156475447110466,1
3212,Biological Process,GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,0.05508982163838194,0.3201252537038258,1
3213,Biological Process,GO:2000630,positive regulation of miRNA metabolic process,0.05507017249826518,0.31974222987709183,1
3214,Phenotype,HP:0001612,Weak cry,0.05505106216732947,0.3193697091437848,1
3215,Phenotype,HP:0003829,Typified by incomplete penetrance,0.05504913129799116,0.3193320703993672,1
3216,Phenotype,HP:0002647,Aortic dissection,0.05504089839452142,0.3191715850970398,1
3217,Biological Process,GO:0043488,regulation of mRNA stability,0.055040190473946926,0.31915778548820933,1
3218,Phenotype,HP:0002457,Abnormal head movements,0.05503463894409544,0.3190495686301021,1
3219,Biological Process,GO:0000271,polysaccharide biosynthetic process,0.05499356720752535,0.31824895070900217,1
3220,Disease,MONDO:0000062,isolated microphthalmia,0.054984218001834284,0.3180667051491743,1
3221,Phenotype,HP:0001956,Truncal obesity,0.05490816396732401,0.3165841717068161,1
3222,Phenotype,HP:0007206,Hemimegalencephaly,0.054906226278259584,0.31654640002438794,1
3223,Biological Process,GO:0086003,cardiac muscle cell contraction,0.05490293376792743,0.3164822185945906,1
3223,Biological Process,GO:0086002,cardiac muscle cell action potential involved in contraction,0.05490293376792743,0.3164822185945906,1
3225,Biological Process,GO:0006622,protein targeting to lysosome,0.05490259336696879,0.31647558310433355,1
3226,Phenotype,HP:0032794,Myoclonic seizure,0.054893203938325974,0.31629255347208274,1
3227,Biological Process,GO:1901875,positive regulation of post-translational protein modification,0.05489038780188682,0.3162376580746699,1
3228,Biological Process,GO:0010888,negative regulation of lipid storage,0.05485412426086311,0.31553076707733946,1
3229,Phenotype,HP:0030087,Abnormal circulating testosterone concentration,0.054845461286035846,0.3153618983253471,1
3230,Phenotype,HP:0001541,Ascites,0.054841262518941614,0.31528005108773566,1
3231,Biological Process,GO:1904814,"regulation of protein localization to chromosome, telomeric region",0.05482424573228806,0.31494834014750983,1
3232,Biological Process,GO:0032740,positive regulation of interleukin-17 production,0.05482210052818104,0.3149065233412113,1
3233,Phenotype,HP:0007033,Cerebellar dysplasia,0.05481415799894751,0.31475169835025013,1
3234,Phenotype,HP:0012499,Descending aortic dissection,0.054755287384379625,0.3136041240574323,1
3235,Phenotype,HP:0005613,Aplasia/hypoplasia of the femur,0.05475006695898432,0.31350236147137484,1
3236,Biological Process,GO:2001257,regulation of cation channel activity,0.054746090329816144,0.31342484440383667,1
3237,Biological Process,GO:0032375,negative regulation of cholesterol transport,0.054734389718770204,0.3131967625238506,1
3237,Biological Process,GO:0032372,negative regulation of sterol transport,0.054734389718770204,0.3131967625238506,1
3239,Phenotype,HP:0005328,Progeroid facial appearance,0.05472969986630116,0.31310534248058985,1
3240,Biological Process,GO:0031644,regulation of nervous system process,0.05472774860012519,0.3130673061373578,1
3241,Phenotype,HP:0006855,Cerebellar vermis atrophy,0.05471925725667326,0.31290178302317845,1
3242,Phenotype,HP:0012200,Abnormality of prothrombin,0.054687028064137055,0.3122735342252969,1
3243,Disease,MONDO:0100284,X-linked intellectual disability,0.05466449948407648,0.3118343810158227,1
3244,Phenotype,HP:0001583,Rotary nystagmus,0.05462153711902007,0.31099690877166025,1
3245,Phenotype,HP:0002751,Kyphoscoliosis,0.054596811871096884,0.3105149355646798,1
3246,Phenotype,HP:0012475,Decreased circulating level of specific antibody,0.054582791263538155,0.31024162962211094,1
3247,Biological Process,GO:0043523,regulation of neuron apoptotic process,0.05457500553837258,0.31008986123789173,1
3248,Biological Process,GO:0022008,neurogenesis,0.05456103110519184,0.3098174553798481,1
3249,Phenotype,HP:0025633,Abnormal ureter morphology,0.05455030958029783,0.3096084589826051,1
3250,Biological Process,GO:0098926,postsynaptic signal transduction,0.054538688185979844,0.30938192128694986,1
3251,Phenotype,HP:0001973,Autoimmune thrombocytopenia,0.05453582191291817,0.3093260485683462,1
3252,Biological Process,GO:0000041,transition metal ion transport,0.054526474186794904,0.30914383184996985,1
3253,Biological Process,GO:0006991,response to sterol depletion,0.054521950934098506,0.30905565936268725,1
3254,Biological Process,GO:0060761,negative regulation of response to cytokine stimulus,0.05450969087031998,0.30881667198122686,1
3255,Phenotype,HP:0002573,Hematochezia,0.05449798682285789,0.30858852311463186,1
3256,Phenotype,HP:0008207,Primary adrenal insufficiency,0.054492744869676035,0.30848634088399257,1
3257,Phenotype,HP:0033454,Tube feeding,0.05447600008700704,0.3081599321608833,1
3258,Phenotype,HP:0011063,Abnormal incisor morphology,0.05447346960165933,0.3081106050058213,1
3259,Phenotype,HP:0032016,Abnormal sputum,0.05446370098092845,0.3079201837216319,1
3260,Phenotype,HP:0001385,Hip dysplasia,0.0544291239191973,0.30724616753452216,1
3261,Phenotype,HP:0003691,Scapular winging,0.054416163732891265,0.3069935325528068,1
3262,Biological Process,GO:0060263,regulation of respiratory burst,0.05436629296729567,0.30602139375349713,1
3263,Phenotype,HP:0040075,Hypopituitarism,0.05433175511740218,0.3053481419290021,1
3264,Phenotype,HP:0031481,Abnormal mitral valve physiology,0.05431488156074393,0.3050192229939521,1
3265,Phenotype,HP:0001278,Orthostatic hypotension,0.054308655388643934,0.3048978552267381,1
3266,Phenotype,HP:0001964,Aplasia/Hypoplasia of metatarsal bones,0.05430618109943908,0.3048496235120647,1
3267,Phenotype,HP:0000089,Renal hypoplasia,0.05425095788672518,0.30377314860616406,1
3268,Biological Process,GO:0072583,clathrin-dependent endocytosis,0.054240113826638736,0.303561763610843,1
3269,Disease,MONDO:0018276,muscular dystrophy-dystroglycanopathy,0.054207855738619415,0.30293295154869376,1
3270,Biological Process,GO:0007420,brain development,0.054200707080162225,0.30279360160757596,1
3271,Biological Process,GO:0050818,regulation of coagulation,0.05419264803952695,0.3026365054412508,1
3272,Biological Process,GO:0035456,response to interferon-beta,0.05415831831764217,0.30196731068927274,1
3273,Phenotype,HP:0010803,Everted upper lip vermilion,0.054148959053593404,0.30178486906027163,1
3274,Phenotype,HP:0012714,Severe hearing impairment,0.05414737752349141,0.30175404004138534,1
3275,Biological Process,GO:0033674,positive regulation of kinase activity,0.05414064033329136,0.3016227109167251,1
3276,Phenotype,HP:0004418,Thrombophlebitis,0.05411524710946425,0.30112771674875777,1
3277,Phenotype,HP:0002923,Rheumatoid factor positive,0.0541139250933913,0.3011019464782902,1
3278,Biological Process,GO:0010819,regulation of T cell chemotaxis,0.054111179901778605,0.3010484340197111,1
3279,Phenotype,HP:0025722,Cerebral infarct,0.05408240246535645,0.30048747085508876,1
3280,Phenotype,HP:0008221,Adrenal hyperplasia,0.05408123862142944,0.3004647838595258,1
3281,Phenotype,HP:0000098,Tall stature,0.0540738963088121,0.3003216589869329,1
3282,Phenotype,HP:0001692,Atrial arrhythmia,0.054071847963878095,0.3002817302719647,1
3283,Phenotype,HP:0000482,Microcornea,0.0540423657660114,0.2997070290799367,1
3284,Biological Process,GO:0044242,cellular lipid catabolic process,0.05403455166882809,0.29955470763544406,1
3285,Biological Process,GO:0032963,collagen metabolic process,0.05399527242003277,0.29878903096484083,1
3286,Phenotype,HP:0004396,Poor appetite,0.05395683192492384,0.29803970425381554,1
3287,Phenotype,HP:0008200,Primary hyperparathyroidism,0.05392820954071631,0.29748176354677835,1
3288,Phenotype,HP:0034281,Phalangeal cone-shaped epiphyses,0.05391634983810978,0.2972505804695909,1
3289,Biological Process,GO:0015813,L-glutamate transmembrane transport,0.05387019809481075,0.2963509371659251,1
3290,Phenotype,HP:0001635,Congestive heart failure,0.053850922347500996,0.29597519194481786,1
3291,Biological Process,GO:0032642,regulation of chemokine production,0.05383699148974119,0.29570363550941464,1
3292,Biological Process,GO:0010310,regulation of hydrogen peroxide metabolic process,0.053811580749039356,0.2952082998822103,1
3293,Phenotype,HP:0006895,Lower limb hypertonia,0.05380093083825255,0.29500069947019747,1
3294,Biological Process,GO:0006851,mitochondrial calcium ion transmembrane transport,0.053793768295143596,0.2948610788733451,1
3295,Biological Process,GO:0006406,mRNA export from nucleus,0.053787395142893324,0.29473684599858563,1
3296,Biological Process,GO:0010498,proteasomal protein catabolic process,0.053779388313219045,0.2945807675888626,1
3297,Biological Process,GO:0045670,regulation of osteoclast differentiation,0.0537762258276645,0.29451912075282327,1
3298,Biological Process,GO:0006900,vesicle budding from membrane,0.053775620030090954,0.2945073118439617,1
3299,Biological Process,GO:0006664,glycolipid metabolic process,0.05375131214504025,0.29403347435811744,1
3300,Biological Process,GO:0051988,regulation of attachment of spindle microtubules to kinetochore,0.05373429523584794,0.293701761029224,1
3301,Biological Process,GO:0090201,negative regulation of release of cytochrome c from mitochondria,0.05373342885904531,0.2936848726078292,1
3302,Phenotype,HP:0012632,Abnormal intraocular pressure,0.0537330424870065,0.2936773409959639,1
3303,Biological Process,GO:0006007,glucose catabolic process,0.053675570675292494,0.29255703379059905,1
3304,Phenotype,HP:0000699,Diastema,0.05366302097799125,0.2923124005366189,1
3305,Phenotype,HP:0003162,Fasting hypoglycemia,0.05364089691502982,0.29188113264356946,1
3306,Biological Process,GO:2000045,regulation of G1/S transition of mitotic cell cycle,0.05363485242648569,0.29176330646292925,1
3307,Biological Process,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,0.05363313493431121,0.2917298271136475,1
3308,Phenotype,HP:0010051,Deviation of the hallux,0.05362870310590884,0.291643436774731,1
3309,Phenotype,HP:0007042,Focal white matter lesions,0.05361740276590188,0.29142315744204056,1
3310,Phenotype,HP:0034670,Abnormal knee physiology,0.05361679741206671,0.2914113571830421,1
3311,Biological Process,GO:0045840,positive regulation of mitotic nuclear division,0.05358842081137094,0.29085820757325725,1
3312,Biological Process,GO:0032328,alanine transport,0.05358743120329956,0.2908389169850578,1
3313,Phenotype,HP:0003154,Increased circulating ACTH level,0.05357748232885151,0.2906449819863686,1
3314,Phenotype,HP:0025615,Abscess,0.053572672423068735,0.2905512217246879,1
3315,Disease,MONDO:0000688,inborn organic aciduria,0.053546994569171114,0.29005067921729377,1
3316,Phenotype,HP:0034674,Abnormal ankle physiology,0.053510802580086,0.28934518299333095,1
3317,Phenotype,HP:0100864,Short femoral neck,0.053498359421161434,0.289102626508944,1
3318,Phenotype,HP:0001266,Choreoathetosis,0.053484836061073904,0.2888390134907536,1
3319,Biological Process,GO:0031398,positive regulation of protein ubiquitination,0.053460497885984615,0.28836458555634903,1
3320,Biological Process,GO:0038093,Fc receptor signaling pathway,0.05346007220710591,0.2883562877299754,1
3321,Phenotype,HP:0001607,Subglottic stenosis,0.05345887759951162,0.2883330010533325,1
3322,Phenotype,HP:0002591,Polyphagia,0.05345293708572629,0.28821720166927284,1
3323,Phenotype,HP:0010652,Abnormal dura mater morphology,0.053407043701035994,0.287322594591233,1
3323,Phenotype,HP:0010653,Abnormality of the falx cerebri,0.053407043701035994,0.287322594591233,1
3325,Phenotype,HP:0007430,Generalized edema,0.05339766339225316,0.2871397427338694,1
3326,Biological Process,GO:0032386,regulation of intracellular transport,0.0533910684899046,0.28701118724902525,1
3327,Biological Process,GO:1900226,negative regulation of NLRP3 inflammasome complex assembly,0.05328974667418007,0.2850361049115882,1
3328,Biological Process,GO:0032868,response to insulin,0.05328851185484196,0.28501203438100015,1
3329,Phenotype,HP:0008625,Severe sensorineural hearing impairment,0.05328445487604605,0.2849329510453349,1
3330,Phenotype,HP:0000907,Anterior rib cupping,0.05326884491030348,0.2846286634898299,1
3331,Biological Process,GO:0032986,protein-DNA complex disassembly,0.05324624106727116,0.28418804316722623,1
3332,Phenotype,HP:0005110,Atrial fibrillation,0.05322946571030063,0.28386103845437366,1
3333,Phenotype,HP:0005616,Accelerated skeletal maturation,0.053201655967729855,0.28331893870056013,1
3334,Disease,MONDO:0021583,melanocytic skin neoplasm,0.053192287885220235,0.2831363251718932,1
3334,Disease,MONDO:0005073,melanocytic nevus,0.053192287885220235,0.2831363251718932,1
3334,Disease,MONDO:0021143,melanocytic neoplasm,0.053192287885220235,0.2831363251718932,1
3337,Phenotype,HP:0001271,Polyneuropathy,0.053183780996288954,0.28297049902720195,1
3338,Biological Process,GO:0031670,cellular response to nutrient,0.05317283831324038,0.2827571915587277,1
3339,Phenotype,HP:0002140,Ischemic stroke,0.05316587626861469,0.282621479310834,1
3340,Phenotype,HP:0007642,Congenital stationary night blindness,0.05315083481119365,0.28232827377884495,1
3341,Phenotype,HP:0007086,Social and occupational deterioration,0.053130777759302306,0.2819372984627358,1
3342,Biological Process,GO:0032728,positive regulation of interferon-beta production,0.053087853398228635,0.28110056703627906,1
3343,Phenotype,HP:0000064,Hypoplastic labia minora,0.05307623546922924,0.28087409689063253,1
3344,Phenotype,HP:0012872,Abnormal vas deferens morphology,0.0530686728569677,0.28072667768188825,1
3344,Phenotype,HP:0012873,Absent vas deferens,0.0530686728569677,0.28072667768188825,1
3346,Biological Process,GO:0006661,phosphatidylinositol biosynthetic process,0.053005741230956915,0.27949994144437323,1
3347,Disease,MONDO:0700223,hereditary skeletal muscle disorder,0.05300322618216324,0.2794509151965247,1
3348,Biological Process,GO:0032872,regulation of stress-activated MAPK cascade,0.05296071349404685,0.27862220857677816,1
3349,Biological Process,GO:0043279,response to alkaloid,0.05288889549949971,0.2772222489380183,1
3349,Biological Process,GO:0071312,cellular response to alkaloid,0.05288889549949971,0.2772222489380183,1
3351,Biological Process,GO:0044070,regulation of monoatomic anion transport,0.05286698422650238,0.27679512899372666,1
3352,Phenotype,HP:0011662,Tricuspid atresia,0.05285815038093811,0.27662292943116573,1
3353,Biological Process,GO:0051281,positive regulation of release of sequestered calcium ion into cytosol,0.05283831256084237,0.27623622763546496,1
3354,Phenotype,HP:0045055,Tiger tail banding,0.05279656944298161,0.27542252237163023,1
3355,Phenotype,HP:0000126,Hydronephrosis,0.05278330594895886,0.2751639749641473,1
3356,Disease,MONDO:0000652,integumentary system benign neoplasm,0.05275332111400666,0.2745794757871283,1
3357,Phenotype,HP:0020179,Abnormal circulating haptoglobin concentration,0.05275153170366009,0.2745445945254311,1
3357,Phenotype,HP:0020181,Reduced haptoglobin level,0.05275153170366009,0.2745445945254311,1
3359,Biological Process,GO:1903509,liposaccharide metabolic process,0.05273348501749653,0.27419280758955705,1
3360,Biological Process,GO:0002274,myeloid leukocyte activation,0.05272624365473444,0.27405165054861674,1
3361,Biological Process,GO:0098727,maintenance of cell number,0.052713159565469625,0.2737966003067355,1
3362,Biological Process,GO:0071901,negative regulation of protein serine/threonine kinase activity,0.05271022539095549,0.2737394039742736,1
3363,Biological Process,GO:0010506,regulation of autophagy,0.052701163064084455,0.27356275058910606,1
3364,Biological Process,GO:0051291,protein heterooligomerization,0.052690827728523515,0.27336128224221623,1
3365,Phenotype,HP:0000758,Abnormal nonverbal communicative behavior,0.0526048147870668,0.2716846182360753,1
3366,Biological Process,GO:0007519,skeletal muscle tissue development,0.05256923766516752,0.2709911077163749,1
3367,Phenotype,HP:0011493,Central opacification of the cornea,0.05253213555316494,0.2702678703210133,1
3368,Biological Process,GO:0038094,Fc-gamma receptor signaling pathway,0.05252856385970961,0.27019824673000364,1
3369,Biological Process,GO:0033619,membrane protein proteolysis,0.052508638702437826,0.26980984245678036,1
3370,Phenotype,HP:0010185,Aplasia/Hypoplasia of the distal phalanges of the toes,0.052502993687084,0.26969980327084414,1
3371,Biological Process,GO:1905048,regulation of metallopeptidase activity,0.052495392125635476,0.2695516248193768,1
3372,Phenotype,HP:0003165,Elevated circulating parathyroid hormone level,0.052462242008586624,0.2689054242928765,1
3373,Phenotype,HP:0008589,Hypoplastic helices,0.05245299552278837,0.26872518106832605,1
3374,Phenotype,HP:0000246,Sinusitis,0.05244462538798378,0.2685620206936693,1
3375,Phenotype,HP:0001845,Overlapping toe,0.05243469858569427,0.26836851595109207,1
3376,Biological Process,GO:0048525,negative regulation of viral process,0.052427186259870084,0.268222076983903,1
3377,Phenotype,HP:0000824,Decreased response to growth hormone stimulation test,0.052423804980640254,0.26815616516780466,1
3378,Biological Process,GO:0009126,purine nucleoside monophosphate metabolic process,0.05241102414265897,0.26790702625162977,1
3379,Phenotype,HP:0001808,Fragile nails,0.05238283798430332,0.2673575889647991,1
3380,Phenotype,HP:0001880,Eosinophilia,0.05237608846473418,0.2672260195017781,1
3381,Biological Process,GO:0006886,intracellular protein transport,0.05227357117076692,0.265227633516009,1
3382,Phenotype,HP:0030666,Retinal neovascularization,0.05225447346916656,0.2648553589683532,1
3383,Biological Process,GO:0017148,negative regulation of translation,0.05224404420549433,0.2646520596657875,1
3384,Phenotype,HP:0025337,Red eye,0.05222097552643201,0.26420237822020554,1
3385,Disease,MONDO:0015756,myeloid hemopathy,0.05219253471184382,0.2636479768787592,1
3386,Phenotype,HP:0007141,Sensorimotor neuropathy,0.05218839317832824,0.263567245304438,1
3387,Biological Process,GO:0051098,regulation of binding,0.052182837179360564,0.26345894132913505,1
3388,Biological Process,GO:0061615,glycolytic process through fructose-6-phosphate,0.05216704438541764,0.26315108987431846,1
3389,Biological Process,GO:0050670,regulation of lymphocyte proliferation,0.05216180158507977,0.26304889112993174,1
3390,Phenotype,HP:0001310,Dysmetria,0.05215828184551641,0.26298028028443643,1
3391,Biological Process,GO:0035924,cellular response to vascular endothelial growth factor stimulus,0.05213258353168926,0.2624793389483681,1
3392,Phenotype,HP:0031828,Abnormal superficial reflex,0.05211729150556477,0.26218124904062085,1
3392,Phenotype,HP:0003487,Babinski sign,0.05211729150556477,0.26218124904062085,1
3394,Phenotype,HP:0002974,Radioulnar synostosis,0.052099438753261285,0.2618332424884573,1
3395,Biological Process,GO:0034243,regulation of transcription elongation by RNA polymerase II,0.05208045957470375,0.2614632783294063,1
3396,Biological Process,GO:1902235,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,0.052080202193508285,0.2614582611566531,1
3397,Phenotype,HP:0040255,Aplasia/Hypoplasia of the clitoris,0.05200751425441763,0.26004134354995556,1
3397,Phenotype,HP:0000060,Clitoral hypoplasia,0.05200751425441763,0.26004134354995556,1
3399,Phenotype,HP:0031392,Abnormal proportion of CD4-positive T cells,0.051982945233222666,0.25956241569554145,1
3400,Phenotype,HP:0005547,Myeloproliferative disorder,0.051934483581607904,0.2586177449801294,1
3401,Biological Process,GO:1901605,alpha-amino acid metabolic process,0.051925743302856264,0.258447369330392,1
3402,Phenotype,HP:0100560,Upper limb asymmetry,0.05191511946858396,0.25824027723204135,1
3403,Biological Process,GO:0046883,regulation of hormone secretion,0.051914821478501794,0.25823446846377357,1
3404,Disease,MONDO:0019507,amelogenesis imperfecta,0.05189260064499357,0.25780131420699887,1
3404,Disease,MONDO:0004038,dental enamel hypoplasia,0.05189260064499357,0.25780131420699887,1
3406,Phenotype,HP:0012745,Short palpebral fissure,0.05187459466938127,0.2574503208484031,1
3407,Phenotype,HP:0005420,Recurrent gram-negative bacterial infections,0.05186600732775082,0.2572829264263967,1
3408,Disease,MONDO:0020120,skeletal muscle disorder,0.05182717900652778,0.2565260397589839,1
3409,Phenotype,HP:0034376,Atrioventricular valve regurgitation,0.051801566341929006,0.2560267679970045,1
3410,Phenotype,HP:0034238,Closed neural tube defect,0.05179327621280316,0.2558651671858225,1
3411,Biological Process,GO:1903351,cellular response to dopamine,0.05178171867811887,0.25563987431620666,1
3411,Biological Process,GO:1903350,response to dopamine,0.05178171867811887,0.25563987431620666,1
3413,Biological Process,GO:0018200,peptidyl-glutamic acid modification,0.0517691532388006,0.2553949342005743,1
3414,Phenotype,HP:0012232,Shortened QT interval,0.051756840574844865,0.255154921475458,1
3415,Phenotype,HP:0002754,Osteomyelitis,0.051756311145130796,0.25514460121747906,1
3416,Biological Process,GO:0046032,ADP catabolic process,0.05175543441147901,0.2551275109083694,1
3416,Biological Process,GO:0006096,glycolytic process,0.05175543441147901,0.2551275109083694,1
3418,Biological Process,GO:0043268,positive regulation of potassium ion transport,0.051750665380002614,0.2550345474160716,1
3419,Phenotype,HP:0000682,Abnormal dental enamel morphology,0.051716611430938975,0.25437072834774344,1
3420,Phenotype,HP:0012103,Abnormality of the mitochondrion,0.05171483143209854,0.2543360305460384,1
3421,Biological Process,GO:0006412,translation,0.05163899788974946,0.2528577951925963,1
3422,Phenotype,HP:0010765,Palmar hyperkeratosis,0.0516363966840655,0.252807089474724,1
3423,Biological Process,GO:0019953,sexual reproduction,0.0516309237047583,0.2527004038149231,1
3424,Phenotype,HP:0033678,Acute coronary syndrome,0.05161948746078726,0.2524774752845537,1
3424,Phenotype,HP:0001658,Myocardial infarction,0.05161948746078726,0.2524774752845537,1
3426,Disease,MONDO:0002220,tooth hard tissue disease,0.051575459793261835,0.25161923692920846,1
3427,Biological Process,GO:0031529,ruffle organization,0.05155587556442154,0.2512374784283545,1
3428,Phenotype,HP:0001419,X-linked recessive inheritance,0.05154904469322763,0.25110432316511805,1
3429,Biological Process,GO:0001836,release of cytochrome c from mitochondria,0.05154380772220535,0.2510022380525111,1
3430,Biological Process,GO:0042446,hormone biosynthetic process,0.05152488105852271,0.2506332975743043,1
3431,Biological Process,GO:0031175,neuron projection development,0.051495633068728064,0.25006316183763333,1
3432,Biological Process,GO:0050773,regulation of dendrite development,0.051489397413742366,0.2499416092190138,1
3433,Biological Process,GO:0045740,positive regulation of DNA replication,0.05145088316489688,0.24919084481462142,1
3434,Phenotype,HP:0010693,Pulverulent cataract,0.05144839277519453,0.24914229925037873,1
3435,Biological Process,GO:0007214,gamma-aminobutyric acid signaling pathway,0.05138104714765035,0.2478295201759516,1
3436,Biological Process,GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",0.05136548291899645,0.24752612418082143,1
3436,Biological Process,GO:0042093,T-helper cell differentiation,0.05136548291899645,0.24752612418082143,1
3438,Phenotype,HP:0030966,Abnormal pulmonary artery morphology,0.05135965361477912,0.2474124926226336,1
3439,Phenotype,HP:0003348,Hyperalaninemia,0.0513556419086072,0.24733429179345878,1
3440,Biological Process,GO:0050890,cognition,0.05131753065300382,0.24659138300070255,1
3441,Phenotype,HP:0100626,Chronic hepatic failure,0.05131376342996585,0.24651794792030782,1
3442,Phenotype,HP:0031020,Bone marrow hypercellularity,0.05130656133045741,0.24637755624424212,1
3443,Phenotype,HP:0045014,Hypolipidemia,0.05130145596858904,0.24627803660989345,1
3444,Biological Process,GO:0002891,positive regulation of immunoglobulin mediated immune response,0.05129119773969826,0.2460780713156408,1
3444,Biological Process,GO:0002714,positive regulation of B cell mediated immunity,0.05129119773969826,0.2460780713156408,1
3446,Biological Process,GO:1901343,negative regulation of vasculature development,0.05128822362535068,0.24602009642962627,1
3447,Phenotype,HP:0000498,Blepharitis,0.05126501533181349,0.24556769345678592,1
3448,Biological Process,GO:0046640,regulation of alpha-beta T cell proliferation,0.051260517091998525,0.24548000854959626,1
3449,Phenotype,HP:0000162,Glossoptosis,0.05125532391063903,0.2453787770358802,1
3450,Phenotype,HP:0100295,Muscle fiber atrophy,0.05125378162875083,0.2453487130886942,1
3451,Phenotype,HP:0031432,Restricted or repetitive behaviors or interests,0.051237992068768556,0.2450409246739892,1
3452,Phenotype,HP:0012269,Abnormal muscle glycogen content,0.05123184513334322,0.2449211014799305,1
3453,Biological Process,GO:0051279,regulation of release of sequestered calcium ion into cytosol,0.05123140425664163,0.2449125073999678,1
3454,Phenotype,HP:0003484,Upper limb muscle weakness,0.05121364630037517,0.24456634872209507,1
3455,Phenotype,HP:0010514,Hyperpituitarism,0.05120650977698926,0.24442723533185998,1
3456,Biological Process,GO:0016266,O-glycan processing,0.0511779676029438,0.24387085817432347,1
3457,Phenotype,HP:0030142,Abnormal bowel sounds,0.05116051585806969,0.24353066852403119,1
3458,Phenotype,HP:0000194,Open mouth,0.051140202890475384,0.24313470460224834,1
3459,Phenotype,HP:0100760,Clubbing of toes,0.05107468987771313,0.2418576489804778,1
3460,Biological Process,GO:2001259,positive regulation of cation channel activity,0.051064803758502086,0.24166493727964705,1
3461,Biological Process,GO:1904353,regulation of telomere capping,0.05105828005442348,0.24153776967405108,1
3462,Biological Process,GO:0060348,bone development,0.051055765275999976,0.24148874869657147,1
3463,Phenotype,HP:0000843,Hyperparathyroidism,0.051051646639762804,0.2414084634625555,1
3464,Phenotype,HP:0000726,Dementia,0.05103125173267431,0.24101090228112473,1
3465,Biological Process,GO:0071375,cellular response to peptide hormone stimulus,0.05102841021839255,0.24095551218937256,1
3466,Phenotype,HP:0000684,Delayed eruption of teeth,0.051016365327971824,0.2407207192165441,1
3467,Biological Process,GO:0034975,protein folding in endoplasmic reticulum,0.051009452205222794,0.2405859606106061,1
3468,Phenotype,HP:0012569,Delayed menarche,0.05099889782726241,0.24038022243523766,1
3469,Phenotype,HP:0000972,Palmoplantar hyperkeratosis,0.05096576768197203,0.23973441122141514,1
3470,Phenotype,HP:0004364,Abnormal circulating nitrogen compound concentration,0.050909942452350254,0.23864620110377271,1
3471,Biological Process,GO:0035304,regulation of protein dephosphorylation,0.05090229651031675,0.23849715753447365,1
3472,Disease,MONDO:0015244,autosomal recessive cerebellar ataxia,0.0508955235948102,0.2383651320107078,1
3473,Phenotype,HP:0003457,EMG abnormality,0.050892441275857236,0.23830504787503762,1
3474,Phenotype,HP:0002566,Intestinal malrotation,0.050892159204540266,0.23829954941380235,1
3475,Phenotype,HP:0001450,Y-linked inheritance,0.05087921109046134,0.23804714975793817,1
3476,Phenotype,HP:0001103,Abnormal macular morphology,0.050870026042395766,0.23786810414892395,1
3477,Phenotype,HP:0003700,Generalized amyotrophy,0.050867052552980185,0.2378101414448086,1
3478,Phenotype,HP:0007941,Limited extraocular movements,0.05086238056956238,0.2377190697258178,1
3479,Phenotype,HP:0007340,Lower limb muscle weakness,0.05082028275140893,0.23689845023252354,1
3480,Biological Process,GO:0120178,steroid hormone biosynthetic process,0.05074905508222849,0.23550999790042584,1
3481,Biological Process,GO:1903541,regulation of exosomal secretion,0.05074879888219297,0.23550500375221217,1
3482,Phenotype,HP:0002827,Hip dislocation,0.05073849653256812,0.23530417840544327,1
3483,Phenotype,HP:0000029,Testicular atrophy,0.05072708765350553,0.23508178330360516,1
3484,Disease,MONDO:0001705,pure red-cell aplasia,0.050723525317980744,0.23501234212823024,1
3484,Disease,MONDO:0015253,Diamond-Blackfan anemia,0.050723525317980744,0.23501234212823024,1
3486,Biological Process,GO:1903715,regulation of aerobic respiration,0.050716062545259066,0.23486686910758317,1
3487,Phenotype,HP:0005913,Abnormal metacarpal epiphysis morphology,0.05070275518051115,0.23460746652104741,1
3488,Biological Process,GO:0010821,regulation of mitochondrion organization,0.05064545904241191,0.2334905837495145,1
3489,Phenotype,HP:0012633,Asymmetry of intraocular pressure,0.050636240002790545,0.23331087553767396,1
3490,Biological Process,GO:0097242,amyloid-beta clearance,0.050605171454866205,0.23270525137059417,1
3491,Phenotype,HP:0005871,Metaphyseal chondrodysplasia,0.0505920634376954,0.23244973469821964,1
3492,Phenotype,HP:0007906,Ocular hypertension,0.05058810194877472,0.23237251276194426,1
3493,Biological Process,GO:2000272,negative regulation of signaling receptor activity,0.0505805681454653,0.232225655130705,1
3494,Biological Process,GO:0010575,positive regulation of vascular endothelial growth factor production,0.05056837145707482,0.23198790313580644,1
3495,Phenotype,HP:0100776,Recurrent pharyngitis,0.05056523460419371,0.23192675596156442,1
3496,Phenotype,HP:0005968,Temperature instability,0.050552883171174234,0.23168598750489636,1
3497,Biological Process,GO:0050768,negative regulation of neurogenesis,0.05053985805617567,0.23143208685780672,1
3497,Biological Process,GO:0051961,negative regulation of nervous system development,0.05053985805617567,0.23143208685780672,1
3499,Biological Process,GO:0060537,muscle tissue development,0.0505352269470033,0.23134181190701072,1
3500,Phenotype,HP:0031466,Impairment in personality functioning,0.050531510856228534,0.23126937355598964,1
3501,Biological Process,GO:0045621,positive regulation of lymphocyte differentiation,0.05051369062780864,0.23092200099708365,1
3502,Phenotype,HP:0002839,Urinary bladder sphincter dysfunction,0.050506096245986454,0.2307739624992193,1
3503,Phenotype,HP:0004341,Abnormality of vitamin B12 metabolism,0.050501540169391235,0.23068515017043423,1
3504,Phenotype,HP:0003311,Hypoplasia of the odontoid process,0.05046494545073166,0.22997180347455073,1
3505,Phenotype,HP:0034398,Toe deformity,0.050450344074262965,0.22968717651085727,1
3506,Phenotype,HP:0006477,Abnormal alveolar ridge morphology,0.05043813537390329,0.22944919036472455,1
3507,Phenotype,HP:0100523,Liver abscess,0.05043540451791528,0.22939595735276722,1
3508,Biological Process,GO:0072525,pyridine-containing compound biosynthetic process,0.05040877084939377,0.2288767829982431,1
3509,Biological Process,GO:0046330,positive regulation of JNK cascade,0.05040282271441554,0.22876083505305297,1
3510,Biological Process,GO:0099173,postsynapse organization,0.050402234590251394,0.22874937065478376,1
3511,Phenotype,HP:0002572,Episodic vomiting,0.05036146088814086,0.2279545623670072,1
3512,Phenotype,HP:0030991,Sclerosing cholangitis,0.050356491268724435,0.2278576887819556,1
3513,Phenotype,HP:0001557,Prenatal movement abnormality,0.050321995680645215,0.22718526077375642,1
3514,Phenotype,HP:0100665,Angioedema,0.050311179813385065,0.22697442534570147,1
3515,Biological Process,GO:0043162,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,0.05028987406648011,0.22655910901824555,1
3516,Biological Process,GO:1900025,negative regulation of substrate adhesion-dependent cell spreading,0.05028772101053536,0.2265171391548199,1
3517,Phenotype,HP:0004809,Neonatal alloimmune thrombocytopenia,0.050276237407410385,0.22629328744489857,1
3518,Biological Process,GO:0090288,negative regulation of cellular response to growth factor stimulus,0.05026360463921409,0.22604703487669275,1
3519,Biological Process,GO:0002886,regulation of myeloid leukocyte mediated immunity,0.050256848444964475,0.22591533530305913,1
3520,Phenotype,HP:0000199,Tongue nodules,0.05025298996416816,0.22584012132060483,1
3521,Phenotype,HP:0001386,Joint swelling,0.05023809554388825,0.2255497820070932,1
3522,Phenotype,HP:0007715,Weak extraocular muscles,0.05022841612802942,0.22536109960772263,1
3523,Biological Process,GO:0015931,nucleobase-containing compound transport,0.05020978253890884,0.22499787207876512,1
3524,Biological Process,GO:0050996,positive regulation of lipid catabolic process,0.05019844726217915,0.2247769117189582,1
3525,Phenotype,HP:0031850,Abnormal hematocrit,0.050196682637968615,0.22474251361736958,1
3526,Phenotype,HP:0040156,Elevated urinary carboxylic acid,0.050193095741325466,0.22467259366819145,1
3527,Biological Process,GO:2000622,"regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",0.05013004828523859,0.22344359953650247,1
3528,Biological Process,GO:0002862,negative regulation of inflammatory response to antigenic stimulus,0.05012059525078372,0.22325933002599774,1
3529,Biological Process,GO:0048864,stem cell development,0.05011504938800093,0.2231512236369659,1
3530,Phenotype,HP:0007556,Plantar hyperkeratosis,0.05008900256726523,0.2226434888000642,1
3531,Disease,MONDO:0002921,congenital structural myopathy,0.05008802864669393,0.22262450401080944,1
3532,Disease,MONDO:0020043,autosomal recessive congenital cerebellar ataxia,0.05007553516873742,0.22238096664949575,1
3533,Phenotype,HP:0002860,Squamous cell carcinoma,0.05004397459444232,0.2217657513337824,1
3534,Phenotype,HP:0002594,Pancreatic hypoplasia,0.05003183985539583,0.221529206927341,1
3535,Phenotype,HP:0006042,Y-shaped metacarpals,0.05002774670603971,0.2214494185131682,1
3536,Phenotype,HP:0045058,Abnormality of the testis size,0.05002386613328447,0.22137377388862992,1
3537,Phenotype,HP:0003027,Mesomelia,0.05001731034556256,0.2212459808714506,1
3538,Biological Process,GO:0072344,rescue of stalled ribosome,0.04998671384141429,0.2206495583290944,1
3539,Disease,MONDO:0021002,syndactyly,0.049978981575867776,0.22049883204176837,1
3540,Biological Process,GO:0051480,regulation of cytosolic calcium ion concentration,0.04997853496447002,0.22049012617445743,1
3541,Phenotype,HP:0000230,Gingivitis,0.049974092235438805,0.22040352334784177,1
3542,Disease,MONDO:0019824,non-acquired pituitary hormone deficiency,0.04997131701426638,0.22034942551825845,1
3543,Phenotype,HP:0011787,Central hypothyroidism,0.049969220551430604,0.22030855883334538,1
3544,Phenotype,HP:0010761,Broad columella,0.049957691756171374,0.2200838261859327,1
3545,Phenotype,HP:0034915,Abnormal anus morphology,0.04994371910539486,0.21981145507257935,1
3546,Phenotype,HP:0012092,Abnormality of exocrine pancreas physiology,0.04994218040699516,0.21978146097890713,1
3547,Phenotype,HP:0001949,Hypokalemic alkalosis,0.04992858542051459,0.2195164517359967,1
3548,Phenotype,HP:0010758,Abnormality of the premaxilla,0.04992374978907632,0.2194221900000044,1
3549,Biological Process,GO:0045444,fat cell differentiation,0.04989709744201842,0.21890265154178715,1
3550,Biological Process,GO:0051444,negative regulation of ubiquitin-protein transferase activity,0.04989229127206407,0.2188089641032066,1
3551,Phenotype,HP:0010534,Transient global amnesia,0.04987706321079299,0.21851212107256365,1
3552,Biological Process,GO:0019724,B cell mediated immunity,0.04987088875779844,0.21839176147413286,1
3553,Phenotype,HP:0012334,Extrahepatic cholestasis,0.04986818062533371,0.21833897141544445,1
3554,Biological Process,GO:0007032,endosome organization,0.04986226849330788,0.21822372528155592,1
3555,Biological Process,GO:0032743,positive regulation of interleukin-2 production,0.04985841500374777,0.21814860859406615,1
3556,Biological Process,GO:0000280,nuclear division,0.049836061478790716,0.21771286776168544,1
3557,Phenotype,HP:0003422,Vertebral segmentation defect,0.04982393018878051,0.2174763905878591,1
3558,Biological Process,GO:0043114,regulation of vascular permeability,0.04982278606702062,0.21745408803964997,1
3559,Phenotype,HP:0011506,Choroidal neovascularization,0.04981204257386318,0.21724466341153903,1
3560,Phenotype,HP:0034370,Abnormal muscle tissue metabolite concentration,0.049799954882447706,0.2170090361120836,1
3561,Phenotype,HP:0000453,Choanal atresia,0.049794594315453855,0.21690454172346163,1
3562,Biological Process,GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,0.04979152231789519,0.216844658784379,1
3563,Phenotype,HP:0009768,Broad phalanges of the hand,0.04978320619697574,0.21668255131101263,1
3564,Phenotype,HP:0031434,Abnormal prosody,0.04977402386800189,0.2165035587056878,1
3565,Biological Process,GO:0006006,glucose metabolic process,0.04976522580674969,0.21633205669243769,1
3566,Biological Process,GO:0031032,actomyosin structure organization,0.04975317794504153,0.2160972057998286,1
3567,Phenotype,HP:0004846,Prolonged bleeding after surgery,0.04974705754055897,0.21597789977767506,1
3568,Biological Process,GO:0042181,ketone biosynthetic process,0.049702353846125646,0.21510648352183645,1
3569,Biological Process,GO:0043518,"negative regulation of DNA damage response, signal transduction by p53 class mediator",0.04969156731898661,0.21489622002544861,1
3570,Disease,MONDO:0020070,neonatal epilepsy syndrome,0.049684649136786496,0.2147613627948226,1
3571,Phenotype,HP:0008208,Parathyroid hyperplasia,0.049660004374522115,0.2142809585076447,1
3572,Phenotype,HP:0005324,Disturbance of facial expression,0.049656704599879475,0.21421663547348274,1
3573,Biological Process,GO:0032204,regulation of telomere maintenance,0.0496525391133259,0.214135436978766,1
3574,Phenotype,HP:0004840,Hypochromic microcytic anemia,0.049638529009756294,0.21386233579213484,1
3575,Phenotype,HP:0100620,Germinoma,0.04962243076493966,0.2135485301346493,1
3576,Biological Process,GO:0019827,stem cell population maintenance,0.049612798305374795,0.213360763061817,1
3577,Biological Process,GO:0050999,regulation of nitric-oxide synthase activity,0.049585741714918585,0.21283334462246914,1
3578,Phenotype,HP:0003174,Abnormal ischium morphology,0.049578206216387644,0.21268645394600602,1
3579,Disease,MONDO:0031520,familial severe combined immunodeficiency,0.04956983995375308,0.21252336905217814,1
3580,Biological Process,GO:0045913,positive regulation of carbohydrate metabolic process,0.04956006243071298,0.21233277423385305,1
3581,Phenotype,HP:5200005,Abnormal pitch,0.04956004318225149,0.21233239902051876,1
3582,Biological Process,GO:0030261,chromosome condensation,0.04949485600109671,0.21106169488631576,1
3583,Phenotype,HP:0012041,Decreased fertility in males,0.04948858216981833,0.2109393980911253,1
3584,Phenotype,HP:0005750,Lower-limb joint contracture,0.049457992008305696,0.21034309918677865,1
3585,Disease,MONDO:0002515,hepatobiliary disorder,0.04945761432091256,0.2103357368660985,1
3586,Biological Process,GO:0071870,cellular response to catecholamine stimulus,0.04945597061194673,0.210303695784688,1
3586,Biological Process,GO:0071869,response to catecholamine,0.04945597061194673,0.210303695784688,1
3586,Biological Process,GO:0071867,response to monoamine,0.04945597061194673,0.210303695784688,1
3586,Biological Process,GO:0071868,cellular response to monoamine stimulus,0.04945597061194673,0.210303695784688,1
3590,Phenotype,HP:0025568,Abnormal morphology of the choroidal vasculature,0.04944163051756001,0.21002416203435137,1
3591,Phenotype,HP:0003019,Abnormality of the wrist,0.04943278773718207,0.20985178830404058,1
3592,Biological Process,GO:0016042,lipid catabolic process,0.04940779505586823,0.20936460197526058,1
3593,Disease,MONDO:0005552,ocular vascular disorder,0.04938704539699157,0.2089601255605607,1
3594,Phenotype,HP:0002245,Meckel diverticulum,0.04938399317041198,0.20890062802033108,1
3595,Phenotype,HP:0003308,Cervical subluxation,0.04935324808603425,0.2083013091798303,1
3596,Biological Process,GO:0032878,regulation of establishment or maintenance of cell polarity,0.04935027241272094,0.20824330390464774,1
3597,Phenotype,HP:0001806,Onycholysis,0.0493271002635175,0.20779160549907824,1
3598,Biological Process,GO:0009311,oligosaccharide metabolic process,0.049315177840858704,0.20755919980989412,1
3599,Biological Process,GO:0009135,purine nucleoside diphosphate metabolic process,0.049294128903149104,0.2071488895051018,1
3600,Phenotype,HP:0008065,Aplasia/Hypoplasia of the skin,0.04926692517318365,0.20661860285179853,1
3601,Phenotype,HP:0005107,Abnormal sacrum morphology,0.04926239901892471,0.2065303738038938,1
3602,Phenotype,HP:0031505,Abnormal circulating T4 concentration,0.049224158832710696,0.2057849517461512,1
3603,Phenotype,HP:0012599,Abnormal urine phosphate concentration,0.04921530315922873,0.2056123266885042,1
3604,Biological Process,GO:2000278,regulation of DNA biosynthetic process,0.049185425253603365,0.20502991190193245,1
3605,Phenotype,HP:0002346,Head tremor,0.049109746385374464,0.2035546916358201,1
3606,Disease,MONDO:0033885,"mitochondrial complex IV deficiency, nuclear-type",0.04910079834448411,0.20338026604552814,1
3607,Biological Process,GO:0006302,double-strand break repair,0.0490974195493481,0.2033144026522674,1
3608,Biological Process,GO:0042026,protein refolding,0.049086522841948255,0.20310199139445734,1
3609,Phenotype,HP:0006101,Finger syndactyly,0.04906878701600814,0.20275626410657085,1
3610,Phenotype,HP:0012605,Hypernatriuria,0.049061362644332585,0.2026115396436494,1
3611,Biological Process,GO:0002092,positive regulation of receptor internalization,0.04903365172196206,0.20207136620778324,1
3612,Phenotype,HP:0012311,Monocytosis,0.04900596641390709,0.20153169207586144,1
3613,Phenotype,HP:0009748,Large earlobe,0.04899408752189671,0.20130013493655988,1
3614,Phenotype,HP:0000460,Narrow nose,0.04898684865033631,0.20115902645701197,1
3615,Phenotype,HP:0012203,Onychomycosis,0.04898615238029436,0.20114545395387315,1
3616,Biological Process,GO:0051938,L-glutamate import,0.04897790527393342,0.20098469179231915,1
3617,Phenotype,HP:0000253,Progressive microcephaly,0.048927037759807,0.19999312321469354,1
3618,Phenotype,HP:0003713,Muscle fiber necrosis,0.048922514530661654,0.19990495118649532,1
3619,Phenotype,HP:0030766,Ear pain,0.04891053277436652,0.19967138889726108,1
3620,Phenotype,HP:0000415,Abnormal choanae morphology,0.048904814975406996,0.19955993092887372,1
3621,Biological Process,GO:0032648,regulation of interferon-beta production,0.04888201917004886,0.19911556865399196,1
3622,Phenotype,HP:0030345,Abnormal circulating luteinizing hormone concentration,0.048842053313204126,0.19833650782301374,1
3623,Phenotype,HP:0200026,Ocular pain,0.048841503839934686,0.1983257968528085,1
3624,Biological Process,GO:0042775,mitochondrial ATP synthesis coupled electron transport,0.048817092606418755,0.19784994477882428,1
3624,Biological Process,GO:0042773,ATP synthesis coupled electron transport,0.048817092606418755,0.19784994477882428,1
3626,Phenotype,HP:0002311,Incoordination,0.04880056342918204,0.19752773888684386,1
3627,Phenotype,HP:0000618,Blindness,0.04879795031843903,0.19747680110175403,1
3628,Phenotype,HP:0001433,Hepatosplenomegaly,0.04877456687749915,0.19702098395261775,1
3629,Phenotype,HP:0030918,Low 1-minute APGAR score,0.04877355746620882,0.1970013073371082,1
3630,Biological Process,GO:0032006,regulation of TOR signaling,0.04875943208960998,0.19672595911490634,1
3631,Phenotype,HP:0001832,Abnormal metatarsal morphology,0.04875796395001153,0.19669734043521675,1
3632,Biological Process,GO:0032924,activin receptor signaling pathway,0.04872323643392451,0.19602039141731709,1
3633,Biological Process,GO:0051354,negative regulation of oxidoreductase activity,0.04872028979674681,0.19596295214816364,1
3634,Phenotype,HP:0002236,Frontal upsweep of hair,0.04871492118342913,0.19585830091126608,1
3635,Phenotype,HP:0001029,Poikiloderma,0.048711077450604545,0.19578337441338037,1
3636,Phenotype,HP:0002253,Colonic diverticula,0.048687655572991484,0.1953268080120346,1
3637,Phenotype,HP:0032158,Unusual infection by anatomical site,0.04864505836727573,0.1944964538772242,1
3638,Phenotype,HP:0001262,Excessive daytime somnolence,0.04864221714444772,0.19444106946682654,1
3639,Phenotype,HP:0009004,Hypoplasia of the musculature,0.04862913366404553,0.19418603109360177,1
3640,Phenotype,HP:0032243,Abnormal tissue metabolite concentration,0.048626646616123925,0.19413755067122482,1
3641,Phenotype,HP:0004691,2-3 toe syndactyly,0.048606133089396875,0.1937376772182333,1
3642,Biological Process,GO:0010560,positive regulation of glycoprotein biosynthetic process,0.04857613657374771,0.19315295034752267,1
3643,Biological Process,GO:0006473,protein acetylation,0.04856012156845513,0.19284076729137478,1
3644,Phenotype,HP:0002191,Progressive spasticity,0.04855104278377287,0.1926637930914643,1
3645,Phenotype,HP:0045027,Abnormality of the thoracic cavity,0.04854950561129312,0.19263382874279336,1
3646,Biological Process,GO:0033700,phospholipid efflux,0.048541153895757305,0.19247102741788488,1
3647,Phenotype,HP:0002072,Chorea,0.04846871221506588,0.19105891016549684,1
3648,Phenotype,HP:0005113,Aortic arch aneurysm,0.04841510523802861,0.19001394079979222,1
3649,Phenotype,HP:0010729,Cherry red spot of the macula,0.04841464090125969,0.1900048894089899,1
3650,Biological Process,GO:0061448,connective tissue development,0.04840562033190854,0.18982905000982717,1
3651,Phenotype,HP:0003175,Hypoplastic ischia,0.04839857890286503,0.18969179030879735,1
3652,Biological Process,GO:0071364,cellular response to epidermal growth factor stimulus,0.04839144187412159,0.18955266706754711,1
3653,Phenotype,HP:0030724,Central nervous system cyst,0.04836769018598441,0.18908967161697615,1
3654,Biological Process,GO:0007093,mitotic cell cycle checkpoint signaling,0.04835070788085716,0.18875863283065003,1
3655,Phenotype,HP:0003701,Proximal muscle weakness,0.04833514346830281,0.18845523325071897,1
3656,Biological Process,GO:0097035,regulation of membrane lipid distribution,0.04833502562921832,0.18845293619462328,1
3657,Phenotype,HP:0007479,Congenital nonbullous ichthyosiform erythroderma,0.04833413696143818,0.18843561325164349,1
3658,Disease,MONDO:0800064,osteogenesis imperfecta and a reduction of bone mineral density.,0.048283087544090275,0.18744049880546715,1
3659,Phenotype,HP:0012189,Hodgkin lymphoma,0.04828298357284255,0.18743847207732858,1
3660,Biological Process,GO:0019080,viral gene expression,0.0482488940142598,0.18677395886695672,1
3661,Phenotype,HP:0012681,Abnormal pineal morphology,0.04824707054520894,0.18673841369349653,1
3662,Phenotype,HP:0002797,Osteolysis,0.04819040158037102,0.18563375651052122,1
3663,Phenotype,HP:0002875,Exertional dyspnea,0.048178267916255346,0.1853972330578778,1
3664,Biological Process,GO:0007224,smoothened signaling pathway,0.04817822755305656,0.18539644625159696,1
3665,Disease,MONDO:0002305,thrombophilia,0.048159517519009154,0.18503172856947062,1
3666,Phenotype,HP:0001548,Overgrowth,0.04815847885782898,0.1850114817811864,1
3667,Phenotype,HP:0100783,Breast aplasia,0.04809744752484657,0.18382178825919587,1
3668,Biological Process,GO:1902548,negative regulation of cellular response to vascular endothelial growth factor stimulus,0.048092215590634035,0.18371980132992582,1
3669,Phenotype,HP:0100598,Pulmonary edema,0.04809139223090453,0.18370375144720827,1
3670,Phenotype,HP:0030347,Abnormal circulating androgen level,0.048065503371261586,0.18319909577111795,1
3671,Phenotype,HP:0005404,Increased B cell count,0.048062960072516536,0.18314951884245503,1
3672,Phenotype,HP:0100323,Juvenile aseptic necrosis,0.048050492310008686,0.18290648275648944,1
3673,Biological Process,GO:0030323,respiratory tube development,0.048045738131141214,0.18281380878846967,1
3673,Biological Process,GO:0030324,lung development,0.048045738131141214,0.18281380878846967,1
3675,Biological Process,GO:1904030,negative regulation of cyclin-dependent protein kinase activity,0.048032605240322046,0.18255780725009468,1
3676,Phenotype,HP:0012240,Increased intramyocellular lipid droplets,0.048029462910442744,0.18249655331185216,1
3677,Phenotype,HP:0008320,Impaired collagen-induced platelet aggregation,0.048026496195369583,0.18243872266107566,1
3678,Biological Process,GO:0045762,positive regulation of adenylate cyclase activity,0.04800080720057509,0.18193796298239936,1
3679,Phenotype,HP:0001621,Weak voice,0.04798583929624556,0.18164619123257125,1
3680,Phenotype,HP:0100716,Self-injurious behavior,0.047969097970331775,0.1813198498925435,1
3681,Phenotype,HP:0000055,Abnormal female external genitalia morphology,0.04795357806579237,0.18101731791445666,1
3682,Biological Process,GO:1901881,positive regulation of protein depolymerization,0.047948204063068545,0.1809125616210043,1
3683,Phenotype,HP:0004416,Precocious atherosclerosis,0.04788794741873581,0.1797379692285982,1
3684,Phenotype,HP:0025454,Abnormal CSF metabolite concentration,0.04783102970449937,0.1786284631338662,1
3685,Phenotype,HP:0430046,Small joint hypermobilty,0.047830135066004975,0.17861102380279975,1
3686,Phenotype,HP:0002157,Azotemia,0.047825555859472346,0.17852176059845032,1
3687,Biological Process,GO:0002065,columnar/cuboidal epithelial cell differentiation,0.047791250516953654,0.17785304107734928,1
3688,Biological Process,GO:0019884,antigen processing and presentation of exogenous antigen,0.047725607284571314,0.17657344706372516,1
3689,Phenotype,HP:0011900,Hypofibrinogenemia,0.04768717671936773,0.17582431391793074,1
3690,Biological Process,GO:0006801,superoxide metabolic process,0.04766995023235987,0.17548851525520429,1
3691,Biological Process,GO:0006414,translational elongation,0.04766325158622431,0.1753579374761497,1
3692,Phenotype,HP:0500022,Abnormal circulating dehydroepiandrosterone concentration,0.04763381631341612,0.1747841510017822,1
3693,Phenotype,HP:0002282,Gray matter heterotopia,0.04761490264112689,0.17441546376688208,1
3694,Phenotype,HP:0009098,Chronic oral candidiasis,0.047608859149362304,0.17429765701662475,1
3695,Phenotype,HP:0011081,Incisor macrodontia,0.047592013573588665,0.17396928351742763,1
3696,Disease,MONDO:0000508,syndromic intellectual disability,0.047578555383197885,0.17370694086254507,1
3697,Phenotype,HP:0004188,Abnormal 4th finger morphology,0.047557204904561834,0.17329075257231014,1
3698,Phenotype,HP:0000384,Preauricular skin tag,0.047549090694992246,0.17313258098913673,1
3699,Biological Process,GO:0071637,regulation of monocyte chemotactic protein-1 production,0.047547597651795726,0.1731034768596322,1
3700,Biological Process,GO:0002708,positive regulation of lymphocyte mediated immunity,0.04751620426622316,0.17249152058039122,1
3701,Biological Process,GO:1903020,positive regulation of glycoprotein metabolic process,0.04751000070195166,0.1723705935111892,1
3702,Phenotype,HP:0012135,Abnormal granulocytopoietic cell morphology,0.047504859695866264,0.17227037905842485,1
3703,Disease,MONDO:0019065,amyloidosis,0.047490290864506624,0.17198638650174036,1
3703,Disease,MONDO:0018634,hereditary amyloidosis,0.047490290864506624,0.17198638650174036,1
3705,Biological Process,GO:0046488,phosphatidylinositol metabolic process,0.04747289600835558,0.17164730579241327,1
3706,Biological Process,GO:0018210,peptidyl-threonine modification,0.047449741630366526,0.17119595380396435,1
3707,Biological Process,GO:1904262,negative regulation of TORC1 signaling,0.047445706364865226,0.17111729372901902,1
3708,Phenotype,HP:0025066,Decreased mean corpuscular volume,0.04743857967976506,0.1709783721180593,1
3709,Phenotype,HP:0031221,Abnormal radioactive iodine uptake test result,0.04739109153133092,0.17005267805563887,1
3709,Phenotype,HP:0031219,Reduced radioactive iodine uptake,0.04739109153133092,0.17005267805563887,1
3711,Phenotype,HP:0000349,Widow's peak,0.04737446510856125,0.16972857654095203,1
3712,Phenotype,HP:0030532,Visual acuity test abnormality,0.04737031649221146,0.16964770689981234,1
3713,Biological Process,GO:0071493,cellular response to UV-B,0.04736286585067995,0.16950247035439275,1
3714,Phenotype,HP:0000742,Self-mutilation,0.047347859051286356,0.1692099404168685,1
3715,Phenotype,HP:0000764,Peripheral axonal degeneration,0.04733282602873379,0.1689168993071178,1
3716,Phenotype,HP:0000830,Anterior hypopituitarism,0.04728922732618346,0.16806702283454805,1
3717,Biological Process,GO:0030511,positive regulation of transforming growth factor beta receptor signaling pathway,0.04728515258823629,0.16798759331691074,1
3717,Biological Process,GO:1903846,positive regulation of cellular response to transforming growth factor beta stimulus,0.04728515258823629,0.16798759331691074,1
3719,Phenotype,HP:0100502,Decreased circulating vitamin B12 concentration,0.04726445943661828,0.16758421840722929,1
3720,Disease,MONDO:0044348,hemoglobinopathy,0.04726155151670164,0.16752753385982982,1
3720,Disease,MONDO:0044347,erythrocyte disorder,0.04726155151670164,0.16752753385982982,1
3720,Disease,MONDO:0019050,inherited hemoglobinopathy,0.04726155151670164,0.16752753385982982,1
3723,Biological Process,GO:0034311,diol metabolic process,0.04724768812389801,0.16725729252959315,1
3724,Phenotype,HP:0009183,Joint contracture of the 5th finger,0.04723596729445467,0.16702881652915716,1
3725,Phenotype,HP:0007874,Almond-shaped palpebral fissure,0.04722582381055063,0.16683108797725846,1
3726,Phenotype,HP:0004866,Impaired ADP-induced platelet aggregation,0.047221108524376665,0.1667391721507254,1
3727,Phenotype,HP:0025474,Erythematous plaque,0.047202179782680265,0.16637019116546442,1
3728,Biological Process,GO:1903140,regulation of establishment of endothelial barrier,0.04711353839989885,0.16464229053275606,1
3728,Biological Process,GO:1901550,regulation of endothelial cell development,0.04711353839989885,0.16464229053275606,1
3730,Phenotype,HP:0005317,Increased pulmonary vascular resistance,0.04710710585061195,0.16451689982207457,1
3731,Phenotype,HP:0002583,Colitis,0.047094646173265864,0.1642740213414586,1
3732,Biological Process,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,0.04707342311478235,0.1638603168726092,1
3733,Phenotype,HP:0002061,Lower limb spasticity,0.04706526642563469,0.1637013172282353,1
3734,Phenotype,HP:0100842,Septo-optic dysplasia,0.047061585665107875,0.16362956757538058,1
3735,Phenotype,HP:0003431,Decreased motor nerve conduction velocity,0.047052606620115456,0.163454537617175,1
3736,Phenotype,HP:0001848,Calcaneovalgus deformity,0.04704053001195174,0.16321912636531638,1
3737,Biological Process,GO:0005996,monosaccharide metabolic process,0.04703792872281154,0.1631684190206183,1
3738,Phenotype,HP:0000475,Broad neck,0.04701964224502908,0.1628119577884167,1
3739,Biological Process,GO:2001135,regulation of endocytic recycling,0.04700695620239925,0.16256466673316886,1
3740,Phenotype,HP:0002722,Recurrent abscess formation,0.04700679087070958,0.16256144389613464,1
3741,Biological Process,GO:0051898,negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,0.046991364307477856,0.1622607314350673,1
3742,Phenotype,HP:0032231,Hypochromia,0.04691126459160322,0.16069933487968147,1
3743,Biological Process,GO:0061077,chaperone-mediated protein folding,0.04690313586075501,0.16054088023090443,1
3744,Biological Process,GO:1900027,regulation of ruffle assembly,0.04689094355822576,0.16030321373029935,1
3745,Phenotype,HP:0002505,Loss of ambulation,0.04686561476354856,0.15980947549004193,1
3746,Phenotype,HP:0020216,Visually-induced seizure,0.04685907772091302,0.1596820478738253,1
3747,Phenotype,HP:0009714,Abnormal epididymis morphology,0.04685458215550509,0.15959441509927902,1
3748,Biological Process,GO:0009119,ribonucleoside metabolic process,0.046840895515960934,0.15932761924856098,1
3749,Phenotype,HP:0012514,Lower limb pain,0.046798610472731816,0.15850335014696243,1
3750,Phenotype,HP:0031869,Recurrent joint dislocation,0.046796647641425104,0.15846508836278955,1
3751,Phenotype,HP:0009755,Ankyloblepharon,0.046794625663310274,0.15842567362043888,1
3752,Phenotype,HP:0003251,Male infertility,0.04679319520504688,0.15839778946903207,1
3753,Biological Process,GO:0010640,regulation of platelet-derived growth factor receptor signaling pathway,0.04678428115923283,0.15822402655019244,1
3754,Phenotype,HP:0004311,Abnormal macrophage morphology,0.046757594123917334,0.15770381190822924,1
3755,Phenotype,HP:0000704,Periodontitis,0.04672058811916002,0.15698244794675037,1
3756,Phenotype,HP:0005920,Abnormal epiphysis morphology of the phalanges of the hand,0.04670576254917502,0.15669345074303445,1
3757,Biological Process,GO:0034067,protein localization to Golgi apparatus,0.04662877499232776,0.15519272000065548,1
3758,Biological Process,GO:1900368,regulation of post-transcriptional gene silencing by regulatory ncRNA,0.046619305957835144,0.1550081385988595,1
3758,Biological Process,GO:0060964,regulation of miRNA-mediated gene silencing,0.046619305957835144,0.1550081385988595,1
3758,Biological Process,GO:0060966,regulation of gene silencing by regulatory ncRNA,0.046619305957835144,0.1550081385988595,1
3758,Biological Process,GO:0060147,regulation of post-transcriptional gene silencing,0.046619305957835144,0.1550081385988595,1
3762,Phenotype,HP:0012880,Abnormal labia minora morphology,0.04660588116746933,0.15474644701599843,1
3763,Phenotype,HP:0045081,Abnormality of body mass index,0.04660504708050128,0.15473018802550662,1
3764,Phenotype,HP:0001997,Gout,0.04659303753571176,0.15449608405071266,1
3765,Biological Process,GO:0035307,positive regulation of protein dephosphorylation,0.04657587383533335,0.15416150929778263,1
3766,Biological Process,GO:0051004,regulation of lipoprotein lipase activity,0.04655992256691355,0.15385056867467617,1
3767,Phenotype,HP:0000232,Everted lower lip vermilion,0.04655458458630912,0.15374651456615085,1
3768,Phenotype,HP:0001922,Vacuolated lymphocytes,0.046552471299135645,0.15370531992173572,1
3769,Biological Process,GO:0051656,establishment of organelle localization,0.04652709105089847,0.1532105786890155,1
3770,Biological Process,GO:0046641,positive regulation of alpha-beta T cell proliferation,0.04651015298738603,0.1528804023115534,1
3771,Phenotype,HP:0010576,Intracranial cystic lesion,0.04648476951200198,0.1523855981715435,1
3772,Phenotype,HP:0012725,Cutaneous syndactyly,0.04648256930356953,0.15234270915714393,1
3773,Biological Process,GO:0086001,cardiac muscle cell action potential,0.04642348502333726,0.15119096984540276,1
3774,Biological Process,GO:0006687,glycosphingolipid metabolic process,0.0464089193674555,0.1509070391888158,1
3775,Biological Process,GO:1902916,positive regulation of protein polyubiquitination,0.046391710817843546,0.1505715901826127,1
3776,Phenotype,HP:0000775,Abnormality of the diaphragm,0.04634196884978492,0.1496019620542632,1
3777,Phenotype,HP:0004491,Large posterior fontanelle,0.046330194678135594,0.1493724462456859,1
3778,Disease,MONDO:0037858,inherited fatty acid metabolism disorder,0.046313679946785924,0.14905052194968896,1
3779,Phenotype,HP:0005855,Multiple prenatal fractures,0.04629843327244365,0.14875331609147627,1
3780,Phenotype,HP:0002990,Fibular aplasia,0.046293998838791484,0.1486668749680094,1
3781,Biological Process,GO:1903556,negative regulation of tumor necrosis factor superfamily cytokine production,0.046283397451361785,0.148460220429547,1
3782,Phenotype,HP:0000524,Conjunctival telangiectasia,0.046248014844133545,0.1477705016153978,1
3783,Biological Process,GO:0007005,mitochondrion organization,0.04623557767973552,0.14752806198327423,1
3784,Phenotype,HP:0012411,Premature pubarche,0.046232065326428096,0.14745959511924578,1
3785,Phenotype,HP:0001944,Dehydration,0.04621713124638782,0.14716848271169072,1
3786,Phenotype,HP:0001539,Omphalocele,0.04621502595559601,0.14712744394202068,1
3787,Biological Process,GO:0006650,glycerophospholipid metabolic process,0.04619269787266733,0.14669219905516273,1
3788,Phenotype,HP:0100555,Asymmetric growth,0.04618313702434207,0.14650582791166208,1
3789,Phenotype,HP:0500184,Abnormal CSF amino acid concentration,0.046154053128279915,0.1459388908803283,1
3790,Disease,MONDO:0016537,lymphoproliferative syndrome,0.046077938630873616,0.14445517882508052,1
3791,Phenotype,HP:0031593,Abnormal PR interval,0.046071545602313635,0.14433055849824117,1
3792,Phenotype,HP:0100518,Dysuria,0.04605580772055684,0.14402377745543962,1
3793,Biological Process,GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway,0.0460480209769093,0.14387198921778876,1
3794,Phenotype,HP:0011723,Congenital malformation of the right heart,0.046045635159152276,0.14382548209117893,1
3795,Biological Process,GO:0006575,cellular modified amino acid metabolic process,0.046020738830912955,0.14334017398827043,1
3796,Biological Process,GO:0018107,peptidyl-threonine phosphorylation,0.0460168092189136,0.14326357343391394,1
3797,Phenotype,HP:0012043,Pendular nystagmus,0.0459770607596125,0.14248875036797734,1
3798,Phenotype,HP:0008119,Deformed tarsal bones,0.04592159057302059,0.14140746116082492,1
3799,Phenotype,HP:0031705,Compensatory head posture,0.04591864284191649,0.14135000056758956,1
3800,Biological Process,GO:0098813,nuclear chromosome segregation,0.045881685758042634,0.14062959022870575,1
3801,Biological Process,GO:1903861,positive regulation of dendrite extension,0.04585910215998312,0.14018936454459063,1
3802,Phenotype,HP:0006145,Central Y-shaped metacarpal,0.04585058198922154,0.1400232794950599,1
3803,Biological Process,GO:0042398,cellular modified amino acid biosynthetic process,0.04582525067868726,0.13952949221279862,1
3804,Phenotype,HP:0100338,Non-midline cleft palate,0.0458006869341554,0.13905066721722126,1
3805,Disease,MONDO:0020683,acute disease,0.045753157767311814,0.13812417357639387,1
3806,Phenotype,HP:0008282,Unconjugated hyperbilirubinemia,0.045749371177359,0.13805036097363463,1
3807,Biological Process,GO:0006284,base-excision repair,0.045747566173104603,0.1380151757374013,1
3808,Phenotype,HP:0006725,Pancreatic adenocarcinoma,0.04574607684863885,0.13798614409770962,1
3809,Phenotype,HP:0100769,Synovitis,0.04573387302155907,0.1377482529472002,1
3810,Biological Process,GO:0045814,"negative regulation of gene expression, epigenetic",0.045722659805059296,0.1375296719269511,1
3811,Biological Process,GO:0000281,mitotic cytokinesis,0.04567272020287927,0.1365561912851062,1
3812,Phenotype,HP:0008322,Abnormal mitochondrial morphology,0.045656517428187104,0.136240348010061,1
3813,Biological Process,GO:0030851,granulocyte differentiation,0.04565033926524331,0.13611991609299715,1
3814,Phenotype,HP:0002696,Abnormal parietal bone morphology,0.04563896762052133,0.1358982468061078,1
3815,Biological Process,GO:0043299,leukocyte degranulation,0.04560633507567413,0.13526213539720297,1
3816,Phenotype,HP:0003270,Abdominal distention,0.04560251937451121,0.1351877553249753,1
3817,Phenotype,HP:0006385,Short lower limbs,0.04560183246619853,0.13517436531152063,1
3818,Biological Process,GO:0090161,Golgi ribbon formation,0.04560013871525559,0.13514134875385728,1
3819,Biological Process,GO:0042176,regulation of protein catabolic process,0.04559423491032666,0.1350262649413987,1
3820,Biological Process,GO:0006813,potassium ion transport,0.04557122648157763,0.1345777579647972,1
3821,Disease,MONDO:0003037,hypotrichosis,0.045567337500936334,0.1345019494439931,1
3822,Phenotype,HP:0000400,Macrotia,0.04556673873571637,0.13449027761792326,1
3823,Disease,MONDO:0015127,pituitary deficiency,0.04556670253814221,0.13448957201282855,1
3824,Phenotype,HP:0004432,Agammaglobulinemia,0.04555207775022896,0.13420448868610688,1
3825,Phenotype,HP:0000540,Hypermetropia,0.04553776561394085,0.1339254999274521,1
3826,Phenotype,HP:0003687,Centrally nucleated skeletal muscle fibers,0.04553029755216609,0.13377992380644846,1
3827,Phenotype,HP:0002575,Tracheoesophageal fistula,0.04552969270315521,0.1337681333880706,1
3828,Biological Process,GO:0002712,regulation of B cell mediated immunity,0.04551263082147883,0.133435543403362,1
3829,Phenotype,HP:0200040,Epidermoid cyst,0.04550678753021864,0.13332163919351372,1
3830,Biological Process,GO:1903317,regulation of protein maturation,0.04545250815303692,0.1322635626243949,1
3831,Phenotype,HP:0000601,Hypotelorism,0.045451707950175835,0.13224796414221224,1
3832,Biological Process,GO:1903083,protein localization to condensed chromosome,0.04543574531261352,0.13193680189859477,1
3832,Biological Process,GO:0034501,protein localization to kinetochore,0.04543574531261352,0.13193680189859477,1
3834,Disease,MONDO:0000761,syndrome caused by partial chromosomal deletion,0.04542965251484565,0.13181803401854017,1
3835,Biological Process,GO:1901381,positive regulation of potassium ion transmembrane transport,0.04541702143358284,0.13157181433399814,1
3836,Biological Process,GO:0010830,regulation of myotube differentiation,0.04540784949809151,0.13139302433048813,1
3837,Phenotype,HP:0002823,Abnormal femur morphology,0.04540692947320624,0.13137509013844947,1
3838,Phenotype,HP:0002070,Limb ataxia,0.045374419810388145,0.13074137408856523,1
3839,Phenotype,HP:0033345,Neuralgia,0.04537265472931651,0.13070696708131013,1
3839,Phenotype,HP:0100661,Trigeminal neuralgia,0.04537265472931651,0.13070696708131013,1
3839,Phenotype,HP:0031911,Abnormal fifth cranial nerve physiology,0.04537265472931651,0.13070696708131013,1
3842,Biological Process,GO:0002064,epithelial cell development,0.045345373297992486,0.1301751657830135,1
3843,Phenotype,HP:0000533,Chorioretinal atrophy,0.04534535239345283,0.13017475828748307,1
3844,Biological Process,GO:0035278,miRNA-mediated gene silencing by inhibition of translation,0.045344760753858404,0.13016322536236988,1
3845,Phenotype,HP:0000581,Blepharophimosis,0.045342532902633126,0.1301197975025944,1
3846,Biological Process,GO:0000910,cytokinesis,0.045340772821594766,0.13008548796178657,1
3847,Biological Process,GO:1901699,cellular response to nitrogen compound,0.045322458916367436,0.12972849208202128,1
3848,Phenotype,HP:0010579,Cone-shaped epiphysis,0.045306614478698215,0.12941963392779926,1
3849,Biological Process,GO:1901889,negative regulation of cell junction assembly,0.045302888985711,0.12934701229794907,1
3850,Phenotype,HP:0001817,Absent fingernail,0.045277642624758085,0.1288548809514459,1
3851,Phenotype,HP:0011421,Death in adolescence,0.0452748429152624,0.12880030576706597,1
3852,Biological Process,GO:0031667,response to nutrient levels,0.045268046212960544,0.12866781656349982,1
3853,Phenotype,HP:5201016,Submucous cleft palate,0.04526390631082877,0.12858711679000373,1
3854,Phenotype,HP:0010622,Neoplasm of the skeletal system,0.04526106108208405,0.1285316542916318,1
3855,Phenotype,HP:0040129,Abnormal nerve conduction velocity,0.045251552871325984,0.12834630922063597,1
3856,Phenotype,HP:0005227,Adenomatous colonic polyposis,0.04522351138012426,0.12779969195374352,1
3857,Biological Process,GO:0070536,protein K63-linked deubiquitination,0.045208910757198906,0.1275150796789907,1
3858,Biological Process,GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,0.045197186477272666,0.12728653641774043,1
3859,Biological Process,GO:0097352,autophagosome maturation,0.045197126720155856,0.1272853715627178,1
3860,Biological Process,GO:0045911,positive regulation of DNA recombination,0.04519443371242893,0.12723287633295902,1
3861,Biological Process,GO:0048661,positive regulation of smooth muscle cell proliferation,0.04516928452140856,0.1267426391354713,1
3862,Phenotype,HP:0025335,Delayed ability to stand,0.0451283803879069,0.12594528832775437,1
3863,Biological Process,GO:0030513,positive regulation of BMP signaling pathway,0.04509157496144578,0.1252278342710404,1
3864,Biological Process,GO:0051290,protein heterotetramerization,0.045088045334493065,0.12515903068908524,1
3865,Phenotype,HP:0001171,Split hand,0.045084082909029655,0.12508179049663282,1
3866,Phenotype,HP:0040063,Decreased adipose tissue,0.0450823999927612,0.12504898514100984,1
3867,Phenotype,HP:0000426,Prominent nasal bridge,0.04506772510389967,0.12476292518850106,1
3868,Phenotype,HP:0004757,Paroxysmal atrial fibrillation,0.04505488035220595,0.12451254039212115,1
3869,Phenotype,HP:0011450,Unusual CNS infection,0.04502420601351642,0.12391460060862018,1
3870,Biological Process,GO:0007040,lysosome organization,0.04501566876054863,0.12374818257291546,1
3870,Biological Process,GO:0080171,lytic vacuole organization,0.04501566876054863,0.12374818257291546,1
3872,Biological Process,GO:0070293,renal absorption,0.0450107552340816,0.12365240241668585,1
3873,Phenotype,HP:0000026,Male hypogonadism,0.0449942131852189,0.12332994561604416,1
3874,Biological Process,GO:0036297,interstrand cross-link repair,0.0449835921578966,0.12312290823401834,1
3875,Biological Process,GO:0009123,nucleoside monophosphate metabolic process,0.04498194276639422,0.12309075638201517,1
3876,Phenotype,HP:0003134,Abnormality of peripheral nerve conduction,0.044951576188921094,0.12249881583706233,1
3877,Biological Process,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,0.0449346068588532,0.12216802997564073,1
3877,Biological Process,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,0.0449346068588532,0.12216802997564073,1
3879,Phenotype,HP:0008245,Pituitary hypothyroidism,0.04488344147940393,0.12117065506170055,1
3880,Biological Process,GO:0051606,detection of stimulus,0.04481046693103319,0.11974815053452792,1
3881,Phenotype,HP:0011822,Broad chin,0.04481006220824146,0.11974026120850491,1
3882,Disease,MONDO:0005497,bone development disease,0.04480627421886341,0.1196664213265259,1
3883,Phenotype,HP:0009623,Proximal placement of thumb,0.044796748884839976,0.11948074246898337,1
3884,Phenotype,HP:0003045,Abnormal patella morphology,0.04476721926600402,0.11890511689242728,1
3885,Phenotype,HP:0000180,Lobulated tongue,0.04475532144398653,0.11867319074747339,1
3886,Biological Process,GO:0060765,regulation of androgen receptor signaling pathway,0.04475075979529508,0.11858426980092653,1
3887,Phenotype,HP:0010522,Dyslexia,0.04474175259560942,0.11840869101878856,1
3888,Phenotype,HP:0004942,Aortic aneurysm,0.04474052581669441,0.11838477722145234,1
3889,Biological Process,GO:0032092,positive regulation of protein binding,0.04472534261873384,0.11808880871848694,1
3890,Phenotype,HP:0030612,Abnormal retinal morphology on macular OCT,0.04469053925982769,0.11741038128439996,1
3890,Phenotype,HP:0030603,Abnormal optical coherence tomography,0.04469053925982769,0.11741038128439996,1
3892,Phenotype,HP:0012091,Abnormality of pancreas physiology,0.04465662754094202,0.1167493347316485,1
3893,Phenotype,HP:0006505,Abnormal limb epiphysis morphology,0.044607399378945645,0.11578972230693763,1
3894,Phenotype,HP:0008935,Generalized neonatal hypotonia,0.04460679580129323,0.11577795667135332,1
3895,Phenotype,HP:0009775,Amniotic constriction ring,0.0446021113903573,0.11568664270076673,1
3896,Phenotype,HP:0009020,Exercise-induced muscle fatigue,0.04459390879891778,0.11552674827568599,1
3897,Phenotype,HP:0001050,Plethora,0.044584791743645824,0.11534902806105782,1
3898,Phenotype,HP:0000847,Abnormality of renin-angiotensin system,0.04458154044872753,0.11528565004990592,1
3899,Disease,MONDO:0800066,polydactyly-syndactyly-triphalangism,0.04457706295388386,0.1151983695277552,1
3900,Phenotype,HP:0000300,Oval face,0.044546264863773444,0.11459801743804078,1
3901,Phenotype,HP:0001993,Ketoacidosis,0.04454338726299312,0.11454192390640817,1
3902,Phenotype,HP:0100010,Spinal meningioma,0.044523431129269486,0.11415291580426129,1
3902,Phenotype,HP:0100009,Intracranial meningioma,0.044523431129269486,0.11415291580426129,1
3902,Phenotype,HP:0011752,Neoplasm of the posterior pituitary,0.044523431129269486,0.11415291580426129,1
3902,Phenotype,HP:0030591,Abnormal kinetic perimetry test,0.044523431129269486,0.11415291580426129,1
3902,Phenotype,HP:0012691,Focal T2 hypointense thalamic lesion,0.044523431129269486,0.11415291580426129,1
3907,Biological Process,GO:0048385,regulation of retinoic acid receptor signaling pathway,0.04452000372340015,0.11408610483421154,1
3908,Biological Process,GO:0042733,embryonic digit morphogenesis,0.044518597861690656,0.11405870014735867,1
3909,Phenotype,HP:0000058,Abnormal labia morphology,0.044506153225626566,0.11381611486885515,1
3910,Disease,MONDO:0100172,"intellectual disability, autosomal dominant",0.04450104308151792,0.11371650201353303,1
3911,Biological Process,GO:0086069,bundle of His cell to Purkinje myocyte communication,0.04443773620464986,0.1124824509511206,1
3912,Biological Process,GO:0072527,pyrimidine-containing compound metabolic process,0.04442472750962945,0.11222887038128782,1
3913,Phenotype,HP:0100257,Ectrodactyly,0.04442036826793272,0.11214389498661828,1
3914,Biological Process,GO:1901018,positive regulation of potassium ion transmembrane transporter activity,0.044418061794169406,0.11209893452515095,1
3915,Phenotype,HP:0002495,Impaired vibratory sensation,0.04441554681290649,0.11204990959369028,1
3916,Biological Process,GO:0016525,negative regulation of angiogenesis,0.04438585396055317,0.1114711020801078,1
3917,Phenotype,HP:0007103,Hypointensity of cerebral white matter on MRI,0.04437092781951779,0.11118014442884329,1
3918,Biological Process,GO:0045732,positive regulation of protein catabolic process,0.044365901492832704,0.11108216543994623,1
3919,Biological Process,GO:0051028,mRNA transport,0.044364901812903534,0.11106267851941411,1
3920,Phenotype,HP:0034242,Abnormal fetal genitourinary system morphology,0.044361967964523075,0.111005488544328,1
3921,Phenotype,HP:0002699,Abnormal foramen magnum morphology,0.04436168470666102,0.11099996695357991,1
3922,Biological Process,GO:0006098,pentose-phosphate shunt,0.044338220633391545,0.11054257802556401,1
3923,Biological Process,GO:0030833,regulation of actin filament polymerization,0.04433398253174825,0.110459964033305,1
3924,Phenotype,HP:0002789,Tachypnea,0.04431012911793386,0.10999498562786007,1
3925,Phenotype,HP:0040078,Axonal degeneration,0.04429513148645792,0.10970263440201883,1
3926,Phenotype,HP:0001558,Decreased fetal movement,0.04429308816884281,0.10966280368538081,1
3927,Biological Process,GO:0018394,peptidyl-lysine acetylation,0.04429024972640294,0.10960747347353329,1
3928,Biological Process,GO:0009790,embryo development,0.044283035247071556,0.10946684047560158,1
3929,Phenotype,HP:0010026,Aplasia/Hypoplasia of the 1st metacarpal,0.044255392583460895,0.10892799761864407,1
3930,Phenotype,HP:0001530,Mild postnatal growth retardation,0.04424716362970493,0.10876758930871824,1
3931,Phenotype,HP:0001716,Wolff-Parkinson-White syndrome,0.04421389132227249,0.1081190069055539,1
3932,Biological Process,GO:0032479,regulation of type I interferon production,0.04418444193929061,0.10754494537931682,1
3933,Phenotype,HP:0007924,Slow decrease in visual acuity,0.044177058178871964,0.10740101255811295,1
3934,Phenotype,HP:0006264,Aplasia/Hypoplasia of the 2nd finger,0.044171852824057445,0.10729954374529378,1
3935,Phenotype,HP:0006897,Abducens palsy,0.04416382815054354,0.10714311750275479,1
3936,Biological Process,GO:0031507,heterochromatin formation,0.04416334755187701,0.10713374911618502,1
3937,Phenotype,HP:0000212,Gingival overgrowth,0.044158573180155924,0.10704068152564451,1
3938,Disease,MONDO:0015134,constitutional neutropenia,0.0441497469527381,0.10686863046482913,1
3938,Disease,MONDO:0001609,agranulocytosis,0.0441497469527381,0.10686863046482913,1
3938,Disease,MONDO:0003785,leukopenia,0.0441497469527381,0.10686863046482913,1
3938,Disease,MONDO:0001475,neutropenia,0.0441497469527381,0.10686863046482913,1
3942,Phenotype,HP:0002857,Genu valgum,0.044141548340424275,0.10670881360548112,1
3943,Biological Process,GO:0032682,negative regulation of chemokine production,0.044123017572189394,0.10634759038047142,1
3944,Biological Process,GO:0030521,androgen receptor signaling pathway,0.04411331775341165,0.10615851026374372,1
3945,Phenotype,HP:0012735,Cough,0.044110810313539806,0.10610963233782367,1
3946,Phenotype,HP:0045039,Osteolysis involving bones of the upper limbs,0.04409889845105075,0.10587743249971499,1
3947,Biological Process,GO:0040036,regulation of fibroblast growth factor receptor signaling pathway,0.04409200944199154,0.10574314394578424,1
3948,Biological Process,GO:0034312,diol biosynthetic process,0.044071743889374404,0.10534810429172463,1
3949,Phenotype,HP:0005306,Capillary hemangioma,0.044063991322381146,0.10519698226505457,1
3950,Phenotype,HP:0002063,Rigidity,0.04403937122878587,0.10471705884818376,1
3951,Biological Process,GO:0001919,regulation of receptor recycling,0.04400047080985514,0.10395876676863916,1
3952,Phenotype,HP:0032368,Acidemia,0.04398880197229871,0.10373130425435899,1
3953,Biological Process,GO:1903038,negative regulation of leukocyte cell-cell adhesion,0.043984488346790473,0.10364721806333775,1
3954,Phenotype,HP:0001985,Hypoketotic hypoglycemia,0.04398214997879668,0.10360163588254141,1
3955,Biological Process,GO:0042692,muscle cell differentiation,0.04395184535178198,0.10301090294776973,1
3956,Disease,MONDO:0005336,myopathy,0.043926093059343696,0.10250890939801281,1
3957,Phenotype,HP:0010702,Increased circulating antibody level,0.04391572569393243,0.1023068166881346,1
3958,Biological Process,GO:0030149,sphingolipid catabolic process,0.04388780204046372,0.10176249645099335,1
3959,Phenotype,HP:0000527,Long eyelashes,0.04388110404237788,0.10163193130447555,1
3960,Biological Process,GO:0098739,import across plasma membrane,0.04388103808928112,0.10163064567022609,1
3961,Phenotype,HP:0009914,Cyclopia,0.043873291897176925,0.10147964791028673,1
3962,Biological Process,GO:0045927,positive regulation of growth,0.043861326844709225,0.10124641123142863,1
3963,Phenotype,HP:0500183,Abnormal CSF carboxylic acid concentration,0.04383709899810129,0.10077413394773319,1
3964,Biological Process,GO:0002701,negative regulation of production of molecular mediator of immune response,0.04382347753532834,0.10050860859822648,1
3965,Phenotype,HP:0000859,Hyperaldosteronism,0.043809726391561665,0.100240555356396,1
3966,Phenotype,HP:0100333,Unilateral cleft lip,0.0438063923026224,0.10017556342816909,1
3967,Biological Process,GO:0043604,amide biosynthetic process,0.043777924588979666,0.09962063773915615,1
3968,Phenotype,HP:0100276,Skin pit,0.04370780392302276,0.0982537643977097,1
3969,Phenotype,HP:0000044,Hypogonadotropic hypogonadism,0.04368606530055563,0.09783000995777975,1
3970,Biological Process,GO:0010518,positive regulation of phospholipase activity,0.0436841101772254,0.09779189842642354,1
3971,Phenotype,HP:0200114,Metabolic alkalosis,0.04367736336840278,0.09766038180441733,1
3972,Biological Process,GO:0035725,sodium ion transmembrane transport,0.04367373704596522,0.09758969332193158,1
3973,Biological Process,GO:0007009,plasma membrane organization,0.043660428459139755,0.09733026691324295,1
3974,Disease,MONDO:0021581,connective tissue neoplasm,0.04364365448704366,0.09700328919596898,1
3975,Biological Process,GO:0010921,regulation of phosphatase activity,0.043640201136883716,0.09693597248971855,1
3976,Phenotype,HP:0012332,Abnormal autonomic nervous system physiology,0.04362765476752384,0.096691404107831,1
3977,Biological Process,GO:0006735,NADH regeneration,0.04360331534018058,0.09621695176303988,1
3977,Biological Process,GO:0061718,glucose catabolic process to pyruvate,0.04360331534018058,0.09621695176303988,1
3977,Biological Process,GO:0061621,canonical glycolysis,0.04360331534018058,0.09621695176303988,1
3980,Disease,MONDO:0019189,inborn disorder of amino acid and other organic acid metabolism,0.0435706485565488,0.09558017293203837,1
3981,Biological Process,GO:0006595,polyamine metabolic process,0.043562170622998275,0.09541491121920918,1
3982,Biological Process,GO:0033233,regulation of protein sumoylation,0.04354901308504511,0.0951584292303144,1
3983,Phenotype,HP:0200085,Limb tremor,0.043546117015058505,0.09510197567549387,1
3984,Biological Process,GO:0030900,forebrain development,0.04353649263888382,0.09491436617347747,1
3985,Biological Process,GO:0051180,vitamin transport,0.043514157993253866,0.09447899335883542,1
3986,Biological Process,GO:0061014,positive regulation of mRNA catabolic process,0.04345488673164666,0.09332360918928718,1
3987,Phenotype,HP:0011950,Bronchiolitis,0.043451447371952945,0.09325656520142958,1
3988,Biological Process,GO:0006417,regulation of translation,0.04343610821675259,0.09295755659907887,1
3989,Phenotype,HP:0003391,Gowers sign,0.04341240692577619,0.09249554354841258,1
3990,Phenotype,HP:0000914,Shield chest,0.04337676251265843,0.09180072131024221,1
3991,Biological Process,GO:0042762,regulation of sulfur metabolic process,0.04337631622995619,0.09179202185024546,1
3992,Biological Process,GO:0031397,negative regulation of protein ubiquitination,0.04337198422174671,0.09170757732229261,1
3993,Biological Process,GO:1905710,positive regulation of membrane permeability,0.04336565394941638,0.09158418031266162,1
3994,Phenotype,HP:0002308,Chiari malformation,0.0433589800347024,0.09145408462715802,1
3995,Phenotype,HP:0011705,First degree atrioventricular block,0.04333068372472915,0.09090250013725154,1
3996,Phenotype,HP:5200202,Abnormal interpretation of external stimuli,0.04332708167803878,0.0908322848657832,1
3996,Phenotype,HP:5200204,Disturbed perception with a stimulus,0.04332708167803878,0.0908322848657832,1
3996,Phenotype,HP:0010524,Disturbed sensory perception,0.04332708167803878,0.0908322848657832,1
3999,Phenotype,HP:0033379,Bilateral superior vena cava,0.04329878821208877,0.09028075581487596,1
4000,Biological Process,GO:0060395,SMAD protein signal transduction,0.04328272884971951,0.0899677080991475,1
4001,Phenotype,HP:0001090,Abnormally large globe,0.043269905273052744,0.08971773607095017,1
4002,Phenotype,HP:0004386,Gastrointestinal inflammation,0.043238981860398096,0.08911494104886405,1
4003,Phenotype,HP:0033222,Decreased CD4:CD8 ratio,0.043232425098544636,0.08898712904278278,1
4004,Biological Process,GO:0046033,AMP metabolic process,0.04322299279172859,0.08880326357945241,1
4005,Biological Process,GO:0002357,defense response to tumor cell,0.04321942589542127,0.08873373350001519,1
4006,Phenotype,HP:0009138,Synostosis involving bones of the lower limbs,0.043210275245311514,0.08855535841584788,1
4006,Phenotype,HP:0009140,Synostosis involving bones of the feet,0.043210275245311514,0.08855535841584788,1
4008,Biological Process,GO:0006887,exocytosis,0.043192795037938936,0.08821461394152678,1
4009,Phenotype,HP:0001664,Torsade de pointes,0.043191915216586274,0.08819746344337082,1
4010,Phenotype,HP:0045073,Serositis,0.04316032541474657,0.08758167839046212,1
4011,Phenotype,HP:0001927,Acanthocytosis,0.04315695972379796,0.08751607043921948,1
4012,Phenotype,HP:0011077,Abnormality of molar,0.04311988186567639,0.08679330582863444,1
4013,Biological Process,GO:0002755,MyD88-dependent toll-like receptor signaling pathway,0.043111933094215016,0.08663835915692883,1
4014,Phenotype,HP:0001771,Achilles tendon contracture,0.04311184318433292,0.0866366065292364,1
4015,Biological Process,GO:0010574,regulation of vascular endothelial growth factor production,0.043103307651666034,0.08647022202763194,1
4016,Phenotype,HP:0004404,Abnormal nipple morphology,0.043103101407696465,0.08646620168099102,1
4017,Biological Process,GO:0046889,positive regulation of lipid biosynthetic process,0.04309382315633059,0.08628533924515726,1
4018,Phenotype,HP:0100820,Glomerulopathy,0.04309134217898636,0.08623697715751467,1
4019,Biological Process,GO:0006611,protein export from nucleus,0.043073824137930594,0.08589549518516428,1
4020,Phenotype,HP:0020045,Esodeviation,0.04305943412560542,0.08561498837648036,1
4021,Biological Process,GO:1901532,regulation of hematopoietic progenitor cell differentiation,0.043033440903564646,0.08510829834749987,1
4022,Phenotype,HP:0001707,Abnormal right ventricle morphology,0.04301675892198775,0.08478311381610981,1
4023,Biological Process,GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,0.042994826501681405,0.08435558164394577,1
4024,Phenotype,HP:0010489,Absent palmar crease,0.04299445102275301,0.08434826237322161,1
4025,Phenotype,HP:0000711,Restlessness,0.04296277416080996,0.08373078024381275,1
4026,Phenotype,HP:0010306,Short thorax,0.04296180778434611,0.08371194251304946,1
4027,Biological Process,GO:0072523,purine-containing compound catabolic process,0.04293466938584334,0.08318292937638329,1
4028,Biological Process,GO:0030100,regulation of endocytosis,0.042884261738785234,0.0822003250609721,1
4029,Phenotype,HP:0008202,Reduced circulating prolactin concentration,0.042880157506830496,0.08212032061193432,1
4030,Biological Process,GO:0090596,sensory organ morphogenesis,0.04287205122378335,0.08196230354172884,1
4031,Phenotype,HP:0005265,Abnormal jejunum morphology,0.042850853245938514,0.08154908797377514,1
4032,Biological Process,GO:0000387,spliceosomal snRNP assembly,0.04284100985761796,0.08135720923301794,1
4033,Biological Process,GO:0030856,regulation of epithelial cell differentiation,0.042835293153967946,0.0812457726156738,1
4034,Biological Process,GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,0.0428334885264301,0.0812105947228363,1
4035,Biological Process,GO:0032210,regulation of telomere maintenance via telomerase,0.0428184768032418,0.0809179688049954,1
4036,Phenotype,HP:0410067,Increased level of L-fucose in urine,0.042790573069485305,0.08037403686598596,1
4037,Biological Process,GO:0007033,vacuole organization,0.04278022061564435,0.08017223482972957,1
4038,Biological Process,GO:0032467,positive regulation of cytokinesis,0.04277788996847898,0.08012680315227486,1
4039,Biological Process,GO:0061157,mRNA destabilization,0.042729541971230356,0.07918434791957527,1
4040,Disease,MONDO:0018234,dysostosis,0.04270933366158258,0.07879042411186056,1
4041,Biological Process,GO:0044344,cellular response to fibroblast growth factor stimulus,0.04270072851365825,0.07862268258892345,1
4041,Biological Process,GO:0071774,response to fibroblast growth factor,0.04270072851365825,0.07862268258892345,1
4043,Phenotype,HP:0011911,Abnormal metacarpophalangeal joint morphology,0.04268749092396251,0.0783646401386246,1
4044,Biological Process,GO:2001034,positive regulation of double-strand break repair via nonhomologous end joining,0.04268519113422675,0.07831980996997397,1
4045,Phenotype,HP:0012163,Carotid artery dilatation,0.04268086631532386,0.07823550558432285,1
4046,Phenotype,HP:0200128,Biventricular hypertrophy,0.04266749985956986,0.07797495112736717,1
4047,Phenotype,HP:0010161,Abnormal toe phalanx morphology,0.042636658702370434,0.07737375952400792,1
4048,Biological Process,GO:1900182,positive regulation of protein localization to nucleus,0.042628742160737754,0.07721944111350093,1
4049,Disease,MONDO:0024582,male reproductive system neoplasm,0.042604229724897746,0.07674161628644904,1
4050,Phenotype,HP:0012303,Abnormal aortic arch morphology,0.04258375894204136,0.0763425760465556,1
4051,Phenotype,HP:0008527,Congenital sensorineural hearing impairment,0.0425722978937062,0.07611916400075464,1
4052,Biological Process,GO:2000772,regulation of cellular senescence,0.04255929408046644,0.07586567859225173,1
4053,Phenotype,HP:0012804,Corneal ulceration,0.04255539410981701,0.07578965584146387,1
4054,Disease,MONDO:0001176,lens disorder,0.042548779347838184,0.07566071322967476,1
4055,Biological Process,GO:0030520,intracellular estrogen receptor signaling pathway,0.04250259805381884,0.07476049388909785,1
4056,Biological Process,GO:1900227,positive regulation of NLRP3 inflammasome complex assembly,0.04249308972917287,0.07457514659806701,1
4056,Biological Process,GO:0141087,positive regulation of inflammasome-mediated signaling pathway,0.04249308972917287,0.07457514659806701,1
4058,Biological Process,GO:0006403,RNA localization,0.0424886520553307,0.07448864231305882,1
4059,Phenotype,HP:0007036,Hypoplasia of olfactory tract,0.04248285645166061,0.07437566768502117,1
4060,Biological Process,GO:0032780,negative regulation of ATP-dependent activity,0.04247033222118113,0.07413153085986528,1
4061,Phenotype,HP:0012748,Focal T2 hyperintense brainstem lesion,0.04245134829258623,0.07376147410757727,1
4062,Phenotype,HP:0002518,Abnormal periventricular white matter morphology,0.042425338004330126,0.07325445140413549,1
4063,Phenotype,HP:0009890,High anterior hairline,0.04241436874248261,0.07304062583088823,1
4064,Phenotype,HP:0011172,Complex febrile seizure,0.04241298463662302,0.07301364523429238,1
4065,Phenotype,HP:0033108,Abnormal circulating proteinogenic amino acid derivative concentration,0.04239244024301636,0.07261317008828647,1
4066,Phenotype,HP:0010551,Paraplegia/paraparesis,0.04234795675788616,0.07174604640756638,1
4067,Phenotype,HP:0012072,Aciduria,0.0423321842354466,0.07143859010840271,1
4068,Phenotype,HP:0011969,Elevated circulating luteinizing hormone level,0.04232344891119322,0.07126831103749118,1
4069,Phenotype,HP:0009027,Foot dorsiflexor weakness,0.04232297963037579,0.07125916327156168,1
4070,Phenotype,HP:0011890,Prolonged bleeding following procedure,0.042321431208126925,0.07122897962934446,1
4071,Biological Process,GO:0070528,protein kinase C signaling,0.04227312622366164,0.0702873628517006,1
4072,Biological Process,GO:0008584,male gonad development,0.042262173322459184,0.07007385619912071,1
4072,Biological Process,GO:0046546,development of primary male sexual characteristics,0.042262173322459184,0.07007385619912071,1
4074,Biological Process,GO:1901071,glucosamine-containing compound metabolic process,0.04226050120857949,0.07004126141618729,1
4075,Biological Process,GO:0019318,hexose metabolic process,0.0422427771290631,0.06969576310321463,1
4076,Phenotype,HP:0006479,Abnormal dental pulp morphology,0.042226146766177086,0.06937158478321057,1
4077,Phenotype,HP:0004963,Calcification of the aorta,0.04222032456777369,0.0692580917397888,1
4078,Phenotype,HP:0002783,Recurrent lower respiratory tract infections,0.04219441194738904,0.06875297289176521,1
4079,Biological Process,GO:0051443,positive regulation of ubiquitin-protein transferase activity,0.04218924523086098,0.06865225726123546,1
4080,Disease,MONDO:0043218,neurovascular disorder,0.0421863705699812,0.06859622103755375,1
4081,Biological Process,GO:0062197,cellular response to chemical stress,0.0421524416913035,0.0679348399862354,1
4082,Biological Process,GO:0035723,interleukin-15-mediated signaling pathway,0.04215174148503087,0.06792119075352332,1
4082,Biological Process,GO:0070672,response to interleukin-15,0.04215174148503087,0.06792119075352332,1
4082,Biological Process,GO:0071350,cellular response to interleukin-15,0.04215174148503087,0.06792119075352332,1
4085,Phenotype,HP:0002986,Radial bowing,0.04214431226167403,0.06777637171600374,1
4085,Phenotype,HP:0045008,Abnormal shape of the radius,0.04214431226167403,0.06777637171600374,1
4087,Phenotype,HP:0012506,Small pituitary gland,0.042127223547828274,0.0674432586875318,1
4088,Disease,MONDO:0019950,congenital muscular dystrophy,0.04209132206761901,0.06674342539948701,1
4089,Biological Process,GO:0072331,signal transduction by p53 class mediator,0.04206568376533926,0.06624365387809737,1
4090,Phenotype,HP:0008237,Hypothalamic hypothyroidism,0.04203667423596957,0.06567816648857805,1
4091,Biological Process,GO:0072529,pyrimidine-containing compound catabolic process,0.04202944009725951,0.06553715026723765,1
4092,Biological Process,GO:0090083,regulation of inclusion body assembly,0.041994345493921004,0.06485304555891218,1
4093,Biological Process,GO:0015695,organic cation transport,0.0419822892320757,0.06461803092108809,1
4094,Biological Process,GO:0030111,regulation of Wnt signaling pathway,0.04197341406478283,0.06444502586747165,1
4095,Phenotype,HP:0011037,Decreased urine output,0.041953397454356556,0.06405483888330052,1
4096,Biological Process,GO:0048592,eye morphogenesis,0.041920356565366634,0.0634107675567993,1
4097,Phenotype,HP:0006498,Aplasia/Hypoplasia of the patella,0.0419003766254209,0.06302129539616251,1
4098,Phenotype,HP:0003347,Impaired lymphocyte transformation with phytohemagglutinin,0.041895898385143515,0.06293400034315333,1
4099,Biological Process,GO:0009161,ribonucleoside monophosphate metabolic process,0.04186868477146999,0.06240352102514989,1
4100,Phenotype,HP:0000622,Blurred vision,0.04186600579049038,0.062351299221017,1
4101,Biological Process,GO:1904029,regulation of cyclin-dependent protein kinase activity,0.04185871490787896,0.06220917688174413,1
4102,Phenotype,HP:0000040,Long penis,0.04185729387191972,0.06218147640081727,1
4103,Biological Process,GO:0070098,chemokine-mediated signaling pathway,0.0418297492346551,0.06164454438708026,1
4104,Biological Process,GO:0045821,positive regulation of glycolytic process,0.041827207514516185,0.06159499823043885,1
4104,Biological Process,GO:0030813,positive regulation of nucleotide catabolic process,0.041827207514516185,0.06159499823043885,1
4104,Biological Process,GO:0033123,positive regulation of purine nucleotide catabolic process,0.041827207514516185,0.06159499823043885,1
4107,Phenotype,HP:0000691,Microdontia,0.041825386717866175,0.06155950515051541,1
4108,Phenotype,HP:5200060,Auditory hypersensitivity,0.04181975710936792,0.06144976629287565,1
4109,Biological Process,GO:0006081,cellular aldehyde metabolic process,0.04179017045454769,0.060873028904768194,1
4110,Disease,MONDO:0019587,autosomal dominant nonsyndromic hearing loss,0.04176525798613573,0.06038740617889638,1
4111,Phenotype,HP:0001807,Ridged nail,0.041762905904876524,0.060341556683227035,1
4112,Biological Process,GO:0006641,triglyceride metabolic process,0.041705007280044115,0.059212929541572895,1
4113,Phenotype,HP:0007460,Autoamputation of digits,0.041692114862223795,0.05896161558177373,1
4114,Biological Process,GO:0051085,chaperone cofactor-dependent protein refolding,0.04167394252716794,0.058607379351973146,1
4115,Biological Process,GO:0009181,purine ribonucleoside diphosphate catabolic process,0.04167177560818236,0.05856513925407841,1
4115,Biological Process,GO:0009137,purine nucleoside diphosphate catabolic process,0.04167177560818236,0.05856513925407841,1
4117,Phenotype,HP:0031690,Opportunistic infection,0.041669808028475086,0.058526784908574964,1
4118,Biological Process,GO:0034248,regulation of amide metabolic process,0.04165741771894327,0.05828525862584228,1
4119,Disease,MONDO:0006873,nutritional deficiency disease,0.04164765394631609,0.0580949318465125,1
4120,Biological Process,GO:0009593,detection of chemical stimulus,0.04164683960149573,0.058079057692858975,1
4121,Biological Process,GO:1902003,regulation of amyloid-beta formation,0.04164327774715404,0.05800962589726296,1
4122,Biological Process,GO:0006536,glutamate metabolic process,0.04163134792897083,0.05777707604594019,1
4123,Biological Process,GO:1900274,regulation of phospholipase C activity,0.041621780034456046,0.05759056754994178,1
4124,Biological Process,GO:0035094,response to nicotine,0.04161519963806859,0.05746229483211431,1
4125,Phenotype,HP:0100326,Immunologic hypersensitivity,0.04160008820076688,0.05716772517113396,1
4126,Phenotype,HP:0006380,Knee flexion contracture,0.041588996259239064,0.05695150818328368,1
4127,Biological Process,GO:0045091,regulation of single stranded viral RNA replication via double stranded DNA intermediate,0.04158329582732778,0.05684038875354166,1
4128,Phenotype,HP:0007833,Anterior chamber synechiae,0.041582526500654526,0.05682539214582001,1
4129,Biological Process,GO:0006405,RNA export from nucleus,0.04158193349350747,0.056813832562785056,1
4130,Disease,MONDO:0004907,alopecia,0.041580933294922295,0.05679433553200854,1
4131,Phenotype,HP:0002829,Arthralgia,0.0415334559500844,0.05586885206581521,1
4132,Phenotype,HP:0011119,Abnormal nasal dorsum morphology,0.041528836833315985,0.05577881088486507,1
4133,Phenotype,HP:0031651,Abnormal tricuspid valve physiology,0.04152824618661455,0.05576729731437354,1
4134,Biological Process,GO:0046039,GTP metabolic process,0.04150468701007548,0.0553080545231332,1
4135,Biological Process,GO:0006833,water transport,0.041503130583689374,0.05527771485499027,1
4135,Biological Process,GO:0042044,fluid transport,0.041503130583689374,0.05527771485499027,1
4137,Phenotype,HP:0002077,Migraine with aura,0.041481154062419145,0.054849323015693334,1
4138,Biological Process,GO:0072599,establishment of protein localization to endoplasmic reticulum,0.04147903739418335,0.05480806246369038,1
4139,Biological Process,GO:0002456,T cell mediated immunity,0.04146809192449907,0.05459470067488134,1
4140,Phenotype,HP:0002999,Patellar dislocation,0.04144497194485386,0.05414401921884313,1
4141,Phenotype,HP:0030200,Fatiguable weakness of proximal limb muscles,0.04142937028038762,0.0538398934814436,1
4142,Phenotype,HP:0004719,Hyperechogenic kidneys,0.041420100238766966,0.05365919107948464,1
4143,Phenotype,HP:0011448,Ankle clonus,0.041417177258723514,0.05360221296262777,1
4144,Biological Process,GO:0010884,positive regulation of lipid storage,0.04140031460655447,0.05327350659052743,1
4145,Phenotype,HP:0011376,Abnormal morphology of the vestibule of the inner ear,0.04140007318680383,0.05326880055676779,1
4146,Phenotype,HP:0009660,Short phalanx of the thumb,0.04138924103850783,0.05305764775988049,1
4147,Phenotype,HP:0045007,Abnormal substantia nigra morphology,0.04137140660727856,0.05270999834334288,1
4148,Biological Process,GO:0032212,positive regulation of telomere maintenance via telomerase,0.04136899579473463,0.05266300398935961,1
4149,Phenotype,HP:0002374,Diminished movement,0.041361206487446345,0.05251116577825026,1
4150,Phenotype,HP:0007291,Posterior fossa cyst,0.04136084857219435,0.052504188879075556,1
4151,Biological Process,GO:0043297,apical junction assembly,0.041334931325261115,0.05199897984500137,1
4152,Phenotype,HP:0005180,Tricuspid regurgitation,0.04132977013999717,0.05189837203628646,1
4153,Biological Process,GO:0002507,tolerance induction,0.04131062778976968,0.05152522714581064,1
4154,Phenotype,HP:0000614,Abnormal nasolacrimal system morphology,0.041307514396192846,0.051464537267533896,1
4155,Biological Process,GO:0061640,cytoskeleton-dependent cytokinesis,0.04129545545702662,0.051229470440265476,1
4156,Biological Process,GO:0042558,pteridine-containing compound metabolic process,0.04128482278618939,0.05102220608934337,1
4157,Biological Process,GO:2000181,negative regulation of blood vessel morphogenesis,0.04128138005966575,0.050955096471332256,1
4158,Phenotype,HP:0007350,Hyperreflexia in upper limbs,0.041258736753552405,0.050513706888586925,1
4159,Biological Process,GO:0043242,negative regulation of protein-containing complex disassembly,0.0412447607218408,0.050241269870125886,1
4160,Biological Process,GO:1903319,positive regulation of protein maturation,0.0412397703177233,0.0501439911255765,1
4161,Phenotype,HP:0003265,Neonatal hyperbilirubinemia,0.04122130469287233,0.0497840377509543,1
4162,Biological Process,GO:0034314,Arp2/3 complex-mediated actin nucleation,0.0412158951231415,0.04967858814415349,1
4163,Biological Process,GO:0000413,protein peptidyl-prolyl isomerization,0.041169610471944784,0.04877635404560946,1
4164,Biological Process,GO:0016125,sterol metabolic process,0.041165709100170034,0.04870030398246181,1
4165,Phenotype,HP:0009843,Aplasia/Hypoplasia of the middle phalanges of the hand,0.041129165377080334,0.04798795135136717,1
4166,Biological Process,GO:0002702,positive regulation of production of molecular mediator of immune response,0.041113636603485215,0.04768524648736074,1
4167,Phenotype,HP:0011817,Basal encephalocele,0.041086682646351624,0.04715982869576365,1
4168,Phenotype,HP:0012847,Epilepsia partialis continua,0.041073724996513516,0.04690724315782263,1
4169,Phenotype,HP:0002299,Brittle hair,0.04104602295648141,0.046367242866798025,1
4170,Phenotype,HP:0002419,Molar tooth sign on MRI,0.04104340565880171,0.046316223465082615,1
4171,Biological Process,GO:0032817,regulation of natural killer cell proliferation,0.04103984657330273,0.04624684564297981,1
4172,Phenotype,HP:0002877,Nocturnal hypoventilation,0.04102125482927643,0.04588443380712875,1
4173,Biological Process,GO:0051640,organelle localization,0.04101119312342938,0.045688299367956924,1
4174,Phenotype,HP:0000448,Prominent nose,0.04098692830697237,0.04521530142508856,1
4175,Phenotype,HP:0010966,Abnormal circulating fatty-acid anion concentration,0.040984414070806885,0.04516629101793107,1
4176,Disease,MONDO:0001933,endocrine pancreas disorder,0.04098061735282854,0.045092280987952496,1
4177,Biological Process,GO:0099643,signal release from synapse,0.040954409281673376,0.044581402870868696,1
4177,Biological Process,GO:0007269,neurotransmitter secretion,0.040954409281673376,0.044581402870868696,1
4179,Phenotype,HP:0002690,Large sella turcica,0.040953822764229764,0.04456996979265949,1
4180,Phenotype,HP:0030166,Night sweats,0.04094950336647696,0.044485771082352854,1
4181,Disease,MONDO:0004892,refractive error,0.040945810336874944,0.044413782266455586,1
4181,Disease,MONDO:0001384,myopia,0.040945810336874944,0.044413782266455586,1
4183,Phenotype,HP:0002570,Steatorrhea,0.040934612201752874,0.0441954952299109,1
4184,Biological Process,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,0.04092857502174563,0.044077811515747536,1
4185,Phenotype,HP:0006979,Sleep-wake cycle disturbance,0.040920607224099514,0.04392249396358388,1
4186,Biological Process,GO:0090200,positive regulation of release of cytochrome c from mitochondria,0.04088884890186306,0.04330342391566462,1
4187,Biological Process,GO:0071773,cellular response to BMP stimulus,0.040888008135916976,0.04328703473078711,1
4187,Biological Process,GO:0071772,response to BMP,0.040888008135916976,0.04328703473078711,1
4189,Phenotype,HP:0025401,Staring gaze,0.04085435838500484,0.04263109476158636,1
4190,Biological Process,GO:0071459,"protein localization to chromosome, centromeric region",0.04085377951835267,0.0426198108214768,1
4191,Biological Process,GO:2001252,positive regulation of chromosome organization,0.040805076749782954,0.041670439974749576,1
4192,Phenotype,HP:0001750,Single ventricle,0.040736183787714375,0.04032749846129201,1
4193,Biological Process,GO:0072655,establishment of protein localization to mitochondrion,0.040727707823061565,0.04016227512850039,1
4194,Phenotype,HP:0410291,Negativism,0.04064678456159421,0.03858482506733569,1
4195,Phenotype,HP:0002248,Hematemesis,0.040627176197153836,0.038202596087374474,1
4196,Disease,MONDO:0015159,multiple congenital anomalies/dysmorphic syndrome-intellectual disability,0.04061672626649093,0.03799889391985849,1
4197,Biological Process,GO:0045879,negative regulation of smoothened signaling pathway,0.04060718610972558,0.03781292612024011,1
4198,Phenotype,HP:0031073,Abnormal response to endocrine stimulation test,0.040598202889014834,0.03763781476409022,1
4199,Biological Process,GO:0000305,response to oxygen radical,0.04059426103546626,0.03756097558325955,1
4200,Phenotype,HP:0007178,Motor polyneuropathy,0.04059412970893417,0.037558415614193465,1
4201,Biological Process,GO:1905269,positive regulation of chromatin organization,0.04057695130961381,0.037223554332440185,1
4202,Phenotype,HP:0008515,Aplasia/Hypoplasia of the vertebrae,0.04056987436415549,0.03708560230426365,1
4202,Phenotype,HP:0008417,Vertebral hypoplasia,0.04056987436415549,0.03708560230426365,1
4204,Phenotype,HP:0002652,Skeletal dysplasia,0.04054586428077844,0.03661756991400997,1
4205,Biological Process,GO:0032377,regulation of intracellular lipid transport,0.040536561245848146,0.03643622436819638,1
4205,Biological Process,GO:0032383,regulation of intracellular cholesterol transport,0.040536561245848146,0.03643622436819638,1
4205,Biological Process,GO:0032380,regulation of intracellular sterol transport,0.040536561245848146,0.03643622436819638,1
4208,Phenotype,HP:0002359,Frequent falls,0.04049256615448815,0.035578621025247045,1
4209,Phenotype,HP:0002174,Postural tremor,0.04047808822291343,0.0352964003925889,1
4210,Biological Process,GO:0008209,androgen metabolic process,0.04044969393625342,0.0347429060274781,1
4211,Phenotype,HP:0000616,Miosis,0.040429763471562574,0.03435439829588732,1
4212,Biological Process,GO:0045739,positive regulation of DNA repair,0.04042199184034545,0.034202904647256435,1
4213,Phenotype,HP:0004430,Severe combined immunodeficiency,0.04041370651612208,0.03404139749880578,1
4214,Phenotype,HP:0008046,Abnormal retinal vascular morphology,0.04038511532633171,0.03348406486952481,1
4215,Phenotype,HP:0003749,Pelvic girdle muscle weakness,0.040365894405129055,0.03310938838248033,1
4216,Phenotype,HP:0012747,Abnormal brainstem MRI signal intensity,0.04036262626868514,0.03304568207677954,1
4217,Phenotype,HP:0002777,Tracheal stenosis,0.040359515811452584,0.03298504943713083,1
4218,Biological Process,GO:0033617,mitochondrial cytochrome c oxidase assembly,0.04035661702456228,0.032928542921272494,1
4219,Phenotype,HP:0033748,Hypoesthesia,0.04035645879576977,0.03292545854214712,1
4220,Biological Process,GO:0009185,ribonucleoside diphosphate metabolic process,0.040354012176859966,0.03287776620895476,1
4221,Disease,MONDO:0020641,respiratory tract neoplasm,0.04034248616837999,0.03265308788467515,1
4221,Disease,MONDO:0000376,respiratory system cancer,0.04034248616837999,0.03265308788467515,1
4221,Disease,MONDO:0021117,lung neoplasm,0.04034248616837999,0.03265308788467515,1
4221,Disease,MONDO:0008903,lung cancer,0.04034248616837999,0.03265308788467515,1
4225,Biological Process,GO:0007631,feeding behavior,0.04032337620723658,0.03228057435978864,1
4226,Biological Process,GO:1990928,response to amino acid starvation,0.04030359095704872,0.031894897317698644,1
4227,Phenotype,HP:0032663,Focal motor status epilepticus,0.040302261538622375,0.031868982751973994,1
4228,Phenotype,HP:0004414,Abnormality of the pulmonary artery,0.04029953065934111,0.03181574928595752,1
4229,Phenotype,HP:0100761,Visceral angiomatosis,0.04029895210395573,0.03180447141342121,1
4230,Phenotype,HP:0012806,Proboscis,0.04028218660401872,0.0314776588452975,1
4231,Phenotype,HP:0500018,Abnormal cardiac exercise stress test,0.04025600884121938,0.030967371533834772,1
4232,Phenotype,HP:0005989,Redundant neck skin,0.04024132501140354,0.030681137293875525,1
4233,Biological Process,GO:0051881,regulation of mitochondrial membrane potential,0.040212796968930764,0.030125035605342614,1
4234,Disease,MONDO:0019181,non-syndromic X-linked intellectual disability,0.04021238163224328,0.03011693938095422,1
4235,Biological Process,GO:0016079,synaptic vesicle exocytosis,0.04021192791891459,0.03010809507456928,1
4236,Biological Process,GO:0120193,tight junction organization,0.0402062134631751,0.029996702276104032,1
4236,Biological Process,GO:0120192,tight junction assembly,0.0402062134631751,0.029996702276104032,1
4238,Phenotype,HP:0009110,Diaphragmatic eventration,0.040195850385853826,0.02979469315464899,1
4239,Phenotype,HP:0031072,Abnormal endocrine physiology,0.04019016724238089,0.02968391073119706,1
4240,Disease,MONDO:0002320,congenital nervous system disorder,0.04018199829065572,0.02952467205044116,1
4241,Biological Process,GO:1900121,negative regulation of receptor binding,0.040171638661681275,0.029322730148161665,1
4242,Phenotype,HP:0006892,Frontotemporal cerebral atrophy,0.040162744971841136,0.029149364031572724,1
4243,Biological Process,GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,0.040161018091470435,0.029115701676682537,1
4244,Biological Process,GO:0046165,alcohol biosynthetic process,0.04014867420862667,0.028875080396795462,1
4245,Phenotype,HP:0001695,Cardiac arrest,0.040132746243635276,0.02856459403114108,1
4246,Biological Process,GO:0008217,regulation of blood pressure,0.040129500019360886,0.02850131486286071,1
4247,Phenotype,HP:0001360,Holoprosencephaly,0.04009158425274428,0.02776221676814795,1
4248,Biological Process,GO:0051149,positive regulation of muscle cell differentiation,0.040065647322576226,0.02725662404563354,1
4249,Phenotype,HP:0007149,Distal upper limb amyotrophy,0.04000667795203938,0.026107124686939143,1
4250,Biological Process,GO:0051851,modulation by host of symbiont process,0.0399963372226434,0.02590555119716124,1
4251,Biological Process,GO:0010828,positive regulation of glucose transmembrane transport,0.03999324528268866,0.02584527951776677,1
4252,Biological Process,GO:0051865,protein autoubiquitination,0.03997771590841537,0.025542562944644753,1
4253,Phenotype,HP:0001719,Double outlet right ventricle,0.0399533293793457,0.025067192438377482,1
4254,Phenotype,HP:0000963,Thin skin,0.03994267403814267,0.024859486170393706,1
4255,Biological Process,GO:0030509,BMP signaling pathway,0.039940139811174946,0.024810086079335228,1
4256,Phenotype,HP:0033383,Decreased compound muscle action potential amplitude,0.039914526063842826,0.024310793211461772,1
4257,Phenotype,HP:0001641,Abnormal pulmonary valve morphology,0.03990572739225806,0.024139279300901543,1
4258,Biological Process,GO:0060322,head development,0.039901578947702854,0.024058413008581008,1
4259,Biological Process,GO:0032725,positive regulation of granulocyte macrophage colony-stimulating factor production,0.03986935743798581,0.02343031397312043,1
4260,Phenotype,HP:0002680,J-shaped sella turcica,0.03986645132221034,0.023373664594132964,1
4261,Phenotype,HP:0410030,Cleft lip,0.039839197787803426,0.022842407094897352,1
4262,Biological Process,GO:0051785,positive regulation of nuclear division,0.039814110386134915,0.02235337436711464,1
4263,Biological Process,GO:0002711,positive regulation of T cell mediated immunity,0.0398031025636878,0.02213879712594029,1
4264,Biological Process,GO:0043407,negative regulation of MAP kinase activity,0.03979120585314666,0.021906892647172525,1
4265,Biological Process,GO:0007007,inner mitochondrial membrane organization,0.03974430369053539,0.020992621299993162,1
4266,Biological Process,GO:1900747,negative regulation of vascular endothelial growth factor signaling pathway,0.039741028758467745,0.020928782526113576,1
4267,Phenotype,HP:0001600,Abnormality of the larynx,0.03973803749962779,0.02087047343977067,1
4268,Biological Process,GO:0009167,purine ribonucleoside monophosphate metabolic process,0.039707666386928464,0.020278444488929227,1
4269,Phenotype,HP:0002078,Truncal ataxia,0.039677725217291404,0.019694796486872685,1
4270,Biological Process,GO:0051952,regulation of amine transport,0.039675486154753914,0.019651150083197517,1
4271,Biological Process,GO:0035821,modulation of process of another organism,0.03967029372724462,0.019549933264403935,1
4272,Biological Process,GO:0035020,regulation of Rac protein signal transduction,0.03966032770779726,0.019355664055504727,1
4273,Disease,MONDO:0016764,isolated anophthalmia-microphthalmia syndrome,0.03963051938411155,0.018774605640796537,1
4274,Biological Process,GO:0045834,positive regulation of lipid metabolic process,0.039629094309707735,0.01874682643782447,1
4275,Phenotype,HP:0001889,Megaloblastic anemia,0.03958649295514871,0.017916391428949567,1
4276,Phenotype,HP:0000297,Facial hypotonia,0.039579578326530696,0.01778160346886692,1
4277,Biological Process,GO:0006913,nucleocytoplasmic transport,0.03957083033191622,0.017611077412582818,1
4278,Phenotype,HP:0011386,Narrow internal auditory canal,0.03954411069022978,0.017090227169422927,1
4279,Biological Process,GO:1901987,regulation of cell cycle phase transition,0.03953212736271694,0.016856634252190885,1
4280,Biological Process,GO:0006397,mRNA processing,0.039531335197003026,0.01684119243940173,1
4281,Phenotype,HP:0010535,Sleep apnea,0.03948878300639369,0.01601171579125078,1
4282,Phenotype,HP:0030839,Knee pain,0.039462178939978276,0.015493118475309021,1
4283,Phenotype,HP:0007351,Upper limb postural tremor,0.03943918411949732,0.015044876766850545,1
4284,Biological Process,GO:0006515,protein quality control for misfolded or incompletely synthesized proteins,0.03943031546341247,0.01487199863725198,1
4285,Biological Process,GO:0045039,protein insertion into mitochondrial inner membrane,0.03942684334968538,0.014804316169790204,1
4286,Phenotype,HP:0002448,Progressive encephalopathy,0.039426304520598476,0.014793812688335272,1
4287,Phenotype,HP:0001955,Unexplained fevers,0.039416861216148735,0.014609732846374755,1
4288,Phenotype,HP:0011151,Atypical absence status epilepticus,0.039412011924677026,0.01451520483316883,1
4289,Phenotype,HP:0006783,Posterior pharyngeal cleft,0.03940699009323745,0.014417313470810478,1
4290,Biological Process,GO:0032790,ribosome disassembly,0.03939962031892541,0.014273653283016588,1
4291,Phenotype,HP:0030955,Addictive alcohol use,0.039324662039234015,0.012812479564361084,1
4291,Phenotype,HP:0430037,Abnormal alcohol consumption,0.039324662039234015,0.012812479564361084,1
4291,Phenotype,HP:5200329,Problematic alcohol consumption,0.039324662039234015,0.012812479564361084,1
4294,Biological Process,GO:0010720,positive regulation of cell development,0.03931565725771968,0.012636947920023097,1
4295,Biological Process,GO:0071216,cellular response to biotic stimulus,0.0393146427632336,0.012617172216966802,1
4296,Disease,MONDO:0005564,embryonal neoplasm,0.03927453831088823,0.011835409721757726,1
4297,Phenotype,HP:0010832,Abnormality of pain sensation,0.0392570350212168,0.01149421530049834,1
4298,Biological Process,GO:1902110,positive regulation of mitochondrial membrane permeability involved in apoptotic process,0.03925465531743377,0.01144782735456012,1
4299,Biological Process,GO:1902107,positive regulation of leukocyte differentiation,0.03925338215748808,0.01142300944438464,1
4299,Biological Process,GO:1903708,positive regulation of hemopoiesis,0.03925338215748808,0.01142300944438464,1
4301,Biological Process,GO:0016242,negative regulation of macroautophagy,0.03920198829986721,0.010421180768951942,1
4302,Phenotype,HP:0002208,Coarse hair,0.03918302861209155,0.010051596546825229,1
4303,Biological Process,GO:0032007,negative regulation of TOR signaling,0.03916960829118088,0.009789992087767058,1
4304,Biological Process,GO:0010507,negative regulation of autophagy,0.0391146620914542,0.00871891704027184,1
4305,Phenotype,HP:0002098,Respiratory distress,0.039094799416378834,0.008331730742483171,1
4306,Phenotype,HP:0002893,Pituitary adenoma,0.03909188614247161,0.008274941828890102,1
4307,Phenotype,HP:0001598,Concave nail,0.03908774630410594,0.00819424329839686,1
4308,Biological Process,GO:1904659,glucose transmembrane transport,0.03908209178319977,0.008084018819210517,1
4309,Biological Process,GO:0061620,glycolytic process through glucose-6-phosphate,0.03904812105519717,0.007421821992317657,1
4310,Biological Process,GO:0014032,neural crest cell development,0.03903483715491385,0.007162876802338063,1
4311,Biological Process,GO:0090382,phagosome maturation,0.039026270948747666,0.006995894377312532,1
4312,Phenotype,HP:0002136,Broad-based gait,0.03899713918081105,0.006428024171883512,1
4313,Phenotype,HP:0002349,Focal aware seizure,0.038978381225906356,0.006062372360832059,1
4314,Biological Process,GO:0032770,positive regulation of monooxygenase activity,0.038916828304494167,0.004862511432269645,1
4315,Phenotype,HP:0002480,Hepatic encephalopathy,0.03891063880480361,0.004741858526190402,1
4316,Phenotype,HP:0000796,Urethral obstruction,0.03887914818225324,0.004128006791010045,1
4317,Phenotype,HP:0040189,Scaling skin,0.03887143853478037,0.003977721401406077,1
4318,Phenotype,HP:0030182,Tetraplegia/tetraparesis,0.03885882034314392,0.003731752976409603,1
4319,Disease,MONDO:0016463,syndromic agammaglobulinemia,0.03883782095651489,0.0033224085787453635,1
4319,Disease,MONDO:0015517,common variable immunodeficiency,0.03883782095651489,0.0033224085787453635,1
4321,Biological Process,GO:0006119,oxidative phosphorylation,0.038828733391647496,0.0031452632252836664,1
4322,Disease,MONDO:0015967,monogenic diabetes,0.038823316777311545,0.0030396762968700293,1
4323,Phenotype,HP:0000027,Azoospermia,0.03881972770867392,0.002969714008656717,1
4324,Phenotype,HP:0009943,Complete duplication of thumb phalanx,0.03881753056898618,0.0029268848137877545,1
4325,Biological Process,GO:0051053,negative regulation of DNA metabolic process,0.0387889633223959,0.002370018913130425,1
4326,Phenotype,HP:0031983,Abnormal pulmonary thoracic imaging finding,0.03878842334054655,0.0023594929606931053,1
4327,Biological Process,GO:0098901,regulation of cardiac muscle cell action potential,0.03878458198838275,0.002284612869408232,1
4328,Phenotype,HP:0045025,Narrow palpebral fissure,0.03876249053869485,0.0018539807121087995,1
4329,Biological Process,GO:0043388,positive regulation of DNA binding,0.038751959976699224,0.0016487067851453112,1
4330,Biological Process,GO:0009268,response to pH,0.03874443523022497,0.0015020257002406202,1
4331,Phenotype,HP:0012191,B-cell lymphoma,0.038732752604579423,0.0012742944125370486,1
4332,Phenotype,HP:0000871,Panhypopituitarism,0.03867726190348142,0.00019260531284070046,1
4333,Phenotype,HP:0004385,Protracted diarrhea,0.038674638533907735,0.0001414675507259687,1
4334,Phenotype,HP:0040086,Abnormal prolactin level,0.0386614793472585,-0.00011504657646462592,1
4335,Phenotype,HP:0002474,Expressive language delay,0.03865882048700453,-0.00016687616407883542,1
4336,Phenotype,HP:0003076,Glycosuria,0.038636665255112,-0.0005987516380806453,1
4337,Phenotype,HP:0009053,Distal lower limb muscle weakness,0.03862778105461273,-0.000771932777432361,1
4338,Phenotype,HP:0011958,Retinal perforation,0.03860240889653088,-0.0012665163074626847,1
4339,Biological Process,GO:0034204,lipid translocation,0.03855645008503117,-0.002162398760748664,1
4339,Biological Process,GO:0045332,phospholipid translocation,0.03855645008503117,-0.002162398760748664,1
4341,Biological Process,GO:0141086,negative regulation of inflammasome-mediated signaling pathway,0.03855223354982629,-0.0022445923549790046,1
4342,Phenotype,HP:0007763,Retinal telangiectasia,0.038547640762349955,-0.002334120294833214,1
4343,Phenotype,HP:0001498,Carpal bone hypoplasia,0.038537741821070615,-0.0025270819382892176,1
4344,Phenotype,HP:0004440,Coronal craniosynostosis,0.038527017529242036,-0.0027361322718297593,1
4345,Phenotype,HP:0032120,Abnormal peripheral nervous system physiology,0.03851999045896648,-0.0028731120751024635,1
4346,Phenotype,HP:0002529,Neuronal loss in central nervous system,0.038486293180380104,-0.0035299785088485007,1
4347,Biological Process,GO:0051169,nuclear transport,0.03848315745781383,-0.003591103649682778,1
4348,Disease,MONDO:0016387,mitochondrial oxidative phosphorylation disorder,0.03847274990139404,-0.003793979809309559,1
4349,Phenotype,HP:0012125,Prostate cancer,0.03847174435714451,-0.0038135810439751806,1
4349,Phenotype,HP:0100787,Prostate neoplasm,0.03847174435714451,-0.0038135810439751806,1
4351,Phenotype,HP:0005521,Disseminated intravascular coagulation,0.03841797556064641,-0.004861704782276207,1
4352,Phenotype,HP:0003811,Neonatal death,0.038393472220433544,-0.005339352306815459,1
4353,Biological Process,GO:0032543,mitochondrial translation,0.038391559063860936,-0.005376645773462202,1
4354,Phenotype,HP:0010660,Abnormal hand bone ossification,0.03837266105989734,-0.005745027583188084,1
4355,Phenotype,HP:0009883,Duplication of the distal phalanx of hand,0.03834955117596528,-0.006195512241877248,1
4356,Biological Process,GO:0042633,hair cycle,0.03833748931113046,-0.006430636099670917,1
4356,Biological Process,GO:0042303,molting cycle,0.03833748931113046,-0.006430636099670917,1
4358,Biological Process,GO:0014033,neural crest cell differentiation,0.03833477784502437,-0.006483491141562893,1
4359,Phenotype,HP:0032860,Generalized non-convulsive status epilepticus without coma,0.03832872512890806,-0.006601477703581769,1
4360,Biological Process,GO:0007044,cell-substrate junction assembly,0.03832749050958306,-0.0066255443352821845,1
4360,Biological Process,GO:0150115,cell-substrate junction organization,0.03832749050958306,-0.0066255443352821845,1
4362,Biological Process,GO:0006694,steroid biosynthetic process,0.03832405652960269,-0.0066924834555283546,1
4363,Disease,MONDO:0019249,mucopolysaccharidosis,0.038323683056363134,-0.006699763629039646,1
4364,Phenotype,HP:0000776,Congenital diaphragmatic hernia,0.03831377638611744,-0.006892875934471325,1
4365,Phenotype,HP:0002045,Hypothermia,0.0382931007620364,-0.0072959091770749,1
4366,Biological Process,GO:0010544,negative regulation of platelet activation,0.038279821701440064,-0.007554760026263091,1
4367,Biological Process,GO:0002478,antigen processing and presentation of exogenous peptide antigen,0.03827878951260322,-0.0075748806481250085,1
4368,Biological Process,GO:0030316,osteoclast differentiation,0.03826985950162898,-0.0077489547783823245,1
4369,Phenotype,HP:0011166,Focal myoclonic seizure,0.03826700266205285,-0.007804643608545405,1
4370,Biological Process,GO:0060538,skeletal muscle organ development,0.03826553258177878,-0.007833300118134824,1
4371,Biological Process,GO:0051580,regulation of neurotransmitter uptake,0.03825243128245781,-0.008088685838389575,1
4372,Biological Process,GO:1901874,negative regulation of post-translational protein modification,0.03825042509085974,-0.008127792851647555,1
4373,Phenotype,HP:0032341,Reduced forced vital capacity,0.03824871767780502,-0.008161075727037918,1
4374,Biological Process,GO:0048260,positive regulation of receptor-mediated endocytosis,0.038237804604556835,-0.008373806006943785,1
4375,Phenotype,HP:0010183,Abnormality of the middle phalanges of the toes,0.038235924180459735,-0.008410461414217293,1
4376,Phenotype,HP:0100703,Tongue thrusting,0.03818775982472822,-0.009349336893492016,1
4377,Phenotype,HP:5200283,Sleep-related breathing disorders,0.038185722794625176,-0.00938904504665306,1
4378,Phenotype,HP:0002835,Aspiration,0.03817506824090988,-0.009596735964012509,1
4379,Phenotype,HP:0007633,Bilateral microphthalmos,0.038173206735152676,-0.00963302259306474,1
4380,Biological Process,GO:0150077,regulation of neuroinflammatory response,0.03816307011480069,-0.009830617352646858,1
4381,Phenotype,HP:0010828,Hemifacial spasm,0.03816001623034482,-0.009890147210123613,1
4382,Biological Process,GO:0006740,NADPH regeneration,0.03815982336369672,-0.009893906790500378,1
4383,Disease,MONDO:0018772,Joubert syndrome,0.038148243397817416,-0.010119636914983346,1
4384,Biological Process,GO:1903573,negative regulation of response to endoplasmic reticulum stress,0.038121689255533164,-0.010637261051862275,1
4385,Phenotype,HP:0005216,Impaired mastication,0.03810732001714001,-0.01091736291097125,1
4386,Phenotype,HP:0012126,Stomach cancer,0.03808400050958949,-0.01137193379633703,1
4387,Biological Process,GO:0045861,negative regulation of proteolysis,0.038063046140082823,-0.011780400668044732,1
4388,Phenotype,HP:0000389,Chronic otitis media,0.03802541216733735,-0.012514005709818398,1
4389,Biological Process,GO:0009299,mRNA transcription,0.03801185886622371,-0.012778202373212998,1
4390,Biological Process,GO:0009191,ribonucleoside diphosphate catabolic process,0.0380056408336803,-0.012899411474750384,1
4390,Biological Process,GO:0009134,nucleoside diphosphate catabolic process,0.0380056408336803,-0.012899411474750384,1
4392,Biological Process,GO:0086010,membrane depolarization during action potential,0.03796146231157349,-0.013760590462545639,1
4393,Phenotype,HP:0012090,Abnormal pancreas morphology,0.037955474396763944,-0.013877313842341425,1
4394,Phenotype,HP:0000679,Taurodontia,0.03794554476994294,-0.014070873643962284,1
4394,Phenotype,HP:0011071,Abnormal permanent molar morphology,0.03794554476994294,-0.014070873643962284,1
4396,Biological Process,GO:0007159,leukocyte cell-cell adhesion,0.037924661115867675,-0.014477962048470771,1
4397,Phenotype,HP:0000107,Renal cyst,0.03790610032822139,-0.014839770446661729,1
4398,Phenotype,HP:0000331,Short chin,0.03789371599212554,-0.015081180288252982,1
4399,Phenotype,HP:0000762,Decreased nerve conduction velocity,0.03788059414945133,-0.015336966463373718,1
4400,Phenotype,HP:0001218,Autoamputation,0.037865743854677336,-0.015626445631350645,1
4401,Phenotype,HP:0003763,Bruxism,0.037817262835504684,-0.016571493881662153,1
4402,Phenotype,HP:0007514,Edema of the dorsum of hands,0.0377753240407771,-0.017389013505916064,1
4403,Phenotype,HP:0031857,Ineffective esophageal peristalsis,0.03774574551295673,-0.017965592473117353,1
4404,Disease,MONDO:0019255,sphingolipidosis,0.03773510204136732,-0.01817306736482687,1
4405,Biological Process,GO:0032695,negative regulation of interleukin-12 production,0.037687843758462236,-0.019094280621774398,1
4406,Biological Process,GO:0032273,positive regulation of protein polymerization,0.03765334064416548,-0.019766855339734164,1
4407,Phenotype,HP:0007054,Proximal hyperreflexia,0.037638188523097416,-0.020062218055870263,1
4408,Biological Process,GO:0006631,fatty acid metabolic process,0.037619685710086004,-0.020422896345243753,1
4409,Biological Process,GO:0071222,cellular response to lipopolysaccharide,0.03757041395718852,-0.0213833584943525,1
4410,Disease,MONDO:0016296,holoprosencephaly,0.03756464639741519,-0.021495786458231317,1
4411,Phenotype,HP:0009701,Metacarpal synostosis,0.037538055341427845,-0.022014130159820663,1
4412,Disease,MONDO:0019303,premature aging syndrome,0.03753240341076747,-0.022124304146931992,1
4413,Biological Process,GO:0060337,type I interferon-mediated signaling pathway,0.03748923754354949,-0.022965743291234016,1
4414,Phenotype,HP:0009541,Abnormality of the phalanges of the 2nd finger,0.03747794314960051,-0.023185906716466483,1
4415,Phenotype,HP:0005769,Fifth finger distal phalanx clinodactyly,0.03743284840997141,-0.024064945678765708,1
4416,Biological Process,GO:0089718,amino acid import across plasma membrane,0.037409758590878694,-0.02451503921033667,1
4417,Phenotype,HP:0010662,Abnormality of the diencephalon,0.03738470514163117,-0.025003410098154096,1
4418,Biological Process,GO:0060541,respiratory system development,0.037363411500443644,-0.025418490446926616,1
4419,Biological Process,GO:2000058,regulation of ubiquitin-dependent protein catabolic process,0.03735247763240057,-0.025631626083090622,1
4420,Phenotype,HP:0001702,Abnormal tricuspid valve morphology,0.0373274738407301,-0.0261190289878271,1
4421,Disease,MONDO:0021106,laminopathy,0.037321293924208576,-0.02623949508766166,1
4422,Biological Process,GO:0018212,peptidyl-tyrosine modification,0.03729971884919281,-0.026660061470999818,1
4423,Phenotype,HP:0006315,Solitary median maxillary central incisor,0.037280097756758224,-0.027042538559785216,1
4424,Biological Process,GO:0051302,regulation of cell division,0.03726837707434294,-0.02727101169417982,1
4425,Phenotype,HP:0001657,Prolonged QT interval,0.03725560171213571,-0.027520043870216417,1
4426,Phenotype,HP:0007495,Prematurely aged appearance,0.03724329896413259,-0.027759863302084582,1
4427,Phenotype,HP:0003401,Paresthesia,0.03723946726523486,-0.02783455522071199,1
4428,Biological Process,GO:0045185,maintenance of protein location,0.03722887161176458,-0.02804109798618759,1
4429,Biological Process,GO:0006839,mitochondrial transport,0.03722332249736393,-0.028149267759525816,1
4430,Phenotype,HP:0001457,Abnormality of the musculature of the upper arm,0.03717926688725748,-0.029008050804066154,1
4431,Biological Process,GO:0006310,DNA recombination,0.03716497796101148,-0.029286587125662865,1
4432,Biological Process,GO:0010893,positive regulation of steroid biosynthetic process,0.037154920688084125,-0.029482635153222973,1
4433,Phenotype,HP:0000878,11 pairs of ribs,0.03713399583452781,-0.02989052666579609,1
4434,Biological Process,GO:2000392,regulation of lamellipodium morphogenesis,0.03711229847979702,-0.030313476667150136,1
4435,Biological Process,GO:0021537,telencephalon development,0.03710610495594602,-0.030434208016831773,1
4436,Phenotype,HP:0000179,Thick lower lip vermilion,0.03705392646455263,-0.031451331683716804,1
4437,Biological Process,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,0.037052678190443444,-0.031475664490306476,1
4438,Phenotype,HP:0009932,Single naris,0.03702459320372864,-0.032023129622182664,1
4439,Phenotype,HP:0007957,Corneal opacity,0.037021998736251116,-0.032073703991120577,1
4440,Phenotype,HP:0012727,Thoracic aortic aneurysm,0.03699485447217299,-0.03260283146638409,1
4441,Phenotype,HP:0004950,Peripheral arterial stenosis,0.03699052821675908,-0.03268716385417398,1
4442,Biological Process,GO:0045910,negative regulation of DNA recombination,0.03695000475349208,-0.03347709419620439,1
4443,Phenotype,HP:0009129,Upper limb amyotrophy,0.036924823068499535,-0.03396796480388186,1
4444,Biological Process,GO:0009154,purine ribonucleotide catabolic process,0.036910956027087716,-0.034238277257020826,1
4445,Phenotype,HP:0008067,Abnormally lax or hyperextensible skin,0.03690505697425106,-0.034353268436185656,1
4446,Biological Process,GO:0010799,regulation of peptidyl-threonine phosphorylation,0.036904964946075536,-0.034355062356110265,1
4447,Phenotype,HP:0010574,Abnormality of the epiphysis of the femoral head,0.036903188350783434,-0.034389693811903994,1
4448,Biological Process,GO:0032147,activation of protein kinase activity,0.03688376432072016,-0.034768329532409874,1
4449,Biological Process,GO:0032727,positive regulation of interferon-alpha production,0.03687374873237592,-0.03496356499573322,1
4450,Biological Process,GO:0031331,positive regulation of cellular catabolic process,0.0368331225638201,-0.03575549738836327,1
4451,Biological Process,GO:0050709,negative regulation of protein secretion,0.036817389976439685,-0.03606217522704037,1
4452,Phenotype,HP:0007598,Bilateral single transverse palmar creases,0.03677290320080828,-0.036929363050026004,1
4453,Phenotype,HP:0012490,Panniculitis,0.036764999095351136,-0.037083439040176955,1
4454,Biological Process,GO:0030031,cell projection assembly,0.03675416468773318,-0.037294635878387924,1
4455,Phenotype,HP:0030051,Tip-toe gait,0.03672611307842821,-0.03784145037908301,1
4456,Biological Process,GO:1900076,regulation of cellular response to insulin stimulus,0.03672548224393479,-0.03785374733662261,1
4457,Biological Process,GO:0016358,dendrite development,0.036636279707660035,-0.03959258662400626,1
4458,Phenotype,HP:0000964,Eczematoid dermatitis,0.036633003417284704,-0.03965645187559458,1
4459,Biological Process,GO:0006337,nucleosome disassembly,0.036601576412304215,-0.04026906350332404,1
4460,Phenotype,HP:0011459,Esophageal carcinoma,0.03655848610312984,-0.04110902978261375,1
4461,Biological Process,GO:0072528,pyrimidine-containing compound biosynthetic process,0.03653703450123624,-0.041527189284659816,1
4462,Biological Process,GO:0034383,low-density lipoprotein particle clearance,0.03653382312090203,-0.0415897892344489,1
4463,Phenotype,HP:0040084,Abnormal circulating renin,0.03650573399848134,-0.04213733498430055,1
4464,Phenotype,HP:0032367,Abnormal growth hormone level,0.036497586704341556,-0.04229615149028517,1
4465,Phenotype,HP:0005115,Supraventricular arrhythmia,0.036491269106846635,-0.04241930142732516,1
4466,Phenotype,HP:0001904,Neutropenia in presence of anti-neutropil antibodies,0.03644712666028971,-0.043279777188664464,1
4467,Biological Process,GO:0008037,cell recognition,0.036446562051852927,-0.043290783191104125,1
4468,Phenotype,HP:0100736,Abnormal soft palate morphology,0.03644364191566052,-0.04334770587231837,1
4469,Phenotype,HP:0011483,Anterior synechiae of the anterior chamber,0.03642998192372193,-0.043613982277004845,1
4470,Biological Process,GO:0030514,negative regulation of BMP signaling pathway,0.036424792306698706,-0.04371514431054464,1
4471,Biological Process,GO:0090557,establishment of endothelial intestinal barrier,0.03640748060671495,-0.04405260404342081,1
4472,Phenotype,HP:0000771,Gynecomastia,0.036390595252598024,-0.04438175294821717,1
4473,Biological Process,GO:2000008,regulation of protein localization to cell surface,0.03636664398407541,-0.04484863885111928,1
4474,Phenotype,HP:0012888,Abnormal uterine cervix morphology,0.036359175585902404,-0.04499422152958758,1
4475,Phenotype,HP:0008081,Pes valgus,0.03634348361063844,-0.045300107709792044,1
4476,Biological Process,GO:0140131,positive regulation of lymphocyte chemotaxis,0.03632165960154132,-0.04572552660493865,1
4477,Disease,MONDO:0021129,microphthalmia,0.036300854551499784,-0.04613108276846276,1
4478,Phenotype,HP:0007272,Progressive psychomotor deterioration,0.036283775749100244,-0.046464002591530454,1
4479,Phenotype,HP:0009658,Aplasia/Hypoplasia of the phalanges of the thumb,0.036282583175683114,-0.04648724961563309,1
4480,Phenotype,HP:0000934,Chondrocalcinosis,0.03625499238156782,-0.04702508137223265,1
4481,Biological Process,GO:0051301,cell division,0.03625125219213987,-0.0470979894821494,1
4482,Biological Process,GO:0000077,DNA damage checkpoint signaling,0.0362413640911422,-0.04729073981426331,1
4483,Phenotype,HP:0010907,Abnormal circulating proline concentration,0.03622011953477433,-0.04770486334480631,1
4484,Biological Process,GO:0009261,ribonucleotide catabolic process,0.036191426506137936,-0.048264181134978906,1
4485,Phenotype,HP:0011318,Bicoronal synostosis,0.03617650500048997,-0.04855504842789631,1
4486,Biological Process,GO:0031570,DNA integrity checkpoint signaling,0.036165660426897506,-0.048766443433072085,1
4487,Phenotype,HP:0034274,Gastrointestinal ulcer,0.036148570607058894,-0.049099578020839356,1
4488,Biological Process,GO:0010543,regulation of platelet activation,0.03613285449301262,-0.049405934742182855,1
4489,Phenotype,HP:0002352,Leukoencephalopathy,0.03612960978066038,-0.0494691844383234,1
4490,Phenotype,HP:0003328,Abnormal hairshaft morphology,0.03612855275377247,-0.04948978923228187,1
4491,Biological Process,GO:0061462,protein localization to lysosome,0.036124201053292615,-0.049574617624806375,1
4492,Biological Process,GO:0050779,RNA destabilization,0.03611982890728371,-0.04965984456529425,1
4493,Biological Process,GO:1903050,regulation of proteolysis involved in protein catabolic process,0.03610305390889901,-0.049986842288176014,1
4494,Biological Process,GO:0043487,regulation of RNA stability,0.036070429658252356,-0.05062279201690476,1
4495,Biological Process,GO:0007080,mitotic metaphase chromosome alignment,0.036028887421450495,-0.05143258147417284,1
4496,Phenotype,HP:0004935,Pulmonary artery atresia,0.03602760795457993,-0.0514575223262422,1
4497,Biological Process,GO:0030193,regulation of blood coagulation,0.03602200969865832,-0.05156665002309765,1
4497,Biological Process,GO:1900046,regulation of hemostasis,0.03602200969865832,-0.05156665002309765,1
4499,Phenotype,HP:0000845,Elevated circulating growth hormone concentration,0.036016452811912236,-0.05167497130400684,1
4500,Biological Process,GO:0019369,arachidonic acid metabolic process,0.03599844677095709,-0.0520259659363411,1
4501,Biological Process,GO:0070373,negative regulation of ERK1 and ERK2 cascade,0.035942441133296366,-0.05311769277670231,1
4502,Phenotype,HP:0002438,Cerebellar malformation,0.035927292370757646,-0.05341299002448947,1
4503,Phenotype,HP:0010488,Aplasia/Hypoplasia of the palmar creases,0.035921008549501976,-0.05353548155590289,1
4504,Phenotype,HP:0006482,Abnormal dental morphology,0.03591377092172843,-0.05367656579011504,1
4505,Phenotype,HP:0012118,Laryngeal carcinoma,0.03589841725735843,-0.05397585722202707,1
4506,Phenotype,HP:0009058,Increased muscle lipid content,0.0358900989848534,-0.054138006636594724,1
4507,Biological Process,GO:0050433,regulation of catecholamine secretion,0.03588904359360012,-0.05415857954686615,1
4508,Biological Process,GO:0060828,regulation of canonical Wnt signaling pathway,0.035844198205688294,-0.055032757856313105,1
4509,Disease,MONDO:0015194,sideroblastic anemia,0.03582805684127921,-0.05534740405090156,1
4509,Disease,MONDO:0020099,inherited sideroblastic anemia,0.03582805684127921,-0.05534740405090156,1
4511,Biological Process,GO:0043543,protein acylation,0.03582635915545285,-0.05538049731187591,1
4512,Phenotype,HP:0040160,Generalized osteoporosis,0.03582491293644163,-0.05540868869005729,1
4513,Disease,MONDO:0002427,cerebellar disorder,0.03581833815701241,-0.055536851915620786,1
4514,Biological Process,GO:0006836,neurotransmitter transport,0.035785595330157016,-0.05617511306932598,1
4515,Disease,MONDO:0002129,bone cancer,0.03578403444647149,-0.0562055396243184,1
4515,Disease,MONDO:0000637,musculoskeletal system cancer,0.03578403444647149,-0.0562055396243184,1
4517,Phenotype,HP:0003546,Exercise intolerance,0.035775039329580594,-0.0563808828746081,1
4518,Phenotype,HP:0010181,Duplication of phalanx of toe,0.035734352553307036,-0.05717399670316043,1
4518,Phenotype,HP:0010066,Duplication of phalanx of hallux,0.035734352553307036,-0.05717399670316043,1
4520,Biological Process,GO:0019722,calcium-mediated signaling,0.03572305369960649,-0.05739424706304254,1
4521,Phenotype,HP:0011070,Abnormal molar morphology,0.035716177644910974,-0.057528283095492704,1
4522,Phenotype,HP:0001522,Death in infancy,0.03570736168621602,-0.05770013398645299,1
4523,Biological Process,GO:0071467,cellular response to pH,0.03569213331196819,-0.05799698311800181,1
4524,Biological Process,GO:1901570,fatty acid derivative biosynthetic process,0.03567331564212162,-0.05836379896195324,1
4525,Phenotype,HP:0000884,Prominent sternum,0.03566904975784224,-0.058446954525574905,1
4526,Phenotype,HP:0012700,Abnormal large intestine physiology,0.0356640959260649,-0.058543520359656154,1
4527,Phenotype,HP:0001943,Hypoglycemia,0.035648279782660164,-0.05885182696926125,1
4528,Biological Process,GO:0046632,alpha-beta T cell differentiation,0.03562317033171858,-0.05934128950704579,1
4529,Biological Process,GO:0006783,heme biosynthetic process,0.03561089440241327,-0.0595805861577538,1
4529,Biological Process,GO:0033014,tetrapyrrole biosynthetic process,0.03561089440241327,-0.0595805861577538,1
4529,Biological Process,GO:0006779,porphyrin-containing compound biosynthetic process,0.03561089440241327,-0.0595805861577538,1
4532,Phenotype,HP:0011042,Abnormal blood potassium concentration,0.03560039517441038,-0.05978524928619214,1
4533,Phenotype,HP:0031264,Abnormal Bowman capsule morphology,0.03554641347835308,-0.06083752310960589,1
4534,Phenotype,HP:0100544,Neoplasm of the heart,0.03554555555376204,-0.06085424677069004,1
4535,Phenotype,HP:0002073,Progressive cerebellar ataxia,0.035543460800072646,-0.060895080138939746,1
4536,Phenotype,HP:0002323,Anencephaly,0.03552903279783026,-0.06117632749114777,1
4537,Biological Process,GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,0.03552131158055449,-0.061326838412767516,1
4538,Biological Process,GO:0043392,negative regulation of DNA binding,0.03551334462690403,-0.06148213951278914,1
4539,Phenotype,HP:0010654,Aplasia of the falx cerebri,0.03550413307719669,-0.06166170172253933,1
4540,Biological Process,GO:0051651,maintenance of location in cell,0.035471947337537,-0.06228910348655845,1
4541,Phenotype,HP:0003215,Dicarboxylic aciduria,0.035452652576047794,-0.06266521935410276,1
4542,Biological Process,GO:0043457,regulation of cellular respiration,0.03541747561387065,-0.06335092949642447,1
4543,Phenotype,HP:0002778,Abnormal tracheal morphology,0.0354146638734949,-0.06340573920067123,1
4544,Phenotype,HP:0012591,Abnormal urinary electrolyte concentration,0.035405476789593826,-0.06358482449455204,1
4545,Phenotype,HP:0030212,Collectionism,0.03537954237400376,-0.06409036819999604,1
4546,Disease,MONDO:0018158,mitochondrial DNA depletion syndrome,0.035378233432937445,-0.06411588359727091,1
4547,Biological Process,GO:0002700,regulation of production of molecular mediator of immune response,0.03535652827163349,-0.06453898577340257,1
4548,Phenotype,HP:0005222,Bowel diverticulosis,0.03535571033382523,-0.06455492996574326,1
4549,Phenotype,HP:0000606,Abnormality of the periorbital region,0.03535454563826068,-0.06457763356241275,1
4550,Phenotype,HP:0031273,Shock,0.03533513897894314,-0.06495593067219758,1
4551,Biological Process,GO:0043331,response to dsRNA,0.035328298942575165,-0.06508926459363597,1
4552,Phenotype,HP:0000989,Pruritus,0.035292272223136356,-0.06579153918998593,1
4553,Phenotype,HP:0000537,Epicanthus inversus,0.0352771552755915,-0.06608621626301614,1
4554,Phenotype,HP:0030639,Congenital stationary night blindness with abnormal fundus,0.035254231547189874,-0.06653307216221704,1
4555,Phenotype,HP:0000070,Ureterocele,0.03525353762683647,-0.06654659886250157,1
4556,Biological Process,GO:0032496,response to lipopolysaccharide,0.03522598409904898,-0.06708370418062097,1
4557,Biological Process,GO:0045807,positive regulation of endocytosis,0.03522338916822321,-0.0671342875816803,1
4558,Biological Process,GO:0048812,neuron projection morphogenesis,0.03522194999270911,-0.06716234165984733,1
4559,Disease,MONDO:0016624,inherited deficiency anemia,0.035198837308823006,-0.06761288089848794,1
4559,Disease,MONDO:0001639,deficiency anemia,0.035198837308823006,-0.06761288089848794,1
4561,Phenotype,HP:0003259,Elevated circulating creatinine concentration,0.03518068782386041,-0.06796667170777086,1
4562,Phenotype,HP:0003207,Arterial calcification,0.03517814458113189,-0.06801624754449474,1
4563,Phenotype,HP:0004338,Abnormal circulating aromatic amino acid concentration,0.03515765683456451,-0.06841561846071605,1
4564,Biological Process,GO:0010649,regulation of cell communication by electrical coupling,0.03515404839043268,-0.06848595843853271,1
4565,Biological Process,GO:0046631,alpha-beta T cell activation,0.035128512850757576,-0.06898372679205629,1
4566,Biological Process,GO:0006862,nucleotide transport,0.035079225629583655,-0.06994449046674829,1
4567,Biological Process,GO:0050769,positive regulation of neurogenesis,0.03507375557425774,-0.07005111912891515,1
4568,Phenotype,HP:0001897,Normocytic anemia,0.03505966438606167,-0.070325800911121,1
4569,Biological Process,GO:0010586,miRNA metabolic process,0.035027647759614755,-0.07094990612427222,1
4570,Phenotype,HP:0003541,Urinary glycosaminoglycan excretion,0.03500365588045318,-0.07141758365684613,1
4570,Phenotype,HP:0008155,Mucopolysacchariduria,0.03500365588045318,-0.07141758365684613,1
4572,Biological Process,GO:0043567,regulation of insulin-like growth factor receptor signaling pathway,0.03494239928848164,-0.07261166818829101,1
4573,Phenotype,HP:0030318,Angular cheilitis,0.03491954568385913,-0.07305715715346514,1
4574,Phenotype,HP:0034671,Knee contracture,0.03487539721775923,-0.07391775025471713,1
4575,Phenotype,HP:0002064,Spastic gait,0.03487371395093841,-0.07395056244371331,1
4576,Phenotype,HP:0002562,Low-set nipples,0.03485769188586252,-0.07426288311734494,1
4577,Biological Process,GO:0140448,signaling receptor ligand precursor processing,0.034830396193759605,-0.07479496240328229,1
4578,Biological Process,GO:0032508,DNA duplex unwinding,0.0348240351754151,-0.07491895874987854,1
4579,Biological Process,GO:1905954,positive regulation of lipid localization,0.034777097606203955,-0.07583392028356453,1
4580,Biological Process,GO:0035335,peptidyl-tyrosine dephosphorylation,0.03475899109299274,-0.0761868734376342,1
4581,Phenotype,HP:0012801,Narrow jaw,0.03473921609208208,-0.07657235068892658,1
4582,Biological Process,GO:1902165,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,0.03473535514647208,-0.07664761271838776,1
4583,Biological Process,GO:0071816,tail-anchored membrane protein insertion into ER membrane,0.03473312523289962,-0.07669108077982628,1
4584,Disease,MONDO:0016763,spondylometaphyseal dysplasia,0.03472746800727056,-0.07680135798260793,1
4585,Biological Process,GO:0043691,reverse cholesterol transport,0.034610714074666316,-0.07907726103925955,1
4586,Phenotype,HP:0009465,Ulnar deviation of finger,0.034609926607023334,-0.07909261127180163,1
4587,Biological Process,GO:0071709,membrane assembly,0.034596435841227735,-0.07935558892425339,1
4588,Phenotype,HP:0030346,Abnormal circulating follicle-stimulating hormone concentration,0.034594109492788294,-0.07940093680595692,1
4589,Phenotype,HP:0011203,EEG with abnormally slow frequencies,0.03459297993353927,-0.0794229554848158,1
4590,Biological Process,GO:0006888,endoplasmic reticulum to Golgi vesicle-mediated transport,0.03456143710818671,-0.08003782481755733,1
4591,Biological Process,GO:0006892,post-Golgi vesicle-mediated transport,0.03455266262139833,-0.08020886729001868,1
4592,Biological Process,GO:0062111,zinc ion import into organelle,0.034549756757094374,-0.08026551176703182,1
4593,Disease,MONDO:0000171,"muscular dystrophy-dystroglycanopathy, type A",0.03454726412844755,-0.08031410097537678,1
4594,Biological Process,GO:0006024,glycosaminoglycan biosynthetic process,0.034502320962006006,-0.0811901852973211,1
4595,Biological Process,GO:0006760,folic acid-containing compound metabolic process,0.03449855726987672,-0.08126355154914901,1
4596,Biological Process,GO:0045839,negative regulation of mitotic nuclear division,0.03448991829145054,-0.08143195253546211,1
4597,Phenotype,HP:0000193,Bifid uvula,0.034469560575180136,-0.08182878875033556,1
4598,Phenotype,HP:0010009,Abnormal 1st metacarpal morphology,0.034460615103120595,-0.08200316426599814,1
4599,Biological Process,GO:0048278,vesicle docking,0.03445513867143435,-0.08210991722357536,1
4600,Biological Process,GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,0.03444909601675927,-0.08222770765631317,1
4601,Biological Process,GO:0032720,negative regulation of tumor necrosis factor production,0.03444874262492581,-0.08223459637976799,1
4602,Phenotype,HP:0031404,Impaired antigen-specific response,0.03444819256178999,-0.08224531884833274,1
4603,Disease,MONDO:0004992,cancer,0.034447655048346015,-0.08225579668374994,1
4604,Biological Process,GO:0010669,epithelial structure maintenance,0.03440454426222794,-0.08309616212337378,1
4605,Phenotype,HP:0100867,Duodenal stenosis,0.03437810645585748,-0.08361151850570354,1
4605,Phenotype,HP:0012848,Small intestinal stenosis,0.03437810645585748,-0.08361151850570354,1
4607,Phenotype,HP:0011358,Generalized hypopigmentation of hair,0.0343582285578814,-0.08399900154592736,1
4608,Disease,MONDO:0005833,lymphatic system disorder,0.03435059503355875,-0.08414780305480525,1
4608,Disease,MONDO:0044986,lymphoid system disorder,0.03435059503355875,-0.08414780305480525,1
4610,Biological Process,GO:0099518,vesicle cytoskeletal trafficking,0.034341990898983155,-0.08431552482437356,1
4611,Phenotype,HP:0008921,Neonatal short-limb short stature,0.034319234599874626,-0.08475911699762166,1
4612,Phenotype,HP:0002127,Abnormal upper motor neuron morphology,0.03430798077770714,-0.08497848955063726,1
4613,Phenotype,HP:0012377,Hemianopia,0.034301575785712135,-0.08510334308262632,1
4614,Phenotype,HP:0003124,Hypercholesterolemia,0.03426886293080256,-0.08574101998840453,1
4615,Phenotype,HP:0011891,Post-partum hemorrhage,0.034257861186205885,-0.08595547875306937,1
4616,Biological Process,GO:0032768,regulation of monooxygenase activity,0.03422615964070852,-0.08657344204294498,1
4617,Phenotype,HP:0002747,Respiratory insufficiency due to muscle weakness,0.03420899200933891,-0.08690809342331433,1
4618,Biological Process,GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,0.03419216925776736,-0.08723602200669467,1
4619,Biological Process,GO:0090151,establishment of protein localization to mitochondrial membrane,0.03416740739049118,-0.08771870904057202,1
4620,Phenotype,HP:0009921,Duane anomaly,0.034133751630916476,-0.08837476613759195,1
4620,Phenotype,HP:0025068,Incomitant strabismus,0.034133751630916476,-0.08837476613759195,1
4622,Biological Process,GO:0016126,sterol biosynthetic process,0.03409696139023233,-0.08909192417552993,1
4623,Biological Process,GO:1901623,regulation of lymphocyte chemotaxis,0.03408528254680232,-0.08931958173590185,1
4624,Biological Process,GO:0008299,isoprenoid biosynthetic process,0.034081548636757275,-0.08939236744080471,1
4625,Biological Process,GO:0015701,bicarbonate transport,0.03407299334996072,-0.08955913701281394,1
4626,Phenotype,HP:0003324,Generalized muscle weakness,0.03406771787728491,-0.08966197264430283,1
4627,Phenotype,HP:0007446,Palmoplantar blistering,0.034061747183527724,-0.0897783603313743,1
4628,Phenotype,HP:6000531,Abnormal urinary organic compound level,0.034033812299988364,-0.09032289947807648,1
4629,Phenotype,HP:0000132,Menorrhagia,0.03400491392490379,-0.09088622011936218,1
4630,Phenotype,HP:0004225,Abnormality of the distal phalanx of the 5th finger,0.033968668958536896,-0.09159274903794057,1
4631,Biological Process,GO:0051282,regulation of sequestering of calcium ion,0.03396477347629012,-0.09166868429557867,1
4632,Phenotype,HP:0012817,Noncompaction cardiomyopathy,0.03395424324272678,-0.09187395182035925,1
4633,Phenotype,HP:0011924,Decreased activity of mitochondrial complex III,0.0339301007710443,-0.09234456487699623,1
4634,Phenotype,HP:0030082,Abnormal drinking behavior,0.033915272767665816,-0.09263360951524006,1
4635,Phenotype,HP:5200123,Abnormal response to social norms,0.03389629108738901,-0.0930036224407045,1
4635,Phenotype,HP:5200029,Social disinhibition,0.03389629108738901,-0.0930036224407045,1
4637,Disease,MONDO:0015369,Joubert syndrome and related disorders,0.03384564743382146,-0.09399082726870021,1
4638,Phenotype,HP:0001787,Abnormal delivery,0.03384242169692642,-0.09405370707322262,1
4639,Biological Process,GO:2000378,negative regulation of reactive oxygen species metabolic process,0.03383636365123843,-0.09417179752543338,1
4640,Biological Process,GO:0051703,biological process involved in intraspecies interaction between organisms,0.03383036993072164,-0.09428863407680786,1
4640,Biological Process,GO:0035176,social behavior,0.03383036993072164,-0.09428863407680786,1
4642,Phenotype,HP:0000074,Ureteropelvic junction obstruction,0.03381061194222745,-0.09467377970234861,1
4643,Phenotype,HP:0004303,Abnormal muscle fiber morphology,0.03378661510897207,-0.09514155380586428,1
4644,Biological Process,GO:0006576,biogenic amine metabolic process,0.03378469197518419,-0.095179041759962,1
4645,Phenotype,HP:0012426,Optic disc drusen,0.033783135685155785,-0.09520937877006244,1
4646,Phenotype,HP:3000062,Abnormal internal carotid artery morphology,0.033769515690214136,-0.09547487550689915,1
4647,Phenotype,HP:0006490,Abnormal lower-limb metaphysis morphology,0.03375242233579068,-0.09580807899489341,1
4648,Phenotype,HP:0030211,Slow pupillary light response,0.033713748850800584,-0.09656194741488636,1
4649,Biological Process,GO:0045005,DNA-templated DNA replication maintenance of fidelity,0.03371054999630008,-0.09662430319659837,1
4650,Phenotype,HP:0004878,Intercostal muscle weakness,0.033689270696361184,-0.09703910398912065,1
4651,Phenotype,HP:0003693,Distal amyotrophy,0.03364344988261114,-0.09793229643023073,1
4652,Disease,MONDO:0021138,bone marrow cancer,0.033579443563726885,-0.09917998182758246,1
4652,Disease,MONDO:0005170,myeloid neoplasm,0.033579443563726885,-0.09917998182758246,1
4652,Disease,MONDO:0020076,myeloproliferative neoplasm,0.033579443563726885,-0.09917998182758246,1
4652,Disease,MONDO:0005374,bone marrow neoplasm,0.033579443563726885,-0.09917998182758246,1
4656,Biological Process,GO:0098900,regulation of action potential,0.03357209158024943,-0.0993232952157962,1
4657,Phenotype,HP:0001773,Short foot,0.033568466154866305,-0.09939396621185664,1
4658,Phenotype,HP:0040035,Abnormality of the fourth metatarsal bone,0.03356537720272035,-0.09945417964941738,1
4658,Phenotype,HP:0004689,Short fourth metatarsal,0.03356537720272035,-0.09945417964941738,1
4660,Phenotype,HP:0012335,Abnormality of folate metabolism,0.03356302274241918,-0.09950007552013171,1
4661,Biological Process,GO:1903321,negative regulation of protein modification by small protein conjugation or removal,0.03355049255639975,-0.09974432843757909,1
4662,Phenotype,HP:0009823,Aplasia involving bones of the upper limbs,0.033546627459833056,-0.09981967138230201,1
4662,Phenotype,HP:0009802,Aplasia of the phalanges of the hand,0.033546627459833056,-0.09981967138230201,1
4664,Phenotype,HP:0100759,Clubbing of fingers,0.03351384462586082,-0.10045871240112589,1
4665,Biological Process,GO:1904031,positive regulation of cyclin-dependent protein kinase activity,0.03349877361959108,-0.10075249393354231,1
4666,Phenotype,HP:0000185,Cleft soft palate,0.0334868759699285,-0.10098441671875445,1
4667,Phenotype,HP:0002023,Anal atresia,0.033472390654217477,-0.10126678129156097,1
4668,Biological Process,GO:1904994,regulation of leukocyte adhesion to vascular endothelial cell,0.0334290691495156,-0.1021112543021957,1
4669,Phenotype,HP:0011730,Abnormal central sensory function,0.03341665614742906,-0.10235322293452216,1
4670,Biological Process,GO:0044091,membrane biogenesis,0.03338313306144447,-0.10300669380405883,1
4671,Phenotype,HP:0010314,Premature thelarche,0.033367082413724214,-0.10331957164374234,1
4672,Phenotype,HP:0002133,Status epilepticus,0.03336569706398518,-0.10334657648747887,1
4673,Biological Process,GO:2001138,regulation of phospholipid transport,0.033358795553781184,-0.10348110872822167,1
4674,Phenotype,HP:0000706,Eruption failure,0.033356420360764916,-0.10352740874506296,1
4675,Biological Process,GO:0032663,regulation of interleukin-2 production,0.03333061868035525,-0.1040303650224344,1
4676,Phenotype,HP:0000307,Pointed chin,0.033330532724375805,-0.10403204057607095,1
4677,Biological Process,GO:0051099,positive regulation of binding,0.033309548705751424,-0.10444108540276598,1
4678,Biological Process,GO:1901798,positive regulation of signal transduction by p53 class mediator,0.03329959278821315,-0.10463515769353783,1
4679,Biological Process,GO:0010827,regulation of glucose transmembrane transport,0.033292387530905354,-0.10477561092509073,1
4680,Phenotype,HP:0010767,Sacrococcygeal pilonidal abnormality,0.033221149931228044,-0.10616425683395003,1
4681,Phenotype,HP:0002024,Malabsorption,0.03321143515986724,-0.10635362842376764,1
4682,Phenotype,HP:0009552,Aplasia/Hypoplasia of the phalanges of the 2nd finger,0.033188606763699946,-0.10679862599649792,1
4683,Phenotype,HP:0032599,Abnormal renal tubular epithelial morphology,0.03318235354233723,-0.10692052103931048,1
4683,Phenotype,HP:0000092,Renal tubular atrophy,0.03318235354233723,-0.10692052103931048,1
4685,Biological Process,GO:0045010,actin nucleation,0.03313355343727653,-0.1078717892818033,1
4686,Disease,MONDO:0000066,mitochondrial complex deficiency,0.03312459814027535,-0.10804635631662253,1
4687,Biological Process,GO:0030033,microvillus assembly,0.03307331373746325,-0.10904605137198528,1
4687,Biological Process,GO:0032528,microvillus organization,0.03307331373746325,-0.10904605137198528,1
4689,Biological Process,GO:0007190,activation of adenylate cyclase activity,0.033047363970242216,-0.10955189432922374,1
4690,Phenotype,HP:0012767,Abnormal placental size,0.03304558436832783,-0.10958658439358589,1
4691,Biological Process,GO:0019363,pyridine nucleotide biosynthetic process,0.033025762853450935,-0.10997296834905149,1
4691,Biological Process,GO:0019359,nicotinamide nucleotide biosynthetic process,0.033025762853450935,-0.10997296834905149,1
4691,Biological Process,GO:0009435,NAD biosynthetic process,0.033025762853450935,-0.10997296834905149,1
4694,Biological Process,GO:0022412,cellular process involved in reproduction in multicellular organism,0.032961271713542795,-0.11123010444005929,1
4695,Biological Process,GO:0050657,nucleic acid transport,0.032957741042582755,-0.11129892837301597,1
4695,Biological Process,GO:0050658,RNA transport,0.032957741042582755,-0.11129892837301597,1
4697,Biological Process,GO:0031960,response to corticosteroid,0.032949744615423104,-0.11145480400485984,1
4698,Phenotype,HP:0001890,Autoimmune hemolytic anemia,0.03291082227526476,-0.11221352339839562,1
4699,Disease,MONDO:0019060,bone neoplasm,0.032898911965380195,-0.11244569297133698,1
4700,Disease,MONDO:0800088,lysosomal storage disease with skeletal involvement,0.03287946258563168,-0.11282482283730619,1
4701,Biological Process,GO:0048041,focal adhesion assembly,0.03287741582973236,-0.11286472057696756,1
4702,Phenotype,HP:0030177,Abnormality of peripheral nervous system electrophysiology,0.03286535437841054,-0.11309983637408623,1
4703,Phenotype,HP:0010655,Epiphyseal stippling,0.03286532704924772,-0.11310036910582225,1
4704,Phenotype,HP:0001073,Cigarette-paper scars,0.032803255311624424,-0.11431034340165507,1
4705,Biological Process,GO:0046040,IMP metabolic process,0.03279740544302978,-0.11442437582453445,1
4706,Disease,MONDO:0005528,inborn vitamin metabolic disorder,0.03279366215542667,-0.11449734432767446,1
4706,Disease,MONDO:0024298,vitamin deficiency disorder,0.03279366215542667,-0.11449734432767446,1
4708,Biological Process,GO:0046503,glycerolipid catabolic process,0.03278710424300979,-0.1146251787618723,1
4709,Phenotype,HP:0011360,Acquired abnormal hair pattern,0.03275776534187702,-0.115197086647778,1
4710,Phenotype,HP:0100650,Vaginal neoplasm,0.032752364527020794,-0.11530236559440982,1
4711,Biological Process,GO:1904356,regulation of telomere maintenance via telomere lengthening,0.03273865601639325,-0.1155695877816497,1
4712,Phenotype,HP:0010526,Dysgraphia,0.032722244159386515,-0.11588950673164836,1
4713,Biological Process,GO:0048562,embryonic organ morphogenesis,0.032713146266888815,-0.11606685340325719,1
4714,Biological Process,GO:0014074,response to purine-containing compound,0.03269440218976094,-0.11643223469258854,1
4715,Phenotype,HP:0002871,Central apnea,0.03268374743832292,-0.11663992946418869,1
4716,Phenotype,HP:0001998,Neonatal hypoglycemia,0.03266247653395937,-0.11705456660041977,1
4717,Phenotype,HP:0009886,Trichorrhexis nodosa,0.03265464800058904,-0.11720716945181185,1
4718,Phenotype,HP:0040126,Abnormal circulating vitamin B12 concentration,0.03264234065332594,-0.11744707853778928,1
4719,Phenotype,HP:0008807,Acetabular dysplasia,0.032634450549523075,-0.11760088159145694,1
4720,Phenotype,HP:0011948,Recurrent acute respiratory tract infection,0.03262635683186743,-0.1177586537224788,1
4721,Biological Process,GO:0051349,positive regulation of lyase activity,0.03260821580734463,-0.11811227961105751,1
4722,Biological Process,GO:0060306,regulation of membrane repolarization,0.03260176842219198,-0.11823795951963986,1
4723,Biological Process,GO:0034110,regulation of homotypic cell-cell adhesion,0.0325706130737593,-0.11884527570289277,1
4724,Phenotype,HP:0025336,Delayed ability to sit,0.03256764084845842,-0.11890321376541832,1
4725,Biological Process,GO:0045727,positive regulation of translation,0.03256456292065335,-0.11896321230374134,1
4726,Phenotype,HP:0007641,Dyschromatopsia,0.03256210631575995,-0.11901109929530693,1
4727,Biological Process,GO:2001222,regulation of neuron migration,0.03255010945201153,-0.11924495607654112,1
4728,Phenotype,HP:0002691,Platybasia,0.03251295912973806,-0.11996913324241344,1
4729,Phenotype,HP:0002216,Premature graying of hair,0.03246003515214868,-0.12100078879078902,1
4730,Phenotype,HP:0008689,Bilateral cryptorchidism,0.03244562303558718,-0.1212817264808823,1
4731,Phenotype,HP:0001176,Large hands,0.032426109914723944,-0.12166209886258171,1
4732,Disease,MONDO:0015547,hereditary dementia,0.0324211470558351,-0.12175884066358933,1
4732,Disease,MONDO:0002039,cognitive disorder,0.0324211470558351,-0.12175884066358933,1
4732,Disease,MONDO:0001627,dementia,0.0324211470558351,-0.12175884066358933,1
4735,Phenotype,HP:0000090,Nephronophthisis,0.03242112749077031,-0.1217592220485223,1
4736,Phenotype,HP:0002373,Febrile seizure (within the age range of 3 months to 6 years),0.03241198106557219,-0.12193751477581213,1
4736,Phenotype,HP:0032894,Seizure precipitated by febrile infection,0.03241198106557219,-0.12193751477581213,1
4736,Phenotype,HP:0032892,Infection-related seizure,0.03241198106557219,-0.12193751477581213,1
4739,Phenotype,HP:0000572,Visual loss,0.03240836933204261,-0.12200791887438461,1
4740,Phenotype,HP:0008062,Aplasia/Hypoplasia affecting the anterior segment of the eye,0.032396406366807295,-0.1222411148664884,1
4741,Biological Process,GO:0030330,"DNA damage response, signal transduction by p53 class mediator",0.03239468524696876,-0.12227466493040505,1
4742,Disease,MONDO:0002525,inherited lipid metabolism disorder,0.03234862923076065,-0.12317244221059766,1
4743,Biological Process,GO:0035306,positive regulation of dephosphorylation,0.03233548007301257,-0.1234287608428162,1
4744,Biological Process,GO:0045725,positive regulation of glycogen biosynthetic process,0.03230223929907161,-0.12407672855859439,1
4745,Biological Process,GO:0090150,establishment of protein localization to membrane,0.03229121108432764,-0.12429170331006839,1
4746,Phenotype,HP:0004755,Supraventricular tachycardia,0.032288752824625955,-0.12433962255907628,1
4747,Phenotype,HP:0009939,Mandibular aplasia,0.032223694590363894,-0.1256078131109036,1
4748,Phenotype,HP:0002305,Athetosis,0.032212931472352935,-0.12581762028941876,1
4749,Biological Process,GO:0046626,regulation of insulin receptor signaling pathway,0.032198699588686486,-0.12609504467090127,1
4750,Biological Process,GO:1902893,regulation of miRNA transcription,0.0321318292371956,-0.1273985591133086,1
4751,Biological Process,GO:0033108,mitochondrial respiratory chain complex assembly,0.032110018937591356,-0.12782371076712087,1
4752,Biological Process,GO:0060349,bone morphogenesis,0.03210920153380714,-0.12783964454964553,1
4753,Phenotype,HP:0012864,Abnormal sperm morphology,0.03209987217485699,-0.12802150323378267,1
4754,Disease,MONDO:0003778,inborn error of immunity,0.03209808944376524,-0.12805625429569895,1
4754,Disease,MONDO:0009453,immune deficiency disease,0.03209808944376524,-0.12805625429569895,1
4756,Phenotype,HP:0009892,Anotia,0.03209277230342289,-0.128159902161667,1
4757,Biological Process,GO:0042770,signal transduction in response to DNA damage,0.03208046924146801,-0.12839972771344685,1
4758,Phenotype,HP:0011133,Increased sensitivity to ionizing radiation,0.03207387685118723,-0.12852823423015258,1
4759,Phenotype,HP:0012696,Abnormal thalamic MRI signal intensity,0.03206503853395459,-0.12870052095965923,1
4760,Biological Process,GO:2001032,regulation of double-strand break repair via nonhomologous end joining,0.03204145648514456,-0.12916020960373076,1
4761,Biological Process,GO:0032784,regulation of DNA-templated transcription elongation,0.03203994721052994,-0.12918963013486082,1
4762,Disease,MONDO:0020119,X-linked syndromic intellectual disability,0.03203358985682403,-0.12931355504607164,1
4763,Biological Process,GO:0090114,COPII-coated vesicle budding,0.03201329320446722,-0.12970920093232405,1
4764,Biological Process,GO:1902644,tertiary alcohol metabolic process,0.031976869768021055,-0.13041920879666363,1
4765,Biological Process,GO:0002548,monocyte chemotaxis,0.03197312972147304,-0.13049211412139908,1
4766,Biological Process,GO:0016486,peptide hormone processing,0.03195978235551333,-0.13075229645794534,1
4767,Phenotype,HP:0001789,Hydrops fetalis,0.031954224816987176,-0.13086063044410765,1
4768,Biological Process,GO:0006829,zinc ion transport,0.03193618190670977,-0.13121234377602967,1
4769,Phenotype,HP:0000291,Abnormality of facial adipose tissue,0.03193091505171097,-0.131315011421764,1
4770,Phenotype,HP:0006530,Abnormal pulmonary interstitial morphology,0.03192994304024388,-0.13133395899654554,1
4771,Biological Process,GO:0051236,establishment of RNA localization,0.031883339359575436,-0.13224241198753864,1
4772,Biological Process,GO:1904752,regulation of vascular associated smooth muscle cell migration,0.03188102691388184,-0.13228748886079686,1
4773,Phenotype,HP:0012087,Abnormal mitochondrial shape,0.03186607932059671,-0.13257886468419228,1
4774,Biological Process,GO:0006906,vesicle fusion,0.03185752569556155,-0.1327456018632212,1
4775,Phenotype,HP:0010950,Abnormal fourth ventricle morphology,0.03185287600273157,-0.13283623906822328,1
4775,Phenotype,HP:0002198,Dilated fourth ventricle,0.03185287600273157,-0.13283623906822328,1
4777,Biological Process,GO:0032645,regulation of granulocyte macrophage colony-stimulating factor production,0.031826049413075874,-0.1333591740652301,1
4778,Biological Process,GO:1901879,regulation of protein depolymerization,0.03182156991669671,-0.13344649360363187,1
4779,Phenotype,HP:0002204,Pulmonary embolism,0.031801171529379335,-0.13384412262572012,1
4780,Phenotype,HP:0010644,Midnasal stenosis,0.03177926690451405,-0.13427111297691197,1
4780,Phenotype,HP:0010641,Abnormality of the midnasal cavity,0.03177926690451405,-0.13427111297691197,1
4782,Phenotype,HP:0002110,Bronchiectasis,0.031776059308795346,-0.13433363915258642,1
4783,Biological Process,GO:1902850,microtubule cytoskeleton organization involved in mitosis,0.03176327216929464,-0.13458290090528582,1
4784,Phenotype,HP:0009809,Abnormal upper limb metaphysis morphology,0.03176118497675384,-0.13462358688285825,1
4785,Phenotype,HP:0005155,Ventricular escape rhythm,0.03175582577721381,-0.13472805461548454,1
4786,Phenotype,HP:0012401,Abnormal urine alpha-ketoglutarate concentration,0.03174503379717197,-0.13493842440617754,1
4787,Biological Process,GO:0033013,tetrapyrrole metabolic process,0.03173468509318367,-0.13514015334595725,1
4788,Biological Process,GO:0051017,actin filament bundle assembly,0.03170102752527959,-0.1357962456930305,1
4789,Phenotype,HP:0009797,Cholesteatoma,0.03170032224018682,-0.13580999392799484,1
4789,Phenotype,HP:0100799,Neoplasm of the middle ear,0.03170032224018682,-0.13580999392799484,1
4791,Phenotype,HP:0002149,Hyperuricemia,0.03167105316820629,-0.13638054062308258,1
4792,Phenotype,HP:0007803,Monochromacy,0.03166225844170989,-0.13655197763140514,1
4793,Biological Process,GO:0050868,negative regulation of T cell activation,0.03163420279680973,-0.13709887079860186,1
4794,Phenotype,HP:0025426,Abnormal bronchus morphology,0.03162976507306958,-0.13718537605627923,1
4795,Biological Process,GO:0045787,positive regulation of cell cycle,0.03162452034273888,-0.13728761242232454,1
4796,Biological Process,GO:0009064,glutamine family amino acid metabolic process,0.03155004523431315,-0.13873936760632444,1
4797,Disease,MONDO:0000413,infancy electroclinical syndrome,0.0315473022350653,-0.13879283732878542,1
4798,Biological Process,GO:0006023,aminoglycan biosynthetic process,0.031541925271215465,-0.13889765134394005,1
4799,Disease,MONDO:0100137,telomere syndrome,0.03153909353768525,-0.1389528507779402,1
4800,Phenotype,HP:0100738,Abnormal eating behavior,0.031520067103512295,-0.13932373609825044,1
4801,Biological Process,GO:0030032,lamellipodium assembly,0.03150551307365479,-0.13960744012688966,1
4802,Phenotype,HP:0001193,Ulnar deviation of the hand or of fingers of the hand,0.031482999303395376,-0.1400463046465443,1
4803,Biological Process,GO:0045070,positive regulation of viral genome replication,0.03147354890905685,-0.14023052269283937,1
4804,Phenotype,HP:0004359,Abnormal circulating fatty-acid concentration,0.03146833437959462,-0.14033217034853174,1
4805,Biological Process,GO:0006670,sphingosine metabolic process,0.0314666961600194,-0.1403641044243743,1
4806,Biological Process,GO:0045056,transcytosis,0.031465698170617284,-0.1403835583911926,1
4807,Phenotype,HP:0009906,Aplasia/Hypoplasia of the earlobes,0.0314484254704932,-0.1407202578935749,1
4808,Phenotype,HP:0007110,Central hypoventilation,0.03144635975762222,-0.1407605251645127,1
4809,Biological Process,GO:0022404,molting cycle process,0.03144538429763144,-0.1407795399619173,1
4809,Biological Process,GO:0022405,hair cycle process,0.03144538429763144,-0.1407795399619173,1
4811,Phenotype,HP:0000932,Abnormal posterior cranial fossa morphology,0.03144184668930472,-0.14084849912607078,1
4812,Biological Process,GO:0098659,inorganic cation import across plasma membrane,0.03142753486166805,-0.1411274818681338,1
4812,Biological Process,GO:0099587,inorganic ion import across plasma membrane,0.03142753486166805,-0.1411274818681338,1
4814,Disease,MONDO:0002334,hematopoietic and lymphoid system neoplasm,0.03142192899259122,-0.14123675796943988,1
4815,Phenotype,HP:0004478,Ethmoidal encephalocele,0.031349187402521905,-0.1426547214032338,1
4816,Phenotype,HP:0002451,Limb dystonia,0.03134600644002994,-0.14271672841316552,1
4817,Phenotype,HP:0010831,Impaired proprioception,0.03133582779825095,-0.14291514230313607,1
4818,Phenotype,HP:0000408,Progressive sensorineural hearing impairment,0.031322365563802745,-0.1431775637894759,1
4819,Phenotype,HP:0006143,Abnormal finger flexion crease,0.03130430137982221,-0.143529691813091,1
4820,Phenotype,HP:0001549,Abnormal ileum morphology,0.031303142864137046,-0.14355227494438455,1
4821,Phenotype,HP:0030674,Antenatal onset,0.031298119234810295,-0.14365020135324472,1
4822,Biological Process,GO:0007281,germ cell development,0.03126535390209684,-0.14428890121723592,1
4823,Phenotype,HP:0006970,Periventricular leukomalacia,0.03123769539686383,-0.14482805287746814,1
4824,Phenotype,HP:0000737,Irritability,0.031234152237406665,-0.144897120250694,1
4825,Phenotype,HP:0012428,Prominent calcaneus,0.031232522572630095,-0.14492888756648015,1
4826,Disease,MONDO:0005059,leukemia,0.031224463586980722,-0.14508598266095626,1
4827,Phenotype,HP:0000565,Esotropia,0.031206171893304102,-0.14544254556741584,1
4828,Phenotype,HP:0009568,Aplasia/Hypoplasia of the middle phalanx of the 2nd finger,0.03120459943579923,-0.1454731977327174,1
4828,Phenotype,HP:0009543,Abnormality of the middle phalanx of the 2nd finger,0.03120459943579923,-0.1454731977327174,1
4830,Disease,MONDO:0018117,"disorder of phospholipids, sphingolipids and fatty acids biosynthesis",0.03116219531468234,-0.14629978803860189,1
4831,Disease,MONDO:0015780,dyskeratosis congenita,0.031157114912274797,-0.14639882113419397,1
4832,Biological Process,GO:1901673,regulation of mitotic spindle assembly,0.03114542013271704,-0.14662678934004952,1
4833,Biological Process,GO:0072594,establishment of protein localization to organelle,0.031114565027820618,-0.14722825282809412,1
4834,Biological Process,GO:0006643,membrane lipid metabolic process,0.031113980264186658,-0.14723965171901163,1
4835,Phenotype,HP:0001528,Hemihypertrophy,0.031112890018536343,-0.14726090405161155,1
4836,Biological Process,GO:0042401,biogenic amine biosynthetic process,0.03104041783862166,-0.14867361583023,1
4837,Biological Process,GO:0031122,cytoplasmic microtubule organization,0.031022575855975565,-0.14902141244774192,1
4838,Biological Process,GO:0032774,RNA biosynthetic process,0.030986205182296778,-0.14973039179902953,1
4839,Biological Process,GO:0060766,negative regulation of androgen receptor signaling pathway,0.030964797409926748,-0.1501476969251721,1
4840,Biological Process,GO:0035279,miRNA-mediated gene silencing by mRNA destabilization,0.03094635235644949,-0.1505072492987207,1
4841,Phenotype,HP:0008774,Aplasia/Hypoplasia of the inner ear,0.030913806813590683,-0.15114166476396954,1
4842,Phenotype,HP:0003079,Defective DNA repair after ultraviolet radiation damage,0.030907973911734277,-0.15125536645151047,1
4843,Phenotype,HP:0009103,Aplasia/Hypoplasia involving the pelvis,0.030874053454190253,-0.15191658334832495,1
4844,Phenotype,HP:0006304,Widely-spaced incisors,0.030866790476873796,-0.15205816172522596,1
4845,Phenotype,HP:0001959,Polydipsia,0.030864883815430733,-0.15209532858127506,1
4846,Disease,MONDO:0002561,lysosomal storage disease,0.03086075278528111,-0.15217585541180603,1
4847,Phenotype,HP:0011951,Aspiration pneumonia,0.03085490658498158,-0.15228981632802288,1
4848,Biological Process,GO:0046470,phosphatidylcholine metabolic process,0.030852184725479792,-0.15234287397003732,1
4849,Phenotype,HP:0011134,Low-grade fever,0.03085151496529248,-0.1523559297123453,1
4850,Biological Process,GO:0043032,positive regulation of macrophage activation,0.03081437874777293,-0.15307983193199656,1
4851,Phenotype,HP:0012398,Peripheral edema,0.030810508449132246,-0.15315527628157874,1
4852,Phenotype,HP:0006486,Abnormal dental root morphology,0.030791854061681168,-0.1535189092357147,1
4853,Phenotype,HP:0003502,Mild short stature,0.03078350117431039,-0.15368173340338928,1
4854,Biological Process,GO:0002889,regulation of immunoglobulin mediated immune response,0.030747172508235665,-0.15438989389374128,1
4855,Phenotype,HP:0030001,Lagophthalmos,0.030746043990815042,-0.15441189226407273,1
4856,Phenotype,HP:0006958,Abnormal auditory evoked potentials,0.030735494574344213,-0.15461753372433287,1
4857,Phenotype,HP:0011620,Abnormality of abdominal situs,0.03067696918909557,-0.15575837840688928,1
4858,Biological Process,GO:0000154,rRNA modification,0.03067582995163798,-0.15578058574461362,1
4859,Biological Process,GO:2001140,positive regulation of phospholipid transport,0.030671411390983283,-0.1558667174532055,1
4860,Biological Process,GO:0006220,pyrimidine nucleotide metabolic process,0.030660918063305176,-0.1560712655656704,1
4861,Biological Process,GO:0097164,ammonium ion metabolic process,0.030639310517870832,-0.15649246490006413,1
4862,Phenotype,HP:0032135,Decreased circulating IgG subclass level,0.03057909448532148,-0.15766626564049016,1
4863,Biological Process,GO:0000226,microtubule cytoskeleton organization,0.03054484377334532,-0.1583339202396998,1
4864,Biological Process,GO:0016233,telomere capping,0.03054141886455275,-0.15840068253383327,1
4865,Phenotype,HP:0003839,Abnormal upper limb epiphysis morphology,0.030516861602424727,-0.15887938116687728,1
4866,Biological Process,GO:0042339,keratan sulfate metabolic process,0.03051370989821256,-0.15894081784048764,1
4867,Phenotype,HP:0000399,Prelingual sensorineural hearing impairment,0.030506629265291352,-0.15907884174896728,1
4868,Phenotype,HP:0012146,Abnormality of von Willebrand factor,0.03050583723456657,-0.15909428093039174,1
4869,Phenotype,HP:0000744,Low frustration tolerance,0.030505379892821427,-0.1591031959660782,1
4870,Biological Process,GO:0016137,glycoside metabolic process,0.030499083289890372,-0.15922593665273144,1
4871,Phenotype,HP:0002539,Cortical dysplasia,0.03048368195350959,-0.15952615736276404,1
4872,Biological Process,GO:0006739,NADP metabolic process,0.030465897697233735,-0.1598728287109206,1
4873,Phenotype,HP:0031508,Abnormal circulating thyroid hormone concentration,0.030460666713426954,-0.1599747971137795,1
4874,Biological Process,GO:0006029,proteoglycan metabolic process,0.030456533338702796,-0.16005536964747635,1
4875,Phenotype,HP:0030825,Absent foveal reflex,0.03044699816205132,-0.16024124036893947,1
4876,Phenotype,HP:0034011,Reduced progressive sperm motility,0.030440544349687126,-0.160367045564183,1
4877,Biological Process,GO:0006084,acetyl-CoA metabolic process,0.03040412441437612,-0.16107698518033567,1
4878,Biological Process,GO:0106058,positive regulation of calcineurin-mediated signaling,0.03038186456712233,-0.16151089993828416,1
4878,Biological Process,GO:0070886,positive regulation of calcineurin-NFAT signaling cascade,0.03038186456712233,-0.16151089993828416,1
4880,Biological Process,GO:0072378,"blood coagulation, fibrin clot formation",0.030377807002077595,-0.16158999470179142,1
4881,Biological Process,GO:0046390,ribose phosphate biosynthetic process,0.030359644436111832,-0.16194404050115846,1
4882,Phenotype,HP:0003107,Abnormal circulating cholesterol concentration,0.030357718510431342,-0.1619815828780647,1
4883,Phenotype,HP:0100303,Muscle fiber cytoplasmatic inclusion bodies,0.030333971957185013,-0.16244447823338823,1
4884,Phenotype,HP:0010464,Streak ovary,0.030319432339809826,-0.16272790131720757,1
4885,Phenotype,HP:0008873,Disproportionate short-limb short stature,0.030298804713594474,-0.163129998929749,1
4886,Disease,MONDO:0019694,spondylodysplastic dysplasia,0.030194945038110155,-0.16515455217284056,1
4887,Phenotype,HP:0040154,Acne inversa,0.030172013298018774,-0.16560156424518951,1
4888,Biological Process,GO:0043367,"CD4-positive, alpha-beta T cell differentiation",0.030161526218209,-0.16580599056695905,1
4889,Biological Process,GO:0044088,regulation of vacuole organization,0.030148347054520963,-0.1660628941097578,1
4890,Biological Process,GO:0010962,regulation of glucan biosynthetic process,0.030145248842427197,-0.1661232880529602,1
4890,Biological Process,GO:0005979,regulation of glycogen biosynthetic process,0.030145248842427197,-0.1661232880529602,1
4892,Phenotype,HP:0200055,Small hand,0.030107778710986355,-0.16685369931001326,1
4893,Biological Process,GO:0099116,tRNA 5'-end processing,0.03010099854601478,-0.1669858661487588,1
4894,Biological Process,GO:1903318,negative regulation of protein maturation,0.030045456315396457,-0.16806855972162518,1
4894,Biological Process,GO:0010955,negative regulation of protein processing,0.030045456315396457,-0.16806855972162518,1
4896,Biological Process,GO:0086091,regulation of heart rate by cardiac conduction,0.03003689195620529,-0.1682355061432717,1
4897,Phenotype,HP:0006500,Abnormal lower limb epiphysis morphology,0.030004566835669877,-0.16886562488096388,1
4898,Phenotype,HP:0100832,Vitreous floaters,0.0299839638817313,-0.16926724155287334,1
4899,Phenotype,HP:0200021,Down-sloping shoulders,0.029976766405760302,-0.16940754310158518,1
4900,Biological Process,GO:0019079,viral genome replication,0.029949063417814448,-0.16994756187044388,1
4901,Phenotype,HP:0002101,Abnormal lung lobation,0.0299487082328197,-0.16995448554827808,1
4902,Phenotype,HP:0003010,Prolonged bleeding time,0.02993796914747926,-0.17016382425410817,1
4903,Disease,MONDO:0005015,diabetes mellitus,0.02992323162968935,-0.17045110504232114,1
4904,Biological Process,GO:0060353,regulation of cell adhesion molecule production,0.029914777147142413,-0.1706159096209918,1
4905,Biological Process,GO:0090174,organelle membrane fusion,0.029906778789141608,-0.17077182289103068,1
4906,Disease,MONDO:0019215,classic organic aciduria,0.029899163236531634,-0.1709202740744429,1
4907,Phenotype,HP:0004380,Aortic valve calcification,0.029882504987087777,-0.1712449959915731,1
4908,Biological Process,GO:0048285,organelle fission,0.02987361498991603,-0.17141829012638726,1
4909,Phenotype,HP:0007447,Diffuse palmoplantar hyperkeratosis,0.02986877973744595,-0.1715125444750921,1
4910,Biological Process,GO:0002526,acute inflammatory response,0.029849368835119794,-0.17189092429452146,1
4911,Biological Process,GO:1904995,negative regulation of leukocyte adhesion to vascular endothelial cell,0.029817364376326316,-0.17251479232166073,1
4912,Biological Process,GO:0044790,suppression of viral release by host,0.029814879626992252,-0.17256322793730355,1
4913,Biological Process,GO:1905906,regulation of amyloid fibril formation,0.029810028210370598,-0.1726577973763968,1
4914,Phenotype,HP:0012650,Perisylvian polymicrogyria,0.029784076998293885,-0.1731636684984378,1
4915,Biological Process,GO:0120031,plasma membrane bounded cell projection assembly,0.029742588799349656,-0.1739724045871159,1
4916,Phenotype,HP:0011395,Aplasia/Hypoplasia of the cochlea,0.02973845552489518,-0.17405297516623985,1
4917,Phenotype,HP:0001947,Renal tubular acidosis,0.029724608815574594,-0.1743228912826769,1
4918,Biological Process,GO:0090025,regulation of monocyte chemotaxis,0.029696043078112133,-0.17487972776566454,1
4919,Phenotype,HP:0008059,Aplasia/Hypoplasia of the macula,0.029682047039305437,-0.1751525547856258,1
4920,Phenotype,HP:0002375,Hypokinesia,0.02967387183690051,-0.17531191531188048,1
4921,Disease,MONDO:0005093,skin disorder,0.02966853049850049,-0.1754160348744517,1
4922,Biological Process,GO:0071219,cellular response to molecule of bacterial origin,0.029659159765878962,-0.1755987000621734,1
4923,Disease,MONDO:0019245,lysosomal lipid storage disorder,0.02964634781489528,-0.1758484454690735,1
4924,Biological Process,GO:0140374,antiviral innate immune response,0.02962700694304299,-0.1762254601732903,1
4925,Phenotype,HP:0004283,Narrow palm,0.029622202674819076,-0.17631911054113564,1
4926,Phenotype,HP:0001057,Aplasia cutis congenita,0.02959717039794585,-0.17680706871247912,1
4927,Biological Process,GO:0033344,cholesterol efflux,0.029591830040220035,-0.17691116915861135,1
4928,Phenotype,HP:0002506,Diffuse cerebral atrophy,0.02958589148550428,-0.1770269303542149,1
4929,Disease,MONDO:0800063,primordial dwarfism and slender bone disorder,0.029556790982894654,-0.177594191099631,1
4930,Phenotype,HP:0000973,Cutis laxa,0.02955000813295372,-0.17772641027691308,1
4931,Phenotype,HP:0005387,Combined immunodeficiency,0.02954931164007646,-0.1777399871238161,1
4932,Phenotype,HP:0002139,Arrhinencephaly,0.029535360681615108,-0.17801193538540516,1
4933,Phenotype,HP:0009120,Aplasia/Hypoplasia involving the sinuses,0.029532678638658938,-0.17806421687713622,1
4934,Biological Process,GO:0030834,regulation of actin filament depolymerization,0.029520625422035485,-0.17829917215396435,1
4935,Biological Process,GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,0.029513461604244506,-0.17843881759839703,1
4936,Biological Process,GO:0016579,protein deubiquitination,0.02951154956290558,-0.17847608932561546,1
4937,Biological Process,GO:0045582,positive regulation of T cell differentiation,0.029508915899442045,-0.17852742774816927,1
4938,Phenotype,HP:0003237,Increased circulating IgG level,0.029502170596162003,-0.17865891502239348,1
4939,Phenotype,HP:0010781,Skin dimple,0.029501845411833094,-0.17866525389245663,1
4940,Phenotype,HP:0006494,Aplasia/Hypoplasia involving bones of the feet,0.029498015414188505,-0.17873991264828487,1
4941,Phenotype,HP:0001609,Hoarse voice,0.029490627203783704,-0.17888393221377968,1
4942,Biological Process,GO:0003009,skeletal muscle contraction,0.029484556549714158,-0.17900226844318606,1
4943,Biological Process,GO:0035024,negative regulation of Rho protein signal transduction,0.029480559509477366,-0.17908018338694484,1
4944,Disease,MONDO:0019236,inborn disorder of purine metabolism,0.02947075602606386,-0.17927128425497524,1
4944,Disease,MONDO:0037829,purine metabolism disease,0.02947075602606386,-0.17927128425497524,1
4946,Phenotype,HP:0100800,Aplasia/Hypoplasia of the pancreas,0.029466952993263074,-0.17934541738079632,1
4947,Phenotype,HP:0000217,Xerostomia,0.029449207398900334,-0.1796913350861053,1
4948,Phenotype,HP:0003798,Nemaline bodies,0.029448138012553526,-0.1797121808049702,1
4949,Phenotype,HP:0007109,Periventricular cysts,0.02944437909290598,-0.17978545402604923,1
4950,Biological Process,GO:1903307,positive regulation of regulated secretory pathway,0.029409336423353194,-0.18046854638079465,1
4951,Phenotype,HP:0011510,Drusen,0.02939713486671902,-0.1807063932731452,1
4952,Phenotype,HP:0001660,Truncus arteriosus,0.029387326470726838,-0.1808975899028564,1
4953,Biological Process,GO:1903052,positive regulation of proteolysis involved in protein catabolic process,0.029368612457960408,-0.1812623851427881,1
4954,Phenotype,HP:0000433,Abnormal nasal mucosa morphology,0.0293252515057969,-0.18210762710909312,1
4955,Biological Process,GO:0046685,response to arsenic-containing substance,0.02930465286574291,-0.18250915968976136,1
4956,Phenotype,HP:0031378,Abnormal lymphocyte proliferation,0.02928079036478204,-0.18297431523240407,1
4956,Phenotype,HP:0031377,Abnormal cell proliferation,0.02928079036478204,-0.18297431523240407,1
4958,Biological Process,GO:0051155,positive regulation of striated muscle cell differentiation,0.02925682094922477,-0.18344155487835118,1
4959,Phenotype,HP:0100607,Dysmenorrhea,0.029225759707427024,-0.18404703662593833,1
4960,Biological Process,GO:0006479,protein methylation,0.02921866950839702,-0.18418524700810462,1
4960,Biological Process,GO:0008213,protein alkylation,0.02921866950839702,-0.18418524700810462,1
4962,Phenotype,HP:0008724,Hypoplasia of the ovary,0.029211783970196747,-0.1843194679040278,1
4963,Phenotype,HP:0025502,Overweight,0.029210611403064024,-0.18434232494243302,1
4964,Phenotype,HP:0000600,Abnormality of the pharynx,0.029207804554135963,-0.18439703929690865,1
4965,Biological Process,GO:0055075,potassium ion homeostasis,0.02920297798305649,-0.18449112441787976,1
4966,Biological Process,GO:1904152,"regulation of retrograde protein transport, ER to cytosol",0.0291978503950322,-0.18459107731023575,1
4967,Phenotype,HP:0011147,Typical absence seizure,0.029184274215992012,-0.1848557199367068,1
4968,Biological Process,GO:0046620,regulation of organ growth,0.029174093226383868,-0.18505417959328604,1
4969,Phenotype,HP:0000010,Recurrent urinary tract infections,0.029172241376167696,-0.1850902780053347,1
4970,Biological Process,GO:0033559,unsaturated fatty acid metabolic process,0.029162026942601393,-0.18528938959033212,1
4971,Phenotype,HP:0011117,Abnormal circulating interleukin concentration,0.029130107640124248,-0.1859115976517956,1
4972,Phenotype,HP:0034644,Abnormal liver metabolite concentration,0.02912961939239611,-0.185921115142745,1
4973,Phenotype,HP:0002126,Polymicrogyria,0.02912606940830853,-0.18599031554958165,1
4974,Phenotype,HP:0100571,Cardiac diverticulum,0.029101725733138295,-0.18646485069794255,1
4975,Biological Process,GO:0010639,negative regulation of organelle organization,0.029098798610418974,-0.1865219095686418,1
4976,Biological Process,GO:1902808,positive regulation of cell cycle G1/S phase transition,0.029064789734639662,-0.1871848500162393,1
4977,Phenotype,HP:0006499,Abnormal femoral epiphysis morphology,0.029037724132274567,-0.18771244412616653,1
4978,Biological Process,GO:0046683,response to organophosphorus,0.029009964853982884,-0.18825356017172737,1
4979,Phenotype,HP:0000483,Astigmatism,0.029002838880338278,-0.18839246791417022,1
4980,Phenotype,HP:0011807,Type 1 muscle fiber atrophy,0.028998459497918794,-0.18847783591516537,1
4981,Biological Process,GO:0006939,smooth muscle contraction,0.028949997440918973,-0.18942251453281317,1
4982,Phenotype,HP:0001653,Mitral regurgitation,0.028933045868004603,-0.18975295425120486,1
4983,Disease,MONDO:0003900,connective tissue disorder,0.028916143347267664,-0.19008243778766706,1
4984,Phenotype,HP:0100957,Abnormal renal medulla morphology,0.028890027090659465,-0.1905915261491219,1
4985,Biological Process,GO:0032647,regulation of interferon-alpha production,0.02888864096262156,-0.1906185461643626,1
4986,Phenotype,HP:0040319,Dark urine,0.028882040196583803,-0.19074721595103689,1
4987,Phenotype,HP:0000211,Trismus,0.0288757948607834,-0.19086895727932374,1
4988,Phenotype,HP:0011490,Abnormal Descemet membrane morphology,0.028862179883120342,-0.19113435621354746,1
4989,Disease,MONDO:0002135,optic nerve disorder,0.028857036977214423,-0.1912346076998167,1
4989,Disease,MONDO:0043878,hereditary optic atrophy,0.028857036977214423,-0.1912346076998167,1
4989,Disease,MONDO:0003608,optic atrophy,0.028857036977214423,-0.1912346076998167,1
4989,Disease,MONDO:0001084,primary optic atrophy,0.028857036977214423,-0.1912346076998167,1
4993,Phenotype,HP:0100753,Schizophrenia,0.02884257824938974,-0.19151645399070813,1
4994,Biological Process,GO:0046794,transport of virus,0.028813805047565366,-0.19207733460963955,1
4995,Phenotype,HP:0003298,Spina bifida occulta,0.02877660184122255,-0.19280254265312247,1
4996,Biological Process,GO:0050995,negative regulation of lipid catabolic process,0.0287750061100861,-0.19283364849504175,1
4997,Biological Process,GO:0035794,positive regulation of mitochondrial membrane permeability,0.028765020476553604,-0.1930283000444353,1
4998,Biological Process,GO:0002446,neutrophil mediated immunity,0.02874865548247918,-0.19334730548780926,1
4999,Biological Process,GO:0019218,regulation of steroid metabolic process,0.028725366421594623,-0.19380128287145232,1
5000,Phenotype,HP:0012285,Abnormal hypothalamus physiology,0.02870843754155694,-0.1941312802339741,1
5001,Biological Process,GO:0015669,gas transport,0.028656721599838786,-0.19513938734615965,1
5002,Phenotype,HP:0010783,Erythema,0.02864276966215007,-0.19541135469598414,1
5003,Phenotype,HP:0033130,Abnormal renal echogenicity,0.028630794666874237,-0.19564478519158926,1
5004,Biological Process,GO:0070168,negative regulation of biomineral tissue development,0.0286218623271024,-0.19581890471747015,1
5005,Phenotype,HP:0010034,Short 1st metacarpal,0.02861238232752028,-0.19600369986350719,1
5006,Biological Process,GO:2000679,positive regulation of transcription regulatory region DNA binding,0.028592495516713834,-0.19639135664295684,1
5007,Phenotype,HP:0009119,Aplasia/Hypoplasia of the frontal sinuses,0.02855318270376961,-0.19715768758487567,1
5008,Phenotype,HP:0031913,Rhombencephalosynapsis,0.02852687995408143,-0.19767041128572593,1
5009,Phenotype,HP:0002677,Small foramen magnum,0.028520900942637595,-0.19778696111079183,1
5010,Phenotype,HP:0100605,Neoplasm of the larynx,0.028510586186433873,-0.19798802830098441,1
5011,Phenotype,HP:0009486,Radial deviation of the hand,0.02850821865978137,-0.1980341788761723,1
5012,Biological Process,GO:0044774,mitotic DNA integrity checkpoint signaling,0.028504059234153778,-0.19811525922429077,1
5013,Phenotype,HP:0000387,Absent earlobe,0.02843640866174091,-0.19943398263775025,1
5014,Phenotype,HP:0012177,Abnormal natural killer cell physiology,0.028427640263369525,-0.19960490642772669,1
5014,Phenotype,HP:0012178,Reduced natural killer cell activity,0.028427640263369525,-0.19960490642772669,1
5016,Phenotype,HP:0003100,Slender long bone,0.02840524754887841,-0.2000414111879544,1
5017,Phenotype,HP:0025380,Increased circulating androstenedione concentration,0.02840395853658806,-0.2000665381104163,1
5018,Phenotype,HP:0002548,Parkinsonism with favorable response to dopaminergic medication,0.028348069952968458,-0.2011559831976575,1
5019,Phenotype,HP:0100019,Cortical cataract,0.02834588472822286,-0.20119858013265615,1
5020,Biological Process,GO:0062098,regulation of programmed necrotic cell death,0.02834014427060838,-0.20131047978982364,1
5021,Phenotype,HP:0004749,Atrial flutter,0.02832288600418631,-0.20164689793374724,1
5022,Phenotype,HP:0030828,Wheezing,0.028296173021917115,-0.2021676183638232,1
5023,Phenotype,HP:0010053,Abnormality of the distal phalanx of the hallux,0.02829042297830786,-0.20227970488231795,1
5024,Phenotype,HP:0000768,Pectus carinatum,0.028284985475626412,-0.20238569899058675,1
5025,Phenotype,HP:0100651,Type I diabetes mellitus,0.028284538102816836,-0.20239441970021996,1
5026,Phenotype,HP:0000341,Narrow forehead,0.02824888401088821,-0.20308943060899642,1
5027,Phenotype,HP:0002837,Recurrent bronchitis,0.02824303443809628,-0.20320345726574623,1
5028,Phenotype,HP:0001027,"Soft, doughy skin",0.028218593491968647,-0.20367988853241623,1
5029,Biological Process,GO:1902895,positive regulation of miRNA transcription,0.028190624017441324,-0.20422510196677177,1
5030,Phenotype,HP:0008061,Aplasia/Hypoplasia of the retina,0.0281547851735654,-0.20492371427476622,1
5031,Phenotype,HP:0007661,Abnormality of chorioretinal pigmentation,0.02814660383566192,-0.20508319440127418,1
5032,Phenotype,HP:0003956,Bowed forearm bones,0.028141551781414198,-0.205181674901659,1
5033,Phenotype,HP:0100767,Abnormal placenta morphology,0.02813980223529955,-0.20521577908351624,1
5034,Phenotype,HP:0032943,Abnormal urine pH,0.02811236938072259,-0.20575053209946828,1
5035,Phenotype,HP:0011803,Bifid nose,0.028091502739136076,-0.20615728887681625,1
5036,Phenotype,HP:0000727,Frontal lobe dementia,0.02808430396766115,-0.20629761567899305,1
5037,Biological Process,GO:0045600,positive regulation of fat cell differentiation,0.02807057787501077,-0.20656518059541237,1
5038,Phenotype,HP:0009603,Deviation of the thumb,0.028066329575265336,-0.20664799338090528,1
5039,Biological Process,GO:0070922,RISC complex assembly,0.028064925582900635,-0.2066753616283216,1
5040,Biological Process,GO:0046519,sphingoid metabolic process,0.02805245603115003,-0.20691843259228196,1
5041,Phenotype,HP:0001830,Postaxial foot polydactyly,0.02802410260962762,-0.20747113036673823,1
5042,Phenotype,HP:0002912,Methylmalonic acidemia,0.028021776391099484,-0.20751647571605997,1
5043,Biological Process,GO:0071243,cellular response to arsenic-containing substance,0.028009646935016508,-0.20775291714084984,1
5044,Phenotype,HP:0030406,Primary peritoneal carcinoma,0.028008173480591037,-0.2077816394233115,1
5045,Phenotype,HP:0006489,Abnormal femoral metaphysis morphology,0.02800527648701656,-0.20783811098177793,1
5046,Biological Process,GO:0044794,positive regulation by host of viral process,0.027976807145213445,-0.2083930684087813,1
5047,Phenotype,HP:0034378,Urethrovesical occlusion,0.02797181588524489,-0.20849036383657205,1
5048,Biological Process,GO:0031098,stress-activated protein kinase signaling cascade,0.027957137880689653,-0.20877648452379582,1
5049,Phenotype,HP:0031475,Status epilepticus without prominent motor symptoms,0.027944234055054307,-0.2090280208579554,1
5050,Phenotype,HP:0012100,Abnormal circulating creatinine concentration,0.027934230768885904,-0.20922301651300027,1
5051,Phenotype,HP:0003758,Reduced subcutaneous adipose tissue,0.027929850998361316,-0.20930839207939023,1
5052,Disease,MONDO:0018943,myofibrillar myopathy,0.027914562990978053,-0.20960640364917282,1
5053,Disease,MONDO:0700120,BAFopathy,0.027911347653060692,-0.20966908074476237,1
5054,Biological Process,GO:0014013,regulation of gliogenesis,0.027884115308432156,-0.21019992518826355,1
5055,Phenotype,HP:0002384,Focal impaired awareness seizure,0.027881626090501266,-0.21024844791097808,1
5056,Disease,MONDO:0100310,hereditary cerebellar ataxia,0.0278536814713517,-0.210793176835485,1
5056,Disease,MONDO:0000437,cerebellar ataxia,0.0278536814713517,-0.210793176835485,1
5058,Phenotype,HP:0005344,Abnormal carotid artery morphology,0.02775836135723264,-0.2126512670449112,1
5059,Phenotype,HP:0007695,Abnormal pupillary light reflex,0.02772802994480994,-0.21324252211191938,1
5060,Biological Process,GO:0002718,regulation of cytokine production involved in immune response,0.02772281259756515,-0.21334422469509728,1
5061,Biological Process,GO:0032786,"positive regulation of DNA-templated transcription, elongation",0.027721631839867644,-0.21336724139349,1
5062,Biological Process,GO:0051258,protein polymerization,0.027715136090183834,-0.21349386407960322,1
5063,Biological Process,GO:0006401,RNA catabolic process,0.027706308545702996,-0.2136659408141383,1
5064,Phenotype,HP:0031098,Decreased thyroid-stimulating hormone level,0.02769603707294821,-0.21386616427314736,1
5065,Phenotype,HP:0010468,Aplasia/Hypoplasia of the testes,0.027679371581566303,-0.21419102735853265,1
5066,Biological Process,GO:0001890,placenta development,0.027632571351223212,-0.21510331172372735,1
5067,Phenotype,HP:0008055,Aplasia/Hypoplasia affecting the uvea,0.02760472974615069,-0.2156460325783766,1
5067,Phenotype,HP:0008053,Aplasia/Hypoplasia of the iris,0.02760472974615069,-0.2156460325783766,1
5069,Biological Process,GO:0034728,nucleosome organization,0.027600694470993337,-0.21572469284154894,1
5070,Phenotype,HP:0010997,Chromosomal breakage induced by ionizing radiation,0.027590803121608,-0.21591750649500255,1
5071,Phenotype,HP:0030099,Reduced muscle fiber alpha dystroglycan,0.02757989795676019,-0.21613008261519667,1
5072,Biological Process,GO:0046148,pigment biosynthetic process,0.027550889712446125,-0.21669554495492158,1
5073,Phenotype,HP:0002200,Pseudobulbar signs,0.027548385128739694,-0.216744367205153,1
5074,Biological Process,GO:0008593,regulation of Notch signaling pathway,0.027547910580798196,-0.21675361764397327,1
5075,Biological Process,GO:2000781,positive regulation of double-strand break repair,0.027512681305885245,-0.21744034752680974,1
5076,Phenotype,HP:0031413,Short telomere length,0.027504293456366957,-0.21760385321721,1
5076,Phenotype,HP:0031412,Abnormal telomere morphology,0.027504293456366957,-0.21760385321721,1
5076,Phenotype,HP:0031411,Abnormal chromosome morphology,0.027504293456366957,-0.21760385321721,1
5079,Phenotype,HP:0007210,Lower limb amyotrophy,0.027493587673572684,-0.21781254275118853,1
5080,Phenotype,HP:0003247,Overgrowth of external genitalia,0.027480789237799064,-0.21806202470394018,1
5081,Biological Process,GO:1905037,autophagosome organization,0.027465311324245345,-0.218363738145036,1
5082,Disease,MONDO:0005206,renal carcinoma,0.02746418371190762,-0.218385718872442,1
5082,Disease,MONDO:0005086,renal cell carcinoma,0.02746418371190762,-0.218385718872442,1
5084,Phenotype,HP:0001414,Microvesicular hepatic steatosis,0.027462034736315366,-0.2184276091969046,1
5085,Biological Process,GO:0006457,protein folding,0.02745532091919256,-0.2185584827064367,1
5086,Biological Process,GO:0002763,positive regulation of myeloid leukocyte differentiation,0.027454613339967904,-0.2185722756612803,1
5087,Phenotype,HP:0005245,Intestinal hypoplasia,0.027452649498791004,-0.21861055713101402,1
5088,Phenotype,HP:0010462,Aplasia/Hypoplasia of the ovary,0.02740841682779438,-0.21947279165176733,1
5089,Biological Process,GO:0035113,embryonic appendage morphogenesis,0.02735438162057824,-0.22052610857674732,1
5089,Biological Process,GO:0030326,embryonic limb morphogenesis,0.02735438162057824,-0.22052610857674732,1
5091,Biological Process,GO:0046942,carboxylic acid transport,0.027284599037355917,-0.2218863916174486,1
5092,Biological Process,GO:0007389,pattern specification process,0.02726619578411149,-0.22224512917238215,1
5093,Phenotype,HP:0000960,Sacral dimple,0.02726029050768597,-0.22236024166895882,1
5094,Biological Process,GO:0030218,erythrocyte differentiation,0.027244505110953443,-0.22266794892877156,1
5095,Disease,MONDO:0018993,Charcot-Marie-Tooth disease type 2,0.027235566425986124,-0.22284219214256143,1
5096,Biological Process,GO:0140253,cell-cell fusion,0.02718255725393992,-0.22387550840009143,1
5097,Biological Process,GO:0045047,protein targeting to ER,0.0271649323311145,-0.22421907383584935,1
5098,Phenotype,HP:0000748,Inappropriate laughter,0.027160173764268825,-0.22431183333942908,1
5099,Phenotype,HP:0006536,Airway obstruction,0.02715489170521901,-0.2244147973601584,1
5100,Biological Process,GO:0061387,regulation of extent of cell growth,0.02711382157044462,-0.225215384057199,1
5101,Phenotype,HP:0100585,Telangiectasia of the skin,0.02706837825158237,-0.22610121793016635,1
5102,Phenotype,HP:0003366,Abnormal femoral neck/head morphology,0.027054724993863744,-0.22636736306362754,1
5103,Phenotype,HP:0001349,Facial diplegia,0.02704060128258412,-0.22664267882349592,1
5104,Phenotype,HP:0008554,Cochlear malformation,0.02698880683791116,-0.22765231620631826,1
5105,Biological Process,GO:0050772,positive regulation of axonogenesis,0.026958512112129962,-0.2282428561347639,1
5106,Phenotype,HP:0031803,Fundus hemorrhage,0.026951651990830272,-0.22837658157498428,1
5106,Phenotype,HP:0000573,Retinal hemorrhage,0.026951651990830272,-0.22837658157498428,1
5108,Phenotype,HP:0010543,Opsoclonus,0.026929003257957884,-0.2288180769424104,1
5109,Disease,MONDO:0021003,polydactyly,0.02692167480922747,-0.22896093156404101,1
5110,Biological Process,GO:0009451,RNA modification,0.026915522091938593,-0.2290808674648893,1
5111,Biological Process,GO:1901361,organic cyclic compound catabolic process,0.02691450348735347,-0.22910072328676262,1
5112,Phenotype,HP:0003481,Segmental peripheral demyelination/remyelination,0.02690126975600715,-0.22935869052564,1
5113,Phenotype,HP:0005736,Short tibia,0.0268819207710691,-0.22973586337953336,1
5114,Phenotype,HP:0009771,Osteolytic defects of the phalanges of the hand,0.026859539504426322,-0.23017214498502497,1
5114,Phenotype,HP:0009699,Osteolytic defects of the hand bones,0.026859539504426322,-0.23017214498502497,1
5116,Phenotype,HP:0002607,Bowel incontinence,0.026841266449490586,-0.23052834456353144,1
5117,Disease,MONDO:0019250,inborn disorder of biogenic amine metabolism and transport,0.026817153192239318,-0.23099838813859466,1
5118,Phenotype,HP:0030796,Increased C-peptide level,0.026789398696544175,-0.23153941095623726,1
5119,Biological Process,GO:0009127,purine nucleoside monophosphate biosynthetic process,0.026741373690808312,-0.23247557006378916,1
5120,Biological Process,GO:0018146,keratan sulfate biosynthetic process,0.026691554596221634,-0.23344670163186895,1
5121,Biological Process,GO:1901658,glycosyl compound catabolic process,0.02667474983126894,-0.23377427959921493,1
5122,Biological Process,GO:0072376,protein activation cascade,0.026665623626084156,-0.2339521781745553,1
5123,Phenotype,HP:0000413,Atresia of the external auditory canal,0.02666561611431051,-0.23395232460275883,1
5124,Biological Process,GO:0061035,regulation of cartilage development,0.026635767759703444,-0.2345341633466109,1
5125,Biological Process,GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,0.026619543671107304,-0.23485042209699067,1
5126,Phenotype,HP:0030151,Cholangitis,0.02661543567571778,-0.23493049990726383,1
5127,Biological Process,GO:1990776,response to angiotensin,0.026613334423469914,-0.23497145995295174,1
5128,Phenotype,HP:0020054,Abnormal erythrocyte physiology,0.026571226231264067,-0.23579228166930635,1
5129,Phenotype,HP:0006660,Aplastic clavicle,0.02657072108181191,-0.2358021286282617,1
5130,Biological Process,GO:0090207,regulation of triglyceride metabolic process,0.02654731085061446,-0.23625846800416778,1
5131,Disease,MONDO:0018614,undetermined early-onset epileptic encephalopathy,0.026539894541182996,-0.2364030353084774,1
5132,Biological Process,GO:0006688,glycosphingolipid biosynthetic process,0.026534030865504987,-0.23651733687503815,1
5133,Phenotype,HP:0001615,Hoarse cry,0.026507948609663656,-0.23702576245411366,1
5134,Phenotype,HP:0032671,Non-convulsive status epilepticus without coma,0.026488697003824946,-0.23740103708166982,1
5135,Biological Process,GO:0050796,regulation of insulin secretion,0.026486360979713353,-0.23744657357279605,1
5136,Biological Process,GO:0034145,positive regulation of toll-like receptor 4 signaling pathway,0.026480435870338992,-0.23756207267621224,1
5137,Phenotype,HP:0011030,Abnormal blood transition element cation concentration,0.02643726582705097,-0.23840359322531468,1
5138,Disease,MONDO:0006858,mouth disorder,0.02638335599835806,-0.23945446612671537,1
5138,Disease,MONDO:0006999,tooth disorder,0.02638335599835806,-0.23945446612671537,1
5140,Biological Process,GO:0009124,nucleoside monophosphate biosynthetic process,0.026317306825861864,-0.24074197319581725,1
5141,Biological Process,GO:2000010,positive regulation of protein localization to cell surface,0.02631578656092659,-0.24077160796302322,1
5142,Phenotype,HP:0000187,Broad alveolar ridges,0.02630268540476799,-0.241026990892591,1
5143,Biological Process,GO:0070873,regulation of glycogen metabolic process,0.026298931983501306,-0.24110015693285367,1
5144,Phenotype,HP:0100814,Blue nevus,0.026294995187314707,-0.2411768975297196,1
5145,Phenotype,HP:0012760,Reduced social reciprocity,0.026294268292213263,-0.24119106701203458,1
5146,Phenotype,HP:0004904,Maturity-onset diabetes of the young,0.026278354519902902,-0.24150127671749072,1
5147,Phenotype,HP:0100321,Abnormal dentate nucleus morphology,0.02624411544292793,-0.24216870451376388,1
5148,Phenotype,HP:0006561,Lipid accumulation in hepatocytes,0.02624125793452714,-0.24222440638143292,1
5149,Phenotype,HP:0002244,Abnormal small intestine morphology,0.02623659562332392,-0.24231528955839993,1
5150,Phenotype,HP:0002251,Aganglionic megacolon,0.026225007740938056,-0.24254117400060976,1
5150,Phenotype,HP:0004362,Abnormal enteric ganglion morphology,0.026225007740938056,-0.24254117400060976,1
5152,Biological Process,GO:0030178,negative regulation of Wnt signaling pathway,0.026224551298492216,-0.2425500715061113,1
5153,Biological Process,GO:0043330,response to exogenous dsRNA,0.026216692621145565,-0.2427032619588484,1
5154,Biological Process,GO:0071577,zinc ion transmembrane transport,0.02620092548609476,-0.24301061324078252,1
5155,Phenotype,HP:0100685,Abnormal Sharpey fiber morphology,0.026190725982999208,-0.2432094337837289,1
5156,Phenotype,HP:0000808,Penoscrotal hypospadias,0.026144595043258723,-0.24410867156030522,1
5157,Phenotype,HP:0000680,Delayed eruption of primary teeth,0.026124822765749012,-0.24449409572390793,1
5158,Biological Process,GO:0050862,positive regulation of T cell receptor signaling pathway,0.02611268833829572,-0.2447306340564134,1
5159,Phenotype,HP:0002310,Orofacial dyskinesia,0.02610559364552223,-0.2448689320358393,1
5160,Phenotype,HP:0004327,Abnormal vitreous humor morphology,0.026104092942298207,-0.24489818548348335,1
5161,Phenotype,HP:0011885,Hemorrhage of the eye,0.026088366820306463,-0.24520473729130646,1
5162,Biological Process,GO:0140894,endolysosomal toll-like receptor signaling pathway,0.026080316036071638,-0.24536167251429883,1
5163,Biological Process,GO:0060070,canonical Wnt signaling pathway,0.026074106964351418,-0.2454827069410784,1
5164,Phenotype,HP:0001397,Hepatic steatosis,0.026047795212045255,-0.24599560613139898,1
5165,Phenotype,HP:0008661,Urethral stenosis,0.026031735197959316,-0.24630866655114478,1
5166,Phenotype,HP:0004798,Recurrent infection of the gastrointestinal tract,0.026002448414028878,-0.2468795585081011,1
5167,Phenotype,HP:0008110,Equinovarus deformity,0.025992207503541698,-0.24707918621194616,1
5168,Phenotype,HP:0030483,Reduced amplitude of dark-adapted bright flash electroretinogram a-wave,0.025991125339565713,-0.24710028100717754,1
5169,Phenotype,HP:0009130,Hand muscle atrophy,0.025977407347295256,-0.2473676880215972,1
5170,Phenotype,HP:0002900,Hypokalemia,0.025956079178812153,-0.24778344141645728,1
5171,Disease,MONDO:0018838,lissencephaly spectrum disorders,0.025944098014142658,-0.24801699217303844,1
5172,Biological Process,GO:0060339,negative regulation of type I interferon-mediated signaling pathway,0.025924872942243327,-0.24839174957027618,1
5173,Phenotype,HP:0001153,Septate vagina,0.02591911684062942,-0.24850395417842328,1
5174,Biological Process,GO:0010906,regulation of glucose metabolic process,0.025912184570119567,-0.2486390860347213,1
5175,Biological Process,GO:0043666,regulation of phosphoprotein phosphatase activity,0.025884332888295725,-0.2491820033170936,1
5176,Phenotype,HP:0003205,Curvilinear intracellular accumulation of autofluorescent lipopigment storage material,0.025844381147749784,-0.24996078897680468,1
5177,Phenotype,HP:0002066,Gait ataxia,0.025821231837649394,-0.2504120421760904,1
5178,Biological Process,GO:0043302,positive regulation of leukocyte degranulation,0.025819533199585853,-0.25044515399917616,1
5179,Phenotype,HP:0030341,Decreased circulating follicle stimulating hormone concentration,0.02579948750860983,-0.25083590785514837,1
5180,Biological Process,GO:0051784,negative regulation of nuclear division,0.025793844970415036,-0.2509458987534279,1
5181,Disease,MONDO:0004884,eye degenerative disorder,0.02578601754324683,-0.25109848004144514,1
5182,Biological Process,GO:0019985,translesion synthesis,0.025749130271928045,-0.25181752951304226,1
5183,Phenotype,HP:0100710,Impulsivity,0.02571696548589364,-0.252444522824697,1
5184,Biological Process,GO:0031112,positive regulation of microtubule polymerization or depolymerization,0.025711563950937877,-0.25254981580834407,1
5185,Biological Process,GO:0042982,amyloid precursor protein metabolic process,0.025705992692344082,-0.25265841724197624,1
5186,Phenotype,HP:0011461,Fetal onset,0.02568013045354367,-0.2531625539937311,1
5187,Biological Process,GO:0015012,heparan sulfate proteoglycan biosynthetic process,0.025678685901535214,-0.2531907128767615,1
5188,Phenotype,HP:0000719,Inappropriate behavior,0.025678017750530135,-0.2532037372510232,1
5189,Biological Process,GO:0010719,negative regulation of epithelial to mesenchymal transition,0.025609354759065117,-0.25454219591077376,1
5190,Phenotype,HP:0500015,Abnormal cardiac test,0.025542974879434466,-0.2558361495068694,1
5191,Phenotype,HP:0003750,Increased muscle fatiguability,0.0255322546295933,-0.2560451210493037,1
5192,Phenotype,HP:0025169,Left ventricular systolic dysfunction,0.025528405362011064,-0.25612015543710437,1
5193,Phenotype,HP:0030344,Decreased circulating luteinizing hormone level,0.025527936371893323,-0.2561292975363784,1
5194,Phenotype,HP:0011226,Aplasia/Hypoplasia of the eyelid,0.025514920597504265,-0.256383016105475,1
5195,Phenotype,HP:0100700,Abnormal arachnoid mater morphology,0.025510270620619835,-0.25647365884759576,1
5196,Phenotype,HP:0030260,Microphallus,0.025503115770735607,-0.2566131294791898,1
5197,Biological Process,GO:0045778,positive regulation of ossification,0.025487663129231786,-0.25691435028818044,1
5198,Disease,MONDO:0017305,syndromic oculocutaneous albinism,0.025475527838026646,-0.25715090545793867,1
5199,Phenotype,HP:0001104,Macular hypoplasia,0.025474763553717916,-0.2571658037740432,1
5200,Biological Process,GO:0045652,regulation of megakaryocyte differentiation,0.02546039930842048,-0.2574458083019399,1
5201,Biological Process,GO:0009260,ribonucleotide biosynthetic process,0.025459715918588866,-0.25745912972908125,1
5202,Phenotype,HP:0004415,Pulmonary artery stenosis,0.025454327927008857,-0.2575641587095415,1
5203,Biological Process,GO:0050819,negative regulation of coagulation,0.025450275206406303,-0.2576431590395636,1
5204,Phenotype,HP:0010497,Sirenomelia,0.025448814672280773,-0.2576716294645548,1
5205,Phenotype,HP:0000961,Cyanosis,0.02541826107097578,-0.2582672156949344,1
5206,Phenotype,HP:0011755,Ectopic posterior pituitary,0.02540068042452115,-0.2586099180443245,1
5207,Phenotype,HP:0000123,Nephritis,0.025385019971044476,-0.25891518976529443,1
5208,Phenotype,HP:0008232,Elevated circulating follicle stimulating hormone level,0.0253606778119847,-0.259389695359872,1
5209,Biological Process,GO:0031018,endocrine pancreas development,0.02534551741363511,-0.259685219426379,1
5210,Biological Process,GO:0032507,maintenance of protein location in cell,0.02532617507509327,-0.2600622627210094,1
5211,Phenotype,HP:0011094,Increased overbite,0.025312222002777718,-0.2603342521882961,1
5212,Biological Process,GO:0071103,DNA conformation change,0.025305331639167816,-0.26046856714669986,1
5213,Phenotype,HP:0001231,Abnormal fingernail morphology,0.025297780770702105,-0.26061575743175636,1
5214,Biological Process,GO:0061982,meiosis I cell cycle process,0.025296204630392394,-0.2606464813865609,1
5215,Phenotype,HP:0006886,Impaired distal vibration sensation,0.025289718441497633,-0.26077291770268607,1
5216,Biological Process,GO:0034655,nucleobase-containing compound catabolic process,0.025286666846253025,-0.26083240293620197,1
5217,Phenotype,HP:0012094,Abnormal pancreas size,0.025280100554085028,-0.26096040071822674,1
5218,Phenotype,HP:0010844,EEG with multifocal slow activity,0.025267755470138598,-0.2612010454113999,1
5219,Phenotype,HP:0002392,EEG with polyspike wave complexes,0.025244059222703008,-0.2616629601475196,1
5220,Phenotype,HP:0012715,Profound hearing impairment,0.02523355542504535,-0.2618677123529682,1
5221,Biological Process,GO:0071357,cellular response to type I interferon,0.025172283200913692,-0.26306210160460713,1
5222,Biological Process,GO:0006260,DNA replication,0.025146231308335265,-0.26356993530774914,1
5223,Phenotype,HP:0100639,Erectile dysfunction,0.025138646928803854,-0.26371777882936187,1
5224,Biological Process,GO:0140467,integrated stress response signaling,0.025136892065202976,-0.2637519866658275,1
5225,Biological Process,GO:0032206,positive regulation of telomere maintenance,0.02510033395593103,-0.2644646197290704,1
5226,Biological Process,GO:1902108,regulation of mitochondrial membrane permeability involved in apoptotic process,0.0250894081439742,-0.2646775983266586,1
5227,Biological Process,GO:0006835,dicarboxylic acid transport,0.025069637190348937,-0.2650629966835703,1
5228,Phenotype,HP:0000757,Lack of insight,0.02506636610529922,-0.26512676046691497,1
5229,Biological Process,GO:0060260,regulation of transcription initiation by RNA polymerase II,0.0250526750083504,-0.2653936432065342,1
5230,Biological Process,GO:0007589,body fluid secretion,0.025028217348149195,-0.2658704002833099,1
5231,Phenotype,HP:0002728,Chronic mucocutaneous candidiasis,0.025024175404722016,-0.265949190532131,1
5232,Biological Process,GO:2000677,regulation of transcription regulatory region DNA binding,0.02501871092347241,-0.26605571053793803,1
5233,Biological Process,GO:0006879,intracellular iron ion homeostasis,0.025003883900679202,-0.2663447360614764,1
5234,Phenotype,HP:0030878,Abnormality on pulmonary function testing,0.02500290753895995,-0.26636376843641807,1
5235,Phenotype,HP:0002254,Intermittent diarrhea,0.024989676892800405,-0.2666216755352569,1
5236,Biological Process,GO:0001573,ganglioside metabolic process,0.024988203309320056,-0.2666504003334059,1
5237,Phenotype,HP:0008948,Proximal upper limb amyotrophy,0.024967964398286302,-0.26704492065882535,1
5238,Phenotype,HP:0000075,Renal duplication,0.02496750397079328,-0.26705389584548805,1
5239,Phenotype,HP:0002350,Cerebellar cyst,0.024967430252569645,-0.267055332846596,1
5240,Phenotype,HP:0003710,Exercise-induced muscle cramps,0.024946445337347245,-0.2674643951508194,1
5241,Phenotype,HP:0003739,Myoclonic spasms,0.024939322466797198,-0.26760324240414435,1
5242,Phenotype,HP:0034673,Abnormal ankle morphology,0.02491281404869672,-0.26811997523220577,1
5243,Disease,MONDO:0016073,syndromic microphthalmia,0.02488613579012533,-0.26864001878769417,1
5244,Phenotype,HP:0003388,Easy fatigability,0.024871644404709792,-0.2689225016782203,1
5245,Biological Process,GO:0045123,cellular extravasation,0.024836667439612437,-0.2696043132455214,1
5246,Phenotype,HP:0003724,Shoulder girdle muscle atrophy,0.024798885632986822,-0.2703408000367332,1
5247,Phenotype,HP:0001730,Progressive hearing impairment,0.02479110952166419,-0.2704923810167764,1
5248,Disease,MONDO:0017741,disorder of protein O-glycosylation,0.02477949641980881,-0.2707187570661336,1
5249,Biological Process,GO:0071616,acyl-CoA biosynthetic process,0.024769601020875665,-0.2709116496580694,1
5249,Biological Process,GO:0035384,thioester biosynthetic process,0.024769601020875665,-0.2709116496580694,1
5251,Biological Process,GO:0097553,calcium ion transmembrane import into cytosol,0.02471943498992968,-0.2718895441120152,1
5252,Biological Process,GO:0008637,apoptotic mitochondrial changes,0.024704055056695595,-0.2721893476070906,1
5253,Phenotype,HP:0025452,Pyoderma gangrenosum,0.024676324849433717,-0.27272989696642413,1
5254,Phenotype,HP:0002687,Abnormality of frontal sinus,0.02467142313816062,-0.27282544680719123,1
5255,Biological Process,GO:0045995,regulation of embryonic development,0.024650559720962195,-0.27323214073102714,1
5256,Disease,MONDO:0020058,gonosome anomaly,0.02464032221430623,-0.27343170208344664,1
5257,Biological Process,GO:0007076,mitotic chromosome condensation,0.024634818654612034,-0.27353898385161585,1
5258,Biological Process,GO:0035872,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",0.024629390994606704,-0.2736447860950269,1
5259,Biological Process,GO:0072521,purine-containing compound metabolic process,0.024628927403148926,-0.27365382295736,1
5260,Biological Process,GO:2000737,negative regulation of stem cell differentiation,0.024622633653177073,-0.2737765080308239,1
5261,Phenotype,HP:0031979,Abnormal urine carbohydrate level,0.024611368055518446,-0.273996110125369,1
5262,Biological Process,GO:0031116,positive regulation of microtubule polymerization,0.02460499643000391,-0.2741203132392249,1
5263,Phenotype,HP:0003363,Abdominal situs inversus,0.024597991978462797,-0.27425685213189444,1
5264,Biological Process,GO:0090026,positive regulation of monocyte chemotaxis,0.02459153845661821,-0.2743826516639928,1
5265,Phenotype,HP:0002246,Abnormal duodenum morphology,0.024572093743176815,-0.274761690568892,1
5266,Phenotype,HP:0030339,Decreased circulating gonadotropin concentration,0.0245680048711463,-0.27484139560447357,1
5267,Phenotype,HP:0002509,Limb hypertonia,0.024543777767861097,-0.2753136583984602,1
5268,Disease,MONDO:0020811,"mitochondrial complex III deficiency, nuclear type",0.024532649684989694,-0.2755305798952936,1
5268,Disease,MONDO:0015448,mitochondrial complex III deficiency,0.024532649684989694,-0.2755305798952936,1
5270,Phenotype,HP:0100335,Non-midline cleft of the upper lip,0.024523666165147007,-0.2757056970824702,1
5271,Biological Process,GO:0007416,synapse assembly,0.024522781202906407,-0.2757229477927759,1
5272,Biological Process,GO:0007566,embryo implantation,0.02450662232869305,-0.2760379353087758,1
5273,Biological Process,GO:0015849,organic acid transport,0.02447669476209946,-0.2766213181445332,1
5274,Phenotype,HP:0025143,Chills,0.02447369488339468,-0.2766797952592779,1
5275,Phenotype,HP:0011468,Facial tics,0.02445171174133054,-0.2771083161587681,1
5276,Biological Process,GO:0007423,sensory organ development,0.024446018367506817,-0.27721929800408196,1
5277,Phenotype,HP:0002729,Follicular hyperplasia,0.02442447643805634,-0.27763921827562177,1
5278,Biological Process,GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,0.02441820116729132,-0.27776154313095525,1
5279,Phenotype,HP:0012331,Abnormal autonomic nervous system morphology,0.02440307934329944,-0.27805631526134617,1
5279,Phenotype,HP:0025028,Abnormal enteric nervous system morphology,0.02440307934329944,-0.27805631526134617,1
5281,Phenotype,HP:0000678,Dental crowding,0.024381319751247243,-0.2784804784647472,1
5282,Biological Process,GO:0010508,positive regulation of autophagy,0.024366617740011032,-0.2787670671180377,1
5283,Biological Process,GO:0018205,peptidyl-lysine modification,0.024342654186145007,-0.27923419250110115,1
5284,Biological Process,GO:0002091,negative regulation of receptor internalization,0.024327644446732077,-0.279526779748892,1
5285,Phenotype,HP:0009833,Abnormal middle phalanx morphology of the hand,0.024325734814323874,-0.2795640045184391,1
5286,Phenotype,HP:0001820,Leukonychia,0.024288441166961272,-0.2802909755431663,1
5287,Biological Process,GO:0009166,nucleotide catabolic process,0.024286560717811323,-0.28032763143879896,1
5288,Phenotype,HP:0100026,Arteriovenous malformation,0.024285920641843428,-0.2803401085418766,1
5289,Phenotype,HP:0002304,Akinesia,0.024255502759303993,-0.2809330491846816,1
5290,Phenotype,HP:0000113,Polycystic kidney dysplasia,0.02424573863805357,-0.28112338275977994,1
5291,Biological Process,GO:0006399,tRNA metabolic process,0.02422232502366861,-0.28157978808470047,1
5292,Phenotype,HP:0012743,Abdominal obesity,0.02420906029355474,-0.281838359587505,1
5293,Disease,MONDO:0016800,mitochondrial membrane transport disorder,0.024147141232484848,-0.2830453577348963,1
5293,Disease,MONDO:0016801,mitochondrial substrate carrier disorder,0.024147141232484848,-0.2830453577348963,1
5295,Biological Process,GO:0006195,purine nucleotide catabolic process,0.024123605585630314,-0.28350414185823775,1
5296,Phenotype,HP:0025186,Marcus Gunn jaw winking synkinesis,0.02411926422216293,-0.28358876874972716,1
5297,Phenotype,HP:0040307,Male sexual dysfunction,0.024112254447862358,-0.2837254113997969,1
5298,Phenotype,HP:0005109,Abnormality of the Achilles tendon,0.024108559527621698,-0.28379743707021526,1
5299,Biological Process,GO:0045940,positive regulation of steroid metabolic process,0.024072389728168053,-0.28450250074814776,1
5300,Biological Process,GO:0044406,adhesion of symbiont to host,0.02406351769663717,-0.284675444675855,1
5301,Phenotype,HP:0003144,Increased serum serotonin,0.024045517895317836,-0.2850263176779718,1
5302,Phenotype,HP:0008358,Hyperprolinemia,0.024005019681422435,-0.2858157558299688,1
5303,Phenotype,HP:0004331,Decreased skull ossification,0.02399449416299604,-0.28602093144183177,1
5304,Phenotype,HP:0009738,Abnormal antihelix morphology,0.023972957088298608,-0.28644075707889505,1
5305,Biological Process,GO:0006644,phospholipid metabolic process,0.023969354922157016,-0.28651097467884523,1
5306,Biological Process,GO:0021782,glial cell development,0.02396786991040034,-0.28653992225020997,1
5307,Phenotype,HP:0006507,Aplasia/hypoplasia of the humerus,0.02393654686265445,-0.28715050742296094,1
5308,Phenotype,HP:0040197,Encephalomalacia,0.02392902180153955,-0.28729719464120607,1
5309,Biological Process,GO:0007249,canonical NF-kappaB signal transduction,0.023862342204372,-0.28859699067912054,1
5310,Phenotype,HP:0002694,Sclerosis of skull base,0.02385053498918699,-0.2888271506106168,1
5311,Phenotype,HP:0002180,Neurodegeneration,0.023843000557816185,-0.2889740204847569,1
5312,Phenotype,HP:0000848,Increased circulating renin level,0.023837956686421302,-0.2890723414754843,1
5313,Biological Process,GO:0007062,sister chromatid cohesion,0.023827581592550717,-0.2892745848374544,1
5314,Phenotype,HP:0030179,Abnormal peripheral action potential amplitude,0.023827292885390206,-0.2892802126522477,1
5315,Phenotype,HP:0004347,Weakness of muscles of respiration,0.023809651176774027,-0.28962410529610594,1
5316,Biological Process,GO:0010559,regulation of glycoprotein biosynthetic process,0.023807974150932387,-0.2896567958286982,1
5317,Phenotype,HP:0100582,Nasal polyposis,0.02379171489206844,-0.28997374015872585,1
5318,Phenotype,HP:0025406,Asthenia,0.02377626005780442,-0.29027500371154125,1
5319,Phenotype,HP:0030584,Color vision test abnormality,0.023759141578327037,-0.29060869696622477,1
5320,Biological Process,GO:0032271,regulation of protein polymerization,0.023725150947885076,-0.29127128175454703,1
5321,Biological Process,GO:0090330,regulation of platelet aggregation,0.02367321646215015,-0.29228364898015824,1
5322,Phenotype,HP:0001162,Postaxial hand polydactyly,0.023669165030132167,-0.29236262419159537,1
5323,Phenotype,HP:0003797,Limb-girdle muscle atrophy,0.023650446177061912,-0.29272751378434264,1
5324,Biological Process,GO:0003002,regionalization,0.023629091300847893,-0.29314378779726735,1
5325,Phenotype,HP:0030638,Congenital stationary night blindness with normal fundus,0.023611392020190913,-0.29348880270211253,1
5326,Biological Process,GO:0030307,positive regulation of cell growth,0.023562044460283427,-0.2944507425693755,1
5327,Biological Process,GO:1901990,regulation of mitotic cell cycle phase transition,0.02354644691168828,-0.2947547880754425,1
5328,Biological Process,GO:0048640,negative regulation of developmental growth,0.023544927092629564,-0.29478441415110546,1
5329,Phenotype,HP:0002172,Postural instability,0.023543115965242944,-0.29481971874653323,1
5330,Phenotype,HP:0003413,Atlantoaxial abnormality,0.023521112603177463,-0.29524863379773914,1
5331,Phenotype,HP:0003498,Disproportionate short stature,0.023482062239513657,-0.29600984877391534,1
5332,Phenotype,HP:0008314,Decreased activity of mitochondrial complex II,0.023451296646897712,-0.29660956738477934,1
5333,Phenotype,HP:0003443,Decreased size of nerve terminals,0.02344691753316075,-0.2966949301483032,1
5334,Phenotype,HP:0010719,Abnormality of hair texture,0.02340719615836717,-0.2974692252516086,1
5335,Phenotype,HP:0012671,Abulia,0.023406518813895105,-0.29748242883559073,1
5336,Phenotype,HP:0000589,Coloboma,0.02339119698937908,-0.29778109960814364,1
5337,Phenotype,HP:0012471,Thick vermilion border,0.02337938203239509,-0.29801141045176394,1
5338,Biological Process,GO:0007051,spindle organization,0.023342404805851258,-0.2987322134349309,1
5339,Biological Process,GO:0120039,plasma membrane bounded cell projection morphogenesis,0.023326670897395152,-0.29903891702554747,1
5339,Biological Process,GO:0048858,cell projection morphogenesis,0.023326670897395152,-0.29903891702554747,1
5341,Biological Process,GO:0010765,positive regulation of sodium ion transport,0.02332177772353672,-0.2991343004451269,1
5342,Phenotype,HP:0002362,Shuffling gait,0.02332035595721027,-0.29916201516321844,1
5343,Phenotype,HP:0100315,Lewy bodies,0.023316257591291745,-0.29924190526467537,1
5344,Phenotype,HP:0005990,Thyroid hypoplasia,0.02330856286702332,-0.2993918997538714,1
5345,Phenotype,HP:0008770,Obsessive-compulsive trait,0.02330325568118552,-0.2994953535750922,1
5346,Disease,MONDO:0000621,immune system cancer,0.02326186973924449,-0.3003020963516741,1
5347,Phenotype,HP:0002671,Basal cell carcinoma,0.02323904407075361,-0.3007470407533723,1
5348,Phenotype,HP:0001737,Pancreatic cysts,0.023234738611031203,-0.3008309677674261,1
5349,Biological Process,GO:0010526,retrotransposon silencing,0.023221298845344407,-0.30109295126661106,1
5350,Biological Process,GO:0051225,spindle assembly,0.023215941323091793,-0.3011973863036058,1
5351,Biological Process,GO:0008203,cholesterol metabolic process,0.023213584765821027,-0.3012433230508834,1
5352,Phenotype,HP:0010836,Abnormal circulating copper concentration,0.023189103623370677,-0.3017205378708924,1
5353,Phenotype,HP:0000311,Round face,0.02317861960238743,-0.3019249045664679,1
5354,Biological Process,GO:0019364,pyridine nucleotide catabolic process,0.02317812376084505,-0.3019345700848513,1
5355,Disease,MONDO:0003150,male reproductive system disorder,0.02315037923975649,-0.30247539846589455,1
5356,Biological Process,GO:0099175,regulation of postsynapse organization,0.023144086844838152,-0.3025980571250838,1
5357,Phenotype,HP:0000172,Abnormal uvula morphology,0.0231378012117196,-0.3027205839754298,1
5358,Phenotype,HP:0011039,Abnormal helix morphology,0.02313134705993103,-0.30284639578712685,1
5359,Biological Process,GO:0060544,regulation of necroptotic process,0.02310948464057061,-0.3032725634196711,1
5360,Disease,MONDO:0023603,hereditary disorder of connective tissue,0.023104525157192857,-0.30336923942130184,1
5361,Phenotype,HP:0002411,Myokymia,0.023102888734276905,-0.3034011384745784,1
5362,Disease,MONDO:0015607,partial chromosome Y deletion,0.023099438236807268,-0.303468399572881,1
5362,Disease,MONDO:0700028,chromosome Y disorder,0.023099438236807268,-0.303468399572881,1
5362,Disease,MONDO:0010767,"spermatogenic failure, Y-linked, 2",0.023099438236807268,-0.303468399572881,1
5365,Phenotype,HP:0004934,Vascular calcification,0.02309468017658467,-0.3035611492007762,1
5366,Disease,MONDO:0005501,congenital disorder of glycosylation type II,0.02307016777670423,-0.30403897332686247,1
5367,Biological Process,GO:0006351,DNA-templated transcription,0.02304875047122268,-0.3044564642834706,1
5368,Biological Process,GO:0090263,positive regulation of canonical Wnt signaling pathway,0.02304328544193668,-0.3045629949722386,1
5369,Phenotype,HP:0004871,Perineal fistula,0.023030259864455838,-0.30481690463456906,1
5370,Phenotype,HP:0001934,Persistent bleeding after trauma,0.023020145510259216,-0.3050140653564283,1
5371,Phenotype,HP:0012896,Abnormal motor evoked potentials,0.022998989512551304,-0.3054264625988677,1
5372,Biological Process,GO:0036151,phosphatidylcholine acyl-chain remodeling,0.02298484249185584,-0.30570223273290215,1
5373,Phenotype,HP:0009102,Anterior open-bite malocclusion,0.022982507254959872,-0.30574775387870845,1
5374,Phenotype,HP:0003764,Nevus,0.02293770084211766,-0.30662117244089815,1
5375,Biological Process,GO:0019646,aerobic electron transport chain,0.022932126961089372,-0.30672982499406476,1
5376,Phenotype,HP:0005487,Prominent metopic ridge,0.0229295301190785,-0.3067804456501605,1
5377,Phenotype,HP:6000231,Abnormal tissue enzyme concentration or activity,0.022903886395739814,-0.3072803228451178,1
5378,Biological Process,GO:0051353,positive regulation of oxidoreductase activity,0.022897625159736812,-0.30740237411859356,1
5379,Biological Process,GO:0045717,negative regulation of fatty acid biosynthetic process,0.02286039819022878,-0.30812804538125155,1
5380,Phenotype,HP:0025101,Dysgenesis of the hippocampus,0.022848353413585265,-0.3083628361362027,1
5381,Biological Process,GO:0016055,Wnt signaling pathway,0.022824621406267953,-0.30882544794540856,1
5382,Biological Process,GO:0044773,mitotic DNA damage checkpoint signaling,0.022811701384522043,-0.30907729999293826,1
5383,Biological Process,GO:0019934,cGMP-mediated signaling,0.02280524805626949,-0.3092030957513162,1
5384,Biological Process,GO:0051150,regulation of smooth muscle cell differentiation,0.022803224605830064,-0.3092425391939254,1
5385,Biological Process,GO:0090276,regulation of peptide hormone secretion,0.02279490139797169,-0.3094047848141242,1
5386,Biological Process,GO:1901568,fatty acid derivative metabolic process,0.022787421664204555,-0.30955058845913946,1
5387,Biological Process,GO:0031952,regulation of protein autophosphorylation,0.022783295020759264,-0.3096310297789422,1
5388,Biological Process,GO:0014910,regulation of smooth muscle cell migration,0.022767718552646476,-0.3099346643597995,1
5389,Biological Process,GO:1902653,secondary alcohol biosynthetic process,0.022728481599156525,-0.3106995165612596,1
5389,Biological Process,GO:0006695,cholesterol biosynthetic process,0.022728481599156525,-0.3106995165612596,1
5391,Phenotype,HP:0020207,Reflex seizure,0.02272431650836526,-0.3107807073413184,1
5392,Biological Process,GO:1901379,regulation of potassium ion transmembrane transport,0.022648013157853586,-0.31226810074031364,1
5393,Phenotype,HP:0002406,Limb dysmetria,0.022615031308464095,-0.3129110211984536,1
5394,Biological Process,GO:1905515,non-motile cilium assembly,0.022580719755655787,-0.31357986177772207,1
5395,Phenotype,HP:0003307,Hyperlordosis,0.02257706837577589,-0.3136510387089337,1
5396,Phenotype,HP:0003130,Abnormal peripheral myelination,0.02255538915143962,-0.31407363529161153,1
5397,Phenotype,HP:0008846,Severe intrauterine growth retardation,0.022533677323347767,-0.31449686742450456,1
5398,Biological Process,GO:0032371,regulation of sterol transport,0.02252822614921446,-0.3146031280325681,1
5398,Biological Process,GO:0032374,regulation of cholesterol transport,0.02252822614921446,-0.3146031280325681,1
5400,Biological Process,GO:1903580,positive regulation of ATP metabolic process,0.022509893651858404,-0.31496048633166823,1
5401,Biological Process,GO:0051260,protein homooligomerization,0.022509626847640796,-0.31496568718889706,1
5402,Phenotype,HP:0001989,Fetal akinesia sequence,0.022496974252727675,-0.31521232624246076,1
5403,Disease,MONDO:0019214,inborn carbohydrate metabolic disorder,0.022480922592626462,-0.31552522381664794,1
5403,Disease,MONDO:0037792,carbohydrate metabolism disease,0.022480922592626462,-0.31552522381664794,1
5405,Biological Process,GO:0086012,membrane depolarization during cardiac muscle cell action potential,0.022452241385161886,-0.31608431117483016,1
5406,Phenotype,HP:0025234,Parasomnia,0.02245161428017517,-0.3160965354324999,1
5407,Biological Process,GO:0050810,regulation of steroid biosynthetic process,0.022440851351877567,-0.3163063389129023,1
5408,Phenotype,HP:0200039,Pustule,0.022434012762684086,-0.31643964462433716,1
5409,Phenotype,HP:0002292,Frontal balding,0.022423709080140464,-0.3166404959539047,1
5410,Biological Process,GO:0006275,regulation of DNA replication,0.02241206419692421,-0.3168674915224057,1
5411,Phenotype,HP:5200024,Abnormal relationship,0.02240445340769226,-0.31701584985252923,1
5412,Phenotype,HP:0000122,Unilateral renal agenesis,0.022379716875951305,-0.31749804301677176,1
5413,Phenotype,HP:0006711,Aplasia/Hypoplasia involving bones of the thorax,0.022375698259918808,-0.3175763785409624,1
5414,Phenotype,HP:0002410,Aqueductal stenosis,0.0223664842044472,-0.31775598959597556,1
5415,Phenotype,HP:0010472,Abnormal circulating porphyrin concentration,0.022358766484700143,-0.3179064323397095,1
5416,Biological Process,GO:0030516,regulation of axon extension,0.022317078322282025,-0.3187190663483231,1
5417,Phenotype,HP:0000943,Dysostosis multiplex,0.022315009563010135,-0.3187593930032404,1
5418,Disease,MONDO:0007263,cardiac rhythm disease,0.022293576474405885,-0.31917719162278024,1
5419,Phenotype,HP:0001935,Microcytic anemia,0.02228404280841323,-0.3193630328967297,1
5420,Biological Process,GO:0050853,B cell receptor signaling pathway,0.02228236643916337,-0.3193957106302735,1
5421,Phenotype,HP:0012190,T-cell lymphoma,0.022236754752749777,-0.32028482651881157,1
5422,Phenotype,HP:0002693,Abnormal skull base morphology,0.022214698733963312,-0.32071476801589016,1
5423,Biological Process,GO:0032330,regulation of chondrocyte differentiation,0.022203277524863396,-0.3209374034691152,1
5424,Phenotype,HP:0010696,Polar cataract,0.02213937557952883,-0.3221830542961919,1
5425,Biological Process,GO:0035710,"CD4-positive, alpha-beta T cell activation",0.022127734233622354,-0.32240998091134837,1
5426,Disease,MONDO:0100473,disorder of peptide and amine metabolism,0.02212706030309719,-0.3224231179467182,1
5427,Phenotype,HP:0003376,Steppage gait,0.022123399250298825,-0.3224944834336745,1
5428,Phenotype,HP:0011960,Substantia nigra gliosis,0.02211403167836512,-0.3226770870096036,1
5429,Phenotype,HP:0001769,Broad foot,0.022112389613903827,-0.3227090960344246,1
5430,Biological Process,GO:0071625,vocalization behavior,0.022109251318882306,-0.3227702713205399,1
5431,Biological Process,GO:0009895,negative regulation of catabolic process,0.022109185719155877,-0.32277155006648506,1
5432,Phenotype,HP:0004050,Absent hand,0.022108656728928366,-0.3227818617574823,1
5433,Phenotype,HP:0000320,Bird-like facies,0.022068769714175818,-0.3235593857069646,1
5434,Phenotype,HP:0001698,Pericardial effusion,0.022066974596904654,-0.32359437821465453,1
5435,Biological Process,GO:0006513,protein monoubiquitination,0.022058990378818866,-0.3237500158530715,1
5436,Phenotype,HP:0100033,Tics,0.022045737207579297,-0.32400836203689304,1
5437,Biological Process,GO:0009152,purine ribonucleotide biosynthetic process,0.022044659485963125,-0.32402937023649503,1
5438,Biological Process,GO:0051963,regulation of synapse assembly,0.02203580597417354,-0.32420195315592715,1
5439,Biological Process,GO:0031954,positive regulation of protein autophosphorylation,0.02199418044887269,-0.3250133661692091,1
5440,Disease,MONDO:0018762,non-acquired combined pituitary hormone deficiency,0.021988661039610946,-0.32512095689553006,1
5441,Biological Process,GO:1904645,response to amyloid-beta,0.021970273002206553,-0.32547939784566354,1
5442,Disease,MONDO:0045012,steroid metabolism disease,0.021938822653012724,-0.32609246452587226,1
5443,Biological Process,GO:0000731,DNA synthesis involved in DNA repair,0.021938796130844374,-0.32609298152673616,1
5444,Phenotype,HP:0031960,Arm dystonia,0.0219359559610931,-0.3261483454093408,1
5445,Biological Process,GO:1901019,regulation of calcium ion transmembrane transporter activity,0.021935819578208227,-0.32615100394269925,1
5446,Phenotype,HP:0007587,Numerous pigmented freckles,0.021924853246177767,-0.32636477240455464,1
5447,Biological Process,GO:0048706,embryonic skeletal system development,0.021821958196986402,-0.32837052203324374,1
5448,Biological Process,GO:0070875,positive regulation of glycogen metabolic process,0.021783396421605206,-0.3291222128799878,1
5449,Biological Process,GO:0072337,modified amino acid transport,0.021733243807967262,-0.33009984578820484,1
5450,Disease,MONDO:0015909,aplastic anemia,0.021729808994230715,-0.3301668011609933,1
5451,Phenotype,HP:0009926,Epiphora,0.02172704792112834,-0.33022062319998735,1
5452,Phenotype,HP:0002213,Fine hair,0.02172095338086366,-0.3303394250468107,1
5453,Phenotype,HP:0011794,Embryonal renal neoplasm,0.021709267712848646,-0.3305672156399082,1
5454,Disease,MONDO:0002468,hyperimmunoglobulin syndrome,0.021708912884652376,-0.3305741323626126,1
5455,Disease,MONDO:0021190,DNA repair disease,0.02170622469203287,-0.3306265337307133,1
5456,Phenotype,HP:0040049,Macular edema,0.02169342180168443,-0.33087610251720345,1
5457,Phenotype,HP:0012603,Abnormal urine sodium concentration,0.021679813136856962,-0.3311413783943148,1
5458,Biological Process,GO:0043271,negative regulation of monoatomic ion transport,0.0216632494115252,-0.33146425773783017,1
5459,Disease,MONDO:0019268,epidermal disease,0.021637527692491942,-0.3319656553153195,1
5460,Phenotype,HP:0040159,Abnormal spaced incisors,0.021633097280570834,-0.3320520180425405,1
5461,Biological Process,GO:0045669,positive regulation of osteoblast differentiation,0.021626427811834992,-0.33218202706188205,1
5462,Phenotype,HP:0005943,Respiratory arrest,0.021588929595328432,-0.33291298578560696,1
5463,Biological Process,GO:0014912,negative regulation of smooth muscle cell migration,0.021573950766494265,-0.3332049704885488,1
5464,Biological Process,GO:0033688,regulation of osteoblast proliferation,0.02156755665702037,-0.3333296118858158,1
5465,Phenotype,HP:0000021,Megacystis,0.021517083281029636,-0.3343134974658092,1
5466,Biological Process,GO:0051384,response to glucocorticoid,0.02150140460394745,-0.3346191244224322,1
5467,Phenotype,HP:0002905,Hyperphosphatemia,0.021496669827154702,-0.3347114201827104,1
5468,Phenotype,HP:0002828,Multiple joint contractures,0.021482221953225134,-0.33499305489689074,1
5469,Phenotype,HP:0002298,Absent hair,0.02148014891417871,-0.33503346497813663,1
5470,Biological Process,GO:0031648,protein destabilization,0.021477071229087152,-0.3350934587852063,1
5471,Biological Process,GO:0045050,protein insertion into ER membrane by stop-transfer membrane-anchor sequence,0.02147077017617649,-0.3352162862160228,1
5472,Biological Process,GO:1903059,regulation of protein lipidation,0.021468880137736512,-0.33525312903721766,1
5473,Phenotype,HP:0031381,Decreased lymphocyte proliferation in response to mitogen,0.02145963486535518,-0.33543334860843815,1
5474,Phenotype,HP:0100299,Muscle fiber inclusion bodies,0.021438990209352693,-0.33583577818534033,1
5475,Phenotype,HP:0002718,Recurrent bacterial infections,0.021410732279081524,-0.3363866145335839,1
5476,Biological Process,GO:0007006,mitochondrial membrane organization,0.021397923820975162,-0.33663629185326854,1
5477,Biological Process,GO:0048863,stem cell differentiation,0.02135558272275373,-0.33746165364378555,1
5478,Phenotype,HP:0004150,Abnormal 3rd finger morphology,0.02134780363085209,-0.33761329272473134,1
5479,Phenotype,HP:0007166,Paroxysmal dyskinesia,0.021345973640795712,-0.3376489650131936,1
5480,Phenotype,HP:0032179,Abnormal circulating globulin concentration,0.02132938955580954,-0.33797224123070424,1
5481,Phenotype,HP:0004900,Severe lactic acidosis,0.021316902947130623,-0.3382156446880926,1
5482,Biological Process,GO:2000142,regulation of DNA-templated transcription initiation,0.021316521951761924,-0.33822307149166875,1
5483,Phenotype,HP:0000046,Small scrotum,0.021301318617989007,-0.33851943250524047,1
5484,Phenotype,HP:0010721,Abnormal hair whorl,0.0212960250861568,-0.3386226201667494,1
5485,Biological Process,GO:0043266,regulation of potassium ion transport,0.02123378668816467,-0.33983584319977167,1
5486,Biological Process,GO:0071897,DNA biosynthetic process,0.021230607581758876,-0.33989781402871916,1
5487,Phenotype,HP:0040148,Cortical myoclonus,0.02122414768303249,-0.340023737866393,1
5488,Biological Process,GO:0002237,response to molecule of bacterial origin,0.021212490329164835,-0.3402509765272936,1
5489,Phenotype,HP:0100765,Abnormality of the tonsils,0.021211680472916106,-0.3402667631845035,1
5490,Phenotype,HP:0010955,Dilatation of the bladder,0.02118772989199913,-0.34073363568379905,1
5491,Biological Process,GO:0070830,bicellular tight junction assembly,0.021182155875879904,-0.34084229087031487,1
5492,Phenotype,HP:0011407,Proportionate tall stature,0.021180700376785322,-0.3408706631466436,1
5493,Phenotype,HP:0007665,Curly eyelashes,0.021179351356579557,-0.3408969598129854,1
5494,Biological Process,GO:0034138,toll-like receptor 3 signaling pathway,0.02116870742646626,-0.34110444364277426,1
5495,Biological Process,GO:0031345,negative regulation of cell projection organization,0.021142676291003748,-0.34161187272414034,1
5496,Phenotype,HP:0011915,Cardiovascular calcification,0.02113340758396076,-0.3417925491109636,1
5497,Biological Process,GO:0072522,purine-containing compound biosynthetic process,0.021111890181710558,-0.3422119912698709,1
5498,Phenotype,HP:0000161,Median cleft upper lip,0.021068691833141417,-0.34305406357833923,1
5499,Biological Process,GO:0014902,myotube differentiation,0.021064433494797363,-0.3431370720478384,1
5500,Phenotype,HP:0001120,Abnormality of corneal size,0.02105760543585755,-0.3432701724913566,1
5501,Phenotype,HP:0002280,Enlarged cisterna magna,0.021055276331330308,-0.34331557409791985,1
5502,Biological Process,GO:0072073,kidney epithelium development,0.02104040791392514,-0.3436054065332409,1
5503,Biological Process,GO:0033623,regulation of integrin activation,0.02103649453655254,-0.34368169062342496,1
5504,Phenotype,HP:0000391,Thickened helices,0.02102896140000321,-0.3438285352574033,1
5505,Phenotype,HP:0030046,Hypoglycosylation of alpha-dystroglycan,0.021002099159738608,-0.3443521651974238,1
5505,Phenotype,HP:0030112,Abnormal muscle fiber alpha dystroglycan,0.021002099159738608,-0.3443521651974238,1
5507,Phenotype,HP:0010829,Impaired temperature sensation,0.020996683699042618,-0.3444577296377494,1
5508,Phenotype,HP:0000125,Pelvic kidney,0.02097242344842487,-0.3449306385779838,1
5509,Phenotype,HP:0004756,Ventricular tachycardia,0.020970794251355063,-0.3449623967766873,1
5510,Phenotype,HP:0001480,Freckling,0.020961094113117862,-0.3451514831206893,1
5511,Phenotype,HP:0002667,Nephroblastoma,0.020958464643707764,-0.3452027397878895,1
5512,Biological Process,GO:0015986,proton motive force-driven ATP synthesis,0.020954259639862194,-0.34528470859949095,1
5513,Phenotype,HP:0011496,Corneal neovascularization,0.020914582538549387,-0.34605814067276414,1
5514,Biological Process,GO:0008156,negative regulation of DNA replication,0.020913074315393576,-0.34608754070763964,1
5515,Biological Process,GO:0098927,vesicle-mediated transport between endosomal compartments,0.02090026348958174,-0.3463372641813853,1
5515,Biological Process,GO:0045022,early endosome to late endosome transport,0.02090026348958174,-0.3463372641813853,1
5517,Phenotype,HP:0000689,Dental malocclusion,0.020892980119815552,-0.346479240071566,1
5518,Phenotype,HP:0001305,Dandy-Walker malformation,0.020868551079765707,-0.34695543925115996,1
5519,Phenotype,HP:0001563,Fetal polyuria,0.02084644003590319,-0.34738645336083485,1
5520,Phenotype,HP:0004947,Arteriovenous fistula,0.020842697505029872,-0.34745940711292017,1
5521,Phenotype,HP:0011867,Abnormal iliac wing morphology,0.020785704271112926,-0.34857038532484663,1
5522,Phenotype,HP:0012658,Abnormal brain FDG positron emission tomography,0.02077820485984172,-0.34871657254659166,1
5522,Phenotype,HP:0012657,Abnormal brain positron emission tomography,0.02077820485984172,-0.34871657254659166,1
5524,Phenotype,HP:0002148,Hypophosphatemia,0.02076915622762554,-0.34889295897966477,1
5525,Phenotype,HP:0100702,Arachnoid cyst,0.020767466822735003,-0.3489258908190344,1
5526,Biological Process,GO:0051131,chaperone-mediated protein complex assembly,0.020729212956110077,-0.3496715795512121,1
5527,Biological Process,GO:0015909,long-chain fatty acid transport,0.020726853641578447,-0.3497175700462162,1
5528,Phenotype,HP:0030858,Addictive behavior,0.02071249602434433,-0.3499974453722159,1
5529,Biological Process,GO:0051262,protein tetramerization,0.020672694717627005,-0.35077329860127787,1
5530,Disease,MONDO:0015540,hemophagocytic syndrome,0.02067096475608554,-0.3508070210179219,1
5530,Disease,MONDO:0015541,hereditary hemophagocytic lymphohistiocytosis,0.02067096475608554,-0.3508070210179219,1
5532,Biological Process,GO:0030837,negative regulation of actin filament polymerization,0.020667727281834303,-0.3508701296206034,1
5533,Phenotype,HP:0006655,Rib segmentation abnormalities,0.020656731629830838,-0.3510844696213757,1
5534,Biological Process,GO:0035330,regulation of hippo signaling,0.02065460519457374,-0.35112592056348496,1
5535,Biological Process,GO:0051962,positive regulation of nervous system development,0.02061671547690702,-0.35186451088185694,1
5536,Biological Process,GO:0002752,cell surface pattern recognition receptor signaling pathway,0.020603893613063362,-0.3521144495217199,1
5537,Biological Process,GO:0032465,regulation of cytokinesis,0.020596391841025463,-0.3522606827622672,1
5538,Phenotype,HP:0008544,Abnormally folded helix,0.020591801722018244,-0.3523501586852268,1
5539,Phenotype,HP:0001942,Metabolic acidosis,0.020582771382917864,-0.35252618852767176,1
5540,Phenotype,HP:0002196,Myelopathy,0.020566161513614345,-0.35284996736299884,1
5541,Biological Process,GO:0006691,leukotriene metabolic process,0.020551243434273947,-0.3531407678663555,1
5542,Biological Process,GO:0140527,reciprocal homologous recombination,0.0205370959702994,-0.3534165466412999,1
5542,Biological Process,GO:0007131,reciprocal meiotic recombination,0.0205370959702994,-0.3534165466412999,1
5544,Biological Process,GO:0006858,extracellular transport,0.02052799388774862,-0.3535939749902827,1
5545,Biological Process,GO:0019751,polyol metabolic process,0.020515898557014522,-0.35382975120419624,1
5546,Phenotype,HP:0000403,Recurrent otitis media,0.02051559457510832,-0.353835676772047,1
5547,Biological Process,GO:0060965,negative regulation of miRNA-mediated gene silencing,0.02048019298788073,-0.3545257655663551,1
5547,Biological Process,GO:0060967,negative regulation of gene silencing by regulatory ncRNA,0.02048019298788073,-0.3545257655663551,1
5547,Biological Process,GO:1900369,negative regulation of post-transcriptional gene silencing by regulatory ncRNA,0.02048019298788073,-0.3545257655663551,1
5547,Biological Process,GO:0060149,negative regulation of post-transcriptional gene silencing,0.02048019298788073,-0.3545257655663551,1
5551,Biological Process,GO:0046037,GMP metabolic process,0.020480159737849668,-0.3545264137145214,1
5552,Phenotype,HP:0012751,Abnormal basal ganglia MRI signal intensity,0.020438933628452838,-0.35533004084979014,1
5553,Biological Process,GO:0009308,amine metabolic process,0.020436548553557365,-0.3553765334956811,1
5554,Biological Process,GO:0032660,regulation of interleukin-17 production,0.0204364676384875,-0.35537811078606213,1
5555,Phenotype,HP:0008762,Repetitive compulsive behavior,0.020412559927602936,-0.35584414761296845,1
5556,Biological Process,GO:0006893,Golgi to plasma membrane transport,0.020401478636252968,-0.3560601569952008,1
5557,Phenotype,HP:0008438,Vertebral arch anomaly,0.020370110671520836,-0.35667161774193895,1
5558,Biological Process,GO:1901606,alpha-amino acid catabolic process,0.020368113893567186,-0.35671054125352264,1
5559,Phenotype,HP:0009918,Ectopia pupillae,0.020312632117879925,-0.35779205636876177,1
5560,Phenotype,HP:0011425,Fetal ultrasound soft marker,0.020308115819564154,-0.35788009329319204,1
5561,Biological Process,GO:0051101,regulation of DNA binding,0.02027587296199007,-0.3585086084658396,1
5562,Phenotype,HP:0000749,Paroxysmal bursts of laughter,0.020275124889110208,-0.3585231907699719,1
5563,Phenotype,HP:0002223,Absent eyebrow,0.02026425407344823,-0.3587350973160003,1
5564,Phenotype,HP:0000178,Abnormal lower lip morphology,0.020263244413510018,-0.3587547787784427,1
5565,Biological Process,GO:0006164,purine nucleotide biosynthetic process,0.02024692495034519,-0.3590728966805235,1
5566,Biological Process,GO:0097435,supramolecular fiber organization,0.020246518919417422,-0.3590808115062513,1
5567,Biological Process,GO:0002026,regulation of the force of heart contraction,0.020243113514459177,-0.3591471936090271,1
5568,Biological Process,GO:0000002,mitochondrial genome maintenance,0.020238289825851297,-0.359241222541519,1
5569,Biological Process,GO:0097300,programmed necrotic cell death,0.02022686042012145,-0.3594640177729605,1
5570,Phenotype,HP:0100334,Unilateral cleft palate,0.020216816755113665,-0.35965980053917096,1
5571,Biological Process,GO:0010257,NADH dehydrogenase complex assembly,0.02020717458923993,-0.3598477568186323,1
5571,Biological Process,GO:0032981,mitochondrial respiratory chain complex I assembly,0.02020717458923993,-0.3598477568186323,1
5573,Phenotype,HP:0012440,Abnormal biliary tract morphology,0.020192657545368142,-0.3601307398735444,1
5574,Phenotype,HP:0011267,"Microtia, third degree",0.02018934272792794,-0.36019535613936193,1
5575,Biological Process,GO:0120254,olefinic compound metabolic process,0.020186871280191143,-0.36024353246484464,1
5576,Phenotype,HP:0010862,Delayed fine motor development,0.02018162739592766,-0.3603457523383665,1
5577,Phenotype,HP:0005792,Short humerus,0.020171970788513405,-0.36053399012908394,1
5578,Biological Process,GO:0006626,protein targeting to mitochondrion,0.020154128930849113,-0.3608817843103056,1
5579,Phenotype,HP:0007183,Focal T2 hyperintense basal ganglia lesion,0.020140828724697246,-0.36114104735318514,1
5580,Biological Process,GO:0045931,positive regulation of mitotic cell cycle,0.02011996598243415,-0.36154772812039887,1
5581,Phenotype,HP:0030089,Abnormal muscle fiber protein expression,0.020097596854013466,-0.3619837731135884,1
5582,Phenotype,HP:0007894,Hypopigmentation of the fundus,0.02008046848787437,-0.3623176590905478,1
5583,Disease,MONDO:0100455,neonatal-onset developmental and epileptic encephalopathy,0.020075345033005565,-0.3624175314146438,1
5584,Phenotype,HP:0011347,Abnormality of ocular abduction,0.020057552201286355,-0.3627643699252874,1
5585,Biological Process,GO:1903426,regulation of reactive oxygen species biosynthetic process,0.020055682911865436,-0.36280080828253963,1
5586,Phenotype,HP:0000710,Hyperorality,0.02003853910573694,-0.3631349952336785,1
5587,Phenotype,HP:0001992,Organic aciduria,0.020018936264117437,-0.3635171165564104,1
5588,Phenotype,HP:0009055,Generalized limb muscle atrophy,0.019974457682911395,-0.36438414464415364,1
5589,Phenotype,HP:0011157,Focal sensory seizure,0.019962429508850188,-0.364618611762316,1
5590,Phenotype,HP:0006502,Aplasia/Hypoplasia involving the carpal bones,0.019929261742473114,-0.36526515632999035,1
5591,Biological Process,GO:0051341,regulation of oxidoreductase activity,0.019920907576818636,-0.3654280054154533,1
5592,Biological Process,GO:0031016,pancreas development,0.019912795611795264,-0.36558613324532885,1
5593,Biological Process,GO:0009988,cell-cell recognition,0.019897457046180067,-0.36588513035480186,1
5594,Disease,MONDO:0001941,blindness (disorder),0.019896911077498358,-0.3658957730095187,1
5595,Biological Process,GO:0051168,nuclear export,0.019891006092696006,-0.3660108798214383,1
5596,Phenotype,HP:0005294,Arterial dissection,0.019866741016839384,-0.3664838828208248,1
5597,Phenotype,HP:0002613,Biliary cirrhosis,0.019844740912721703,-0.36691273436433386,1
5598,Phenotype,HP:0031165,Multifocal seizures,0.019833111145719617,-0.36713943527005766,1
5599,Phenotype,HP:0100831,Abnormality of vitamin K metabolism,0.01981686058579002,-0.3674562100303686,1
5599,Phenotype,HP:0011892,Decreased circulating vitamin K concentration,0.01981686058579002,-0.3674562100303686,1
5601,Biological Process,GO:0090278,negative regulation of peptide hormone secretion,0.019815870403992797,-0.3674755118022976,1
5602,Disease,MONDO:0100309,hereditary ataxia,0.019804270135717172,-0.3677016376846348,1
5602,Disease,MONDO:0100308,atactic disorder,0.019804270135717172,-0.3677016376846348,1
5604,Phenotype,HP:0033107,Abnormal circulating proteinogenic amino acid concentration,0.019759009682342343,-0.3685839069314479,1
5605,Biological Process,GO:0010800,positive regulation of peptidyl-threonine phosphorylation,0.019743323880312413,-0.3688896727758153,1
5606,Disease,MONDO:0000992,heart conduction disease,0.0197058702598768,-0.3696197621812062,1
5607,Phenotype,HP:0000713,Agitation,0.01970576937746893,-0.3696217286980962,1
5608,Phenotype,HP:0006568,Increased hepatic glycogen content,0.019693728912670294,-0.3698564354015664,1
5608,Phenotype,HP:0500030,Abnormal hepatic glycogen storage,0.019693728912670294,-0.3698564354015664,1
5610,Phenotype,HP:0011381,Aplasia of the semicircular canal,0.019692281218232854,-0.3698846555404668,1
5611,Phenotype,HP:0031137,Storage in hepatocytes,0.019690006766506674,-0.3699289917912496,1
5612,Phenotype,HP:0002032,Esophageal atresia,0.019685596906146796,-0.37001495390360495,1
5613,Phenotype,HP:0100798,Fingernail dysplasia,0.019681358862170373,-0.3700975667717544,1
5614,Biological Process,GO:1904707,positive regulation of vascular associated smooth muscle cell proliferation,0.019591946238261326,-0.3718405013309493,1
5615,Biological Process,GO:0046520,sphingoid biosynthetic process,0.01958012242108198,-0.37207098488777285,1
5615,Biological Process,GO:0046512,sphingosine biosynthetic process,0.01958012242108198,-0.37207098488777285,1
5617,Biological Process,GO:0051303,establishment of chromosome localization,0.019551089978843805,-0.3726369189214974,1
5618,Phenotype,HP:0031101,Abnormal circulating antimullerian hormone concentration,0.019533471649755385,-0.3729803558244868,1
5619,Phenotype,HP:0100694,Tibial torsion,0.019525520314640943,-0.3731353524698911,1
5620,Phenotype,HP:0000418,Narrow nasal ridge,0.019456942884500505,-0.3744721432690754,1
5621,Biological Process,GO:0010863,positive regulation of phospholipase C activity,0.019452897418608228,-0.3745510021818713,1
5622,Disease,MONDO:0019005,nephronophthisis,0.019448628639457732,-0.3746342141756781,1
5623,Phenotype,HP:0010754,Abnormality of the temporomandibular joint,0.019427087723668635,-0.37505411468775474,1
5624,Phenotype,HP:0001525,Severe failure to thrive,0.019414943468125334,-0.37529084460078854,1
5625,Phenotype,HP:0010930,Abnormal blood monovalent inorganic cation concentration,0.01939855585547523,-0.3756102909516709,1
5626,Biological Process,GO:0070862,negative regulation of protein exit from endoplasmic reticulum,0.01935944514560828,-0.3763726822660238,1
5627,Phenotype,HP:0001334,Communicating hydrocephalus,0.019317542587996894,-0.37718949551438374,1
5628,Biological Process,GO:0006493,protein O-linked glycosylation,0.019310752273404175,-0.37732186020131536,1
5629,Biological Process,GO:0006814,sodium ion transport,0.019306629025709787,-0.3774022353272034,1
5630,Biological Process,GO:0044598,doxorubicin metabolic process,0.019292437710987653,-0.37767886889177454,1
5630,Biological Process,GO:0030638,polyketide metabolic process,0.019292437710987653,-0.37767886889177454,1
5632,Phenotype,HP:0000876,Oligomenorrhea,0.01927388981918743,-0.3780404259091785,1
5633,Phenotype,HP:0001238,Slender finger,0.019233237829665906,-0.37883286163401714,1
5634,Biological Process,GO:0045684,positive regulation of epidermis development,0.01920907320065446,-0.37930390660700686,1
5634,Biological Process,GO:0045606,positive regulation of epidermal cell differentiation,0.01920907320065446,-0.37930390660700686,1
5636,Phenotype,HP:0005264,Abnormality of the gallbladder,0.019202142828170676,-0.37943900146477955,1
5637,Phenotype,HP:0010850,EEG with spike-wave complexes,0.019168096080606878,-0.38010268015312104,1
5638,Biological Process,GO:1901796,regulation of signal transduction by p53 class mediator,0.019149902206796465,-0.3804573362413045,1
5639,Phenotype,HP:0000603,Central scotoma,0.019147356471581944,-0.380506960664456,1
5640,Biological Process,GO:0010656,negative regulation of muscle cell apoptotic process,0.019136291299562513,-0.38072265583000353,1
5641,Biological Process,GO:0090311,regulation of protein deacetylation,0.019108583261333467,-0.38126277304483913,1
5642,Biological Process,GO:0000076,DNA replication checkpoint signaling,0.01907680339631901,-0.38188226302957096,1
5643,Phenotype,HP:0004924,Abnormal oral glucose tolerance,0.019063167679738036,-0.38214806623083414,1
5644,Biological Process,GO:0010907,positive regulation of glucose metabolic process,0.019045201814498647,-0.38249827771152417,1
5645,Phenotype,HP:0002335,Agenesis of cerebellar vermis,0.0190409690504989,-0.3825807876562449,1
5646,Phenotype,HP:0002630,Fat malabsorption,0.018990425858188775,-0.3835660341769036,1
5647,Phenotype,HP:0003458,EMG,0.018982158308020303,-0.3837271948528633,1
5648,Biological Process,GO:0014911,positive regulation of smooth muscle cell migration,0.01897858879859693,-0.3837967758701892,1
5649,Biological Process,GO:0015844,monoamine transport,0.018968991700494597,-0.38398385363638415,1
5650,Biological Process,GO:1904358,positive regulation of telomere maintenance via telomere lengthening,0.018953172448547106,-0.3842922208413097,1
5651,Biological Process,GO:0006402,mRNA catabolic process,0.018949938269460453,-0.38435526521082164,1
5652,Biological Process,GO:0044283,small molecule biosynthetic process,0.018946620427133132,-0.38441994044124694,1
5653,Phenotype,HP:0010307,Stridor,0.018924997912667996,-0.38484143156934886,1
5654,Biological Process,GO:0010882,regulation of cardiac muscle contraction by calcium ion signaling,0.018921460182400485,-0.3849103931105136,1
5655,Biological Process,GO:0032309,icosanoid secretion,0.018900033491198176,-0.3853280670244756,1
5656,Biological Process,GO:0090307,mitotic spindle assembly,0.018845632950461155,-0.3863885054541306,1
5657,Phenotype,HP:0000100,Nephrotic syndrome,0.01883919694903291,-0.3865139634579548,1
5658,Phenotype,HP:0000625,Eyelid coloboma,0.018827672689611497,-0.38673860768755647,1
5659,Phenotype,HP:0010182,Abnormality of the distal phalanges of the toes,0.018801757877859537,-0.387243769252253,1
5660,Biological Process,GO:0009117,nucleotide metabolic process,0.018783147833280722,-0.38760653782369736,1
5661,Biological Process,GO:0051209,release of sequestered calcium ion into cytosol,0.0187581687853835,-0.38809345839410964,1
5661,Biological Process,GO:0051283,negative regulation of sequestering of calcium ion,0.0187581687853835,-0.38809345839410964,1
5663,Biological Process,GO:0032418,lysosome localization,0.018740540386351867,-0.3884370915921105,1
5663,Biological Process,GO:1990849,vacuolar localization,0.018740540386351867,-0.3884370915921105,1
5665,Phenotype,HP:0008255,Transient neonatal diabetes mellitus,0.018739152027724804,-0.3884641550885819,1
5666,Biological Process,GO:0031054,pre-miRNA processing,0.018736014157298198,-0.3885253220980008,1
5667,Biological Process,GO:0051310,metaphase chromosome alignment,0.01872598082538579,-0.38872090343953253,1
5668,Biological Process,GO:0010837,regulation of keratinocyte proliferation,0.018725392734392332,-0.3887323671912002,1
5669,Biological Process,GO:0048736,appendage development,0.0186846951731916,-0.38952569125206055,1
5669,Biological Process,GO:0060173,limb development,0.0186846951731916,-0.38952569125206055,1
5671,Phenotype,HP:0002186,Apraxia,0.01866774946622296,-0.3898560166246352,1
5672,Phenotype,HP:0002187,"Intellectual disability, profound",0.01864671885853819,-0.39026596961932575,1
5673,Phenotype,HP:0007328,Impaired pain sensation,0.018642042763154953,-0.39035712149351554,1
5674,Biological Process,GO:0010447,response to acidic pH,0.01863721747763436,-0.39045118155488207,1
5675,Phenotype,HP:0011751,Abnormal posterior pituitary morphogenesis,0.018623118340583167,-0.39072601828539055,1
5676,Phenotype,HP:0031379,Abnormal T cell proliferation,0.018610666719659053,-0.3909687397208862,1
5677,Phenotype,HP:0001394,Cirrhosis,0.018601878210195766,-0.3911400555395893,1
5678,Biological Process,GO:0043603,amide metabolic process,0.018597136974897954,-0.3912324771965383,1
5679,Phenotype,HP:0045059,Hyperkeratotic papule,0.01855961896991587,-0.39196382166017735,1
5680,Biological Process,GO:0042987,amyloid precursor protein catabolic process,0.01851304886487959,-0.3928716201560098,1
5681,Biological Process,GO:0048193,Golgi vesicle transport,0.01850769280108422,-0.39297602676306453,1
5682,Phenotype,HP:0002028,Chronic diarrhea,0.01850562712041537,-0.3930162934062811,1
5683,Biological Process,GO:0042537,benzene-containing compound metabolic process,0.01850141080229717,-0.39309848276880605,1
5684,Biological Process,GO:0071356,cellular response to tumor necrosis factor,0.018460655837084228,-0.3938929258152452,1
5685,Phenotype,HP:0012156,Hemophagocytosis,0.0184337734756852,-0.3944169479797529,1
5686,Biological Process,GO:0044788,modulation by host of viral process,0.018430100977905095,-0.39448853656556626,1
5687,Phenotype,HP:0001283,Bulbar palsy,0.01842315920994353,-0.3946238535572075,1
5688,Biological Process,GO:0006837,serotonin transport,0.01839774240667602,-0.3951193073629728,1
5689,Phenotype,HP:0030692,Brain neoplasm,0.018392499489484848,-0.3952215083851997,1
5690,Biological Process,GO:0071466,cellular response to xenobiotic stimulus,0.01833520676254463,-0.39633832466246494,1
5691,Phenotype,HP:0006476,Abnormality of the pancreatic islet cells,0.01832980145230323,-0.396443691238358,1
5692,Biological Process,GO:0010635,regulation of mitochondrial fusion,0.01827148359129438,-0.3975804906177616,1
5693,Biological Process,GO:0035107,appendage morphogenesis,0.01822451655317414,-0.39849602659359934,1
5693,Biological Process,GO:0035108,limb morphogenesis,0.01822451655317414,-0.39849602659359934,1
5695,Biological Process,GO:0051125,regulation of actin nucleation,0.018215400212588606,-0.3986737328767309,1
5696,Phenotype,HP:0030014,Female sexual dysfunction,0.01821311900578082,-0.39871820080539844,1
5697,Biological Process,GO:0002720,positive regulation of cytokine production involved in immune response,0.018204369805766007,-0.39888875035874377,1
5698,Disease,MONDO:0018940,congenital myasthenic syndrome,0.018190782160300456,-0.3991536165020759,1
5698,Disease,MONDO:0021017,synaptopathy,0.018190782160300456,-0.3991536165020759,1
5698,Disease,MONDO:0020124,neuromuscular junction disease,0.018190782160300456,-0.3991536165020759,1
5701,Phenotype,HP:0001953,Diabetic ketoacidosis,0.018190558518731192,-0.39915797598290653,1
5702,Biological Process,GO:0033209,tumor necrosis factor-mediated signaling pathway,0.01816871587085578,-0.3995837582067356,1
5703,Biological Process,GO:0048268,clathrin coat assembly,0.018162265718989157,-0.3997094920473152,1
5704,Phenotype,HP:0011922,Abnormal activity of mitochondrial respiratory chain,0.018139947133790968,-0.4001445517933957,1
5705,Biological Process,GO:0000132,establishment of mitotic spindle orientation,0.018125112806173793,-0.4004337197110344,1
5706,Phenotype,HP:0002342,"Intellectual disability, moderate",0.01810071292169757,-0.4009093505563749,1
5707,Phenotype,HP:0002992,Abnormal tibia morphology,0.018090668670547427,-0.4011051447483519,1
5708,Phenotype,HP:0002571,Achalasia,0.018087091564760294,-0.4011748738428099,1
5709,Biological Process,GO:0070934,CRD-mediated mRNA stabilization,0.018085900840347224,-0.40119808482398106,1
5710,Disease,MONDO:0018542,severe congenital neutropenia,0.018064610683741544,-0.4016130972472431,1
5711,Phenotype,HP:0007301,Oromotor apraxia,0.018049204052273726,-0.401913421175253,1
5712,Biological Process,GO:0060148,positive regulation of post-transcriptional gene silencing,0.01801575387008869,-0.40256547091938055,1
5712,Biological Process,GO:1900370,positive regulation of post-transcriptional gene silencing by RNA,0.01801575387008869,-0.40256547091938055,1
5712,Biological Process,GO:2000637,positive regulation of miRNA-mediated gene silencing,0.01801575387008869,-0.40256547091938055,1
5715,Biological Process,GO:0006298,mismatch repair,0.01801304743551091,-0.40261822788088764,1
5716,Biological Process,GO:0062207,regulation of pattern recognition receptor signaling pathway,0.0179965199234976,-0.4029404013124023,1
5717,Biological Process,GO:0042255,ribosome assembly,0.017989790081344048,-0.4030715872004183,1
5718,Biological Process,GO:0033273,response to vitamin,0.01798066647232066,-0.40324943516836986,1
5719,Disease,MONDO:0017672,focal palmoplantar keratoderma,0.017938858931015655,-0.4040643962486932,1
5720,Biological Process,GO:0032370,positive regulation of lipid transport,0.017925538164100474,-0.4043240600858161,1
5721,Biological Process,GO:1901016,regulation of potassium ion transmembrane transporter activity,0.017907321856276748,-0.40467915348380434,1
5722,Phenotype,HP:0003587,Insidious onset,0.01789878317384952,-0.4048455993841902,1
5723,Phenotype,HP:0006785,Limb-girdle muscular dystrophy,0.017894166401545397,-0.4049355948641235,1
5724,Phenotype,HP:0000944,Abnormal metaphysis morphology,0.017881978855574188,-0.405173168644383,1
5725,Phenotype,HP:0002792,Reduced vital capacity,0.01786494928714233,-0.4055051287418549,1
5726,Biological Process,GO:0009116,nucleoside metabolic process,0.017861655184726488,-0.4055693412063939,1
5727,Phenotype,HP:0003003,Colon cancer,0.01785709810346625,-0.4056581731192746,1
5728,Biological Process,GO:0048568,embryonic organ development,0.017848915821154443,-0.405817671655285,1
5729,Phenotype,HP:0011170,Generalized myoclonic-atonic seizure,0.017845404315481095,-0.405886121996247,1
5730,Phenotype,HP:0000974,Hyperextensible skin,0.017835525818362563,-0.406078685118411,1
5731,Phenotype,HP:0000011,Neurogenic bladder,0.017833659895286846,-0.4061150578549585,1
5732,Phenotype,HP:0006863,Severe expressive language delay,0.017832403413580722,-0.4061395506535462,1
5733,Phenotype,HP:0003212,Increased circulating IgE level,0.017826605869554868,-0.40625256310524865,1
5734,Phenotype,HP:0011112,Abnormal circulating cytokine concentration,0.017810906308831975,-0.4065585971500156,1
5735,Biological Process,GO:1903588,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,0.017799219552125045,-0.4067864089651585,1
5736,Disease,MONDO:0018555,hypogonadotropic hypogonadism,0.01775363594530488,-0.40767497749369686,1
5737,Biological Process,GO:0006509,membrane protein ectodomain proteolysis,0.01773754904594793,-0.4079885619923247,1
5738,Disease,MONDO:0019707,primary osteolysis,0.01771360807833977,-0.408455247097856,1
5739,Biological Process,GO:0044272,sulfur compound biosynthetic process,0.01770790394536892,-0.4085664386729434,1
5740,Biological Process,GO:0042454,ribonucleoside catabolic process,0.017701281043786987,-0.40869553995131586,1
5741,Phenotype,HP:0005445,Enlarged posterior fossa,0.01769307001620668,-0.4088555988234364,1
5742,Biological Process,GO:0097237,cellular response to toxic substance,0.01768821971480028,-0.40895014652346057,1
5743,Biological Process,GO:0055117,regulation of cardiac muscle contraction,0.01768616284785096,-0.4089902413594345,1
5744,Biological Process,GO:0018242,protein O-linked glycosylation via serine,0.01767560312010774,-0.4091960838189743,1
5745,Phenotype,HP:0009617,Abnormality of the distal phalanx of the thumb,0.01767377922571134,-0.409231637283763,1
5746,Biological Process,GO:0050685,positive regulation of mRNA processing,0.01763097249221257,-0.41006607577711424,1
5747,Phenotype,HP:0004388,Microcolon,0.0176151021407166,-0.41037543907370017,1
5747,Phenotype,HP:0100811,Aplasia/Hypoplasia of the colon,0.0176151021407166,-0.41037543907370017,1
5749,Phenotype,HP:0000837,Increased circulating gonadotropin level,0.017610056892658932,-0.41047378689993513,1
5750,Biological Process,GO:2000641,regulation of early endosome to late endosome transport,0.017477027431134107,-0.4130669514414272,1
5751,Biological Process,GO:0007263,nitric oxide mediated signal transduction,0.017465849553754853,-0.4132848435905555,1
5752,Biological Process,GO:1904779,regulation of protein localization to centrosome,0.017462036336936326,-0.413359175235061,1
5753,Phenotype,HP:0009710,Chilblains,0.01745551135911061,-0.41348636767001284,1
5754,Biological Process,GO:1905897,regulation of response to endoplasmic reticulum stress,0.017449776975356324,-0.4135981489284534,1
5755,Phenotype,HP:0011120,Concave nasal ridge,0.0174412072055824,-0.4137652008194539,1
5756,Phenotype,HP:0002656,Epiphyseal dysplasia,0.01744088790566911,-0.4137714249836634,1
5757,Biological Process,GO:0043506,regulation of JUN kinase activity,0.01743497304136188,-0.41388672437834967,1
5758,Biological Process,GO:1900077,negative regulation of cellular response to insulin stimulus,0.017409935959171285,-0.4143747762205121,1
5758,Biological Process,GO:0046627,negative regulation of insulin receptor signaling pathway,0.017409935959171285,-0.4143747762205121,1
5760,Phenotype,HP:0011324,Multiple suture craniosynostosis,0.017402207556538096,-0.4145254272074517,1
5761,Biological Process,GO:0006213,pyrimidine nucleoside metabolic process,0.017367177209964613,-0.4152082793483933,1
5762,Phenotype,HP:0012418,Hypoxemia,0.017361240738492878,-0.4153239999349884,1
5762,Phenotype,HP:0500165,Abnormal blood oxygen level,0.017361240738492878,-0.4153239999349884,1
5764,Phenotype,HP:0002876,Episodic tachypnea,0.01734279592096888,-0.4156835477090625,1
5765,Biological Process,GO:0061572,actin filament bundle organization,0.017342305103361766,-0.4156931152950733,1
5766,Phenotype,HP:0010841,Multifocal epileptiform discharges,0.017340803704394725,-0.4157223823049472,1
5767,Phenotype,HP:0001850,Abnormality of the tarsal bones,0.017330612987772387,-0.41592103157176774,1
5768,Phenotype,HP:0100324,Scleroderma,0.01733041407154501,-0.4159249090775597,1
5769,Phenotype,HP:0004751,Paroxysmal ventricular tachycardia,0.017324693922060708,-0.4160364128651019,1
5770,Biological Process,GO:0032787,monocarboxylic acid metabolic process,0.017311475144029864,-0.4162940886166124,1
5771,Phenotype,HP:0002396,Cogwheel rigidity,0.017293257444019994,-0.4166492091527074,1
5772,Phenotype,HP:0000966,Hypohidrosis,0.01728725414448129,-0.416766232429486,1
5773,Phenotype,HP:0002104,Apnea,0.017259815632242437,-0.417301095731145,1
5774,Biological Process,GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization,0.017241209298365034,-0.417663791969294,1
5775,Phenotype,HP:0100764,Lymphangioma,0.017233354715454285,-0.4178169026085381,1
5776,Phenotype,HP:0007270,Atypical absence seizure,0.017220603328877204,-0.41806546742378675,1
5777,Biological Process,GO:0034356,NAD biosynthesis via nicotinamide riboside salvage pathway,0.01719706434184043,-0.4185243166578342,1
5778,Biological Process,GO:0038095,Fc-epsilon receptor signaling pathway,0.0171817844860227,-0.4188221693278478,1
5779,Biological Process,GO:0002791,regulation of peptide secretion,0.01717524659097658,-0.41894961356024013,1
5779,Biological Process,GO:0090087,regulation of peptide transport,0.01717524659097658,-0.41894961356024013,1
5781,Phenotype,HP:0005019,Diaphyseal undertubulation,0.017141971923974486,-0.4195982419588726,1
5782,Phenotype,HP:0030478,Abnormal amplitude of dark-adapted bright flash electroretinogram,0.017100538799330156,-0.4204059044754261,1
5782,Phenotype,HP:0030469,Abnormal dark-adapted electroretinogram,0.017100538799330156,-0.4204059044754261,1
5782,Phenotype,HP:0030470,Abnormal dark-adapted bright flash electroretinogram,0.017100538799330156,-0.4204059044754261,1
5785,Biological Process,GO:0050892,intestinal absorption,0.01708172762500959,-0.4207725937010516,1
5786,Phenotype,HP:0012387,Bronchitis,0.017052354086590782,-0.4213451767771065,1
5787,Disease,MONDO:0002283,neuroaxonal dystrophy,0.017013601022843772,-0.4221005964385186,1
5787,Disease,MONDO:0018307,neurodegeneration with brain iron accumulation,0.017013601022843772,-0.4221005964385186,1
5789,Biological Process,GO:0009416,response to light stimulus,0.016980094577972893,-0.42275374292016776,1
5790,Phenotype,HP:0030016,Dyspareunia,0.016979719760425893,-0.4227610492984788,1
5791,Biological Process,GO:0015711,organic anion transport,0.01696687146276532,-0.42301150321695696,1
5792,Phenotype,HP:0000124,Renal tubular dysfunction,0.01694885077555286,-0.4233627833511244,1
5793,Biological Process,GO:0040001,establishment of mitotic spindle localization,0.01694335772696176,-0.4234698602246821,1
5794,Phenotype,HP:0011065,Conical incisor,0.016935070625647253,-0.42363140201425414,1
5795,Biological Process,GO:0072089,stem cell proliferation,0.016929251111791666,-0.42374484272735674,1
5796,Biological Process,GO:0072384,organelle transport along microtubule,0.01690618366082075,-0.42419450023355676,1
5797,Biological Process,GO:0009132,nucleoside diphosphate metabolic process,0.016854726604012105,-0.42519756086085114,1
5798,Biological Process,GO:0045454,cell redox homeostasis,0.016836822748430014,-0.425546563577387,1
5799,Biological Process,GO:0010565,regulation of cellular ketone metabolic process,0.016804608700840995,-0.42617451715239413,1
5800,Phenotype,HP:0010536,Central sleep apnea,0.01679306718261442,-0.42639949781064146,1
5801,Phenotype,HP:0030352,Abnormal serum insulin-like growth factor 1 level,0.016744436406576413,-0.42734746529544904,1
5802,Phenotype,HP:0000570,Abnormal saccadic eye movements,0.016741661113194417,-0.427401564532625,1
5803,Phenotype,HP:0011474,Childhood onset sensorineural hearing impairment,0.01673301620279677,-0.42757008115180545,1
5804,Biological Process,GO:0007606,sensory perception of chemical stimulus,0.016723477355142125,-0.4277560234327197,1
5805,Biological Process,GO:1901679,nucleotide transmembrane transport,0.016717370219676342,-0.4278750707998099,1
5806,Phenotype,HP:0200153,Agenesis of lateral incisor,0.01665168400909678,-0.42915550259429713,1
5807,Phenotype,HP:0012110,Hypoplasia of the pons,0.016602131836338963,-0.4301214310125331,1
5808,Phenotype,HP:0001602,Laryngeal stenosis,0.016598216459220105,-0.4301977540840904,1
5809,Phenotype,HP:0020072,Persistent EBV viremia,0.016595940442441615,-0.43024212084268787,1
5810,Biological Process,GO:0039535,regulation of RIG-I signaling pathway,0.016592709004840445,-0.4303051117719854,1
5811,Phenotype,HP:0000608,Macular degeneration,0.016579527998524135,-0.4305620512334314,1
5812,Disease,MONDO:0005516,osteochondrodysplasia,0.016517212915951096,-0.43177676909123763,1
5813,Disease,MONDO:0002012,methylmalonic acidemia,0.016499872691450035,-0.43211478485708565,1
5814,Phenotype,HP:0032140,Decreased specific antibody response to vaccination,0.016458702021701965,-0.43291733129842597,1
5815,Biological Process,GO:1903432,regulation of TORC1 signaling,0.01645090351947065,-0.43306934874802844,1
5816,Phenotype,HP:0100297,Increased endomysial connective tissue,0.016435301171971006,-0.4333734877999073,1
5817,Phenotype,HP:0009723,Abnormality of the subungual region,0.016406591874153387,-0.4339331227278281,1
5818,Biological Process,GO:0060325,face morphogenesis,0.016400043356597394,-0.434060774026502,1
5819,Phenotype,HP:0002058,Myopathic facies,0.016391716555189006,-0.43422308969634515,1
5820,Phenotype,HP:0000204,Cleft upper lip,0.016381104752923203,-0.43442994725287126,1
5821,Biological Process,GO:0060338,regulation of type I interferon-mediated signaling pathway,0.016364839792679997,-0.4347470027207955,1
5822,Phenotype,HP:0001194,Abnormalities of placenta or umbilical cord,0.016357714998548212,-0.4348858874708065,1
5823,Phenotype,HP:0032324,Non-periodic recurrent fever,0.016334086215336052,-0.4353464871160433,1
5824,Phenotype,HP:0012213,Decreased glomerular filtration rate,0.01632606022168004,-0.4355029390923232,1
5824,Phenotype,HP:0012212,Abnormal glomerular filtration rate,0.01632606022168004,-0.4355029390923232,1
5826,Biological Process,GO:0031113,regulation of microtubule polymerization,0.016317384683207425,-0.43567205274946097,1
5827,Phenotype,HP:0008915,Childhood-onset truncal obesity,0.016305245241285182,-0.43590868882981065,1
5828,Biological Process,GO:0035148,tube formation,0.01626201390368598,-0.4367514041987111,1
5829,Biological Process,GO:1901021,positive regulation of calcium ion transmembrane transporter activity,0.01625441250092774,-0.4368995795568034,1
5830,Phenotype,HP:0000134,Female hypogonadism,0.01624619212766143,-0.43705982060587395,1
5831,Biological Process,GO:0031293,membrane protein intracellular domain proteolysis,0.01623186948533417,-0.4373390141604279,1
5832,Biological Process,GO:0030865,cortical cytoskeleton organization,0.01622448893290407,-0.43748288444779876,1
5833,Biological Process,GO:0045604,regulation of epidermal cell differentiation,0.01621950897530322,-0.4375799595567305,1
5833,Biological Process,GO:0045682,regulation of epidermis development,0.01621950897530322,-0.4375799595567305,1
5835,Phenotype,HP:0020201,Abnormal sarcomere morphology,0.016208762119266806,-0.43778944973797845,1
5836,Biological Process,GO:0060586,multicellular organismal-level iron ion homeostasis,0.016179624712638008,-0.43835742985933474,1
5837,Biological Process,GO:0061564,axon development,0.016155108915476002,-0.43883532020917326,1
5838,Phenotype,HP:0030356,Increased circulating interferon-gamma concentration,0.016103056993888143,-0.4398499766306229,1
5839,Phenotype,HP:0011194,EEG with series of focal spikes,0.016092526956689834,-0.4400552403276285,1
5840,Biological Process,GO:0043524,negative regulation of neuron apoptotic process,0.016090710337073655,-0.4400906519839643,1
5841,Biological Process,GO:0070525,tRNA threonylcarbamoyladenosine metabolic process,0.01608244994400654,-0.4402516731454041,1
5842,Phenotype,HP:0002697,Parietal foramina,0.016061228359364965,-0.4406653488844172,1
5843,Phenotype,HP:0031878,Acromicria,0.01605622963506148,-0.4407627898156809,1
5844,Phenotype,HP:0008905,Rhizomelia,0.016054128950927504,-0.44080373878703405,1
5845,Biological Process,GO:1901657,glycosyl compound metabolic process,0.016048390422011893,-0.4409156008477665,1
5846,Phenotype,HP:0002465,Poor speech,0.016044215458850375,-0.4409969840715155,1
5847,Phenotype,HP:0030853,Heterotaxy,0.016030732452158025,-0.4412598104745283,1
5848,Biological Process,GO:0002673,regulation of acute inflammatory response,0.016030592387972553,-0.4412625407680673,1
5849,Biological Process,GO:0006753,nucleoside phosphate metabolic process,0.016009592185295518,-0.4416719010730857,1
5850,Biological Process,GO:1900544,positive regulation of purine nucleotide metabolic process,0.016003494467203727,-0.4417907648658005,1
5850,Biological Process,GO:0045981,positive regulation of nucleotide metabolic process,0.016003494467203727,-0.4417907648658005,1
5852,Phenotype,HP:0000149,Ovarian gonadoblastoma,0.015989937129535003,-0.44205504021440817,1
5852,Phenotype,HP:0000030,Testicular gonadoblastoma,0.015989937129535003,-0.44205504021440817,1
5852,Phenotype,HP:0012870,Vanishing testis,0.015989937129535003,-0.44205504021440817,1
5855,Phenotype,HP:0100314,Cerebral inclusion bodies,0.01597524739246814,-0.44234138960535513,1
5856,Phenotype,HP:0032012,Heterotropia,0.015952790099246883,-0.44277915320908423,1
5857,Phenotype,HP:0032560,Coiled sperm flagella,0.01593651831796805,-0.4430963416405454,1
5858,Disease,MONDO:0100118,hereditary skin disorder,0.015918981048286818,-0.44343819843956334,1
5859,Phenotype,HP:0000698,Conical tooth,0.015833312355826856,-0.44510815194502573,1
5860,Phenotype,HP:0011802,Hamartoma of tongue,0.015798731178110925,-0.44578224836568403,1
5861,Phenotype,HP:0008391,Dystrophic fingernails,0.01577053105282178,-0.4463319579121803,1
5862,Phenotype,HP:0011111,Abnormal immune serum protein physiology,0.015740433125335018,-0.446918661620039,1
5863,Biological Process,GO:0034112,positive regulation of homotypic cell-cell adhesion,0.01573263260996971,-0.4470707183119839,1
5864,Phenotype,HP:0032445,Pulmonary cyst,0.015670768089099063,-0.44827665329856,1
5865,Biological Process,GO:0090559,regulation of membrane permeability,0.015650206008768652,-0.448677473214697,1
5866,Biological Process,GO:0034656,nucleobase-containing small molecule catabolic process,0.01564817706516175,-0.44871702373649713,1
5867,Phenotype,HP:0002132,Porencephalic cyst,0.015628446040535815,-0.44910164375104733,1
5868,Phenotype,HP:0010481,Urethral valve,0.015620412769926206,-0.449258237578146,1
5869,Phenotype,HP:0011027,Abnormal fallopian tube morphology,0.015612767361369406,-0.44940727074829845,1
5870,Biological Process,GO:0019081,viral translation,0.015609917019745678,-0.4494628329128375,1
5871,Biological Process,GO:0042304,regulation of fatty acid biosynthetic process,0.015560223105784865,-0.45043152431498296,1
5872,Phenotype,HP:0010553,Oculogyric crisis,0.015558858235999673,-0.4504581299397081,1
5873,Phenotype,HP:5200016,Abnormal peer relationships,0.01553851314438126,-0.4508547200602238,1
5873,Phenotype,HP:0002332,Lack of peer relationships,0.01553851314438126,-0.4508547200602238,1
5875,Phenotype,HP:0031845,Abnormal libido,0.01548007299184373,-0.4519939032879288,1
5876,Phenotype,HP:0006257,Abnormality of carpal bone ossification,0.015474463828801355,-0.4521032435990314,1
5877,Biological Process,GO:0002431,Fc receptor mediated stimulatory signaling pathway,0.015459881394281894,-0.45238750132428307,1
5877,Biological Process,GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,0.015459881394281894,-0.45238750132428307,1
5877,Biological Process,GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,0.015459881394281894,-0.45238750132428307,1
5880,Biological Process,GO:1900181,negative regulation of protein localization to nucleus,0.01544396198796505,-0.45269782085432747,1
5881,Phenotype,HP:0000054,Micropenis,0.015441892843585214,-0.45273815501621545,1
5882,Phenotype,HP:0009193,Pseudoepiphyses of the metacarpals,0.015439257560916242,-0.4527895250021995,1
5883,Phenotype,HP:0010863,Receptive language delay,0.01540310488583696,-0.4534942548719673,1
5884,Biological Process,GO:0003351,epithelial cilium movement involved in extracellular fluid movement,0.015402537787918447,-0.453505309402272,1
5885,Phenotype,HP:0006488,Bowing of the arm,0.015391641022536207,-0.4537177217903422,1
5886,Biological Process,GO:0015850,organic hydroxy compound transport,0.015381778531176837,-0.4539099729096863,1
5887,Disease,MONDO:0021179,proteostasis deficiencies,0.015378513293192952,-0.45397362271524283,1
5888,Phenotype,HP:0005932,Abnormal renal corticomedullary differentiation,0.015343791201628987,-0.45465046599204817,1
5889,Biological Process,GO:0060416,response to growth hormone,0.015331806361625455,-0.4548840883925028,1
5890,Biological Process,GO:0045471,response to ethanol,0.015296995323341611,-0.45556266552192565,1
5891,Phenotype,HP:0007015,Poor gross motor coordination,0.015255464040652367,-0.45637224144892685,1
5892,Phenotype,HP:0001519,Disproportionate tall stature,0.015248844135999362,-0.45650128430768505,1
5893,Phenotype,HP:0000751,Personality changes,0.015241672285789098,-0.45664108632934985,1
5894,Biological Process,GO:0009164,nucleoside catabolic process,0.01522325792191559,-0.45700004046555076,1
5895,Phenotype,HP:0000646,Amblyopia,0.015210714615572996,-0.45724454913955315,1
5896,Phenotype,HP:0031394,Abnormal CD4:CD8 ratio,0.015193333000068976,-0.45758337174683295,1
5897,Phenotype,HP:0010932,Abnormal circulating nucleobase concentration,0.015169970728467153,-0.45803877623868117,1
5898,Biological Process,GO:0070935,3'-UTR-mediated mRNA stabilization,0.015131831561605469,-0.4587822291100537,1
5899,Phenotype,HP:0006870,Lobar holoprosencephaly,0.015126142911183527,-0.4588931188813422,1
5900,Phenotype,HP:0003737,Mitochondrial myopathy,0.015115050095171778,-0.4591093529156474,1
5901,Phenotype,HP:0033811,Abnormal circulating androstenedione concentration,0.0151071129017466,-0.45926407389484414,1
5902,Phenotype,HP:0011167,Focal tonic seizure,0.015103149425466644,-0.4593413345710313,1
5903,Phenotype,HP:0002190,Choroid plexus cyst,0.015095831643218038,-0.45948398126922835,1
5904,Biological Process,GO:0009063,amino acid catabolic process,0.015065770029856429,-0.46006997710004527,1
5905,Biological Process,GO:0072526,pyridine-containing compound catabolic process,0.015051449966347552,-0.46034912038528064,1
5906,Phenotype,HP:0003282,Low alkaline phosphatase,0.015037808778832207,-0.4606150302323414,1
5907,Phenotype,HP:0003097,Short femur,0.01503615410745096,-0.46064728500586666,1
5908,Biological Process,GO:0035510,DNA dealkylation,0.015027751700641634,-0.4608110744638663,1
5908,Biological Process,GO:0080111,DNA demethylation,0.015027751700641634,-0.4608110744638663,1
5910,Phenotype,HP:0010969,Abnormality of glycolipid metabolism,0.014980265938027149,-0.46173672201912314,1
5911,Phenotype,HP:0003127,Hypocalciuria,0.01497707129389958,-0.461798995727363,1
5912,Biological Process,GO:1903311,regulation of mRNA metabolic process,0.01496714279939515,-0.461992533456556,1
5913,Biological Process,GO:0000027,ribosomal large subunit assembly,0.014966946054903563,-0.4619963686283553,1
5914,Biological Process,GO:0070213,protein auto-ADP-ribosylation,0.014958521045945306,-0.46216059867365417,1
5915,Biological Process,GO:0098773,skin epidermis development,0.014920850542455955,-0.46289491581505304,1
5916,Disease,MONDO:0044881,hematopoietic and lymphoid cell neoplasm,0.014902353082186126,-0.46325548976257985,1
5917,Biological Process,GO:0007276,gamete generation,0.01488958565661147,-0.46350436722857,1
5918,Phenotype,HP:0011505,Cystoid macular edema,0.014885138304280732,-0.46359106017790175,1
5919,Phenotype,HP:0001441,Abnormality thigh musculature morphology,0.014882339264146394,-0.46364562231431405,1
5920,Biological Process,GO:0002275,myeloid cell activation involved in immune response,0.014869666826766048,-0.46389264816026066,1
5921,Biological Process,GO:0045723,positive regulation of fatty acid biosynthetic process,0.014861236060471184,-0.4640569904342416,1
5922,Phenotype,HP:0000206,Glossitis,0.014847179278395628,-0.46433100153244494,1
5923,Phenotype,HP:0003677,Slowly progressive,0.014842215004142512,-0.46442777092337434,1
5924,Biological Process,GO:1904888,cranial skeletal system development,0.014822797622133899,-0.46480627705228883,1
5925,Biological Process,GO:0045672,positive regulation of osteoclast differentiation,0.014806159044009504,-0.46513061551324675,1
5926,Phenotype,HP:0012734,Ketotic hypoglycemia,0.014804375249799495,-0.46516538729869705,1
5927,Biological Process,GO:0001822,kidney development,0.014800475491275167,-0.4652414059144966,1
5928,Phenotype,HP:0001566,Widely-spaced maxillary central incisors,0.014795545407083277,-0.4653375088331015,1
5929,Phenotype,HP:0000813,Bicornuate uterus,0.014794162852279635,-0.465364459194716,1
5930,Phenotype,HP:0002401,Stroke-like episode,0.014793830052285739,-0.46537094651815314,1
5931,Biological Process,GO:0030201,heparan sulfate proteoglycan metabolic process,0.014758141921397794,-0.4660666209538004,1
5932,Biological Process,GO:0051497,negative regulation of stress fiber assembly,0.014723987021580398,-0.4667324078712958,1
5933,Phenotype,HP:0001258,Spastic paraplegia,0.01469026774685589,-0.4673897030792758,1
5934,Phenotype,HP:0002907,Microscopic hematuria,0.014682091845092504,-0.46754907723823663,1
5935,Phenotype,HP:0003678,Rapidly progressive,0.01467644922205269,-0.46765906979041366,1
5936,Biological Process,GO:0043516,"regulation of DNA damage response, signal transduction by p53 class mediator",0.01465110636122402,-0.46815308222440827,1
5937,Phenotype,HP:0011197,EEG with focal spike waves,0.014640123352444578,-0.4683671757687953,1
5938,Biological Process,GO:0010801,negative regulation of peptidyl-threonine phosphorylation,0.014637723900909894,-0.4684139486608107,1
5939,Biological Process,GO:1901880,negative regulation of protein depolymerization,0.014634714381603575,-0.4684726137013411,1
5940,Phenotype,HP:0001988,Recurrent hypoglycemia,0.014627604212101963,-0.4686112133711002,1
5941,Biological Process,GO:0006665,sphingolipid metabolic process,0.014608999835271197,-0.46897387146022657,1
5942,Biological Process,GO:0051294,establishment of spindle orientation,0.014602481845882864,-0.4691009276684522,1
5943,Biological Process,GO:0030262,apoptotic nuclear changes,0.014590364221352847,-0.46933713845889047,1
5944,Biological Process,GO:0042157,lipoprotein metabolic process,0.014586643728705329,-0.4694096626163203,1
5945,Biological Process,GO:0090090,negative regulation of canonical Wnt signaling pathway,0.014585904903023028,-0.46942406466335346,1
5946,Disease,MONDO:0100038,complex neurodevelopmental disorder,0.014585367265504079,-0.46943454491738396,1
5947,Disease,MONDO:0019287,ectodermal dysplasia syndrome,0.014577648243174868,-0.46958501305255984,1
5948,Biological Process,GO:0032874,positive regulation of stress-activated MAPK cascade,0.014569805577230532,-0.4697378913924742,1
5949,Disease,MONDO:0020242,hereditary macular dystrophy,0.014546783387567985,-0.4701866666127609,1
5950,Phenotype,HP:0100280,Crohn's disease,0.0145013990423154,-0.4710713509037356,1
5951,Phenotype,HP:0100244,Fibrosarcoma,0.014492449950051611,-0.47124579698861785,1
5952,Phenotype,HP:0001582,Redundant skin,0.014463903231009656,-0.47180226274249687,1
5953,Biological Process,GO:0042552,myelination,0.01446247116143129,-0.47183017830352375,1
5954,Phenotype,HP:0007305,CNS demyelination,0.014459646852071018,-0.4718852330169933,1
5955,Biological Process,GO:0098930,axonal transport,0.01442932652217721,-0.4724762720504956,1
5956,Phenotype,HP:0011760,Pituitary growth hormone cell adenoma,0.0144129020060757,-0.47279643776625063,1
5957,Phenotype,HP:0000635,Blue irides,0.014368560499261274,-0.47366079384098403,1
5958,Phenotype,HP:0002464,Spastic dysarthria,0.014364544221583841,-0.4737390837832459,1
5959,Phenotype,HP:0000777,Abnormal thymus morphology,0.014362834821012527,-0.4737724054016147,1
5960,Phenotype,HP:0006579,Prolonged neonatal jaundice,0.014351504533264059,-0.4739932685104137,1
5961,Phenotype,HP:0002185,Neurofibrillary tangles,0.014332058423838445,-0.47437233462745626,1
5962,Phenotype,HP:0031374,Ankle weakness,0.01431648123853868,-0.4746759831885538,1
5963,Phenotype,HP:0001891,Iron deficiency anemia,0.014315929362507585,-0.4746867409961758,1
5964,Biological Process,GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,0.014307338169511241,-0.47485421049347265,1
5965,Biological Process,GO:1905459,regulation of vascular associated smooth muscle cell apoptotic process,0.01430574602333512,-0.47488524645318764,1
5966,Biological Process,GO:0032688,negative regulation of interferon-beta production,0.014305640934592412,-0.4748872949648344,1
5967,Biological Process,GO:0032008,positive regulation of TOR signaling,0.014304169303547387,-0.4749159817038498,1
5968,Biological Process,GO:0033260,nuclear DNA replication,0.014293325873370955,-0.4751273544202343,1
5968,Biological Process,GO:0044786,cell cycle DNA replication,0.014293325873370955,-0.4751273544202343,1
5970,Biological Process,GO:0035270,endocrine system development,0.014289794480206952,-0.4751961924312282,1
5971,Disease,MONDO:0020380,autosomal dominant cerebellar ataxia,0.014281940874921295,-0.4753492840134702,1
5972,Phenotype,HP:0040134,Abnormal hepatic iron concentration,0.014270098627240935,-0.4755801268389938,1
5972,Phenotype,HP:0012465,Elevated hepatic iron concentration,0.014270098627240935,-0.4755801268389938,1
5974,Phenotype,HP:0000668,Hypodontia,0.014256668108902915,-0.475841930078132,1
5975,Biological Process,GO:0031297,replication fork processing,0.014237379199981803,-0.47621793186063166,1
5976,Phenotype,HP:0100874,Thick hair,0.014234310247429716,-0.4762777554429147,1
5977,Phenotype,HP:0005208,Secretory diarrhea,0.014214784603548858,-0.4766583719377968,1
5978,Phenotype,HP:0012865,Abnormal sperm head morphology,0.014212669838132408,-0.47669959539783835,1
5979,Biological Process,GO:0006163,purine nucleotide metabolic process,0.014210154700537436,-0.47674862337670476,1
5980,Phenotype,HP:0011834,Moyamoya phenomenon,0.014207067619433023,-0.4768088003417538,1
5981,Biological Process,GO:0046326,positive regulation of glucose import,0.014204494075219953,-0.47685896685015583,1
5982,Phenotype,HP:0100265,Synostosis of metacarpals/metatarsals,0.014194416375144514,-0.4770554130673762,1
5983,Phenotype,HP:0003112,Abnormal circulating amino acid concentration,0.014181798486721853,-0.47730137558177793,1
5984,Phenotype,HP:0200160,Agenesis of maxillary incisor,0.014171496906118186,-0.4775021859378941,1
5985,Biological Process,GO:1904294,positive regulation of ERAD pathway,0.014150622200203689,-0.47790909991447555,1
5986,Phenotype,HP:0000718,Aggressive behavior,0.014146403339593383,-0.4779913388382052,1
5987,Phenotype,HP:0030208,Anti-acetylcholine receptor antibody positivity,0.014141157828162276,-0.4780935904303655,1
5988,Phenotype,HP:0410019,Epigastric pain,0.014138702557276783,-0.47814145141790193,1
5989,Phenotype,HP:0009895,Abnormality of the crus of the helix,0.014131091563879705,-0.47828981372784896,1
5990,Phenotype,HP:0002937,Hemivertebrae,0.01410284316604582,-0.4788404642587701,1
5991,Phenotype,HP:0200020,Corneal erosion,0.014088589175440425,-0.4791183195743444,1
5992,Phenotype,HP:0000597,Ophthalmoparesis,0.014041102751217616,-0.48004398002643806,1
5993,Biological Process,GO:1905168,positive regulation of double-strand break repair via homologous recombination,0.014032717303044673,-0.48020743890702994,1
5994,Phenotype,HP:0032011,Heterophoria,0.014030916179364583,-0.48024254849860853,1
5995,Phenotype,HP:0100529,Abnormal blood phosphate concentration,0.014016699641536734,-0.4805196737412081,1
5996,Phenotype,HP:0001623,Breech presentation,0.014012177320282926,-0.4806078280717315,1
5997,Biological Process,GO:0042730,fibrinolysis,0.013997857927985913,-0.4808869582729268,1
5998,Biological Process,GO:0000045,autophagosome assembly,0.013994925139229508,-0.480944127592592,1
5999,Phenotype,HP:0000419,Abnormal nasal septum morphology,0.013989340758337687,-0.4810529848212755,1
6000,Disease,MONDO:0016056,isolated congenital microcephaly,0.01398072602233369,-0.48122091324618094,1
6001,Biological Process,GO:0070498,interleukin-1-mediated signaling pathway,0.013968988185194542,-0.4814497207803478,1
6002,Disease,MONDO:0004643,myeloid leukemia,0.013952255094150323,-0.4817759015967479,1
6003,Biological Process,GO:1900102,negative regulation of endoplasmic reticulum unfolded protein response,0.013936737168893987,-0.48207839499235366,1
6004,Phenotype,HP:0010554,Cutaneous finger syndactyly,0.013918574175958764,-0.4824324491147046,1
6005,Phenotype,HP:0002909,Generalized aminoaciduria,0.013917848552190026,-0.4824465938147281,1
6006,Biological Process,GO:0070861,regulation of protein exit from endoplasmic reticulum,0.013905599177707062,-0.48268537282804275,1
6007,Phenotype,HP:0000559,Corneal scarring,0.013904670566602606,-0.48270347439262334,1
6008,Phenotype,HP:0410252,Chronic neutropenia,0.013893214028807277,-0.482926798513751,1
6009,Phenotype,HP:0100705,Abnormal glial cell morphology,0.013889570020602648,-0.4829978317477191,1
6010,Phenotype,HP:0003074,Hyperglycemia,0.013880836003263175,-0.483168085342749,1
6011,Phenotype,HP:0025331,Upgaze palsy,0.013876461331913337,-0.48325336151011117,1
6012,Phenotype,HP:0006938,Impaired vibration sensation at ankles,0.013865761338331728,-0.4834619381940425,1
6013,Biological Process,GO:0051494,negative regulation of cytoskeleton organization,0.013795273642853156,-0.48483596610057816,1
6014,Phenotype,HP:0009468,Deviation of the 2nd finger,0.013759788231443304,-0.4855276888930598,1
6015,Phenotype,HP:0000017,Nocturia,0.013750896403585733,-0.4857010187137252,1
6016,Phenotype,HP:0011146,Dialeptic seizure,0.013735960709289174,-0.4859921625882358,1
6017,Biological Process,GO:0071806,protein transmembrane transport,0.013726804157555006,-0.4861706527137104,1
6018,Biological Process,GO:0006221,pyrimidine nucleotide biosynthetic process,0.013689207063888098,-0.486903538865715,1
6019,Biological Process,GO:0051235,maintenance of location,0.013677199718461597,-0.48713759996797423,1
6020,Phenotype,HP:0011488,Abnormal corneal endothelium morphology,0.013635062250452523,-0.48795899236223716,1
6021,Biological Process,GO:1904996,positive regulation of leukocyte adhesion to vascular endothelial cell,0.013604847435415901,-0.4885479745777751,1
6022,Phenotype,HP:0410294,Decreased specific antibody response to protein vaccine,0.013583820324126417,-0.4889578594166739,1
6023,Biological Process,GO:0040008,regulation of growth,0.013583679172605057,-0.48896061090582504,1
6024,Disease,MONDO:0018911,maturity-onset diabetes of the young,0.013577809516679418,-0.48907502904630806,1
6025,Biological Process,GO:0007586,digestion,0.013563629855903536,-0.48935143543864346,1
6026,Biological Process,GO:1903018,regulation of glycoprotein metabolic process,0.013531906889061363,-0.48996981629821496,1
6027,Phenotype,HP:0000182,Movement abnormality of the tongue,0.013498197651486521,-0.49062691585043333,1
6028,Biological Process,GO:0032527,protein exit from endoplasmic reticulum,0.013492035037832695,-0.49074704466270425,1
6029,Phenotype,HP:0000696,Delayed eruption of permanent teeth,0.013487562671653741,-0.4908342252109745,1
6030,Phenotype,HP:0000137,Abnormality of the ovary,0.013475250935506056,-0.49107421985018024,1
6031,Phenotype,HP:0001051,Seborrheic dermatitis,0.013465923628779297,-0.491256038529999,1
6032,Phenotype,HP:0007984,Electronegative electroretinogram,0.013377943618349875,-0.49297104692581295,1
6033,Phenotype,HP:0033259,Non-motor seizure,0.013354610958372759,-0.493425874193531,1
6034,Phenotype,HP:0003138,Increased blood urea nitrogen,0.013329399566143652,-0.4939173238891157,1
6035,Biological Process,GO:0009156,ribonucleoside monophosphate biosynthetic process,0.013306690749362748,-0.4943599904817674,1
6036,Phenotype,HP:0010626,Anterior pituitary agenesis,0.013303333031035813,-0.4944254430214223,1
6037,Biological Process,GO:1903725,regulation of phospholipid metabolic process,0.013279171766466202,-0.4948964224108099,1
6038,Disease,MONDO:0004976,amyotrophic lateral sclerosis,0.01327305019933167,-0.4950157510967241,1
6038,Disease,MONDO:0005144,familial amyotrophic lateral sclerosis,0.01327305019933167,-0.4950157510967241,1
6040,Disease,MONDO:0015770,congenital hypogonadotropic hypogonadism,0.013270448965346682,-0.49506645736627275,1
6041,Phenotype,HP:0002226,White eyebrow,0.013255921511606594,-0.49534964334241033,1
6042,Biological Process,GO:0001894,tissue homeostasis,0.013255900062157044,-0.4953500614599564,1
6042,Biological Process,GO:0060249,anatomical structure homeostasis,0.013255900062157044,-0.4953500614599564,1
6044,Biological Process,GO:0010001,glial cell differentiation,0.013227494988209965,-0.4959037661033769,1
6045,Phenotype,HP:0012402,Increased urine alpha-ketoglutarate concentration,0.013224207494562545,-0.4959678497421375,1
6046,Phenotype,HP:0012862,Abnormal germ cell morphology,0.013217746205479664,-0.49609380068225256,1
6046,Phenotype,HP:0012863,Abnormal male germ cell morphology,0.013217746205479664,-0.49609380068225256,1
6048,Phenotype,HP:0001152,Saccadic smooth pursuit,0.013194540624146711,-0.4965461507856625,1
6049,Phenotype,HP:0000958,Dry skin,0.013190227349504369,-0.49663023013719887,1
6050,Biological Process,GO:0051788,response to misfolded protein,0.013178918831664999,-0.4968506688816826,1
6051,Phenotype,HP:0007126,Proximal amyotrophy,0.013174198995530295,-0.4969426734013272,1
6052,Phenotype,HP:0100872,Abnormality of the plantar skin of foot,0.013134486701842252,-0.4977167914851919,1
6053,Biological Process,GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway,0.013129202667298778,-0.49781979401453463,1
6054,Biological Process,GO:0032984,protein-containing complex disassembly,0.013101323031729173,-0.49836325620373795,1
6055,Phenotype,HP:0100785,Insomnia,0.013076792549048255,-0.4988414328207422,1
6056,Biological Process,GO:0060271,cilium assembly,0.0130593343390768,-0.4991817484962097,1
6057,Biological Process,GO:0051926,negative regulation of calcium ion transport,0.013040338704393584,-0.4995520334371471,1
6058,Phenotype,HP:0004409,Hyposmia,0.013036492923224063,-0.49962699986374787,1
6059,Biological Process,GO:0140056,organelle localization by membrane tethering,0.013019844130108371,-0.49995153744716275,1
6060,Phenotype,HP:0030386,Abnormal proportion of class-switched memory B cells,0.013005254640060082,-0.5002359327069648,1
6060,Phenotype,HP:0030388,Decreased proportion of class-switched memory B cells,0.013005254640060082,-0.5002359327069648,1
6062,Phenotype,HP:0000529,Progressive visual loss,0.012981755417948104,-0.5006940067969816,1
6063,Biological Process,GO:0009163,nucleoside biosynthetic process,0.012975472189029724,-0.5008164867818696,1
6063,Biological Process,GO:0034404,nucleobase-containing small molecule biosynthetic process,0.012975472189029724,-0.5008164867818696,1
6065,Biological Process,GO:0006244,pyrimidine nucleotide catabolic process,0.012968759281603348,-0.500947342558544,1
6066,Biological Process,GO:0070507,regulation of microtubule cytoskeleton organization,0.012959718315898594,-0.5011235795470853,1
6067,Biological Process,GO:0015718,monocarboxylic acid transport,0.012942428736783085,-0.5014606080743436,1
6068,Biological Process,GO:0006998,nuclear envelope organization,0.012937057856334366,-0.5015653035047886,1
6069,Biological Process,GO:0035567,non-canonical Wnt signaling pathway,0.012932173793908985,-0.5016605093137482,1
6070,Biological Process,GO:0006895,Golgi to endosome transport,0.012928064932113625,-0.5017406040130087,1
6071,Biological Process,GO:0031053,primary miRNA processing,0.012894482084119252,-0.5023952398329475,1
6072,Phenotype,HP:0012594,Moderate albuminuria,0.012880168827616889,-0.5026742504281176,1
6073,Biological Process,GO:0050869,negative regulation of B cell activation,0.012877814181612934,-0.502720149918766,1
6074,Biological Process,GO:0031468,nuclear membrane reassembly,0.012864805564753445,-0.5029737289649955,1
6075,Biological Process,GO:0034612,response to tumor necrosis factor,0.012861439198138536,-0.5030393500871093,1
6076,Phenotype,HP:0034058,Abnormal fetal morphology,0.012856360669295852,-0.5031383466610023,1
6077,Phenotype,HP:0011883,Abnormal platelet granules,0.01284454939206825,-0.5033685857745436,1
6078,Phenotype,HP:0100686,Enthesitis,0.012835747308471368,-0.503540166196001,1
6079,Phenotype,HP:0000324,Facial asymmetry,0.012819748581297419,-0.5038520319401824,1
6080,Phenotype,HP:0100792,Acantholysis,0.012800592724621418,-0.5042254401140164,1
6081,Biological Process,GO:0090279,regulation of calcium ion import,0.012783589491745184,-0.504556886848296,1
6082,Biological Process,GO:0006986,response to unfolded protein,0.012781224305685512,-0.504602991797934,1
6083,Phenotype,HP:0031970,Abnormal blood urea nitrogen concentration,0.012778230749106556,-0.5046613456744703,1
6084,Phenotype,HP:0001783,Broad metatarsal,0.012772694797784312,-0.5047692588578186,1
6085,Disease,MONDO:0100365,mucopolysaccharidosis or mucopolysaccharidosis-like disorder,0.012751616520842779,-0.5051801410769452,1
6086,Phenotype,HP:0009023,Abdominal wall muscle weakness,0.012747481690513207,-0.5052607419849909,1
6087,Biological Process,GO:0035966,response to topologically incorrect protein,0.012713437513281578,-0.505924370569437,1
6088,Biological Process,GO:0099003,vesicle-mediated transport in synapse,0.012710517613141015,-0.5059812886492548,1
6088,Biological Process,GO:0099504,synaptic vesicle cycle,0.012710517613141015,-0.5059812886492548,1
6090,Phenotype,HP:0002300,Mutism,0.012696458796653709,-0.5062553394045713,1
6091,Phenotype,HP:0001642,Pulmonic stenosis,0.012688511949675574,-0.5064102485620178,1
6092,Phenotype,HP:0000183,Difficulty in tongue movements,0.012649212997966286,-0.5071763093046701,1
6093,Phenotype,HP:0001747,Accessory spleen,0.012623277569669744,-0.5076818727509631,1
6094,Biological Process,GO:0042789,mRNA transcription by RNA polymerase II,0.012602881132711574,-0.5080794637543878,1
6095,Phenotype,HP:0008734,Decreased testicular size,0.012597464712410522,-0.5081850469004482,1
6096,Disease,MONDO:0005586,head and neck neoplasm,0.01256339123623218,-0.5088492466139422,1
6097,Phenotype,HP:0001659,Aortic regurgitation,0.01252852744138111,-0.5095288521355564,1
6098,Biological Process,GO:0051084,'de novo' post-translational protein folding,0.012487240816201672,-0.5103336589146413,1
6099,Phenotype,HP:0010537,Wide cranial sutures,0.012420859485113067,-0.5116276408042387,1
6100,Phenotype,HP:0007281,Developmental stagnation,0.01241148242743284,-0.5118104292873399,1
6101,Phenotype,HP:0011359,Dry hair,0.012398865643375445,-0.5120563702741731,1
6102,Phenotype,HP:0001620,High pitched voice,0.01239863786508344,-0.5120608103928007,1
6103,Phenotype,HP:0100707,Abnormal astrocyte morphology,0.012394582501209839,-0.5121398622485275,1
6104,Disease,MONDO:0003832,complement deficiency,0.01239055145045842,-0.5122184401646802,1
6105,Phenotype,HP:0001681,Angina pectoris,0.01237147014387363,-0.5125903951216788,1
6106,Phenotype,HP:0011100,Intestinal atresia,0.012298905519083525,-0.5140049089430195,1
6107,Phenotype,HP:0011476,Profound sensorineural hearing impairment,0.01228941520048532,-0.5141899052392853,1
6108,Phenotype,HP:0012868,Abnormal sperm tail morphology,0.01227906912893073,-0.5143915828646142,1
6109,Phenotype,HP:0004398,Peptic ulcer,0.012258173037320241,-0.5147989137159833,1
6110,Biological Process,GO:0045601,regulation of endothelial cell differentiation,0.01224983289710746,-0.5149614894012711,1
6111,Phenotype,HP:0030338,Abnormal circulating gonadotropin concentration,0.012201334489797544,-0.5159068766013195,1
6112,Biological Process,GO:0044743,protein transmembrane import into intracellular organelle,0.012139014371179924,-0.5171216926275471,1
6113,Biological Process,GO:0044058,regulation of digestive system process,0.012122193551769467,-0.5174495835470027,1
6114,Phenotype,HP:0000476,Cystic hygroma,0.01211067192893689,-0.517674176381157,1
6115,Disease,MONDO:0003757,paraplegia,0.01210393440794899,-0.5178055119539174,1
6115,Disease,MONDO:0019064,hereditary spastic paraplegia,0.01210393440794899,-0.5178055119539174,1
6117,Phenotype,HP:0005261,Joint hemorrhage,0.012103409737594273,-0.5178157394369444,1
6118,Phenotype,HP:0000274,Small face,0.01209384311199646,-0.5180022231977415,1
6119,Biological Process,GO:0043001,Golgi to plasma membrane protein transport,0.012068369507160615,-0.518498784245551,1
6120,Biological Process,GO:0044571,[2Fe-2S] cluster assembly,0.012065164103510995,-0.5185612676908727,1
6121,Phenotype,HP:0000396,Overfolded helix,0.012064148256398899,-0.5185810697608839,1
6122,Biological Process,GO:0042129,regulation of T cell proliferation,0.012002302016140165,-0.519786648400572,1
6123,Biological Process,GO:0015872,dopamine transport,0.011986559746467451,-0.5200935149777195,1
6123,Biological Process,GO:0051937,catecholamine transport,0.011986559746467451,-0.5200935149777195,1
6125,Phenotype,HP:0002003,Large forehead,0.011982305763012624,-0.5201764385566674,1
6126,Biological Process,GO:0002224,toll-like receptor signaling pathway,0.011964670966793212,-0.5205201964560714,1
6127,Phenotype,HP:0006846,Acute encephalopathy,0.011946577120774404,-0.5208729026865362,1
6128,Phenotype,HP:0003180,Flat acetabular roof,0.011941364895270867,-0.5209745054307938,1
6129,Disease,MONDO:0019270,erythrokeratoderma,0.011932322762499559,-0.5211507651691499,1
6130,Phenotype,HP:0030188,Tremor by anatomical site,0.011926939522962754,-0.521255701517273,1
6131,Biological Process,GO:0000209,protein polyubiquitination,0.011907690087277656,-0.5216309338416781,1
6132,Phenotype,HP:0011587,Abnormal branching pattern of the aortic arch,0.011903258354859614,-0.5217173223095568,1
6133,Phenotype,HP:0011823,Chin with horizontal crease,0.011876004342479818,-0.5222485891259941,1
6134,Phenotype,HP:0032679,Focal non-motor seizure,0.011875397203443994,-0.5222604241841942,1
6135,Biological Process,GO:0019320,hexose catabolic process,0.011838404840293082,-0.5229815222276605,1
6136,Phenotype,HP:0031295,Left atrial enlargement,0.011830893375973761,-0.5231279444013976,1
6137,Biological Process,GO:0030501,positive regulation of bone mineralization,0.011809561466807339,-0.5235437707139952,1
6138,Phenotype,HP:0011526,Abnormality of lens shape,0.011803310917663401,-0.5236656136668202,1
6139,Phenotype,HP:0003103,Abnormal cortical bone morphology,0.011799803101975037,-0.5237339920783156,1
6140,Biological Process,GO:0051152,positive regulation of smooth muscle cell differentiation,0.011785028384194596,-0.5240219980118858,1
6141,Biological Process,GO:0043304,regulation of mast cell degranulation,0.011781076569474025,-0.5240990313674332,1
6142,Biological Process,GO:0031167,rRNA methylation,0.01177996467042397,-0.5241207057932128,1
6143,Phenotype,HP:0032248,Persistent viremia,0.011776305228008321,-0.5241920398887217,1
6143,Phenotype,HP:0020071,Viremia,0.011776305228008321,-0.5241920398887217,1
6145,Phenotype,HP:0001129,Large central visual field defect,0.01177011200191036,-0.5243127654342555,1
6146,Disease,MONDO:0020143,cerebral lipidosis with dementia,0.01174618670955252,-0.5247791449796287,1
6147,Biological Process,GO:0002181,cytoplasmic translation,0.011740038712747536,-0.5248989888633305,1
6148,Phenotype,HP:0011193,EEG with focal spikes,0.011733028155368919,-0.5250356467780657,1
6149,Phenotype,HP:0040085,Abnormal circulating aldosterone,0.011708007207694271,-0.5255233841075317,1
6150,Phenotype,HP:0001651,Dextrocardia,0.011702372390234528,-0.5256332245042897,1
6151,Biological Process,GO:0098754,detoxification,0.01169879005273311,-0.5257030555813899,1
6152,Phenotype,HP:0001742,Nasal congestion,0.011692974377157772,-0.5258164214742824,1
6153,Biological Process,GO:0090257,regulation of muscle system process,0.011665795144499724,-0.5263462305976597,1
6154,Phenotype,HP:0000612,Iris coloboma,0.011664112328374943,-0.526379034001166,1
6155,Phenotype,HP:0003031,Ulnar bowing,0.011662556403565283,-0.5264093638919992,1
6156,Phenotype,HP:0200123,Chronic hepatitis,0.011651600675127272,-0.5266229256563334,1
6157,Biological Process,GO:1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,0.011641674752217668,-0.5268164132570177,1
6158,Biological Process,GO:0000768,syncytium formation by plasma membrane fusion,0.01162557040563783,-0.527130337857148,1
6159,Phenotype,HP:0008940,Generalized lymphadenopathy,0.011623188816392349,-0.527176762556707,1
6160,Biological Process,GO:1903671,negative regulation of sprouting angiogenesis,0.011618429282914122,-0.5272695409030095,1
6161,Phenotype,HP:0100508,Abnormality of vitamin metabolism,0.011599037037031468,-0.5276475570494058,1
6162,Biological Process,GO:0055078,sodium ion homeostasis,0.011592349958170267,-0.5277779093457338,1
6163,Biological Process,GO:0046653,tetrahydrofolate metabolic process,0.011589430091853092,-0.527834826766227,1
6164,Phenotype,HP:0100262,Synostosis involving digits,0.011581843216032173,-0.5279827189484098,1
6165,Phenotype,HP:0011108,Recurrent sinusitis,0.011563622262757978,-0.528337902900906,1
6166,Biological Process,GO:0006366,transcription by RNA polymerase II,0.011556769283266988,-0.5284714891247086,1
6167,Biological Process,GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,0.011544763909210554,-0.5287055117987363,1
6168,Biological Process,GO:0046579,positive regulation of Ras protein signal transduction,0.011526440736068011,-0.5290626883394531,1
6169,Phenotype,HP:0004319,Decreased circulating aldosterone level,0.011513650792066343,-0.5293120047607377,1
6170,Phenotype,HP:0000803,Renal cortical cysts,0.011511014827668253,-0.5293633880357763,1
6171,Biological Process,GO:0044793,negative regulation by host of viral process,0.01150074240392962,-0.5295636300324654,1
6172,Biological Process,GO:1902931,negative regulation of alcohol biosynthetic process,0.011493993932281787,-0.529695179068189,1
6173,Disease,MONDO:0045022,disorder of organic acid metabolism,0.011493456836198845,-0.5297056487679209,1
6174,Phenotype,HP:0002580,Volvulus,0.011468681322142515,-0.5301886018206635,1
6175,Phenotype,HP:0006288,Advanced eruption of teeth,0.011456396093302401,-0.5304280797486889,1
6176,Biological Process,GO:1901292,nucleoside phosphate catabolic process,0.011448655466498647,-0.5305789690233378,1
6177,Phenotype,HP:0006989,Dysplastic corpus callosum,0.011442506591007207,-0.530698830035415,1
6178,Biological Process,GO:1904292,regulation of ERAD pathway,0.011430942341392858,-0.5309242538002349,1
6179,Biological Process,GO:0006446,regulation of translational initiation,0.011422686702612705,-0.5310851822855995,1
6180,Biological Process,GO:0032945,negative regulation of mononuclear cell proliferation,0.011407918190416533,-0.5313730672527244,1
6181,Phenotype,HP:0000586,Shallow orbits,0.011406831182773414,-0.5313942564663328,1
6181,Phenotype,HP:3000030,Abnormal morphology of bony orbit of skull,0.011406831182773414,-0.5313942564663328,1
6183,Disease,MONDO:0002887,bile duct disorder,0.011394694877346678,-0.5316308314064746,1
6184,Phenotype,HP:0003444,EMG,0.011383997929577894,-0.5318393487178901,1
6185,Biological Process,GO:0070664,negative regulation of leukocyte proliferation,0.011340633751493079,-0.5326846535675943,1
6186,Phenotype,HP:0011116,Abnormal circulating interferon concentration,0.011329009688291425,-0.5329112432882253,1
6186,Phenotype,HP:0030355,Abnormal circulating interferon-gamma concentration,0.011329009688291425,-0.5329112432882253,1
6188,Phenotype,HP:0000169,Gingival fibromatosis,0.01132672584495753,-0.5329557626111173,1
6189,Phenotype,HP:0025613,Focal emotional seizure,0.011282217660265492,-0.5338233677643415,1
6190,Biological Process,GO:0048593,camera-type eye morphogenesis,0.01127606685691751,-0.5339432663564342,1
6191,Biological Process,GO:0099623,regulation of cardiac muscle cell membrane repolarization,0.011272871513950844,-0.5340055536872561,1
6192,Phenotype,HP:0031652,Abnormal aortic valve physiology,0.011250902327847978,-0.5344338025409641,1
6193,Disease,MONDO:0019054,congenital limb malformation,0.011191147073549401,-0.5355986212573504,1
6194,Phenotype,HP:0000802,Impotence,0.011132673616520705,-0.5367384536948212,1
6195,Phenotype,HP:0004054,Sclerosis of hand bone,0.011115484241282836,-0.5370735289318876,1
6196,Biological Process,GO:0015908,fatty acid transport,0.01109947937961342,-0.537385514256769,1
6197,Phenotype,HP:0009141,Depletion of mitochondrial DNA in muscle tissue,0.011087052449662349,-0.5376277543871832,1
6198,Phenotype,HP:0007807,Optic nerve compression,0.011078798868856543,-0.5377886427561253,1
6199,Biological Process,GO:0015865,purine nucleotide transport,0.011076750008487957,-0.5378285815185422,1
6200,Phenotype,HP:0030195,Fatigable weakness of swallowing muscles,0.01107319468895307,-0.5378978859301053,1
6201,Biological Process,GO:0006268,DNA unwinding involved in DNA replication,0.011059033113121841,-0.538173939789726,1
6202,Biological Process,GO:0022600,digestive system process,0.011010681848570236,-0.5391164587124845,1
6203,Phenotype,HP:0000971,Abnormal sweat gland morphology,0.010998223775375071,-0.5393593059231303,1
6204,Phenotype,HP:0011380,Abnormal semicircular canal morphology,0.010988531390672573,-0.5395482411262419,1
6205,Disease,MONDO:0016106,progressive muscular dystrophy,0.010973910740548876,-0.5398332437943708,1
6206,Biological Process,GO:0060391,positive regulation of SMAD protein signal transduction,0.010970216316129155,-0.5399052597996724,1
6207,Biological Process,GO:0016239,positive regulation of macroautophagy,0.010920562474344697,-0.5408731700684837,1
6208,Biological Process,GO:0019693,ribose phosphate metabolic process,0.010891254350635982,-0.5414444780051465,1
6209,Disease,MONDO:0019242,inborn disorder of branched-chain amino acid metabolism,0.010890461657406703,-0.5414599301008769,1
6210,Phenotype,HP:0100520,Oliguria,0.01088792931438165,-0.54150929346794,1
6211,Phenotype,HP:0006889,"Intellectual disability, borderline",0.010877706905614182,-0.5417085605148075,1
6212,Biological Process,GO:1905606,regulation of presynapse assembly,0.010877271838667713,-0.5417170413442857,1
6213,Biological Process,GO:0046677,response to antibiotic,0.010865603183732864,-0.5419445002986941,1
6214,Phenotype,HP:0011974,Myelofibrosis,0.010841812491037772,-0.5424082560713426,1
6215,Phenotype,HP:0007754,Macular dystrophy,0.010835503614878284,-0.5425312360019979,1
6216,Phenotype,HP:0001863,Toe clinodactyly,0.010789958013065482,-0.5434190636928575,1
6217,Phenotype,HP:0000935,Thickened cortex of long bones,0.010786416078002792,-0.5434881071987663,1
6217,Phenotype,HP:0100039,Thickened cortex of bones,0.010786416078002792,-0.5434881071987663,1
6219,Disease,MONDO:0002406,dermatitis,0.010782953315335853,-0.543555607384519,1
6220,Phenotype,HP:0001520,Large for gestational age,0.010771943782056037,-0.5437702179752284,1
6221,Phenotype,HP:0012120,Methylmalonic aciduria,0.01076767170450077,-0.5438534942653662,1
6222,Phenotype,HP:0040162,Orthokeratosis,0.010733841129864419,-0.5445129590603051,1
6223,Biological Process,GO:0045048,protein insertion into ER membrane,0.010712908236950258,-0.5449210072853647,1
6224,Phenotype,HP:0002268,Paroxysmal dystonia,0.010707112854993706,-0.545033977591505,1
6225,Phenotype,HP:0008887,Adipose tissue loss,0.010691519662895721,-0.545337938175677,1
6226,Phenotype,HP:0000414,Bulbous nose,0.010650177458860766,-0.5461438283622697,1
6227,Phenotype,HP:0000493,Abnormal foveal morphology,0.01064728552079841,-0.5462002013728309,1
6228,Disease,MONDO:0019072,intrahepatic cholestasis,0.010646114289558417,-0.5462230323704658,1
6228,Disease,MONDO:0015762,progressive familial intrahepatic cholestasis,0.010646114289558417,-0.5462230323704658,1
6228,Disease,MONDO:0017290,familial intrahepatic cholestasis,0.010646114289558417,-0.5462230323704658,1
6228,Disease,MONDO:0001751,cholestasis,0.010646114289558417,-0.5462230323704658,1
6232,Biological Process,GO:0042158,lipoprotein biosynthetic process,0.010631950309635263,-0.5464991330934343,1
6233,Disease,MONDO:0004868,biliary tract disorder,0.010626463242166984,-0.5466060933760095,1
6234,Biological Process,GO:0000086,G2/M transition of mitotic cell cycle,0.010607506258037303,-0.5469756248955334,1
6235,Biological Process,GO:0000398,"mRNA splicing, via spliceosome",0.010587306432083277,-0.5473693833292509,1
6235,Biological Process,GO:0000377,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",0.010587306432083277,-0.5473693833292509,1
6237,Biological Process,GO:0006120,"mitochondrial electron transport, NADH to ubiquinone",0.010586785371277663,-0.5473795404507606,1
6238,Biological Process,GO:0006066,alcohol metabolic process,0.010544986470207962,-0.5481943331055971,1
6239,Phenotype,HP:0031834,Aortopulmonary collateral arteries,0.010539589648807635,-0.5482995342071553,1
6240,Phenotype,HP:0011409,Abnormal placental membrane morphology,0.010526919792290812,-0.5485465097439169,1
6241,Biological Process,GO:0007612,learning,0.010526865534906671,-0.5485475673917722,1
6242,Phenotype,HP:0004443,Lambdoidal craniosynostosis,0.010508314682321496,-0.5489091821242301,1
6243,Biological Process,GO:0042574,retinal metabolic process,0.010506910913929857,-0.5489365460057037,1
6244,Phenotype,HP:0000143,Rectovaginal fistula,0.010505179553026323,-0.5489702957003362,1
6245,Phenotype,HP:0000013,Hypoplasia of the uterus,0.010497630304645789,-0.5491174544048135,1
6246,Biological Process,GO:0006497,protein lipidation,0.010453326218049175,-0.5499810810412642,1
6247,Biological Process,GO:0009259,ribonucleotide metabolic process,0.010427922969134307,-0.5504762706298685,1
6248,Biological Process,GO:0060323,head morphogenesis,0.010399589357663941,-0.5510285822438161,1
6248,Biological Process,GO:0010171,body morphogenesis,0.010399589357663941,-0.5510285822438161,1
6250,Biological Process,GO:0003044,regulation of systemic arterial blood pressure mediated by a chemical signal,0.010393762522990735,-0.551142165662786,1
6250,Biological Process,GO:0001990,regulation of systemic arterial blood pressure by hormone,0.010393762522990735,-0.551142165662786,1
6252,Phenotype,HP:0011897,Neutrophilia,0.010386709979293252,-0.551279642023541,1
6253,Phenotype,HP:0003812,Phenotypic variability,0.010379143716398698,-0.5514271323946578,1
6253,Phenotype,HP:0003828,Variable expressivity,0.010379143716398698,-0.5514271323946578,1
6255,Phenotype,HP:0001045,Vitiligo,0.010374128418624062,-0.5515248963952418,1
6256,Phenotype,HP:0025579,Abnormal left atrium morphology,0.01033184098089035,-0.5523492121733009,1
6257,Biological Process,GO:0043517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",0.010330421010485091,-0.5523768918832138,1
6258,Phenotype,HP:0009700,Finger symphalangism,0.010299778701471696,-0.552974207307122,1
6259,Phenotype,HP:0003077,Hyperlipidemia,0.010283287433530797,-0.5532956742271441,1
6260,Biological Process,GO:0045649,regulation of macrophage differentiation,0.010276944271068955,-0.5534193225061677,1
6261,Biological Process,GO:0006612,protein targeting to membrane,0.01025882828397684,-0.5537724603361109,1
6262,Biological Process,GO:0051170,import into nucleus,0.01024241455526198,-0.5540924157716149,1
6263,Biological Process,GO:0072001,renal system development,0.01024120585529631,-0.5541159771531041,1
6264,Disease,MONDO:0016293,congenital stationary night blindness,0.010227081208720734,-0.5543913111448459,1
6264,Disease,MONDO:0004587,hereditary night blindness,0.010227081208720734,-0.5543913111448459,1
6264,Disease,MONDO:0004588,night blindness,0.010227081208720734,-0.5543913111448459,1
6267,Phenotype,HP:0008684,Aplasia/hypoplasia of the uterus,0.010216520192369072,-0.554597178723436,1
6268,Biological Process,GO:1902932,positive regulation of alcohol biosynthetic process,0.010209538874340507,-0.5547332666708503,1
6269,Phenotype,HP:0006714,Aplasia/Hypoplasia of the sternum,0.01020291352198488,-0.5548624157225458,1
6270,Phenotype,HP:0003193,Allergic rhinitis,0.01019289631433884,-0.555057682751178,1
6271,Biological Process,GO:0007030,Golgi organization,0.010183338532618547,-0.5552439941168581,1
6272,Phenotype,HP:0004279,Short palm,0.010178705372408059,-0.5553343090488676,1
6273,Phenotype,HP:0007973,Retinal dysplasia,0.010168818789208833,-0.5555270297942941,1
6274,Phenotype,HP:0006443,Patellar aplasia,0.010151766905416415,-0.5558594248886536,1
6275,Biological Process,GO:0001881,receptor recycling,0.010126951337174228,-0.5563431587240387,1
6276,Biological Process,GO:0140029,exocytic process,0.010126529689285624,-0.5563513779736785,1
6277,Phenotype,HP:0000746,Delusion,0.010110273394706604,-0.5566682645204266,1
6278,Phenotype,HP:0040216,Hypoinsulinemia,0.010100832579425179,-0.5568522958406316,1
6279,Biological Process,GO:0072662,protein localization to peroxisome,0.010087383224880231,-0.55711446625696,1
6279,Biological Process,GO:0072663,establishment of protein localization to peroxisome,0.010087383224880231,-0.55711446625696,1
6281,Phenotype,HP:0004307,Abnormal anatomic location of the heart,0.010080612388988053,-0.5572464512424709,1
6282,Phenotype,HP:0010294,Palate fistula,0.010068085719987852,-0.5574906356021005,1
6283,Biological Process,GO:0010755,regulation of plasminogen activation,0.010016015062999983,-0.5585056572356951,1
6284,Biological Process,GO:0006921,cellular component disassembly involved in execution phase of apoptosis,0.009998090211270183,-0.5588550692334919,1
6285,Biological Process,GO:0046856,phosphatidylinositol dephosphorylation,0.009961200974540896,-0.5595741570171499,1
6286,Biological Process,GO:0097428,protein maturation by iron-sulfur cluster transfer,0.009955048575402636,-0.5596940867162373,1
6287,Biological Process,GO:0045058,T cell selection,0.00993469950142234,-0.5600907544655693,1
6288,Disease,MONDO:0005365,hearing loss disorder,0.009931017003511733,-0.5601625379855238,1
6288,Disease,MONDO:0037940,inherited auditory system disease,0.009931017003511733,-0.5601625379855238,1
6288,Disease,MONDO:0021945,hearing disorder,0.009931017003511733,-0.5601625379855238,1
6288,Disease,MONDO:0002409,auditory system disorder,0.009931017003511733,-0.5601625379855238,1
6292,Phenotype,HP:0002211,White forelock,0.009919334325005469,-0.5603902703036497,1
6293,Phenotype,HP:0000114,Proximal tubulopathy,0.009901748864345805,-0.5607330664971075,1
6294,Phenotype,HP:0007377,Abnormality of somatosensory evoked potentials,0.009872199735832532,-0.5613090723789197,1
6295,Phenotype,HP:0001802,Absent toenail,0.009862977986866084,-0.5614888334044568,1
6296,Phenotype,HP:0010780,Hyperacusis,0.009862328318373637,-0.5615014974961476,1
6297,Disease,MONDO:0700007,idiopathic disease,0.009858725499238719,-0.561571727825001,1
6298,Phenotype,HP:0004469,Chronic bronchitis,0.009818432314507852,-0.5623571693107456,1
6299,Biological Process,GO:0032232,negative regulation of actin filament bundle assembly,0.009804831480339948,-0.5626222925435593,1
6300,Phenotype,HP:0006323,Premature loss of primary teeth,0.009791125145464763,-0.5628894723185109,1
6301,Biological Process,GO:0031023,microtubule organizing center organization,0.00976567299422293,-0.5633856151679857,1
6302,Phenotype,HP:0200037,Skin vesicle,0.009763945234923521,-0.5634192946559736,1
6303,Biological Process,GO:0035196,miRNA processing,0.009763059258458107,-0.5634365651367256,1
6304,Phenotype,HP:0002273,Tetraparesis,0.009741070904362048,-0.5638651876351864,1
6305,Phenotype,HP:0000099,Glomerulonephritis,0.009728497853933482,-0.5641102761154074,1
6306,Biological Process,GO:0060396,growth hormone receptor signaling pathway,0.009721870397568666,-0.5642394661808903,1
6306,Biological Process,GO:0071378,cellular response to growth hormone stimulus,0.009721870397568666,-0.5642394661808903,1
6308,Biological Process,GO:0070266,necroptotic process,0.009714520469104815,-0.5643827395103955,1
6309,Phenotype,HP:0000641,Dysmetric saccades,0.009703925809817604,-0.5645892628961018,1
6310,Disease,MONDO:0022687,cerebellar degeneration,0.00968762329201045,-0.5649070504796189,1
6311,Phenotype,HP:0100259,Postaxial polydactyly,0.009676026569728768,-0.5651331072393297,1
6312,Biological Process,GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,0.009623590182143427,-0.5661552581178768,1
6313,Phenotype,HP:0007385,Aplasia cutis congenita of scalp,0.00960130644164725,-0.5665896386306154,1
6314,Phenotype,HP:0002049,Proximal renal tubular acidosis,0.00958226329358236,-0.5669608497574908,1
6315,Phenotype,HP:5200017,Steroetypic movements of face and head,0.009554307111436011,-0.5675058040813409,1
6316,Disease,MONDO:0006424,soft tissue neoplasm,0.009522640419571737,-0.5681230879637797,1
6317,Biological Process,GO:0007026,negative regulation of microtubule depolymerization,0.00947190568017331,-0.5691120683424253,1
6317,Biological Process,GO:0031114,regulation of microtubule depolymerization,0.00947190568017331,-0.5691120683424253,1
6319,Phenotype,HP:0010819,Atonic seizure,0.009465117300559212,-0.5692443953105096,1
6320,Phenotype,HP:0033079,Aplasia/Hypoplasia of the thyroid gland,0.00945979573803557,-0.5693481293787639,1
6321,Phenotype,HP:0000395,Prominent antihelix,0.009458760178016945,-0.5693683157156106,1
6322,Phenotype,HP:0011704,Sick sinus syndrome,0.009445507724104796,-0.5696266479164542,1
6323,Phenotype,HP:0002183,Phonophobia,0.009429961457380953,-0.5699296937768129,1
6324,Biological Process,GO:1904646,cellular response to amyloid-beta,0.009415283383476192,-0.5702158158158781,1
6325,Biological Process,GO:0006289,nucleotide-excision repair,0.009413725423813801,-0.5702461853724206,1
6326,Biological Process,GO:0043923,positive regulation by host of viral transcription,0.00937915744347484,-0.5709200245345016,1
6327,Biological Process,GO:0046676,negative regulation of insulin secretion,0.00934465329198042,-0.571592619470721,1
6328,Phenotype,HP:0009088,Speech articulation difficulties,0.009339490031907594,-0.5716932677240169,1
6329,Phenotype,HP:0010585,Small epiphyses,0.009324625220936023,-0.5719830298585518,1
6330,Phenotype,HP:0040087,Abnormal blood folate concentration,0.009277428951715239,-0.5729030342728462,1
6331,Phenotype,HP:0000946,Hypoplastic ilia,0.00926690112328532,-0.5731082549139768,1
6332,Phenotype,HP:0010451,Aplasia/Hypoplasia of the spleen,0.009221980573375754,-0.5739838983682508,1
6333,Biological Process,GO:0000956,nuclear-transcribed mRNA catabolic process,0.009213081939332235,-0.5741573608629859,1
6334,Phenotype,HP:0033683,Jaw hyperreflexia,0.009120865468737027,-0.5759549512534755,1
6335,Biological Process,GO:1902373,negative regulation of mRNA catabolic process,0.009072677735535106,-0.5768942824335148,1
6336,Phenotype,HP:0008972,Decreased activity of mitochondrial respiratory chain,0.009065779835908838,-0.5770287442926892,1
6337,Phenotype,HP:0025104,Capillary malformation,0.009044493639330464,-0.5774436795225065,1
6338,Biological Process,GO:1902001,fatty acid transmembrane transport,0.009028442498845601,-0.5777565669677293,1
6339,Disease,MONDO:0000411,electroclinical syndrome,0.008927938952716596,-0.5797156986452434,1
6340,Biological Process,GO:0071417,cellular response to organonitrogen compound,0.008918919670336312,-0.5798915129572776,1
6341,Phenotype,HP:0011044,Abnormal number of permanent teeth,0.008912319364573151,-0.5800201737717456,1
6342,Biological Process,GO:0046655,folic acid metabolic process,0.00891205374155346,-0.5800253516036948,1
6343,Phenotype,HP:0011902,Abnormal hemoglobin,0.008905072183607143,-0.5801614442278643,1
6344,Phenotype,HP:0009067,Progressive spinal muscular atrophy,0.00890169190999568,-0.5802273364412831,1
6345,Phenotype,HP:0025425,Laryngospasm,0.008874555390119276,-0.5807563129575855,1
6346,Phenotype,HP:0100513,Decreased circulating vitamin E concentration,0.008861211344547981,-0.5810164305692702,1
6346,Phenotype,HP:0100514,Abnormal circulating vitamin E concentration,0.008861211344547981,-0.5810164305692702,1
6348,Biological Process,GO:0070936,protein K48-linked ubiquitination,0.008844780057819857,-0.5813367282659312,1
6349,Phenotype,HP:0001326,EEG with irregular generalized spike and wave complexes,0.008819165149133612,-0.5818360437722662,1
6350,Disease,MONDO:0037821,porphyrin metabolism disease,0.008817922846704351,-0.5818602601719451,1
6350,Disease,MONDO:0017754,inborn disorder of porphyrin metabolism,0.008817922846704351,-0.5818602601719451,1
6352,Phenotype,HP:0000041,Chordee,0.00881586205539131,-0.5819004315061679,1
6353,Phenotype,HP:0100552,Neoplasm of the tracheobronchial system,0.008810578490159648,-0.5820034248871405,1
6354,Biological Process,GO:1902600,proton transmembrane transport,0.008807544048346605,-0.5820625757460751,1
6355,Phenotype,HP:0003173,Hypoplastic pubic bone,0.00880625063010243,-0.5820877885544987,1
6356,Biological Process,GO:0050907,detection of chemical stimulus involved in sensory perception,0.008803842850589882,-0.5821347237851168,1
6356,Biological Process,GO:0050912,detection of chemical stimulus involved in sensory perception of taste,0.008803842850589882,-0.5821347237851168,1
6358,Phenotype,HP:0003139,Panhypogammaglobulinemia,0.008799184838868879,-0.5822255231515903,1
6359,Phenotype,HP:0003336,Abnormal enchondral ossification,0.008728601919892887,-0.5836014072649707,1
6360,Phenotype,HP:0100285,EMG,0.00871012897226553,-0.5839615033836425,1
6361,Phenotype,HP:0000592,Blue sclerae,0.008702090871377632,-0.5841181913681274,1
6362,Biological Process,GO:0140627,ubiquitin-dependent protein catabolic process via the C-end degron rule pathway,0.00869039065060706,-0.5843462656404134,1
6363,Biological Process,GO:0048147,negative regulation of fibroblast proliferation,0.008690356829006207,-0.584346924930281,1
6364,Phenotype,HP:0002673,Coxa valga,0.008666398074276938,-0.5848139567630051,1
6365,Biological Process,GO:0009223,pyrimidine deoxyribonucleotide catabolic process,0.008665838772269674,-0.5848248593263666,1
6366,Biological Process,GO:1901989,positive regulation of cell cycle phase transition,0.008660361285196316,-0.5849316328567733,1
6367,Phenotype,HP:0001442,Typified by somatic mosaicism,0.0086548360130968,-0.5850393378683274,1
6368,Biological Process,GO:1905907,negative regulation of amyloid fibril formation,0.008645990470342868,-0.5852117654460747,1
6369,Biological Process,GO:0007127,meiosis I,0.008610873622573734,-0.5858963037686394,1
6370,Biological Process,GO:0061951,establishment of protein localization to plasma membrane,0.00849923774692074,-0.5880724397236642,1
6371,Biological Process,GO:1902652,secondary alcohol metabolic process,0.008494210785111811,-0.5881704310931317,1
6372,Phenotype,HP:0033763,Death in adulthood,0.008480675192390708,-0.5884342825640023,1
6373,Biological Process,GO:0009309,amine biosynthetic process,0.008479420358811884,-0.5884587432353813,1
6374,Phenotype,HP:0001739,Abnormal nasopharynx morphology,0.008456612058506563,-0.5889033490762643,1
6375,Phenotype,HP:0002166,Impaired vibration sensation in the lower limbs,0.008447362773148726,-0.5890836468730768,1
6376,Disease,MONDO:0100500,Mendelian neurodevelopmental disorder,0.008435641244892489,-0.5893121364955842,1
6377,Biological Process,GO:0009150,purine ribonucleotide metabolic process,0.00838312323241841,-0.5903358785011249,1
6378,Biological Process,GO:0045109,intermediate filament organization,0.008382956790553564,-0.5903391229789811,1
6379,Biological Process,GO:0016558,protein import into peroxisome matrix,0.008351698943666275,-0.5909484371809812,1
6380,Biological Process,GO:0050909,sensory perception of taste,0.008344384551317474,-0.5910910177993198,1
6381,Phenotype,HP:0030358,Non-small cell lung carcinoma,0.00834110787205089,-0.5911548906316275,1
6382,Biological Process,GO:0015804,neutral amino acid transport,0.008339251078896992,-0.5911910853971507,1
6383,Phenotype,HP:0012263,Immotile cilia,0.008332537023989395,-0.5913219635418597,1
6384,Phenotype,HP:0002160,Hyperhomocystinemia,0.008320036426472055,-0.5915656396859098,1
6385,Phenotype,HP:0010880,Increased nuchal translucency,0.008318039232740992,-0.591604571302309,1
6386,Biological Process,GO:0006635,fatty acid beta-oxidation,0.008309746589400424,-0.5917662211234803,1
6387,Phenotype,HP:0000528,Anophthalmia,0.008283719579000426,-0.592273569794344,1
6388,Phenotype,HP:0010675,Abnormal foot bone ossification,0.008281114892777164,-0.5923243433589247,1
6389,Phenotype,HP:0010821,Focal emotional seizure with laughing,0.00827378840249382,-0.5924671598042338,1
6390,Phenotype,HP:0002530,Axial dystonia,0.008272710019976426,-0.5924881808868888,1
6391,Phenotype,HP:0100613,Death in early adulthood,0.008267052552573984,-0.5925984628025976,1
6392,Biological Process,GO:0032200,telomere organization,0.008255737878071545,-0.592819021559898,1
6393,Phenotype,HP:0004233,Advanced ossification of carpal bones,0.008241511505108434,-0.59309633852036,1
6394,Biological Process,GO:0034260,negative regulation of GTPase activity,0.00823965234093027,-0.593132579504638,1
6395,Disease,MONDO:0021026,hereditary epidermal appendage anomaly,0.008223876282082099,-0.5934401047395795,1
6396,Phenotype,HP:0003234,Decreased circulating carnitine concentration,0.008194303433780581,-0.5940165729950126,1
6396,Phenotype,HP:0010967,Abnormal circulating carnitine concentration,0.008194303433780581,-0.5940165729950126,1
6398,Phenotype,HP:0000825,Hyperinsulinemic hypoglycemia,0.008193775519461322,-0.5940268637131585,1
6399,Disease,MONDO:0000904,complex cortical dysplasia with other brain malformations,0.008186961356568823,-0.5941596932788069,1
6400,Phenotype,HP:0040157,Abnormal intermamillary distance,0.008132102278335718,-0.5952290700531125,1
6400,Phenotype,HP:0006610,Wide intermamillary distance,0.008132102278335718,-0.5952290700531125,1
6402,Biological Process,GO:1902902,negative regulation of autophagosome assembly,0.008072670008082095,-0.5963875927899223,1
6403,Biological Process,GO:0010922,positive regulation of phosphatase activity,0.008050517924030554,-0.5968194069025569,1
6404,Phenotype,HP:0002589,Gastrointestinal atresia,0.008026933921563506,-0.5972791336295766,1
6405,Phenotype,HP:0007021,Pain insensitivity,0.008020744964965743,-0.5973997759490614,1
6406,Biological Process,GO:1901838,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,0.007983497629402314,-0.5981258442104901,1
6407,Biological Process,GO:0008202,steroid metabolic process,0.007983078521538456,-0.5981340139470218,1
6408,Disease,MONDO:0018958,nemaline myopathy,0.007970194635972039,-0.5983851615862329,1
6409,Biological Process,GO:0009312,oligosaccharide biosynthetic process,0.007959212726105891,-0.5985992337093275,1
6410,Biological Process,GO:0106027,neuron projection organization,0.007956589547865156,-0.5986503677417585,1
6411,Biological Process,GO:0035461,vitamin transmembrane transport,0.007944446549621342,-0.5988870731460526,1
6412,Phenotype,HP:0010054,Abnormality of the first metatarsal bone,0.007922919061941869,-0.5993067119018436,1
6413,Biological Process,GO:1901617,organic hydroxy compound biosynthetic process,0.007896283436944151,-0.5998259243942708,1
6414,Phenotype,HP:0000857,Neonatal insulin-dependent diabetes mellitus,0.007895590342864023,-0.5998394349878785,1
6415,Phenotype,HP:0000921,Missing ribs,0.007820142888447124,-0.6013101442675911,1
6416,Phenotype,HP:0000643,Blepharospasm,0.007814681824695358,-0.6014165976555669,1
6417,Biological Process,GO:0045947,negative regulation of translational initiation,0.00780453623054822,-0.6016143673427712,1
6418,Disease,MONDO:0016022,early myoclonic encephalopathy,0.0077841532054157,-0.6020116969073364,1
6419,Phenotype,HP:0100614,Myositis,0.007736298046232659,-0.6029445451689055,1
6420,Biological Process,GO:0031664,regulation of lipopolysaccharide-mediated signaling pathway,0.0077121667146367034,-0.6034149410700567,1
6421,Phenotype,HP:0030167,Antimitochondrial antibody positivity,0.007665307123966847,-0.6043283825555822,1
6422,Phenotype,HP:5200020,Abnormal interest in others,0.007661287235500636,-0.6044067428835265,1
6422,Phenotype,HP:0100962,Excessive shyness,0.007661287235500636,-0.6044067428835265,1
6424,Phenotype,HP:0001166,Arachnodactyly,0.0076537261670636125,-0.6045541319982529,1
6425,Phenotype,HP:0001841,Preaxial foot polydactyly,0.007623498247112059,-0.6051433696699908,1
6426,Biological Process,GO:1900152,"negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",0.0075782767761298775,-0.6060248790267976,1
6427,Biological Process,GO:0006937,regulation of muscle contraction,0.007553500509480893,-0.606507846749949,1
6428,Biological Process,GO:0071108,protein K48-linked deubiquitination,0.0075162569959543735,-0.6072338405078018,1
6429,Biological Process,GO:0071542,dopaminergic neuron differentiation,0.0075118871885930805,-0.6073190218606583,1
6430,Phenotype,HP:0046504,Decreased libido,0.007492473281395129,-0.6076974602545335,1
6431,Biological Process,GO:0032272,negative regulation of protein polymerization,0.007384716442744632,-0.6097979815216936,1
6432,Biological Process,GO:0001504,neurotransmitter uptake,0.007376107056816128,-0.609965805656723,1
6433,Phenotype,HP:0002000,Short columella,0.007356434280294422,-0.6103492902316737,1
6434,Biological Process,GO:1903894,regulation of IRE1-mediated unfolded protein response,0.007332573733079162,-0.6108144076896412,1
6435,Phenotype,HP:0000887,Cupped ribs,0.007284810546520637,-0.6117454631141506,1
6436,Phenotype,HP:0010640,Abnormal nasal cavity morphology,0.007253991789188841,-0.6123462180733124,1
6437,Phenotype,HP:0008443,Neuropathic spinal arthropathy,0.007225188441423724,-0.6129076863318816,1
6438,Biological Process,GO:0031453,positive regulation of heterochromatin formation,0.007207814937459811,-0.6132463508196146,1
6439,Phenotype,HP:0003355,Aminoaciduria,0.007149278529452685,-0.6143874103705628,1
6440,Biological Process,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",0.0071428979027784445,-0.6145117889454624,1
6441,Phenotype,HP:0100540,Palpebral edema,0.00712186743795562,-0.6149217391553223,1
6442,Phenotype,HP:0032046,Focal cortical dysplasia,0.0070946443721259245,-0.6154524027257157,1
6443,Phenotype,HP:0030215,Inappropriate crying,0.007037726401671551,-0.6165619138149449,1
6444,Biological Process,GO:0061136,regulation of proteasomal protein catabolic process,0.0070337559253513815,-0.616639310944034,1
6445,Biological Process,GO:0007584,response to nutrient,0.007009779517665127,-0.6171066868886682,1
6446,Phenotype,HP:0005146,Cardiac valve calcification,0.006983376538630348,-0.6176213643761808,1
6447,Biological Process,GO:0071360,cellular response to exogenous dsRNA,0.006982334494958553,-0.6176416770999144,1
6448,Phenotype,HP:0001663,Ventricular fibrillation,0.0069666958918126465,-0.6179465228888967,1
6449,Biological Process,GO:0042273,ribosomal large subunit biogenesis,0.00696639821878664,-0.6179523254767382,1
6450,Phenotype,HP:0430030,Positive infectious agent test,0.006951733231542745,-0.6182381924154329,1
6450,Phenotype,HP:0031863,Bloodstream infectious agent,0.006951733231542745,-0.6182381924154329,1
6450,Phenotype,HP:0430150,Positive blood infectious agent test,0.006951733231542745,-0.6182381924154329,1
6453,Phenotype,HP:0008955,Progressive distal muscular atrophy,0.006935631233110029,-0.6185520712427562,1
6454,Phenotype,HP:0007185,Loss of consciousness,0.006874775161916258,-0.6197383483587074,1
6455,Phenotype,HP:0011813,Increased cerebral lipofuscin,0.006840076083611257,-0.62041474303438,1
6456,Phenotype,HP:0000544,External ophthalmoplegia,0.006816373154518329,-0.6208767880171134,1
6457,Phenotype,HP:0012415,Abnormal blood gas level,0.006811867279124195,-0.6209646217658674,1
6458,Phenotype,HP:0000741,Apathy,0.006805190559667329,-0.621094772124672,1
6459,Phenotype,HP:0000890,Long clavicles,0.006783297633719765,-0.6215215344269921,1
6460,Biological Process,GO:0030301,cholesterol transport,0.006753974494030035,-0.6220931350725711,1
6461,Biological Process,GO:0032693,negative regulation of interleukin-10 production,0.006737908411946436,-0.6224063137767646,1
6462,Biological Process,GO:0070102,interleukin-6-mediated signaling pathway,0.006734217750518745,-0.6224782564294615,1
6463,Phenotype,HP:0000338,Hypomimic face,0.006720056892432602,-0.6227542962979626,1
6464,Phenotype,HP:0006520,Progressive pulmonary function impairment,0.006713522264472305,-0.6228816768445292,1
6465,Biological Process,GO:0071805,potassium ion transmembrane transport,0.006698130012469328,-0.6231817204713342,1
6466,Phenotype,HP:0003028,Abnormality of the ankle,0.0066711724347883194,-0.6237072088388403,1
6467,Phenotype,HP:0020049,Exodeviation,0.006606068712238566,-0.6249762861011252,1
6468,Biological Process,GO:0071071,regulation of phospholipid biosynthetic process,0.00660450004261659,-0.6250068644286205,1
6469,Biological Process,GO:0034219,carbohydrate transmembrane transport,0.0065775430329272355,-0.6255323417241747,1
6469,Biological Process,GO:0008643,carbohydrate transport,0.0065775430329272355,-0.6255323417241747,1
6471,Phenotype,HP:0000642,Red-green dyschromatopsia,0.006531142749518715,-0.6264368298598927,1
6472,Biological Process,GO:0031647,regulation of protein stability,0.006520769866860121,-0.6266390301183542,1
6473,Phenotype,HP:0003521,Disproportionate short-trunk short stature,0.006516063155967644,-0.6267307787855557,1
6474,Biological Process,GO:0071763,nuclear membrane organization,0.006505958364126485,-0.6269277531068924,1
6475,Biological Process,GO:0000723,telomere maintenance,0.006454152706650507,-0.627937609062675,1
6476,Biological Process,GO:0050000,chromosome localization,0.006433893152204995,-0.6283325317934171,1
6477,Phenotype,HP:0012523,Oral aversion,0.0063697767205638245,-0.6295823636363269,1
6478,Phenotype,HP:0002199,Hypocalcemic seizures,0.006369346569806034,-0.629590748633754,1
6479,Phenotype,HP:0000588,Optic disc coloboma,0.006352165052244008,-0.62992567069989,1
6480,Phenotype,HP:0031245,Productive cough,0.006312983541457484,-0.6306894421478767,1
6481,Biological Process,GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,0.0062886709793736895,-0.6311633708038741,1
6482,Phenotype,HP:0033044,Motor regression,0.006274841023707678,-0.6314329603386466,1
6483,Phenotype,HP:0012664,Reduced left ventricular ejection fraction,0.006270236735578361,-0.6315227124625663,1
6483,Phenotype,HP:0034314,Abnormal left ventricular ejection fraction,0.006270236735578361,-0.6315227124625663,1
6485,Phenotype,HP:0001217,Clubbing,0.006242378789684144,-0.632065751851463,1
6486,Phenotype,HP:0012093,Abnormality of endocrine pancreas physiology,0.006228074001259354,-0.6323445973770444,1
6487,Biological Process,GO:0007029,endoplasmic reticulum organization,0.006154699927178098,-0.6337748899227059,1
6488,Biological Process,GO:0046337,phosphatidylethanolamine metabolic process,0.006119262405256398,-0.634465679197746,1
6489,Phenotype,HP:0008347,Decreased activity of mitochondrial complex IV,0.0061089806221783505,-0.6346661036375332,1
6490,Disease,MONDO:0016333,familial dilated cardiomyopathy,0.006099055351517002,-0.6348595785238381,1
6490,Disease,MONDO:0005021,dilated cardiomyopathy,0.006099055351517002,-0.6348595785238381,1
6492,Phenotype,HP:0003496,Increased circulating IgM level,0.006091287417380298,-0.6350110001046898,1
6493,Biological Process,GO:0046386,deoxyribose phosphate catabolic process,0.00608373493328529,-0.6351582218834663,1
6493,Biological Process,GO:0009264,deoxyribonucleotide catabolic process,0.00608373493328529,-0.6351582218834663,1
6495,Phenotype,HP:0007311,Short stepped shuffling gait,0.006076936711709835,-0.6352907407024753,1
6496,Biological Process,GO:0009062,fatty acid catabolic process,0.0060607336076217155,-0.6356065903984885,1
6497,Phenotype,HP:0002121,Generalized non-motor (absence) seizure,0.005988688789270502,-0.6370109715498904,1
6498,Biological Process,GO:0032392,DNA geometric change,0.005982395114988326,-0.6371336551479232,1
6499,Biological Process,GO:0071044,histone mRNA catabolic process,0.00596759878719233,-0.6374220823289782,1
6500,Phenotype,HP:3000022,Abnormality of cartilage of external ear,0.0059464481291920945,-0.6378343754836431,1
6501,Biological Process,GO:0046890,regulation of lipid biosynthetic process,0.005944520364134953,-0.6378719537158122,1
6502,Disease,MONDO:0021084,vision disorder,0.0059395751960581444,-0.6379683506669951,1
6503,Phenotype,HP:0006913,Frontal cortical atrophy,0.00589703836537836,-0.638797527901586,1
6504,Phenotype,HP:0000458,Anosmia,0.005896160502576575,-0.6388146402213968,1
6505,Biological Process,GO:0006940,regulation of smooth muscle contraction,0.005887698291972332,-0.6389795954443229,1
6506,Biological Process,GO:0061635,regulation of protein complex stability,0.005884703363032595,-0.639037976072507,1
6507,Phenotype,HP:0010919,Abnormal circulating homocysteine concentration,0.005852936582837254,-0.6396572109927698,1
6508,Biological Process,GO:1901800,positive regulation of proteasomal protein catabolic process,0.005804801215019029,-0.6405955214060207,1
6509,Disease,MONDO:0100062,developmental and epileptic encephalopathy,0.005772976651124306,-0.641215882713165,1
6509,Disease,MONDO:0005579,"epilepsy, idiopathic generalized",0.005772976651124306,-0.641215882713165,1
6511,Biological Process,GO:1990748,cellular detoxification,0.00576212315461655,-0.6414274516541538,1
6512,Phenotype,HP:0000858,Irregular menstruation,0.005757710997073229,-0.6415134585458729,1
6513,Phenotype,HP:0011504,Bull's eye maculopathy,0.005757406061639547,-0.6415194027009872,1
6514,Phenotype,HP:0000127,Renal salt wasting,0.005739860729142343,-0.6418614166697646,1
6515,Phenotype,HP:0001348,Brisk reflexes,0.005723465074434775,-0.6421810197857577,1
6516,Biological Process,GO:0007098,centrosome cycle,0.005680294055136592,-0.6430225593603821,1
6517,Biological Process,GO:0051224,negative regulation of protein transport,0.005679441284047848,-0.643039182563423,1
6518,Phenotype,HP:0001650,Aortic valve stenosis,0.00565474900163776,-0.6435205131683912,1
6519,Biological Process,GO:0032490,detection of molecule of bacterial origin,0.005644715469631301,-0.6437160984103883,1
6520,Biological Process,GO:0061515,myeloid cell development,0.005596670774763668,-0.6446526413213306,1
6521,Disease,MONDO:0100022,neonatal/infantile epilepsy syndrome,0.005573208777002958,-0.6451099897911227,1
6522,Biological Process,GO:0022406,membrane docking,0.005547451637631595,-0.6456120778229202,1
6523,Phenotype,HP:0006670,Impaired myocardial contractility,0.005540373936435583,-0.6457500445828124,1
6524,Biological Process,GO:0090043,regulation of tubulin deacetylation,0.005518319360682478,-0.6461799579506112,1
6525,Biological Process,GO:0071359,cellular response to dsRNA,0.005505327210142741,-0.6464332160162396,1
6526,Phenotype,HP:0002901,Hypocalcemia,0.0054966295090425055,-0.6466027616930176,1
6527,Phenotype,HP:0003325,Limb-girdle muscle weakness,0.005480405915354036,-0.646919010796083,1
6528,Biological Process,GO:1901615,organic hydroxy compound metabolic process,0.005468249907686351,-0.6471559697951546,1
6529,Phenotype,HP:0001765,Hammertoe,0.005457219006109848,-0.6473709969214843,1
6530,Biological Process,GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,0.005443010737224752,-0.6476479609762621,1
6531,Phenotype,HP:0032104,Saccadic oscillation,0.005387878011786085,-0.6487226719992537,1
6532,Biological Process,GO:0044273,sulfur compound catabolic process,0.005360236222280768,-0.649261497817136,1
6533,Phenotype,HP:0011185,EEG with focal epileptiform discharges,0.005335888039009418,-0.6497361208426321,1
6534,Phenotype,HP:0011470,Nasogastric tube feeding in infancy,0.005316615984809592,-0.6501117940733575,1
6535,Phenotype,HP:0012020,Right aortic arch,0.0053124779680086,-0.6501924570957996,1
6536,Phenotype,HP:0002703,Abnormality of skull ossification,0.00529228725097719,-0.6505860379678335,1
6537,Phenotype,HP:0012741,Unilateral cryptorchidism,0.005260291223668778,-0.6512097416386877,1
6538,Phenotype,HP:0011190,Uni- and bilateral multifocal epileptiform discharges,0.005229472759306075,-0.6518104908869562,1
6539,Disease,MONDO:0020246,inherited vitreoretinopathy,0.005228632206311978,-0.6518268759207265,1
6540,Biological Process,GO:0048255,mRNA stabilization,0.0052041123159408675,-0.6523048460601439,1
6541,Phenotype,HP:0001545,Anteriorly placed anus,0.005198830622521022,-0.6524078029535898,1
6542,Phenotype,HP:0002371,Loss of speech,0.005185530416168427,-0.6526670660003822,1
6543,Phenotype,HP:0100679,Lack of skin elasticity,0.005180796748045502,-0.6527593401491825,1
6544,Phenotype,HP:0003204,Intracellular accumulation of autofluorescent lipopigment storage material,0.005127182908944539,-0.6538044432781907,1
6545,Phenotype,HP:0003049,Ulnar deviation of the wrist,0.005119007638237805,-0.6539638051358635,1
6546,Biological Process,GO:0045926,negative regulation of growth,0.005100246427660382,-0.6543295204102635,1
6547,Phenotype,HP:0046508,Abnormal cervical spine morphology,0.005099966605950357,-0.6543349750195512,1
6548,Phenotype,HP:0004446,Stomatocytosis,0.0050808934620193424,-0.654706770860636,1
6549,Phenotype,HP:0006813,Focal hemiclonic seizure,0.005052551763863322,-0.6552592401096388,1
6550,Phenotype,HP:0003179,Protrusio acetabuli,0.005013939604231021,-0.6560119131046371,1
6551,Phenotype,HP:0006481,Abnormality of primary teeth,0.005006564820756676,-0.656155670936832,1
6552,Phenotype,HP:0012171,Stereotypical hand wringing,0.0050061272374748444,-0.6561642008176373,1
6552,Phenotype,HP:5200009,Midline hand movements,0.0050061272374748444,-0.6561642008176373,1
6554,Disease,MONDO:0100033,metabolic epilepsy,0.004992630710973223,-0.6564272907644516,1
6555,Phenotype,HP:0006961,Jerky head movements,0.00498445802378733,-0.65658660226114,1
6556,Phenotype,HP:0003394,Muscle spasm,0.0049625404259139305,-0.6570138454972511,1
6557,Phenotype,HP:0004736,Crossed fused renal ectopia,0.004960053811975618,-0.6570623174599224,1
6558,Biological Process,GO:0007272,ensheathment of neurons,0.0048966238472859525,-0.6582987678929013,1
6558,Biological Process,GO:0008366,axon ensheathment,0.0048966238472859525,-0.6582987678929013,1
6560,Biological Process,GO:0007158,neuron cell-cell adhesion,0.004886599289872229,-0.6584941781917287,1
6561,Biological Process,GO:0009247,glycolipid biosynthetic process,0.004848273849563323,-0.6592412621211603,1
6562,Biological Process,GO:0019677,NAD catabolic process,0.004801560481634715,-0.6601518532634354,1
6563,Phenotype,HP:0007731,Chorioretinal dysplasia,0.004790061071772933,-0.6603760130966021,1
6564,Phenotype,HP:0009104,Aplasia/Hypoplasia of the pubic bone,0.004780224149775525,-0.6605677657882895,1
6565,Disease,MONDO:0005372,male infertility,0.004737249818176692,-0.6614054712981746,1
6565,Disease,MONDO:0004983,spermatogenic failure,0.004737249818176692,-0.6614054712981746,1
6567,Phenotype,HP:0010808,Protruding tongue,0.00471518702599294,-0.6618355448301685,1
6568,Phenotype,HP:0010818,Generalized tonic seizure,0.004696699527168113,-0.6621959245976567,1
6569,Biological Process,GO:0030449,regulation of complement activation,0.00469487211690689,-0.66223154659776,1
6570,Phenotype,HP:0002383,Infectious encephalitis,0.004692810423657212,-0.6622717355135777,1
6571,Biological Process,GO:0019933,cAMP-mediated signaling,0.004674279233539469,-0.6626329669624175,1
6572,Phenotype,HP:0012852,Hepatic bridging fibrosis,0.004656815276713799,-0.662973394662232,1
6573,Phenotype,HP:0000621,Entropion,0.004650474745613975,-0.6630969916476954,1
6574,Phenotype,HP:0003445,EMG,0.0046092334904683785,-0.663900914021464,1
6575,Biological Process,GO:0034392,negative regulation of smooth muscle cell apoptotic process,0.004589414445358431,-0.6642872498333681,1
6576,Biological Process,GO:0048609,multicellular organismal reproductive process,0.004571588920944447,-0.6646347256279327,1
6577,Biological Process,GO:0038061,non-canonical NF-kappaB signal transduction,0.0045646788510804726,-0.6647694247234947,1
6578,Phenotype,HP:0005565,Reduced renal corticomedullary differentiation,0.004493997219058521,-0.6661472330660467,1
6579,Disease,MONDO:0700264,type 1 interferonopathy,0.0044887376593127915,-0.6662497585042477,1
6579,Disease,MONDO:0957408,type 1 interferonopathy of childhood,0.0044887376593127915,-0.6662497585042477,1
6579,Disease,MONDO:0957018,autoinflammatory syndrome of childhood,0.0044887376593127915,-0.6662497585042477,1
6582,Biological Process,GO:2000736,regulation of stem cell differentiation,0.004479558866605338,-0.666428682176567,1
6583,Phenotype,HP:0011169,Generalized clonic seizure,0.004448909908052134,-0.6670261272210167,1
6584,Biological Process,GO:0045292,"mRNA cis splicing, via spliceosome",0.004411446592426205,-0.6677564056163011,1
6585,Phenotype,HP:0001946,Ketosis,0.0043713162750763646,-0.6685386723021736,1
6586,Biological Process,GO:0140861,DNA repair-dependent chromatin remodeling,0.004363699010810573,-0.6686871568511661,1
6587,Phenotype,HP:0025129,Abnormal small intestinal mucosa morphology,0.004359723718562747,-0.6687646478579022,1
6588,Biological Process,GO:0033048,negative regulation of mitotic sister chromatid segregation,0.004308114092512305,-0.6697706825417958,1
6588,Biological Process,GO:0033046,negative regulation of sister chromatid segregation,0.004308114092512305,-0.6697706825417958,1
6588,Biological Process,GO:0045841,negative regulation of mitotic metaphase/anaphase transition,0.004308114092512305,-0.6697706825417958,1
6588,Biological Process,GO:2000816,negative regulation of mitotic sister chromatid separation,0.004308114092512305,-0.6697706825417958,1
6592,Phenotype,HP:0002365,Hypoplasia of the brainstem,0.00429609585969315,-0.6700049558737391,1
6592,Phenotype,HP:0007362,Aplasia/Hypoplasia of the brainstem,0.00429609585969315,-0.6700049558737391,1
6594,Biological Process,GO:0009410,response to xenobiotic stimulus,0.004264654992647721,-0.6706178377169145,1
6595,Biological Process,GO:0031110,regulation of microtubule polymerization or depolymerization,0.004242016290929462,-0.671059137545451,1
6596,Phenotype,HP:0012708,Reduced brain N-acetyl aspartate level by MRS,0.00424028753891903,-0.6710928363845134,1
6597,Biological Process,GO:0008645,hexose transmembrane transport,0.0041933973293903914,-0.6720068747283438,1
6598,Phenotype,HP:0030829,Abnormal breath sound,0.004165205373510283,-0.6725564250272448,1
6599,Biological Process,GO:0008334,histone mRNA metabolic process,0.004146269346839038,-0.672925548019684,1
6600,Biological Process,GO:0051452,intracellular pH reduction,0.004124459554789572,-0.67335068977965,1
6601,Phenotype,HP:0010565,Aplasia/Hypoplasia of the Epiglottis,0.004106898552450056,-0.6736930092031664,1
6602,Phenotype,HP:0004445,Elliptocytosis,0.004106209207509037,-0.6737064467142067,1
6603,Biological Process,GO:0003073,regulation of systemic arterial blood pressure,0.004098337129960994,-0.6738598983792098,1
6604,Phenotype,HP:0100777,Exostoses,0.004078239342343193,-0.6742516677633412,1
6605,Biological Process,GO:0034620,cellular response to unfolded protein,0.004067545483334101,-0.6744601248650707,1
6606,Phenotype,HP:0001188,Hand clenching,0.004066993625211457,-0.6744708823236003,1
6607,Phenotype,HP:0010459,True hermaphroditism,0.004004275842911964,-0.6756934500714952,1
6608,Phenotype,HP:0003805,Rimmed vacuoles,0.0039621961319706855,-0.6765137165980103,1
6609,Biological Process,GO:0052652,cyclic purine nucleotide metabolic process,0.003929107665459508,-0.6771587153607327,1
6609,Biological Process,GO:0009187,cyclic nucleotide metabolic process,0.003929107665459508,-0.6771587153607327,1
6611,Phenotype,HP:0012251,ST segment elevation,0.003908536353837588,-0.6775597152239096,1
6612,Biological Process,GO:1903845,negative regulation of cellular response to transforming growth factor beta stimulus,0.003898785142351313,-0.6777497971469133,1
6613,Biological Process,GO:0086013,membrane repolarization during cardiac muscle cell action potential,0.003868766053169992,-0.6783349640470918,1
6613,Biological Process,GO:0099622,cardiac muscle cell membrane repolarization,0.003868766053169992,-0.6783349640470918,1
6615,Phenotype,HP:0000855,Insulin resistance,0.0038455677832074375,-0.6787871716287908,1
6616,Phenotype,HP:0430106,Abnormal brain-evoked potentials,0.003844918457182267,-0.6787998290447123,1
6617,Phenotype,HP:0031654,Abnormal pulmonary valve physiology,0.0038096956013975447,-0.6794864337984569,1
6618,Phenotype,HP:0000045,Abnormal scrotum morphology,0.003794597405588851,-0.6797807453408989,1
6619,Phenotype,HP:0007394,Prominent superficial blood vessels,0.0037890513479252874,-0.679888855528773,1
6620,Phenotype,HP:0007344,Atrophy/Degeneration involving the spinal cord,0.003719732289076627,-0.6812401030148225,1
6621,Biological Process,GO:1900103,positive regulation of endoplasmic reticulum unfolded protein response,0.003699248604556171,-0.6816393947489143,1
6622,Biological Process,GO:0044458,motile cilium assembly,0.003697343899625505,-0.6816765234663548,1
6623,Phenotype,HP:0007392,Excessive wrinkled skin,0.0036914691757565787,-0.6817910403970657,1
6624,Biological Process,GO:0031111,negative regulation of microtubule polymerization or depolymerization,0.0036589916175061576,-0.6824241306274845,1
6625,Biological Process,GO:1900037,regulation of cellular response to hypoxia,0.003643146908682504,-0.6827329940673632,1
6626,Phenotype,HP:0002227,White eyelashes,0.00362447498498486,-0.6830969688583545,1
6627,Phenotype,HP:0025667,Fetal neck anomaly,0.0036153771386110423,-0.6832743146308631,1
6628,Biological Process,GO:0000375,"RNA splicing, via transesterification reactions",0.00361523303639133,-0.6832771236384485,1
6629,Disease,MONDO:0018424,inherited lipoic acid biosynthesis defect,0.0036115245523231643,-0.6833494137107229,1
6630,Biological Process,GO:0006505,GPI anchor metabolic process,0.003604007191148839,-0.6834959508327965,1
6631,Phenotype,HP:0011933,Elongated superior cerebellar peduncle,0.003589232380040275,-0.6837839585856267,1
6632,Disease,MONDO:0015951,hereditary photodermatosis,0.0035687873603963416,-0.6841824966191048,1
6633,Biological Process,GO:0098719,sodium ion import across plasma membrane,0.003525163171639867,-0.6850328698983617,1
6634,Biological Process,GO:0046467,membrane lipid biosynthetic process,0.003522646633377091,-0.6850819251806693,1
6635,Biological Process,GO:0010833,telomere maintenance via telomere lengthening,0.003513174038413891,-0.6852665759872871,1
6636,Biological Process,GO:0050855,regulation of B cell receptor signaling pathway,0.0035058509521227466,-0.6854093260780325,1
6637,Disease,MONDO:0018054,familial atrial fibrillation,0.0034943900836121866,-0.6856327346184838,1
6637,Disease,MONDO:0004981,atrial fibrillation,0.0034943900836121866,-0.6856327346184838,1
6639,Disease,MONDO:0017758,disorder of vitamin and non-protein cofactor absorption and transport,0.003468402349090516,-0.6861393176783779,1
6640,Biological Process,GO:0009168,purine ribonucleoside monophosphate biosynthetic process,0.003450683935180998,-0.6864847055507709,1
6641,Biological Process,GO:0051503,adenine nucleotide transport,0.0034482142422711526,-0.6865328476691316,1
6642,Biological Process,GO:1903115,regulation of actin filament-based movement,0.0034365083010073905,-0.6867610334519051,1
6643,Biological Process,GO:0051653,spindle localization,0.0034285340855407798,-0.6869164761076687,1
6644,Disease,MONDO:0005047,infertility disorder,0.0034030499931131386,-0.6874132415917802,1
6645,Biological Process,GO:1901264,carbohydrate derivative transport,0.003370076243424891,-0.6880560041611501,1
6646,Phenotype,HP:0033684,Abnormal muscle fiber-type distribution,0.0033542793506197155,-0.6883639355157433,1
6647,Biological Process,GO:0150078,positive regulation of neuroinflammatory response,0.0033105997321140057,-0.6892153892959555,1
6648,Biological Process,GO:0086011,membrane repolarization during action potential,0.003310183245349485,-0.6892235079389791,1
6649,Phenotype,HP:0011062,Misalignment of incisors,0.003301380573556001,-0.6893950998262469,1
6650,Biological Process,GO:0051917,regulation of fibrinolysis,0.0032847463237073438,-0.6897193539154345,1
6651,Disease,MONDO:0020071,infantile epilepsy syndrome,0.0032805417510684,-0.6898013143214563,1
6652,Phenotype,HP:0001919,Acute kidney injury,0.0032670313065028544,-0.6900646755753138,1
6653,Phenotype,HP:0004397,Ectopic anus,0.0032328012252327287,-0.6907319280168756,1
6654,Biological Process,GO:0034308,primary alcohol metabolic process,0.003230973883061594,-0.6907675486896878,1
6655,Phenotype,HP:0003403,EMG,0.0032301936236415196,-0.6907827584111894,1
6656,Phenotype,HP:0001746,Asplenia,0.0032203580094776196,-0.6909744856090693,1
6657,Biological Process,GO:0071391,cellular response to estrogen stimulus,0.0032183378391680284,-0.6910138651115837,1
6658,Phenotype,HP:0005390,Recurrent opportunistic infections,0.003212010787605024,-0.6911371993382829,1
6659,Phenotype,HP:0003438,Absent Achilles reflex,0.0031992012550597915,-0.691386897602176,1
6660,Biological Process,GO:0090314,positive regulation of protein targeting to membrane,0.0031866599925213235,-0.6916313664359781,1
6661,Phenotype,HP:0007502,Follicular hyperkeratosis,0.0031533983929751264,-0.6922797401086056,1
6662,Biological Process,GO:1904893,negative regulation of receptor signaling pathway via STAT,0.0031375097803097995,-0.6925894593730825,1
6663,Phenotype,HP:0002145,Frontotemporal dementia,0.0031229771688702224,-0.69287274588908,1
6664,Phenotype,HP:0010625,Anterior pituitary dysgenesis,0.003097216910168399,-0.6933748947264844,1
6665,Phenotype,HP:0002486,Myotonia,0.0030759682652005127,-0.6937890979567606,1
6666,Biological Process,GO:0033047,regulation of mitotic sister chromatid segregation,0.0030288489218972536,-0.6947076028418577,1
6667,Biological Process,GO:0050905,neuromuscular process,0.003019546267194473,-0.6948889409758356,1
6668,Phenotype,HP:0025691,Impaired fasting glucose,0.003008696372370001,-0.6951004397086369,1
6669,Phenotype,HP:0007440,Generalized hyperpigmentation,0.003000028778813113,-0.6952693984942635,1
6670,Biological Process,GO:0001676,long-chain fatty acid metabolic process,0.0029769494259745954,-0.6957192880054697,1
6671,Phenotype,HP:0008187,Absence of secondary sex characteristics,0.002954789571461114,-0.69615125358896,1
6672,Phenotype,HP:0002286,Fair hair,0.0029495587399549494,-0.6962532190229986,1
6673,Phenotype,HP:0003016,Metaphyseal widening,0.00294830915625921,-0.6962775773575681,1
6674,Disease,MONDO:0005137,nutritional disorder,0.0029338597747370354,-0.6965592414594919,1
6675,Biological Process,GO:0015749,monosaccharide transmembrane transport,0.0029096283086311736,-0.6970315892986385,1
6676,Phenotype,HP:0000787,Nephrolithiasis,0.0028549414397601725,-0.6980976091683426,1
6677,Phenotype,HP:0002150,Hypercalciuria,0.002846768404345168,-0.6982569274531167,1
6678,Biological Process,GO:0070050,neuron cellular homeostasis,0.0028259932478573724,-0.698661900896823,1
6679,Disease,MONDO:0100133,mitochondrial complex I deficiency,0.0028061132900134567,-0.6990494240903794,1
6679,Disease,MONDO:0100223,"mitochondrial complex I deficiency, nuclear type",0.0028061132900134567,-0.6990494240903794,1
6681,Biological Process,GO:0046931,pore complex assembly,0.0027872042422003585,-0.6994180211796276,1
6682,Phenotype,HP:0008956,Proximal lower limb amyotrophy,0.002784119480535252,-0.6994781529314757,1
6683,Disease,MONDO:0023369,disorder of facial skeleton,0.00275564148961438,-0.7000332789571131,1
6684,Phenotype,HP:0030830,Crackles,0.0027393965762851913,-0.7003499436473404,1
6685,Phenotype,HP:0005464,Craniofacial osteosclerosis,0.0026985856727858026,-0.7011454771077319,1
6686,Phenotype,HP:0100256,Senile plaques,0.0026979812113621104,-0.7011572599708109,1
6687,Disease,MONDO:0020248,vitreoretinal degeneration,0.0026789049953661603,-0.7015291156961482,1
6687,Disease,MONDO:0001377,vitreous syneresis,0.0026789049953661603,-0.7015291156961482,1
6689,Biological Process,GO:0015015,"heparan sulfate proteoglycan biosynthetic process, enzymatic modification",0.002653816299895917,-0.7020181736442147,1
6690,Biological Process,GO:0071715,icosanoid transport,0.0026454506310277237,-0.7021812469636599,1
6691,Phenotype,HP:0000579,Nasolacrimal duct obstruction,0.002583168068555408,-0.7033953309019485,1
6692,Biological Process,GO:1903035,negative regulation of response to wounding,0.00255971814732725,-0.7038524439619626,1
6693,Biological Process,GO:1902882,regulation of response to oxidative stress,0.002553125474779927,-0.7039809559809351,1
6694,Phenotype,HP:0030794,Abnormal circulating C-peptide concentration,0.0025151110196894866,-0.7047219778258313,1
6695,Phenotype,HP:0030462,Abnormal amplitude of flash visual evoked potentials,0.0025023173670347676,-0.7049713665404823,1
6696,Phenotype,HP:0002263,Exaggerated cupid's bow,0.0024770542470884394,-0.7054638245727208,1
6697,Biological Process,GO:0016101,diterpenoid metabolic process,0.0024740274067024393,-0.705522827255824,1
6698,Biological Process,GO:0032516,positive regulation of phosphoprotein phosphatase activity,0.002462393790238937,-0.705749603199714,1
6699,Biological Process,GO:0065002,intracellular protein transmembrane transport,0.0024607762650450393,-0.7057811338766762,1
6700,Phenotype,HP:0001015,Prominent superficial veins,0.002460609546594994,-0.7057843837460518,1
6701,Disease,MONDO:0015229,Bardet-Biedl syndrome,0.002457993547627768,-0.7058353778317576,1
6702,Disease,MONDO:0002367,kidney cancer,0.0024364819756073075,-0.7062547063410654,1
6702,Disease,MONDO:0021163,kidney neoplasm,0.0024364819756073075,-0.7062547063410654,1
6704,Phenotype,HP:0030838,Hip pain,0.0024110016604838025,-0.7067513981935839,1
6705,Biological Process,GO:0043651,linoleic acid metabolic process,0.0023533539804142523,-0.7078751336288938,1
6706,Biological Process,GO:1905898,positive regulation of response to endoplasmic reticulum stress,0.002335129339515407,-0.7082303894648462,1
6707,Phenotype,HP:0003146,Hypocholesterolemia,0.0022807662084729508,-0.7092900986613498,1
6708,Phenotype,HP:0002578,Gastroparesis,0.002244422963953996,-0.7099985433316438,1
6709,Phenotype,HP:0011451,Primary microcephaly,0.0022388637714099158,-0.7101069095598416,1
6710,Phenotype,HP:0003409,Distal sensory impairment of all modalities,0.0022154916761263355,-0.7105625055462874,1
6711,Phenotype,HP:0001684,Secundum atrial septal defect,0.002186984302218531,-0.711118204339182,1
6712,Disease,MONDO:0019256,sterol metabolism disorder,0.0021480553111371536,-0.7118770533802229,1
6713,Disease,MONDO:0020121,muscular dystrophy,0.0021303511720377477,-0.7122221629914622,1
6714,Biological Process,GO:0050857,positive regulation of antigen receptor-mediated signaling pathway,0.0020798955318003243,-0.7132057028455836,1
6715,Biological Process,GO:0043627,response to estrogen,0.002057985662684114,-0.7136327954237963,1
6716,Phenotype,HP:0002753,Thin bony cortex,0.002054586217085763,-0.7136990613598178,1
6717,Biological Process,GO:0032509,endosome transport via multivesicular body sorting pathway,0.002038862454672108,-0.7140055671720084,1
6718,Phenotype,HP:0012768,Neonatal asphyxia,0.0020347534928309985,-0.7140856638214766,1
6719,Phenotype,HP:0008726,Hypoplasia of the vagina,0.0020119864555343536,-0.7145294653159409,1
6720,Biological Process,GO:0071168,protein localization to chromatin,0.0019877323766507304,-0.7150022539495762,1
6721,Phenotype,HP:0012108,Open angle glaucoma,0.0019760500483952947,-0.7152299794402067,1
6722,Biological Process,GO:2000785,regulation of autophagosome assembly,0.001975785184021972,-0.7152351424837411,1
6723,Biological Process,GO:0042219,cellular modified amino acid catabolic process,0.0019263869693567637,-0.7161980697722871,1
6724,Phenotype,HP:0002155,Hypertriglyceridemia,0.0019041582179291083,-0.7166313783743299,1
6725,Phenotype,HP:0004295,Abnormal gastric mucosa morphology,0.001891061733844901,-0.7168866702304053,1
6726,Biological Process,GO:0050885,neuromuscular process controlling balance,0.0018884398676163316,-0.7169377786875736,1
6727,Phenotype,HP:0025424,Abnormal larynx physiology,0.0018750033513840192,-0.7171996988446232,1
6728,Phenotype,HP:0030157,Flank pain,0.0018597070308931096,-0.717497872463141,1
6729,Disease,MONDO:0000412,neonatal period electroclinical syndrome,0.0018260581360939332,-0.7181537957439951,1
6730,Phenotype,HP:0003200,Ragged-red muscle fibers,0.0018219700487906998,-0.7182334854827624,1
6731,Phenotype,HP:0030197,Fatigable weakness of skeletal muscles,0.001793209813783725,-0.7187941133374512,1
6732,Phenotype,HP:0003261,Increased circulating IgA level,0.001787294628227798,-0.7189094189942896,1
6733,Biological Process,GO:0007259,cell surface receptor signaling pathway via JAK-STAT,0.001774775788896843,-0.7191534507289261,1
6734,Phenotype,HP:0005502,Increased red cell osmotic fragility,0.0017669736503044264,-0.7193055390626963,1
6735,Phenotype,HP:0006492,Aplasia/Hypoplasia of the fibula,0.001760880514609764,-0.719424313530012,1
6736,Biological Process,GO:0007094,mitotic spindle assembly checkpoint signaling,0.001760118724665305,-0.7194391632230754,1
6736,Biological Process,GO:0071174,mitotic spindle checkpoint signaling,0.001760118724665305,-0.7194391632230754,1
6736,Biological Process,GO:0071173,spindle assembly checkpoint signaling,0.001760118724665305,-0.7194391632230754,1
6739,Phenotype,HP:0032989,Delayed ability to roll over,0.0017536183469719635,-0.7195658761237176,1
6740,Biological Process,GO:0003081,regulation of systemic arterial blood pressure by renin-angiotensin,0.0017334233472549032,-0.719959540478827,1
6741,Phenotype,HP:0012113,Abnormal circulating creatine concentration,0.0017217583409178117,-0.7201869283105367,1
6742,Biological Process,GO:0051133,regulation of NK T cell activation,0.0017183226133278273,-0.7202539014972161,1
6743,Phenotype,HP:0007260,Type II lissencephaly,0.001710830313825018,-0.7203999500881239,1
6744,Phenotype,HP:0100643,Abnormality of nail color,0.0016711271128279082,-0.7211738909267119,1
6745,Phenotype,HP:0030078,Lung adenocarcinoma,0.001660114843331173,-0.7213885548549348,1
6746,Phenotype,HP:0000738,Hallucinations,0.0016198011263524048,-0.7221743965790672,1
6747,Phenotype,HP:0010511,Long toe,0.001617485956480924,-0.7222195265551601,1
6748,Biological Process,GO:0006304,DNA modification,0.0015828522631703423,-0.7228946466706929,1
6749,Biological Process,GO:0006334,nucleosome assembly,0.0015804194837470975,-0.7229420692285633,1
6750,Biological Process,GO:0042149,cellular response to glucose starvation,0.0015635900722544838,-0.7232701276348485,1
6751,Phenotype,HP:0002067,Bradykinesia,0.001557486827914345,-0.7233890991516051,1
6752,Biological Process,GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity,0.0015548882156548594,-0.7234397543154398,1
6753,Phenotype,HP:0011713,Left bundle branch block,0.0015544560230433824,-0.7234481791150469,1
6754,Phenotype,HP:0003680,Nonprogressive,0.0015403485416187745,-0.7237231785037591,1
6755,Biological Process,GO:0006942,regulation of striated muscle contraction,0.0015293123729360758,-0.7239383083026312,1
6756,Phenotype,HP:0100817,Renovascular hypertension,0.0015213124755203422,-0.7240942515807312,1
6757,Phenotype,HP:0034665,Shoulder contracture,0.0015018653283718209,-0.7244733379262721,1
6758,Biological Process,GO:0010043,response to zinc ion,0.0014263120943046603,-0.7259461091856029,1
6759,Phenotype,HP:0008057,Aplasia/Hypoplasia affecting the fundus,0.0013831210126974414,-0.7267880398380218,1
6760,Phenotype,HP:0010807,Open bite,0.0013682836472216353,-0.727077266973124,1
6761,Phenotype,HP:0003367,Abnormal femoral neck morphology,0.0013522067722064879,-0.7273906560656559,1
6762,Biological Process,GO:0046324,regulation of glucose import,0.001348146899333047,-0.7274697958160368,1
6763,Phenotype,HP:0002312,Clumsiness,0.0012768974431512925,-0.728858672845631,1
6764,Phenotype,HP:0002503,Spinocerebellar tract degeneration,0.0012660466161690254,-0.7290701897491331,1
6765,Biological Process,GO:0046209,nitric oxide metabolic process,0.0012320498573606953,-0.7297328939986798,1
6766,Phenotype,HP:0007052,Multifocal cerebral white matter abnormalities,0.0012186467457853123,-0.7299941629934165,1
6767,Disease,MONDO:0016660,autosomal recessive primary microcephaly,0.0011987166282005912,-0.7303826639588121,1
6768,Biological Process,GO:0045618,positive regulation of keratinocyte differentiation,0.0011481823219479104,-0.7313677372621338,1
6769,Phenotype,HP:0011198,EEG with generalized epileptiform discharges,0.0011395346139772,-0.7315363084148527,1
6770,Phenotype,HP:0003482,EMG,0.0011332935265866428,-0.7316579669282078,1
6771,Phenotype,HP:0006532,Recurrent pneumonia,0.0011283948067136729,-0.7317534584571345,1
6772,Biological Process,GO:1905819,negative regulation of chromosome separation,0.001128250977222911,-0.7317562621483709,1
6772,Biological Process,GO:0051985,negative regulation of chromosome segregation,0.001128250977222911,-0.7317562621483709,1
6772,Biological Process,GO:1902100,negative regulation of metaphase/anaphase transition of cell cycle,0.001128250977222911,-0.7317562621483709,1
6775,Phenotype,HP:0000154,Wide mouth,0.0011207987009171916,-0.7319015305607052,1
6776,Disease,MONDO:0015650,epilepsy syndrome,0.001102473568288409,-0.7322587452980003,1
6777,Phenotype,HP:0100309,Subdural hemorrhage,0.001080781640487749,-0.7326815895113385,1
6778,Biological Process,GO:0071468,cellular response to acidic pH,0.0010727131597612072,-0.7328388696948704,1
6779,Biological Process,GO:0006261,DNA-templated DNA replication,0.0010586532727570042,-0.7331129413179438,1
6780,Biological Process,GO:0072530,purine-containing compound transmembrane transport,0.0010180169982815235,-0.7339050707068799,1
6781,Phenotype,HP:0004905,Reduced circulating vitamin A concentration,0.0010023387875174317,-0.7342106885734898,1
6781,Phenotype,HP:0008372,Abnormal circulating vitamin A concentration,0.0010023387875174317,-0.7342106885734898,1
6783,Biological Process,GO:0015918,sterol transport,0.0009824863151861596,-0.7345976759875582,1
6784,Phenotype,HP:0008839,Hypoplastic pelvis,0.0008612897543285314,-0.7369601799063472,1
6785,Phenotype,HP:0001669,Transposition of the great arteries,0.0008485541170668576,-0.737208437717675,1
6786,Phenotype,HP:0002366,Abnormal lower motor neuron morphology,0.0008406393652401478,-0.7373627212392083,1
6787,Biological Process,GO:0043094,cellular metabolic compound salvage,0.0008027854659365952,-0.7381006133445062,1
6788,Biological Process,GO:1901661,quinone metabolic process,0.0007903053494301426,-0.7383438902489396,1
6789,Phenotype,HP:0030199,Fatigable weakness of neck muscles,0.0007638574043562496,-0.7388594442666349,1
6790,Phenotype,HP:0003547,Shoulder girdle muscle weakness,0.0007311439338160142,-0.7394971331729998,1
6791,Phenotype,HP:0002068,Neuromuscular dysphagia,0.0007268579407141429,-0.7395806807211103,1
6792,Biological Process,GO:0046365,monosaccharide catabolic process,0.000706766846340634,-0.7399723196327617,1
6793,Phenotype,HP:0001216,Delayed ossification of carpal bones,0.0006892851524826771,-0.7403130930833797,1
6794,Biological Process,GO:0031665,negative regulation of lipopolysaccharide-mediated signaling pathway,0.0006840599094872779,-0.7404149495796853,1
6795,Biological Process,GO:0050654,chondroitin sulfate proteoglycan metabolic process,0.0006715204966412092,-0.7406593823571381,1
6795,Biological Process,GO:0050650,chondroitin sulfate proteoglycan biosynthetic process,0.0006715204966412092,-0.7406593823571381,1
6797,Biological Process,GO:0046605,regulation of centrosome cycle,0.0006570356459909554,-0.7409417378644407,1
6798,Phenotype,HP:5200261,Abnormal affect,0.0006348706623322542,-0.7413738034311782,1
6799,Phenotype,HP:0030353,Decreased serum insulin-like growth factor 1,0.0006315976813111579,-0.7414376041729958,1
6800,Biological Process,GO:1904385,cellular response to angiotensin,0.0006122273049889992,-0.7418151940125562,1
6801,Biological Process,GO:0097502,mannosylation,0.0006038405908036504,-0.7419786775717303,1
6802,Phenotype,HP:0033144,Abnormal circulating ceruloplasmin concentration,0.0005956148393988503,-0.7421390234577134,1
6803,Phenotype,HP:0009139,Osteolysis involving bones of the lower limbs,0.0005898557435588536,-0.7422512864327878,1
6804,Biological Process,GO:0007215,glutamate receptor signaling pathway,0.000586054576398376,-0.7423253831913844,1
6805,Biological Process,GO:0016482,cytosolic transport,0.0005766464280013706,-0.7425087777307937,1
6806,Biological Process,GO:0046173,polyol biosynthetic process,0.0005425885105424522,-0.7431726741556849,1
6807,Biological Process,GO:0045132,meiotic chromosome segregation,0.0005280439398979153,-0.7434561937943749,1
6808,Phenotype,HP:0011171,Simple febrile seizure,0.0005011859946306707,-0.7439797400113258,1
6809,Phenotype,HP:0007354,Amyotrophic lateral sclerosis,0.0004762489495199196,-0.7444658418147126,1
6810,Disease,MONDO:0006496,palsy,0.00042720727894141053,-0.745421818932428,1
6811,Phenotype,HP:0006682,Premature ventricular contraction,0.0004262430784067739,-0.7454406142474556,1
6812,Disease,MONDO:0005044,hypertensive disorder,0.0004227498724147516,-0.7455087078698066,1
6813,Biological Process,GO:0002792,negative regulation of peptide secretion,0.00038271454630944834,-0.746289122876177,1
6814,Phenotype,HP:0032044,Decreased vigilance,0.0003390279483171943,-0.7471407127086351,1
6815,Biological Process,GO:0002726,positive regulation of T cell cytokine production,0.00032617470408713434,-0.7473912630513824,1
6816,Biological Process,GO:0042116,macrophage activation,0.0003128229690794182,-0.7476515305544794,1
6817,Phenotype,HP:0011280,Abnormality of urine calcium concentration,0.0002821741780257847,-0.7482489723338334,1
6818,Phenotype,HP:0005133,Right ventricular dilatation,0.00026094161663814397,-0.7486628620443108,1
6819,Biological Process,GO:1901385,regulation of voltage-gated calcium channel activity,0.0002593882097320366,-0.7486931428532478,1
6820,Disease,MONDO:0017739,disorder of lysosomal-related organelles,0.0002551973355655601,-0.7487748362327579,1
6821,Biological Process,GO:0030177,positive regulation of Wnt signaling pathway,0.00022377557103137047,-0.7493873457076305,1
6822,Biological Process,GO:0006891,intra-Golgi vesicle-mediated transport,0.0002208655438287188,-0.7494440713326929,1
6823,Phenotype,HP:0011937,Hypoplastic fifth toenail,0.0001996491989875171,-0.7498576449314404,1
6824,Biological Process,GO:0014742,positive regulation of muscle hypertrophy,0.0001872876360111686,-0.7500986108529758,1
6824,Biological Process,GO:0010613,positive regulation of cardiac muscle hypertrophy,0.0001872876360111686,-0.7500986108529758,1
6826,Biological Process,GO:1901992,positive regulation of mitotic cell cycle phase transition,0.00018108422917473277,-0.750219534853271,1
6827,Phenotype,HP:0002442,Dyscalculia,0.0001747051067044758,-0.7503438841064822,1
6828,Phenotype,HP:0025268,Stuttering,0.00016785636505223245,-0.7504773877214174,1
6829,Biological Process,GO:0006613,cotranslational protein targeting to membrane,0.00016247405825287053,-0.7505823058875405,1
6830,Biological Process,GO:0061008,hepaticobiliary system development,0.00015772272099912055,-0.7506749244635301,1
6831,Phenotype,HP:0005659,Thoracic kyphoscoliosis,0.00013366695345073953,-0.7511438473826325,1
6832,Phenotype,HP:0002247,Duodenal atresia,0.00011747916383886281,-0.7514593985511142,1
6833,Phenotype,HP:0010881,Abnormality of the umbilical cord,0.00010586590095829074,-0.7516857777393612,1
6834,Biological Process,GO:0140013,meiotic nuclear division,0.00009452594867209729,-0.7519068292405378,1
6835,Phenotype,HP:0012675,Iron accumulation in brain,0.00009040783258840168,-0.7519871043351188,1
6836,Phenotype,HP:0000048,Bifid scrotum,0.00007614369039454782,-0.7522651575372286,1
6837,Disease,MONDO:0003996,basal ganglia disorder,-0.000001933606986526115,-0.7537871307658908,1
6838,Phenotype,HP:6000441,Abnormal circulating interleukin 6 concentration,-0.00003265287268261474,-0.7543859463187065,1
6838,Phenotype,HP:0030783,Increased circulating interleukin 6 concentration,-0.00003265287268261474,-0.7543859463187065,1
6840,Phenotype,HP:0010322,Abnormal fifth toe morphology,-0.00005831961182334311,-0.7548862721643692,1
6841,Biological Process,GO:0007602,phototransduction,-0.00006523911223443868,-0.7550211550910925,1
6842,Biological Process,GO:0030166,proteoglycan biosynthetic process,-0.00006631740890927773,-0.7550421745004049,1
6843,Biological Process,GO:0098810,neurotransmitter reuptake,-0.0001173992760610254,-0.7560379214957906,1
6844,Biological Process,GO:0099174,regulation of presynapse organization,-0.00015945023537677905,-0.7568576275622771,1
6845,Phenotype,HP:0001818,Paronychia,-0.000183815847484059,-0.7573325903308556,1
6846,Phenotype,HP:0008060,Aplasia/Hypoplasia of the fovea,-0.00019890116895227017,-0.7576266509117224,1
6846,Phenotype,HP:0007750,Hypoplasia of the fovea,-0.00019890116895227017,-0.7576266509117224,1
6848,Biological Process,GO:0044782,cilium organization,-0.00020926036142698834,-0.757828584305243,1
6849,Biological Process,GO:0034766,negative regulation of monoatomic ion transmembrane transport,-0.00026086990595808324,-0.758834617400067,1
6850,Biological Process,GO:0090140,regulation of mitochondrial fission,-0.0003223911201022389,-0.7600338602537893,1
6851,Phenotype,HP:0033098,Increased urinary non-proteinogenic amino acid level,-0.0003238284802948854,-0.7600618789456053,1
6852,Phenotype,HP:4000059,Abnormal lung development,-0.00036010025827271086,-0.7607689305071981,1
6853,Biological Process,GO:0035331,negative regulation of hippo signaling,-0.0004263699591755543,-0.7620607363717543,1
6854,Biological Process,GO:0090208,positive regulation of triglyceride metabolic process,-0.0004711482321877458,-0.7629336063997428,1
6855,Biological Process,GO:0050672,negative regulation of lymphocyte proliferation,-0.0004920549136846475,-0.7633411436814593,1
6856,Phenotype,HP:0025487,Abnormal bladder morphology,-0.0005286912911670605,-0.7640553024394302,1
6857,Biological Process,GO:0097696,cell surface receptor signaling pathway via STAT,-0.0005393739451748925,-0.7642635411202804,1
6858,Biological Process,GO:1903312,negative regulation of mRNA metabolic process,-0.0005565758936227905,-0.7645988614489381,1
6859,Biological Process,GO:0010894,negative regulation of steroid biosynthetic process,-0.0005781634268109404,-0.7650196706814204,1
6860,Phenotype,HP:0007371,Corpus callosum atrophy,-0.0005788707595948406,-0.765033458832355,1
6861,Biological Process,GO:1904063,negative regulation of cation transmembrane transport,-0.0005975626903564901,-0.7653978236242405,1
6862,Disease,MONDO:0019046,leukodystrophy,-0.0006279978545506992,-0.7659911011411022,1
6863,Biological Process,GO:0170033,L-amino acid metabolic process,-0.0006331170784934503,-0.7660908909910809,1
6864,Biological Process,GO:0044839,cell cycle G2/M phase transition,-0.0006334027100327599,-0.7660964588522988,1
6865,Biological Process,GO:0006672,ceramide metabolic process,-0.0006645270695304628,-0.7667031709632927,1
6866,Phenotype,HP:0011110,Recurrent tonsillitis,-0.0006692607623643987,-0.7667954455937885,1
6867,Phenotype,HP:0010663,Abnormal thalamus morphology,-0.0007107773327597044,-0.7676047347316941,1
6868,Biological Process,GO:0070914,UV-damage excision repair,-0.0007191735579201719,-0.7677684036898252,1
6869,Biological Process,GO:0030866,cortical actin cytoskeleton organization,-0.0007292426222906823,-0.7679646815698701,1
6870,Biological Process,GO:0000245,spliceosomal complex assembly,-0.000770774312995437,-0.7687742654503829,1
6871,Biological Process,GO:0045616,regulation of keratinocyte differentiation,-0.0007844027002912313,-0.7690399257807193,1
6872,Biological Process,GO:0000902,cell morphogenesis,-0.0008067905635107397,-0.7694763359743347,1
6873,Disease,MONDO:0015802,autosomal dominant non-syndromic intellectual disability,-0.0008235055321073048,-0.7698021635269681,1
6874,Phenotype,HP:0003554,Type 2 muscle fiber atrophy,-0.0008475011941850852,-0.7702699148005318,1
6875,Biological Process,GO:0035967,cellular response to topologically incorrect protein,-0.0008499896705000953,-0.7703184230668094,1
6876,Phenotype,HP:0010665,Bilateral coxa valga,-0.000850809753445203,-0.7703344090746453,1
6877,Biological Process,GO:0051095,regulation of helicase activity,-0.000882006772461752,-0.7709425375492455,1
6878,Biological Process,GO:0006633,fatty acid biosynthetic process,-0.0009196129587143442,-0.7716756009444752,1
6879,Biological Process,GO:0097581,lamellipodium organization,-0.0009938532474402795,-0.7731227787505606,1
6880,Biological Process,GO:0090329,regulation of DNA-templated DNA replication,-0.000997528019878624,-0.7731944116766504,1
6881,Biological Process,GO:0046426,negative regulation of receptor signaling pathway via JAK-STAT,-0.0010011887048790857,-0.7732657699940634,1
6882,Biological Process,GO:0007052,mitotic spindle organization,-0.0010557355503424404,-0.7743290603651172,1
6883,Phenotype,HP:0010550,Paraplegia,-0.0010772030264685206,-0.7747475293061125,1
6884,Phenotype,HP:0000774,Narrow chest,-0.0010822162529224855,-0.7748452529301119,1
6885,Phenotype,HP:0031526,Subretinal fluid,-0.0010894308898190541,-0.7749858889994868,1
6886,Phenotype,HP:0030191,Abnormal peripheral nervous system synaptic transmission,-0.0011017884623065743,-0.7752267771337862,1
6886,Phenotype,HP:0003398,Abnormal synaptic transmission at the neuromuscular junction,-0.0011017884623065743,-0.7752267771337862,1
6886,Phenotype,HP:0012535,Abnormal synaptic transmission,-0.0011017884623065743,-0.7752267771337862,1
6889,Biological Process,GO:0051983,regulation of chromosome segregation,-0.0011038044264966018,-0.77526607464574,1
6890,Biological Process,GO:0086004,regulation of cardiac muscle cell contraction,-0.001146044498185228,-0.7760894671099168,1
6891,Disease,MONDO:0100510,spondyloepimetaphyseal dysplasia,-0.0012170283622789935,-0.7774731669105185,1
6892,Phenotype,HP:0001406,Intrahepatic cholestasis,-0.0012369062718515789,-0.7778606501767947,1
6893,Biological Process,GO:0090169,regulation of spindle assembly,-0.0012660605003820269,-0.7784289582101668,1
6894,Biological Process,GO:0031577,spindle checkpoint signaling,-0.0013564434954154159,-0.7801908083686799,1
6895,Biological Process,GO:0010824,regulation of centrosome duplication,-0.0013896706903280265,-0.7808385113862897,1
6896,Biological Process,GO:0030308,negative regulation of cell growth,-0.0014330694875348549,-0.7816844910720688,1
6897,Phenotype,HP:0030289,Flattened femoral epiphysis,-0.0014653600005085643,-0.782313935199033,1
6898,Disease,MONDO:0015548,Huntington disease-like syndrome,-0.0014711854446021189,-0.7824274915112116,1
6899,Phenotype,HP:0011150,Myoclonic absence seizure,-0.0015136403754296701,-0.7832550722589015,1
6900,Phenotype,HP:0030506,Yellow/white lesions of the retina,-0.001521505237128018,-0.783408383264194,1
6901,Phenotype,HP:0001080,Biliary tract abnormality,-0.0015416029675741072,-0.7838001515338682,1
6902,Phenotype,HP:0010747,Medial flaring of the eyebrow,-0.0015689794857667305,-0.7843338063756821,1
6903,Phenotype,HP:0001810,Dystrophic toenail,-0.0015944317616336523,-0.7848299516544935,1
6904,Biological Process,GO:0010587,miRNA catabolic process,-0.0015945406678632423,-0.7848320745810219,1
6905,Phenotype,HP:0011008,Temporal pattern,-0.0016016294039038481,-0.7849702564449023,1
6906,Phenotype,HP:0001561,Polyhydramnios,-0.0016052785449025553,-0.7850413897332451,1
6907,Biological Process,GO:0070670,response to interleukin-4,-0.001606345935918796,-0.7850621965568126,1
6907,Biological Process,GO:0071353,cellular response to interleukin-4,-0.001606345935918796,-0.7850621965568126,1
6909,Phenotype,HP:0005558,Chronic leukemia,-0.001609917033575048,-0.7851318085338157,1
6910,Biological Process,GO:0007409,axonogenesis,-0.0016236766849979656,-0.7854000276167482,1
6911,Phenotype,HP:0034980,Synkinesis,-0.001690714041222341,-0.7867067975091001,1
6911,Phenotype,HP:0001335,Bimanual synkinesia,-0.001690714041222341,-0.7867067975091001,1
6913,Phenotype,HP:0000705,Amelogenesis imperfecta,-0.0016915871072245015,-0.7867238163241298,1
6914,Phenotype,HP:0000629,Periorbital fullness,-0.0016958392463528593,-0.7868067039513272,1
6915,Disease,MONDO:0019497,nonsyndromic genetic hearing loss,-0.0017176804573610926,-0.7872324581660748,1
6916,Phenotype,HP:0012473,Tongue atrophy,-0.0018503983888629172,-0.7898195500030697,1
6917,Biological Process,GO:0048667,cell morphogenesis involved in neuron differentiation,-0.0018688062519205406,-0.7901783774178283,1
6918,Biological Process,GO:0008380,RNA splicing,-0.0018803123110913145,-0.7904026668670371,1
6919,Phenotype,HP:0004339,Abnormal circulating sulfur amino acid concentration,-0.0019012781781078125,-0.7908113578615404,1
6920,Disease,MONDO:0018874,acute myeloid leukemia,-0.001923403800303758,-0.7912426561489974,1
6920,Disease,MONDO:0010643,acute leukemia,-0.001923403800303758,-0.7912426561489974,1
6922,Phenotype,HP:0031956,Elevated circulating aspartate aminotransferase concentration,-0.0019471905730095163,-0.7917063355086675,1
6923,Disease,MONDO:0005395,movement disorder,-0.0020006863241794903,-0.7927491367307755,1
6924,Disease,MONDO:0019716,overgrowth syndrome,-0.0020294618137608467,-0.7933100619453193,1
6925,Phenotype,HP:0011109,Chronic sinusitis,-0.002034784273216017,-0.7934138134976031,1
6926,Biological Process,GO:0030239,myofibril assembly,-0.0020435347665805903,-0.7935843882624218,1
6926,Biological Process,GO:0055002,striated muscle cell development,-0.0020435347665805903,-0.7935843882624218,1
6928,Biological Process,GO:0042130,negative regulation of T cell proliferation,-0.002067275270928315,-0.7940471657055987,1
6929,Biological Process,GO:0006883,intracellular sodium ion homeostasis,-0.0020751863813666116,-0.7942013782449662,1
6930,Phenotype,HP:0003038,Fibular hypoplasia,-0.002085488209630393,-0.7944021934287605,1
6931,Biological Process,GO:0000724,double-strand break repair via homologous recombination,-0.002112997164969377,-0.7949384298890219,1
6932,Phenotype,HP:0030349,Decreased circulating androgen concentration,-0.0021226389541522117,-0.7951263788255873,1
6933,Phenotype,HP:0005268,Miscarriage,-0.0021354708704739434,-0.795376513420011,1
6934,Phenotype,HP:0005263,Gastritis,-0.0021457958393937826,-0.79557777968831,1
6935,Biological Process,GO:0036152,phosphatidylethanolamine acyl-chain remodeling,-0.0021774201115116742,-0.7961942366758572,1
6936,Phenotype,HP:0430028,Hyperplasia of the maxilla,-0.0021911692271630034,-0.7964622503833113,1
6937,Disease,MONDO:0018800,Kallmann syndrome,-0.002204673877244545,-0.7967254986843667,1
6938,Biological Process,GO:0030968,endoplasmic reticulum unfolded protein response,-0.002210081472296954,-0.7968309097984456,1
6939,Disease,MONDO:0005180,Parkinson disease,-0.0022288953758757835,-0.7971976522259384,1
6940,Biological Process,GO:0051293,establishment of spindle localization,-0.002257916834644158,-0.7977633721571318,1
6941,Phenotype,HP:0046503,Increased libido,-0.00229399881662129,-0.7984667239949681,1
6941,Phenotype,HP:0030019,Increased female libido,-0.00229399881662129,-0.7984667239949681,1
6943,Biological Process,GO:0001558,regulation of cell growth,-0.0023731797206199,-0.8000102100036982,1
6944,Phenotype,HP:0004844,Coombs-positive hemolytic anemia,-0.00237650192257588,-0.8000749702170613,1
6945,Biological Process,GO:0032886,regulation of microtubule-based process,-0.002393411793239819,-0.8004045970268245,1
6946,Biological Process,GO:0098869,cellular oxidant detoxification,-0.0023953288352445146,-0.8004419662328195,1
6947,Biological Process,GO:0046902,regulation of mitochondrial membrane permeability,-0.002439717089859572,-0.8013072335698974,1
6948,Phenotype,HP:0008002,Abnormality of macular pigmentation,-0.0024649352766903387,-0.8017988157137375,1
6949,Biological Process,GO:1902904,negative regulation of supramolecular fiber organization,-0.0024994999681338115,-0.8024725907648536,1
6950,Phenotype,HP:0012437,Abnormal gallbladder morphology,-0.002510533327120479,-0.8026876657938721,1
6951,Phenotype,HP:0006827,Atrophy of the spinal cord,-0.002514113977863941,-0.80275746399073,1
6952,Phenotype,HP:0006986,Upper limb spasticity,-0.0025329299445839837,-0.803124246635364,1
6953,Biological Process,GO:0050913,sensory perception of bitter taste,-0.002545531940285839,-0.8033698993504206,1
6953,Biological Process,GO:0001580,detection of chemical stimulus involved in sensory perception of bitter taste,-0.002545531940285839,-0.8033698993504206,1
6955,Phenotype,HP:0012330,Pyelonephritis,-0.0025455496933048938,-0.8033702454128566,1
6956,Biological Process,GO:0034033,purine nucleoside bisphosphate biosynthetic process,-0.0025557011923909023,-0.8035681302059775,1
6956,Biological Process,GO:0033866,nucleoside bisphosphate biosynthetic process,-0.0025557011923909023,-0.8035681302059775,1
6956,Biological Process,GO:0034030,ribonucleoside bisphosphate biosynthetic process,-0.0025557011923909023,-0.8035681302059775,1
6959,Phenotype,HP:0025114,Hypergranulosis,-0.0025740857499096936,-0.8039265033221451,1
6960,Biological Process,GO:0010968,regulation of microtubule nucleation,-0.0026295751752805074,-0.8050081675538876,1
6961,Phenotype,HP:0010851,EEG with burst suppression,-0.0026661850028142364,-0.8057218087694681,1
6962,Phenotype,HP:0006673,Reduced systolic function,-0.0026725441227839486,-0.8058457681107414,1
6963,Phenotype,HP:0011715,Trifascicular block,-0.002709450832530935,-0.8065651964987242,1
6964,Phenotype,HP:0002527,Falls,-0.002751359555151822,-0.8073821299225991,1
6965,Disease,MONDO:0002816,adrenal cortex disorder,-0.002782200573991922,-0.807983318828898,1
6966,Phenotype,HP:0004927,Pulmonary artery dilatation,-0.0028027694037826567,-0.808384270313343,1
6967,Biological Process,GO:0061045,negative regulation of wound healing,-0.0028251041041631453,-0.8088196441952461,1
6968,Disease,MONDO:0020344,postsynaptic congenital myasthenic syndrome,-0.0028370134553488136,-0.8090517950801167,1
6969,Disease,MONDO:0001071,intellectual disability,-0.0029093311161949575,-0.8104614947938517,1
6970,Biological Process,GO:0001523,retinoid metabolic process,-0.002912819456219129,-0.8105294935631143,1
6971,Biological Process,GO:0032989,cellular anatomical entity morphogenesis,-0.0029323883106402437,-0.8109109523679594,1
6971,Biological Process,GO:0010927,cellular component assembly involved in morphogenesis,-0.0029323883106402437,-0.8109109523679594,1
6973,Phenotype,HP:0001355,Megalencephaly,-0.002946641330735078,-0.8111887887652164,1
6974,Phenotype,HP:0000659,Peters anomaly,-0.002972883372108548,-0.8117003290691915,1
6975,Phenotype,HP:0000695,Natal tooth,-0.0030093191921729545,-0.8124105783293795,1
6976,Biological Process,GO:0062013,positive regulation of small molecule metabolic process,-0.0030317851218637504,-0.8128485102851887,1
6977,Phenotype,HP:0002781,Upper airway obstruction,-0.0030331598823911676,-0.8128753087117319,1
6978,Phenotype,HP:0010465,Precocious puberty in females,-0.003078963343951857,-0.8137681629038434,1
6979,Disease,MONDO:0018778,intermediate Charcot-Marie-Tooth disease,-0.0031019142407600064,-0.8142155484011321,1
6980,Phenotype,HP:0100025,Overfriendliness,-0.003103096997714383,-0.8142386040713583,1
6981,Disease,MONDO:0100198,Mendelian encephalopathy,-0.0031162924998917596,-0.8144958261029394,1
6982,Phenotype,HP:0000467,Neck muscle weakness,-0.003123467449496875,-0.8146356885416031,1
6983,Biological Process,GO:0044827,modulation by host of viral genome replication,-0.0031301089725292996,-0.8147651528108842,1
6984,Phenotype,HP:0002896,Neoplasm of the liver,-0.003146911764303484,-0.8150926923147465,1
6985,Phenotype,HP:0002188,Delayed CNS myelination,-0.003177152535275951,-0.8156821804934875,1
6986,Phenotype,HP:0002478,Progressive spastic quadriplegia,-0.003203319146968253,-0.8161922504346397,1
6987,Phenotype,HP:0002684,Thickened calvaria,-0.003282571494202191,-0.8177371290977673,1
6988,Biological Process,GO:0045653,negative regulation of megakaryocyte differentiation,-0.003285445997496028,-0.8177931622496011,1
6989,Biological Process,GO:0072595,maintenance of protein localization in organelle,-0.003293086459782879,-0.8179420990013233,1
6990,Biological Process,GO:0046949,fatty-acyl-CoA biosynthetic process,-0.0033018493377570124,-0.8181129151813145,1
6991,Biological Process,GO:0097194,execution phase of apoptosis,-0.0033027436961603485,-0.8181303490525211,1
6992,Biological Process,GO:0042254,ribosome biogenesis,-0.003313498197683451,-0.8183399882684622,1
6993,Phenotype,HP:0040171,Decreased serum testosterone concentration,-0.0033515852775303223,-0.8190824257993354,1
6994,Phenotype,HP:0000150,Gonadoblastoma,-0.0033949949942477797,-0.8199286183408794,1
6995,Phenotype,HP:0000275,Narrow face,-0.0033966397883054,-0.8199606805741576,1
6996,Phenotype,HP:0030291,Lower-limb metaphyseal irregularity,-0.0034971232505456307,-0.8219194207532201,1
6997,Disease,MONDO:0019713,non-syndromic limb reduction defect,-0.003523454231465939,-0.8224326947699875,1
6998,Biological Process,GO:0050821,protein stabilization,-0.003525455603503147,-0.8224717078347757,1
6999,Phenotype,HP:0000444,Convex nasal ridge,-0.0035304795197146355,-0.8225696398359259,1
7000,Biological Process,GO:0032373,positive regulation of sterol transport,-0.0035722095386843122,-0.8233830897609845,1
7000,Biological Process,GO:0032376,positive regulation of cholesterol transport,-0.0035722095386843122,-0.8233830897609845,1
7002,Phenotype,HP:0002044,Zollinger-Ellison syndrome,-0.003581977117105284,-0.8235734907272606,1
7003,Phenotype,HP:0007513,Generalized hypopigmentation,-0.0036594629956510083,-0.8250839353341015,1
7004,Biological Process,GO:0006544,glycine metabolic process,-0.0036920753066254086,-0.8257196523208921,1
7005,Biological Process,GO:2000243,positive regulation of reproductive process,-0.0036944708069832632,-0.8257663481919865,1
7006,Biological Process,GO:0009165,nucleotide biosynthetic process,-0.0037894787832539745,-0.8276183538484789,1
7007,Phenotype,HP:0005338,Sparse lateral eyebrow,-0.003812204118778917,-0.8280613424436466,1
7008,Phenotype,HP:0001081,Cholelithiasis,-0.0038227609739893698,-0.8282671289084463,1
7009,Phenotype,HP:0000613,Photophobia,-0.0038368786557370083,-0.8285423271336847,1
7010,Phenotype,HP:0008422,Vertebral wedging,-0.0038446220007752885,-0.8286932693953134,1
7011,Biological Process,GO:0006743,ubiquinone metabolic process,-0.0038540600068788233,-0.8288772459557651,1
7012,Disease,MONDO:0024654,skull disorder,-0.003907447460952174,-0.829917936125271,1
7013,Phenotype,HP:0010751,Dimple chin,-0.003923947917264359,-0.8302395821556822,1
7014,Biological Process,GO:0042573,retinoic acid metabolic process,-0.003927742290245728,-0.8303135464742601,1
7015,Phenotype,HP:0000142,Abnormal vagina morphology,-0.003929680265145397,-0.8303513237285204,1
7016,Phenotype,HP:0004122,Midline defect of the nose,-0.003931634041981047,-0.8303894090124426,1
7017,Phenotype,HP:0000110,Renal dysplasia,-0.00394203520556613,-0.8305921605555213,1
7018,Phenotype,HP:0030891,Periventricular white matter hyperintensities,-0.003967978550989182,-0.8310978783316261,1
7019,Biological Process,GO:1903046,meiotic cell cycle process,-0.003970147974671434,-0.8311401672539731,1
7020,Phenotype,HP:0033151,Abnormal pharynx morphology,-0.003971444229229348,-0.8311654353511133,1
7021,Biological Process,GO:1904666,regulation of ubiquitin protein ligase activity,-0.003973654900856216,-0.831208528326233,1
7022,Biological Process,GO:0099601,regulation of neurotransmitter receptor activity,-0.003994416936716094,-0.8316132460074437,1
7023,Biological Process,GO:0033059,cellular pigmentation,-0.003998220297582344,-0.8316873855282972,1
7024,Disease,MONDO:0017763,disorder of iron metabolism and transport,-0.004012089881976877,-0.8319577475522044,1
7025,Phenotype,HP:0003402,Decreased miniature endplate potentials,-0.004034600952737,-0.8323965594500882,1
7026,Biological Process,GO:0032968,positive regulation of transcription elongation by RNA polymerase II,-0.004041543047761831,-0.8325318828172259,1
7027,Biological Process,GO:0035871,protein K11-linked deubiquitination,-0.004042969677449326,-0.8325596923375912,1
7028,Phenotype,HP:0200101,Decreased/absent ankle reflexes,-0.004050143710377263,-0.8326995369073202,1
7029,Phenotype,HP:0000495,Recurrent corneal erosions,-0.004095863673165834,-0.83359076344453,1
7030,Biological Process,GO:0046599,regulation of centriole replication,-0.004104791987521228,-0.8337648045023252,1
7031,Phenotype,HP:0007000,Morning myoclonic jerks,-0.004143964614393036,-0.8345284027747434,1
7032,Phenotype,HP:0002367,Visual hallucination,-0.0041499954640569214,-0.8346459630905124,1
7033,Phenotype,HP:0002521,Hypsarrhythmia,-0.004151180781835739,-0.8346690686792986,1
7034,Phenotype,HP:0012301,Type II transferrin isoform profile,-0.0041532811312201545,-0.8347100111253251,1
7035,Phenotype,HP:0000722,Compulsive behaviors,-0.004154122223539947,-0.8347264066722573,1
7036,Biological Process,GO:1902116,negative regulation of organelle assembly,-0.004159649035854862,-0.8348341417074762,1
7037,Biological Process,GO:0030148,sphingolipid biosynthetic process,-0.004172520822352865,-0.8350850534976141,1
7038,Biological Process,GO:0070979,protein K11-linked ubiquitination,-0.004237311305786529,-0.8363480247397772,1
7039,Biological Process,GO:0006869,lipid transport,-0.004237493177669638,-0.836351569997444,1
7040,Phenotype,HP:0011931,Abnormal cerebellar peduncle morphology,-0.0042478520319646496,-0.8365534967987736,1
7041,Disease,MONDO:0018134,disorder of melanin metabolism,-0.0043071429032481845,-0.8377092632228746,1
7042,Phenotype,HP:0006519,Alveolar cell carcinoma,-0.004335957405703583,-0.8382709489216033,1
7043,Disease,MONDO:0000090,progressive external ophthalmoplegia with mitochondrial DNA deletions,-0.004359452541615294,-0.8387289433586658,1
7043,Disease,MONDO:0005181,progressive external ophthalmoplegia,-0.004359452541615294,-0.8387289433586658,1
7045,Phenotype,HP:0011001,Increased bone mineral density,-0.004374919514121611,-0.8390304435241771,1
7046,Phenotype,HP:0000627,Posterior embryotoxon,-0.004379029086792663,-0.839110552080651,1
7046,Phenotype,HP:0008048,Abnormal line of Schwalbe morphology,-0.004379029086792663,-0.839110552080651,1
7048,Phenotype,HP:0008828,Delayed proximal femoral epiphyseal ossification,-0.004392576297761686,-0.8393746300278839,1
7049,Biological Process,GO:0010039,response to iron ion,-0.004435124959950354,-0.8402040378959672,1
7050,Biological Process,GO:0019216,regulation of lipid metabolic process,-0.004444220817265254,-0.8403813448954327,1
7051,Phenotype,HP:0004288,Pseudoepiphyses of hand bones,-0.004485590559726749,-0.8411877718929726,1
7052,Phenotype,HP:0011484,Posterior synechiae of the anterior chamber,-0.00451420136120384,-0.8417454868159951,1
7053,Phenotype,HP:0001978,Extramedullary hematopoiesis,-0.0045549235405564215,-0.8425392907624216,1
7054,Phenotype,HP:0000003,Multicystic kidney dysplasia,-0.004584962839144557,-0.843124851607795,1
7055,Biological Process,GO:0008088,axo-dendritic transport,-0.004660436541570556,-0.8445960725441415,1
7056,Biological Process,GO:0007202,activation of phospholipase C activity,-0.0046939467294333515,-0.8452492919885299,1
7057,Phenotype,HP:0200073,Respiratory insufficiency due to defective ciliary clearance,-0.004698147028751043,-0.8453311690940181,1
7058,Biological Process,GO:0051205,protein insertion into membrane,-0.004725473903277599,-0.84586385622392,1
7059,Biological Process,GO:1901797,negative regulation of signal transduction by p53 class mediator,-0.004743343169540726,-0.8462121846853367,1
7060,Biological Process,GO:0045103,intermediate filament-based process,-0.00477433372503544,-0.8468162885335284,1
7060,Biological Process,GO:0045104,intermediate filament cytoskeleton organization,-0.00477433372503544,-0.8468162885335284,1
7062,Phenotype,HP:0011422,Abnormal blood chloride concentration,-0.004799635270097857,-0.8473094955926924,1
7063,Phenotype,HP:0009792,Teratoma,-0.00480199865546882,-0.8473555654412178,1
7064,Biological Process,GO:0014015,positive regulation of gliogenesis,-0.004865314719281866,-0.8485897955862162,1
7065,Phenotype,HP:0008193,Primary gonadal insufficiency,-0.004933535667015931,-0.8499196374169142,1
7066,Biological Process,GO:1905063,regulation of vascular associated smooth muscle cell differentiation,-0.004944444675106352,-0.8501322884540505,1
7067,Biological Process,GO:0061025,membrane fusion,-0.005014914805838266,-0.8515059739681741,1
7068,Phenotype,HP:0003477,Peripheral axonal neuropathy,-0.00501590603182156,-0.8515252960945889,1
7069,Biological Process,GO:0086009,membrane repolarization,-0.00501984728452598,-0.8516021235630685,1
7070,Biological Process,GO:0090068,positive regulation of cell cycle process,-0.005037722552682755,-0.8519505690203567,1
7071,Biological Process,GO:1902992,negative regulation of amyloid precursor protein catabolic process,-0.005064756869294307,-0.852477553272093,1
7072,Phenotype,HP:0040030,Chorioretinal hypopigmentation,-0.005097514072931686,-0.8531160946747057,1
7073,Biological Process,GO:0006285,"base-excision repair, AP site formation",-0.005107267299927942,-0.8533062158863676,1
7074,Biological Process,GO:0032410,negative regulation of transporter activity,-0.005161853945698791,-0.8543702820911724,1
7075,Biological Process,GO:0140115,export across plasma membrane,-0.005176072124434716,-0.8546474393202552,1
7076,Disease,MONDO:0014769,inherited oocyte maturation defect,-0.005178621106378678,-0.8546971270324223,1
7077,Biological Process,GO:0006287,"base-excision repair, gap-filling",-0.005232194527646117,-0.8557414422901459,1
7078,Biological Process,GO:0060993,kidney morphogenesis,-0.0052329720630146515,-0.8557565989112758,1
7079,Phenotype,HP:0001849,Foot oligodactyly,-0.005247282046856316,-0.8560355457119482,1
7080,Biological Process,GO:0001570,vasculogenesis,-0.005261863904639119,-0.85631979219478,1
7081,Phenotype,HP:0000112,Nephropathy,-0.00526645458335806,-0.8564092790282896,1
7082,Phenotype,HP:0000269,Prominent occiput,-0.0053252021509990755,-0.8575544547477084,1
7083,Phenotype,HP:0005425,Recurrent sinopulmonary infections,-0.0053321191317630134,-0.8576892885585472,1
7084,Biological Process,GO:0018904,ether metabolic process,-0.005337496772503281,-0.8577941157684351,1
7085,Biological Process,GO:0010885,regulation of cholesterol storage,-0.005352437518423736,-0.8580853581150573,1
7086,Phenotype,HP:0002492,Abnormal corticospinal tract morphology,-0.0053788378149073335,-0.8585999833111712,1
7087,Biological Process,GO:0043574,peroxisomal transport,-0.005392505555503746,-0.8588664107616824,1
7087,Biological Process,GO:0015919,peroxisomal membrane transport,-0.005392505555503746,-0.8588664107616824,1
7089,Disease,MONDO:0700092,neurodevelopmental disorder,-0.0053955837421793,-0.858926414346209,1
7090,Phenotype,HP:5200269,Abnormal thought pattern,-0.005403115350352428,-0.8590732291873058,1
7091,Biological Process,GO:0034502,protein localization to chromosome,-0.0054104046464775735,-0.8592153206009483,1
7092,Phenotype,HP:0040082,Happy demeanor,-0.005435830683919063,-0.8597109544099419,1
7093,Phenotype,HP:0003419,Low back pain,-0.005489013167185419,-0.8607476490507684,1
7094,Phenotype,HP:0003473,Fatigable weakness,-0.005573675703090641,-0.8623979893858019,1
7095,Phenotype,HP:0031331,Abnormal cardiomyocyte morphology,-0.005600263753371637,-0.8629162744966773,1
7096,Biological Process,GO:0015748,organophosphate ester transport,-0.005629295472365126,-0.8634821944320777,1
7097,Phenotype,HP:0000336,Prominent supraorbital ridges,-0.00563347949774351,-0.8635637543070676,1
7098,Phenotype,HP:0010648,Dermal translucency,-0.005679153475314891,-0.8644540844470937,1
7099,Disease,MONDO:0017749,disorder of multiple glycosylation,-0.005731354199578265,-0.8654716415028646,1
7100,Phenotype,HP:0009794,Branchial anomaly,-0.005736154086645184,-0.8655652064681169,1
7101,Phenotype,HP:0001362,Calvarial skull defect,-0.005737528612336007,-0.8655920003169527,1
7102,Phenotype,HP:0012469,Infantile spasms,-0.0057484130221880925,-0.8658041718567002,1
7103,Phenotype,HP:0000602,Ophthalmoplegia,-0.005787123298295338,-0.8665587574518162,1
7104,Phenotype,HP:0003657,Vascular granular osmiophilic material deposition,-0.005797669337002542,-0.8667643330687905,1
7105,Phenotype,HP:0002524,Cataplexy,-0.005798754406930673,-0.8667854845102112,1
7106,Phenotype,HP:0003417,Coronal cleft vertebrae,-0.005808994921529864,-0.8669851044969484,1
7107,Biological Process,GO:0008210,estrogen metabolic process,-0.005822848738178177,-0.86725515915766,1
7108,Biological Process,GO:2000765,regulation of cytoplasmic translation,-0.005830572237491394,-0.8674057145634003,1
7109,Disease,MONDO:0019269,ichthyosis,-0.005837127333905734,-0.8675334941048108,1
7109,Disease,MONDO:0015947,inherited ichthyosis,-0.005837127333905734,-0.8675334941048108,1
7111,Phenotype,HP:0007058,Generalized cerebral atrophy/hypoplasia,-0.005871574070707153,-0.8682049698472492,1
7112,Biological Process,GO:0000725,recombinational repair,-0.005882685744342142,-0.8684215714762161,1
7113,Biological Process,GO:0007063,regulation of sister chromatid cohesion,-0.005892255826929427,-0.8686081226246614,1
7114,Phenotype,HP:0011971,Dermatographic urticaria,-0.005916847278651938,-0.8690874877209316,1
7115,Phenotype,HP:0007968,Remnants of the hyaloid vascular system,-0.005972660573241084,-0.8701754651870767,1
7116,Biological Process,GO:0006775,fat-soluble vitamin metabolic process,-0.0060016015373605125,-0.8707396160232213,1
7117,Biological Process,GO:0006997,nucleus organization,-0.006068305418762243,-0.8720398854375914,1
7118,Biological Process,GO:0045724,positive regulation of cilium assembly,-0.006090278175394648,-0.8724682038922019,1
7119,Phenotype,HP:0012206,Abnormal sperm motility,-0.006093714583131016,-0.8725351903370835,1
7119,Phenotype,HP:0034809,Abnormal sperm physiology,-0.006093714583131016,-0.8725351903370835,1
7121,Biological Process,GO:0046434,organophosphate catabolic process,-0.006109655599145558,-0.8728459311084167,1
7122,Phenotype,HP:0001233,2-3 finger syndactyly,-0.006123018444108341,-0.8731064151796424,1
7123,Disease,MONDO:0019171,familial long QT syndrome,-0.006123214371228425,-0.8731102344182884,1
7123,Disease,MONDO:0002442,long QT syndrome,-0.006123214371228425,-0.8731102344182884,1
7125,Phenotype,HP:0005930,Abnormal epiphysis morphology,-0.006127605827899618,-0.8731958377846007,1
7126,Biological Process,GO:0050994,regulation of lipid catabolic process,-0.006135584267401573,-0.87335136278016,1
7127,Phenotype,HP:0031605,Abnormality of fundus pigmentation,-0.006142326017298805,-0.8734827807877256,1
7128,Biological Process,GO:0046460,neutral lipid biosynthetic process,-0.006144573810835441,-0.8735265973861617,1
7128,Biological Process,GO:0046463,acylglycerol biosynthetic process,-0.006144573810835441,-0.8735265973861617,1
7130,Biological Process,GO:1905820,positive regulation of chromosome separation,-0.0061639155750903285,-0.8739036294861248,1
7131,Biological Process,GO:1903975,regulation of glial cell migration,-0.006188987929508505,-0.8743923688954534,1
7132,Biological Process,GO:0034976,response to endoplasmic reticulum stress,-0.0062239527694238905,-0.8750739441046457,1
7133,Disease,MONDO:0004860,vitreous disorder,-0.00624438765714852,-0.8754722846350025,1
7133,Disease,MONDO:0044137,vitreous body disorder,-0.00624438765714852,-0.8754722846350025,1
7135,Biological Process,GO:0035751,regulation of lysosomal lumen pH,-0.006251979099296534,-0.8756202658293287,1
7136,Phenotype,HP:0002576,Intussusception,-0.006264710720774946,-0.875868445360352,1
7137,Disease,MONDO:0016298,postlingual non-syndromic genetic hearing loss,-0.0062789769434428155,-0.876146539117474,1
7138,Biological Process,GO:0042147,"retrograde transport, endosome to Golgi",-0.006285714625402061,-0.8762778778280746,1
7139,Phenotype,HP:0011736,Primary hyperaldosteronism,-0.00628735185204321,-0.8763097925484948,1
7140,Phenotype,HP:0002475,Myelomeningocele,-0.0063203579959083545,-0.8769531865827291,1
7141,Biological Process,GO:0060324,face development,-0.006346583937314465,-0.8774644130474689,1
7142,Biological Process,GO:0045589,regulation of regulatory T cell differentiation,-0.0063523749256568784,-0.877577297708187,1
7143,Phenotype,HP:0006703,Aplasia/Hypoplasia of the lungs,-0.0063553338958657335,-0.8776349773870866,1
7144,Biological Process,GO:0002920,regulation of humoral immune response,-0.006384167077135627,-0.8781970271949296,1
7145,Phenotype,HP:0007334,Bilateral tonic-clonic seizure with focal onset,-0.006400633579275228,-0.8785180113512314,1
7146,Disease,MONDO:0019312,Hermansky-Pudlak syndrome,-0.0064259914827651254,-0.879012317014224,1
7147,Phenotype,HP:0031685,Abnormal stool composition,-0.006452380839243821,-0.879526728955075,1
7148,Phenotype,HP:0000996,Facial capillary hemangioma,-0.0064601409059110715,-0.879677997174088,1
7149,Phenotype,HP:0002381,Aphasia,-0.006464522744923151,-0.879763413061835,1
7150,Phenotype,HP:0002655,Spondyloepiphyseal dysplasia,-0.0064662345182344705,-0.8797967809324038,1
7151,Phenotype,HP:0008275,Abnormal light-adapted electroretinogram,-0.006475730487747411,-0.8799818873828531,1
7152,Phenotype,HP:0010948,Abnormal fetal cardiovascular morphology,-0.006488803373296603,-0.8802367192289162,1
7153,Phenotype,HP:0012695,Decreased thalamic volume,-0.006517577320995338,-0.8807976143872956,1
7153,Phenotype,HP:0012693,Abnormal thalamic size,-0.006517577320995338,-0.8807976143872956,1
7155,Phenotype,HP:0011753,Posterior pituitary dysgenesis,-0.006522263152940022,-0.8808889560578329,1
7156,Biological Process,GO:0043201,response to L-leucine,-0.00653546742701594,-0.8811463490814334,1
7156,Biological Process,GO:0071233,cellular response to L-leucine,-0.00653546742701594,-0.8811463490814334,1
7158,Phenotype,HP:0012736,Profound global developmental delay,-0.006568443375514654,-0.8817891545125669,1
7159,Phenotype,HP:0001714,Ventricular hypertrophy,-0.006641944875300787,-0.8832219309878465,1
7160,Phenotype,HP:0009049,Peroneal muscle atrophy,-0.0066527137150402815,-0.8834318497009299,1
7161,Biological Process,GO:0140895,cell surface toll-like receptor signaling pathway,-0.006663911839306369,-0.8836501365258572,1
7162,Biological Process,GO:1902930,regulation of alcohol biosynthetic process,-0.0066719138302338,-0.8838061206131151,1
7163,Phenotype,HP:0012592,Albuminuria,-0.006734508972009001,-0.8850262977096812,1
7164,Disease,MONDO:0001149,microcephaly,-0.006739149513679044,-0.8851167565296609,1
7165,Phenotype,HP:0005562,Multiple renal cysts,-0.0067526794474346286,-0.8853804976894127,1
7166,Phenotype,HP:0005556,Abnormality of the metopic suture,-0.006765055540341125,-0.8856217468451973,1
7167,Phenotype,HP:0001118,Juvenile cataract,-0.006807352175401737,-0.8864462419082186,1
7168,Biological Process,GO:0042476,odontogenesis,-0.0068359793621946,-0.8870042762328187,1
7169,Biological Process,GO:0070988,demethylation,-0.006836266943895497,-0.887009882108848,1
7170,Phenotype,HP:0001772,Talipes equinovalgus,-0.006868351542832274,-0.8876353123206009,1
7171,Phenotype,HP:0001245,Small thenar eminence,-0.006880753070088064,-0.8878770572722188,1
7172,Phenotype,HP:0010845,EEG with generalized slow activity,-0.006982242476175404,-0.8898554064753662,1
7173,Phenotype,HP:0003560,Muscular dystrophy,-0.007013902859563048,-0.8904725673856625,1
7174,Phenotype,HP:0007078,Decreased amplitude of sensory action potentials,-0.00702450174628555,-0.89067917317744,1
7175,Disease,MONDO:0003916,overnutrition,-0.0070786991848037495,-0.8917356525031033,1
7176,Phenotype,HP:0010627,Anterior pituitary hypoplasia,-0.007079222330957258,-0.8917458502746326,1
7177,Biological Process,GO:0034453,microtubule anchoring,-0.007082016453487716,-0.891800316551407,1
7178,Phenotype,HP:0030237,Hand muscle weakness,-0.007085638217442236,-0.8918709161746549,1
7179,Biological Process,GO:0060340,positive regulation of type I interferon-mediated signaling pathway,-0.007096530980625015,-0.8920832505472117,1
7180,Biological Process,GO:0120033,negative regulation of plasma membrane bounded cell projection assembly,-0.007107136655153168,-0.892289988654769,1
7181,Biological Process,GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,-0.00712788207091708,-0.8926943823577944,1
7182,Biological Process,GO:1902369,negative regulation of RNA catabolic process,-0.007138290283394966,-0.8928972713060664,1
7183,Phenotype,HP:0002415,Leukodystrophy,-0.007167213900830083,-0.893461084000523,1
7184,Phenotype,HP:0003301,Irregular vertebral endplates,-0.007184643479985153,-0.8938008415709138,1
7185,Phenotype,HP:0031065,Abnormal ovarian morphology,-0.007305227892050459,-0.8961514127755191,1
7186,Biological Process,GO:0046831,regulation of RNA export from nucleus,-0.0073275050763457195,-0.8965856654871861,1
7187,Biological Process,GO:0051151,negative regulation of smooth muscle cell differentiation,-0.007344896544272839,-0.8969246801493231,1
7188,Phenotype,HP:0000723,Restrictive behavior,-0.007350732343154309,-0.8970384383090363,1
7189,Phenotype,HP:0100720,Hypoplasia of the ear cartilage,-0.00740984901363162,-0.8981908090089976,1
7190,Biological Process,GO:1990573,potassium ion import across plasma membrane,-0.007475341314134187,-0.8994674608833818,1
7191,Biological Process,GO:0070131,positive regulation of mitochondrial translation,-0.0074972070860575,-0.89989369386797,1
7192,Phenotype,HP:0007204,Diffuse white matter abnormalities,-0.00752619875331928,-0.900458833068567,1
7193,Biological Process,GO:0042761,very long-chain fatty acid biosynthetic process,-0.007546865429615135,-0.9008616918905649,1
7194,Phenotype,HP:0000649,Abnormality of visual evoked potentials,-0.00763812424167809,-0.9026406144903244,1
7195,Biological Process,GO:0006413,translational initiation,-0.007647810450258641,-0.9028294293013044,1
7196,Phenotype,HP:0001840,Metatarsus adductus,-0.007684882886149547,-0.9035520882154809,1
7197,Phenotype,HP:0002870,Obstructive sleep apnea,-0.0076870182972830214,-0.903593714125782,1
7198,Phenotype,HP:0003448,Decreased sensory nerve conduction velocity,-0.007717111513787289,-0.9041803260017066,1
7199,Disease,MONDO:0044334,connective and soft tissue neoplasm,-0.00771727403812128,-0.9041834941145082,1
7200,Biological Process,GO:0090136,epithelial cell-cell adhesion,-0.007742638187794748,-0.9046779215353548,1
7201,Phenotype,HP:0034207,Abnormal fetal gastrointestinal system morphology,-0.007755692665328384,-0.9049323945510304,1
7202,Phenotype,HP:0003819,Death in childhood,-0.007771190253542892,-0.9052344915134315,1
7203,Phenotype,HP:0031162,Impaired oropharyngeal swallow response,-0.007780339686856763,-0.9054128428784023,1
7204,Biological Process,GO:0034063,stress granule assembly,-0.007853977581554261,-0.9068482781214746,1
7205,Phenotype,HP:0012721,Venous malformation,-0.00793125716400156,-0.9083547013655185,1
7206,Phenotype,HP:0031382,Decreased lymphocyte proliferation in response to anti-CD3,-0.00794727027033515,-0.9086668474049555,1
7207,Biological Process,GO:0045948,positive regulation of translational initiation,-0.007980615935196278,-0.9093168597761943,1
7208,Phenotype,HP:0033348,Epileptic aura,-0.00804185771595245,-0.9105106555902522,1
7209,Phenotype,HP:0000321,Square face,-0.008074987401907485,-0.9111564578501775,1
7210,Phenotype,HP:0003803,Type 1 muscle fiber predominance,-0.00808575135889833,-0.9113662813830615,1
7211,Phenotype,HP:0000329,Facial hemangioma,-0.008086897564269835,-0.9113886245474447,1
7212,Biological Process,GO:2000767,positive regulation of cytoplasmic translation,-0.008100092874145481,-0.9116458428304575,1
7213,Phenotype,HP:0003066,Limited knee extension,-0.008113299804629381,-0.911903287635843,1
7214,Biological Process,GO:0035561,regulation of chromatin binding,-0.00815324938252382,-0.912682031138643,1
7215,Phenotype,HP:0002714,Downturned corners of mouth,-0.008246155548527145,-0.9144930658718838,1
7216,Phenotype,HP:0002608,Celiac disease,-0.008275088546840559,-0.9150570614292994,1
7217,Phenotype,HP:0002231,Sparse body hair,-0.008288374500809992,-0.9153160466521104,1
7218,Biological Process,GO:0010838,positive regulation of keratinocyte proliferation,-0.008314099709106904,-0.9158175122463735,1
7219,Phenotype,HP:0002611,Cholestatic liver disease,-0.008330089408154828,-0.9161292020038524,1
7220,Phenotype,HP:0011364,White hair,-0.00834611254379225,-0.9164415435461108,1
7221,Phenotype,HP:0034261,Aplasia/Hypoplasia of facial bones,-0.008383720782798143,-0.9171746469559885,1
7222,Phenotype,HP:0010476,Aplasia/Hypoplasia of the bladder,-0.008421605488600381,-0.9179131395772857,1
7223,Disease,MONDO:0015362,"neuronopathy, distal hereditary motor, autosomal dominant",-0.008427214810978967,-0.9180224829943545,1
7224,Phenotype,HP:0001408,Bile duct proliferation,-0.008451507990282936,-0.9184960338187289,1
7225,Phenotype,HP:0006480,Premature loss of teeth,-0.008456701433642744,-0.9185972704396588,1
7226,Phenotype,HP:3000036,Abnormal head blood vessel morphology,-0.008527813125765116,-0.9199834620124393,1
7227,Phenotype,HP:0100678,Premature skin wrinkling,-0.00853328842149148,-0.920090192826569,1
7228,Biological Process,GO:1905818,regulation of chromosome separation,-0.00855791800858352,-0.9205703013016887,1
7229,Biological Process,GO:1902254,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,-0.008569148326289966,-0.9207892156784909,1
7230,Phenotype,HP:0007485,Absence of subcutaneous fat,-0.008581568312433285,-0.9210313204521516,1
7231,Phenotype,HP:0011961,Non-obstructive azoospermia,-0.008617277459297412,-0.9217274045555794,1
7232,Phenotype,HP:0007190,Neuronal loss in the cerebral cortex,-0.008619711188687651,-0.9217748456313082,1
7233,Phenotype,HP:0006557,Polycystic liver disease,-0.008626247635229456,-0.9219022616277744,1
7234,Disease,MONDO:0016297,prelingual non-syndromic genetic hearing loss,-0.00867112175873963,-0.9227770000848298,1
7235,Phenotype,HP:0003738,Exercise-induced myalgia,-0.008675891884896592,-0.9228699849159107,1
7236,Phenotype,HP:0012501,Abnormal brainstem white matter morphology,-0.0086826820791841,-0.9230023472577137,1
7237,Biological Process,GO:1900044,regulation of protein K63-linked ubiquitination,-0.008713784141151093,-0.9236086247193799,1
7238,Biological Process,GO:0000380,"alternative mRNA splicing, via spliceosome",-0.008724595868958795,-0.9238193794564271,1
7239,Phenotype,HP:0007902,Vitreous hemorrhage,-0.00876352133833258,-0.9245781598482593,1
7240,Biological Process,GO:0030901,midbrain development,-0.008802529272050608,-0.9253385477307253,1
7241,Biological Process,GO:0015867,ATP transport,-0.008823975001301054,-0.9257565927564004,1
7242,Phenotype,HP:0001540,Diastasis recti,-0.008848970948604817,-0.9262438427496437,1
7243,Phenotype,HP:0011712,Right bundle branch block,-0.008901557087348966,-0.9272689127514482,1
7244,Biological Process,GO:0045577,regulation of B cell differentiation,-0.008907395638161564,-0.9273827245549945,1
7245,Disease,MONDO:0003004,macular degeneration,-0.008911833520528267,-0.9274692329048047,1
7246,Phenotype,HP:0005576,Tubulointerstitial fibrosis,-0.008957900968966426,-0.9283672330352837,1
7247,Phenotype,HP:0002522,Areflexia of lower limbs,-0.00905314947350866,-0.930223927347791,1
7248,Phenotype,HP:0011098,Speech apraxia,-0.0091243979341189,-0.9316127849705507,1
7249,Phenotype,HP:5200297,Abnormal hypnopompia,-0.009130186268445195,-0.9317256178961087,1
7250,Phenotype,HP:0009879,Simplified gyral pattern,-0.009130557889881485,-0.9317328619721231,1
7251,Biological Process,GO:0015721,bile acid and bile salt transport,-0.009131301669940584,-0.9317473605956146,1
7252,Phenotype,HP:0002179,Opisthotonus,-0.009133166555681083,-0.9317837131112211,1
7253,Biological Process,GO:0099054,presynapse assembly,-0.0091393483226474,-0.9319042152820716,1
7253,Biological Process,GO:0099172,presynapse organization,-0.0091393483226474,-0.9319042152820716,1
7255,Phenotype,HP:0001138,Optic neuropathy,-0.00919198282342415,-0.9329302280127022,1
7256,Phenotype,HP:0008167,Very long chain fatty acid accumulation,-0.009201261526226467,-0.9331110992484587,1
7257,Phenotype,HP:0031964,Elevated circulating alanine aminotransferase concentration,-0.00923681752833505,-0.9338041980767057,1
7258,Phenotype,HP:0006543,Cardiorespiratory arrest,-0.009245809087687906,-0.9339794719793382,1
7259,Biological Process,GO:0007286,spermatid development,-0.009286188246006688,-0.9347665893619641,1
7259,Biological Process,GO:0048515,spermatid differentiation,-0.009286188246006688,-0.9347665893619641,1
7261,Biological Process,GO:0006301,postreplication repair,-0.00928798593307767,-0.9348016319631723,1
7262,Phenotype,HP:0030196,Fatigable weakness of respiratory muscles,-0.009317256173241306,-0.93537220142984,1
7263,Biological Process,GO:0072329,monocarboxylic acid catabolic process,-0.009331129295450324,-0.93564263241693,1
7264,Biological Process,GO:0170044,non-proteinogenic amino acid catabolic process,-0.009345884373437752,-0.935930255508878,1
7265,Phenotype,HP:0100819,Intestinal fistula,-0.00943486394288473,-0.9376647484682746,1
7266,Phenotype,HP:0010804,Tented upper lip vermilion,-0.009454500724955794,-0.9380475313976498,1
7267,Biological Process,GO:0007422,peripheral nervous system development,-0.009475105915348836,-0.9384491916651235,1
7268,Biological Process,GO:0006303,double-strand break repair via nonhomologous end joining,-0.009505165689635442,-0.9390351516465576,1
7269,Biological Process,GO:0070085,glycosylation,-0.009522335033945506,-0.9393698364175489,1
7270,Biological Process,GO:0008033,tRNA processing,-0.009524163343609393,-0.9394054759498518,1
7271,Biological Process,GO:0006518,peptide metabolic process,-0.009571239915074692,-0.94032314707668,1
7272,Biological Process,GO:0090110,COPII-coated vesicle cargo loading,-0.009584095462543907,-0.940573742316836,1
7273,Phenotype,HP:0002363,Abnormal brainstem morphology,-0.009592676793792165,-0.9407410195775022,1
7274,Biological Process,GO:0032042,mitochondrial DNA metabolic process,-0.009606462937542526,-0.9410097550796052,1
7275,Phenotype,HP:0012590,Abnormal urine output,-0.009633881463111393,-0.9415442287779138,1
7276,Biological Process,GO:0042178,xenobiotic catabolic process,-0.009639904933887111,-0.9416616452558373,1
7277,Phenotype,HP:0003380,Decreased number of peripheral myelinated nerve fibers,-0.00967039261252367,-0.9422559464451116,1
7278,Phenotype,HP:0025710,Late young adult onset,-0.00969692919391063,-0.9427732282646147,1
7279,Phenotype,HP:0100633,Esophagitis,-0.009713160637646379,-0.9430896303899057,1
7280,Biological Process,GO:0015868,purine ribonucleotide transport,-0.009764375663624758,-0.9440879730715676,1
7281,Biological Process,GO:0006516,glycoprotein catabolic process,-0.009765381710099552,-0.9441075840961903,1
7282,Biological Process,GO:0044772,mitotic cell cycle phase transition,-0.009766294460719749,-0.944125376489818,1
7283,Biological Process,GO:0051321,meiotic cell cycle,-0.00980512268132716,-0.9448822611959143,1
7284,Phenotype,HP:0012157,Subcortical cerebral atrophy,-0.009811673416491029,-0.9450099557227728,1
7285,Biological Process,GO:0008543,fibroblast growth factor receptor signaling pathway,-0.009819986530170466,-0.9451720045755293,1
7286,Phenotype,HP:0100803,Abnormality of the periungual region,-0.00984666191597916,-0.9456919921317957,1
7287,Phenotype,HP:0000558,Rieger anomaly,-0.009855939439704864,-0.9458728403836233,1
7288,Phenotype,HP:0002585,Abnormal peritoneum morphology,-0.009856177540878308,-0.9458774817278277,1
7289,Phenotype,HP:0000888,Horizontal ribs,-0.009862574184434258,-0.946002172522361,1
7290,Biological Process,GO:0042776,proton motive force-driven mitochondrial ATP synthesis,-0.00987616523796242,-0.9462671050996019,1
7291,Biological Process,GO:0051055,negative regulation of lipid biosynthetic process,-0.009981642063784824,-0.9483231817125314,1
7292,Biological Process,GO:0042403,thyroid hormone metabolic process,-0.009982537312673623,-0.9483406329421133,1
7293,Phenotype,HP:0012554,Absent thumbnail,-0.010001953195023727,-0.948719109837945,1
7294,Phenotype,HP:0003327,Axial muscle weakness,-0.010016077184584304,-0.9489944310223885,1
7295,Disease,MONDO:0005084,mental disorder,-0.010055314697836826,-0.9497592941353897,1
7295,Disease,MONDO:0005503,developmental disorder of mental health,-0.010055314697836826,-0.9497592941353897,1
7297,Disease,MONDO:0019701,chondrodysplasia punctata,-0.010152634649269077,-0.9516563674929839,1
7298,Disease,MONDO:0002350,familial nephrotic syndrome,-0.010185364779702555,-0.9522943811533088,1
7299,Biological Process,GO:0032239,regulation of nucleobase-containing compound transport,-0.010196310364416927,-0.9525077451844179,1
7300,Biological Process,GO:0046578,regulation of Ras protein signal transduction,-0.010199758309620499,-0.9525749565309904,1
7301,Phenotype,HP:0000056,Abnormal clitoris morphology,-0.010237560828755488,-0.9533118470744558,1
7302,Phenotype,HP:0004428,Elfin facies,-0.01025799553891149,-0.953710184143439,1
7303,Biological Process,GO:0044090,positive regulation of vacuole organization,-0.01030339182846296,-0.9545951012665397,1
7304,Phenotype,HP:0000690,Agenesis of maxillary lateral incisor,-0.010310614933247253,-0.9547359024018026,1
7305,Biological Process,GO:0001101,response to acid chemical,-0.010331752223039281,-0.9551479349678497,1
7306,Phenotype,HP:0005743,Avascular necrosis of the capital femoral epiphysis,-0.010342223414565366,-0.9553520515767675,1
7307,Phenotype,HP:0010310,Chylothorax,-0.010417256961972488,-0.9568146925010277,1
7308,Phenotype,HP:0002056,Abnormality of the glabella,-0.010438702358751328,-0.9572327310457808,1
7309,Phenotype,HP:0009107,Abnormal ossification involving the femoral head and neck,-0.010464848808238614,-0.9577424079618501,1
7310,Phenotype,HP:0030146,Abnormal liver parenchyma morphology,-0.010474406343797371,-0.9579287145290641,1
7311,Phenotype,HP:0002062,Abnormal pyramidal tract morphology,-0.0104771646437134,-0.9579824825098937,1
7312,Phenotype,HP:0040130,Abnormal circulating iron concentration,-0.010477222027462707,-0.9579836011004845,1
7313,Phenotype,HP:0025052,Abnormal brain N-acetyl aspartate level by MRS,-0.01048128737902676,-0.9580628476478565,1
7314,Biological Process,GO:1900151,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",-0.010506217819622465,-0.9585488207083767,1
7315,Biological Process,GO:0019748,secondary metabolic process,-0.010521479931111521,-0.9588463274853573,1
7316,Biological Process,GO:1900101,regulation of endoplasmic reticulum unfolded protein response,-0.010542054970131831,-0.9592474000073062,1
7317,Phenotype,HP:0011923,Decreased activity of mitochondrial complex I,-0.010571287101162063,-0.9598172266065496,1
7318,Biological Process,GO:0006637,acyl-CoA metabolic process,-0.010586033368878534,-0.9601046779584785,1
7318,Biological Process,GO:0035383,thioester metabolic process,-0.010586033368878534,-0.9601046779584785,1
7320,Phenotype,HP:0030329,Retinal thinning,-0.010604536676545706,-0.9604653658902558,1
7321,Phenotype,HP:0006712,Aplasia/Hypoplasia of the ribs,-0.010664175584196967,-0.9616279166428626,1
7322,Biological Process,GO:0006970,response to osmotic stress,-0.010741388019697595,-0.9631330309807501,1
7323,Biological Process,GO:0046618,xenobiotic export from cell,-0.010777833954850546,-0.9638434774159746,1
7324,Phenotype,HP:0002692,Hypoplastic facial bones,-0.01078464614604635,-0.9639762685470245,1
7325,Biological Process,GO:0006721,terpenoid metabolic process,-0.01080090471305617,-0.9642931993906291,1
7326,Biological Process,GO:0015740,C4-dicarboxylate transport,-0.010804859664771627,-0.964370293896119,1
7327,Phenotype,HP:0011499,Mydriasis,-0.010820221191736312,-0.9646697385948451,1
7328,Biological Process,GO:0043502,regulation of muscle adaptation,-0.010821416825750774,-0.9646930452796603,1
7329,Phenotype,HP:0032973,Abnormal bronchoalveolar lavage fluid morphology,-0.010856557813949008,-0.9653780541754653,1
7330,Disease,MONDO:0000015,classic complement early component deficiency,-0.010897939560995162,-0.9661847151802913,1
7331,Disease,MONDO:0043009,hereditary lethal multiple congenital anomalies/dysmorphic syndrome,-0.01094332509100382,-0.9670694225659053,1
7332,Phenotype,HP:0003021,Metaphyseal cupping,-0.01095299485018586,-0.9672579167261328,1
7333,Biological Process,GO:1901293,nucleoside phosphate biosynthetic process,-0.010980533902767764,-0.9677947398767576,1
7334,Phenotype,HP:0005978,Type II diabetes mellitus,-0.011022311056264389,-0.9686091086026786,1
7335,Phenotype,HP:0011026,Aplasia/Hypoplasia of the vagina,-0.011067082870919842,-0.9694818527368876,1
7336,Phenotype,HP:0004626,Lumbar scoliosis,-0.01115261277347357,-0.9711491007885397,1
7337,Disease,MONDO:0005089,sarcoma,-0.011170910493950359,-0.9715057811763775,1
7338,Phenotype,HP:0003555,Muscle fiber splitting,-0.01118473021031785,-0.9717751711148686,1
7339,Phenotype,HP:0002557,Hypoplastic nipples,-0.011201579232961167,-0.9721036118044468,1
7340,Phenotype,HP:0008450,Narrow vertebral interpedicular distance,-0.01121039437841631,-0.9722754468427937,1
7341,Biological Process,GO:0009065,glutamine family amino acid catabolic process,-0.011222823195029763,-0.972517723750219,1
7342,Biological Process,GO:0002183,cytoplasmic translational initiation,-0.011232908637720751,-0.972714320895481,1
7343,Phenotype,HP:0003071,Flattened epiphysis,-0.011260467783625216,-0.973251535728452,1
7344,Phenotype,HP:0032245,Abnormal metabolism,-0.01126848584464657,-0.9734078330726175,1
7345,Phenotype,HP:0002624,Abnormal venous morphology,-0.011274909269810784,-0.9735330459253182,1
7346,Phenotype,HP:0012463,Elevated transferrin saturation,-0.011292042694865723,-0.9738670305165321,1
7347,Phenotype,HP:0010547,Muscle flaccidity,-0.011325675834835902,-0.9745226466859882,1
7348,Disease,MONDO:0015129,chronic primary adrenal insufficiency,-0.011363600599118895,-0.975261920173649,1
7348,Disease,MONDO:0000004,adrenocortical insufficiency,-0.011363600599118895,-0.975261920173649,1
7348,Disease,MONDO:0015128,primary adrenal insufficiency,-0.011363600599118895,-0.975261920173649,1
7351,Disease,MONDO:0002331,nephrosis,-0.011373835951752786,-0.9754614395373722,1
7351,Disease,MONDO:0005377,nephrotic syndrome,-0.011373835951752786,-0.9754614395373722,1
7353,Biological Process,GO:0050931,pigment cell differentiation,-0.011415371182801781,-0.9762710924303807,1
7354,Biological Process,GO:0070169,positive regulation of biomineral tissue development,-0.011428524347762536,-0.9765274891758359,1
7355,Disease,MONDO:0002321,sensory peripheral neuropathy,-0.011472115651238957,-0.9773772214170762,1
7355,Disease,MONDO:0015364,hereditary sensory and autonomic neuropathy,-0.011472115651238957,-0.9773772214170762,1
7357,Phenotype,HP:0002168,Scanning speech,-0.011510594071388214,-0.9781272874069702,1
7358,Biological Process,GO:0043043,peptide biosynthetic process,-0.011608012764892095,-0.9800262855595381,1
7359,Biological Process,GO:0007417,central nervous system development,-0.01164528666913478,-0.9807528717284753,1
7360,Phenotype,HP:0002561,Absent nipple,-0.01165328399758181,-0.9809087649292579,1
7361,Biological Process,GO:2001251,negative regulation of chromosome organization,-0.01175507130814002,-0.9828929212318386,1
7362,Phenotype,HP:0010996,Abnormal circulating monocarboxylic acid concentration,-0.011764130852506716,-0.9830695203772046,1
7363,Phenotype,HP:0040080,Anteverted ears,-0.01177872349024578,-0.9833539769954457,1
7364,Biological Process,GO:0046485,ether lipid metabolic process,-0.01180563339570706,-0.9838785360807583,1
7364,Biological Process,GO:0006662,glycerol ether metabolic process,-0.01180563339570706,-0.9838785360807583,1
7366,Phenotype,HP:0002057,Prominent glabella,-0.01181150474557624,-0.9839929872415533,1
7367,Biological Process,GO:0061756,leukocyte adhesion to vascular endothelial cell,-0.011813716118464379,-0.984036093886471,1
7368,Biological Process,GO:0090370,negative regulation of cholesterol efflux,-0.011819110084041684,-0.9841412393190148,1
7369,Biological Process,GO:1901836,regulation of transcription of nucleolar large rRNA by RNA polymerase I,-0.011844620353708146,-0.9846385150802237,1
7370,Biological Process,GO:0045933,positive regulation of muscle contraction,-0.011852972888185542,-0.9848013323688912,1
7371,Biological Process,GO:0009100,glycoprotein metabolic process,-0.011959130183978317,-0.9868706734916405,1
7372,Phenotype,HP:0001821,Broad nail,-0.011969875875893266,-0.9870801409804827,1
7373,Disease,MONDO:0002279,iron metabolism disease,-0.01197365813040041,-0.987153869071707,1
7374,Phenotype,HP:0005257,Thoracic hypoplasia,-0.011986476131967905,-0.9874037324236038,1
7375,Phenotype,HP:0002153,Hyperkalemia,-0.012050510975132545,-0.988651973849309,1
7376,Phenotype,HP:0009085,Alveolar ridge overgrowth,-0.012070511051734956,-0.9890418385370107,1
7377,Phenotype,HP:0031879,Abnormal eyelid physiology,-0.012089343449567025,-0.9894089414759358,1
7377,Phenotype,HP:0032040,Abnormal ocular adnexa physiology,-0.012089343449567025,-0.9894089414759358,1
7379,Biological Process,GO:0061512,protein localization to cilium,-0.012106167326562334,-0.9897368919973811,1
7380,Phenotype,HP:0011031,Abnormality of iron homeostasis,-0.012179421812972713,-0.9911648534014733,1
7381,Biological Process,GO:0022613,ribonucleoprotein complex biogenesis,-0.012182766624889041,-0.9912300543544048,1
7382,Phenotype,HP:0002322,Resting tremor,-0.012199861759214281,-0.9915632925383088,1
7383,Phenotype,HP:0000773,Short ribs,-0.012222384691823684,-0.9920023356611152,1
7384,Phenotype,HP:0006392,Increased density of long bones,-0.012258525894209171,-0.9927068418918304,1
7385,Biological Process,GO:1905064,negative regulation of vascular associated smooth muscle cell differentiation,-0.012267002541405336,-0.9928720785295487,1
7386,Biological Process,GO:0032703,negative regulation of interleukin-2 production,-0.012294009736241396,-0.9933985340921834,1
7387,Disease,MONDO:0011348,non-syndromic polydactyly,-0.012307359324365219,-0.9936587597457297,1
7388,Biological Process,GO:0034142,toll-like receptor 4 signaling pathway,-0.012357407885345228,-0.994634364338866,1
7389,Biological Process,GO:0036503,ERAD pathway,-0.012422933974830075,-0.9959116748672787,1
7390,Phenotype,HP:0005106,Abnormality of the vertebral endplates,-0.012439977003395608,-0.9962438973452862,1
7391,Phenotype,HP:0000068,Urethral atresia,-0.012452804433141784,-0.9964939444821759,1
7392,Phenotype,HP:0003375,Narrow greater sciatic notch,-0.01248083173432879,-0.997040285140845,1
7393,Phenotype,HP:0005938,Abnormal respiratory motile cilium morphology,-0.0124912121998757,-0.9972426332137597,1
7393,Phenotype,HP:0012253,Abnormal respiratory epithelium morphology,-0.0124912121998757,-0.9972426332137597,1
7395,Phenotype,HP:0003370,Flat capital femoral epiphysis,-0.01249302545988873,-0.9972779793808146,1
7396,Phenotype,HP:0410134,Physical urticaria,-0.012496541140939232,-0.9973465111130705,1
7397,Biological Process,GO:0140694,non-membrane-bounded organelle assembly,-0.012546059813796973,-0.9983117865124036,1
7398,Biological Process,GO:0042984,regulation of amyloid precursor protein biosynthetic process,-0.012563194861955562,-0.9986458027430362,1
7399,Biological Process,GO:0090657,telomeric loop disassembly,-0.01257069931936039,-0.99879208832987,1
7400,Biological Process,GO:0006400,tRNA modification,-0.012592435479962028,-0.9992157947802627,1
7401,Phenotype,HP:0100704,Cerebral visual impairment,-0.012603224152391235,-0.9994261000951344,1
7402,Biological Process,GO:0006606,protein import into nucleus,-0.012717559775122123,-1.0016548626511628,1
7403,Disease,MONDO:0005554,rheumatic disorder,-0.012726279776234195,-1.0018248430256333,1
7404,Phenotype,HP:0030192,Fatigable weakness of bulbar muscles,-0.01273092599641057,-1.001915412537644,1
7405,Phenotype,HP:0005912,Biliary atresia,-0.012747047533012479,-1.00222967222562,1
7406,Phenotype,HP:0005948,Multiple pulmonary cysts,-0.012750196251182011,-1.0022910506918246,1
7407,Phenotype,HP:0008398,Hypoplastic fifth fingernail,-0.012751185596547643,-1.0023103361590588,1
7408,Biological Process,GO:0043171,peptide catabolic process,-0.01276374773899236,-1.0025552120082084,1
7409,Biological Process,GO:0035459,vesicle cargo loading,-0.012805047228517719,-1.0033602695540431,1
7410,Phenotype,HP:0011153,Focal motor seizure,-0.012823997445268187,-1.0037296691559632,1
7411,Biological Process,GO:0032897,negative regulation of viral transcription,-0.012845776812755894,-1.0041542178450873,1
7412,Biological Process,GO:0051284,positive regulation of sequestering of calcium ion,-0.012865885020319823,-1.0045461903468929,1
7413,Disease,MONDO:0042973,familial osteosclerosis,-0.012879339055847927,-1.0048084520103737,1
7413,Disease,MONDO:0002933,osteosclerosis,-0.012879339055847927,-1.0048084520103737,1
7415,Biological Process,GO:0090317,negative regulation of intracellular protein transport,-0.012906827076495375,-1.0053442803873491,1
7416,Biological Process,GO:0048232,male gamete generation,-0.012970270766855307,-1.0065809983770109,1
7417,Biological Process,GO:0002756,MyD88-independent toll-like receptor signaling pathway,-0.012986562570417304,-1.006898577106036,1
7418,Disease,MONDO:0020066,Ehlers-Danlos syndrome,-0.013048312663257677,-1.0081022815287408,1
7419,Phenotype,HP:0003208,Fingerprint intracellular accumulation of autofluorescent lipopigment storage material,-0.013112919206277773,-1.0093616671910426,1
7419,Disease,MONDO:0016295,neuronal ceroid lipofuscinosis,-0.013112919206277773,-1.0093616671910426,1
7421,Phenotype,HP:0002982,Tibial bowing,-0.01312992354309217,-1.0096931354445653,1
7422,Biological Process,GO:0035269,protein O-linked mannosylation,-0.01313193811408353,-1.009732405798675,1
7422,Biological Process,GO:0035268,protein mannosylation,-0.01313193811408353,-1.009732405798675,1
7424,Biological Process,GO:0006458,'de novo' protein folding,-0.013132501726742518,-1.009743392390259,1
7425,Phenotype,HP:0007366,Atrophy/Degeneration affecting the brainstem,-0.013152337079993526,-1.0101300460993616,1
7426,Biological Process,GO:0050879,multicellular organismal movement,-0.013201520604704475,-1.011088788402338,1
7426,Biological Process,GO:0050881,musculoskeletal movement,-0.013201520604704475,-1.011088788402338,1
7428,Phenotype,HP:0002898,Embryonal neoplasm,-0.013259942146797599,-1.0122276088536777,1
7429,Biological Process,GO:0001889,liver development,-0.01327563832393075,-1.0125335769415893,1
7430,Biological Process,GO:0006809,nitric oxide biosynthetic process,-0.013285504915836244,-1.012725907993534,1
7431,Phenotype,HP:0003351,Decreased circulating renin level,-0.013308170068927927,-1.0131677234429175,1
7432,Phenotype,HP:0001285,Spastic tetraparesis,-0.013310933130373126,-1.013221584240996,1
7433,Phenotype,HP:0006934,Congenital nystagmus,-0.013321723581142031,-1.0134319242213274,1
7434,Phenotype,HP:0005550,Chronic lymphatic leukemia,-0.013361666695917318,-1.0142105417375133,1
7435,Phenotype,HP:0001195,Single umbilical artery,-0.01343980891762242,-1.0157337805463937,1
7435,Phenotype,HP:0011403,Abnormal umbilical cord blood vessel morphology,-0.01343980891762242,-1.0157337805463937,1
7437,Biological Process,GO:0014743,regulation of muscle hypertrophy,-0.013440231165722016,-1.0157420114960423,1
7437,Biological Process,GO:0010611,regulation of cardiac muscle hypertrophy,-0.013440231165722016,-1.0157420114960423,1
7439,Biological Process,GO:0010875,positive regulation of cholesterol efflux,-0.013441432324781122,-1.0157654258814353,1
7440,Phenotype,HP:0012262,Abnormal ciliary motility,-0.013469589618086752,-1.0163143004972355,1
7441,Phenotype,HP:0012265,Ciliary dyskinesia,-0.013471493003651913,-1.0163514034960734,1
7442,Phenotype,HP:0004930,Abnormality of the pulmonary vasculature,-0.013500523323897395,-1.0169172961654556,1
7443,Disease,MONDO:0016139,qualitative or quantitative protein defects in neuromuscular diseases,-0.013518238992265674,-1.0172626305185746,1
7444,Phenotype,HP:0030760,Renal fibrosis,-0.013518439286347883,-1.017266534883111,1
7445,Phenotype,HP:0000791,Uric acid nephrolithiasis,-0.013552010562380312,-1.0179209451289473,1
7446,Biological Process,GO:0048284,organelle fusion,-0.01355548642381521,-1.017988700651076,1
7447,Disease,MONDO:0001411,synostosis,-0.013587402272650317,-1.0186108413901436,1
7448,Biological Process,GO:2000279,negative regulation of DNA biosynthetic process,-0.01363469097558001,-1.0195326476294897,1
7449,Phenotype,HP:0030846,Abnormality of venous physiology,-0.013675475242748814,-1.0203276618636345,1
7450,Biological Process,GO:1900426,positive regulation of defense response to bacterium,-0.01370991256252907,-1.020998954038575,1
7451,Phenotype,HP:0012230,Rhegmatogenous retinal detachment,-0.013717850174893353,-1.021153683184219,1
7452,Biological Process,GO:0031163,metallo-sulfur cluster assembly,-0.013751573471100231,-1.021811056783597,1
7452,Biological Process,GO:0016226,iron-sulfur cluster assembly,-0.013751573471100231,-1.021811056783597,1
7454,Phenotype,HP:0000640,Gaze-evoked nystagmus,-0.013754868377904295,-1.021875284928204,1
7455,Phenotype,HP:0005474,Decreased calvarial ossification,-0.013769199333631743,-1.0221546405371957,1
7456,Disease,MONDO:0017755,inborn disorder of bilirubin metabolism,-0.013800112379473317,-1.022757233477339,1
7456,Disease,MONDO:0024431,bilirubin metabolism disease,-0.013800112379473317,-1.022757233477339,1
7458,Biological Process,GO:0034763,negative regulation of transmembrane transport,-0.01380140801498575,-1.0227824895073268,1
7459,Biological Process,GO:0071229,cellular response to acid chemical,-0.01381719345453214,-1.0230901976017168,1
7460,Phenotype,HP:0008197,Absence of pubertal development,-0.013820281933786704,-1.0231504018211302,1
7461,Phenotype,HP:0025539,Abnormal B cell subset distribution,-0.013827594071402327,-1.0232929384875948,1
7462,Phenotype,HP:0000561,Absent eyelashes,-0.013862769582625445,-1.023978620346238,1
7463,Disease,MONDO:0000167,Huntington disease and related disorders,-0.013869920731521379,-1.024118018833876,1
7464,Biological Process,GO:0045922,negative regulation of fatty acid metabolic process,-0.014014110052808615,-1.0269287243042136,1
7465,Biological Process,GO:0006790,sulfur compound metabolic process,-0.014041014260354201,-1.0274531723191453,1
7466,Phenotype,HP:0034200,Abnormal CSF homovanillic acid concentration,-0.01408233128527403,-1.0282585716852253,1
7467,Phenotype,HP:0012261,Abnormal respiratory motile cilium physiology,-0.014101099578126997,-1.0286244250155538,1
7468,Biological Process,GO:0032413,negative regulation of ion transmembrane transporter activity,-0.014106526572634115,-1.028730214286302,1
7469,Phenotype,HP:0011718,Abnormality of the pulmonary veins,-0.014126657108434415,-1.0291226220359855,1
7469,Phenotype,HP:0030968,Abnormal pulmonary vein morphology,-0.014126657108434415,-1.0291226220359855,1
7471,Biological Process,GO:2001057,reactive nitrogen species metabolic process,-0.014128344420014871,-1.0291555130701273,1
7472,Phenotype,HP:0100281,Chronic colitis,-0.014135313697874574,-1.029291366316607,1
7472,Phenotype,HP:0100279,Ulcerative colitis,-0.014135313697874574,-1.029291366316607,1
7474,Phenotype,HP:0008058,Aplasia/Hypoplasia of the optic nerve,-0.014162622128548463,-1.0298236939175431,1
7475,Biological Process,GO:0062125,regulation of mitochondrial gene expression,-0.0141674188095815,-1.0299171963870648,1
7476,Phenotype,HP:0040288,Nasogastric tube feeding,-0.01420371998988279,-1.030624821092845,1
7477,Phenotype,HP:0012598,Abnormal urine potassium concentration,-0.014206781349764608,-1.0306844966699937,1
7478,Phenotype,HP:0011534,Abnormal spatial orientation of the cardiac segments,-0.01425831857927995,-1.0316891201166651,1
7479,Phenotype,HP:0001136,Retinal arteriolar tortuosity,-0.01426057909784273,-1.0317331847660685,1
7480,Phenotype,HP:0002131,Episodic ataxia,-0.01427955915530621,-1.0321031660577735,1
7481,Phenotype,HP:0002788,Recurrent upper respiratory tract infections,-0.014289055892066749,-1.0322882874643027,1
7482,Biological Process,GO:0009636,response to toxic substance,-0.014309505587349225,-1.0326869166407497,1
7483,Phenotype,HP:0410018,Recurrent ear infections,-0.01435730249131395,-1.0336186293240437,1
7484,Disease,MONDO:0015452,Coffin-Siris syndrome,-0.014378387573753537,-1.0340296442038308,1
7485,Phenotype,HP:0006089,Palmar hyperhidrosis,-0.014399579276136665,-1.034442737443207,1
7486,Biological Process,GO:0030575,nuclear body organization,-0.014445998054816167,-1.0353475861101964,1
7487,Biological Process,GO:0030705,cytoskeleton-dependent intracellular transport,-0.014448479414864712,-1.0353959556579553,1
7488,Phenotype,HP:0007704,Paroxysmal involuntary eye movements,-0.014458973527132102,-1.0356005190645445,1
7489,Disease,MONDO:0044765,steroid-resistant nephrotic syndrome,-0.014465569189528349,-1.0357290893651196,1
7490,Biological Process,GO:1901976,regulation of cell cycle checkpoint,-0.014483091126655134,-1.0360706472842047,1
7491,Biological Process,GO:0009084,glutamine family amino acid biosynthetic process,-0.014483232148273073,-1.0360733962411277,1
7492,Biological Process,GO:0030278,regulation of ossification,-0.014496796492350805,-1.0363378081667853,1
7493,Phenotype,HP:0004976,Knee dislocation,-0.014504111679654041,-1.0364804042812978,1
7494,Phenotype,HP:0010321,Abnormal fourth toe morphology,-0.014542661970314619,-1.0372318712545483,1
7495,Biological Process,GO:0006270,DNA replication initiation,-0.014607062711915919,-1.0384872451969223,1
7496,Disease,MONDO:0017265,autosomal recessive congenital ichthyosis,-0.014610877131514766,-1.0385616002874165,1
7497,Phenotype,HP:0040163,Abnormal pelvis bone morphology,-0.01465547386656696,-1.039430931566955,1
7498,Biological Process,GO:0071826,protein-RNA complex organization,-0.014705486669392975,-1.0404058391206839,1
7499,Disease,MONDO:0018170,idiopathic nephrotic syndrome,-0.014709940747935635,-1.040492663185139,1
7499,Disease,MONDO:0019006,familial idiopathic steroid-resistant nephrotic syndrome,-0.014709940747935635,-1.040492663185139,1
7501,Phenotype,HP:0007325,Generalized dystonia,-0.014718345941078903,-1.040656506957591,1
7502,Disease,MONDO:0002145,disorder of sexual differentiation,-0.014726143614423703,-1.0408085082495764,1
7503,Biological Process,GO:0007283,spermatogenesis,-0.014740235587919592,-1.0410832053397572,1
7504,Phenotype,HP:0001022,Albinism,-0.014749909452286492,-1.0412717795230089,1
7505,Phenotype,HP:0009487,Ulnar deviation of the hand,-0.014769522918181899,-1.0416541079464479,1
7506,Biological Process,GO:0000729,DNA double-strand break processing,-0.014834615723124722,-1.042922972390077,1
7507,Phenotype,HP:0030010,Hydrometrocolpos,-0.014845355184755382,-1.0431323184309924,1
7508,Phenotype,HP:0009799,Supernumerary spleens,-0.014849437526513132,-1.043211896170924,1
7509,Phenotype,HP:0034317,Unusual viral infection,-0.014859209818346208,-1.043402389016495,1
7509,Phenotype,HP:0034318,Unusual virus reactivation,-0.014859209818346208,-1.043402389016495,1
7511,Phenotype,HP:0034444,Abnormal gamma-glutamyltransferase level,-0.014910981852663374,-1.0444115895506725,1
7512,Phenotype,HP:0100267,Lip pit,-0.014912509854798639,-1.0444413751403536,1
7513,Phenotype,HP:0033685,Fiber type grouping,-0.014956342129662792,-1.0452958046753438,1
7514,Phenotype,HP:0020221,Clonic seizure,-0.014957890735568968,-1.0453259918976223,1
7515,Biological Process,GO:1903170,negative regulation of calcium ion transmembrane transport,-0.015044975202046729,-1.0470235433121466,1
7516,Biological Process,GO:0097202,activation of cysteine-type endopeptidase activity,-0.015064564765077337,-1.0474054057932245,1
7517,Phenotype,HP:0002868,Narrow iliac wing,-0.015075583134946058,-1.0476201886369727,1
7518,Phenotype,HP:5200300,Abnormal movement during sleep,-0.015102149827376898,-1.0481380574158636,1
7519,Phenotype,HP:0002979,Bowing of the legs,-0.015150361227771691,-1.0490778499442739,1
7520,Phenotype,HP:0012704,Widened subarachnoid space,-0.015183475304439753,-1.0497233479298749,1
7521,Phenotype,HP:5200018,Steroetypic upper-extremity movements,-0.015185529350734361,-1.049763387782376,1
7522,Phenotype,HP:0004425,Flat forehead,-0.015238240255370572,-1.0507908898656426,1
7523,Phenotype,HP:0011932,Abnormal superior cerebellar peduncle morphology,-0.015241584750654846,-1.0508560846464148,1
7524,Phenotype,HP:0005772,Aplasia/Hypoplasia of the tibia,-0.015250570547970854,-1.0510312462287428,1
7525,Phenotype,HP:0010584,Pseudoepiphyses,-0.015259194957994104,-1.0511993632308505,1
7526,Biological Process,GO:0031115,negative regulation of microtubule polymerization,-0.015261612274833025,-1.051246484374095,1
7527,Biological Process,GO:0048753,pigment granule organization,-0.015320114052074896,-1.0523868688620046,1
7527,Biological Process,GO:0032438,melanosome organization,-0.015320114052074896,-1.0523868688620046,1
7529,Disease,MONDO:0015498,oromandibular-limb anomalies syndrome,-0.015324913020722253,-1.0524804159243577,1
7529,Disease,MONDO:0015375,orofaciodigital syndrome,-0.015324913020722253,-1.0524804159243577,1
7531,Disease,MONDO:0017436,lethal congenital contracture syndrome,-0.015338924565521106,-1.052753545205101,1
7532,Phenotype,HP:0005195,Polyarticular arthropathy,-0.015375923757945609,-1.0534747763726882,1
7533,Biological Process,GO:0031124,mRNA 3'-end processing,-0.015413323846700244,-1.0542038222764714,1
7534,Biological Process,GO:0070129,regulation of mitochondrial translation,-0.015443841688093762,-1.054798711433185,1
7535,Phenotype,HP:0001788,Premature rupture of membranes,-0.015452306505627789,-1.0549637174734097,1
7536,Phenotype,HP:0031457,Pulmonary opacity,-0.015532934765030149,-1.0565354170122023,1
7537,Phenotype,HP:0005349,Hypoplasia of the epiglottis,-0.01554043270356087,-1.056681575525582,1
7538,Phenotype,HP:0008499,High hypermetropia,-0.015555966650000919,-1.0569843812246809,1
7539,Phenotype,HP:0009917,Persistent pupillary membrane,-0.01556259093644341,-1.0571135094983615,1
7540,Biological Process,GO:0006475,internal protein amino acid acetylation,-0.015579478630098897,-1.0574427040081567,1
7541,Phenotype,HP:0031865,Abnormal liver physiology,-0.015610452280647724,-1.058046478325538,1
7542,Phenotype,HP:0007333,Hypoplasia of the frontal lobes,-0.01564626963164728,-1.0587446716694606,1
7543,Disease,MONDO:0002118,urinary system disorder,-0.015692249557611726,-1.05964096571038,1
7544,Biological Process,GO:0016556,mRNA modification,-0.015746389607655065,-1.0606963263533367,1
7545,Phenotype,HP:0000455,Broad nasal tip,-0.01577064873258549,-1.0611692133503683,1
7546,Phenotype,HP:0012028,Hepatocellular adenoma,-0.015804168368459992,-1.0618226169663578,1
7547,Disease,MONDO:0019792,autosomal dominant cerebellar ataxia type I,-0.01581867972749329,-1.0621054892058053,1
7548,Phenotype,HP:0006191,Deep palmar crease,-0.015828727244115548,-1.0623013470521518,1
7549,Biological Process,GO:0016093,polyprenol metabolic process,-0.01583199342352426,-1.062365015209053,1
7550,Phenotype,HP:0000615,Abnormal pupil morphology,-0.015874790522272253,-1.0631992658906684,1
7551,Phenotype,HP:0007773,Vitreoretinopathy,-0.01590181158888737,-1.063725991858108,1
7552,Phenotype,HP:0003561,Birth length less than 3rd percentile,-0.015916456539515345,-1.064011468219848,1
7553,Phenotype,HP:0002653,Bone pain,-0.015961971752531667,-1.064898703537044,1
7554,Phenotype,HP:0002283,Global brain atrophy,-0.01599006568796746,-1.0654463431077676,1
7555,Disease,MONDO:0019588,"hearing loss, autosomal recessive",-0.016020623504149567,-1.06604201149942,1
7556,Biological Process,GO:0002724,regulation of T cell cytokine production,-0.01602091735976985,-1.066047739673962,1
7557,Phenotype,HP:0011124,Abnormal epidermal morphology,-0.016047725798261858,-1.066570320847436,1
7558,Biological Process,GO:0042759,long-chain fatty acid biosynthetic process,-0.016065628397395226,-1.0669192990718162,1
7559,Biological Process,GO:0007031,peroxisome organization,-0.0160748208467294,-1.0670984889549413,1
7560,Disease,MONDO:0017704,familial partial epilepsy,-0.016079087152245153,-1.067181652729791,1
7560,Disease,MONDO:0005384,focal epilepsy,-0.016079087152245153,-1.067181652729791,1
7562,Phenotype,HP:0007588,Reticular hyperpigmentation,-0.016079160132936643,-1.067183075354067,1
7563,Biological Process,GO:0043507,positive regulation of JUN kinase activity,-0.016083960119318785,-1.0672766422552868,1
7564,Phenotype,HP:0003552,Muscle stiffness,-0.016118690057199236,-1.0679536384815926,1
7565,Phenotype,HP:0003508,Proportionate short stature,-0.016124017125550782,-1.0680574798758298,1
7566,Phenotype,HP:0000835,Adrenal hypoplasia,-0.016128043039648432,-1.06813595766237,1
7567,Biological Process,GO:0046823,negative regulation of nucleocytoplasmic transport,-0.016147891978443463,-1.068522876196652,1
7568,Biological Process,GO:0030195,negative regulation of blood coagulation,-0.016160460166542157,-1.0687678698947003,1
7568,Biological Process,GO:1900047,negative regulation of hemostasis,-0.016160460166542157,-1.0687678698947003,1
7570,Biological Process,GO:0090205,positive regulation of cholesterol metabolic process,-0.016173589556744083,-1.0690238031949844,1
7571,Phenotype,HP:0002651,Spondyloepimetaphyseal dysplasia,-0.01619839016177571,-1.069507245350116,1
7572,Biological Process,GO:0044770,cell cycle phase transition,-0.016212641717233245,-1.0697850531969642,1
7573,Biological Process,GO:0006949,syncytium formation,-0.01622859698688739,-1.0700960718167707,1
7574,Biological Process,GO:0032495,response to muramyl dipeptide,-0.01624135696168727,-1.070344804043618,1
7575,Phenotype,HP:0001123,Visual field defect,-0.016277376287958667,-1.071046934523775,1
7576,Phenotype,HP:0009025,Increased connective tissue,-0.016284951597713482,-1.071194601246784,1
7577,Phenotype,HP:0100512,Decreased circulating vitamin D concentration,-0.01630072627221213,-1.0715020994963789,1
7578,Phenotype,HP:0000551,Color vision defect,-0.01632868018222422,-1.072047009529153,1
7579,Phenotype,HP:0004921,Abnormal magnesium concentration,-0.016346916834187875,-1.0724024994987102,1
7580,Biological Process,GO:0071354,cellular response to interleukin-6,-0.016388957385598646,-1.0732220026822425,1
7581,Biological Process,GO:0055070,copper ion homeostasis,-0.01639496463245438,-1.0733391029047026,1
7582,Phenotype,HP:0008180,Mildly elevated creatine kinase,-0.016399478807822554,-1.0734270984461762,1
7583,Biological Process,GO:0072330,monocarboxylic acid biosynthetic process,-0.016442041935511575,-1.0742567882925684,1
7584,Phenotype,HP:0034237,Open neural tube defect,-0.01651092219682515,-1.07559948222818,1
7585,Phenotype,HP:0030374,Decreased proportion of memory B cells,-0.016512691972327964,-1.075633980744732,1
7585,Phenotype,HP:0030373,Abnormal proportion of memory B cells,-0.016512691972327964,-1.075633980744732,1
7587,Biological Process,GO:0032387,negative regulation of intracellular transport,-0.0165465261993627,-1.0762935167364558,1
7588,Phenotype,HP:0011073,Abnormality of dental color,-0.01659095199981042,-1.0771595159604468,1
7589,Biological Process,GO:0046839,phospholipid dephosphorylation,-0.016591023569711538,-1.0771609110839606,1
7590,Phenotype,HP:0000091,Abnormal renal tubule morphology,-0.016600338473757636,-1.0773424879963442,1
7591,Phenotype,HP:0002867,Abnormal ilium morphology,-0.016628701411970592,-1.0778953712811694,1
7592,Biological Process,GO:0015914,phospholipid transport,-0.016650697956540172,-1.078324153437839,1
7593,Disease,MONDO:0019234,peroxisome biogenesis disorder,-0.016676785652031345,-1.0788326850528775,1
7593,Disease,MONDO:0019609,Zellweger spectrum disorders,-0.016676785652031345,-1.0788326850528775,1
7595,Biological Process,GO:0000244,spliceosomal tri-snRNP complex assembly,-0.016705729019385274,-1.0793968827356561,1
7596,Biological Process,GO:0043555,regulation of translation in response to stress,-0.016716410473408327,-1.0796050980250114,1
7597,Phenotype,HP:0007108,Demyelinating peripheral neuropathy,-0.016791448897233163,-1.081067834006061,1
7598,Biological Process,GO:0009404,toxin metabolic process,-0.01684938293557936,-1.0821971514689959,1
7599,Phenotype,HP:0000340,Sloping forehead,-0.01685739222341831,-1.0823532777961153,1
7600,Phenotype,HP:0003323,Progressive muscle weakness,-0.016896635723306463,-1.0831182576075613,1
7601,Phenotype,HP:0004979,Metaphyseal sclerosis,-0.016930944227904865,-1.0837870387675872,1
7602,Biological Process,GO:0009066,aspartate family amino acid metabolic process,-0.016932744487485385,-1.0838221315151348,1
7603,Phenotype,HP:0009773,Symphalangism affecting the phalanges of the hand,-0.016969477533529176,-1.084538174648813,1
7604,Phenotype,HP:0007676,Hypoplasia of the iris,-0.017030992108410414,-1.0857372880823226,1
7605,Phenotype,HP:0003761,Calcinosis,-0.017044053234531065,-1.0859918906999668,1
7606,Phenotype,HP:0007112,Temporal cortical atrophy,-0.0170516113449648,-1.0861392221538628,1
7607,Phenotype,HP:0100786,Hypersomnia,-0.017052963041625402,-1.0861655709927662,1
7608,Phenotype,HP:0010989,Abnormality of the intrinsic pathway,-0.017057023552883077,-1.086244723187273,1
7609,Phenotype,HP:0012086,Abnormal urinary color,-0.017124654067823597,-1.0875630556172202,1
7610,Phenotype,HP:0012515,Hip flexor weakness,-0.01719952761447474,-1.0890225776211881,1
7611,Phenotype,HP:0002425,Anarthria,-0.017205612421257177,-1.0891411897316874,1
7612,Phenotype,HP:0002224,Woolly hair,-0.01721583213085842,-1.0893404041632768,1
7613,Biological Process,GO:0097722,sperm motility,-0.01721684902304821,-1.0893602266051543,1
7613,Biological Process,GO:0030317,flagellated sperm motility,-0.01721684902304821,-1.0893602266051543,1
7615,Biological Process,GO:0007042,lysosomal lumen acidification,-0.0172419009845175,-1.089848568491473,1
7616,Biological Process,GO:0032480,negative regulation of type I interferon production,-0.017249355501035346,-1.08999388057262,1
7617,Phenotype,HP:0001604,Vocal cord paresis,-0.017249779093911455,-1.090002137736212,1
7618,Biological Process,GO:2000059,negative regulation of ubiquitin-dependent protein catabolic process,-0.017288135061380494,-1.0907498167364518,1
7619,Biological Process,GO:0072531,pyrimidine-containing compound transmembrane transport,-0.017297256171710407,-1.0909276159969725,1
7620,Phenotype,HP:0010548,Percussion myotonia,-0.017299231606884957,-1.0909661234703543,1
7621,Phenotype,HP:0002232,Patchy alopecia,-0.017315356179438135,-1.0912804423386135,1
7622,Biological Process,GO:0050901,leukocyte tethering or rolling,-0.017331343028239132,-1.0915920765357736,1
7623,Phenotype,HP:0001454,Abnormality of the upper arm,-0.017343397914633796,-1.0918270643617187,1
7624,Biological Process,GO:0043413,macromolecule glycosylation,-0.01739674280920034,-1.0928669249119605,1
7624,Biological Process,GO:0006486,protein glycosylation,-0.01739674280920034,-1.0928669249119605,1
7626,Phenotype,HP:0011473,Villous atrophy,-0.017405137015903183,-1.093030554523975,1
7626,Phenotype,HP:0011472,Abnormal small intestinal villus morphology,-0.017405137015903183,-1.093030554523975,1
7628,Phenotype,HP:0045049,Abnormal DLCO,-0.017420713501397733,-1.0933341894436577,1
7628,Phenotype,HP:0045051,Decreased DLCO,-0.017420713501397733,-1.0933341894436577,1
7630,Phenotype,HP:0007010,Poor fine motor coordination,-0.01745326122055757,-1.09396864733189,1
7631,Phenotype,HP:0000617,Abnormality of ocular smooth pursuit,-0.01746072719787728,-1.0941141828202783,1
7632,Biological Process,GO:0070989,oxidative demethylation,-0.01747590710948166,-1.0944100872617777,1
7633,Phenotype,HP:0002108,Spontaneous pneumothorax,-0.017516151048305284,-1.0951945687891866,1
7634,Biological Process,GO:0009072,aromatic amino acid metabolic process,-0.017562143008500897,-1.0960910974152964,1
7635,Phenotype,HP:0006709,Aplasia/Hypoplasia of the nipples,-0.017579913427233196,-1.0964374990260064,1
7636,Biological Process,GO:0034139,regulation of toll-like receptor 3 signaling pathway,-0.017609890895487368,-1.0970218546028039,1
7637,Phenotype,HP:0100829,Galactorrhea,-0.017658222307008975,-1.0979639865272777,1
7637,Phenotype,HP:0031094,Abnormal breast physiology,-0.017658222307008975,-1.0979639865272777,1
7639,Biological Process,GO:0009855,determination of bilateral symmetry,-0.017784623480123996,-1.1004279447841012,1
7639,Biological Process,GO:0009799,specification of symmetry,-0.017784623480123996,-1.1004279447841012,1
7641,Biological Process,GO:0071786,endoplasmic reticulum tubular network organization,-0.01782311659864466,-1.1011782972916968,1
7642,Disease,MONDO:0018894,distal hereditary motor neuropathy,-0.0178307010365506,-1.1013261419512135,1
7643,Phenotype,HP:0011196,EEG with focal sharp waves,-0.01794012691172142,-1.1034591980138493,1
7644,Phenotype,HP:0000677,Oligodontia,-0.01797977179010335,-1.104232001960384,1
7645,Phenotype,HP:0040135,Abnormal transferrin saturation,-0.018058234518381067,-1.105761488455077,1
7646,Biological Process,GO:0035337,fatty-acyl-CoA metabolic process,-0.01808568158874846,-1.1062965185817026,1
7647,Phenotype,HP:0002361,Psychomotor deterioration,-0.0181991128761112,-1.1085076527839557,1
7648,Biological Process,GO:1901659,glycosyl compound biosynthetic process,-0.018203050198596582,-1.1085844036400478,1
7649,Biological Process,GO:0072006,nephron development,-0.018204860317487803,-1.1086196885767137,1
7650,Biological Process,GO:0007601,visual perception,-0.018211047294723226,-1.108740292312172,1
7651,Biological Process,GO:1902018,negative regulation of cilium assembly,-0.018255393218482352,-1.109604734487114,1
7652,Phenotype,HP:0033643,Increased circulating very long-chain fatty acid concentration,-0.018282425265828683,-1.110131674503701,1
7653,Phenotype,HP:0000687,Widely spaced teeth,-0.01831581227135093,-1.11078249273505,1
7654,Biological Process,GO:0030258,lipid modification,-0.01833612616339697,-1.1111784746773181,1
7655,Phenotype,HP:0500093,Food allergy,-0.01833741777187936,-1.1112036522077662,1
7656,Phenotype,HP:0007361,Abnormal pons morphology,-0.018373542301984624,-1.11190783344306,1
7657,Phenotype,HP:0031013,Ankylosis,-0.018385406720975217,-1.1121391084574754,1
7658,Phenotype,HP:0006706,Cystic liver disease,-0.01843927037866644,-1.1131890813401655,1
7659,Phenotype,HP:0004442,Sagittal craniosynostosis,-0.018443855864497483,-1.113278466947882,1
7660,Biological Process,GO:0010874,regulation of cholesterol efflux,-0.018445476773291114,-1.113310063581894,1
7661,Phenotype,HP:0012169,Self-biting,-0.01849421919644545,-1.114260207421773,1
7662,Disease,MONDO:0000270,lower respiratory tract disorder,-0.018512646850671777,-1.1146194206289441,1
7663,Biological Process,GO:1901983,regulation of protein acetylation,-0.018583371734468557,-1.1159980720852514,1
7664,Biological Process,GO:0031998,regulation of fatty acid beta-oxidation,-0.018617661472402514,-1.1166664874236896,1
7665,Biological Process,GO:0006040,amino sugar metabolic process,-0.018619875723596246,-1.116709650175878,1
7666,Biological Process,GO:0046782,regulation of viral transcription,-0.018673079154368333,-1.1177467531497793,1
7667,Biological Process,GO:0045214,sarcomere organization,-0.018725452534356313,-1.1187676758111673,1
7668,Biological Process,GO:0042908,xenobiotic transport,-0.018760759591722076,-1.1194559219197802,1
7669,Phenotype,HP:0000474,Thickened nuchal skin fold,-0.018765740075361137,-1.1195530072828588,1
7670,Phenotype,HP:0100750,Atelectasis,-0.01878024635580644,-1.119835780524579,1
7671,Phenotype,HP:0001281,Tetany,-0.018792539310955814,-1.1200754090627851,1
7672,Phenotype,HP:0003645,Prolonged partial thromboplastin time,-0.018805671412957192,-1.120331395224609,1
7673,Biological Process,GO:0033045,regulation of sister chromatid segregation,-0.01880715436583169,-1.1203603026618545,1
7674,Phenotype,HP:0031123,Recurrent gastroenteritis,-0.018834236800626902,-1.1208882248890306,1
7675,Phenotype,HP:0010772,Anomalous pulmonary venous return,-0.018879275658230554,-1.121766174534082,1
7676,Phenotype,HP:0012692,Focal T2 hyperintense thalamic lesion,-0.018896721524864102,-1.122106249598892,1
7677,Disease,MONDO:0019220,inborn disorder of cobalamin metabolism and transport,-0.018906337243523863,-1.1222936903385872,1
7678,Phenotype,HP:0010296,Ankyloglossia,-0.018924085135314073,-1.122639652828017,1
7679,Phenotype,HP:0002761,Generalized joint hypermobility,-0.01892646134221776,-1.1226859726087275,1
7680,Phenotype,HP:0002036,Hiatus hernia,-0.01892677737241355,-1.1226921330358117,1
7681,Phenotype,HP:0011344,Severe global developmental delay,-0.018945262847915645,-1.1230524733623468,1
7682,Phenotype,HP:0002275,Poor motor coordination,-0.01895762592400918,-1.1232934687793172,1
7683,Phenotype,HP:0003084,Fractures of the long bones,-0.01896662196541432,-1.1234688300513107,1
7684,Phenotype,HP:0001954,Recurrent fever,-0.0189762100508577,-1.1236557321323053,1
7685,Phenotype,HP:0001052,Nevus flammeus,-0.018977356600291317,-1.1236780820035461,1
7686,Biological Process,GO:0007064,mitotic sister chromatid cohesion,-0.01899641123671514,-1.124049517074837,1
7687,Phenotype,HP:0001357,Plagiocephaly,-0.019025481916097986,-1.1246161964713302,1
7688,Phenotype,HP:0000062,Ambiguous genitalia,-0.01904323048262757,-1.1249621721135623,1
7689,Biological Process,GO:0051642,centrosome localization,-0.019048523934477313,-1.1250653582159602,1
7689,Biological Process,GO:0061842,microtubule organizing center localization,-0.019048523934477313,-1.1250653582159602,1
7691,Biological Process,GO:0006890,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum",-0.01905163866239379,-1.1251260741047326,1
7692,Phenotype,HP:0012805,Iris transillumination defect,-0.019068230436110944,-1.1254495001999045,1
7693,Phenotype,HP:0001748,Polysplenia,-0.019089156174458166,-1.125857408959848,1
7694,Biological Process,GO:0007254,JNK cascade,-0.019091151626878577,-1.1258963066326007,1
7695,Phenotype,HP:0100336,Bilateral cleft lip,-0.019174489632290737,-1.1275208276831736,1
7696,Biological Process,GO:0030071,regulation of mitotic metaphase/anaphase transition,-0.019175467489457754,-1.1275398892091175,1
7697,Biological Process,GO:0006364,rRNA processing,-0.01926313999724827,-1.1292489034068758,1
7698,Biological Process,GO:0070555,response to interleukin-1,-0.019275890356400538,-1.1294974481943685,1
7699,Phenotype,HP:0032558,Absent sperm flagella,-0.019289653211628677,-1.1297657297295878,1
7700,Phenotype,HP:0003782,Eunuchoid habitus,-0.019291567831199563,-1.1298030517146938,1
7701,Biological Process,GO:0001654,eye development,-0.01930984561195359,-1.130159343414331,1
7701,Biological Process,GO:0150063,visual system development,-0.01930984561195359,-1.130159343414331,1
7703,Biological Process,GO:1902430,negative regulation of amyloid-beta formation,-0.019409720908939,-1.1321062285309427,1
7704,Phenotype,HP:0009134,Osteolysis involving bones of the feet,-0.01944529707755005,-1.1327997204680433,1
7705,Phenotype,HP:0100526,Neoplasm of the lung,-0.01945366720341979,-1.1329628806685317,1
7706,Biological Process,GO:0141137,"positive regulation of gene expression, epigenetic",-0.01946829387894633,-1.1332480007908006,1
7706,Biological Process,GO:0045815,transcription initiation-coupled chromatin remodeling,-0.01946829387894633,-1.1332480007908006,1
7708,Phenotype,HP:0010669,Hypoplasia of the zygomatic bone,-0.019481480966860643,-1.1335050588018079,1
7709,Phenotype,HP:0001562,Oligohydramnios,-0.019500490816500626,-1.133875620837168,1
7710,Biological Process,GO:1902115,regulation of organelle assembly,-0.019548222223571,-1.1348060567790388,1
7711,Biological Process,GO:0006352,DNA-templated transcription initiation,-0.0195723639494918,-1.1352766552984244,1
7712,Biological Process,GO:2000369,regulation of clathrin-dependent endocytosis,-0.019580248948244616,-1.135430358838536,1
7713,Biological Process,GO:0008608,attachment of spindle microtubules to kinetochore,-0.019582821559817942,-1.1354805071668423,1
7714,Phenotype,HP:0009073,Progressive proximal muscle weakness,-0.01958422550473138,-1.1355078744892837,1
7715,Phenotype,HP:0040132,Abnormal sensory nerve conduction velocity,-0.019635723562455132,-1.136511734353965,1
7716,Phenotype,HP:0005340,Spastic/hyperactive bladder,-0.019655279400636383,-1.1368929394311675,1
7717,Phenotype,HP:0003236,Elevated circulating creatine kinase concentration,-0.019707475195005264,-1.1379104003877176,1
7718,Phenotype,HP:0012757,Abnormal neuron morphology,-0.01971803735832167,-1.1381162903242745,1
7719,Disease,MONDO:0002661,uveal disorder,-0.019799109702613116,-1.1396966464807412,1
7720,Disease,MONDO:0019235,inborn disorder of phenylalanine and tyrosine metabolism,-0.019815981272107264,-1.1400255266796842,1
7721,Phenotype,HP:0009795,Branchial fistula,-0.019868968949181776,-1.1410584239322976,1
7722,Biological Process,GO:0009226,nucleotide-sugar biosynthetic process,-0.019884863931194374,-1.1413682673554784,1
7723,Biological Process,GO:0006353,DNA-templated transcription termination,-0.019972380558003433,-1.143074242940367,1
7724,Phenotype,HP:0012294,Abnormal occipital bone morphology,-0.020020510822413184,-1.1440124538720613,1
7725,Phenotype,HP:0025116,Fetal distress,-0.020021317164289343,-1.1440281720230454,1
7726,Phenotype,HP:0006254,Elevated circulating alpha-fetoprotein concentration,-0.0200284160932358,-1.1441665525788676,1
7727,Phenotype,HP:0025723,Abnormal fetal skin morphology,-0.0200341620278226,-1.1442785589995312,1
7728,Phenotype,HP:0012165,Oligodactyly,-0.020045150524744537,-1.1444927595251566,1
7729,Phenotype,HP:0011097,Epileptic spasm,-0.020059229950994295,-1.1447672120298644,1
7730,Phenotype,HP:0025179,Ground-glass opacification,-0.02006881229959312,-1.1449540022816316,1
7731,Biological Process,GO:0006506,GPI anchor biosynthetic process,-0.020084303681948024,-1.1452559782722203,1
7732,Phenotype,HP:0009317,Deviation of the 3rd finger,-0.020124665441746847,-1.1460427565027178,1
7733,Biological Process,GO:0048880,sensory system development,-0.020125929849566848,-1.1460674038063092,1
7734,Biological Process,GO:0022618,protein-RNA complex assembly,-0.020164154973637327,-1.1468125322552822,1
7735,Phenotype,HP:0001847,Long hallux,-0.02017071509540025,-1.1469404097566152,1
7736,Phenotype,HP:0002600,Hyporeflexia of lower limbs,-0.020178669962787277,-1.1470954752571734,1
7737,Phenotype,HP:0003707,Calf muscle pseudohypertrophy,-0.020241940162129435,-1.148328811358715,1
7738,Biological Process,GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,-0.020278839705177187,-1.149048100045085,1
7739,Biological Process,GO:0001539,cilium or flagellum-dependent cell motility,-0.020308882572199982,-1.149633730450525,1
7739,Biological Process,GO:0060285,cilium-dependent cell motility,-0.020308882572199982,-1.149633730450525,1
7741,Phenotype,HP:0003722,Neck flexor weakness,-0.02032456089611978,-1.1499393505228972,1
7742,Biological Process,GO:0070646,protein modification by small protein removal,-0.020334002370056004,-1.1501233946823655,1
7743,Phenotype,HP:0003186,Inverted nipples,-0.02040991929393976,-1.151603255405381,1
7744,Phenotype,HP:0007380,Facial telangiectasia,-0.020422667955257046,-1.1518517670967052,1
7745,Phenotype,HP:0100670,Coarse metaphyseal trabecularization,-0.020433642327184254,-1.152065692281552,1
7746,Phenotype,HP:0000158,Macroglossia,-0.02046150931636137,-1.1526089079526067,1
7747,Phenotype,HP:0001591,Bell-shaped thorax,-0.020482018170744798,-1.1530086903268577,1
7748,Biological Process,GO:0043489,RNA stabilization,-0.020525671808484303,-1.1538596376598445,1
7749,Phenotype,HP:0025235,NREM parasomnia,-0.0205483965618527,-1.1543026149069415,1
7750,Disease,MONDO:0006510,renal tubular transport disease,-0.020565195840988038,-1.1546300859383736,1
7751,Phenotype,HP:0003938,Synostosis involving the elbow,-0.020571455464080124,-1.1547521057711192,1
7751,Phenotype,HP:0003041,Humeroradial synostosis,-0.020571455464080124,-1.1547521057711192,1
7753,Biological Process,GO:0046189,phenol-containing compound biosynthetic process,-0.02062093477052529,-1.1557166137946844,1
7754,Phenotype,HP:0003316,Butterfly vertebrae,-0.020623604853761135,-1.155768662153677,1
7755,Phenotype,HP:0000215,Thick upper lip vermilion,-0.020665948426623837,-1.1565940721827714,1
7756,Biological Process,GO:0090235,regulation of metaphase plate congression,-0.020735180788155505,-1.1579436296641732,1
7757,Phenotype,HP:0020073,Hypopigmented macule,-0.020738203422304924,-1.158002550354435,1
7758,Biological Process,GO:0030970,"retrograde protein transport, ER to cytosol",-0.020756749886863046,-1.1583640795503805,1
7758,Biological Process,GO:1903513,endoplasmic reticulum to cytosol transport,-0.020756749886863046,-1.1583640795503805,1
7760,Phenotype,HP:0002943,Thoracic scoliosis,-0.02076004007084653,-1.1584282156322916,1
7761,Phenotype,HP:0006361,Irregular femoral epiphysis,-0.02076788876126323,-1.1585812114082081,1
7762,Phenotype,HP:0032658,Status epilepticus with prominent motor symptoms,-0.02080504439016817,-1.1593054920170953,1
7763,Biological Process,GO:0090181,regulation of cholesterol metabolic process,-0.02082059125236313,-1.1596085494850676,1
7764,Biological Process,GO:0060315,negative regulation of ryanodine-sensitive calcium-release channel activity,-0.020830258953108194,-1.1597970035198542,1
7764,Biological Process,GO:0051280,negative regulation of release of sequestered calcium ion into cytosol,-0.020830258953108194,-1.1597970035198542,1
7766,Phenotype,HP:0000454,Flared nostrils,-0.020836154845837784,-1.1599119330985472,1
7767,Phenotype,HP:0005905,Abnormal cervical curvature,-0.020847836029822764,-1.160139636283731,1
7768,Biological Process,GO:0045939,negative regulation of steroid metabolic process,-0.020934614434170662,-1.1618312215802726,1
7769,Phenotype,HP:0001302,Pachygyria,-0.020938080830043004,-1.1618987925886786,1
7770,Biological Process,GO:0070167,regulation of biomineral tissue development,-0.02096294139510424,-1.1623834035542444,1
7771,Phenotype,HP:0006487,Bowing of the long bones,-0.02098966324233187,-1.162904296790371,1
7772,Biological Process,GO:0071474,cellular hyperosmotic response,-0.020994830365123507,-1.1630050203402618,1
7772,Biological Process,GO:0006972,hyperosmotic response,-0.020994830365123507,-1.1630050203402618,1
7774,Biological Process,GO:0060632,regulation of microtubule-based movement,-0.021009491404628156,-1.1632908103250448,1
7775,Phenotype,HP:0006349,Agenesis of permanent teeth,-0.0211192122890993,-1.1654296170510918,1
7776,Phenotype,HP:0002084,Encephalocele,-0.021135810852495718,-1.165753175498566,1
7776,Phenotype,HP:0011815,Cephalocele,-0.021135810852495718,-1.165753175498566,1
7778,Biological Process,GO:0016180,snRNA processing,-0.021191993323924407,-1.1668483493878106,1
7779,Disease,MONDO:0000462,eye adnexa disorder,-0.021196361636978134,-1.1669335016118911,1
7780,Phenotype,HP:0030842,Choking episodes,-0.02125045048498797,-1.1679878641654302,1
7781,Biological Process,GO:0009069,serine family amino acid metabolic process,-0.021281694033631338,-1.1685968996494778,1
7782,Phenotype,HP:0010677,Enuresis nocturna,-0.0212976663089115,-1.1689082497626686,1
7783,Phenotype,HP:0002266,Focal clonic seizure,-0.021319038516873334,-1.1693248616261218,1
7784,Biological Process,GO:0009303,rRNA transcription,-0.02139084591345508,-1.1707246146770494,1
7785,Phenotype,HP:0002453,Abnormal globus pallidus morphology,-0.02141259745197366,-1.1711486208916333,1
7786,Phenotype,HP:0045074,Thin eyebrow,-0.021417173691060443,-1.171237826251087,1
7787,Phenotype,HP:0002483,Bulbar signs,-0.021434105343175025,-1.1715678776501466,1
7788,Phenotype,HP:0007302,Bipolar affective disorder,-0.021466704794518288,-1.1722033439620934,1
7789,Biological Process,GO:0009219,pyrimidine deoxyribonucleotide metabolic process,-0.02147423410619531,-1.1723501140372248,1
7790,Phenotype,HP:0008730,"Female external genitalia in individual with 46,XY karyotype",-0.021478105426886218,-1.1724255783097952,1
7791,Biological Process,GO:1902099,regulation of metaphase/anaphase transition of cell cycle,-0.021499281052215213,-1.1728383581565873,1
7792,Phenotype,HP:0000654,Decreased light- and dark-adapted electroretinogram amplitude,-0.021499917718529993,-1.1728507687947523,1
7793,Biological Process,GO:2001258,negative regulation of cation channel activity,-0.021630737429108926,-1.175400858308106,1
7794,Biological Process,GO:0042177,negative regulation of protein catabolic process,-0.021635781367294715,-1.175499180600799,1
7795,Phenotype,HP:0030602,Abnormal fundus autofluorescence imaging,-0.0216645460677376,-1.1760598955009434,1
7796,Phenotype,HP:0007076,Extrapyramidal muscular rigidity,-0.021669352327534197,-1.176153584690833,1
7797,Phenotype,HP:0010456,Abnormal greater sciatic notch morphology,-0.021670567458273338,-1.1761772714284167,1
7798,Biological Process,GO:0048066,developmental pigmentation,-0.021687571635428782,-1.1765087365696818,1
7799,Phenotype,HP:0031469,Low self-esteem,-0.021727021516814604,-1.1772777394086258,1
7800,Phenotype,HP:0012697,Small basal ganglia,-0.021867636707529003,-1.1800187737808325,1
7801,Phenotype,HP:0000577,Exotropia,-0.02186838305351113,-1.1800333224222717,1
7802,Phenotype,HP:0011535,Abnormal atrial arrangement,-0.021895343205990958,-1.1805588609807425,1
7803,Biological Process,GO:1902751,positive regulation of cell cycle G2/M phase transition,-0.02203294090847341,-1.1832410749728788,1
7804,Biological Process,GO:2000144,positive regulation of DNA-templated transcription initiation,-0.022067930467110974,-1.1839231320280708,1
7805,Phenotype,HP:0000778,Hypoplasia of the thymus,-0.02212022014567383,-1.1849424230842096,1
7806,Biological Process,GO:0045923,positive regulation of fatty acid metabolic process,-0.022162247434358795,-1.1857616677353093,1
7807,Phenotype,HP:0100766,Abnormal lymphatic vessel morphology,-0.022186550302793595,-1.1862354074314585,1
7808,Phenotype,HP:0005879,Congenital finger flexion contractures,-0.022248958983562828,-1.1874519498138532,1
7809,Biological Process,GO:0055062,phosphate ion homeostasis,-0.022260313677487487,-1.1876732886761427,1
7810,Biological Process,GO:0016925,protein sumoylation,-0.022315117026766362,-1.1887415791170424,1
7811,Phenotype,HP:0030973,Postexertional symptom exacerbation,-0.022421197505134716,-1.1908094228254678,1
7812,Phenotype,HP:0031329,Interstitial cardiac fibrosis,-0.022477781799684182,-1.1919124295169865,1
7813,Phenotype,HP:0008049,Abnormality of the extraocular muscles,-0.022490546391891186,-1.1921612517516884,1
7814,Phenotype,HP:0007925,Lacrimal duct aplasia,-0.022521040391711322,-1.192755676160804,1
7815,Phenotype,HP:0011199,EEG with generalized sharp slow waves,-0.022525485069250895,-1.1928423169700042,1
7816,Biological Process,GO:1903659,regulation of complement-dependent cytotoxicity,-0.022567793607308317,-1.1936670440600436,1
7817,Phenotype,HP:0004568,Beaking of vertebral bodies,-0.022570787362587774,-1.1937254018098804,1
7818,Phenotype,HP:0006515,Interstitial pneumonitis,-0.022659078064951155,-1.1954464665731879,1
7819,Biological Process,GO:2000774,positive regulation of cellular senescence,-0.02268723243936921,-1.1959952842906465,1
7820,Biological Process,GO:0018958,phenol-containing compound metabolic process,-0.022701537807672922,-1.1962741411199003,1
7821,Phenotype,HP:0001776,Bilateral talipes equinovarus,-0.022708375963034655,-1.1964074383745837,1
7822,Phenotype,HP:0004637,Decreased cervical spine mobility,-0.022811016995176514,-1.1984082364083541,1
7823,Phenotype,HP:0002883,Hyperventilation,-0.02282169976056614,-1.1986164772603873,1
7824,Biological Process,GO:0071347,cellular response to interleukin-1,-0.02285424928140789,-1.199250970269093,1
7825,Biological Process,GO:0051289,protein homotetramerization,-0.022864722493813217,-1.1994551262713327,1
7826,Phenotype,HP:0030601,Abnormal posterior segment imaging,-0.022907426185817314,-1.2002875561603703,1
7827,Phenotype,HP:0005272,Prominent nasolabial fold,-0.022932539634168192,-1.2007770966202926,1
7828,Phenotype,HP:0006872,Cerebral hypoplasia,-0.02294199449757106,-1.2009614017827728,1
7829,Phenotype,HP:0007605,Excessive wrinkling of palmar skin,-0.022998860038721203,-1.2020698908592002,1
7830,Phenotype,HP:0000571,Hypometric saccades,-0.023005682949275297,-1.2022028909444133,1
7831,Phenotype,HP:0031817,Decreased circulating parathyroid hormone level,-0.02302302779743437,-1.2025409968399654,1
7832,Phenotype,HP:0002380,Fasciculations,-0.02303595283847648,-1.2027929467294376,1
7833,Disease,MONDO:0020040,"46,XY disorder of sex development",-0.023037246412103807,-1.2028181625667698,1
7834,Phenotype,HP:0009063,Progressive distal muscle weakness,-0.023055184892917246,-1.203167840238471,1
7835,Biological Process,GO:0033044,regulation of chromosome organization,-0.02310167126347351,-1.20407400648471,1
7836,Phenotype,HP:0010931,Abnormal blood sodium concentration,-0.023186509859808524,-1.2057277787938225,1
7837,Biological Process,GO:0170035,L-amino acid catabolic process,-0.02325935027748538,-1.2071476686899554,1
7837,Biological Process,GO:0170040,proteinogenic amino acid catabolic process,-0.02325935027748538,-1.2071476686899554,1
7839,Phenotype,HP:0030048,Colpocephaly,-0.023311762493703148,-1.2081693483921736,1
7840,Phenotype,HP:0009825,Aplasia involving bones of the extremities,-0.023333666689772325,-1.2085963303847744,1
7841,Biological Process,GO:0070071,proton-transporting two-sector ATPase complex assembly,-0.02339848748818163,-1.2098598925615998,1
7842,Phenotype,HP:0005353,Recurrent herpes,-0.023400524698718783,-1.2098996042319918,1
7843,Phenotype,HP:0012143,Abnormal megakaryocyte morphology,-0.023441796153153893,-1.2107041152853344,1
7844,Phenotype,HP:0031629,Impaired tandem gait,-0.023492793502351228,-1.211698214758735,1
7845,Biological Process,GO:0070059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,-0.023514027503947155,-1.2121121325434228,1
7846,Biological Process,GO:0045591,positive regulation of regulatory T cell differentiation,-0.023542559928831697,-1.2126683196590082,1
7847,Phenotype,HP:0002659,Increased susceptibility to fractures,-0.02354731962733192,-1.2127611012221107,1
7848,Phenotype,HP:0100574,Biliary tract neoplasm,-0.023578161593198255,-1.2133623085889433,1
7849,Biological Process,GO:0046513,ceramide biosynthetic process,-0.023590422848301484,-1.2136013191930863,1
7850,Biological Process,GO:0043009,chordate embryonic development,-0.02360497913570092,-1.213885067228351,1
7851,Phenotype,HP:0007722,Retinal pigment epithelial atrophy,-0.02361691142280642,-1.2141176652067704,1
7852,Phenotype,HP:0001696,Situs inversus totalis,-0.02363335366250663,-1.2144381764114658,1
7853,Phenotype,HP:0000815,Hypergonadotropic hypogonadism,-0.023639958674698702,-1.2145669289691043,1
7854,Phenotype,HP:0007814,Retinal pigment epithelial mottling,-0.023658180938619378,-1.2149221384702418,1
7855,Phenotype,HP:0012256,Absent outer dynein arms,-0.023679574697402117,-1.215339170427289,1
7856,Biological Process,GO:0009712,catechol-containing compound metabolic process,-0.023699514568369606,-1.2157278615169327,1
7856,Biological Process,GO:0006584,catecholamine metabolic process,-0.023699514568369606,-1.2157278615169327,1
7858,Phenotype,HP:0040217,Elevated hemoglobin A1c,-0.023709854553909615,-1.2159294205066074,1
7859,Phenotype,HP:0500012,Abnormal gonadotropin-releasing hormone concentration,-0.02377060216583926,-1.2171135834087992,1
7859,Phenotype,HP:0003164,Hypothalamic gonadotropin-releasing hormone deficiency,-0.02377060216583926,-1.2171135834087992,1
7861,Phenotype,HP:0002616,Aortic root aneurysm,-0.023835000459263345,-1.2183689096284638,1
7862,Phenotype,HP:0031358,Vegetative state,-0.023966310308179528,-1.2209285534867123,1
7863,Biological Process,GO:0010965,regulation of mitotic sister chromatid separation,-0.02401660723738308,-1.2219089995613004,1
7864,Phenotype,HP:0012389,Appendicular hypotonia,-0.02411739206075514,-1.22387361422104,1
7865,Biological Process,GO:0009070,serine family amino acid biosynthetic process,-0.024132404393126805,-1.2241662520137897,1
7866,Phenotype,HP:0100023,Recurrent hand flapping,-0.024218121369883994,-1.2258371467327702,1
7867,Biological Process,GO:0035627,ceramide transport,-0.024280136785180817,-1.227046023128497,1
7868,Phenotype,HP:0005108,Abnormal intervertebral disk morphology,-0.024313290451372538,-1.2276922928390062,1
7869,Phenotype,HP:0003452,Increased circulating iron concentration,-0.024334736330432705,-1.228110340784946,1
7870,Phenotype,HP:0001995,Hyperchloremic acidosis,-0.024351012578161635,-1.2284276162816326,1
7871,Phenotype,HP:0030038,Enchondroma,-0.024356282818991826,-1.228530349927919,1
7872,Phenotype,HP:0020110,Bone fracture,-0.024437455239802786,-1.2301126568919651,1
7873,Phenotype,HP:0010656,Abnormal epiphyseal ossification,-0.02455818403962362,-1.2324660426701513,1
7874,Biological Process,GO:0007219,Notch signaling pathway,-0.024607977543890547,-1.2334366754020407,1
7875,Disease,MONDO:0005275,lung disorder,-0.024615508417101584,-1.2335834759164042,1
7876,Phenotype,HP:0007772,Impaired smooth pursuit,-0.024625584699166314,-1.2337798944921154,1
7877,Biological Process,GO:0043473,pigmentation,-0.024709774308693255,-1.2354210159977195,1
7878,Phenotype,HP:0008959,Distal upper limb muscle weakness,-0.024712852209167746,-1.235481014003283,1
7879,Phenotype,HP:0000657,Oculomotor apraxia,-0.02474504908702002,-1.2361086328858695,1
7880,Phenotype,HP:0000485,Megalocornea,-0.024745814837460633,-1.236123559781517,1
7881,Biological Process,GO:0060294,cilium movement involved in cell motility,-0.02475350507795948,-1.2362734668678763,1
7882,Phenotype,HP:0006580,Portal fibrosis,-0.024769736871895986,-1.2365898758196867,1
7883,Biological Process,GO:0060972,left/right pattern formation,-0.024794113097318826,-1.2370650454753207,1
7883,Biological Process,GO:0007368,determination of left/right symmetry,-0.024794113097318826,-1.2370650454753207,1
7885,Phenotype,HP:0000926,Platyspondyly,-0.024828003405268584,-1.2377256746612786,1
7886,Phenotype,HP:0002938,Lumbar hyperlordosis,-0.024830799033411344,-1.237780170287194,1
7887,Phenotype,HP:0030453,Abnormal visual electrophysiology,-0.024849158086915013,-1.2381380462495213,1
7888,Biological Process,GO:0009101,glycoprotein biosynthetic process,-0.02485071162498942,-1.238168329615343,1
7889,Biological Process,GO:0019432,triglyceride biosynthetic process,-0.024863254221980435,-1.2384128244618415,1
7890,Phenotype,HP:0011274,Recurrent mycobacterial infections,-0.02486779303017972,-1.2385013001750265,1
7891,Biological Process,GO:1901616,organic hydroxy compound catabolic process,-0.02504755427212979,-1.2420054147765316,1
7892,Phenotype,HP:0012244,Abnormal sex determination,-0.02509243993830168,-1.2428803782365354,1
7893,Biological Process,GO:0045747,positive regulation of Notch signaling pathway,-0.02518740064883418,-1.2447314625344434,1
7894,Phenotype,HP:0000956,Acanthosis nigricans,-0.025214387724081133,-1.245257525902714,1
7895,Phenotype,HP:0001395,Hepatic fibrosis,-0.02527884778144518,-1.2465140560967252,1
7896,Phenotype,HP:0004510,Pancreatic islet-cell hyperplasia,-0.02532594450745984,-1.2474321200994032,1
7897,Phenotype,HP:0045056,Abnormal circulating alpha-fetoprotein concentration,-0.025397418494236934,-1.2488253739397552,1
7898,Biological Process,GO:0045943,positive regulation of transcription by RNA polymerase I,-0.025541097714766314,-1.2516261359345444,1
7899,Phenotype,HP:0007401,Macular atrophy,-0.02557068759035941,-1.2522029361056919,1
7900,Disease,MONDO:0018078,soft tissue sarcoma,-0.025572563760591693,-1.252239508591699,1
7900,Disease,MONDO:0024637,malignant soft tissue neoplasm,-0.025572563760591693,-1.252239508591699,1
7902,Phenotype,HP:0033076,Abnormal circulating free T4 concentration,-0.025644318797001242,-1.253638240977427,1
7903,Phenotype,HP:0011334,Facial shape deformation,-0.02571652719224593,-1.2550458107593405,1
7904,Phenotype,HP:0003063,Abnormality of the humerus,-0.025731512043671412,-1.255337912861617,1
7905,Phenotype,HP:0010344,Deviation of the 5th toe,-0.02575217431368637,-1.2557406857912774,1
7906,Phenotype,HP:0008428,Vertebral clefting,-0.0258468719755518,-1.257586642439503,1
7907,Phenotype,HP:0005345,Abnormal vena cava morphology,-0.025863890357275432,-1.2579183844726847,1
7908,Phenotype,HP:0100606,Neoplasm of the respiratory system,-0.025872915732750412,-1.258094317558387,1
7909,Phenotype,HP:0001958,Nonketotic hypoglycemia,-0.02593393417552603,-1.2592837598095177,1
7910,Phenotype,HP:0011003,High myopia,-0.025958205376503507,-1.2597568822068632,1
7911,Phenotype,HP:0000207,Triangular mouth,-0.025977810084800934,-1.260139039917046,1
7912,Disease,MONDO:0045011,keratinization disease,-0.026026420194136923,-1.2610866045425302,1
7913,Phenotype,HP:0002970,Genu varum,-0.026033084241760873,-1.261216507887272,1
7914,Phenotype,HP:0012508,Metamorphopsia,-0.026080532754085173,-1.2621414293166724,1
7915,Phenotype,HP:0000666,Horizontal nystagmus,-0.0261138305567854,-1.262790508703164,1
7916,Biological Process,GO:0009581,detection of external stimulus,-0.02618111339806828,-1.264102063874971,1
7917,Biological Process,GO:0019692,deoxyribose phosphate metabolic process,-0.02619104319549659,-1.2642956270022672,1
7917,Biological Process,GO:0009394,2'-deoxyribonucleotide metabolic process,-0.02619104319549659,-1.2642956270022672,1
7917,Biological Process,GO:0009262,deoxyribonucleotide metabolic process,-0.02619104319549659,-1.2642956270022672,1
7920,Phenotype,HP:0008981,Calf muscle hypertrophy,-0.026199758007231067,-1.2644655062193715,1
7921,Biological Process,GO:1903051,negative regulation of proteolysis involved in protein catabolic process,-0.026281313897152714,-1.2660552882080416,1
7922,Phenotype,HP:0012622,Chronic kidney disease,-0.026385253000050568,-1.2680813897423915,1
7923,Biological Process,GO:0007035,vacuolar acidification,-0.026431169215373806,-1.2689764418616059,1
7924,Phenotype,HP:0025389,Pulmonary interstitial high-resolution computed tomography abnormality,-0.026475754399875928,-1.2698455479844266,1
7925,Disease,MONDO:0005152,hypopituitarism,-0.02648492166664962,-1.2700242469798781,1
7925,Disease,MONDO:0013099,"combined pituitary hormone deficiencies, genetic form",-0.02648492166664962,-1.2700242469798781,1
7927,Phenotype,HP:0007549,Desquamation of skin soon after birth,-0.02649682755646965,-1.2702563303917955,1
7928,Phenotype,HP:0031692,Severe cytomegalovirus infection,-0.026548013706671814,-1.2712541101933394,1
7929,Phenotype,HP:0007269,Spinal muscular atrophy,-0.02661596398335897,-1.2725786757900874,1
7930,Disease,MONDO:0019751,autoinflammatory syndrome,-0.02663604652024132,-1.2729701478891968,1
7931,Biological Process,GO:0006896,Golgi to vacuole transport,-0.02668744924999955,-1.2739721495106202,1
7931,Biological Process,GO:0090160,Golgi to lysosome transport,-0.02668744924999955,-1.2739721495106202,1
7933,Biological Process,GO:0097320,plasma membrane tubulation,-0.026748719122056785,-1.2751664929128967,1
7934,Biological Process,GO:0120316,sperm flagellum assembly,-0.02675755290967685,-1.275338691345942,1
7935,Phenotype,HP:0002009,Potter facies,-0.026781203907461526,-1.275799724023389,1
7936,Biological Process,GO:0002922,positive regulation of humoral immune response,-0.026862905555341543,-1.2773923472952227,1
7937,Biological Process,GO:0033146,regulation of intracellular estrogen receptor signaling pathway,-0.026948893522146244,-1.2790685244664828,1
7938,Disease,MONDO:0020072,childhood-onset epilepsy syndrome,-0.026953133356900194,-1.2791511722425446,1
7939,Phenotype,HP:0002100,Recurrent aspiration pneumonia,-0.026982011269711448,-1.2797140940094682,1
7940,Phenotype,HP:0002779,Tracheomalacia,-0.02698505098726023,-1.2797733477091622,1
7941,Phenotype,HP:0004972,Elevated mean arterial pressure,-0.026990321682147655,-1.279876090206459,1
7942,Phenotype,HP:0010557,Overlapping fingers,-0.02699522597875581,-1.2799716904435752,1
7943,Biological Process,GO:0030204,chondroitin sulfate metabolic process,-0.027011382805757433,-1.2802866380529498,1
7943,Biological Process,GO:0030206,chondroitin sulfate biosynthetic process,-0.027011382805757433,-1.2802866380529498,1
7945,Biological Process,GO:0044282,small molecule catabolic process,-0.027074956129811367,-1.2815258830129144,1
7946,Biological Process,GO:0042417,dopamine metabolic process,-0.027142650610098684,-1.2828454623295835,1
7947,Biological Process,GO:0006658,phosphatidylserine metabolic process,-0.027151372680502828,-1.283015483041095,1
7948,Phenotype,HP:0012448,Delayed myelination,-0.027165613985809633,-1.2832930910801177,1
7949,Phenotype,HP:0010899,Abnormal circulating aspartate family amino acid concentration,-0.027170752735408366,-1.283393261546827,1
7950,Disease,MONDO:0019290,hypopigmentation of the skin,-0.027205156917796458,-1.2840639077692895,1
7951,Phenotype,HP:0009894,Thickened ears,-0.02721582141898904,-1.2842717925944125,1
7952,Phenotype,HP:0001864,Clinodactyly of the 5th toe,-0.027219280611273877,-1.2843392231821367,1
7953,Phenotype,HP:0007928,Abnormal flash visual evoked potentials,-0.027271839370087925,-1.2853637594625904,1
7954,Biological Process,GO:0099111,microtubule-based transport,-0.02727924404058757,-1.2855080998873432,1
7955,Biological Process,GO:1902017,regulation of cilium assembly,-0.027296216454520073,-1.2858389458630302,1
7956,Phenotype,HP:0005089,Abnormal metaphyseal trabeculation,-0.02732637833114948,-1.2864268961417407,1
7957,Phenotype,HP:0006248,Limited wrist movement,-0.027349664682531527,-1.2868808207086184,1
7958,Phenotype,HP:0030223,Perseverative thought,-0.027363445672893505,-1.2871494557548986,1
7959,Phenotype,HP:0003170,Abnormal acetabulum morphology,-0.027421647280382766,-1.2882839889858761,1
7960,Phenotype,HP:0000667,Phthisis bulbi,-0.02745868640538429,-1.2890059985655657,1
7961,Phenotype,HP:0011036,Abnormality of renal excretion,-0.027493668265926807,-1.2896879055605612,1
7962,Phenotype,HP:0010958,Bilateral renal agenesis,-0.027499645392979444,-1.2898044186528885,1
7963,Biological Process,GO:0034035,purine ribonucleoside bisphosphate metabolic process,-0.027503923358211724,-1.2898878097124546,1
7963,Biological Process,GO:0050427,3'-phosphoadenosine 5'-phosphosulfate metabolic process,-0.027503923358211724,-1.2898878097124546,1
7965,Disease,MONDO:0015993,cone-rod dystrophy,-0.027582002733275823,-1.291409823441724,1
7966,Phenotype,HP:0010173,Aplasia/Hypoplasia of the phalanges of the toes,-0.027586198807105333,-1.291491618179096,1
7967,Phenotype,HP:0002340,Caudate atrophy,-0.027624739705689905,-1.292242902071109,1
7968,Phenotype,HP:0001088,Brushfield spots,-0.027670751034674534,-1.2931398082561167,1
7969,Phenotype,HP:0010895,Abnormal circulating glycine concentration,-0.027679463538291316,-1.293309642480714,1
7970,Disease,MONDO:0003382,eyelid disorder,-0.02773480195507183,-1.294388363077886,1
7971,Phenotype,HP:0004991,Rhizomelic arm shortening,-0.02778567140710031,-1.2953799694313461,1
7972,Biological Process,GO:1905038,regulation of membrane lipid metabolic process,-0.027807084023068862,-1.2957973689745284,1
7973,Disease,MONDO:0006566,keratosis,-0.02791631513056192,-1.2979266283997124,1
7974,Phenotype,HP:0011481,Abnormal lacrimal duct morphology,-0.027918564018947212,-1.297970466340208,1
7975,Phenotype,HP:0100590,Rectal fistula,-0.027938442896739968,-1.298357968480155,1
7976,Phenotype,HP:0000105,Enlarged kidney,-0.027969443150544837,-1.2989622613790557,1
7977,Biological Process,GO:0016072,rRNA metabolic process,-0.028023557297234936,-1.30001711708381,1
7978,Biological Process,GO:0071318,cellular response to ATP,-0.02810009550339143,-1.3015090885614018,1
7979,Phenotype,HP:0012384,Rhinitis,-0.02811795634783043,-1.3018572528548555,1
7980,Biological Process,GO:1904754,positive regulation of vascular associated smooth muscle cell migration,-0.028130151355556077,-1.3020949720882862,1
7981,Biological Process,GO:0042274,ribosomal small subunit biogenesis,-0.028132772019565877,-1.3021460571104118,1
7982,Phenotype,HP:0032153,Joint subluxation,-0.028206160703675875,-1.3035766344516972,1
7983,Biological Process,GO:1901020,negative regulation of calcium ion transmembrane transporter activity,-0.02827859486078843,-1.3049886050457606,1
7984,Biological Process,GO:0009812,flavonoid metabolic process,-0.028279529727518904,-1.3050068285522582,1
7985,Phenotype,HP:0000147,Polycystic ovaries,-0.02832948147910086,-1.3059805460243357,1
7986,Phenotype,HP:0010501,Limitation of knee mobility,-0.02833969574161821,-1.3061796542750483,1
7987,Phenotype,HP:0010577,Absent epiphyses,-0.02842866126157162,-1.307913873365423,1
7988,Phenotype,HP:0000308,Microretrognathia,-0.028483902715749743,-1.3089907038550992,1
7989,Phenotype,HP:0012255,Dynein arm defect of respiratory motile cilia,-0.028557132672520025,-1.310418187098999,1
7990,Disease,MONDO:0005027,epilepsy,-0.028562958877379252,-1.3105317582409042,1
7991,Phenotype,HP:0009005,Weakness of the intrinsic hand muscles,-0.028749575191701293,-1.3141694998630753,1
7992,Phenotype,HP:0040252,Abnormal size of the clitoris,-0.028781534796925135,-1.3147924935524173,1
7992,Phenotype,HP:0040253,Increased size of the clitoris,-0.028781534796925135,-1.3147924935524173,1
7992,Phenotype,HP:0008665,Clitoral hypertrophy,-0.028781534796925135,-1.3147924935524173,1
7995,Disease,MONDO:0015905,syndromic dyslipidemia,-0.028793283090803312,-1.3150215049214684,1
7996,Phenotype,HP:0000919,Abnormality of the costochondral junction,-0.028807611934936306,-1.315300819368812,1
7997,Phenotype,HP:0001036,Parakeratosis,-0.028837322677504496,-1.3158799756192106,1
7998,Biological Process,GO:0006383,transcription by RNA polymerase III,-0.028879904639365073,-1.3167100326031171,1
7999,Biological Process,GO:0090141,positive regulation of mitochondrial fission,-0.028984825706830808,-1.3187552757296321,1
8000,Biological Process,GO:0006767,water-soluble vitamin metabolic process,-0.02899532397237503,-1.31895992009671,1
8001,Phenotype,HP:0001361,Nystagmus-induced head nodding,-0.02900429567907281,-1.319134807008366,1
8002,Phenotype,HP:0012841,Retinal vascular tortuosity,-0.029057009623954855,-1.32016236835563,1
8003,Biological Process,GO:0032211,negative regulation of telomere maintenance via telomerase,-0.029154789069368192,-1.3220683987027897,1
8004,Disease,MONDO:0015653,monogenic epilepsy,-0.029185686506099318,-1.3226706873720497,1
8005,Disease,MONDO:0015469,craniosynostosis,-0.02924228593692102,-1.3237739891173408,1
8006,Biological Process,GO:0050953,sensory perception of light stimulus,-0.02925753907085582,-1.3240713208934223,1
8007,Phenotype,HP:0010965,Abnormal circulating phytanic acid concentration,-0.029268975934821917,-1.3242942615094544,1
8007,Phenotype,HP:0010571,Elevated circulating phytanic acid concentration,-0.029268975934821917,-1.3242942615094544,1
8009,Biological Process,GO:0065004,protein-DNA complex assembly,-0.02931569299018988,-1.3252049245315738,1
8010,Phenotype,HP:0002403,Positive Romberg sign,-0.02931608453390333,-1.325212556955719,1
8011,Biological Process,GO:0030279,negative regulation of ossification,-0.029318281489512543,-1.3252553825623157,1
8012,Phenotype,HP:0012610,Abnormality of urinary uric acid level,-0.02944207182856906,-1.327668447413824,1
8013,Biological Process,GO:0001764,neuron migration,-0.029481053618920283,-1.3284283256794653,1
8014,Biological Process,GO:0007288,sperm axoneme assembly,-0.029562416718149853,-1.3300143495683814,1
8015,Phenotype,HP:0001407,Hepatic cysts,-0.029629517077214507,-1.3313223475851619,1
8016,Biological Process,GO:0051123,RNA polymerase II preinitiation complex assembly,-0.029668751879807775,-1.3320871578588493,1
8017,Biological Process,GO:0034143,regulation of toll-like receptor 4 signaling pathway,-0.029713038927567936,-1.3329504523545397,1
8018,Phenotype,HP:0000630,Abnormal retinal artery morphology,-0.029718073246346455,-1.3330485871345905,1
8019,Phenotype,HP:0005684,Distal arthrogryposis,-0.029764602299787724,-1.3339555854051244,1
8020,Biological Process,GO:0010561,negative regulation of glycoprotein biosynthetic process,-0.029765605724447752,-1.3339751453222932,1
8021,Biological Process,GO:0046395,carboxylic acid catabolic process,-0.029788062299867413,-1.3344128949338012,1
8021,Biological Process,GO:0016054,organic acid catabolic process,-0.029788062299867413,-1.3344128949338012,1
8023,Phenotype,HP:0002804,Arthrogryposis multiplex congenita,-0.029935420657484446,-1.3372853749354863,1
8024,Phenotype,HP:0005994,Nodular goiter,-0.02993592617597929,-1.3372952290882498,1
8025,Phenotype,HP:0030948,Elevated gamma-glutamyltransferase level,-0.02998957034066918,-1.3383409233588066,1
8026,Phenotype,HP:0008715,Testicular dysgenesis,-0.029993248002962103,-1.3384126126172933,1
8027,Biological Process,GO:0006367,transcription initiation at RNA polymerase II promoter,-0.030005183667725754,-1.3386452764369425,1
8028,Phenotype,HP:0012666,Severely reduced left ventricular ejection fraction,-0.030025163451204318,-1.3390347455475398,1
8029,Phenotype,HP:0011217,Abnormal shape of the occiput,-0.030030881773362772,-1.3391462137147274,1
8030,Biological Process,GO:0015936,coenzyme A metabolic process,-0.030047023555423547,-1.3394608680506668,1
8031,Phenotype,HP:0004918,Hyperchloremic metabolic acidosis,-0.030062724091189263,-1.3397669211020993,1
8032,Phenotype,HP:0006808,Cerebral hypomyelination,-0.03013389528163879,-1.3411542724852743,1
8033,Biological Process,GO:0006805,xenobiotic metabolic process,-0.030166567926215748,-1.3417911655646162,1
8034,Phenotype,HP:0007720,Flat cornea,-0.030179122463317887,-1.342035893161608,1
8035,Phenotype,HP:0002780,Bronchomalacia,-0.03018218184217658,-1.3420955301223567,1
8036,Biological Process,GO:0019217,regulation of fatty acid metabolic process,-0.030215696330126995,-1.34274883338904,1
8037,Phenotype,HP:0032807,Neonatal seizure,-0.03022588441866203,-1.342947431426135,1
8038,Phenotype,HP:0000977,Soft skin,-0.030299943530335938,-1.3443910775190069,1
8039,Phenotype,HP:0000289,Broad philtrum,-0.030327186309796472,-1.344922125370355,1
8040,Phenotype,HP:0000272,Malar flattening,-0.03038937083337867,-1.3461342982208993,1
8041,Phenotype,HP:0010515,Aplasia/Hypoplasia of the thymus,-0.030422277733520353,-1.3467757576813806,1
8042,Phenotype,HP:0001994,Renal Fanconi syndrome,-0.03043290793607034,-1.3469829739175854,1
8043,Disease,MONDO:0000824,congenital diarrhea,-0.030498194079327856,-1.3482556071358636,1
8043,Disease,MONDO:0001673,diarrheal disease,-0.030498194079327856,-1.3482556071358636,1
8045,Biological Process,GO:0070918,regulatory ncRNA processing,-0.03050753273646789,-1.3484376470711013,1
8046,Biological Process,GO:0075522,IRES-dependent viral translational initiation,-0.03054470873297288,-1.3491623247088693,1
8047,Biological Process,GO:0043649,dicarboxylic acid catabolic process,-0.030545780382145837,-1.349183214537366,1
8048,Biological Process,GO:0030858,positive regulation of epithelial cell differentiation,-0.030634265917765635,-1.3509080772164601,1
8049,Phenotype,HP:0006342,Peg-shaped maxillary lateral incisors,-0.03070225812836247,-1.3522334602376074,1
8050,Phenotype,HP:0000138,Ovarian cyst,-0.030746065470346418,-1.3530874037519813,1
8051,Biological Process,GO:0034504,protein localization to nucleus,-0.030746650442879275,-1.3530988067149985,1
8052,Phenotype,HP:0032559,Short sperm flagella,-0.03077724711985752,-1.353695232626357,1
8053,Phenotype,HP:0012245,Sex reversal,-0.030786594621077468,-1.3538774449606572,1
8054,Biological Process,GO:0009792,embryo development ending in birth or egg hatching,-0.03082365085802352,-1.3545997881062144,1
8055,Phenotype,HP:0200106,Absent/shortened dynein arms,-0.030863393174090037,-1.355374491421098,1
8056,Phenotype,HP:0006698,Dilatation of the ventricular cavity,-0.03088493552743743,-1.3557944199557281,1
8057,Biological Process,GO:0019348,dolichol metabolic process,-0.030888815612848175,-1.3558700550803822,1
8058,Biological Process,GO:0036109,alpha-linolenic acid metabolic process,-0.030905522538203112,-1.3561957258448218,1
8059,Biological Process,GO:1903358,regulation of Golgi organization,-0.030933828099749316,-1.3567474906771175,1
8060,Phenotype,HP:0003510,Severe short stature,-0.03095509777249572,-1.357162103805239,1
8061,Phenotype,HP:0000879,Short sternum,-0.031005185856785245,-1.3581384788325603,1
8062,Phenotype,HP:0002763,Abnormal cartilage morphology,-0.03101253586998909,-1.358281753813916,1
8063,Phenotype,HP:0001339,Lissencephaly,-0.031021212016026034,-1.3584508793144023,1
8064,Biological Process,GO:0034440,lipid oxidation,-0.031029798936567765,-1.358618265528059,1
8065,Phenotype,HP:0007678,Lacrimal duct stenosis,-0.0310541218953182,-1.3590923968479398,1
8066,Biological Process,GO:0033198,response to ATP,-0.03110885107779615,-1.3601592415435426,1
8067,Phenotype,HP:0000506,Telecanthus,-0.031117079272269033,-1.360319635052642,1
8068,Phenotype,HP:0003090,Hypoplasia of the capital femoral epiphysis,-0.031123339520225946,-1.3604416670659776,1
8069,Biological Process,GO:0000082,G1/S transition of mitotic cell cycle,-0.03113640630670078,-1.3606963800218101,1
8070,Phenotype,HP:0031882,Agyria,-0.031149253100535956,-1.3609468046259796,1
8071,Disease,MONDO:0020065,combined dystonia,-0.031157806189341608,-1.3611135313522011,1
8072,Phenotype,HP:5200293,Disturbance during transitions between sleep and wake states,-0.03125228194518215,-1.36295516235084,1
8073,Biological Process,GO:0006376,mRNA splice site recognition,-0.031311588190713335,-1.364111228467606,1
8074,Biological Process,GO:0034249,negative regulation of amide metabolic process,-0.031327202165994494,-1.3644155941816873,1
8075,Biological Process,GO:0030497,fatty acid elongation,-0.03135746455163191,-1.3650055036985447,1
8076,Phenotype,HP:0008968,Muscle hypertrophy of the lower extremities,-0.0313694707555503,-1.3652395425492039,1
8077,Phenotype,HP:0002025,Anal stenosis,-0.03146476720795799,-1.367097171517111,1
8078,Biological Process,GO:0006766,vitamin metabolic process,-0.03147759757577795,-1.3673472759263423,1
8079,Phenotype,HP:0005003,Aplasia/Hypoplasia of the capital femoral epiphysis,-0.031538907367305136,-1.3685423974852227,1
8080,Phenotype,HP:0002314,Degeneration of the lateral corticospinal tracts,-0.0315500009965799,-1.3687586473725937,1
8081,Biological Process,GO:0046320,regulation of fatty acid oxidation,-0.031569186138812766,-1.3691326264144654,1
8082,Biological Process,GO:0060261,positive regulation of transcription initiation by RNA polymerase II,-0.0315802974995536,-1.3693492219441366,1
8083,Disease,MONDO:0056803,sulfur metabolism disease,-0.03163762571240891,-1.3704667299540128,1
8084,Phenotype,HP:0011054,Agenesis of molar,-0.031699000985014214,-1.3716631279460079,1
8085,Biological Process,GO:0010971,positive regulation of G2/M transition of mitotic cell cycle,-0.03190937166673935,-1.3757639172461082,1
8086,Phenotype,HP:0001533,Slender build,-0.03198693594826407,-1.3772758901747417,1
8087,Biological Process,GO:0033144,negative regulation of intracellular steroid hormone receptor signaling pathway,-0.032017510058177656,-1.3778718761827042,1
8088,Biological Process,GO:0009067,aspartate family amino acid biosynthetic process,-0.0320420210331569,-1.3783496725329638,1
8089,Phenotype,HP:0002942,Thoracic kyphosis,-0.032053462535647226,-1.3785727035684896,1
8090,Phenotype,HP:0001047,Atopic dermatitis,-0.03206740733173152,-1.3788445317058784,1
8091,Phenotype,HP:0001884,Talipes calcaneovalgus,-0.03209072452782524,-1.3792990575336477,1
8092,Disease,MONDO:0002545,spinal cord disorder,-0.032192526266837884,-1.381283495092395,1
8092,Disease,MONDO:0003182,anterior horn disorder,-0.032192526266837884,-1.381283495092395,1
8094,Phenotype,HP:0004381,Supravalvular aortic stenosis,-0.032203553902747206,-1.3814984585605528,1
8095,Biological Process,GO:0001522,pseudouridine synthesis,-0.03221056383000409,-1.3816351041922244,1
8096,Phenotype,HP:0002908,Conjugated hyperbilirubinemia,-0.032216093541598934,-1.38174289574357,1
8097,Biological Process,GO:0170039,proteinogenic amino acid metabolic process,-0.032252076821925435,-1.3824443235743653,1
8098,Biological Process,GO:0000096,sulfur amino acid metabolic process,-0.03229017387872446,-1.3831869555875604,1
8099,Disease,MONDO:0019942,distal arthrogryposis,-0.03246962611298709,-1.3866850466528584,1
8100,Phenotype,HP:0003596,Middle age onset,-0.03251092404740086,-1.3874900738846543,1
8101,Phenotype,HP:0001436,Abnormality of the foot musculature,-0.03256818335624434,-1.3886062387376223,1
8102,Phenotype,HP:0004684,Talipes valgus,-0.03265050766511268,-1.390210999639555,1
8103,Biological Process,GO:0034310,primary alcohol catabolic process,-0.0326795851497379,-1.3907778116917247,1
8104,Biological Process,GO:0007600,sensory perception,-0.03285299728846236,-1.3941581622099493,1
8105,Phenotype,HP:0003273,Hip contracture,-0.03290210326537779,-1.3951153928613613,1
8106,Biological Process,GO:1902275,regulation of chromatin organization,-0.032996979300211615,-1.3969648265623504,1
8107,Phenotype,HP:0002446,Astrocytosis,-0.03302846792170855,-1.3975786392906766,1
8108,Phenotype,HP:0000264,Abnormal mastoid morphology,-0.03305562206723778,-1.3981079593866448,1
8109,Phenotype,HP:0002450,Abnormal motor neuron morphology,-0.033068130570754306,-1.3983517896435997,1
8110,Phenotype,HP:0002267,Exaggerated startle response,-0.03306907931484093,-1.3983702836636176,1
8111,Phenotype,HP:5200065,Tactile sensory seeking,-0.03313855688275069,-1.3997246209921128,1
8112,Phenotype,HP:0002046,Heat intolerance,-0.03313949587559861,-1.399742924929677,1
8113,Phenotype,HP:0000375,Abnormal cochlea morphology,-0.03316506098601035,-1.4002412697102928,1
8114,Phenotype,HP:0100711,Abnormal thoracic spine morphology,-0.033187608933340496,-1.4006808004490463,1
8115,Biological Process,GO:0019395,fatty acid oxidation,-0.03327197153363004,-1.4023252940912165,1
8116,Biological Process,GO:0009301,snRNA transcription,-0.0332964075026021,-1.4028016283373979,1
8117,Biological Process,GO:0046475,glycerophospholipid catabolic process,-0.03330608228849008,-1.402990220484007,1
8118,Phenotype,HP:0012207,Reduced sperm motility,-0.03338441520725799,-1.4045171765811917,1
8119,Phenotype,HP:0100541,Femoral hernia,-0.03339217786044402,-1.4046684952196284,1
8120,Phenotype,HP:0002427,Expressive aphasia,-0.03342622573609111,-1.4053321958978777,1
8121,Phenotype,HP:0100034,Motor tics,-0.03350173837377679,-1.4068041758054601,1
8122,Biological Process,GO:0010970,transport along microtubule,-0.03351017374969323,-1.4069686079355308,1
8123,Phenotype,HP:0003025,Metaphyseal irregularity,-0.03351303969511088,-1.407024474267317,1
8124,Biological Process,GO:0071218,cellular response to misfolded protein,-0.03351369133368265,-1.4070371767620788,1
8125,Phenotype,HP:0001795,Hyperconvex nail,-0.03351777973060388,-1.4071168725362793,1
8126,Biological Process,GO:0060236,regulation of mitotic spindle organization,-0.03360709815795504,-1.4088579709069258,1
8127,Biological Process,GO:0016197,endosomal transport,-0.03371852003991438,-1.4110299354487001,1
8128,Phenotype,HP:0011519,Anomalous trichromacy,-0.03374923554043585,-1.4116286776063658,1
8129,Phenotype,HP:0003712,Skeletal muscle hypertrophy,-0.03377124028841427,-1.412057619673394,1
8130,Biological Process,GO:1903019,negative regulation of glycoprotein metabolic process,-0.033788167860268725,-1.4123875915352913,1
8131,Disease,MONDO:0017757,disorder of metabolite absorption and transport,-0.03379467546293968,-1.412514445273576,1
8132,Phenotype,HP:0007082,Dilated third ventricle,-0.03380074731608129,-1.4126328048766856,1
8132,Phenotype,HP:0010951,Abnormal third ventricle morphology,-0.03380074731608129,-1.4126328048766856,1
8134,Phenotype,HP:0011219,Short face,-0.0338080988672218,-1.4127761098372864,1
8135,Phenotype,HP:0000350,Small forehead,-0.0338847352438032,-1.4142699949666508,1
8136,Phenotype,HP:0000073,Ureteral duplication,-0.0339159805634337,-1.4148790649728336,1
8137,Biological Process,GO:0046164,alcohol catabolic process,-0.03400344092701113,-1.4165839438095615,1
8138,Phenotype,HP:0007418,Alopecia totalis,-0.034076184291111034,-1.418001941824817,1
8139,Phenotype,HP:0002623,Overriding aorta,-0.0341731180301279,-1.4198914866821106,1
8140,Phenotype,HP:0009836,Broad distal phalanx of finger,-0.034188996750577294,-1.4202010131160423,1
8141,Phenotype,HP:0002756,Pathologic fracture,-0.03423226729275464,-1.4210444927060464,1
8142,Phenotype,HP:0011706,Second degree atrioventricular block,-0.03424536888442131,-1.4212998841250426,1
8143,Disease,MONDO:0021095,parkinsonian disorder,-0.03426355343230725,-1.4216543584214907,1
8144,Biological Process,GO:0016073,snRNA metabolic process,-0.034266039705245666,-1.4217028237369966,1
8145,Disease,MONDO:0024321,disorder of GPI anchor biosynthesis,-0.03438076456999206,-1.4239391738498046,1
8146,Biological Process,GO:0010876,lipid localization,-0.03456388046897896,-1.4275086813167475,1
8147,Biological Process,GO:0033119,negative regulation of RNA splicing,-0.034596430791952404,-1.4281431899615344,1
8148,Phenotype,HP:0006739,Squamous cell carcinoma of the skin,-0.03460081857851649,-1.4282287217858627,1
8149,Phenotype,HP:0007374,Atrophy/Degeneration involving the caudate nucleus,-0.034703169968850034,-1.4302238737856008,1
8150,Phenotype,HP:0007209,Facial paralysis,-0.03477230191153491,-1.4315714737863827,1
8151,Biological Process,GO:0070897,transcription preinitiation complex assembly,-0.0348036884616012,-1.4321832968200083,1
8152,Phenotype,HP:0012769,Abnormal arm span,-0.034841630386672096,-1.4329229048256487,1
8153,Phenotype,HP:0011231,Prominent eyelashes,-0.03485828237463817,-1.4332475046867923,1
8154,Phenotype,HP:0005764,Polyarticular arthritis,-0.034875335359829895,-1.4335799212509044,1
8155,Disease,MONDO:0020074,progressive myoclonus epilepsy,-0.03488136162091937,-1.4336973921208598,1
8156,Biological Process,GO:0060021,roof of mouth development,-0.034951408972437426,-1.4350628363322395,1
8157,Phenotype,HP:0002171,Gliosis,-0.03500729406086678,-1.436152213287179,1
8158,Phenotype,HP:0009916,Anisocoria,-0.035022811098054385,-1.436454689371519,1
8159,Phenotype,HP:0004320,Vaginal fistula,-0.035101215961483856,-1.4379830478974829,1
8160,Phenotype,HP:0002803,Congenital contracture,-0.035188896473693054,-1.439692218126653,1
8161,Disease,MONDO:0024417,perceptual disorders,-0.03521672068726489,-1.4402345999660016,1
8162,Phenotype,HP:0005117,Elevated diastolic blood pressure,-0.035272920175444256,-1.441330105565485,1
8163,Biological Process,GO:0042402,cellular biogenic amine catabolic process,-0.03530473998134176,-1.4419503741242297,1
8163,Biological Process,GO:0009310,amine catabolic process,-0.03530473998134176,-1.4419503741242297,1
8165,Biological Process,GO:0033540,fatty acid beta-oxidation using acyl-CoA oxidase,-0.03530891620986476,-1.4420317820138722,1
8166,Disease,MONDO:0019289,hyperpigmentation of the skin,-0.03531733289403349,-1.4421958497827192,1
8167,Biological Process,GO:0060211,regulation of nuclear-transcribed mRNA poly(A) tail shortening,-0.035403327181760647,-1.4438721501687302,1
8168,Phenotype,HP:0025709,Intermediate young adult onset,-0.035426158629754845,-1.4443172072312098,1
8169,Biological Process,GO:0010972,negative regulation of G2/M transition of mitotic cell cycle,-0.03546298706463347,-1.4450351097946812,1
8170,Biological Process,GO:0018345,protein palmitoylation,-0.03547699382314895,-1.445308145775638,1
8171,Biological Process,GO:0071539,protein localization to centrosome,-0.03552440578706828,-1.4462323547611429,1
8171,Biological Process,GO:1905508,protein localization to microtubule organizing center,-0.03552440578706828,-1.4462323547611429,1
8173,Phenotype,HP:0000652,Lower eyelid coloboma,-0.03562302861381528,-1.4481548252753478,1
8174,Disease,MONDO:0005087,respiratory system disorder,-0.035624588513942346,-1.448185232657678,1
8175,Phenotype,HP:0006289,Agenesis of central incisor,-0.03562824485180238,-1.4482565062355883,1
8176,Phenotype,HP:0033993,Viral encephalitis,-0.03569814664731874,-1.4496191131005784,1
8177,Biological Process,GO:1903504,regulation of mitotic spindle checkpoint,-0.03571699691917374,-1.4499865644606873,1
8177,Biological Process,GO:0090231,regulation of spindle checkpoint,-0.03571699691917374,-1.4499865644606873,1
8177,Biological Process,GO:0090266,regulation of mitotic cell cycle spindle assembly checkpoint,-0.03571699691917374,-1.4499865644606873,1
8180,Phenotype,HP:0009077,Weakness of long finger extensor muscles,-0.035848554769613905,-1.4525510426522545,1
8181,Phenotype,HP:0000868,Decreased fertility in females,-0.035851167741772993,-1.4526019777359058,1
8182,Phenotype,HP:0000916,Broad clavicles,-0.03592773342285693,-1.4540944847866468,1
8183,Phenotype,HP:0000895,Lateral clavicle hook,-0.03593848623879725,-1.4543040911452534,1
8184,Phenotype,HP:0011195,EEG with focal sharp slow waves,-0.03595731754894649,-1.4546711728818034,1
8185,Biological Process,GO:0042572,retinol metabolic process,-0.035974094531344036,-1.4549982092793643,1
8186,Phenotype,HP:0003037,Enlarged joints,-0.035976510472325085,-1.4550453036027915,1
8187,Phenotype,HP:0003551,Difficulty climbing stairs,-0.03598651766036065,-1.4552403753175562,1
8188,Disease,MONDO:0020073,adolescent-onset epilepsy syndrome,-0.03608208181782269,-1.4571032227028466,1
8189,Phenotype,HP:0002758,Osteoarthritis,-0.03608821657971406,-1.4572228085962635,1
8190,Phenotype,HP:0000575,Scotoma,-0.03610927919441154,-1.457633385508765,1
8191,Biological Process,GO:0006855,xenobiotic transmembrane transport,-0.03612529954635613,-1.4579456727880546,1
8192,Phenotype,HP:0012179,Craniofacial dystonia,-0.03615034676857665,-1.45843392229144,1
8193,Phenotype,HP:0010852,EEG with photoparoxysmal response,-0.036207201501815556,-1.4595422006875276,1
8194,Disease,MONDO:0015168,arthrogryposis multiplex congenita,-0.03628119689260623,-1.460984604659045,1
8195,Phenotype,HP:0100021,Cerebral palsy,-0.03628168471919291,-1.4609941139406166,1
8196,Disease,MONDO:0017748,inborn disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation,-0.03629243839105256,-1.4612037369837956,1
8197,Disease,MONDO:0020128,motor neuron disorder,-0.03631799022937465,-1.461701823049448,1
8197,Disease,MONDO:0024257,hereditary motor neuron disease,-0.03631799022937465,-1.461701823049448,1
8199,Disease,MONDO:0800096,abnormal mineralization disorder,-0.03633254033022015,-1.461985450489229,1
8200,Biological Process,GO:0034032,purine nucleoside bisphosphate metabolic process,-0.03634538277165311,-1.4622357902513268,1
8200,Biological Process,GO:0033865,nucleoside bisphosphate metabolic process,-0.03634538277165311,-1.4622357902513268,1
8200,Biological Process,GO:0033875,ribonucleoside bisphosphate metabolic process,-0.03634538277165311,-1.4622357902513268,1
8203,Phenotype,HP:0010894,Abnormal circulating serine family amino acid concentration,-0.03635150055546155,-1.462355045188261,1
8204,Phenotype,HP:0040140,Degeneration of the striatum,-0.0363759747851673,-1.4628321252570353,1
8205,Biological Process,GO:0043267,negative regulation of potassium ion transport,-0.03640087231328204,-1.4633174567493072,1
8206,Disease,MONDO:0018921,Meckel syndrome,-0.03642965599879133,-1.4638785417283833,1
8207,Phenotype,HP:0001970,Tubulointerstitial nephritis,-0.036439406595709656,-1.4640686116715158,1
8208,Phenotype,HP:0030043,Hip subluxation,-0.03646503184748018,-1.4645681287972445,1
8209,Biological Process,GO:1904263,positive regulation of TORC1 signaling,-0.036536099551129686,-1.4659534628956974,1
8210,Phenotype,HP:0003689,Multiple mitochondrial DNA deletions,-0.03654406850454994,-1.466108802977551,1
8211,Disease,MONDO:0019288,skin pigmentation disorder,-0.036565786525487365,-1.466532155828572,1
8212,Phenotype,HP:0001685,Myocardial fibrosis,-0.03660140619477237,-1.4672264957312582,1
8213,Phenotype,HP:0003133,Abnormality of the spinocerebellar tracts,-0.03661347586755448,-1.4674617717906153,1
8214,Phenotype,HP:0200136,Oral-pharyngeal dysphagia,-0.036614208665444625,-1.4674760563369333,1
8215,Phenotype,HP:0002550,Absent facial hair,-0.036615171362727406,-1.4674948223488324,1
8216,Phenotype,HP:0002944,Thoracolumbar scoliosis,-0.036694661350769486,-1.46904433338219,1
8217,Disease,MONDO:0006590,palmoplantar keratosis,-0.03670446677275496,-1.4692354720391136,1
8217,Disease,MONDO:0019272,hereditary palmoplantar keratoderma,-0.03670446677275496,-1.4692354720391136,1
8219,Biological Process,GO:0030500,regulation of bone mineralization,-0.03688443156197696,-1.4727435544201017,1
8220,Phenotype,HP:0006286,Yellow-brown discoloration of the teeth,-0.03694023410529357,-1.473831322309974,1
8221,Biological Process,GO:1901028,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,-0.03708021385979987,-1.476559970022682,1
8222,Phenotype,HP:0009046,Difficulty running,-0.03710698212176755,-1.47708176802875,1
8223,Phenotype,HP:0000445,Wide nose,-0.03710875980152095,-1.477116420624121,1
8224,Phenotype,HP:0030799,Scaphocephaly,-0.03711198109056135,-1.4771792137259026,1
8225,Phenotype,HP:0012345,Abnormal glycosylation,-0.03715464032511351,-1.4780107769987283,1
8226,Biological Process,GO:0009225,nucleotide-sugar metabolic process,-0.03721951636153831,-1.4792754159390127,1
8227,Biological Process,GO:0006563,L-serine metabolic process,-0.037339700687326616,-1.4816181881979171,1
8228,Disease,MONDO:0005308,ciliopathy,-0.03748867546562051,-1.4845221773460373,1
8229,Phenotype,HP:0025575,Abnormal superior vena cava morphology,-0.03755433554781251,-1.4858020998156924,1
8230,Biological Process,GO:0048025,"negative regulation of mRNA splicing, via spliceosome",-0.03764597086554011,-1.48758836170051,1
8230,Biological Process,GO:0050686,negative regulation of mRNA processing,-0.03764597086554011,-1.48758836170051,1
8232,Biological Process,GO:0035338,long-chain fatty-acyl-CoA biosynthetic process,-0.03768954157267612,-1.4884376924539968,1
8233,Phenotype,HP:0010582,Irregular epiphyses,-0.03769377643280203,-1.4885202432588396,1
8234,Phenotype,HP:0005301,Persistent left superior vena cava,-0.03784769489110196,-1.4915206003509414,1
8235,Phenotype,HP:0006858,Impaired distal proprioception,-0.03793577273906035,-1.4932375159093345,1
8236,Biological Process,GO:0097267,omega-hydroxylase P450 pathway,-0.037955613546933664,-1.4936242759462608,1
8237,Phenotype,HP:0002757,Recurrent fractures,-0.03798056626777879,-1.4941106833192417,1
8238,Biological Process,GO:0044843,cell cycle G1/S phase transition,-0.03807149918268493,-1.4958832531536697,1
8239,Biological Process,GO:0007549,sex-chromosome dosage compensation,-0.038176104196195215,-1.4979223353899496,1
8240,Phenotype,HP:0025158,Hyperautofluorescent retinal lesion,-0.038208753781199256,-1.4985587789653534,1
8241,Phenotype,HP:0001799,Short nail,-0.038311581655521953,-1.5005632191435982,1
8242,Phenotype,HP:0003768,Periodic paralysis,-0.03845043259006742,-1.5032698625885101,1
8243,Phenotype,HP:0005116,Arterial tortuosity,-0.03848407082574545,-1.5039255780894134,1
8244,Phenotype,HP:0012049,Laryngeal dystonia,-0.03854973510059878,-1.5052055822872854,1
8245,Biological Process,GO:2000738,positive regulation of stem cell differentiation,-0.038599049308971844,-1.5061668720277608,1
8246,Biological Process,GO:0086005,ventricular cardiac muscle cell action potential,-0.038767563693212326,-1.5094517498355404,1
8247,Biological Process,GO:0009190,cyclic nucleotide biosynthetic process,-0.03879015767870442,-1.509892178003538,1
8248,Phenotype,HP:0000015,Bladder diverticulum,-0.03881926612900455,-1.5104595936745546,1
8249,Phenotype,HP:0006376,Limited elbow flexion,-0.03884012283116589,-1.5108661567011001,1
8250,Biological Process,GO:0009582,detection of abiotic stimulus,-0.03884169698350193,-1.5108968419040163,1
8251,Phenotype,HP:0003429,CNS hypomyelination,-0.038862963239452375,-1.5113113884279883,1
8252,Phenotype,HP:0002089,Pulmonary hypoplasia,-0.03887978678637949,-1.5116393325153616,1
8253,Biological Process,GO:0032365,intracellular lipid transport,-0.03891514475124436,-1.5123285709719856,1
8254,Biological Process,GO:0090224,regulation of spindle organization,-0.03891919828561252,-1.5124075871648708,1
8255,Disease,MONDO:0003381,pituitary gland disorder,-0.03894991841430584,-1.5130064195402293,1
8256,Phenotype,HP:0006335,Persistence of primary teeth,-0.039024937480320654,-1.5144687781763961,1
8257,Phenotype,HP:0011006,Abnormal morphology of the musculature of the neck,-0.03910030268266662,-1.5159378841033526,1
8258,Phenotype,HP:0001816,Thin nail,-0.03912633475392613,-1.516445331426359,1
8259,Biological Process,GO:0072348,sulfur compound transport,-0.03915278776641795,-1.5169609842240412,1
8260,Disease,MONDO:0015338,syndromic craniosynostosis,-0.03915857074154294,-1.517073712681832,1
8261,Biological Process,GO:0070741,response to interleukin-6,-0.03937023634035852,-1.521199744007606,1
8262,Phenotype,HP:0002289,Alopecia universalis,-0.03950332723384897,-1.523794106052216,1
8263,Phenotype,HP:0010668,Abnormal zygomatic bone morphology,-0.03956006514669208,-1.5249001072496693,1
8264,Phenotype,HP:0008997,Proximal muscle weakness in upper limbs,-0.03961064558152483,-1.52588607974477,1
8265,Phenotype,HP:0007410,Palmoplantar hyperhidrosis,-0.03963403292493628,-1.5263419729654077,1
8266,Biological Process,GO:1901380,negative regulation of potassium ion transmembrane transport,-0.03967846753262805,-1.5272081438704137,1
8267,Disease,MONDO:0015225,arthrogryposis syndrome,-0.03968838505863981,-1.527401467789027,1
8268,Disease,MONDO:0016761,spondyloepiphyseal dysplasia,-0.039737021826416585,-1.5283495520717556,1
8269,Biological Process,GO:0010389,regulation of G2/M transition of mitotic cell cycle,-0.03977316144909593,-1.5290540275090068,1
8270,Phenotype,HP:0025517,Hypoplastic hippocampus,-0.03982744049781983,-1.5301120976754448,1
8271,Phenotype,HP:0010794,Impaired visuospatial constructive cognition,-0.039992835539871985,-1.533336169647714,1
8272,Disease,MONDO:0017198,osteopetrosis,-0.04005175650592707,-1.534484725450114,1
8273,Phenotype,HP:0001538,Protuberant abdomen,-0.040105490006961286,-1.5355321611683,1
8274,Biological Process,GO:0090737,telomere maintenance via telomere trimming,-0.040112403880645076,-1.5356669344123293,1
8274,Biological Process,GO:0090656,t-circle formation,-0.040112403880645076,-1.5356669344123293,1
8274,Biological Process,GO:0001325,formation of extrachromosomal circular DNA,-0.040112403880645076,-1.5356669344123293,1
8277,Biological Process,GO:0036465,synaptic vesicle recycling,-0.0401920965164857,-1.5372203956915915,1
8278,Phenotype,HP:0011486,Abnormality of corneal thickness,-0.04021711796119698,-1.537708142709872,1
8279,Biological Process,GO:0035082,axoneme assembly,-0.04022848738873952,-1.5379297687769284,1
8280,Phenotype,HP:0002991,Abnormal fibula morphology,-0.040235680621437675,-1.538069987610845,1
8281,Biological Process,GO:0032366,intracellular sterol transport,-0.04025443641768245,-1.538435597342794,1
8281,Biological Process,GO:0032367,intracellular cholesterol transport,-0.04025443641768245,-1.538435597342794,1
8283,Phenotype,HP:0000097,Focal segmental glomerulosclerosis,-0.04026001326347206,-1.5385443076885266,1
8284,Phenotype,HP:0011078,Abnormality of canine,-0.040359712405148684,-1.540487758981568,1
8285,Phenotype,HP:0010994,Abnormal corpus striatum morphology,-0.04050804097061156,-1.5433791513997575,1
8286,Phenotype,HP:0007979,Gaze-evoked horizontal nystagmus,-0.040563380078975975,-1.5444578854780848,1
8287,Disease,MONDO:0017666,diffuse palmoplantar keratoderma,-0.04061489027394938,-1.5454619819361124,1
8288,Biological Process,GO:0050435,amyloid-beta metabolic process,-0.0407319340265635,-1.5477435345005077,1
8289,Phenotype,HP:0000590,Progressive external ophthalmoplegia,-0.04076899413423729,-1.548465953098779,1
8290,Biological Process,GO:0051292,nuclear pore complex assembly,-0.040844682730915904,-1.5499413630031156,1
8291,Phenotype,HP:0410011,Abnormality of masticatory muscle,-0.0408517481736943,-1.550079090807715,1
8292,Phenotype,HP:0030629,Perifoveal ring of hyperautofluorescence,-0.04089215050145811,-1.5508666598360337,1
8293,Disease,MONDO:0024322,disorder of glycosylation,-0.04091338188016369,-1.5512805264923009,1
8294,Phenotype,HP:0045080,Decreased proportion of CD3-positive T cells,-0.040968057461858054,-1.5523463263392678,1
8295,Disease,MONDO:0017761,disorder of mineral absorption and transport,-0.04099407054841109,-1.5528534035903587,1
8296,Phenotype,HP:0045084,Limb myoclonus,-0.04100618219927754,-1.553089497935219,1
8297,Biological Process,GO:0070286,axonemal dynein complex assembly,-0.041017559152142447,-1.5533112706945862,1
8298,Phenotype,HP:0010444,Pulmonary insufficiency,-0.04102487698633239,-1.553453918405284,1
8299,Phenotype,HP:0100589,Urogenital fistula,-0.04118649299363586,-1.5566043250495947,1
8300,Disease,MONDO:0005240,kidney disorder,-0.04121008855855535,-1.5570642771653465,1
8301,Phenotype,HP:0000480,Retinal coloboma,-0.041265517251662054,-1.5581447575333645,1
8302,Phenotype,HP:0100689,Decreased corneal thickness,-0.04155918961464433,-1.5638693598114823,1
8303,Phenotype,HP:0000033,"Ambiguous genitalia, male",-0.041575354934939135,-1.5641844729819774,1
8304,Phenotype,HP:0001804,Hypoplastic fingernail,-0.041584103875166756,-1.5643550174712497,1
8305,Phenotype,HP:0006118,Shortening of all distal phalanges of the fingers,-0.04159722196828053,-1.5646107305555899,1
8306,Biological Process,GO:0006278,RNA-templated DNA biosynthetic process,-0.041605194038123905,-1.564766131386377,1
8306,Biological Process,GO:0007004,telomere maintenance via telomerase,-0.041605194038123905,-1.564766131386377,1
8308,Biological Process,GO:0006656,phosphatidylcholine biosynthetic process,-0.041820743715434316,-1.5689678756746308,1
8309,Phenotype,HP:0034197,Third trimester onset,-0.041834943113191025,-1.569244666803086,1
8310,Phenotype,HP:0000593,Abnormal anterior chamber morphology,-0.04193071679947602,-1.571111598567189,1
8311,Biological Process,GO:0000381,"regulation of alternative mRNA splicing, via spliceosome",-0.04193757993266489,-1.5712453827186466,1
8312,Phenotype,HP:0007373,Motor neuron atrophy,-0.04194569702358075,-1.571403610468363,1
8313,Phenotype,HP:0031589,Suicidal ideation,-0.04196364695275778,-1.5717535113048442,1
8314,Phenotype,HP:0030631,Hyperautofluorescent macular lesion,-0.04204791740662883,-1.5733962087221607,1
8315,Phenotype,HP:0009817,Aplasia involving bones of the lower limbs,-0.042080727003098506,-1.5740357714266218,1
8316,Biological Process,GO:0051298,centrosome duplication,-0.04208418355781518,-1.5741031505998084,1
8317,Phenotype,HP:0008052,Retinal fold,-0.042086909447408116,-1.5741562868010333,1
8318,Biological Process,GO:0006490,oligosaccharide-lipid intermediate biosynthetic process,-0.042235996586395874,-1.5770624662141057,1
8318,Biological Process,GO:0006488,dolichol-linked oligosaccharide biosynthetic process,-0.042235996586395874,-1.5770624662141057,1
8320,Phenotype,HP:0011154,Focal autonomic seizure,-0.042315751329560225,-1.5786171381613494,1
8321,Disease,MONDO:0019342,Seckel syndrome,-0.04233654520464136,-1.5790224764895857,1
8322,Disease,MONDO:0015286,congenital disorder of glycosylation,-0.04233895152149114,-1.5790693832082847,1
8323,Biological Process,GO:0097485,neuron projection guidance,-0.042358570586847,-1.5794518207829007,1
8323,Biological Process,GO:0007411,axon guidance,-0.042358570586847,-1.5794518207829007,1
8325,Phenotype,HP:0025461,Abnormal cell morphology,-0.042415155780237246,-1.5805548449956663,1
8326,Phenotype,HP:0000121,Nephrocalcinosis,-0.04247193547112493,-1.5816616605792155,1
8327,Phenotype,HP:0002141,Gait imbalance,-0.04249418275077965,-1.5820953303549479,1
8328,Phenotype,HP:0002257,Chronic rhinitis,-0.04255562378462319,-1.5832930102412635,1
8329,Biological Process,GO:0051315,attachment of mitotic spindle microtubules to kinetochore,-0.042591047113462954,-1.5839835228482904,1
8330,Phenotype,HP:0000151,Aplasia of the uterus,-0.042634309856592445,-1.584826850410209,1
8331,Phenotype,HP:0001929,Reduced factor XI activity,-0.042724346437325034,-1.586581947859426,1
8332,Biological Process,GO:2000786,positive regulation of autophagosome assembly,-0.042766359995192404,-1.5874009248535053,1
8333,Biological Process,GO:1902749,regulation of cell cycle G2/M phase transition,-0.04280590855246302,-1.5881718511972325,1
8334,Phenotype,HP:0007787,Posterior subcapsular cataract,-0.04299485384091195,-1.5918549918840519,1
8335,Biological Process,GO:0036296,response to increased oxygen levels,-0.04316697640331779,-1.5952102044851213,1
8335,Biological Process,GO:0036295,cellular response to increased oxygen levels,-0.04316697640331779,-1.5952102044851213,1
8337,Biological Process,GO:0051081,nuclear membrane disassembly,-0.04320787203825405,-1.5960073896289453,1
8337,Biological Process,GO:0030397,membrane disassembly,-0.04320787203825405,-1.5960073896289453,1
8339,Phenotype,HP:0004912,Hypophosphatemic rickets,-0.04321372221055797,-1.5961214279720781,1
8340,Disease,MONDO:0045010,glycoprotein metabolism disease,-0.04322340683911019,-1.5963102119833135,1
8341,Biological Process,GO:0051923,sulfation,-0.04322482493003643,-1.596337855056242,1
8342,Phenotype,HP:0008063,Aplasia/Hypoplasia of the lens,-0.0432272112035581,-1.5963843710671448,1
8343,Phenotype,HP:0012762,Cerebral white matter atrophy,-0.0433046232929708,-1.5978933772906299,1
8344,Phenotype,HP:0011962,Obstructive azoospermia,-0.04340259766287935,-1.5998032073321087,1
8345,Biological Process,GO:0046321,positive regulation of fatty acid oxidation,-0.0434326509787033,-1.6003890414176987,1
8346,Phenotype,HP:0034198,Second trimester onset,-0.04352570216229412,-1.6022029030019356,1
8347,Phenotype,HP:0010636,Schizencephaly,-0.04371248922353521,-1.6058439730210718,1
8348,Biological Process,GO:0060382,regulation of DNA strand elongation,-0.04373602861497439,-1.6063028301381999,1
8349,Biological Process,GO:0045833,negative regulation of lipid metabolic process,-0.04375875052424982,-1.6067457519449386,1
8350,Biological Process,GO:0006706,steroid catabolic process,-0.04377172289829434,-1.606998624504187,1
8351,Biological Process,GO:0045945,positive regulation of transcription by RNA polymerase III,-0.04380740863812571,-1.6076942523305866,1
8352,Biological Process,GO:0006356,regulation of transcription by RNA polymerase I,-0.043817231670683965,-1.607885734273218,1
8353,Disease,MONDO:0009627,Galloway-Mowat syndrome,-0.043883454668645516,-1.60917662974988,1
8354,Phenotype,HP:0100511,Abnormality of vitamin D metabolism,-0.04395924208004809,-1.6106539658654138,1
8355,Phenotype,HP:0033095,Increased sulfur amino acid level in urine,-0.043960435829489164,-1.610677235813939,1
8356,Biological Process,GO:1990166,protein localization to site of double-strand break,-0.04398115031623395,-1.6110810266126543,1
8357,Phenotype,HP:0010964,Abnormal circulating long-chain fatty-acid concentration,-0.04400573608968772,-1.611560281021525,1
8358,Biological Process,GO:1902750,negative regulation of cell cycle G2/M phase transition,-0.0440682969487971,-1.6127797898406107,1
8359,Phenotype,HP:0045037,Abnormality of jaw muscles,-0.04417342032616367,-1.6148289766263364,1
8360,Biological Process,GO:1902117,positive regulation of organelle assembly,-0.04417587253999811,-1.6148767780222881,1
8361,Phenotype,HP:0004373,Focal dystonia,-0.04423171975798934,-1.6159654167627286,1
8362,Phenotype,HP:0410299,Decreased specific antibody response to polysaccharide vaccine,-0.04423326248651005,-1.6159954894161934,1
8363,Phenotype,HP:0002730,Chronic noninfectious lymphadenopathy,-0.044401063670183705,-1.6192664646914088,1
8364,Disease,MONDO:0005500,congenital disorder of glycosylation type I,-0.04454080236194691,-1.6219904133295622,1
8365,Phenotype,HP:0000510,Rod-cone dystrophy,-0.04455930430845889,-1.6223510747281238,1
8366,Phenotype,HP:0003537,Hypouricemia,-0.04457118389727288,-1.6225826454503296,1
8367,Phenotype,HP:0020206,Simple ear,-0.044670746727121236,-1.6245234395951302,1
8368,Biological Process,GO:0032205,negative regulation of telomere maintenance,-0.04470179907520544,-1.6251287479761387,1
8369,Phenotype,HP:0002917,Hypomagnesemia,-0.04481157694157756,-1.6272686654594828,1
8370,Biological Process,GO:0006699,bile acid biosynthetic process,-0.044870608500026554,-1.6284193770570816,1
8371,Phenotype,HP:0025576,Abnormal inferior vena cava morphology,-0.0449140342403076,-1.6292658819485102,1
8372,Phenotype,HP:0033100,Increased proteinogenic amino acid level in urine,-0.04503884136875924,-1.6316987672381031,1
8373,Biological Process,GO:1901017,negative regulation of potassium ion transmembrane transporter activity,-0.04510729489143639,-1.6330331426893145,1
8374,Biological Process,GO:0008053,mitochondrial fusion,-0.045188887273693634,-1.6346236360289113,1
8375,Phenotype,HP:0011410,Caesarian section,-0.0451967608745345,-1.6347771173877048,1
8376,Phenotype,HP:0007372,Atrophy/Degeneration involving the corticospinal tracts,-0.04521308845006522,-1.6350953934254295,1
8377,Phenotype,HP:0000594,Shallow anterior chamber,-0.04522918129506959,-1.6354090938235122,1
8378,Phenotype,HP:0002181,Cerebral edema,-0.04526334499149942,-1.636075052214779,1
8379,Biological Process,GO:0018198,peptidyl-cysteine modification,-0.04535478724386377,-1.6378575506456332,1
8380,Biological Process,GO:0006368,transcription elongation by RNA polymerase II,-0.04535671748828163,-1.6378951772083767,1
8380,Biological Process,GO:0006354,DNA-templated transcription elongation,-0.04535671748828163,-1.6378951772083767,1
8382,Biological Process,GO:0032435,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,-0.04543221067154257,-1.6393667778877503,1
8383,Phenotype,HP:0002085,Occipital encephalocele,-0.04557786029514421,-1.6422059492643477,1
8384,Phenotype,HP:0008954,Intrinsic hand muscle atrophy,-0.04562460541138336,-1.643117159281511,1
8385,Biological Process,GO:0071230,cellular response to amino acid stimulus,-0.04580690876149651,-1.6466708276034745,1
8386,Phenotype,HP:0001869,Deep plantar creases,-0.04582434736894636,-1.6470107611638574,1
8387,Phenotype,HP:0001181,Adducted thumb,-0.045891455024057226,-1.6483189014036321,1
8388,Phenotype,HP:0012548,Fatty replacement of skeletal muscle,-0.045902341256466306,-1.648531108470774,1
8389,Biological Process,GO:0015697,quaternary ammonium group transport,-0.04594604691866899,-1.6493830699249312,1
8390,Phenotype,HP:0000456,Bifid nasal tip,-0.045956011558133225,-1.6495773122335988,1
8391,Phenotype,HP:0010546,Muscle fibrillation,-0.04603413547793278,-1.6511001942805112,1
8392,Phenotype,HP:0000609,Optic nerve hypoplasia,-0.04605567077928541,-1.651519985349481,1
8393,Disease,MONDO:0100191,inherited kidney disorder,-0.046059999275112506,-1.651604361410003,1
8394,Phenotype,HP:0012434,Delayed early-childhood social milestone development,-0.04614046890859802,-1.6531729688284624,1
8395,Phenotype,HP:0012048,Oromandibular dystonia,-0.04614394942545541,-1.6532408150994853,1
8396,Biological Process,GO:0043200,response to amino acid,-0.046268168919824104,-1.6556622455440404,1
8397,Phenotype,HP:0033099,Increased serine family amino acid in urine,-0.046276174925050206,-1.6558183078826634,1
8397,Phenotype,HP:0003108,Hyperglycinuria,-0.046276174925050206,-1.6558183078826634,1
8399,Phenotype,HP:0025100,Abnormal hippocampus morphology,-0.04627726496428752,-1.6558395561916217,1
8400,Phenotype,HP:0002454,Eye of the tiger anomaly of globus pallidus,-0.04642016585275455,-1.6586251460352013,1
8401,Biological Process,GO:1900424,regulation of defense response to bacterium,-0.046475514845923716,-1.6597040727996066,1
8402,Disease,MONDO:0020022,central nervous system malformation,-0.04648088923032567,-1.6598088365331718,1
8403,Phenotype,HP:0001063,Acrocyanosis,-0.04657330363860024,-1.6616102853544605,1
8404,Biological Process,GO:0034389,lipid droplet organization,-0.04658390558776593,-1.6618169508429323,1
8405,Phenotype,HP:0000674,Anodontia,-0.04660262259784598,-1.6621818045099772,1
8406,Phenotype,HP:0011076,Abnormality of premolar,-0.046707009030504176,-1.6642166259147948,1
8406,Phenotype,HP:0011051,Agenesis of premolar,-0.046707009030504176,-1.6642166259147948,1
8408,Phenotype,HP:0004421,Elevated systolic blood pressure,-0.046721580407136365,-1.6645006680868837,1
8409,Phenotype,HP:0011330,Metopic synostosis,-0.046774485109748465,-1.6655319479050483,1
8410,Phenotype,HP:0001405,Periportal fibrosis,-0.04688941272812697,-1.6677722503267915,1
8411,Phenotype,HP:0002812,Coxa vara,-0.04696835929375953,-1.669311168340323,1
8412,Phenotype,HP:0000511,Vertical supranuclear gaze palsy,-0.04698260228222484,-1.6695888091894233,1
8413,Phenotype,HP:0008376,Nasal dysarthria,-0.04700710736773428,-1.6700664907353076,1
8414,Phenotype,HP:0002091,Restrictive ventilatory defect,-0.0470622211744216,-1.6711408329720574,1
8415,Biological Process,GO:0061158,3'-UTR-mediated mRNA destabilization,-0.047115912992373055,-1.6721874561552532,1
8416,Phenotype,HP:0033367,Orthodeoxia,-0.047138362157024494,-1.6726250613074727,1
8416,Phenotype,HP:0025175,Honeycomb lung,-0.047138362157024494,-1.6726250613074727,1
8416,Phenotype,HP:0025390,Reticular pattern on pulmonary HRCT,-0.047138362157024494,-1.6726250613074727,1
8416,Phenotype,HP:0031950,Usual interstitial pneumonia,-0.047138362157024494,-1.6726250613074727,1
8416,Phenotype,HP:0031631,Subpleural honeycombing,-0.047138362157024494,-1.6726250613074727,1
8421,Phenotype,HP:0007343,Abnormal morphology of the limbic system,-0.04717648701014254,-1.6733682351587542,1
8422,Phenotype,HP:0011069,Supernumerary tooth,-0.04719790259081691,-1.6737856924934205,1
8423,Phenotype,HP:0005469,Flat occiput,-0.047244780503705286,-1.674699491136878,1
8424,Phenotype,HP:0100692,Increased corneal curvature,-0.047346308804513404,-1.6766785985210302,1
8425,Phenotype,HP:0002884,Hepatoblastoma,-0.0473555749473733,-1.6768592249238228,1
8426,Phenotype,HP:0000839,Pituitary dwarfism,-0.04737658099824005,-1.6772686992285373,1
8427,Phenotype,HP:0001105,Retinal atrophy,-0.0474411037996354,-1.6785264525019725,1
8428,Phenotype,HP:0011040,Abnormal intrahepatic bile duct morphology,-0.047457726425061075,-1.6788504799944262,1
8429,Phenotype,HP:0002154,Hyperglycinemia,-0.04753594560154095,-1.680375218895023,1
8430,Phenotype,HP:0001308,Tongue fasciculations,-0.04760930235384797,-1.6818051737845725,1
8431,Phenotype,HP:0011539,Atrial situs ambiguous,-0.04765449981933001,-1.6826862151983308,1
8432,Disease,MONDO:0019053,peroxisomal disease,-0.047656876860677544,-1.6827325512449887,1
8433,Phenotype,HP:0005619,Thoracolumbar kyphosis,-0.0476977269394121,-1.6835288483544966,1
8434,Phenotype,HP:0003300,Ovoid vertebral bodies,-0.047711806813421465,-1.6838033095874538,1
8435,Disease,MONDO:0019501,Usher syndrome,-0.047746051247693266,-1.68447084181437,1
8436,Phenotype,HP:0010679,Elevated tissue non-specific alkaline phosphatase,-0.04777372943395686,-1.6850103771200748,1
8437,Biological Process,GO:0031929,TOR signaling,-0.04781297328933731,-1.6857753638611888,1
8438,Phenotype,HP:0002878,Respiratory failure,-0.04793368748316329,-1.6881284649223842,1
8439,Phenotype,HP:0002329,Drowsiness,-0.04795956102699428,-1.6886328220449058,1
8440,Phenotype,HP:0008800,Limited hip movement,-0.04797046925852544,-1.6888454579444483,1
8441,Disease,MONDO:0004580,retinal degeneration,-0.048077442908488255,-1.6909307123894255,1
8441,Disease,MONDO:0019118,inherited retinal dystrophy,-0.048077442908488255,-1.6909307123894255,1
8443,Biological Process,GO:0140042,lipid droplet formation,-0.04813204072504518,-1.6919949963481475,1
8444,Biological Process,GO:2000234,positive regulation of rRNA processing,-0.048150350260067754,-1.6923519070388136,1
8445,Phenotype,HP:0012229,CSF pleocytosis,-0.048157180091689344,-1.6924850420375008,1
8446,Phenotype,HP:0012346,Abnormal protein glycosylation,-0.04816385525138278,-1.6926151619915877,1
8447,Biological Process,GO:0016053,organic acid biosynthetic process,-0.04816404452198331,-1.6926188514736347,1
8448,Phenotype,HP:0007338,Hypermetric saccades,-0.0482814646628309,-1.6949077410339835,1
8449,Phenotype,HP:0001116,Macular coloboma,-0.048366488177636,-1.6965651179883694,1
8450,Phenotype,HP:0001350,Slurred speech,-0.04840452119320959,-1.697306501635728,1
8451,Phenotype,HP:0010319,Abnormal second toe morphology,-0.04857352044853935,-1.7006008311130967,1
8452,Biological Process,GO:0009111,vitamin catabolic process,-0.048603435748135304,-1.7011839748263098,1
8453,Phenotype,HP:0011056,Agenesis of first permanent molar tooth,-0.04871006926665644,-1.7032625990347672,1
8453,Phenotype,HP:0011055,Agenesis of permanent molar,-0.04871006926665644,-1.7032625990347672,1
8453,Phenotype,HP:0011053,Agenesis of mandibular premolar,-0.04871006926665644,-1.7032625990347672,1
8456,Phenotype,HP:0001966,Abnormal glomerular mesangium morphology,-0.048788867437514094,-1.704798624365249,1
8457,Disease,MONDO:0015925,interstitial lung disease,-0.04880623736446332,-1.7051372191256633,1
8458,Phenotype,HP:0005543,Reduced protein C activity,-0.04883248869640067,-1.705648940532084,1
8459,Biological Process,GO:0000097,sulfur amino acid biosynthetic process,-0.04894657852153683,-1.7078729117163387,1
8460,Disease,MONDO:0005283,retinal disorder,-0.04904769533408038,-1.7098439978940247,1
8461,Biological Process,GO:0006555,methionine metabolic process,-0.04907337755845398,-1.7103446255958052,1
8462,Biological Process,GO:1901799,negative regulation of proteasomal protein catabolic process,-0.049080086885056495,-1.7104754115709082,1
8463,Biological Process,GO:0046415,urate metabolic process,-0.04924026637613532,-1.7135978159750058,1
8464,Biological Process,GO:0006817,phosphate ion transport,-0.049282197745277534,-1.714415190851138,1
8465,Disease,MONDO:0100036,variable age onset epilepsy,-0.04928583654859331,-1.7144861226253765,1
8466,Phenotype,HP:0002748,Rickets,-0.049316001918287444,-1.7150741409949557,1
8467,Phenotype,HP:0006802,Abnormal anterior horn cell morphology,-0.04937228905548552,-1.7161713551507607,1
8468,Biological Process,GO:0046394,carboxylic acid biosynthetic process,-0.0495372633481288,-1.7193872253875988,1
8469,Phenotype,HP:0008765,Auditory hallucination,-0.049580518932868634,-1.7202304134098845,1
8470,Disease,MONDO:0020087,hereditary lipodystrophy,-0.04974236439923385,-1.7233852929363358,1
8470,Disease,MONDO:0006573,lipodystrophy,-0.04974236439923385,-1.7233852929363358,1
8472,Phenotype,HP:0001572,Macrodontia,-0.049754852448253395,-1.723628724470514,1
8473,Phenotype,HP:0011617,Pulmonary situs ambiguus,-0.04975603369197534,-1.7236517506430589,1
8473,Phenotype,HP:0011615,Abnormal pulmonary situs morphology,-0.04975603369197534,-1.7236517506430589,1
8473,Phenotype,HP:0032543,Lithoptysis,-0.04975603369197534,-1.7236517506430589,1
8473,Phenotype,HP:0025177,Peribronchovascular interstitial thickening,-0.04975603369197534,-1.7236517506430589,1
8477,Biological Process,GO:0006999,nuclear pore organization,-0.04977416902505216,-1.724005265587372,1
8478,Phenotype,HP:0003073,Hypoalbuminemia,-0.04978450314620808,-1.7242067102616707,1
8478,Phenotype,HP:0012116,Abnormal circulating albumin concentration,-0.04978450314620808,-1.7242067102616707,1
8480,Biological Process,GO:1901607,alpha-amino acid biosynthetic process,-0.04979185795065,-1.7243500786393953,1
8481,Biological Process,GO:0009395,phospholipid catabolic process,-0.04990087775511132,-1.7264752191008317,1
8482,Biological Process,GO:0101024,mitotic nuclear membrane organization,-0.050081079565939435,-1.729987921781846,1
8482,Biological Process,GO:0007084,mitotic nuclear membrane reassembly,-0.050081079565939435,-1.729987921781846,1
8484,Phenotype,HP:4000079,Sensory seeking,-0.05021254630822081,-1.7325506239875217,1
8485,Phenotype,HP:0012208,Immotile sperm,-0.050306515511340244,-1.7343823806730594,1
8486,Phenotype,HP:0001403,Macrovesicular hepatic steatosis,-0.050393149747940624,-1.7360711556846715,1
8487,Phenotype,HP:0025708,Early young adult onset,-0.050404010526056364,-1.7362828665672079,1
8488,Biological Process,GO:1904357,negative regulation of telomere maintenance via telomere lengthening,-0.050494523106049405,-1.7380472427460372,1
8489,Biological Process,GO:0006720,isoprenoid metabolic process,-0.05054433858434981,-1.7390183038212712,1
8490,Phenotype,HP:0002047,Malignant hyperthermia,-0.05054453754969934,-1.739022182284609,1
8491,Phenotype,HP:0004361,Abnormal circulating leptin concentration,-0.05066763029780419,-1.7414216488842746,1
8492,Phenotype,HP:0002902,Hyponatremia,-0.0506887465189072,-1.7418332707550015,1
8493,Biological Process,GO:0003341,cilium movement,-0.050722958813574026,-1.742500176479464,1
8494,Phenotype,HP:0003698,Difficulty standing,-0.050740384131284566,-1.7428398509808358,1
8495,Phenotype,HP:0011038,Abnormal renal tubular resorption,-0.050781670154785186,-1.7436446460312993,1
8496,Disease,MONDO:0003441,dystonic disorder,-0.050786887099798284,-1.7437463407737106,1
8496,Disease,MONDO:0001815,extrapyramidal and movement disease,-0.050786887099798284,-1.7437463407737106,1
8496,Disease,MONDO:0044807,inherited dystonia,-0.050786887099798284,-1.7437463407737106,1
8499,Phenotype,HP:0000563,Keratoconus,-0.05080432187816575,-1.7440861996931791,1
8500,Phenotype,HP:0005483,Abnormal epiglottis morphology,-0.05081423400522711,-1.74427941836919,1
8501,Phenotype,HP:0031179,Nuchal rigidity,-0.05086439120623609,-1.7452571406997635,1
8502,Phenotype,HP:0011002,Osteopetrosis,-0.050868022349155106,-1.7453279231486643,1
8503,Biological Process,GO:0034144,negative regulation of toll-like receptor 4 signaling pathway,-0.05097459755425571,-1.747405410644301,1
8504,Biological Process,GO:0042475,odontogenesis of dentin-containing tooth,-0.05104966595560767,-1.7488687309820752,1
8505,Phenotype,HP:0002378,Hand tremor,-0.051098271936958595,-1.7498162151400871,1
8506,Phenotype,HP:0034033,Peripheral cyanosis,-0.05118991504860393,-1.7516026289529878,1
8507,Phenotype,HP:0002398,Degeneration of anterior horn cells,-0.051285704589325354,-1.7534698697701525,1
8508,Phenotype,HP:0033346,Psychic epileptic aura,-0.05130705511407574,-1.7538860589593015,1
8508,Phenotype,HP:0012002,Experiential epileptic aura,-0.05130705511407574,-1.7538860589593015,1
8510,Biological Process,GO:0045540,regulation of cholesterol biosynthetic process,-0.05134180525320775,-1.7545634489718307,1
8510,Biological Process,GO:0106118,regulation of sterol biosynthetic process,-0.05134180525320775,-1.7545634489718307,1
8512,Phenotype,HP:0000605,Supranuclear gaze palsy,-0.05154691371211273,-1.758561660921995,1
8513,Phenotype,HP:0006429,Broad femoral neck,-0.051654691926187324,-1.760662598863711,1
8514,Phenotype,HP:0000103,Polyuria,-0.051894744531360226,-1.7653419826384924,1
8515,Biological Process,GO:0070198,"protein localization to chromosome, telomeric region",-0.051966005515263536,-1.766731084379804,1
8516,Biological Process,GO:0050795,regulation of behavior,-0.052202029775836545,-1.7713319429898766,1
8517,Phenotype,HP:0200149,CSF lymphocytic pleiocytosis,-0.05246110394728376,-1.7763821171942424,1
8518,Phenotype,HP:0003800,Muscle abnormality related to mitochondrial dysfunction,-0.05254936158518286,-1.7781025374266666,1
8519,Phenotype,HP:0031108,Triceps weakness,-0.052672854449579365,-1.7805098035571134,1
8520,Phenotype,HP:0031095,Abnormal humerus morphology,-0.0527136995987767,-1.7813060045743647,1
8521,Phenotype,HP:0008969,Leg muscle stiffness,-0.05294627120991091,-1.7858395601374562,1
8522,Phenotype,HP:0002612,Congenital hepatic fibrosis,-0.05311197634993814,-1.7890696768990835,1
8523,Phenotype,HP:0002510,Spastic tetraplegia,-0.053203593940574834,-1.7908555932268861,1
8524,Phenotype,HP:0000148,Vaginal atresia,-0.05321117378357454,-1.791003348317162,1
8524,Phenotype,HP:0001827,Genital tract atresia,-0.05321117378357454,-1.791003348317162,1
8526,Disease,MONDO:0000226,mineral metabolism disease,-0.053291068308626066,-1.792560745055059,1
8527,Phenotype,HP:0031038,Spermatogenesis maturation arrest,-0.05334455138287142,-1.7936032991638504,1
8528,Disease,MONDO:0021154,dermis disorder,-0.053356343948058216,-1.7938331735205915,1
8529,Biological Process,GO:0045494,photoreceptor cell maintenance,-0.0534345833677603,-1.795358307025552,1
8530,Phenotype,HP:0000541,Retinal detachment,-0.053447572374039076,-1.7956115037995994,1
8531,Biological Process,GO:0044818,mitotic G2/M transition checkpoint,-0.05346245414481765,-1.795901596534361,1
8532,Biological Process,GO:0035336,long-chain fatty-acyl-CoA metabolic process,-0.05352030333752045,-1.7970292600876172,1
8533,Phenotype,HP:0011229,Broad eyebrow,-0.053693348334435065,-1.800402453851901,1
8534,Phenotype,HP:0002663,Delayed epiphyseal ossification,-0.0538418358942907,-1.8032969455731838,1
8535,Phenotype,HP:0000548,Cone/cone-rod dystrophy,-0.05386681079436584,-1.8037837852894376,1
8536,Phenotype,HP:0004463,Absent brainstem auditory responses,-0.053925040620013354,-1.8049188685814814,1
8537,Phenotype,HP:0000831,Insulin-resistant diabetes mellitus,-0.05395093900458492,-1.8054237099285269,1
8538,Biological Process,GO:0070269,pyroptosis,-0.05410629128280808,-1.8084520167014075,1
8539,Biological Process,GO:0051457,maintenance of protein location in nucleus,-0.05416596475775437,-1.8096152412798177,1
8540,Phenotype,HP:0030780,Abnormality of the protein C anticoagulant pathway,-0.05424451858034596,-1.8111465034905208,1
8541,Biological Process,GO:0034121,regulation of toll-like receptor signaling pathway,-0.05436182067265127,-1.8134330919117796,1
8542,Biological Process,GO:0072698,protein localization to microtubule cytoskeleton,-0.054516059479728485,-1.8164396936137643,1
8543,Biological Process,GO:0071470,cellular response to osmotic stress,-0.054720963939867584,-1.820433928983402,1
8544,Phenotype,HP:0025092,Epidermal acanthosis,-0.05474831490636034,-1.8209670857418492,1
8545,Phenotype,HP:0000037,Male pseudohermaphroditism,-0.055195873285762476,-1.829691412717319,1
8546,Phenotype,HP:0012202,Increased serum bile acid concentration,-0.05549023783964868,-1.8354295079832865,1
8547,Phenotype,HP:0030984,Abnormal serum bile acid concentration,-0.055520824000034,-1.8360257288930193,1
8548,Phenotype,HP:0010901,Abnormal circulating methionine concentration,-0.05573348860943428,-1.8401712340916865,1
8549,Biological Process,GO:0042359,vitamin D metabolic process,-0.0558010911988569,-1.841489022165053,1
8550,Phenotype,HP:0006844,Absent patellar reflexes,-0.05582002206203751,-1.8418580445047446,1
8551,Phenotype,HP:0002958,Immune dysregulation,-0.05582087930572244,-1.8418747548928172,1
8552,Phenotype,HP:0000543,Optic disc pallor,-0.05597431103381956,-1.8448656240753332,1
8553,Phenotype,HP:0005701,Multiple enchondromatosis,-0.05607394948198774,-1.8468078922601203,1
8554,Phenotype,HP:0010988,Abnormality of the extrinsic pathway,-0.05607429016001442,-1.8468145331513088,1
8555,Phenotype,HP:0004492,Widely patent fontanelles and sutures,-0.05610741104606909,-1.8474601638733705,1
8556,Phenotype,HP:0002265,Large fleshy ears,-0.05611632337958716,-1.8476338934141514,1
8557,Phenotype,HP:0000512,Abnormal electroretinogram,-0.05616026761953119,-1.848490505502327,1
8558,Phenotype,HP:0010297,Bifid tongue,-0.05621350960032179,-1.8495283599378967,1
8559,Phenotype,HP:0030810,Abnormal tongue physiology,-0.05633813629750528,-1.8519577280519606,1
8560,Biological Process,GO:0052695,cellular glucuronidation,-0.05643258789578032,-1.8537988881433165,1
8561,Phenotype,HP:0008222,Female infertility,-0.056699745298563586,-1.8590066300672015,1
8562,Phenotype,HP:0000632,Lacrimation abnormality,-0.05676168744138921,-1.860214078150944,1
8563,Biological Process,GO:0008206,bile acid metabolic process,-0.05680826315608245,-1.8611219859967156,1
8564,Disease,MONDO:0021568,renal tubule disorder,-0.05688224262702235,-1.8625640796400391,1
8564,Disease,MONDO:0015962,inherited renal tubular disease,-0.05688224262702235,-1.8625640796400391,1
8566,Phenotype,HP:0008323,Abnormal light- and dark-adapted electroretinogram,-0.056919565527219884,-1.86329162089495,1
8567,Phenotype,HP:0006955,Olivopontocerebellar hypoplasia,-0.05692723888026907,-1.8634411987915558,1
8568,Phenotype,HP:0100732,Pancreatic fibrosis,-0.05698831999385079,-1.8646318626947198,1
8569,Phenotype,HP:0040220,Abnormal size of the dental root,-0.05706885314706911,-1.8662017083134765,1
8570,Biological Process,GO:0048024,"regulation of mRNA splicing, via spliceosome",-0.05714217309974767,-1.8676309458619909,1
8571,Disease,MONDO:0000509,non-syndromic intellectual disability,-0.0571947017119816,-1.8686548944903432,1
8572,Phenotype,HP:0000805,Enuresis,-0.05722619037927901,-1.8692687081114654,1
8573,Biological Process,GO:0001682,tRNA 5'-leader removal,-0.05729188690658438,-1.8705493410115366,1
8574,Phenotype,HP:0032792,Tonic seizure,-0.05732851363530189,-1.8712633116845923,1
8575,Phenotype,HP:0004379,Abnormality of alkaline phosphatase level,-0.05752424704385417,-1.8750787742808113,1
8576,Biological Process,GO:0003352,regulation of cilium movement,-0.05758670880056971,-1.8762963512811046,1
8577,Phenotype,HP:0100593,Calcification of cartilage,-0.057764393567507843,-1.8797599888235392,1
8578,Phenotype,HP:0000200,Short lingual frenulum,-0.057765372968141104,-1.879779080436517,1
8579,Phenotype,HP:0003160,Abnormal isoelectric focusing of serum transferrin,-0.05779075105850673,-1.8802737796055027,1
8580,Phenotype,HP:0004586,Biconcave vertebral bodies,-0.05779885679136165,-1.8804317859507231,1
8581,Phenotype,HP:0003642,Type I transferrin isoform profile,-0.05781733652500054,-1.8807920143502017,1
8582,Phenotype,HP:0000473,Torticollis,-0.05784373248206531,-1.8813065549573313,1
8583,Biological Process,GO:0043484,regulation of RNA splicing,-0.05790036490881456,-1.8824104998975084,1
8584,Phenotype,HP:0003774,Stage 5 chronic kidney disease,-0.057983637934800436,-1.8840337542937462,1
8585,Phenotype,HP:0001756,Vestibular hypofunction,-0.058044905888251064,-1.8852280602963176,1
8586,Phenotype,HP:0000546,Retinal degeneration,-0.05847966070463584,-1.8937028053728546,1
8587,Phenotype,HP:0030350,Erythematous papule,-0.05854552901053278,-1.8949867867804484,1
8588,Biological Process,GO:0019915,lipid storage,-0.05870172544229235,-1.898031548773046,1
8589,Phenotype,HP:0004969,Peripheral pulmonary artery stenosis,-0.05870456321667761,-1.8980868659623982,1
8590,Phenotype,HP:0012347,Abnormal protein N-linked glycosylation,-0.05879845447460341,-1.8999171032498268,1
8591,Phenotype,HP:0002497,Spastic ataxia,-0.05889692085122,-1.9018365240566508,1
8592,Phenotype,HP:0001437,Abnormality of the musculature of the lower limbs,-0.058975788087232583,-1.903373895685229,1
8593,Biological Process,GO:0018279,protein N-linked glycosylation via asparagine,-0.059287257715638475,-1.9094454229008988,1
8594,Disease,MONDO:0016575,primary ciliary dyskinesia,-0.05936375269789096,-1.9109365518080257,1
8595,Phenotype,HP:0006829,Severe muscular hypotonia,-0.059432396412011146,-1.9122746346914143,1
8596,Biological Process,GO:0021953,central nervous system neuron differentiation,-0.059578374658944666,-1.9151202119751092,1
8597,Phenotype,HP:0100539,Periorbital edema,-0.05971363341032654,-1.9177568324198555,1
8598,Phenotype,HP:0000662,Nyctalopia,-0.05976138423147237,-1.9186876468034,1
8599,Phenotype,HP:0000522,Alacrima,-0.05978846068147847,-1.9192154523681262,1
8600,Biological Process,GO:0031445,regulation of heterochromatin formation,-0.06000061131258283,-1.9233509385057763,1
8601,Biological Process,GO:0090308,regulation of DNA methylation-dependent heterochromatin formation,-0.0600117115313632,-1.9235673168434326,1
8602,Phenotype,HP:0010544,Vertical nystagmus,-0.060291379030461556,-1.9290189200729493,1
8603,Disease,MONDO:0037871,amino acid metabolism disease,-0.06029994722218923,-1.9291859412028423,1
8603,Disease,MONDO:0004736,inborn disorder of amino acid metabolism,-0.06029994722218923,-1.9291859412028423,1
8605,Biological Process,GO:0006359,regulation of transcription by RNA polymerase III,-0.06037693162439428,-1.9306866104512765,1
8606,Biological Process,GO:0031503,protein-containing complex localization,-0.06055861577088972,-1.9342282085382185,1
8607,Phenotype,HP:0012579,Minimal change glomerulonephritis,-0.060620317403213164,-1.9354309683123265,1
8608,Biological Process,GO:0033120,positive regulation of RNA splicing,-0.060638156669853505,-1.9357787119863046,1
8609,Disease,MONDO:0005523,steroid inherited metabolic disorder,-0.06071556913832277,-1.9372877255987997,1
8610,Phenotype,HP:0032391,Subcortical heterotopia,-0.06077328569457041,-1.9384128036484503,1
8611,Phenotype,HP:0001969,Abnormal tubulointerstitial morphology,-0.06085894684969162,-1.9400826102273645,1
8612,Phenotype,HP:0009896,Abnormal antitragus morphology,-0.06116787137077573,-1.9461045252594962,1
8613,Biological Process,GO:0098534,centriole assembly,-0.0612680796799272,-1.948057901835451,1
8614,Biological Process,GO:0007018,microtubule-based movement,-0.061352721490304685,-1.949707838164462,1
8615,Phenotype,HP:0200117,Recurrent upper and lower respiratory tract infections,-0.06141456318794902,-1.9509133282542421,1
8616,Biological Process,GO:0008652,amino acid biosynthetic process,-0.06146568704479627,-1.951909893761469,1
8617,Phenotype,HP:0001667,Right ventricular hypertrophy,-0.061551675063440614,-1.9535860719432476,1
8618,Disease,MONDO:0016971,limb-girdle muscular dystrophy,-0.061552336170110244,-1.953598959001153,1
8619,Phenotype,HP:0007020,Progressive spastic paraplegia,-0.06178961820524509,-1.9582243356116562,1
8620,Biological Process,GO:0007605,sensory perception of sound,-0.06198701769399295,-1.9620722753752409,1
8620,Biological Process,GO:0050954,sensory perception of mechanical stimulus,-0.06198701769399295,-1.9620722753752409,1
8622,Phenotype,HP:0003088,Premature osteoarthritis,-0.06201721153276263,-1.9626608486970567,1
8623,Biological Process,GO:2000050,regulation of non-canonical Wnt signaling pathway,-0.06202049188429681,-1.9627247931134633,1
8624,Disease,MONDO:0001516,spinal muscular atrophy,-0.062132336275495526,-1.9649049936953256,1
8625,Phenotype,HP:0001430,Abnormal calf musculature morphology,-0.062170245995472495,-1.9656439739219262,1
8626,Phenotype,HP:0012808,Abnormal nasal base norphology,-0.062301012159396096,-1.9681930196417747,1
8627,Phenotype,HP:0002515,Waddling gait,-0.0623492295065875,-1.969132928092041,1
8628,Biological Process,GO:0044380,protein localization to cytoskeleton,-0.06242195852868182,-1.970550646536291,1
8629,Biological Process,GO:0098876,vesicle-mediated transport to the plasma membrane,-0.06247363230763758,-1.971557931763015,1
8630,Biological Process,GO:0170038,proteinogenic amino acid biosynthetic process,-0.06258002811377028,-1.973631922205916,1
8630,Biological Process,GO:0170034,L-amino acid biosynthetic process,-0.06258002811377028,-1.973631922205916,1
8632,Biological Process,GO:0001895,retina homeostasis,-0.06272399944271512,-1.9764383783167043,1
8633,Phenotype,HP:0003688,Cytochrome C oxidase-negative muscle fibers,-0.06273371148385865,-1.9766276966859606,1
8634,Phenotype,HP:0000282,Facial edema,-0.06286587835038304,-1.9792040465253322,1
8635,Phenotype,HP:0003155,Elevated circulating alkaline phosphatase concentration,-0.06292604569136584,-1.980376898113274,1
8636,Biological Process,GO:0036158,outer dynein arm assembly,-0.0632972729146748,-1.9876132896711074,1
8637,Phenotype,HP:0005289,Abnormal nasolabial region morphology,-0.06332946169897924,-1.988240750784873,1
8638,Phenotype,HP:0001967,Diffuse mesangial sclerosis,-0.0635349782037733,-1.9922469168387278,1
8639,Phenotype,HP:0002356,Writer's cramp,-0.06358895105609985,-1.9932990182698855,1
8640,Biological Process,GO:0036159,inner dynein arm assembly,-0.06367364917847018,-1.9949500522975674,1
8641,Phenotype,HP:0006336,Short dental root,-0.06369833972618966,-1.9954313490879345,1
8642,Disease,MONDO:0019200,retinitis pigmentosa,-0.06404148182949476,-2.0021202729156666,1
8643,Disease,MONDO:0019216,inborn disorder of amino acid transport,-0.06431365494433838,-2.0074257869158734,1
8644,Phenotype,HP:0004692,4-5 toe syndactyly,-0.06445400465833528,-2.010161646308023,1
8645,Biological Process,GO:0006684,sphingomyelin metabolic process,-0.06452170647963151,-2.0114813687241515,1
8646,Phenotype,HP:0032581,Abnormal renal insterstitial morphology,-0.06463437071479827,-2.013677550655432,1
8647,Phenotype,HP:0011819,Submucous cleft soft palate,-0.06482158555702067,-2.017326959477564,1
8648,Phenotype,HP:0000452,Choanal stenosis,-0.0651335725716089,-2.023408572184725,1
8649,Phenotype,HP:0100671,Abnormal trabecular bone morphology,-0.06514781009003068,-2.0236861064053926,1
8650,Biological Process,GO:0085020,protein K6-linked ubiquitination,-0.06525797279285772,-2.0258335255672204,1
8651,Phenotype,HP:0002643,Neonatal respiratory distress,-0.06548850362676162,-2.0303272999338002,1
8652,Phenotype,HP:0007687,Unilateral ptosis,-0.06568831011104925,-2.0342221596458963,1
8653,Disease,MONDO:0100257,peroxisomal single enzyme/protein defect,-0.06579938131026108,-2.036387288272861,1
8654,Phenotype,HP:0010639,Elevated alkaline phosphatase of bone origin,-0.06587082989281456,-2.0377800469046248,1
8655,Disease,MONDO:0005557,calcium metabolic disease,-0.06590255871177875,-2.0383985418405453,1
8656,Phenotype,HP:0001345,Psychotic mentation,-0.06592323740405592,-2.0388016348919864,1
8657,Phenotype,HP:0005716,Lethal skeletal dysplasia,-0.06616682311085897,-2.043549889981165,1
8658,Disease,MONDO:0018949,distal myopathy,-0.06637540218580895,-2.0476157552042347,1
8659,Phenotype,HP:0030466,Abnormal full-field electroretinogram,-0.06661832200130768,-2.0523510299678596,1
8660,Phenotype,HP:0003177,Squared iliac bones,-0.06663356656566277,-2.052648194695755,1
8661,Phenotype,HP:0008994,Proximal muscle weakness in lower limbs,-0.06672007404472824,-2.054334498802493,1
8662,Phenotype,HP:0000580,Pigmentary retinopathy,-0.06682454802195315,-2.056371026727532,1
8663,Phenotype,HP:0012075,Personality disorder,-0.0669545719313549,-2.058905603561431,1
8664,Phenotype,HP:0006467,Limited shoulder movement,-0.06715101663168421,-2.0627349314818697,1
8665,Phenotype,HP:0008365,Abnormal talus morphology,-0.06761702947342374,-2.071818994239302,1
8666,Phenotype,HP:0032898,Focal automatism seizure,-0.06789414330328869,-2.0772208183865697,1
8667,Phenotype,HP:0003040,Arthropathy,-0.06816486841420355,-2.082498106214912,1
8668,Phenotype,HP:0005348,Inspiratory stridor,-0.06833224078933897,-2.0857607226568007,1
8669,Phenotype,HP:0032409,Subcortical band heterotopia,-0.06840222549371577,-2.08712494567745,1
8670,Phenotype,HP:0012588,Steroid-resistant nephrotic syndrome,-0.06862428985912294,-2.091453681821325,1
8671,Phenotype,HP:0001838,Rocker bottom foot,-0.06877440741726693,-2.0943799473595925,1
8672,Phenotype,HP:0003731,Quadriceps muscle weakness,-0.06890388835955341,-2.0969039400487883,1
8673,Phenotype,HP:0006344,Abnormal primary molar morphology,-0.06910601763822766,-2.1008440783628686,1
8674,Biological Process,GO:0007020,microtubule nucleation,-0.06920839399167766,-2.102839716972623,1
8675,Phenotype,HP:0031958,Spastic paraparetic gait,-0.06951680867233478,-2.1088516936038775,1
8676,Phenotype,HP:0100712,Abnormal lumbar spine morphology,-0.06958520252008249,-2.110184905802158,1
8677,Phenotype,HP:0033129,Abnormal shoulder physiology,-0.06999863073902879,-2.1182439281084586,1
8678,Phenotype,HP:0004948,Vascular tortuosity,-0.0700246644398379,-2.1187514071965357,1
8679,Disease,MONDO:0004737,homocystinuria,-0.07070990689130041,-2.132108947752513,1
8680,Biological Process,GO:0070199,establishment of protein localization to chromosome,-0.07085681273665512,-2.1349726068603916,1
8681,Phenotype,HP:0002586,Peritonitis,-0.07100710520343623,-2.1379022819206592,1
8682,Biological Process,GO:0007099,centriole replication,-0.07111743590425013,-2.140052975894078,1
8683,Phenotype,HP:0010580,Enlarged epiphyses,-0.07122035874294874,-2.1420592672280705,1
8684,Biological Process,GO:0018230,peptidyl-L-cysteine S-palmitoylation,-0.07131378881872807,-2.1438805146182562,1
8684,Biological Process,GO:0018231,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,-0.07131378881872807,-2.1438805146182562,1
8686,Phenotype,HP:0012811,Wide nasal ridge,-0.07134077072900213,-2.144406477304885,1
8687,Biological Process,GO:0006487,protein N-linked glycosylation,-0.07145085691469522,-2.1465524049059987,1
8688,Biological Process,GO:0007095,mitotic G2 DNA damage checkpoint signaling,-0.07165049024330572,-2.1504438892668234,1
8689,Phenotype,HP:0003777,Pili torti,-0.07186726022740553,-2.1546694211902353,1
8690,Phenotype,HP:0000550,Undetectable electroretinogram,-0.07233751376934094,-2.163836148593927,1
8691,Biological Process,GO:1902019,regulation of cilium-dependent cell motility,-0.07245130137066225,-2.166054228481086,1
8691,Biological Process,GO:0060295,regulation of cilium movement involved in cell motility,-0.07245130137066225,-2.166054228481086,1
8693,Phenotype,HP:0002243,Protein-losing enteropathy,-0.07246703643549846,-2.1663609546132045,1
8694,Phenotype,HP:0500087,Peripapillary atrophy,-0.07250917395190104,-2.16718234795081,1
8695,Phenotype,HP:0002339,Abnormal caudate nucleus morphology,-0.07257516179585788,-2.168468659532899,1
8696,Phenotype,HP:0005949,Apneic episodes in infancy,-0.0726949011574265,-2.170802758033197,1
8697,Phenotype,HP:0003762,Uterus didelphys,-0.07270841325732258,-2.1710661515546774,1
8698,Phenotype,HP:0000885,Broad ribs,-0.07278217027393818,-2.172503908860326,1
8699,Phenotype,HP:0008672,Calcium oxalate nephrolithiasis,-0.07329955107301878,-2.1825892954148993,1
8700,Biological Process,GO:0050906,detection of stimulus involved in sensory perception,-0.07352020164414474,-2.1868904722410347,1
8701,Phenotype,HP:0033072,Abnormal macroscopic urine appearance,-0.07352072627344075,-2.1869006989236977,1
8702,Phenotype,HP:0007843,Attenuation of retinal blood vessels,-0.0735617586660382,-2.1877005499064546,1
8703,Biological Process,GO:0043647,inositol phosphate metabolic process,-0.07391993760888305,-2.194682589249078,1
8704,Phenotype,HP:0004599,Absent or minimally ossified vertebral bodies,-0.07397594752265668,-2.1957743994443915,1
8705,Phenotype,HP:0031504,Foamy urine,-0.07410059048337314,-2.198204084586101,1
8706,Disease,MONDO:0019222,inborn disorder of methionine cycle and sulfur amino acid metabolism,-0.07412384726986043,-2.198657432839763,1
8707,Phenotype,HP:0000523,Subcapsular cataract,-0.0743444489552294,-2.202957656728029,1
8708,Phenotype,HP:0001976,Reduced antithrombin III activity,-0.0750767288662153,-2.2172321059955036,1
8709,Phenotype,HP:0012408,Medullary nephrocalcinosis,-0.07507731109228599,-2.217243455421295,1
8710,Phenotype,HP:0033393,Irregularly shaped sperm tail,-0.07517354464439419,-2.219119351423341,1
8711,Phenotype,HP:0033036,Decreased nasal nitric oxide,-0.07554403599717352,-2.2263413985394043,1
8712,Phenotype,HP:0031630,Abnormal subpleural morphology,-0.07559168368841673,-2.227270202595285,1
8713,Phenotype,HP:0001083,Ectopia lentis,-0.07561295343415675,-2.2276848171462826,1
8714,Phenotype,HP:0009123,Mixed hypo- and hyperpigmentation of the skin,-0.07571728658545318,-2.229718599929005,1
8715,Phenotype,HP:0000970,Anhidrosis,-0.0757903395671875,-2.2311426333702618,1
8716,Phenotype,HP:0002654,Multiple epiphyseal dysplasia,-0.07597330615623155,-2.23470923031464,1
8717,Disease,MONDO:0020135,pontocerebellar hypoplasia,-0.0762047144778395,-2.2392201096891906,1
8718,Phenotype,HP:0000842,Hyperinsulinemia,-0.07653372360069421,-2.2456335370716283,1
8719,Biological Process,GO:0050684,regulation of mRNA processing,-0.07660252760664998,-2.2469747445493704,1
8720,Phenotype,HP:0001141,Severely reduced visual acuity,-0.07663818919961263,-2.247669901677001,1
8721,Disease,MONDO:0015152,autosomal recessive limb-girdle muscular dystrophy,-0.07677002181967785,-2.250239735996757,1
8722,Phenotype,HP:0009912,Abnormal tragus morphology,-0.07730539663812364,-2.2606758828448914,1
8723,Phenotype,HP:0100569,Abnormally ossified vertebrae,-0.07741417445696053,-2.2627963062419,1
8724,Disease,MONDO:0017740,disorder of protein N-glycosylation,-0.07746708727868912,-2.2638277443272994,1
8725,Phenotype,HP:0034251,Abnormal corneal reflex,-0.07805327762967362,-2.275254446467668,1
8726,Biological Process,GO:0006063,uronic acid metabolic process,-0.07865055736446558,-2.286897315737835,1
8726,Biological Process,GO:0019585,glucuronate metabolic process,-0.07865055736446558,-2.286897315737835,1
8728,Disease,MONDO:0001519,entropion,-0.07867484635006461,-2.2873707848136493,1
8728,Disease,MONDO:0020159,congenital entropion,-0.07867484635006461,-2.2873707848136493,1
8730,Phenotype,HP:0040214,Abnormal circulating insulin concentration,-0.07882330259897086,-2.2902646661855943,1
8731,Biological Process,GO:0006312,mitotic recombination,-0.07911055741776418,-2.2958641702498017,1
8732,Disease,MONDO:0018998,Leber congenital amaurosis,-0.07978187505003764,-2.3089502720812,1
8733,Biological Process,GO:0001578,microtubule bundle formation,-0.07998947387657962,-2.3129970291654836,1
8734,Biological Process,GO:0000338,protein deneddylation,-0.0800017093846157,-2.3132355378779343,1
8735,Disease,MONDO:0015929,thoracic malformation,-0.08019133968448999,-2.3169320316018807,1
8735,Disease,MONDO:0020001,respiratory or thoracic malformation,-0.08019133968448999,-2.3169320316018807,1
8737,Disease,MONDO:0000833,bone remodeling disease,-0.08062559831428273,-2.3253971044339266,1
8738,Phenotype,HP:0002749,Osteomalacia,-0.08062611708222911,-2.325407216860365,1
8739,Phenotype,HP:0012430,Cerebral white matter hypoplasia,-0.08113277326375012,-2.3352835467318713,1
8739,Phenotype,HP:0012429,Aplasia/Hypoplasia of the cerebral white matter,-0.08113277326375012,-2.3352835467318713,1
8741,Phenotype,HP:0007994,Peripheral visual field loss,-0.08136591973218432,-2.3398283080801296,1
8742,Phenotype,HP:0003387,Decreased number of large peripheral myelinated nerve fibers,-0.08212203202545476,-2.3545673257820785,1
8743,Phenotype,HP:0034241,Prenatal death,-0.08278143025600548,-2.367421080811882,1
8744,Phenotype,HP:0012512,Diffuse optic disc pallor,-0.08342259248400707,-2.379919358531269,1
8745,Biological Process,GO:0009583,detection of light stimulus,-0.08355695228217241,-2.382538455537381,1
8746,Disease,MONDO:0020249,hereditary optic neuropathy,-0.0835934518341126,-2.3832499471332027,1
8747,Disease,MONDO:0018770,Jeune syndrome,-0.08370751863900328,-2.3854734695801354,1
8748,Phenotype,HP:0000117,Renal phosphate wasting,-0.0837713761335066,-2.386718253920059,1
8749,Phenotype,HP:0002980,Femoral bowing,-0.08398799941852153,-2.3909409262147774,1
8750,Phenotype,HP:0012810,Wide nasal base,-0.08411139255180977,-2.3933462482708014,1
8751,Phenotype,HP:0003292,Decreased serum leptin,-0.08449890541651861,-2.400900098437649,1
8752,Biological Process,GO:1901978,positive regulation of cell cycle checkpoint,-0.08487935442194083,-2.4083162516671557,1
8753,Disease,MONDO:0019691,short rib dysplasia,-0.0850293021558639,-2.4112392067947597,1
8754,Disease,MONDO:0016175,cutis laxa,-0.08529468346231406,-2.416412326989138,1
8754,Disease,MONDO:0100237,inherited cutis laxa,-0.08529468346231406,-2.416412326989138,1
8756,Phenotype,HP:0007002,Motor axonal neuropathy,-0.08547877422275474,-2.4200008375861084,1
8757,Phenotype,HP:0002006,Tessier cleft,-0.085483633348437,-2.4200955572991516,1
8758,Biological Process,GO:0043010,camera-type eye development,-0.08594399945239029,-2.429069547294997,1
8759,Disease,MONDO:0004689,inborn metal metabolism disorder,-0.08614123963747389,-2.4329143817268095,1
8760,Phenotype,HP:0012510,Extra-axial cerebrospinal fluid accumulation,-0.08641003031097405,-2.438153961257651,1
8761,Phenotype,HP:0012393,Allergy,-0.08684570289110494,-2.44664659644948,1
8762,Biological Process,GO:0034508,centromere complex assembly,-0.08693950578498999,-2.4484751112425482,1
8763,Phenotype,HP:0008000,Decreased corneal reflex,-0.08697725392906142,-2.4492109418442145,1
8764,Biological Process,GO:0051261,protein depolymerization,-0.08752489606959402,-2.459886217561172,1
8765,Phenotype,HP:0001132,Lens subluxation,-0.08824060951526369,-2.4738377340741766,1
8766,Disease,MONDO:0015461,short rib-polydactyly syndrome,-0.08824195332434503,-2.473863929159238,1
8767,Biological Process,GO:2000232,regulation of rRNA processing,-0.08868187896190394,-2.482439469878826,1
8768,Phenotype,HP:0009072,Decreased Achilles reflex,-0.08877250762737754,-2.48420610893047,1
8769,Biological Process,GO:0046785,microtubule polymerization,-0.08881320069893128,-2.4849993454739243,1
8770,Disease,MONDO:0017706,disorder of carbohydrate transmembrane transport and absorption,-0.09015410799587653,-2.5111378655882635,1
8771,Biological Process,GO:0000038,very long-chain fatty acid metabolic process,-0.09029559274112753,-2.513895850325941,1
8772,Biological Process,GO:1900153,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",-0.09143840374447665,-2.536172847748492,1
8773,Phenotype,HP:0001133,Constriction of peripheral visual field,-0.09219273582117404,-2.550877163404439,1
8774,Phenotype,HP:0010502,Fibular bowing,-0.0931645786168569,-2.5698214502472374,1
8775,Phenotype,HP:0003826,Stillbirth,-0.09355139094484555,-2.577361644739906,1
8776,Phenotype,HP:0030786,Photopsia,-0.09379435082623888,-2.5820977005144137,1
8777,Phenotype,HP:0031367,Metaphyseal striations,-0.0938554739451063,-2.583289183233321,1
8778,Phenotype,HP:0007675,Progressive night blindness,-0.09395314053243187,-2.5851930136197496,1
8779,Phenotype,HP:0002156,Homocystinuria,-0.09455461902657314,-2.5969177299765556,1
8780,Biological Process,GO:0042073,intraciliary transport,-0.0947320984528266,-2.600377364780226,1
8781,Biological Process,GO:0032456,endocytic recycling,-0.09721972354914321,-2.6488690381159863,1
8782,Phenotype,HP:0003182,Shallow acetabular fossae,-0.09722816062378481,-2.6490335033595778,1
8783,Phenotype,HP:0000633,Decreased lacrimation,-0.09740214725168395,-2.652425052487044,1
8784,Phenotype,HP:0006956,Lateral ventricle dilatation,-0.0974256524248307,-2.6528832425815323,1
8785,Phenotype,HP:0030047,Abnormal lateral ventricle morphology,-0.10019544959678606,-2.7068753412573523,1
8786,Phenotype,HP:0005054,Metaphyseal spurs,-0.10126382571306913,-2.727701367537292,1
8787,Biological Process,GO:0031109,microtubule polymerization or depolymerization,-0.10202849242340584,-2.742607137857459,1
8788,Phenotype,HP:0007737,Bone spicule pigmentation of the retina,-0.10222694899317397,-2.7464756834702126,1
8789,Phenotype,HP:0007074,Thick corpus callosum,-0.10238459002951528,-2.7495486053706597,1
8790,Phenotype,HP:0004724,Calcium nephrolithiasis,-0.10298616484894918,-2.7612751994117803,1
8791,Biological Process,GO:0007019,microtubule depolymerization,-0.10357694795072936,-2.772791428776981,1
8792,Phenotype,HP:0007688,Undetectable light- and dark-adapted electroretinogram,-0.10914308572801734,-2.8812930415150655,1
8793,Biological Process,GO:0009584,detection of visible light,-0.11390893612450204,-2.974194524514105,1
8794,Biological Process,GO:0060041,retina development in camera-type eye,-0.12004615981573741,-3.093828406188853,1
8795,Disease,MONDO:0019502,autosomal recessive non-syndromic intellectual disability,-0.12181168596767233,-3.128244089465299,1
8796,Phenotype,HP:0000968,Ectodermal dysplasia,-0.1317139615668248,-3.321270729349969,1
8797,Biological Process,GO:0034498,early endosome to Golgi transport,-0.13271178871020695,-3.3407215332327915,1
8798,Phenotype,HP:0031951,Nocturnal seizures,-0.13684927614406206,-3.4213742366366895,1
